CellID,Hoechst_1,CD4,FOXP3,PD-L1,Vimentin,Hoechst_2,IBA1,SOX2,PD-1,Hoechst_3,CD163,PAN-CK,gH2AX,Hoechst_4,TIM3,CD11c,CD8a,Hoechst_5,E-cadherin,CD66b,CD20,Hoechst_6,Ki67,p-S6,CD31,Hoechst_7,CD45RO,HLA-DBP1,NKG2A,CD45,Area,MajorAxisLength,MinorAxisLength,Eccentricity,Solidity,Extent,Orientation,X_centroid,Y_centroid,Sample,Condition,Replicate,phenotype,Delete,tim3,pd_l1,pd_1,p_s6,ki67,imageid,gh2ax,FinalPhenotype,GlobalCellType,Group,Batch,Tumor type,Same patient,Year,Tumor site,Tumor stage,Age at tumor,FA gene,Smoking,Gender,BMT,VPH status,Patient status,RCN,unique_cellid,Desmoplastic grade,Desmoplastic category,TDA,TDA_general
8,2245.13453815261,521.688085676038,340.362784471218,624.656626506024,995.852074966533,631.129852744311,344.340696117804,260.531459170013,1086.91298527443,3411.20414993307,628.542838018742,127.469879518072,1070.31124497992,707.03547523427,500.073627844712,275.592369477912,1493.84270414993,1040.29518072289,292.4906291834,227.408969210174,989.517402945114,925.442436412316,210.376171352075,146.581659973226,584.413654618474,1104.25903614458,529.425033467202,258.916331994645,1028.87416331995,131.898929049531,1494,50.067574693159,38.228378586194,0.645765668808471,0.976470588235294,0.747,1.25354666294505,52662.7248995984,33343.2148594378,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_8,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
96,2266.57630979499,303.883826879271,107.148063781321,628.314350797267,1324.71298405467,818.813211845103,321.025056947608,262.102505694761,1084.39179954442,3756.93166287016,720.986332574032,126.271070615034,1078.60364464692,705.132118451025,634.881548974943,278.854214123007,1588.72665148064,1024.91343963554,296.457858769932,229.886104783599,984.366742596811,880.496583143508,210.674259681093,130.227790432802,587.874715261959,1502.56264236902,534.405466970387,235.191343963554,1056.0979498861,131.225512528474,439,26.7636749023414,20.9777738294418,0.620994212783688,0.954347826086957,0.762152777777778,-0.853818911528187,52319.84738041,32818.9840546697,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_96,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
472,1524.82471264368,417.386494252874,171.748563218391,675.432471264368,4110.75,290.586206896552,296.300287356322,258.103448275862,1083.66666666667,2067.62643678161,2570.15948275862,130.83908045977,1077.23563218391,738.548850574713,515.406609195402,267.574712643678,1423.44683908046,1088.88218390805,298.916666666667,226.997126436782,976.07183908046,984.153735632184,217.829022988506,115.235632183908,582.369252873563,1008.9683908046,493.015804597701,275.852011494253,1034.86350574713,129.942528735632,696,32.9162226592915,26.9884762075481,0.572486517137205,0.966666666666667,0.774193548387097,-0.627401262101308,53488.5201149425,32386.7514367816,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_472,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
975,1660.85553278689,257.933401639344,121.352459016393,726.63012295082,6776.57581967213,277.194672131148,266.847336065574,233.001024590164,1060.32889344262,1436.09323770492,599.570696721311,111.712090163934,1074.71004098361,731.055327868852,443.793032786885,288.826844262295,1546.30737704918,1071.69979508197,253.858606557377,218.786885245902,1066.80635245902,1014.59016393443,192.686475409836,197.326844262295,583.483606557377,587.861680327869,357.661885245902,234.748975409836,993.787909836066,130.084016393443,976,38.4040887747292,32.4055504546029,0.536650384300089,0.978936810431294,0.802631578947368,0.0166544200796079,52365.1086065574,33410.2694672131,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_975,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
1046,3069.16818181818,417.463636363636,131.243181818182,644.677272727273,1836.76590909091,2842.54090909091,783.884090909091,257.020454545455,1128.13181818182,4976.39318181818,2221.4,126.143181818182,1087.31136363636,6428.65681818182,999.234090909091,361.684090909091,7575.06590909091,8415.52045454545,537.018181818182,256.863636363636,1110.23863636364,7786.86818181818,401.288636363636,313.206818181818,615.520454545455,1295.02954545455,497.122727272727,356.836363636364,1045.55909090909,130.381818181818,440,29.7024304339522,19.0989660020978,0.765857604963523,0.958605664488017,0.733333333333333,-1.48185779806697,53320.9068181818,33456.3181818182,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_1046,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
1058,1828.71262135922,849.021359223301,654.366990291262,610.747572815534,523.566990291262,343.244660194175,791.2,252.809708737864,1083.92815533981,2378.28737864078,574.279611650485,113.998058252427,1068.67766990291,1578.51844660194,863.518446601942,777.833009708738,1607.39223300971,3436.95339805825,389.955339805825,242.18640776699,1015.89902912621,3246.03300970874,277.13786407767,677.834951456311,675.170873786408,940.157281553398,500.429126213592,240.55145631068,1020.00194174757,129.722330097087,515,28.6785385243613,23.0117429168929,0.596782675358025,0.966228893058161,0.799689440993789,-0.156369946440698,53701.5825242718,33141.467961165,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_1058,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
1114,1408.77941176471,543.099547511312,979.7092760181,607.695701357466,367.786199095023,246.856334841629,303.554298642534,246.147058823529,1074.78393665158,2140.69230769231,571.628959276018,118.989819004525,1068.49095022624,644.622171945701,426.954751131222,269.256787330317,1434.30769230769,1096.87104072398,286.64592760181,227.804298642534,980.993212669683,1047.6628959276,221.851809954751,130.441176470588,584.631221719457,925.912895927602,502.044117647059,224.495475113122,1015.48642533937,129.842760180995,884,35.2017316652635,32.002478944586,0.416541702710655,0.969298245614035,0.789285714285714,-0.10711268401374,52428.0407239819,33181.9909502262,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_1114,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
1498,2818.35604770017,272.700170357751,107.175468483816,618.591141396934,906.310051107325,462.177172061329,605.620102214651,251.165247018739,1086.60647359455,3286.06984667802,584.574105621806,119.533219761499,1072.28279386712,1945.77512776831,576.880749574106,368.151618398637,3266.23850085179,2631.37819420784,279.282793867121,221.262350936968,1001.24872231687,2684.45996592845,206.541737649063,150.281090289608,665.664395229983,847.964224872232,469.50936967632,227.850085178876,1005.56218057922,128.923339011925,587,28.0074048429221,26.7430006190497,0.297073402063302,0.967051070840198,0.776455026455027,-0.0924297542763312,54038.0391822828,32794.8875638842,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_1498,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
1530,2538.00985915493,507.584507042254,123.460563380282,643.140845070423,2154.80845070423,1027.35915492958,851.47323943662,247.711267605634,1085.62394366197,4593.60985915493,1050.86338028169,127.692957746479,1078.91971830986,859.492957746479,527.12676056338,307.971830985916,1645.68450704225,1135.47323943662,279.401408450704,220.861971830986,995.135211267606,991.759154929577,199.118309859155,200.90985915493,584.685915492958,1763.22957746479,583.695774647887,414.311267605634,1081.19014084507,131.352112676056,710,31.296279502697,28.9714903569443,0.378217512058969,0.971272229822161,0.789766407119021,-1.35241257470569,53690.6056338028,33023.7535211268,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_1530,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
1736,1684.84489187174,329.287099179717,126.374347501864,646.605518269948,2265.54884414616,286.86428038777,330.592841163311,262.088739746458,1080.17971662938,2318.25354213274,1864.2475764355,123.65249813572,1068.25055928412,665.874720357942,534.185682326622,279.473527218494,1424.00149142431,1031.90604026846,292.568978374348,230.111111111111,990.561521252796,952.219985085757,223.555555555556,138.970171513796,590.434750186428,860.508575689784,471.201342281879,309.157345264728,1025.451901566,129.668903803132,1341,48.9447753609265,35.1928002446254,0.694978222941574,0.975272727272727,0.739658025372311,-0.227457201579542,52383.7882177479,32851.7151379568,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_1736,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
1947,2415.03016591252,155.429864253394,93.8084464555053,642.438914027149,2000.82805429864,272.809954751131,288.876319758673,255.349924585219,1080.48416289593,4791.57918552036,627.407239819005,127.764705882353,1081.35595776772,570.168929110106,418.754147812971,266.419306184012,1356.56862745098,864.31221719457,256.242835595777,220.224736048265,973.11161387632,804.318250377074,185.218702865762,120.066365007541,586.574660633484,1586.30467571644,506.598793363499,241.173453996983,1043.74358974359,130.941176470588,663,34.6922083469723,24.5004565056016,0.707988853896247,0.963662790697674,0.8125,0.0556242875201442,53366.467571644,32675.1463046757,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_1947,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
2540,1467.29229406554,253.286093888397,95.6324180690877,607.62976085031,362.597874224978,214.574844995571,229.387068201949,242.11426040744,1078.3684676705,1852.071744907,618.571302037201,120.924712134632,1066.00974313552,521.308237378211,413.178919397697,255.659875996457,1398.67139061116,890.612931798051,237.116917626218,215.033658104517,984.683790965456,809.995571302037,176.490699734278,121.333038086802,594.8928255093,852.774136403897,494.825509300266,225.708591674048,1016.55713020372,129.314437555359,1129,40.2624301335927,35.7318241127512,0.460859499070644,0.973275862068966,0.782397782397782,-0.507356208739976,53466.765279008,32524.6713906112,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_2540,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
3241,2272.92291220557,752.184154175589,970.428265524625,646.58244111349,2562.84154175589,293.192719486081,308.261241970021,257.573875802998,1077.41113490364,3608.62312633833,559.736616702355,124.974304068522,1073.36402569593,712.952890792291,555.52034261242,276.901498929336,1400.4539614561,1115.11563169165,322.884368308351,233.428265524625,979.079229122056,1006.93576017131,231.704496788009,132.837259100642,586.82226980728,1705.62740899358,565.605995717345,246.269807280514,1040.80942184154,129.764453961456,467,27.6750650251063,21.5081349904387,0.629294957261966,0.976987447698745,0.778333333333333,-0.685258972315217,53028.1391862955,33127.7837259101,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_3241,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
3282,2374.75650118203,651.022458628842,131.124113475177,637.143026004728,1731.43498817967,947.501182033097,433.239952718676,255.872340425532,1094.84397163121,3417.75059101655,608.602836879433,123.68085106383,1074.77304964539,1178.63829787234,1031.68321513002,340.078014184397,1750.50591016548,2146.02245862884,339.283687943262,229.862884160756,1015.02364066194,1786.56146572104,216.232860520095,464.669030732861,664.463356973995,1257.71867612293,571.072104018913,240.222222222222,1025.72576832151,130.230496453901,846,35.9276193977527,30.0441100148458,0.548363725582969,0.972413793103448,0.783333333333333,-1.48051921094476,53655.6170212766,33003.9113475177,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_3282,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
4369,4820.45645645646,471.426426426426,148.54954954955,640.780780780781,1660.67867867868,844.045045045045,544.099099099099,262.48048048048,1087.81381381381,7015.85585585586,825.960960960961,127.222222222222,1081.5015015015,1722.72972972973,551.81981981982,294.456456456456,1762.20720720721,2581.42342342342,329.036036036036,222.804804804805,1049.84984984985,1356.53453453453,184.324324324324,141.990990990991,940.108108108108,1230.41741741742,473.042042042042,239.324324324324,1043.60660660661,130.897897897898,333,21.9653311700335,19.3453127053561,0.473636761052929,0.968023255813954,0.796650717703349,-0.076667140380034,53818.1081081081,32294.1951951952,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_4369,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
4842,2963.81761006289,308.996855345912,71.7452830188679,617.619496855346,895.056603773585,1981.92452830189,2592.12578616352,253.827044025157,1146.47798742138,4877.37421383648,532.64465408805,113.830188679245,1083.40251572327,2134.70125786163,738.289308176101,1383.55974842767,1733.93396226415,1896.64465408805,315.767295597484,232.660377358491,1011.76100628931,1350.69811320755,233.283018867925,236.682389937107,614.619496855346,1497.8679245283,496.581761006289,327.874213836478,1042.79874213836,129.270440251572,318,23.8661775641419,17.0439128041312,0.699997738239156,0.949253731343284,0.736111111111111,1.44158473386104,53410.5534591195,33647.3647798742,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_4842,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
5253,2984.98611111111,450.460648148148,154.585648148148,675.175925925926,2441.5625,949.530092592593,982.62037037037,245.259259259259,1116.74537037037,4625.92824074074,538.164351851852,118.56712962963,1089.97453703704,1596.28703703704,539.671296296296,489.275462962963,1602.2037037037,2210.24537037037,297.224537037037,235.185185185185,1015.27314814815,2049.99074074074,224.724537037037,231.490740740741,590.106481481482,1448.2337962963,499.5625,778.75462962963,1050.34490740741,130.395833333333,432,26.4254943390441,20.8769051675794,0.613069556235793,0.964285714285714,0.791208791208791,-0.299934836901002,53416.1898148148,33623.5277777778,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_5253,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
5294,1840.31693989071,135.626593806922,103.0,665.978142076503,2954.22222222222,335.085610200364,307.622950819672,247.621129326047,1072.77413479053,3049.98178506375,440.938069216758,127.061930783242,1062.30054644809,849.750455373406,500.624772313297,369.748633879781,1579.78506375228,1813.16757741348,358.204007285975,743.908925318761,996.036429872495,1990.67941712204,260.868852459016,370.224043715847,604.462659380692,995.262295081967,426.526411657559,212.754098360656,1039.27686703097,130.100182149362,549,29.4827911397499,23.7156353103773,0.594102856563269,0.971681415929204,0.788793103448276,-0.202034463724029,52509.752276867,33485.7613843352,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_5294,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
5635,3550.42788461538,701.194711538462,145.932692307692,659.668269230769,2347.04567307692,269.036057692308,283.1875,252.53125,1077.51201923077,5740.12019230769,1922.88221153846,130.033653846154,1077.47115384615,814.771634615385,745.927884615385,275.90625,1668.11057692308,1254.69230769231,288.966346153846,224.302884615385,994.995192307692,1042.69711538462,203.512019230769,145.377403846154,591.086538461538,1808.17067307692,498.461538461538,426.314903846154,1096.75480769231,131.649038461538,416,25.8848217277748,20.570228198661,0.6070246322163,0.951945080091533,0.727272727272727,-1.45068516856437,52543.1153846154,32303.4711538462,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_5635,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
6116,1677.24350649351,245.034632034632,100.831168831169,650.613636363636,2265.920995671,260.636363636364,308.984848484848,257.494588744589,1086.37662337662,2605.99458874459,692.918831168831,130.166666666667,1077.87445887446,621.478354978355,526.969696969697,273.599567099567,1416.65476190476,936.271645021645,278.892857142857,229.255411255411,987.557359307359,890.660173160173,217.391774891775,160.904761904762,586.439393939394,719.843073593074,401.900432900433,207.484848484848,1007.46103896104,128.781385281385,924,37.9138504598769,31.0609568783471,0.573435200975904,0.971608832807571,0.777777777777778,1.03095924739402,52308.1720779221,32968.2305194805,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_6116,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
7098,1844.01652892562,508.536157024793,145.377066115702,658.214876033058,600.672520661157,573.329545454545,441.14152892562,251.392561983471,1082.03512396694,3476.5826446281,836.446280991736,138.270661157025,1073.08161157025,1993.60743801653,610.296487603306,296.01652892562,1702.02169421488,3283.83780991736,324.385330578512,227.040289256198,1018.60330578512,2948.7923553719,212.385330578512,527.861570247934,2912.91115702479,1009.98760330579,432.113636363636,221.322314049587,1063.25103305785,130.198347107438,968,40.616359725897,30.4515645226117,0.661736568576104,0.97286432160804,0.761605035405193,1.44885449932514,52790.25,32450.4101239669,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_7098,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
7128,2708.5472027972,508.592657342657,137.632867132867,667.391608391608,2959.71853146853,424.870629370629,769.363636363636,251.062937062937,1076.77272727273,3952.04195804196,1165.83216783217,131.66958041958,1072.76748251748,722.781468531468,821.353146853147,1089.33216783217,1663.3986013986,1017.98426573427,257.382867132867,219.952797202797,1010.16958041958,894.472027972028,190.166083916084,239.036713286713,767.881118881119,996.916083916084,457.223776223776,416.517482517483,1054.0472027972,131.916083916084,572,28.6864072317224,25.4549846564897,0.461089705730891,0.969491525423729,0.756613756613757,0.693019211183443,52665.3339160839,32470.7797202797,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_7128,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
7742,4272.68387096774,834.125806451613,164.709677419355,644.558064516129,3018.51612903226,2041.0935483871,1938.84838709677,256.906451612903,1090.23548387097,6320.56129032258,593.929032258064,127.11935483871,1076.77419354839,1163.21612903226,589.412903225806,323.2,1460.45483870968,1067.42258064516,275.735483870968,222.248387096774,998.103225806452,949.648387096774,207.290322580645,147.406451612903,598.941935483871,1879.0935483871,559.612903225806,240.164516129032,1033.51290322581,129.967741935484,310,23.6632800348428,16.7490400753376,0.706405664034964,0.962732919254658,0.759803921568627,-1.56386515496069,53908.4064516129,33213.3612903226,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_7742,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
8077,3664.51662404092,491.516624040921,119.703324808184,664.670076726343,2711.35549872123,547.314578005115,385.271099744246,272.713554987212,1106.66496163683,5369.91815856778,1553.91304347826,127.915601023018,1070.78772378517,715.879795396419,479.79283887468,315.406649616368,1394.37595907928,965.43989769821,285.409207161125,222.442455242967,984.657289002558,912.49104859335,202.710997442455,117.342710997442,613.659846547315,1218.1074168798,488.271099744246,270.09462915601,1042.20204603581,130.386189258312,391,24.8969610256245,20.1379292470577,0.588013798429129,0.944444444444444,0.716117216117216,1.44511377148659,53560.0358056266,32704.1176470588,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_8077,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
8212,2356.99522292994,241.925159235669,96.5143312101911,804.165605095541,3417.59872611465,1050.91560509554,404.390127388535,240.985668789809,1095.53662420382,4312.67675159236,638.525477707006,138.417197452229,1082.76433121019,828.148089171975,622.34872611465,342.546178343949,2377.08280254777,1374.46337579618,292.418789808917,228.527070063694,1031.22770700637,1234.85031847134,208.977707006369,429.855095541401,694.007961783439,1819.08121019108,556.460191082803,292.65923566879,1090.99681528662,130.5,628,34.3254961162518,23.448213066745,0.730312135832701,0.970633693972179,0.747619047619048,-0.672875750434494,53002.7929936306,33713.1863057325,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_8212,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
9563,3260.25171624714,569.231121281465,142.299771167048,667.16704805492,2520.71853546911,276.240274599542,303.139588100687,253.112128146453,1080.67734553776,6296.65217391304,1523.28375286041,132.66819221968,1076.53546910755,614.778032036613,452.855835240275,270.462242562929,1426.73455377574,976.524027459954,295.604118993135,230.37299771167,988.66590389016,918.75057208238,228.061784897025,129.393592677346,582.645308924485,2495.75743707094,561.91533180778,524.121281464531,1110.52402745995,131.766590389016,437,24.9052634835604,22.4364705432527,0.434083495182542,0.968957871396896,0.791666666666667,-0.426576596777826,52429.8306636156,33229.9130434783,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_9563,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
10087,2127.58620689655,744.592592592593,94.183908045977,659.051085568327,3173.96551724138,712.243933588761,291.212005108557,243.240102171137,1085.68582375479,3252.43295019157,683.841634738186,119.077905491699,1082.79054916986,1097.04980842912,525.528735632184,286.464878671775,1576.04469987229,1165.84546615581,268.689655172414,223.526181353768,992.83908045977,1098.81098339719,208.577266922095,130.564495530013,587.733077905492,748.616858237548,443.011494252874,235.213282247765,1000.23243933589,129.034482758621,783,33.0409527523797,30.2329039558816,0.403424172275017,0.973880597014925,0.81477627471384,-0.601679870811036,53635.6947637292,33221.7266922094,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_10087,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
10238,3410.91787439614,315.574879227053,164.93961352657,655.130434782609,2844.80434782609,592.231884057971,297.359903381643,239.070048309179,1100.36714975845,5440.43719806763,787.934782608696,128.183574879227,1126.6884057971,4091.24396135266,1027.03140096618,329.81884057971,2994.05314009662,4121.52898550725,435.224637681159,251.751207729469,1026.57729468599,3500.27777777778,282.432367149758,211.429951690821,586.787439613527,1522.13768115942,498.628019323671,247.789855072464,1201.40096618357,130.86231884058,414,24.0896940763822,21.9452944555724,0.41244457516671,0.962790697674419,0.784090909090909,-0.325414750577765,52654.4130434783,33492.5483091787,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_10238,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
10259,3109.39105058366,331.900778210117,244.801556420233,773.324902723735,6792.25875486381,322.828793774319,506.11673151751,261.741245136187,1088.06031128405,5348.21789883269,722.873540856031,147.188715953307,1079.05836575875,706.972762645914,476.470817120623,277.356031128405,1539.27237354086,957.357976653696,267.700389105058,224.558365758755,988.95719844358,861.402723735409,204.068093385214,143.902723735409,609.252918287938,1420.19844357977,451.848249027237,228.140077821012,1076.15564202335,130.737354085603,514,30.5637724627471,21.4321646682396,0.712937357699888,0.97164461247637,0.815873015873016,1.47844941571461,52582.3190661479,32334.8073929961,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_10259,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
10468,4204.57894736842,1076.42659279778,1942.72576177285,638.925207756233,1517.00554016621,2287.24930747922,460.886426592798,254.393351800554,1108.25207756233,6271.67867036011,640.204986149584,125.12188365651,1082.4432132964,3558.03601108033,603.656509695291,314.113573407202,1706.14958448753,4663.21052631579,387.426592797784,241.135734072022,1021.34903047091,5039.91135734072,247.739612188366,188.116343490305,580.487534626039,1225.03047091413,475.700831024931,265.961218836565,1032.21606648199,129.853185595568,361,23.5639910179754,19.61713624314,0.554017792698313,0.955026455026455,0.752083333333333,1.49710312183345,52988.3822714682,33465.8670360111,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_10468,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
10772,1807.08045977011,402.577996715928,512.00328407225,609.555008210181,453.655172413793,260.499178981938,266.03776683087,239.679802955665,1077.74876847291,2377.0065681445,732.065681444992,115.59934318555,1068.95894909688,594.121510673235,475.216748768473,271.712643678161,1411.65845648604,1008.77996715928,263.68144499179,222.282430213465,990.597701149425,957.806239737274,205.045977011494,146.688013136289,591.564860426929,881.045977011494,501.945812807882,251.973727422003,1009.37438423645,128.032840722496,609,30.8163851037011,25.2321912349513,0.574091139298397,0.966666666666667,0.785806451612903,0.0770293740298589,53810.8407224959,33174.8456486043,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_10772,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
11186,2053.08919382504,245.180102915952,92.9399656946827,632.528301886792,1566.13036020583,291.711835334477,271.253859348199,254.665523156089,1076.83876500858,4040.58833619211,549.408233276158,127.102915951973,1070.61234991424,615.337907375643,419.499142367067,266.78730703259,1456.84562607204,979.6243567753,242.710120068611,213.03602058319,982.600343053173,851.720411663808,173.219554030875,116.2487135506,588.320754716981,1938.74957118353,477.48885077187,218.758147512864,1030.39622641509,129.447684391081,583,29.563343500913,25.1273938880324,0.526861716130312,0.96523178807947,0.773209549071618,-0.214347724583491,53367.0394511149,32202.2744425386,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_11186,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
12430,2792.35223367698,369.063573883161,133.36941580756,656.835051546392,1850.68384879725,662.821305841924,707.116838487972,260.295532646048,1090.7147766323,4154.9793814433,798.003436426117,128.477663230241,1101.29896907216,1094.78006872852,596.651202749141,765.878006872852,1649.54639175258,1192.35567010309,309.503436426117,629.577319587629,998.09793814433,864.683848797251,205.768041237113,183.707903780069,601.231958762887,1426.66323024055,456.231958762887,219.384879725086,1060.81271477663,132.697594501718,582,32.8652427245238,22.6201700119211,0.725454349567709,0.97979797979798,0.816269284712483,-0.351159970668909,53340.3642611684,32010.4656357388,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_12430,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
13375,2900.69467213115,559.758196721311,157.706967213115,659.604508196721,2663.92213114754,1238.6618852459,2020.78893442623,673.952868852459,1120.25,4645.73565573771,2195.01229508197,127.440573770492,1093.89549180328,619.176229508197,447.245901639344,278.553278688525,1363.60245901639,904.129098360656,265.190573770492,221.969262295082,979.83606557377,869.454918032787,205.348360655738,127.098360655738,590.06762295082,956.829918032787,426.598360655738,318.774590163934,1042.40573770492,129.342213114754,488,28.3460205935182,21.9464781425084,0.632898360528692,0.970178926441352,0.785829307568438,-0.454359917691126,52784.8032786885,32753.612704918,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_13375,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
13545,2581.86871165644,963.941104294479,297.984049079755,667.699386503067,3537.74110429448,351.731288343558,473.026993865031,260.01226993865,1087.61226993865,4303.0736196319,599.884662576687,132.122699386503,1081.31411042945,721.628220858896,532.265030674847,283.593865030675,1604.48220858896,993.98282208589,255.531288343558,221.946012269939,1005.33374233129,884.79509202454,190.226993865031,179.981595092025,586.168098159509,1530.23680981595,530.644171779141,230.959509202454,1052.90674846626,131.115337423313,815,38.6622352503083,27.1022963478733,0.713159506704909,0.967933491686461,0.746336996336996,-0.0542696212870979,52644.9325153374,33385.8466257669,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_13545,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
13633,2838.41256830601,423.133879781421,151.027322404372,659.814207650273,2014.54918032787,2194.30054644809,486.513661202186,244.48087431694,1077.19398907104,4315.95081967213,720.685792349727,120.907103825137,1093.78415300546,772.169398907104,570.338797814208,483.420765027322,1612.70765027322,1309.8087431694,347.469945355191,238.931693989071,1008.74043715847,1254.24316939891,264.92349726776,349.051912568306,601.986338797814,1300.53825136612,493.549180327869,461.527322404372,1048.94808743169,129.385245901639,366,25.3835869425973,18.3771542351368,0.689823237667429,0.968253968253968,0.813333333333333,-1.50315945155254,53430.9863387978,33588.2131147541,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_13633,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
13782,3065.01492537313,977.860074626866,417.852611940299,619.393656716418,1106.13805970149,649.865671641791,1027.75,253.285447761194,1088.81156716418,4230.5578358209,556.078358208955,120.453358208955,1075.07462686567,789.847014925373,796.888059701493,412.667910447761,1507.06529850746,1105.00373134328,283.805970149254,221.759328358209,974.899253731343,971.408582089552,206.535447761194,142.994402985075,606.016791044776,1178.85447761194,514.449626865672,230.28171641791,1018.46455223881,129.682835820896,536,26.9903962870268,25.3316048791225,0.345166628524247,0.96229802513465,0.792899408284024,0.340791756143845,53739.2947761194,33108.2854477612,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_13782,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
13953,2966.71544715447,824.630081300813,1376.56504065041,604.081300813008,422.382113821138,294.89837398374,282.94512195122,249.170731707317,1078.66463414634,3985.98170731707,952.656504065041,117.560975609756,1068.21951219512,605.55081300813,413.565040650407,261.821138211382,1402.98577235772,948.485772357724,229.073170731707,210.290650406504,991.961382113821,968.658536585366,188.80081300813,122.491869918699,586.174796747967,1225.07926829268,510.447154471545,259.617886178862,1012.17682926829,130.067073170732,492,26.0138465065421,24.1296908755812,0.373646825586121,0.970414201183432,0.788461538461538,-1.39488472405205,54074.8516260163,33013.1016260163,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_13953,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
14065,2996.00459770115,725.36091954023,114.041379310345,619.636781609195,613.367816091954,3346.0367816092,927.754022988506,253.675862068966,1123.08045977011,3369.51264367816,2405.48965517241,128.144827586207,15393.108045977,2983.13563218391,724.080459770115,571.648275862069,2413.45517241379,2286.29195402299,275.788505747126,225.055172413793,1031.46896551724,1515.64367816092,201.740229885057,217.747126436782,624.864367816092,930.937931034483,498.590804597701,378.641379310345,1034.26436781609,130.289655172414,435,24.6299874331987,22.5246707258716,0.404535676535509,0.953947368421053,0.756521739130435,0.293552708478999,53393.9816091954,33483.3218390805,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX+,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_14065,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
14967,2859.35933147632,515.568245125348,1037.94428969359,628.292479108635,986.83286908078,1030.62674094708,615.866295264624,245.8356545961,1087.57381615599,5342.28133704735,650.646239554318,130.484679665738,1065.4791086351,4511.92479108635,711.384401114206,360.189415041783,5420.52924791086,5610.08356545961,418.339832869081,241.192200557103,1056.03899721448,4763.28133704735,288.685236768802,469.590529247911,654.523676880223,2835.93036211699,537.005571030641,343.813370473538,1055.56267409471,128.33704735376,359,23.5289271646331,19.5824873666275,0.554366211297806,0.93979057591623,0.743271221532091,1.09989630508025,53594.1504178273,33826.1587743733,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_14967,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
16435,3686.5150812065,1416.19489559165,213.034802784223,692.593967517401,4184.59628770302,233.921113689095,293.900232018561,246.721577726218,1072.88399071926,4200.20649651972,590.187935034803,136.009280742459,1079.74245939675,661.243619489559,454.187935034803,404.547563805104,1601.89559164733,998.867749419954,255.060324825986,218.285382830626,995.867749419954,870.278422273782,181.141531322506,163.373549883991,641.162412993039,805.125290023202,411.350348027842,212.649651972158,1024.17401392111,129.84686774942,431,26.0777258017371,21.0637051170244,0.589555542368487,0.968539325842697,0.789377289377289,0.0868702440915877,53141.9419953596,32206.373549884,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_16435,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
16775,4926.63595505618,715.132584269663,221.143820224719,701.995505617978,4363.46292134831,477.307865168539,746.905617977528,255.903370786517,1089.01123595506,8496.50337078652,613.894382022472,140.14606741573,1078.56404494382,840.41797752809,645.620224719101,441.573033707865,1513.21123595506,1300.14606741573,287.539325842697,224.806741573034,1006.10561797753,1222.17752808989,204.669662921348,413.442696629214,764.01797752809,1734.20224719101,495.957303370787,258.294382022472,1055.68539325843,132.222471910112,445,30.396827735623,19.1766701430602,0.775882574057117,0.948827292110874,0.686728395061728,-0.606972535645562,53084.9033707865,32826.9842696629,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_16775,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
17029,3300.20967741935,434.604838709677,82.9233870967742,648.04435483871,1701.41935483871,2076.07258064516,822.560483870968,256.754032258065,1193.64516129032,5592.65725806452,763.516129032258,133.064516129032,1083.03225806452,4682.16129032258,839.322580645161,1016.08870967742,2660.55241935484,3697.92338709677,395.306451612903,239.274193548387,1033.25806451613,2898.18951612903,261.157258064516,267.427419354839,640.491935483871,1976.57258064516,500.270161290323,277.866935483871,1064.35887096774,130.04435483871,248,19.1037961656542,16.6165974016927,0.493393800907477,0.961240310077519,0.767801857585139,1.46507204389373,53197.685483871,33857.3911290323,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_17029,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
17350,3970.87368421053,183.963157894737,203.755263157895,631.25,1604.14736842105,519.128947368421,732.771052631579,258.168421052632,1078.57368421053,6283.34210526316,593.573684210526,120.052631578947,1145.38684210526,844.221052631579,612.836842105263,428.005263157895,1511.53684210526,1277.24473684211,372.215789473684,241.502631578947,999.244736842105,1236.52105263158,271.263157894737,426.573684210526,609.884210526316,1552.61578947368,484.984210526316,359.792105263158,1037.72894736842,130.665789473684,380,26.7092085819775,18.1892697562365,0.732273014295026,0.962025316455696,0.740740740740741,1.4888578975939,53561.9894736842,33482.7736842105,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_17350,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
17634,3335.337995338,820.981351981352,147.27972027972,649.822843822844,1456.97435897436,248.554778554778,322.841491841492,247.221445221445,1077.93706293706,3206.39160839161,974.193473193473,127.104895104895,1078.2703962704,582.962703962704,544.214452214452,389.344988344988,1458.39393939394,903.347319347319,248.960372960373,218.370629370629,988.620046620047,795.449883449883,183.27972027972,130.862470862471,614.902097902098,723.079254079254,374.174825174825,224.801864801865,1011.63636363636,130.393939393939,429,24.5474029137603,22.2711794749067,0.420543596331581,0.961883408071749,0.744791666666667,-0.838937989529913,53197.8438228438,32069.4848484848,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_17634,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
17706,1987.84843982169,181.575037147103,81.7622585438336,639.524517087667,1374.04011887073,751.674591381872,599.306092124814,245.096582466568,1079.58395245171,2729.17830609212,3805.79346210996,112.520059435364,1069.68647845468,2819.36849925706,656.297176820208,454.958395245171,1798.13521545319,4126.65676077266,368.078751857355,232.154531946508,1025.88558692422,3985.63298662704,235.277860326895,307.208023774146,597.711738484398,872.408618127786,449.838038632987,468.835066864785,1022.22882615156,129.780089153046,673,34.5812267444911,24.8184297293187,0.696367831833688,0.969740634005764,0.769142857142857,-0.12177496389449,53606.2020802378,33661.6404160476,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_17706,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
17742,3832.00775193798,645.71834625323,155.633074935401,657.018087855297,2428.21447028424,274.40826873385,996.423772609819,253.452196382429,1157.53746770026,3815.03875968992,2560.41860465116,129.731266149871,1071.90697674419,599.382428940569,1093.18087855297,807.020671834625,1657.84237726098,923.041343669251,241.46511627907,215.43669250646,1001.21705426357,796.242894056847,171.832041343669,285.669250645995,633.478036175711,776.299741602067,386.390180878553,405.361757105943,1027.84754521964,130.594315245478,387,23.0340612029238,21.4389781095189,0.365653339932448,0.962686567164179,0.731568998109641,-0.376545152521339,53274.6563307494,32082.0697674419,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_17742,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
18250,5325.6064516129,645.703225806452,126.570967741935,638.267741935484,1439.99677419355,318.329032258065,288.029032258064,253.432258064516,1090.31935483871,7574.69032258065,701.616129032258,134.506451612903,10411.5806451613,760.048387096774,623.690322580645,272.629032258065,1520.67419354839,1180.66774193548,290.993548387097,224.958064516129,985.716129032258,1132.79677419355,211.274193548387,161.796774193548,607.403225806452,1538.55483870968,513.341935483871,248.922580645161,1064.01612903226,131.470967741935,310,24.7036728024988,16.0939753405649,0.758664884851165,0.94224924012158,0.729411764705882,1.52021114548262,53540.964516129,32922.0612903226,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX+,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_18250,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
19071,2158.90491803279,841.734426229508,197.022950819672,712.396721311475,5347.74098360656,334.311475409836,307.629508196721,249.67868852459,1081.51475409836,2875.37049180328,554.629508196721,123.780327868852,1073.0393442623,3054.35737704918,566.944262295082,287.029508196721,1946.32459016393,4364.8131147541,281.085245901639,224.481967213115,1024.79344262295,4269.69180327869,202.003278688525,209.747540983607,697.911475409836,1143.2393442623,524.134426229508,231.337704918033,1070.85245901639,130.652459016393,305,21.0979111287442,18.5228885137448,0.478754295257521,0.965189873417722,0.806878306878307,-0.185351022675293,53857.6131147541,33056.8196721311,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_19071,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
19907,3631.4578313253,1023.55421686747,118.718072289157,642.057831325301,1407.06506024096,295.959036144578,298.486746987952,249.549397590361,1078.70602409639,6167.08674698795,517.098795180723,118.55421686747,1077.42891566265,739.327710843373,534.595180722892,275.115662650602,1577.29156626506,1254.47228915663,334.915662650602,238.190361445783,982.992771084337,1177.42168674699,247.609638554217,168.146987951807,583.650602409639,1791.67469879518,494.103614457831,254.380722891566,1043.62409638554,131.368674698795,415,24.7636618380184,21.4341977973164,0.500821802580425,0.971896955503513,0.823412698412698,0.310250352376852,52751.4385542169,33357.3469879518,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_19907,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
21190,5472.82009345794,721.642523364486,204.114485981308,675.661214953271,3145.33177570093,1177.28738317757,1318.71261682243,249.960280373832,1091.99299065421,8272.40654205607,862.565420560748,138.943925233645,1117.65887850467,735.376168224299,711.492990654206,446.383177570093,1804.14018691589,1078.6191588785,281.303738317757,225.778037383178,998.794392523364,976.843457943925,210.67523364486,148.558411214953,596.838785046729,1465.3738317757,474.908878504673,253.39953271028,1071.81542056075,133.560747663551,428,25.1155450931015,21.7085933172626,0.502892643130095,0.963963963963964,0.778181818181818,1.17200254516301,52711.3271028037,33403.2570093458,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_21190,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
22790,4035.65507246377,260.559420289855,158.257971014493,675.628985507246,3585.06376811594,1740.33043478261,667.585507246377,252.205797101449,1125.90434782609,6322.82898550725,763.547826086957,123.866666666667,1088.4,4406.07536231884,920.669565217391,367.260869565217,10016.5420289855,2586.35362318841,348.249275362319,242.420289855072,1016.96231884058,2165.29565217391,238.321739130435,175.08115942029,589.759420289855,1489.00289855072,462.521739130435,266.976811594203,1059.96811594203,130.431884057971,345,23.0764670154013,19.1595234834899,0.557372679880071,0.963687150837989,0.784090909090909,-1.12875310344987,52648.0811594203,33538.1188405797,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_22790,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
22832,4206.94666666667,450.496,93.6026666666667,661.064,2249.86933333333,2169.688,475.893333333333,245.696,1123.45333333333,6004.056,659.154666666667,126.832,1081.90933333333,3528.872,675.957333333333,363.461333333333,7781.20266666667,3858.104,337.597333333333,240.082666666667,1056.33066666667,3440.86933333333,237.266666666667,246.954666666667,630.464,1044.288,457.530666666667,339.344,1042.656,130.528,375,24.6791407109487,19.358997115676,0.620220499212242,0.966494845360825,0.789473684210526,1.54516717274848,52992.6826666667,33509.888,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_22832,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
23047,4511.06529209622,343.120274914089,172.171821305842,665.6735395189,2713.02749140893,1730.70103092784,358.40206185567,269.941580756014,1091.13745704467,7079.98969072165,866.780068728522,135.501718213058,1090.4295532646,984.498281786942,574.756013745704,291.618556701031,1686.42611683849,1175.61512027491,282.463917525773,229.171821305842,998.580756013746,1036.08591065292,202.508591065292,133.109965635739,586.982817869416,1391.25429553265,495.701030927835,267.676975945017,1042.00343642612,131.635738831615,291,21.6057190912487,17.220203927492,0.603952075106565,0.954098360655738,0.76984126984127,-1.35560764251481,52830.5807560137,33385.5326460481,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_23047,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
23443,1480.94429469901,134.443845462713,69.0080862533693,620.733153638814,511.038634321653,1063.68553459119,1297.78706199461,247.3683737646,1086.5525606469,3361.84007187781,1142.52920035939,129.3683737646,1069.32165318958,676.017969451932,452.048517520216,403.425876010782,1463.73405211141,945.089847259658,209.675651392632,211.517520215633,996.11051212938,878.061994609164,167.619047619048,147.194968553459,599.403414195867,1588.09074573226,472.70260557053,237.805031446541,1058.57053009883,129.053009883199,1113,44.3993696437105,32.2193873213866,0.688040615396733,0.964471403812825,0.779411764705882,-0.314917035152976,52735.371967655,32476.41868823,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_23443,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
23501,3990.97427652733,829.929260450161,109.636655948553,625.794212218649,1294.14790996785,991.983922829582,344.816720257235,253.67845659164,1101.75241157556,7459.69131832797,568.713826366559,124.353697749196,1105.41800643087,5953.80064308682,1013.65594855305,871.938906752412,1936.9807073955,7363.52090032154,418.344051446945,246.636655948553,1064.36334405145,5888.7459807074,568.430868167203,507.016077170418,687.864951768489,2684.03536977492,522.028938906752,245.926045016077,1054.87781350482,131.424437299035,311,24.6732576072014,16.0863740722114,0.758239523785767,0.962848297213622,0.7775,-1.55018703070348,53202.9453376206,33310.4019292604,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_23501,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
24268,4044.0278551532,944.738161559889,139.484679665738,657.105849582173,2093.41504178273,3235.85515320334,364.155988857939,259.016713091922,1142.44568245125,5645.27855153203,693.980501392758,124.030640668524,1080.39275766017,3629.66573816156,710.325905292479,445.111420612813,7942.83286908078,6303.49582172702,396.130919220056,234.091922005571,1031.99721448468,5477.43732590529,243.554317548746,184.966573816156,605.306406685237,1463.59331476323,557.08635097493,254.376044568245,1045.65459610028,132.077994428969,359,23.9488132763026,19.1197637944544,0.602181059688041,0.97554347826087,0.815909090909091,-1.03822907992831,53990.2646239554,33272.5292479109,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_24268,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
24819,3166.96196868009,580.541387024609,934.901565995526,625.944071588367,1087.27516778523,1517.55704697987,448.335570469799,245.657718120805,1098.06711409396,3822.63310961969,684.890380313199,118.51677852349,1087.6711409396,5990.63982102908,976.800894854586,359.982102908277,3492.23042505593,7424.13422818792,502.143176733781,255.514541387025,1078.51454138702,6020.04250559284,291.973154362416,304.422818791946,591.62192393736,806.109619686801,466.762863534676,237.353467561521,1013.01789709172,130.48322147651,447,26.1967704574567,21.8642324092504,0.55083287535743,0.969631236442516,0.812727272727273,1.37220305299038,53348.5883668904,33440.5659955257,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_24819,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
24981,1053.89303661163,173.533381191673,96.2368987796124,637.339554917444,1925.44221105528,234.845656855707,282.627422828428,249.984206748026,1079.31299353912,1758.71787508973,626.465183058148,118.409906676238,1073.6992103374,614.451543431443,537.48528356066,280.059583632448,1406.77386934673,1003.26274228284,317.746590093324,235.875089734386,981.613065326633,901.714285714286,235.824838478105,143.91959798995,588.890165111271,890.345297918162,463.574300071787,217.252692031586,1022.09619526202,129.172290021536,1393,51.20986854563,34.7053047076451,0.735331719105632,0.97480755773268,0.780392156862745,-0.184946000354365,52326.5405599426,32751.9418521177,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_24981,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
25242,4432.72222222222,1053.17708333333,153.256944444444,650.1875,1759.19097222222,751.111111111111,1581.80902777778,238.510416666667,1074.05902777778,6291.61111111111,864.680555555556,124.680555555556,1083.43402777778,2404.20138888889,905.611111111111,1670.77083333333,1714.40277777778,2167.53819444444,301.847222222222,227.454861111111,1023.0625,1476.06597222222,215.5625,397.159722222222,688.194444444444,1204.46527777778,476.743055555556,561.173611111111,1049.86111111111,133.059027777778,288,20.6120255647657,17.8419122049682,0.500724115472424,0.976271186440678,0.757894736842105,1.13093673784998,53364.6215277778,33598.1076388889,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_25242,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
26028,2413.42574257426,558.393564356436,170.136138613861,627.054455445545,1244.71534653465,1360.14603960396,623.490099009901,255.19801980198,1078.35643564356,2795.98514851485,538.064356435644,118.75,1071.84405940594,3993.93811881188,828.831683168317,390.727722772277,3861.96287128713,3468.49752475248,321.581683168317,222.717821782178,1028.16831683168,2116.41584158416,192.391089108911,503.836633663366,653.856435643564,727.131188118812,383.252475247525,211.024752475248,1016.01237623762,130.388613861386,404,24.7928244094218,20.7532099329893,0.547103181107858,0.966507177033493,0.769523809523809,-1.53487368113852,52688.1336633663,32529.5693069307,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_26028,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
26770,3356.30580357143,516.263392857143,123.5625,643.035714285714,1798.421875,709.705357142857,1811.828125,255.265625,1089.74776785714,5320.5,1313.73214285714,122.129464285714,1073.12276785714,963.174107142857,676.368303571429,625.511160714286,1475.109375,1098.0,294.151785714286,223.993303571429,990.609375,965.303571428571,210.625,155.566964285714,596.162946428571,964.654017857143,442.948660714286,367.491071428571,1042.54910714286,132.102678571429,448,25.3815230280748,22.567920893243,0.457620478980312,0.9760348583878,0.779130434782609,-0.501582277211098,53465.4977678571,32734.4508928571,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_26770,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
26785,1897.99410029498,438.477876106195,84.4631268436578,658.01179941003,1718.33628318584,381.194690265487,274.410029498525,233.805309734513,1108.35693215339,3542.6814159292,492.787610619469,114.029498525074,1086.66076696165,629.410029498525,321.097345132743,274.117994100295,1512.06489675516,1136.04424778761,214.430678466077,547.171091445428,1010.75516224189,1104.84955752212,215.976401179941,215.380530973451,675.88790560472,1060.90560471976,448.575221238938,696.784660766962,1037.21238938053,130.129793510324,339,24.1227271747036,17.9562599466098,0.667766222679789,0.957627118644068,0.784722222222222,1.43415356468788,53810.5693215339,33691.0678466077,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_26785,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
26825,3031.93347193347,286.931392931393,111.640332640333,646.189189189189,1849.82952182952,423.058212058212,780.022869022869,258.264033264033,1082.3264033264,4604.99376299376,655.476091476091,127.305613305613,1089.41995841996,615.259875259875,599.698544698545,517.673596673597,1508.81496881497,1187.57796257796,264.781704781705,223.22869022869,1013.55717255717,957.607068607069,203.831600831601,223.091476091476,649.343035343035,1059.11018711019,439.735966735967,217.56340956341,1061.1288981289,130.775467775468,481,28.9580672054257,21.2100609021322,0.680831058479287,0.967806841046278,0.763492063492063,-0.209354391766172,52709.5841995842,32330.6673596674,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_26825,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
27400,4986.2619047619,1302.77891156463,528.867346938776,634.71768707483,1238.49319727891,4883.36394557823,463.945578231292,266.197278911565,1177.82653061224,6882.49659863946,620.768707482993,125.52380952381,1081.1156462585,5802.45918367347,976.493197278912,915.547619047619,2722.5612244898,6001.39455782313,440.391156462585,246.044217687075,1085.65306122449,5575.41836734694,279.47619047619,403.017006802721,597.928571428571,1372.65646258503,481.87074829932,257.350340136054,1081.63265306122,131.210884353742,294,23.9751466168592,15.6677128515799,0.756928152717904,0.948387096774194,0.765625,1.51135536284848,53977.4489795918,33539.8571428571,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_27400,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
28310,3124.59395973154,982.046979865772,72.3389261744966,616.258389261745,882.778523489933,4112.3255033557,588.268456375839,274.191275167785,1132.62751677852,4419.47986577181,535.446308724832,114.674496644295,1072.57382550336,5260.81208053691,1031.60402684564,485.258389261745,2717.77516778523,7421.51006711409,461.701342281879,467.06711409396,1058.29530201342,6616.14429530201,317.332214765101,348.768456375839,644.171140939597,1313.42953020134,494.946308724832,232.654362416107,1034.93959731544,131.265100671141,298,25.1380036941911,15.1691826593645,0.797411244753097,0.94006309148265,0.716346153846154,-1.43275324211844,53618.9362416107,33483.6308724832,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_28310,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
28640,1089.64893617021,179.007092198582,71.2730496453901,612.393617021277,1028.06737588652,410.390070921986,724.588652482269,241.58865248227,1080.68794326241,2384.1914893617,921.897163120567,107.560283687943,1069.48581560284,3347.13829787234,1263.07092198582,1034.60992907801,1909.30496453901,4770.48581560284,408.702127659574,233.464539007092,1074.59219858156,3457.89007092199,227.446808510638,368.659574468085,629.748226950355,1183.91134751773,470.872340425532,286.698581560284,1020.09929078014,130.223404255319,282,20.3654804623953,17.694459396324,0.495083035497981,0.959183673469388,0.781163434903047,-0.548667296886763,53536.1914893617,33080.6170212766,FAAGSCC_12,AG,1,other APCs,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_28640,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
28934,4377.96594427245,661.489164086687,126.102167182663,681.25386996904,3963.57894736842,699.191950464396,860.086687306502,240.699690402477,1125.23529411765,6727.94736842105,600.46439628483,127.092879256966,1097.84210526316,1264.38080495356,731.578947368421,1077.03095975232,1882.31578947368,2181.4613003096,316.287925696594,234.312693498452,1021.16099071207,2351.37770897833,220.473684210526,184.934984520124,635.015479876161,1557.68421052632,496.547987616099,263.724458204334,1077.20123839009,132.145510835913,323,22.5420001604796,18.3039997130224,0.583663878053208,0.96996996996997,0.815656565656566,1.53514335184976,52953.6253869969,33427.1114551084,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_28934,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
29178,2420.29281767956,870.704419889503,103.058011049724,639.497237569061,1432.0773480663,1078.59944751381,325.201657458564,266.613259668508,1089.38950276243,4318.12983425414,776.395027624309,128.831491712707,1095.06629834254,1449.6270718232,791.262430939227,277.060773480663,1726.80939226519,1133.2817679558,286.698895027624,228.049723756906,984.254143646409,988.593922651934,221.397790055249,131.577348066298,583.342541436464,1610.41160220994,500.732044198895,235.687845303867,1065.75414364641,131.370165745856,362,25.7685033599031,17.937649566838,0.717937523914264,0.960212201591512,0.724,1.11547483069733,52519.9834254144,32289.7182320442,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_29178,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
29193,4544.59717314488,635.190812720848,204.749116607774,687.378091872792,3885.46996466431,2471.51943462897,430.812720848056,268.318021201413,1091.43816254417,7418.54416961131,4382.85512367491,136.190812720848,1073.79858657244,993.600706713781,499.678445229682,289.872791519435,1464.38869257951,1228.47703180212,335.530035335689,234.833922261484,999.406360424028,1047.55477031802,233.070671378092,126.91519434629,587.038869257951,2329.97879858657,539.501766784452,636.770318021201,1084.41342756184,130.904593639576,283,20.2054992059818,17.8460891491016,0.468941343431415,0.952861952861953,0.744736842105263,1.04450643095813,53082.6713780919,33071.6961130742,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_29193,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
29534,2882.1975308642,664.946502057613,129.572016460905,647.975308641975,2024.93827160494,319.415637860082,803.901234567901,252.831275720165,1073.91358024691,5687.41769547325,567.27366255144,121.059670781893,1070.47530864198,881.374485596708,753.106995884774,426.20987654321,1467.70781893004,1266.70781893004,307.526748971193,228.337448559671,998.748971193416,1110.57201646091,221.588477366255,248.977366255144,650.230452674897,2640.97325102881,548.942386831276,237.141975308642,1052.91975308642,130.366255144033,486,30.442044923452,20.4409199251571,0.74103173899622,0.958579881656805,0.771428571428571,0.119652960039271,53765.9197530864,33110.049382716,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_29534,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
29571,3770.43126684636,1109.18598382749,90.3611859838275,627.714285714286,934.250673854447,1450.92722371968,363.33153638814,265.727762803234,1126.39622641509,4989.79245283019,868.242587601078,132.708894878706,1069.89218328841,870.455525606469,606.215633423181,287.989218328841,1621.17789757412,1205.26684636119,291.566037735849,223.309973045822,1059.9730458221,1063.25876010782,207.547169811321,422.024258760108,2046.04851752022,1188.0,463.714285714286,222.094339622642,1044.67654986523,129.431266846361,371,23.0492146437719,20.5380859805228,0.453898071285894,0.966145833333333,0.768115942028985,1.07711427243298,52794.320754717,32512.9407008086,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_29571,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
29896,2446.68026101142,649.804241435563,90.3132137030995,622.797716150082,931.045676998369,322.63132137031,348.402936378467,258.216965742251,1080.71125611746,3282.45350734095,552.634584013051,120.215334420881,1069.13539967374,721.148450244698,464.36867862969,278.799347471452,1676.33605220228,1022.07993474715,276.05383360522,225.311582381729,992.199021207178,923.585644371941,200.978792822186,132.853181076672,599.595432300163,937.296900489396,487.776508972268,226.065252854812,1016.76672104405,129.753670473083,613,33.2187865114649,23.5597877470075,0.704976326179502,0.962323390894819,0.751225490196078,-1.52160711913639,52882.8760195759,33258.396411093,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_29896,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
29928,2716.98790322581,216.387096774194,89.7157258064516,618.747983870968,305.679435483871,846.846774193548,698.60685483871,253.91935483871,1094.85685483871,5786.49193548387,1106.31653225806,124.975806451613,1078.31451612903,859.879032258065,637.735887096774,373.931451612903,1463.88911290323,1238.79838709677,320.048387096774,233.296370967742,990.076612903226,1133.73588709677,237.421370967742,150.798387096774,595.288306451613,3094.36088709677,622.991935483871,552.8125,1059.71169354839,131.145161290323,496,28.3452522737468,22.3282607044768,0.616027190193324,0.959381044487427,0.777429467084639,0.0566010004977169,53561.7318548387,33324.0665322581,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_29928,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
30193,3594.76878612717,254.080924855491,78.364161849711,620.231213872832,911.676300578035,1126.68208092486,4354.96531791908,261.057803468208,1087.45664739884,6463.24277456647,911.277456647399,127.739884393064,1064.14450867052,868.335260115607,817.838150289017,950.595375722543,1599.37572254335,1201.35260115607,264.872832369942,220.341040462428,1005.0,1065.14450867052,186.71098265896,336.179190751445,830.549132947977,2317.71098265896,501.277456647399,328.50289017341,1073.25433526012,129.768786127168,173,16.2890621878312,13.5756023298478,0.552642702289822,0.977401129943503,0.831730769230769,-1.40310119490234,52522.7919075145,32660.7167630058,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_30193,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
30465,493.908839779006,1082.32872928177,242.831491712707,606.872928176796,107.812154696133,470.494475138122,337.881215469613,260.955801104972,1099.67403314917,1137.3591160221,746.546961325967,113.767955801105,1065.53867403315,759.720994475138,452.533149171271,284.157458563536,1484.08011049724,988.469613259669,207.28453038674,211.842541436464,1289.70165745856,670.005524861878,146.776243093923,128.668508287293,586.193370165746,560.339779005525,342.897790055249,199.28729281768,984.665745856354,128.906077348066,362,23.6774494109589,19.5379766092981,0.56488104077489,0.952631578947368,0.747933884297521,-0.762663589683918,52621.6298342541,32903.4806629834,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_30465,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
30576,3533.61904761905,806.78431372549,1932.98319327731,686.582633053221,3691.38655462185,3057.01400560224,567.341736694678,260.672268907563,1135.081232493,6075.75630252101,534.0,130.789915966387,1070.99719887955,5132.92156862745,946.361344537815,587.257703081233,4520.15406162465,4442.09523809524,395.448179271709,241.364145658263,1069.90196078431,3602.34733893557,244.563025210084,206.389355742297,603.96918767507,1456.64705882353,500.857142857143,722.955182072829,1052.49019607843,130.834733893557,357,24.4980553269345,18.6290274923649,0.649421279335733,0.964864864864865,0.772727272727273,-0.847324170204874,52961.9467787115,33519.675070028,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_30576,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
30724,1405.5244648318,123.542813455657,62.3318042813456,624.709480122324,1211.17125382263,2501.77370030581,1721.125382263,266.932721712538,1097.77828746177,2881.27675840979,466.519877675841,109.990825688073,1078.14220183486,1493.74311926606,648.998470948012,782.622324159021,1514.32721712538,1244.59327217125,285.747706422018,227.152905198777,982.932721712538,1084.33486238532,212.877675840979,144.762996941896,610.704892966361,1327.38532110092,449.909785932722,221.567278287462,1035.96941896024,128.925076452599,654,33.7431399469794,24.8041866654762,0.677971402307773,0.964601769911504,0.753456221198157,-0.625308631748994,52558.7584097859,33280.9403669725,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_30724,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
30895,4647.3947368421,837.581871345029,1015.29824561404,665.745614035088,3340.37134502924,1090.64035087719,667.657894736842,249.505847953216,1088.27192982456,7043.61695906433,662.418128654971,123.75730994152,1083.61988304094,1433.95906432749,728.599415204678,561.023391812865,1748.58771929825,1458.0730994152,336.973684210526,236.611111111111,1031.75730994152,1351.55847953216,237.119883040936,703.029239766082,1873.16666666667,2070.96783625731,512.24269005848,278.637426900585,1057.19883040936,131.40350877193,342,23.184536382438,18.8106811878637,0.584566202443281,0.960674157303371,0.782608695652174,1.39638422880647,53561.1169590643,33695.1257309942,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_30895,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
30925,4235.10335917313,932.472868217054,153.658914728682,661.284237726098,2742.04392764858,483.614987080103,283.273901808786,243.529715762274,1085.97416020672,5599.67183462532,660.15503875969,123.821705426357,1082.10335917313,693.444444444444,493.772609819121,264.687338501292,1480.85788113695,1075.25839793282,261.821705426357,219.235142118863,1001.7519379845,1023.1188630491,195.162790697674,161.377260981912,667.751937984496,1205.94832041344,492.413436692506,269.064599483204,1032.07751937984,130.457364341085,387,23.141877042965,21.4230824687379,0.378190106454825,0.969924812030075,0.801242236024845,0.180479351711206,53656.6046511628,33251.0206718346,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_30925,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
31934,4039.68072289157,519.737951807229,116.415662650602,663.581325301205,2742.04518072289,829.876506024096,313.448795180723,243.364457831325,1083.17168674699,6923.7921686747,705.939759036145,134.64156626506,1090.67168674699,1566.57228915663,722.810240963855,302.186746987952,2203.71385542169,1939.70180722892,343.328313253012,240.246987951807,1006.25,1588.26506024096,245.28313253012,175.846385542169,608.093373493976,2268.90060240964,520.35843373494,332.268072289157,1085.61144578313,132.415662650602,332,25.074109586703,16.926973859024,0.737746576548981,0.970760233918129,0.721739130434783,0.936029789803423,52842.5060240964,33512.593373494,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_31934,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
31957,3694.82898550725,885.020289855073,88.2985507246377,631.614492753623,1330.15942028986,294.452173913043,618.898550724638,244.614492753623,1084.84927536232,6734.3652173913,685.16231884058,117.750724637681,1081.09565217391,762.536231884058,527.669565217391,274.828985507246,1435.2231884058,1069.27246376812,291.405797101449,226.542028985507,984.223188405797,995.278260869565,221.466666666667,123.695652173913,583.63768115942,2255.22028985507,521.773913043478,248.626086956522,1048.25507246377,131.315942028986,345,23.2450097886788,18.977418037514,0.577475151011336,0.942622950819672,0.75,1.14548486104345,53853.9594202899,33201.3768115942,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_31957,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
32166,4167.80952380952,510.161904761905,148.698412698413,652.196825396825,1857.57777777778,252.869841269841,286.063492063492,254.15873015873,1084.42222222222,6341.76507936508,1920.53968253968,129.066666666667,1078.30476190476,718.063492063492,620.930158730159,295.555555555556,1472.63492063492,1007.29206349206,301.990476190476,227.244444444444,990.92380952381,900.257142857143,220.419047619048,131.390476190476,598.044444444444,1429.23492063492,465.660317460318,342.469841269841,1068.07301587302,132.425396825397,315,26.1830279552884,15.361284687447,0.80981260578479,0.95166163141994,0.757211538461538,-1.5577699016017,52690.346031746,32271.5714285714,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_32166,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
32573,4972.12396694215,686.446280991736,1524.09090909091,640.421487603306,2138.07438016529,3022.29752066116,505.615702479339,254.185950413223,1116.04958677686,7682.18595041322,994.214876033058,127.152892561983,1082.37190082645,1464.64049586777,698.276859504132,483.694214876033,1638.61570247934,1085.06198347107,318.677685950413,223.289256198347,1013.67768595041,932.545454545454,194.561983471074,241.98347107438,597.925619834711,3339.1694214876,588.231404958678,277.681818181818,1061.52892561983,128.921487603306,242,19.157779505669,16.091383709586,0.542679405759579,0.968,0.796052631578947,0.116253648565038,53602.4752066116,33693.0578512397,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_32573,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
32933,4150.66086956522,386.730434782609,134.608695652174,684.03768115942,3253.54492753623,919.794202898551,394.501449275362,254.124637681159,1082.90724637681,6625.89275362319,2051.94202898551,135.275362318841,1079.92753623188,1827.34492753623,1087.64057971014,294.701449275362,1708.41449275362,1692.48695652174,263.489855072464,219.484057971014,1001.19130434783,1299.20869565217,184.846376811594,354.44347826087,645.35652173913,1619.85217391304,479.231884057971,428.255072463768,1095.73623188406,131.492753623188,345,24.5442938236519,17.9066164268899,0.683913273599264,0.969101123595506,0.798611111111111,1.35518936244475,52619.4579710145,32337.7420289855,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_32933,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
33135,2157.77327935223,251.008097165992,212.052631578947,709.026315789474,6213.87651821862,1964.8967611336,519.981781376518,244.591093117409,1092.33198380567,3856.89271255061,567.006072874494,122.451417004049,1076.23886639676,3374.99190283401,743.303643724696,348.115384615385,4846.7044534413,4939.43927125506,356.880566801619,230.838056680162,1026.04655870445,4574.65991902834,231.811740890688,242.384615384615,603.975708502024,1409.03643724696,488.811740890688,342.026315789474,1062.33400809717,129.475708502024,494,33.5704067387387,18.8431754563061,0.827610270711695,0.957364341085271,0.742857142857143,-1.56934295362708,53848.6700404858,33641.3825910931,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_33135,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
33142,4089.26366559486,818.022508038585,825.623794212219,626.752411575563,1184.4308681672,703.176848874598,446.749196141479,262.916398713826,1128.75241157556,7665.79421221865,554.810289389068,118.463022508039,1068.15434083601,851.607717041801,453.450160771704,271.022508038585,1469.93247588424,1041.73633440514,208.897106109325,214.498392282958,1372.16720257235,721.212218649518,145.8038585209,116.83922829582,584.360128617363,2258.05466237942,513.392282958199,246.665594855305,1058.96784565916,130.881028938907,311,20.7310356274108,19.1229764567055,0.386158891075248,0.974921630094044,0.818421052631579,1.27180295882398,53816.4855305466,32741.922829582,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_33142,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
33180,4943.76140350877,347.687719298246,145.308771929825,651.371929824561,2646.94035087719,3107.86666666667,419.175438596491,263.40350877193,1124.76140350877,7500.10877192982,628.943859649123,129.287719298246,1086.8701754386,3795.50877192982,738.014035087719,322.161403508772,2012.0701754386,3310.05964912281,364.624561403509,237.347368421053,1028.02807017544,2745.25263157895,241.687719298246,417.954385964912,584.375438596491,2093.91578947368,550.533333333333,326.315789473684,1067.19649122807,130.259649122807,285,23.2754951018445,15.6074908807561,0.741860158929452,0.956375838926174,0.714285714285714,0.890454461999079,52964.0771929825,33401.4526315789,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_33180,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
33213,2527.7847082495,331.587525150905,104.708249496982,639.281690140845,1820.2555331992,282.438631790744,265.398390342052,245.780684104628,1074.3199195171,3826.96780684105,1729.56941649899,121.398390342052,1076.67605633803,688.657947686117,467.643863179074,270.567404426559,1388.33400402414,1054.61569416499,287.851106639839,225.23138832998,979.637826961771,978.710261569416,207.334004024145,136.736418511066,584.718309859155,1025.95573440644,498.808853118712,368.1046277666,1044.82092555332,132.800804828974,497,27.4307509838886,23.1859900361718,0.534362546307609,0.950286806883365,0.736296296296296,1.11275662110476,53603.7987927565,32917.2696177062,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_33213,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
33236,5477.07058823529,879.274509803922,2167.01176470588,645.521568627451,1739.9568627451,329.607843137255,403.913725490196,236.396078431373,1071.26274509804,7692.30196078431,655.937254901961,123.705882352941,1174.22745098039,717.564705882353,543.61568627451,397.01568627451,1684.29411764706,1455.01960784314,337.38431372549,236.345098039216,1013.39215686275,1154.91764705882,243.152941176471,337.929411764706,589.505882352941,2218.18823529412,559.074509803922,635.898039215686,1056.78039215686,130.098039215686,255,21.889707241562,14.8367508290725,0.735250231689208,0.955056179775281,0.772727272727273,1.44421613260168,53528.7725490196,33485.9137254902,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_33236,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
33598,3396.86086956522,474.71884057971,93.0086956521739,625.991304347826,488.527536231884,493.405797101449,328.086956521739,255.008695652174,1098.71304347826,6346.31014492754,696.869565217391,122.208695652174,1088.81739130435,918.388405797101,527.672463768116,288.617391304348,1808.04927536232,1194.4231884058,298.269565217391,228.147826086957,996.060869565217,1044.90434782609,217.91884057971,132.202898550725,585.086956521739,2526.33333333333,547.35652173913,248.263768115942,1065.64057971014,131.83768115942,345,28.3238770166556,15.6637104152777,0.833167041869469,0.950413223140496,0.743534482758621,-1.53588042525535,53161.3623188406,33344.5594202899,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_33598,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
35364,4371.46505376344,669.841397849462,143.698924731183,642.954301075269,1728.68817204301,664.470430107527,400.295698924731,272.798387096774,1123.06989247312,8124.63172043011,1149.4435483871,127.52688172043,1069.84946236559,1714.36290322581,577.817204301075,278.467741935484,1823.88978494624,3087.02150537634,318.897849462366,224.236559139785,1046.09946236559,2659.90591397849,210.344086021505,151.043010752688,2095.15860215054,2114.20698924731,516.271505376344,365.38440860215,1071.81182795699,132.0,372,23.4702615780304,20.3498760168677,0.498222192299442,0.963730569948186,0.808695652173913,-1.30479097089215,53330.6586021505,32748.4462365591,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_35364,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
35390,3650.97909407666,227.790940766551,115.891986062718,644.585365853659,1983.48780487805,654.473867595819,688.926829268293,249.717770034843,1086.56097560976,5888.89198606272,560.648083623693,129.334494773519,1086.09407665505,5086.40766550523,1092.1149825784,355.407665505226,3062.70034843206,8548.6968641115,445.519163763066,247.965156794425,1022.89895470383,9379.7456445993,705.383275261324,295.668989547038,671.682926829268,1860.54703832753,506.031358885017,243.675958188153,1037.29616724739,130.627177700348,287,20.6665071112145,17.7006296813455,0.51616578477443,0.956666666666667,0.759259259259259,-1.54639475250507,52802.118466899,33431.8466898955,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_35390,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
36072,2109.99640933573,153.904847396768,85.2692998204668,648.608617594255,2343.64272890485,316.03052064632,349.980251346499,253.05026929982,1080.18132854578,4436.38599640934,891.064631956912,120.003590664273,1079.70197486535,678.357271095153,472.666068222621,303.57091561939,1410.68402154399,1028.33572710952,283.692998204668,225.842010771993,984.472172351885,950.285457809695,206.739676840215,131.184919210054,601.942549371634,1419.20825852783,492.682226211849,248.802513464991,1062.79892280072,130.289048473968,557,34.221733664253,21.3437150474645,0.781672674323092,0.963667820069204,0.682598039215686,-1.25178820134015,53608.7145421903,32882.4937163375,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_36072,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
36097,3308.04672897196,511.928348909657,531.897196261682,612.01246105919,857.841121495327,444.510903426791,343.688473520249,255.130841121495,1079.38317757009,6662.65732087227,503.473520249221,116.579439252336,1069.1277258567,3645.70093457944,582.370716510903,289.853582554517,5958.96884735202,3565.77570093458,279.09968847352,222.408099688474,1002.83177570093,3153.23364485981,214.485981308411,128.996884735202,629.302180685358,3221.6230529595,548.841121495327,252.8753894081,1041.52959501558,131.358255451713,321,21.9675978124189,18.7362066084758,0.522071158889981,0.958208955223881,0.767942583732057,1.53875308602339,53994.7320872274,33046.9127725857,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_36097,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
36988,3380.66176470588,772.685294117647,1090.50294117647,655.647058823529,2500.81470588235,327.997058823529,321.282352941176,258.061764705882,1081.67941176471,6835.07352941176,3130.51764705882,130.823529411765,1068.22647058824,1189.59117647059,645.802941176471,460.564705882353,1455.43823529412,2301.02058823529,313.091176470588,225.802941176471,987.308823529412,2693.28529411765,217.65,1145.66470588235,631.941176470588,2497.61764705882,541.744117647059,470.567647058824,1071.0,130.126470588235,340,27.8832053573337,15.8198008127498,0.823470232425095,0.949720670391062,0.714285714285714,1.36790284866317,53737.3235294118,32462.6529411765,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_36988,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
37329,2737.63736263736,260.10989010989,145.714285714286,648.071428571429,2194.65384615385,294.065934065934,297.527472527473,238.862637362637,1070.25824175824,4596.47802197802,1472.56043956044,124.582417582418,1072.57142857143,707.961538461538,451.049450549451,281.846153846154,1415.04945054945,1069.50549450549,291.736263736264,233.225274725275,988.835164835165,984.505494505494,215.675824175824,165.335164835165,575.60989010989,2018.07142857143,526.978021978022,361.252747252747,1033.62087912088,129.038461538462,182,18.6083993138218,12.6843713367708,0.731680603211019,0.933333333333333,0.674074074074074,-1.01808427710166,53272.956043956,33549.4725274725,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_37329,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
37354,5797.0487012987,1362.07792207792,222.746753246753,655.655844155844,1947.95779220779,1067.81493506494,289.435064935065,240.49025974026,1093.83116883117,8962.54545454545,656.409090909091,130.717532467532,1087.50974025974,5384.11363636364,940.12987012987,342.061688311688,9965.76298701299,6394.82467532467,421.948051948052,247.094155844156,1157.67532467532,5728.90584415584,314.185064935065,233.805194805195,667.542207792208,2090.11688311688,529.62987012987,250.548701298701,1059.9025974026,132.298701298701,308,20.5021346995285,19.2643188899016,0.342205796073408,0.953560371517028,0.733333333333333,-0.602300797489754,52729.6883116883,33530.9545454545,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_37354,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
37420,4555.18309859155,287.218309859155,105.133802816901,626.154929577465,987.401408450704,1995.9014084507,1901.30281690141,259.69014084507,1096.78169014085,7087.53873239437,672.091549295775,125.475352112676,1076.54225352113,876.292253521127,503.707746478873,292.658450704225,1474.34507042254,1048.94366197183,267.718309859155,222.43661971831,992.531690140845,999.908450704225,206.426056338028,124.264084507042,599.954225352113,1642.66197183099,540.482394366197,265.566901408451,1039.0176056338,131.820422535211,284,22.5691518537122,16.1275963359858,0.699547766231149,0.956228956228956,0.747368421052632,0.947116761198935,52845.2711267606,33350.7852112676,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_37420,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
37632,3466.01089324619,517.095860566449,109.997821350763,633.119825708061,1204.62745098039,1462.43790849673,344.588235294118,253.152505446623,1104.86928104575,5574.07843137255,1558.24618736383,130.485838779956,1074.80392156863,1677.3834422658,537.098039215686,299.758169934641,1598.40740740741,1248.81045751634,259.888888888889,218.318082788671,988.531590413943,980.357298474946,181.507625272331,139.087145969499,718.342047930283,1616.02396514161,497.799564270152,571.596949891068,1055.48583877996,130.899782135076,459,26.1004306835652,22.5678529001925,0.50236712105595,0.962264150943396,0.735576923076923,-1.20789654188839,53053.2069716776,32840.0610021786,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_37632,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
37698,3298.25961538462,1095.08012820513,109.737179487179,655.070512820513,2500.63782051282,316.121794871795,305.48717948718,260.134615384615,1084.92948717949,4217.97435897436,534.461538461538,125.634615384615,1067.69230769231,731.541666666667,462.064102564103,267.586538461538,1535.25961538462,1168.23076923077,321.310897435897,230.503205128205,1030.99358974359,1046.64423076923,220.647435897436,182.583333333333,838.115384615385,756.36858974359,395.557692307692,205.897435897436,1022.12820512821,129.13141025641,312,22.9293917922438,17.3386255554902,0.654369811145913,0.962962962962963,0.787878787878788,-1.28174987907482,53149.3173076923,32073.6506410256,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_37698,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
37725,2315.99856011519,550.349892008639,322.897048236141,655.424046076314,1742.5154787617,2085.10367170626,1948.92656587473,263.324694024478,1120.61627069834,3066.68610511159,947.65154787617,120.918646508279,1073.5939524838,1985.64794816415,857.323974082073,675.112311015119,2358.86897048236,2241.43340532757,357.012239020878,233.705543556515,1085.80489560835,1701.71418286537,608.863930885529,217.951043916487,601.004319654428,773.583153347732,458.098632109431,283.976241900648,1007.77753779698,130.364290856731,1389,47.8676989374144,37.1695592563572,0.630109758580064,0.978858350951374,0.798734905117884,0.070969723971175,53469.2109431245,33346.0813534917,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_37725,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
38194,2681.74891774892,437.91341991342,142.480519480519,634.441558441558,1459.86147186147,732.930735930736,444.69696969697,249.316017316017,1092.64935064935,5861.9696969697,801.489177489177,122.398268398268,1075.99134199134,3710.59307359307,653.168831168831,409.463203463203,1596.33766233766,2480.14718614719,291.87012987013,223.649350649351,1030.01298701299,1500.31168831169,194.441558441558,326.30303030303,748.926406926407,2488.42857142857,537.978354978355,394.995670995671,1055.98268398268,130.987012987013,231,19.9908648743177,14.8911846283012,0.667176724106888,0.95850622406639,0.77,1.5498349741507,53690.3506493507,32832.2121212121,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_38194,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
38239,1667.5297029703,114.094059405941,308.826732673267,860.019801980198,13038.2772277228,637.19801980198,423.811881188119,283.618811881188,1141.28712871287,2040.75742574257,889.306930693069,346.024752475248,1070.80198019802,1009.94059405941,578.227722772277,288.678217821782,1594.45544554455,1028.09900990099,212.455445544554,209.00495049505,1205.89603960396,599.539603960396,135.217821782178,96.1188118811881,593.306930693069,868.920792079208,432.232673267327,220.806930693069,1063.72772277228,130.029702970297,202,17.5196324474771,14.7198734297602,0.542287412618297,0.948356807511737,0.742647058823529,0.951747950146352,52907.8663366337,32274.0940594059,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_38239,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
38471,3442.04203539823,1034.05309734513,2234.36504424779,613.232300884956,584.778761061947,666.652654867257,805.772123893805,254.524336283186,1097.94469026549,5005.90044247788,532.49778761062,117.761061946903,1073.02876106195,2680.37168141593,1272.1482300885,3190.39601769911,1871.0110619469,3641.73672566372,395.550884955752,240.059734513274,1027.69690265487,2809.54646017699,270.28982300885,605.805309734513,837.311946902655,1145.88495575221,495.758849557522,241.103982300885,1033.27212389381,131.219026548673,452,25.8157710699453,22.3815866933026,0.498354424156905,0.965811965811966,0.79020979020979,-1.44089561307228,53616.8053097345,32855.1637168142,FAAGSCC_12,AG,1,regulatory T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_38471,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
38495,3006.06821705426,168.896124031008,124.634108527132,648.119379844961,2784.8480620155,897.381395348837,593.598449612403,240.868217054264,1082.63255813953,4881.31162790698,598.55503875969,124.517829457364,1080.48217054264,3894.47596899225,712.491472868217,524.217054263566,2543.77364341085,5137.17364341085,399.838759689922,592.406201550388,1014.4015503876,5675.54573643411,383.547286821705,536.137984496124,620.237209302326,1473.78604651163,469.316279069767,240.082170542636,1025.2015503876,130.223255813954,645,34.4434649710053,23.955441331396,0.718525773950546,0.972850678733032,0.770609318996416,-0.999339382933561,52796.4294573643,33529.615503876,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_38495,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
39048,1381.80409356725,498.710526315789,1129.84502923977,616.219298245614,722.470760233918,287.479532163743,300.119883040936,254.154970760234,1084.21052631579,1897.47076023392,484.219298245614,110.166666666667,1079.49122807018,660.201754385965,462.728070175439,271.578947368421,1384.72807017544,922.953216374269,252.953216374269,220.27485380117,989.956140350877,868.052631578947,196.804093567251,147.149122807018,589.713450292398,786.365497076023,468.909356725146,228.362573099415,1004.3216374269,131.567251461988,342,23.2950235151071,18.7680725996769,0.592366319740289,0.955307262569832,0.782608695652174,1.33862763449638,53452.3713450292,33224.0994152047,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_39048,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
39093,2594.19545454545,626.722727272727,452.781818181818,632.554545454545,2031.56363636364,308.945454545455,291.704545454545,256.672727272727,1086.81363636364,5385.91363636364,1201.28636363636,117.018181818182,1056.86363636364,1291.12727272727,474.154545454545,278.004545454545,1419.75,3751.15,339.018181818182,227.9,1000.87727272727,3445.25454545455,224.586363636364,402.159090909091,580.527272727273,2184.69090909091,522.668181818182,322.054545454545,1056.28181818182,131.604545454545,220,18.7974626444477,14.9490659134379,0.606254870024486,0.960698689956332,0.771929824561403,1.47806668544762,53460.1318181818,32910.3227272727,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_39093,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
39170,3663.95303867403,991.533149171271,1977.09944751381,655.577348066298,2590.14364640884,782.060773480663,449.737569060774,283.25138121547,1130.2182320442,4749.65193370166,935.908839779006,124.03591160221,1071.1270718232,974.82044198895,501.654696132597,278.002762430939,1572.39502762431,1244.36740331492,250.596685082873,218.450276243094,1101.82596685083,981.411602209945,171.140883977901,111.809392265193,1114.65745856354,854.831491712707,439.259668508287,272.450276243094,1028.22928176796,130.386740331492,362,21.6614797902654,21.3307677794365,0.174073209637457,0.952631578947368,0.747933884297521,-0.574718283095952,53614.270718232,32752.4364640884,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_39170,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
40406,4423.38719512195,383.838414634146,82.9176829268293,637.286585365854,1122.09756097561,454.454268292683,771.664634146341,238.283536585366,1078.12804878049,7432.0,588.649390243902,128.0,1102.78048780488,657.018292682927,443.283536585366,481.185975609756,1901.85365853659,1022.46646341463,220.746951219512,216.213414634146,1009.85365853659,942.289634146341,174.810975609756,201.579268292683,678.125,2216.75304878049,498.875,277.469512195122,1056.3993902439,133.676829268293,328,21.1997269702527,19.8335551707592,0.353175459336525,0.953488372093023,0.743764172335601,-1.51385754791282,52829.9634146341,33659.4756097561,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_40406,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
40538,3589.60683760684,396.19943019943,186.680911680912,635.769230769231,1941.06552706553,1023.65242165242,561.837606837607,244.441595441595,1088.4188034188,6381.62393162393,549.826210826211,118.97150997151,1091.47863247863,1039.37321937322,631.846153846154,440.293447293447,4668.64672364672,1365.54985754986,256.626780626781,230.547008547008,1021.06837606838,911.247863247863,186.538461538462,129.410256410256,589.934472934473,1850.86894586895,497.683760683761,257.105413105413,1049.73219373219,130.381766381766,351,22.3882511243316,20.0213893697059,0.44750570047436,0.961643835616438,0.797727272727273,0.0808995361042769,53969.1396011396,33171.1965811966,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_40538,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
40685,3744.09375,1115.30397727273,101.730113636364,638.96875,1429.43181818182,1299.66193181818,723.4375,240.75,1115.86363636364,5229.48863636364,600.892045454545,122.505681818182,1076.47443181818,4502.48011363636,685.403409090909,351.46875,7586.62784090909,5841.32102272727,419.897727272727,248.482954545455,1021.76420454545,4781.79829545455,260.085227272727,225.758522727273,641.928977272727,857.338068181818,439.494318181818,327.471590909091,1027.28409090909,130.676136363636,352,23.2410512633072,19.5665576619474,0.539639168354385,0.943699731903485,0.765217391304348,-1.3479378165562,52972.8607954545,33501.9403409091,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_40685,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
41012,4320.00284090909,441.556818181818,151.96875,676.539772727273,2843.63636363636,251.838068181818,283.8125,252.710227272727,1081.07670454545,5645.50852272727,1452.71306818182,134.670454545455,1080.95170454545,595.585227272727,413.261363636364,275.073863636364,1417.50284090909,943.860795454546,269.90625,221.238636363636,998.724431818182,874.238636363636,205.136363636364,126.272727272727,593.829545454545,1176.03693181818,449.627840909091,444.96875,1082.0,131.46875,352,25.0193151640939,17.9528670078733,0.696496397930601,0.967032967032967,0.761904761904762,-0.732402569987958,52647.1448863636,32281.9318181818,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_41012,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
41353,3219.21296296296,760.037037037037,143.037037037037,640.979166666667,1533.10416666667,259.608796296296,416.418981481482,239.372685185185,1075.82638888889,5551.24537037037,1281.34722222222,122.583333333333,1066.55092592593,1783.33564814815,712.997685185185,327.043981481481,4764.59953703704,3942.50694444444,344.247685185185,232.263888888889,1038.57175925926,3493.4212962963,228.259259259259,159.657407407407,677.62037037037,2121.12962962963,545.668981481482,340.55787037037,1079.94444444444,130.053240740741,432,24.4566257026121,22.6039286007121,0.381798478414303,0.951541850220264,0.75,-0.754067065247726,54138.087962963,32840.7037037037,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_41353,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
41656,3237.19033232628,213.963746223565,84.3716012084592,650.519637462236,1074.36555891239,2293.9335347432,2498.47129909366,268.435045317221,1139.61329305136,6979.35951661631,552.081570996979,116.851963746224,1068.0996978852,2429.34441087613,1232.73413897281,804.87915407855,2605.97885196375,2132.00302114804,275.380664652568,219.0,1004.92749244713,1551.29305135952,199.749244712991,147.308157099698,641.051359516616,3411.31419939577,531.015105740181,349.791540785499,1057.42900302115,129.208459214502,331,26.9099451238293,15.7067198581598,0.811985833645462,0.959420289855072,0.748868778280543,1.26002597443996,53905.6042296072,32934.9516616314,FAAGSCC_12,AG,1,M2 macrophages,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_41656,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
41957,3911.66966966967,198.957957957958,124.129129129129,635.483483483483,1903.21621621622,2951.82882882883,593.378378378378,262.27027027027,1138.63063063063,7604.62762762763,837.441441441441,124.564564564565,1077.14414414414,3227.65465465465,1541.07207207207,549.606606606607,6137.77777777778,5877.95795795796,385.828828828829,233.618618618619,1047.27927927928,4805.83483483483,251.687687687688,409.738738738739,666.324324324324,3146.93393393393,551.822822822823,286.261261261261,1064.54354354354,131.285285285285,333,23.2306525715015,18.2890302269263,0.61659554106979,0.959654178674352,0.756818181818182,0.641666220527589,54009.7567567568,32803.5615615616,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_41957,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
42194,3209.73641851107,334.851106639839,168.529175050302,714.251509054326,4084.74647887324,312.79476861167,304.760563380282,253.917505030181,1085.08853118712,5922.0523138833,3270.54124748491,128.796780684105,1092.68209255533,752.951710261569,501.486921529175,280.507042253521,1435.3722334004,1104.43058350101,283.140845070423,224.116700201207,985.382293762576,1005.77464788732,205.832997987928,160.851106639839,589.183098591549,1564.5754527163,519.879275653924,376.82092555332,1081.29175050302,132.758551307847,497,27.7220903850103,22.8918067937061,0.564020940993557,0.972602739726027,0.796474358974359,0.573226158851283,53620.7484909457,32903.0744466801,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_42194,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
42358,3746.46701846966,935.968337730871,124.364116094987,666.467018469657,3163.72823218997,415.303430079156,429.018469656992,243.203166226913,1113.15831134565,5694.12928759894,689.514511873351,123.664907651715,1078.52506596306,1430.48021108179,550.538258575198,269.915567282322,1550.6253298153,1842.74934036939,254.654353562005,221.424802110818,995.585751978892,1700.95778364116,206.788918205805,136.873350923483,626.67018469657,871.641160949868,438.823218997361,253.401055408971,1017.88390501319,131.158311345646,379,24.068866929092,20.1006873104543,0.550049182356343,0.9475,0.751984126984127,-0.126009199626951,53674.0686015831,33275.6015831135,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_42358,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
42607,3570.06024096385,374.457831325301,133.848192771084,659.238554216867,2757.26265060241,368.392771084337,431.359036144578,246.710843373494,1083.50361445783,6052.07228915663,4252.69156626506,132.197590361446,1085.17108433735,917.722891566265,463.525301204819,383.455421686747,1554.55421686747,1565.04337349398,279.416867469879,224.6,1030.02891566265,1320.16144578313,206.872289156626,239.734939759036,1101.38313253012,1295.5421686747,459.431325301205,465.53734939759,1084.76144578313,132.833734939759,415,26.781908769712,19.7650817202306,0.674799361775504,0.954022988505747,0.721739130434783,0.600293201793968,52528.0144578313,32618.2024096386,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_42607,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
43048,2406.74006116208,239.299694189602,173.932721712538,699.241590214067,4969.10397553517,687.981651376147,441.7125382263,279.932721712538,1160.8379204893,4619.33944954128,574.948012232416,131.633027522936,1076.06116207951,906.394495412844,495.761467889908,290.403669724771,1564.96024464832,1004.74923547401,216.733944954128,213.211009174312,1202.4006116208,656.192660550459,146.045871559633,120.302752293578,1109.74006116208,1569.50458715596,465.581039755352,223.159021406728,1073.35779816514,131.415902140673,327,21.3229523785184,19.6455392669815,0.38877440647185,0.967455621301775,0.741496598639456,1.07832513177695,52463.3975535168,32543.4220183486,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_43048,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
44189,1924.24014336918,402.075268817204,126.913978494624,657.541218637993,2773.57347670251,617.727598566308,391.007168458781,272.792114695341,1133.64874551971,2908.16845878136,3566.20788530466,118.078853046595,1071.84946236559,734.996415770609,413.906810035842,269.032258064516,1443.90681003584,1582.92831541219,260.838709677419,215.953405017921,1080.93189964158,1274.43727598566,169.465949820789,125.405017921147,760.5770609319,921.268817204301,449.146953405018,449.154121863799,1024.90681003584,131.15770609319,279,20.730643558746,17.1623668861954,0.56091367826567,0.96875,0.781512605042017,-1.48322959435485,53885.7383512545,32693.7204301075,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_44189,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
44307,3987.13365155131,1067.81622911695,116.298329355609,668.520286396181,2104.62529832936,2475.80668257757,696.761336515513,254.119331742243,1108.84725536993,5560.19093078759,642.174224343675,139.792362768496,1079.94510739857,4515.13603818616,856.99522673031,369.601431980907,5136.07875894988,5631.6276849642,391.178997613365,240.587112171838,1036.05011933174,4379.87589498807,299.873508353222,323.17661097852,625.649164677804,1212.6491646778,490.303102625298,555.704057279236,1059.99284009547,130.589498806683,419,25.0538336064681,21.4200348521678,0.518693325182268,0.95662100456621,0.761818181818182,1.30960647309444,53579.8162291169,33796.3412887828,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_44307,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
44519,2701.00356506239,272.160427807487,108.26559714795,625.96256684492,1145.19251336898,907.814616755793,518.224598930481,257.381461675579,1091.39572192513,4629.02139037433,782.72192513369,122.005347593583,1074.13725490196,2310.8431372549,1100.21390374332,756.101604278075,1755.61497326203,2866.94295900178,365.251336898396,240.44385026738,1031.29946524064,2700.44563279857,267.588235294118,292.028520499109,641.654188948307,2306.73440285205,594.345811051693,381.142602495544,1053.86274509804,130.281639928699,561,30.2874431845088,23.5974719378297,0.62687812405671,0.972270363951473,0.81304347826087,-0.0086861595740202,53584.0926916221,33339.7843137255,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_44519,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
44596,2337.47317073171,395.4,164.204878048781,649.49512195122,2490.98048780488,421.592682926829,330.834146341463,257.619512195122,1116.61951219512,3765.5,724.160975609756,140.775609756098,1064.54634146341,885.509756097561,484.273170731707,283.458536585366,1558.70243902439,960.50243902439,201.748780487805,211.282926829268,1202.55853658537,630.675609756098,139.9,112.692682926829,593.241463414634,873.617073170732,438.170731707317,223.978048780488,1041.91707317073,130.60243902439,410,33.2239692496655,15.918605147543,0.877743872540612,0.946882217090069,0.689075630252101,-1.52375123976776,52508.3219512195,32513.1341463415,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,1,FAAGSCC_12_44596,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
44830,4428.53642384106,1105.60927152318,137.006622516556,641.73178807947,1645.57947019868,663.87417218543,321.473509933775,248.533112582781,1100.08609271523,7392.12913907285,587.109271523179,122.917218543046,1092.3642384106,1485.61589403974,650.03642384106,285.94701986755,1679.89735099338,1757.58940397351,294.46357615894,226.218543046358,1053.03973509934,1435.23509933775,216.94701986755,616.569536423841,889.168874172185,1786.11589403974,487.860927152318,244.056291390728,1044.45033112583,130.82119205298,302,22.4149298653556,17.1678399263295,0.642946683047811,0.961783439490446,0.762626262626263,1.2306345500075,53730.3774834437,33440.5,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_44830,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
45606,4080.72674418605,297.220930232558,100.779069767442,651.994186046512,1632.88662790698,2176.28779069767,1595.20058139535,260.627906976744,1093.18895348837,6664.24418604651,1131.96511627907,146.293604651163,1074.61337209302,4160.18895348837,1006.13662790698,1432.75,2125.12209302326,4566.8023255814,406.334302325581,244.389534883721,1070.68313953488,3797.95348837209,259.456395348837,348.642441860465,658.671511627907,2217.79651162791,529.459302325581,422.569767441861,1077.87209302326,131.375,344,23.0951657918332,19.0817180821206,0.563345676027926,0.96358543417367,0.747826086956522,-1.33761582958967,53362.2558139535,33780.3546511628,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_45606,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
45608,2039.54881266491,377.081794195251,101.321899736148,613.527704485488,735.174142480211,1048.12401055409,819.836411609499,254.696569920844,1086.41688654354,4103.28496042216,710.282321899736,143.889182058047,1070.1635883905,896.580474934037,459.633245382586,344.973614775726,1444.35883905013,1086.36411609499,261.625329815303,220.461741424802,977.686015831135,1052.63324538259,199.963060686016,121.445910290237,590.503957783641,1814.38786279683,507.058047493404,304.324538258575,1039.34564643799,129.155672823219,379,23.1603853868807,21.0262592171995,0.419285434595101,0.964376590330789,0.784679089026915,-1.35218788713056,54160.0026385224,32770.9023746702,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_45608,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
45666,2421.47228915663,440.990361445783,114.573493975904,653.53734939759,1990.22891566265,727.6,375.614457831325,237.187951807229,1077.03855421687,3589.61204819277,1804.51325301205,129.636144578313,1075.33012048193,767.640963855422,486.930120481928,431.363855421687,2755.99277108434,1332.88915662651,252.380722891566,221.95421686747,1012.5686746988,1261.28192771084,190.224096385542,231.46265060241,602.580722891566,1120.65301204819,506.886746987952,340.226506024096,1052.30120481928,130.775903614458,415,28.0680207921415,18.9351086925022,0.738169737334732,0.947488584474886,0.691666666666667,-0.725336464577401,52725.4819277108,33707.2602409639,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_45666,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
46015,4117.32110091743,1221.20795107034,129.993883792049,639.440366972477,1578.11926605505,277.749235474006,298.253822629969,248.730886850153,1076.81345565749,7681.40061162079,596.403669724771,125.74006116208,1083.14067278287,637.360856269113,482.464831804281,269.39755351682,1400.62385321101,990.015290519878,271.018348623853,221.247706422018,988.042813455657,949.761467889908,222.807339449541,123.186544342508,582.162079510703,1554.77370030581,481.140672782875,229.749235474006,1036.44036697248,129.951070336391,327,21.9401584902171,19.026407193928,0.497967796833402,0.950581395348837,0.743181818181818,-1.40087056012541,54158.8562691132,33093.370030581,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_46015,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
46428,2696.38486842105,213.69572368421,126.539473684211,685.162828947368,2235.92434210526,2165.12664473684,2011.11842105263,261.455592105263,1104.04605263158,4025.40131578947,533.046052631579,134.506578947368,1083.66118421053,3765.8240131579,1034.34703947368,919.74177631579,2382.25328947368,4808.02960526316,522.036184210526,246.432565789474,1080.47203947368,4293.1990131579,264.800986842105,752.276315789474,603.40625,1200.66776315789,489.162828947368,686.824013157895,1048.75493421053,129.560855263158,608,30.5475063803145,25.8871957167021,0.530890297696224,0.965079365079365,0.806366047745358,1.38631674504946,53554.7384868421,33813.3092105263,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_46428,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
46500,2265.54026354319,383.525622254759,114.016105417277,628.546120058565,1235.44509516837,1116.69838945827,452.06588579795,261.421669106881,1087.74231332357,4450.41434846266,1529.98535871157,119.493411420205,1066.76866764275,1578.57979502196,512.805270863836,283.866764275256,1537.43191800878,1384.8345534407,247.900439238653,214.758418740849,992.345534407028,1142.4055636896,184.409956076135,165.364568081991,797.354319180088,1919.06442166911,497.657393850659,488.88140556369,1066.76134699854,131.269399707174,683,33.0085044710655,26.5435893988628,0.594434602354635,0.971550497866287,0.762276785714286,1.08723624693034,53725.4172767203,32352.9194729136,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_46500,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
46607,4180.5487804878,550.350609756098,130.765243902439,650.048780487805,1662.93902439024,289.100609756098,328.618902439024,260.536585365854,1080.97256097561,6252.3993902439,1201.13109756098,126.746951219512,1076.60975609756,599.378048780488,466.990853658537,271.814024390244,1382.28658536585,892.390243902439,272.515243902439,225.344512195122,989.268292682927,799.137195121951,201.536585365854,127.887195121951,588.384146341463,1315.0762195122,437.134146341463,294.201219512195,1053.91158536585,131.451219512195,328,22.453193859477,18.6383314438984,0.557618848113465,0.961876832844575,0.750572082379863,1.52759354673347,52650.7530487805,32303.5884146341,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_46607,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
46886,4490.85161290323,947.041935483871,130.91935483871,661.909677419355,2091.91935483871,321.545161290323,693.993548387097,235.132258064516,1076.3935483871,7409.87096774194,659.667741935484,130.138709677419,1113.29677419355,883.2,641.716129032258,1098.65806451613,2904.24516129032,1399.76451612903,283.887096774194,227.4,1025.97096774194,1384.52903225806,211.083870967742,363.948387096774,721.470967741936,2038.90322580645,513.741935483871,290.183870967742,1067.52258064516,132.241935483871,310,22.2038440790327,17.8905379364665,0.592268636124836,0.959752321981424,0.828877005347594,-1.5631664256131,52833.3064516129,33642.1322580645,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_46886,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
47245,1351.24234234234,491.631531531531,172.696396396396,669.774774774775,3491.91531531532,611.53963963964,585.916216216216,280.176576576577,1130.94594594595,2131.22072072072,912.657657657658,132.444144144144,1069.37477477477,1365.14684684685,807.714414414414,399.898198198198,1751.9027027027,2097.32342342342,321.33963963964,235.990990990991,1029.72882882883,1950.02432432432,230.042342342342,965.568468468468,1141.11531531532,800.6,464.855855855856,221.428828828829,1020.92342342342,129.624324324324,1110,50.730019356368,27.9225952216473,0.834890796259935,0.977112676056338,0.822222222222222,-0.086867915878423,52422.3558558559,32806.3072072072,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_47245,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
47434,3930.4109947644,226.795811518325,113.180628272251,691.32722513089,3510.40314136126,1071.02356020942,389.060209424084,256.277486910995,1148.21204188482,6158.16230366492,954.434554973822,122.507853403141,1094.99738219895,784.34554973822,387.806282722513,325.094240837696,1531.61780104712,1067.48429319372,292.251308900524,543.157068062827,1037.47120418848,864.15445026178,180.164921465968,256.591623036649,619.952879581152,1631.5890052356,494.756544502618,560.664921465969,1074.19109947644,131.819371727749,382,24.1221454644238,20.3420439433623,0.537453616405793,0.969543147208122,0.790890269151139,-1.1652667238357,53735.1465968586,33679.9947643979,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_47434,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
48905,2611.11608961303,270.146639511202,124.230142566191,624.236252545825,1366.34012219959,339.584521384929,393.22199592668,263.50916496945,1084.1283095723,3934.34012219959,540.446028513238,120.431771894094,1074.45417515275,898.134419551935,564.600814663951,286.181262729124,1441.91853360489,1498.59877800407,334.496945010183,234.698574338086,979.095723014257,1825.16293279022,235.026476578411,159.659877800407,582.706720977597,1106.98574338086,460.877800407332,223.040733197556,1037.76578411405,130.537678207739,491,26.4080289400938,23.6820289890009,0.442489226894045,0.974206349206349,0.821070234113712,-0.205320164892246,52738.1018329939,33314.6272912424,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_48905,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
48913,2721.93333333333,485.625,141.541666666667,652.689583333333,1978.24166666667,2363.34375,573.360416666667,258.852083333333,1097.94375,4383.00416666667,2464.2125,145.329166666667,1078.54791666667,3675.54583333333,755.404166666667,391.958333333333,3699.125,4771.14791666667,396.975,245.270833333333,1043.1875,5144.35833333333,265.09375,298.010416666667,597.079166666667,1499.09583333333,508.633333333333,361.633333333333,1071.84791666667,131.227083333333,480,34.7244944152539,17.6492142993046,0.861201250009679,0.95427435387674,0.613026819923372,0.832331210416396,53304.1541666667,33767.0083333333,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_48913,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
49056,4501.4478021978,213.75,188.450549450549,701.07967032967,4805.54120879121,1594.84340659341,3966.23901098901,256.31043956044,1090.8021978022,7221.28571428571,594.486263736264,133.346153846154,1097.06318681319,976.052197802198,658.406593406593,616.307692307692,1766.78296703297,1430.81593406593,302.821428571429,228.524725274725,1006.46703296703,1191.39010989011,209.315934065934,156.989010989011,609.89010989011,1734.10714285714,496.228021978022,241.601648351648,1072.31043956044,131.447802197802,364,22.5943045721896,20.5387730879236,0.416742997829601,0.970666666666667,0.753623188405797,0.377658618300581,52935.7335164835,33413.5604395604,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_49056,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
49258,3548.55844155844,336.78961038961,127.402597402597,625.246753246753,1038.87792207792,618.758441558442,266.542857142857,236.563636363636,1075.91688311688,4905.84155844156,543.451948051948,120.475324675325,1077.74285714286,817.238961038961,498.041558441558,283.327272727273,1662.52467532468,1234.30649350649,291.361038961039,234.096103896104,1007.58701298701,1048.98701298701,210.197402597403,232.418181818182,956.968831168831,822.571428571429,429.314285714286,222.472727272727,1023.08051948052,132.792207792208,385,25.0569814706666,19.6555252151366,0.620213462411989,0.952970297029703,0.733333333333333,-1.33880721989506,52495.0623376623,33575.7636363636,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_49258,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
49292,1415.7342519685,387.683070866142,122.007874015748,643.450787401575,1916.59842519685,847.879921259842,354.952755905512,264.145669291339,1108.60826771654,2863.87992125984,958.82874015748,126.885826771654,1072.97637795276,1985.01968503937,671.466535433071,300.411417322835,1927.75393700787,2478.9094488189,314.277559055118,226.021653543307,1100.34842519685,1760.79527559055,201.005905511811,382.322834645669,3548.40748031496,1077.12007874016,488.944881889764,245.86811023622,1048.52362204724,131.125984251969,508,29.7497421917409,21.784687116515,0.681020085014874,0.967619047619048,0.76969696969697,-1.51868030593532,52587.7086614173,32510.1082677165,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_49292,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
49343,3171.24928366762,166.9111747851,109.779369627507,677.266475644699,1028.28653295129,307.570200573066,300.985673352436,255.934097421203,1081.46991404011,5541.40974212034,725.065902578797,121.045845272206,1178.90544412607,790.43553008596,516.971346704871,274.446991404011,1473.05730659026,2924.02005730659,354.249283667622,232.997134670487,1060.53581661891,2453.80515759312,218.309455587393,147.246418338109,586.47564469914,1777.46418338109,512.862464183381,325.613180515759,1042.8223495702,130.676217765043,349,23.3148844421977,19.2797564812246,0.56230619630825,0.972144846796657,0.79862700228833,-1.23608047194577,53525.9570200573,32657.452722063,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_49343,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
49349,3426.71327014218,508.665876777251,163.857819905213,650.156398104265,2226.4644549763,2312.336492891,1060.72274881517,244.881516587678,1094.95260663507,5708.65402843602,672.476303317536,123.388625592417,1081.98578199052,2818.07345971564,594.189573459716,364.57345971564,1885.24644549763,2268.93838862559,310.194312796209,226.976303317536,1017.35545023697,1685.00236966825,217.526066350711,258.969194312796,660.594786729858,2314.86255924171,556.68009478673,307.357819905213,1056.38862559242,129.834123222749,422,27.1650131457246,19.9137518408072,0.680157339742046,0.959090909090909,0.811538461538462,-1.30846659058613,53674.3815165877,33696.2677725118,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_49349,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
49369,4031.26785714286,727.940476190476,108.630952380952,641.532738095238,1634.70238095238,4446.33035714286,701.97619047619,266.401785714286,1094.08333333333,6585.37202380952,754.27380952381,125.598214285714,1086.08630952381,5761.36607142857,1182.68154761905,631.28869047619,9107.875,4478.3005952381,385.035714285714,244.35119047619,1050.75297619048,3270.55357142857,250.08630952381,292.1875,783.291666666667,2459.79761904762,524.860119047619,244.41369047619,1060.77380952381,131.270833333333,336,25.2367974100194,17.0066397871082,0.738838399734251,0.96,0.746666666666667,1.36817286308964,52865.4077380952,33643.4583333333,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_49369,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
49964,3081.61111111111,231.161111111111,110.013888888889,636.341666666667,1758.43055555556,726.558333333333,1107.79166666667,249.172222222222,1083.775,5888.61944444444,543.669444444444,121.027777777778,1075.2,1394.375,1326.11944444444,1319.57777777778,1718.99166666667,1290.58888888889,256.322222222222,215.6,1004.43888888889,1108.99722222222,186.805555555556,354.483333333333,713.430555555556,1953.16111111111,499.358333333333,273.983333333333,1039.46944444444,130.325,360,24.755890157094,18.6109247436511,0.659416693777877,0.96514745308311,0.779220779220779,-0.826012883095138,54067.1444444444,32735.425,FAAGSCC_12,AG,1,M2 macrophages,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_49964,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
50024,2102.61338289963,452.788104089219,119.223048327138,616.014869888476,473.444237918216,459.315985130112,335.843866171004,258.775092936803,1078.96468401487,4393.3717472119,666.241635687732,120.581784386617,1073.89591078067,3587.85501858736,731.526022304833,285.210037174721,1526.59479553903,5098.20260223048,344.797397769517,234.585501858736,1010.67286245353,4645.16356877323,233.031598513011,186.388475836431,584.827137546468,2000.16171003717,559.591078066915,242.957249070632,1039.05576208178,128.836431226766,538,28.0263243284384,24.5013671830312,0.485517551888765,0.96588868940754,0.797037037037037,-1.16605032943695,53783.624535316,33207.1356877323,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_50024,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
51593,1963.23955431755,149.016713091922,76.8732590529248,634.618384401114,1748.36490250696,267.910863509749,285.863509749304,256.736768802228,1077.27019498607,3684.6643454039,741.509749303621,124.444289693593,1069.56267409471,686.991643454039,532.458217270195,274.305013927577,1361.04317548747,1087.08356545961,340.143454038997,234.448467966574,978.91504178273,1062.13509749304,248.674094707521,123.267409470752,587.012534818942,1118.95264623955,482.055710306407,234.58774373259,1059.12813370474,130.479108635098,718,39.9485530357773,23.3668699806973,0.811088059154165,0.957333333333333,0.747916666666667,1.54536883734781,53329.7855153203,32639.6782729805,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_51593,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
51621,2355.17396184063,551.058361391695,313.198653198653,626.283950617284,965.914702581369,951.683501683502,3183.3569023569,255.416386083053,1106.20426487093,3173.63748597082,603.182940516274,118.985409652076,1075.74747474747,2572.73512906846,1250.59147025814,1352.31762065095,3016.3569023569,3543.22109988777,398.260381593715,245.301907968575,1080.73288439955,2704.52076318743,240.928170594837,1265.94163860831,709.061728395062,930.887766554433,486.470258136925,259.86531986532,1008.86307519641,129.497194163861,891,37.0774291095311,32.0317141768527,0.503639166700882,0.915724563206578,0.63371266002845,-0.510275953039496,53488.2053872054,33373.8204264871,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_51621,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
52244,3155.21066666667,391.506666666667,127.08,630.8,1643.04266666667,300.256,299.762666666667,252.850666666667,1078.98133333333,6375.23733333333,1862.45066666667,125.216,1068.81333333333,696.261333333333,430.562666666667,266.0,1381.424,1116.20533333333,282.68,225.901333333333,980.602666666667,1028.48266666667,213.176,133.2,582.917333333333,3149.624,543.776,770.848,1070.19733333333,130.517333333333,375,28.6443035245452,16.8762655174641,0.808011618117998,0.968992248062015,0.744047619047619,1.27552396647333,52998.7946666667,33217.824,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_52244,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
52331,4462.07396449704,313.736686390532,158.171597633136,648.896449704142,2559.83431952663,376.973372781065,267.233727810651,235.047337278107,1084.4201183432,7383.14201183432,597.396449704142,120.665680473373,1107.65384615385,3285.51775147929,636.183431952663,305.639053254438,1883.55621301775,4676.24556213018,360.579881656805,236.58875739645,1034.9349112426,3785.07100591716,235.292899408284,300.58875739645,2174.62130177515,1951.36982248521,507.03550295858,253.647928994083,1050.37869822485,131.257396449704,338,23.3202988095843,18.5463784084671,0.606230417082879,0.957507082152974,0.773455377574371,-1.49173253744809,53753.5295857988,33442.3934911243,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_52331,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
52394,3339.15652173913,659.304347826087,141.721739130435,635.095652173913,1478.57826086957,1081.08695652174,1562.60869565217,244.904347826087,1090.19565217391,5381.05217391304,2305.60434782609,121.073913043478,1094.27826086957,1614.99565217391,705.882608695652,967.665217391304,1960.97826086956,3216.52608695652,292.778260869565,225.2,1047.97826086957,3427.99565217391,213.152173913043,250.95652173913,608.369565217391,1721.1347826087,499.85652173913,271.426086956522,1050.47391304348,132.282608695652,230,19.0371185638369,15.4887771907859,0.581411958726455,0.974576271186441,0.751633986928105,-0.603297779255919,53285.5086956522,33624.3913043478,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_52394,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
52515,3187.13725490196,431.937254901961,575.239215686275,679.756862745098,3913.54509803922,842.341176470588,655.070588235294,233.705882352941,1093.52156862745,5566.26274509804,542.094117647059,123.717647058824,1080.67843137255,3257.01960784314,776.109803921569,429.901960784314,4918.19215686274,5204.50588235294,339.23137254902,234.149019607843,1028.31764705882,5503.15294117647,242.494117647059,213.521568627451,619.380392156863,2243.71764705882,526.686274509804,326.517647058824,1049.55294117647,130.956862745098,255,22.5980001801842,14.459161475101,0.768506047043245,0.955056179775281,0.739130434782609,1.42379450487029,53003.2823529412,33526.5490196078,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_52515,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
52938,3138.27121771218,910.782287822878,2079.35055350554,648.531365313653,2508.93173431734,267.929889298893,256.549815498155,242.607011070111,1081.92988929889,4488.48339483395,674.852398523985,125.588560885609,1076.27675276753,710.245387453875,472.749077490775,268.972324723247,1456.49446494465,1126.30073800738,271.909594095941,219.116236162362,1031.15867158672,996.621771217712,191.988929889299,255.872693726937,1051.79151291513,1016.52398523985,468.365313653137,274.627306273063,1042.94095940959,130.577490774908,542,29.6124431788963,23.3807921036241,0.613673741834319,0.974820143884892,0.772079772079772,0.834680043347681,53167.4188191882,32814.9594095941,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_52938,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
53571,1839.26702997275,483.626702997275,103.907356948229,624.435967302452,1137.58038147139,543.942779291553,354.904632152589,264.653950953678,1113.98910081744,3816.81198910082,1385.20163487738,113.893732970027,1072.57765667575,861.234332425068,445.544959128065,277.144414168937,1487.28882833787,938.272479564033,187.874659400545,208.689373297003,1180.05722070845,637.065395095368,135.226158038147,102.801089918256,584.724795640327,1088.50136239782,448.073569482289,308.032697547684,1040.74386920981,130.392370572207,367,26.7923470617018,17.482646802708,0.757768143660237,0.955729166666667,0.742914979757085,-1.21736843336889,53730.5558583106,32745.9564032698,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_53571,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
54063,2660.43612334802,198.334801762114,122.339207048458,660.687224669604,2621.50660792952,3263.46696035242,1521.03083700441,272.603524229075,1139.63876651982,3461.73127753304,500.995594713656,131.229074889868,1067.140969163,637.211453744493,524.925110132159,684.872246696035,1413.44933920705,804.154185022026,215.330396475771,212.123348017621,979.370044052864,724.511013215859,166.20704845815,119.211453744493,591.506607929515,813.550660792952,400.26872246696,210.766519823789,1023.74889867841,130.594713656388,227,20.5773997178518,14.0974363353073,0.728455438785399,0.93801652892562,0.756666666666667,1.36173060534343,53225.7709251101,32088.8502202643,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_54063,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
54069,3484.49340369393,725.873350923483,170.284960422164,656.192612137203,2256.2110817942,1742.08970976253,349.366754617414,245.720316622691,1087.6253298153,4382.49340369393,638.316622691293,118.292875989446,1080.8364116095,3142.38258575198,681.232189973615,295.353562005277,2043.85488126649,3953.69129287599,362.31926121372,239.02110817942,1077.11081794195,3436.36675461741,249.688654353562,239.807387862797,1896.29023746702,821.002638522427,435.76253298153,423.775725593668,1012.09498680739,130.76253298153,379,26.707717777545,18.2142644653062,0.731366105496744,0.969309462915601,0.797894736842105,-0.351708241719102,53637.8759894459,33635.8522427441,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_54069,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
54367,3118.13879003559,508.548042704626,142.932384341637,667.814946619217,2749.22775800712,463.010676156584,343.612099644128,255.690391459075,1126.9537366548,5816.871886121,1493.00355871886,135.046263345196,1069.60142348754,867.202846975089,486.238434163701,295.259786476868,1542.21352313167,1029.79715302491,208.875444839858,214.633451957295,1391.84341637011,627.654804270463,142.44128113879,121.142348754448,587.775800711744,1830.39145907473,496.555160142349,688.626334519573,1081.12455516014,132.508896797153,281,22.2098724356248,16.1171613689041,0.688037061390891,0.965635738831615,0.787114845938375,-1.15028186107991,52594.8185053381,32971.7580071174,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_54367,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
54489,2570.01954397394,283.250814332248,115.117263843648,626.0,1070.34853420195,241.045602605863,294.684039087948,248.644951140065,1077.2345276873,4118.55700325733,771.345276872964,126.71661237785,1116.99022801303,536.407166123779,402.820846905538,295.517915309446,1415.61237785016,865.019543973941,238.074918566775,220.055374592834,1005.35830618893,780.087947882736,179.547231270358,129.241042345277,623.032573289902,1377.85993485342,471.599348534202,222.416938110749,1065.21172638436,129.420195439739,307,22.1103743090618,17.805773049757,0.592849800368572,0.959375,0.812169312169312,-1.3787218374763,52724.7035830619,32272.8925081433,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_54489,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
54690,3073.91163793103,409.224137931034,101.838362068966,659.993534482759,2223.67025862069,1222.65086206897,576.185344827586,259.284482758621,1092.56034482759,4822.78448275862,1978.04310344828,132.534482758621,1074.5,918.995689655172,718.5,1076.32974137931,2217.04310344828,1951.35344827586,318.226293103448,228.616379310345,1087.86853448276,1853.41810344828,232.32974137931,868.995689655172,1032.64224137931,1150.67672413793,452.640086206897,335.79525862069,1076.02370689655,132.752155172414,464,27.8939837230895,21.2871900262614,0.646225772548544,0.97071129707113,0.775919732441472,-0.558723037236091,52417.4568965517,32565.1724137931,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_54690,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
55876,1778.51652892562,452.413223140496,115.417355371901,625.760330578512,1504.85123966942,1552.37603305785,598.495867768595,242.772727272727,1092.57851239669,3698.27685950413,2632.4173553719,111.623966942149,1069.12809917355,642.268595041322,414.661157024793,286.404958677686,1403.04132231405,1046.9132231405,260.925619834711,634.099173553719,997.495867768595,913.739669421488,191.876033057851,146.446280991736,592.326446280992,1234.35123966942,470.710743801653,414.330578512397,1034.7520661157,130.615702479339,242,21.0075875435197,14.8280318528737,0.708369577056307,0.952755905511811,0.720238095238095,1.25243261018208,53916.6239669421,33151.3925619835,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_55876,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
56304,3751.25196850394,449.283464566929,56.6561679790026,616.979002624672,765.312335958005,2434.29658792651,514.577427821522,243.884514435696,1082.4750656168,5778.34120734908,737.803149606299,115.049868766404,2728.23097112861,898.503937007874,599.02624671916,408.267716535433,1523.23097112861,1265.36220472441,358.839895013123,240.286089238845,998.784776902887,1248.06036745407,264.695538057743,203.464566929134,590.299212598425,1266.28608923885,458.488188976378,269.341207349081,1029.68503937008,128.716535433071,381,22.6594381182336,21.6307047030857,0.297889933304137,0.964556962025316,0.824675324675325,-0.101864156288612,53560.0236220472,33505.750656168,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX+,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_56304,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
56527,909.165957446808,196.109929078014,83.9673758865248,637.285815602837,2151.80496453901,473.305673758865,572.468794326241,264.613475177305,1086.90354609929,1206.84893617021,1552.47588652482,125.378723404255,1068.05744680851,651.479432624113,616.383687943262,283.432624113475,1464.93262411348,960.054609929078,277.524822695035,225.81134751773,985.190070921986,855.641134751773,214.657446808511,134.893617021277,584.781560283688,929.623404255319,522.126241134752,305.373758865248,1032.78723404255,129.504964539007,1410,49.2877888944477,36.4673479957047,0.672732202500955,0.978487161693268,0.762987012987013,-0.864376229872564,52247.7141843972,32683.5879432624,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_56527,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
57335,2857.98324022346,821.944134078212,142.826815642458,643.72905027933,1775.42458100559,753.969273743017,348.393854748603,255.435754189944,1131.89664804469,4116.15642458101,2420.42458100559,124.949720670391,1081.38268156425,886.810055865922,606.243016759777,293.069832402235,1792.0251396648,1169.5530726257,272.178770949721,226.977653631285,1021.49720670391,1008.96927374302,210.491620111732,247.041899441341,870.832402234637,1225.27094972067,543.488826815642,634.932960893855,1053.96089385475,130.550279329609,358,23.2604797990511,19.773969705177,0.526604930000108,0.972826086956522,0.778260869565217,1.41784695241827,54085.7206703911,33364.905027933,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_57335,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
57456,2497.79891304348,535.038043478261,138.413043478261,626.157608695652,1265.03532608696,476.603260869565,1243.85054347826,257.557065217391,1096.3097826087,3557.65489130435,1560.32608695652,124.682065217391,1066.9347826087,614.60597826087,613.195652173913,473.491847826087,1470.44565217391,937.51902173913,302.432065217391,235.736413043478,987.785326086956,878.239130434783,226.747282608696,145.14402173913,593.589673913043,1034.01630434783,460.445652173913,367.532608695652,1055.64673913043,130.464673913043,368,23.4983475205691,19.9641732111982,0.527429134346643,0.976127320954907,0.834467120181406,0.835927734920384,52411.972826087,32910.0434782609,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_57456,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
57492,4263.40697674419,296.44476744186,67.7674418604651,651.502906976744,2261.81395348837,1124.90406976744,1841.4011627907,250.845930232558,1093.73546511628,5932.6773255814,670.063953488372,141.029069767442,1079.4738372093,2545.54941860465,621.279069767442,943.002906976744,1823.77325581395,4114.81686046512,382.822674418605,240.34011627907,1031.66860465116,3583.91569767442,243.406976744186,228.037790697674,638.34011627907,1384.5261627907,500.976744186047,390.345930232558,1059.63662790698,131.566860465116,344,21.4486710343646,20.5471254640334,0.286877418946547,0.977272727272727,0.780045351473923,0.62306608625593,53478.1511627907,33761.8895348837,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_57492,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
57611,4019.7106918239,761.801886792453,96.8490566037736,639.861635220126,1656.41509433962,1666.93710691824,438.194968553459,238.179245283019,1086.69496855346,5316.23899371069,618.465408805031,123.905660377358,1084.16037735849,1383.25786163522,575.025157232704,349.650943396226,1847.28301886792,2355.26729559748,313.364779874214,234.814465408805,1057.08176100629,1779.57547169811,203.572327044025,174.842767295597,592.827044025157,1235.11006289308,501.03144654088,298.88679245283,1033.30817610063,130.559748427673,318,21.0992533870805,19.2078627714811,0.413822776919263,0.969512195121951,0.795,0.836939715109618,53014.2672955975,33562.4402515723,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_57611,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
57948,3884.66465256798,788.719033232628,92.380664652568,631.404833836858,1587.32628398792,4170.32326283988,1028.71299093656,259.737160120846,1163.48036253776,6370.19033232628,539.187311178248,117.456193353474,1090.46525679758,1457.47734138973,549.580060422961,414.368580060423,1580.67673716012,1670.38972809668,289.196374622356,228.764350453172,1006.32326283988,1695.87009063444,217.441087613293,177.141993957704,591.918429003021,1365.44712990937,464.299093655589,242.030211480363,1031.2416918429,129.353474320242,331,21.3988946464489,19.7923788450918,0.3801489276319,0.953890489913545,0.716450216450216,0.961473968383212,53907.8731117825,33608.1782477341,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_57948,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
58461,2002.55147058824,271.272058823529,84.1789215686274,629.051470588235,1272.05882352941,1915.18137254902,325.259803921569,256.335784313725,1107.42892156863,3829.19607843137,2960.48039215686,119.875,1078.57598039216,1039.83088235294,503.531862745098,273.671568627451,1671.52696078431,954.232843137255,205.617647058824,212.424019607843,1116.07107843137,743.879901960784,151.382352941176,127.335784313725,1918.74264705882,1073.97549019608,461.428921568627,319.46568627451,1041.73284313725,128.759803921569,408,24.976594267501,20.9373297360111,0.545243045036198,0.964539007092198,0.772727272727273,1.11439941345638,53228.7034313726,33088.1397058823,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_58461,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
58975,2262.28621908127,566.678445229682,1291.87632508834,618.339222614841,720.86925795053,2633.63957597173,562.908127208481,262.487632508834,1142.93286219081,3836.87632508834,785.268551236749,108.883392226148,1063.02120141343,2664.82332155477,863.296819787986,324.484098939929,1644.81978798587,1690.78445229682,269.332155477032,222.360424028269,1014.96466431095,1128.20848056537,200.621908127208,159.791519434629,656.469964664311,781.194346289753,425.840989399293,403.643109540636,1013.41342756184,130.385159010601,283,20.3591482607397,17.7739276424917,0.487685810125295,0.969178082191781,0.786111111111111,-0.364261082125596,53672.6855123675,33306.7703180212,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_58975,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
59129,4340.37572254335,984.130057803468,129.895953757225,655.49710982659,1917.28901734104,1444.90173410405,533.421965317919,252.037572254335,1096.56069364162,6530.00867052023,714.309248554913,119.040462427746,1073.60693641618,2019.78323699422,750.754335260116,472.179190751445,1723.84104046243,2455.72543352601,347.095375722543,241.543352601156,1047.50578034682,2335.48843930636,259.343930635838,887.063583815029,1021.59826589595,1964.7774566474,529.028901734104,372.684971098266,1062.34971098266,131.196531791908,346,22.3503539327925,19.8383065810575,0.460603649084922,0.95054945054945,0.786363636363636,-1.49656383318225,53493.6907514451,33646.7803468208,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_59129,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
59391,2933.79569892473,361.897849462366,100.760752688172,627.096774193548,931.69623655914,272.685483870968,4403.48655913978,247.666666666667,1080.37365591398,5632.43817204301,1587.18548387097,117.833333333333,1086.16935483871,706.516129032258,500.091397849462,361.228494623656,1547.16666666667,1301.54032258065,310.309139784946,228.389784946236,1049.93817204301,1176.20161290323,208.491935483871,578.27688172043,766.333333333333,1824.77688172043,504.11559139785,346.615591397849,1049.99193548387,131.833333333333,372,24.5094861415148,19.3663906250371,0.612901935688301,0.971279373368146,0.815789473684211,-1.50383039154507,53239.0483870968,33216.1827956989,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_59391,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
59518,2195.41168289291,590.044506258693,146.331015299026,632.351877607789,1537.9471488178,260.083449235049,293.56050069541,246.015299026426,1082.02364394993,3068.98470097357,1050.15438108484,115.870653685675,1066.67315716273,632.467315716273,520.290681502086,272.730180806676,1502.76773296245,1018.44228094576,275.842837273992,228.058414464534,978.867872044506,974.290681502086,212.808066759388,139.702364394993,579.089012517385,939.38942976356,493.357440890125,237.043115438108,1029.41585535466,129.04033379694,719,34.9580225788245,26.2381552728027,0.660800295617428,0.980900409276944,0.78322440087146,-0.346582605622411,52386.504867872,33213.0584144645,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_59518,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
60089,3024.16,632.067692307692,86.1538461538462,632.907692307692,1860.65846153846,582.593846153846,891.433846153846,252.806153846154,1154.04923076923,5199.45230769231,496.249230769231,130.655384615385,1071.61538461538,2089.66153846154,889.655384615385,578.621538461538,1809.60615384615,3270.40615384615,471.083076923077,252.738461538462,1028.93846153846,2803.00923076923,348.809230769231,284.972307692308,587.470769230769,2156.33846153846,516.104615384615,296.4,1049.28,130.430769230769,325,22.6546168418383,18.3045348184841,0.589206430647444,0.961538461538462,0.773809523809524,-1.02878850959632,53649.92,33796.2153846154,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_60089,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
60264,4382.65189873418,357.563291139241,1026.62341772152,684.873417721519,3802.84810126582,289.430379746835,295.778481012658,250.756329113924,1077.93670886076,6910.99683544304,1516.4082278481,135.028481012658,1072.87341772152,729.006329113924,495.082278481013,271.54746835443,1417.17405063291,1088.66139240506,298.120253164557,225.867088607595,984.275316455696,984.594936708861,213.927215189873,142.946202531646,579.670886075949,2071.61075949367,526.25,396.370253164557,1064.76582278481,132.705696202532,316,21.1584215836883,19.0312933703395,0.436989529033511,0.966360856269113,0.791979949874687,-0.183723636286482,52842.3101265823,33176.1455696203,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_60264,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
60280,3288.06115107914,586.0,129.525179856115,676.388489208633,3564.58633093525,1454.51079136691,2443.52517985612,251.003597122302,1132.06115107914,4702.88489208633,626.557553956835,130.010791366906,1089.40647482014,1087.36690647482,678.359712230216,615.58273381295,1792.01079136691,1367.86690647482,325.974820143885,234.726618705036,1002.25179856115,1248.21942446043,242.428057553957,174.938848920863,659.23381294964,1172.73021582734,467.0,255.384892086331,1038.09712230216,131.913669064748,278,23.2832226865119,15.3430257785596,0.752166192409425,0.952054794520548,0.755434782608696,-1.35104504519628,53075.5755395683,33593.4856115108,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_60280,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
60586,3658.55524861878,1113.38121546961,721.698895027624,673.060773480663,2770.3729281768,286.853591160221,282.494475138122,244.668508287293,1076.6408839779,5575.74585635359,2313.90607734807,130.698895027624,1075.30939226519,684.582872928177,465.116022099447,271.441988950276,1448.18232044199,1047.07458563536,283.397790055249,225.831491712707,989.930939226519,994.466850828729,216.049723756906,134.187845303867,607.914364640884,1103.74309392265,486.574585635359,987.002762430939,1059.95303867403,132.599447513812,362,22.4396122349424,20.592886865647,0.397268466508361,0.967914438502674,0.783549783549784,-1.39332178358131,53477.317679558,33268.3342541436,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_60586,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
60719,2756.38744588745,372.15367965368,113.74025974026,613.19696969697,729.816017316017,2298.14285714286,521.019480519481,259.45670995671,1089.93506493506,5722.79437229437,535.989177489177,117.484848484848,1078.90909090909,2353.07359307359,634.91341991342,565.138528138528,2803.19264069264,2178.70346320346,273.577922077922,221.632034632035,1018.14285714286,1847.48484848485,194.480519480519,201.0,643.885281385281,2203.17532467532,514.844155844156,292.536796536797,1050.49567099567,130.387445887446,462,29.2890073768006,20.207839548411,0.723860643599612,0.95850622406639,0.758620689655172,-1.44786136417312,53537.7727272727,33025.1948051948,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_60719,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
60949,3422.98711340206,557.610824742268,396.675257731959,628.948453608247,876.448453608247,3281.96391752577,1310.25773195876,259.548969072165,1156.15979381443,4069.75,549.118556701031,122.028350515464,1071.4587628866,4947.55412371134,1378.71134020619,480.546391752577,7864.35309278351,4178.87886597938,367.940721649484,241.65206185567,1044.9793814433,3167.43298969072,260.724226804124,1275.99742268041,671.938144329897,829.198453608247,427.463917525773,324.752577319588,1014.52319587629,129.213917525773,388,24.4271677214325,20.2518091761942,0.559146206746603,0.96039603960396,0.734848484848485,-0.873892482347951,52945.4484536082,33504.5953608247,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_60949,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
61017,5110.79924242424,702.545454545455,97.6893939393939,625.469696969697,1657.67424242424,1108.4053030303,1829.33712121212,239.219696969697,1093.9696969697,8398.25757575758,528.625,118.791666666667,1084.04924242424,1410.14393939394,955.231060606061,1436.43939393939,1769.99242424242,1336.57575757576,309.136363636364,225.481060606061,1027.98484848485,1221.39772727273,206.82196969697,213.348484848485,601.44696969697,2325.875,546.784090909091,241.92803030303,1056.70075757576,130.651515151515,264,23.1618620927679,14.5193547165038,0.779128098977185,0.963503649635036,0.75,1.19567889733637,53848.2424242424,33568.2840909091,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_61017,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
61557,3798.39444444444,387.916666666667,144.927777777778,628.3,1051.64166666667,302.188888888889,286.955555555556,232.233333333333,1085.00555555556,5135.875,976.038888888889,127.605555555556,1080.39444444444,778.616666666667,541.769444444444,280.833333333333,1509.1,1415.4,287.919444444444,229.130555555556,996.397222222222,1342.13888888889,211.719444444444,149.525,581.872222222222,1191.32777777778,514.605555555556,338.063888888889,1042.1,130.280555555556,360,23.8135474819555,19.4744756858363,0.575517054974363,0.952380952380952,0.75,-0.230589824092191,53138.8333333333,33443.6611111111,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_61557,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
62549,3291.45283018868,275.518867924528,107.59748427673,639.584905660377,1469.62893081761,506.040880503145,326.135220125786,252.965408805031,1096.5,5326.39622641509,514.955974842767,138.691823899371,1099.24213836478,1847.63522012579,679.974842767296,313.559748427673,1970.79245283019,1849.31132075472,359.374213836478,241.487421383648,1050.70440251572,1407.55031446541,237.141509433962,759.616352201258,4316.10377358491,2152.74842767296,520.276729559748,243.946540880503,1040.5534591195,129.657232704403,318,24.2089738155944,17.1962530055684,0.703873278079099,0.952095808383234,0.736111111111111,1.32506293228568,52950.9150943396,33847.1006289308,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_62549,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
62552,3017.24719101124,228.937078651685,149.514606741573,708.597752808989,4813.69438202247,688.424719101124,978.440449438202,248.901123595506,1095.12584269663,4954.12808988764,556.202247191011,130.348314606742,1120.22471910112,1550.40898876405,818.067415730337,1476.87865168539,1765.14831460674,2025.67865168539,340.725842696629,234.887640449438,1084.67865168539,1675.69662921348,234.541573033708,548.802247191011,1192.86741573034,1486.87865168539,489.885393258427,508.901123595506,1059.18202247191,129.907865168539,445,31.0659292924181,18.5860928777321,0.801287867840923,0.959051724137931,0.755517826825127,1.50847808984977,53534.6674157303,33708.3595505618,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_62552,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
63581,2718.0,154.06976744186,125.686046511628,655.697674418605,3190.8023255814,368.139534883721,292.46511627907,250.779069767442,1078.3488372093,4480.26744186046,500.488372093023,127.563953488372,1073.51162790698,2042.61627906977,544.21511627907,285.145348837209,1555.16279069767,3315.78488372093,326.651162790698,228.78488372093,1002.08720930233,3110.22674418605,1169.97093023256,162.604651162791,585.162790697674,1641.01744186047,513.546511627907,236.412790697674,1068.13953488372,129.06976744186,172,16.5924617143594,13.3846494366493,0.591001437931012,0.955555555555556,0.767857142857143,0.317381583932253,53572.5523255814,33176.8895348837,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_63581,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
63650,1921.48214285714,157.534226190476,89.0461309523809,640.66369047619,2392.31994047619,3472.2693452381,1938.76041666667,254.675595238095,1111.1994047619,3212.68303571429,822.479166666667,115.904761904762,1075.99255952381,2264.88392857143,789.111607142857,1075.24553571429,1998.52529761905,2158.43601190476,315.790178571429,231.087797619048,1025.96577380952,2234.90029761905,237.669642857143,360.235119047619,644.568452380952,1290.04017857143,504.016369047619,270.339285714286,1043.69791666667,130.662202380952,672,34.7860125581106,24.786064017494,0.701642040201972,0.96137339055794,0.738461538461539,1.46305112174325,53534.8050595238,33573.1220238095,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_63650,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
64029,4826.78353658537,324.899390243902,108.487804878049,663.393292682927,2460.03353658537,3923.34756097561,1116.74695121951,260.0,1114.8506097561,7487.3506097561,1448.57012195122,145.734756097561,1093.29573170732,6260.88414634146,1036.05182926829,1283.8993902439,6861.875,5841.4756097561,460.271341463415,249.731707317073,1459.60975609756,4245.26829268293,344.283536585366,467.253048780488,675.213414634146,2435.92073170732,567.146341463415,485.576219512195,1088.91768292683,132.353658536585,328,24.8672825500014,16.8125587366475,0.736817659367336,0.953488372093023,0.759259259259259,1.39406503858912,53216.5762195122,33774.2743902439,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_64029,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
64704,3996.25748502994,241.97005988024,152.601796407186,688.287425149701,4075.96107784431,1245.65269461078,776.700598802395,256.889221556886,1090.79341317365,6542.40119760479,820.218562874251,129.458083832335,1101.83832335329,913.497005988024,1047.38323353293,315.035928143713,2618.29041916168,1471.52395209581,339.973053892216,239.044910179641,1036.47604790419,1294.57784431138,238.104790419162,305.362275449102,771.293413173653,2097.37125748503,528.122754491018,332.137724550898,1082.08383233533,130.745508982036,334,22.8660019709994,18.6788568144618,0.576802873696253,0.973760932944606,0.806763285024155,-1.45486433629188,53079.6856287425,33570.245508982,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_64704,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
64728,3050.55578093306,296.898580121704,127.920892494929,622.182555780933,1176.57606490872,343.874239350913,333.15415821501,249.57200811359,1082.41176470588,4479.43610547667,689.30831643002,127.586206896552,1087.6369168357,729.004056795132,470.070993914807,267.513184584178,1452.43204868154,1022.53955375254,274.395537525355,224.760649087221,980.683569979716,925.799188640974,202.600405679513,128.831643002028,581.569979716024,1433.36105476673,524.649087221095,317.265720081136,1270.03651115619,139.391480730223,493,25.9718975826755,24.1994791868657,0.363084285032979,0.962890625,0.7888,1.14441077778558,52792.8174442191,33240.8194726166,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_64728,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
65462,3191.43107769424,932.135338345865,114.531328320802,651.416040100251,2385.90977443609,1305.34335839599,542.418546365915,258.390977443609,1113.14035087719,6035.97994987469,616.378446115288,119.817042606516,1081.59899749373,1257.66666666667,461.736842105263,458.761904761905,1642.14035087719,1148.32080200501,220.31328320802,346.636591478697,1230.81954887218,752.533834586466,145.684210526316,139.318295739348,592.674185463659,1504.74686716792,482.408521303258,235.388471177945,1044.68671679198,130.491228070175,399,25.2302138047091,20.2749736090343,0.595171159632129,0.956834532374101,0.730769230769231,-1.42420279800901,53834.3308270677,32755.1102756892,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_65462,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
65930,1727.58578431373,198.879901960784,137.321078431373,655.046568627451,2473.50245098039,327.735294117647,375.200980392157,260.267156862745,1075.30637254902,3091.27941176471,549.593137254902,120.470588235294,1067.9681372549,887.375,759.887254901961,296.637254901961,1655.96323529412,1556.75735294118,386.049019607843,244.274509803922,1006.80637254902,1315.32843137255,303.245098039216,179.227941176471,600.629901960784,1336.34558823529,525.308823529412,267.767156862745,1056.34068627451,129.120098039216,408,26.8061229204455,19.4124162507639,0.689612636603707,0.955503512880562,0.739130434782609,-0.653601633029501,52333.1078431373,33109.193627451,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_65930,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
66674,4374.29179331307,584.103343465046,1336.90881458967,661.80547112462,1639.55623100304,559.303951367781,357.826747720365,249.227963525836,1137.52279635258,6505.55015197568,1351.54407294833,120.829787234043,1080.87537993921,1923.04863221884,471.127659574468,293.45896656535,1782.10334346505,3267.3009118541,416.36170212766,246.340425531915,1073.04863221884,2663.83282674772,232.659574468085,207.693009118541,1597.03647416413,1261.32218844985,510.577507598784,882.617021276596,1049.87234042553,131.857142857143,329,21.3036523329238,19.7905949913554,0.370138399562798,0.953623188405797,0.783333333333333,-0.490844980373725,53740.3829787234,33653.0516717325,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_66674,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
66830,1894.16849015317,357.2647702407,176.041575492341,679.240700218818,3523.03719912473,222.371991247265,233.778993435449,242.118161925602,1075.51203501094,2811.07002188184,553.433260393873,129.590809628009,1073.54266958425,1047.14004376368,779.17943107221,313.439824945295,1967.9124726477,2038.12910284464,341.474835886214,221.369803063457,1059.14223194748,1293.30853391685,185.404814004376,168.549234135667,589.879649890591,851.986870897155,424.671772428884,211.746170678337,1027.11159737418,130.295404814004,457,27.8358615154344,20.913722416037,0.659934678728524,0.972340425531915,0.769360269360269,1.13268312128886,53180.6455142232,32172.7330415755,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_66830,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
67665,3850.7581120944,713.156342182891,241.879056047198,689.501474926254,4423.02654867257,1096.47787610619,349.392330383481,269.097345132743,1094.91740412979,6571.95575221239,4174.16224188791,145.182890855457,1078.60471976401,2049.98820058997,714.793510324484,321.87610619469,2036.66371681416,1656.92920353982,320.811209439528,226.581120943953,1083.61356932153,1138.19764011799,198.17994100295,196.371681415929,2127.10324483776,2224.05604719764,530.06784660767,362.345132743363,1108.89970501475,131.020648967552,339,25.7587092224253,16.8930717669958,0.754917464287325,0.963068181818182,0.766968325791855,-1.55426742095725,52758.3215339233,32247.2330383481,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_67665,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
67692,3977.90178571429,305.508928571429,109.764880952381,636.077380952381,1304.65476190476,2531.66369047619,371.113095238095,268.241071428571,1095.61607142857,6098.04464285714,841.190476190476,126.755952380952,1107.25,3807.8869047619,606.092261904762,317.282738095238,1932.08035714286,3884.0505952381,375.255952380952,231.809523809524,1079.81845238095,2726.14880952381,237.755952380952,179.125,2213.89583333333,1041.52678571429,451.794642857143,306.675595238095,1053.61904761905,131.065476190476,336,22.6302605235699,18.9356903120079,0.547597262380227,0.957264957264957,0.763636363636364,0.322634293653814,53353.4910714286,32744.7529761905,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_67692,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
67857,4711.32075471698,612.154088050314,93.066037735849,639.867924528302,1744.7641509434,2948.76100628931,1104.88050314465,266.735849056604,1178.4465408805,6673.59433962264,1277.82704402516,129.679245283019,1097.29559748428,3896.05660377358,1184.28301886792,2338.40566037736,2167.29245283019,3827.91194968554,366.238993710692,236.858490566038,1055.55031446541,3143.22955974843,254.182389937107,374.018867924528,696.921383647799,1730.53144654088,531.48427672956,288.606918238994,1054.0534591195,131.751572327044,318,22.2446019165593,18.2240331930944,0.573427326646802,0.972477064220184,0.760765550239234,-1.19161360022449,53201.5,33724.9811320755,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_67857,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
67978,1762.54421768707,218.751700680272,72.391156462585,605.697278911565,571.248299319728,727.244897959184,913.836734693878,255.251700680272,1093.92176870748,2632.0612244898,871.102040816327,107.56462585034,1068.56802721088,4911.34693877551,635.605442176871,372.97619047619,1579.86054421769,3167.40476190476,346.486394557823,231.727891156463,1025.36734693878,1753.54081632653,233.632653061224,351.625850340136,645.605442176871,633.221088435374,378.639455782313,237.085034013605,993.299319727891,129.357142857143,294,22.3830574686791,16.8127097704098,0.660148023687653,0.96078431372549,0.786096256684492,-1.56802393997565,53538.2551020408,32753.0816326531,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_67978,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
68350,2490.57611241218,746.742388758782,645.093676814988,618.046838407494,809.878220140515,312.348946135831,294.372365339578,249.775175644028,1078.51053864169,3420.38407494145,540.189695550351,117.451990632318,1072.77283372365,646.27868852459,443.955503512881,271.091334894614,1399.4355971897,940.599531615925,235.395784543326,218.690866510539,984.388758782201,859.049180327869,183.505854800937,130.957845433255,580.470725995316,896.393442622951,503.510538641686,235.829039812646,1016.65807962529,129.112412177986,427,27.0833304785484,20.1339906267189,0.668837135386676,0.955257270693512,0.746503496503496,-0.368895692857251,53833.3348946136,33184.8056206089,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_68350,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
68644,4155.61609907121,252.882352941176,128.325077399381,664.84520123839,3187.25386996904,456.919504643963,277.448916408669,243.823529411765,1078.06191950464,6028.91640866873,674.575851393189,122.572755417957,1085.5572755418,760.656346749226,474.962848297214,272.486068111455,1457.16408668731,1281.17956656347,306.739938080495,229.021671826625,990.489164086687,1185.94117647059,222.442724458204,132.752321981424,957.003095975232,1214.64705882353,459.77399380805,240.523219814241,1044.82352941176,130.439628482972,323,23.5831552711168,17.5321137109522,0.668828429945354,0.967065868263473,0.772727272727273,-1.12735749171278,53210.572755418,33361.4024767802,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_68644,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
68927,1415.35238095238,471.47619047619,141.895238095238,655.295238095238,2283.39523809524,2046.58095238095,321.804761904762,266.180952380952,1104.90952380952,2313.31428571429,4368.62857142857,141.657142857143,1063.74285714286,1410.30476190476,603.557142857143,333.890476190476,2104.00476190476,1952.64285714286,312.67619047619,219.67619047619,1046.48095238095,1231.54761904762,180.490476190476,214.633333333333,594.061904761905,809.895238095238,394.661904761905,345.695238095238,1027.99523809524,129.404761904762,210,18.6681721809472,14.3172613747479,0.641725638433636,0.972222222222222,0.777777777777778,-1.19592134473694,53164.7285714286,32147.9857142857,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_68927,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
68929,4574.15157480315,1057.6062992126,141.962598425197,649.779527559055,2216.96850393701,478.748031496063,379.860236220472,253.192913385827,1089.38385826772,7072.77362204724,611.25,126.259842519685,1085.42519685039,1812.76968503937,958.665354330709,1150.30511811024,1657.70275590551,3441.8188976378,362.616141732283,238.100393700787,1054.51968503937,2909.66338582677,258.92125984252,495.427165354331,720.129921259842,1629.29527559055,539.043307086614,267.65157480315,1039.09842519685,132.137795275591,508,28.8559494413599,22.5559135640256,0.62368861124888,0.973180076628352,0.824675324675325,1.46712011239248,53811.5019685039,33285.9468503937,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_68929,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
69599,2857.18279569893,415.088709677419,112.766129032258,638.14247311828,1827.85215053763,693.725806451613,299.64247311828,258.451612903226,1079.30913978495,4726.10483870968,980.540322580645,121.83064516129,1077.41666666667,970.059139784946,537.02688172043,274.905913978495,1540.09408602151,1344.43817204301,287.33064516129,221.497311827957,1032.84408602151,1103.14784946237,205.639784946236,218.922043010753,1012.69892473118,1133.95430107527,461.201612903226,364.905913978495,1056.4435483871,131.438172043011,372,22.0906896778384,21.5173309897393,0.226353446440676,0.963730569948186,0.768595041322314,-0.145141081410744,53783.6290322581,32275.1290322581,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_69599,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
69616,3655.42068965517,970.234482758621,66.051724137931,650.189655172414,1967.42068965517,317.448275862069,302.803448275862,240.668965517241,1077.05172413793,4584.38965517241,568.420689655172,120.027586206897,1183.33793103448,759.468965517241,474.168965517241,282.686206896552,1566.80689655172,1395.31379310345,353.055172413793,242.172413793103,1057.90689655172,1315.16896551724,251.31724137931,155.255172413793,587.510344827586,975.048275862069,444.927586206896,237.41724137931,1047.25172413793,131.037931034483,290,20.4996526846227,18.1035299072076,0.469158496889206,0.953947368421053,0.763157894736842,-0.884467045071676,52682.6551724138,33482.4413793103,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_69616,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
70315,5108.3,594.308571428571,1789.94571428571,648.448571428571,1217.40285714286,597.202857142857,358.934285714286,250.337142857143,1120.06,7433.87714285714,581.142857142857,120.185714285714,1082.66285714286,3367.03142857143,598.582857142857,317.397142857143,1746.68571428571,5932.71714285714,398.371428571429,248.288571428571,1067.76,5413.26,253.002857142857,264.728571428571,750.98,1592.21142857143,531.625714285714,511.842857142857,1053.74285714286,130.925714285714,350,24.8796211164487,17.9550689801391,0.692229171316052,0.940860215053764,0.736842105263158,-1.5564301803724,53758.7942857143,33642.9,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_70315,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
70547,3696.7995545657,832.073496659243,727.200445434298,629.917594654788,1501.91982182628,2449.38752783964,4039.8285077951,264.287305122494,1096.74610244989,5283.32516703786,654.031180400891,121.436525612472,1082.1714922049,1207.0,521.875278396437,1361.46325167038,1540.10022271715,1078.75723830735,252.102449888641,218.037861915367,987.409799554566,1062.73719376392,199.369710467706,133.864142538975,594.140311804009,1047.81737193764,509.24276169265,245.396436525612,1029.53006681514,130.993318485523,449,24.1927668934198,23.7446511267651,0.19157855388627,0.959401709401709,0.779513888888889,0.935831390673715,54075.2182628062,33316.991091314,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_70547,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
70704,3806.8,948.302857142857,1354.68571428571,630.494285714286,1406.98,252.354285714286,402.768571428571,239.82,1075.51428571429,7230.54,2225.78571428571,125.9,1073.14571428571,910.677142857143,738.828571428571,539.645714285714,1699.82,2274.51142857143,280.291428571429,218.5,1006.04285714286,1634.18,194.7,213.502857142857,669.117142857143,2505.96857142857,553.542857142857,342.031428571429,1065.92,129.634285714286,350,26.0683724506243,17.1590492166795,0.752814727500477,0.961538461538462,0.791855203619909,0.0149227081154657,54110.9171428571,32846.3,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_70704,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
70990,1275.42039355993,284.640429338104,85.7388193202147,620.075134168157,1561.44186046512,307.796064400716,271.127012522361,241.8228980322,1084.21645796064,2160.72093023256,434.763864042934,109.338103756708,1069.67262969589,1523.31127012522,637.035778175313,281.332737030411,2647.65474060823,2844.30590339893,294.885509838998,222.12343470483,1004.80500894454,2827.81395348837,203.119856887299,148.559928443649,584.584973166369,915.361359570662,460.513416815742,224.084078711986,1016.84615384615,129.874776386404,559,29.1074618022389,24.5196783530273,0.53887673934196,0.968804159445407,0.745333333333333,-1.44030091771011,53636.0590339893,33127.030411449,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_70990,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
71080,2692.59587020649,124.442477876106,65.1976401179941,625.129793510324,1200.17699115044,2744.78761061947,379.262536873156,255.486725663717,1095.58112094395,4706.35398230089,453.103244837758,115.421828908555,1091.94100294985,657.076696165192,411.377581120944,271.787610619469,1675.89085545723,1021.86135693215,248.920353982301,219.070796460177,985.430678466077,927.398230088496,190.896755162242,121.365781710914,582.120943952802,1312.54867256637,436.855457227139,218.864306784661,1025.81710914454,130.59587020649,339,22.8212527101229,18.9512655740084,0.557135214439866,0.957627118644068,0.770454545454546,-1.24141977974666,52736.3421828908,33390.2182890855,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_71080,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
71270,1289.91362126246,210.634551495017,85.6112956810631,609.265780730897,1064.43521594684,535.328903654485,824.897009966777,508.199335548173,1106.06312292359,2471.64784053156,992.614617940199,114.75415282392,1063.073089701,577.345514950166,412.813953488372,265.508305647841,1371.81063122924,866.205980066445,244.830564784053,218.162790697674,978.720930232558,829.734219269103,192.41196013289,126.285714285714,588.02657807309,736.641196013289,386.109634551495,261.003322259136,1011.92026578073,128.667774086379,301,25.0304932604852,15.3466778625897,0.789990351532021,0.940625,0.7525,-1.5195906204813,52765.0764119601,32726.0,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_71270,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
71453,4674.76896551724,557.772413793103,63.748275862069,645.196551724138,1475.7275862069,834.513793103448,1139.88620689655,240.096551724138,1094.01034482759,6745.13103448276,1028.34482758621,129.655172413793,1096.39655172414,3320.04137931034,661.751724137931,865.031034482759,1787.74482758621,5092.72413793103,373.196551724138,237.744827586207,1037.05862068966,4280.82068965517,245.8,1262.03793103448,639.472413793103,1846.44827586207,522.355172413793,451.089655172414,1058.85172413793,129.658620689655,290,19.6727299609811,18.8467228827974,0.286726153483743,0.963455149501661,0.763157894736842,-0.864715757118562,53512.0206896552,33721.1206896552,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_71453,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
72322,3646.84,1215.745,150.67,658.755,1883.595,644.815,969.6825,253.415,1080.7575,4581.8075,817.7325,126.25,1088.4925,1672.435,1266.1925,2295.2125,2102.105,2124.7325,352.06,227.8325,1048.625,1391.2275,215.6475,496.615,915.2175,738.2675,389.4325,210.5675,1015.97,130.4125,400,24.8539373611707,20.5805077111087,0.560642083377902,0.954653937947494,0.761904761904762,1.28437283988661,53217.285,32058.2675,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_72322,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
72659,2864.64644714038,281.71403812825,133.443674176776,665.760831889081,2992.56152512998,239.36568457539,253.525129982669,248.939341421144,1074.19757365685,3971.50779896014,672.850953206239,128.724436741768,1069.14558058925,532.715771230503,452.816291161179,259.265164644714,1414.55285961872,892.233968804159,243.398613518198,215.150779896014,981.975736568458,932.636048526863,208.173310225303,232.493934142114,606.235701906412,1179.51819757366,449.159445407279,213.584055459272,1062.98440207972,130.738301559792,577,37.1235846739786,19.8373295838227,0.845257492593039,0.963272120200334,0.708845208845209,-1.28396466339857,53364.4714038128,32167.0311958406,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_72659,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
72716,4811.55020080321,285.080321285141,82.425702811245,611.277108433735,594.78313253012,616.751004016064,463.879518072289,252.807228915663,1080.44979919679,8925.29718875502,578.971887550201,125.867469879518,1075.55020080321,971.839357429719,561.369477911647,281.5140562249,1554.19678714859,1519.10843373494,266.638554216867,219.638554216867,1013.14457831325,1419.72690763052,203.473895582329,220.586345381526,2477.91164658635,2598.30923694779,517.795180722892,240.160642570281,1042.93574297189,130.429718875502,249,20.1211597575495,15.8309161502649,0.617234159522478,0.957692307692308,0.778125,1.34171327249743,54092.1807228916,32692.4698795181,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_72716,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
72867,2971.8949044586,1035.83121019108,238.885350318471,710.595541401274,5876.82802547771,1290.05414012739,1662.23248407643,243.585987261146,1082.80573248408,5606.12420382166,694.194267515924,131.990445859873,1070.96496815287,776.474522292994,561.894904458599,585.207006369427,1520.06369426752,1202.70382165605,268.512738853503,220.363057324841,1025.75796178344,1031.6974522293,199.050955414013,203.652866242038,3012.5,1746.23885350318,519.035031847134,282.054140127389,1057.41401273885,132.375796178344,314,20.9884288912427,19.0999544309863,0.414557616670484,0.966153846153846,0.786967418546366,-0.14280471450173,54012.703821656,32731.9968152866,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_72867,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
73627,2512.15398230088,506.223008849558,279.904424778761,735.853097345133,6580.22123893805,265.922123893805,449.626548672566,252.833628318584,1080.66725663717,2854.15044247788,601.01592920354,134.233628318584,1078.14867256637,584.284955752212,504.065486725664,264.090265486726,1370.70796460177,929.221238938053,276.697345132743,221.780530973451,978.056637168142,896.240707964602,206.13982300885,120.592920353982,588.759292035398,741.849557522124,415.713274336283,213.711504424779,1003.8017699115,129.047787610619,565,34.2386394418904,21.1665763300686,0.786015109793289,0.959252971137521,0.755347593582888,-1.51225453201655,53424.7610619469,32489.2902654867,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_73627,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
73828,2980.87673956262,650.479125248509,811.588469184891,620.842942345924,1135.17296222664,444.467196819085,1255.03180914513,244.542743538767,1089.57852882704,5314.94632206759,521.755467196819,115.75745526839,1072.28230616302,3119.91451292247,1656.27833001988,2110.33399602386,1855.34791252485,4113.59840954274,388.671968190855,289.182902584493,1043.86878727634,3212.98608349901,260.683896620278,411.902584493042,877.499005964215,1398.12524850895,511.0337972167,230.721669980119,1027.22664015905,130.65407554672,503,27.3289841550954,23.4795540247842,0.511732596618873,0.956273764258555,0.718571428571429,0.194367521942423,53625.8866799205,33014.7057654076,FAAGSCC_12,AG,1,regulatory T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_73828,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
74428,5149.23361823362,362.860398860399,129.076923076923,635.541310541311,1826.8433048433,618.837606837607,393.307692307692,268.615384615385,1129.47293447293,8490.88034188034,1007.08547008547,130.769230769231,1095.76923076923,943.230769230769,473.65811965812,284.472934472934,1496.8603988604,1033.42735042735,212.245014245014,211.122507122507,1272.05982905983,695.279202279202,141.774928774929,119.797720797721,600.786324786325,2005.13675213675,493.555555555556,349.390313390313,1078.37321937322,129.868945868946,351,22.9056334489395,19.5466255511648,0.521331069956414,0.951219512195122,0.75974025974026,-1.06454326350846,53284.735042735,32741.9287749288,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_74428,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
74893,2629.06962025316,229.221518987342,79.3575949367089,621.069620253165,754.079113924051,1756.80379746835,422.433544303797,255.29746835443,1092.17721518987,3580.27215189873,931.594936708861,118.348101265823,1076.38291139241,1767.70569620253,631.613924050633,291.946202531646,1574.31962025316,1499.75,313.012658227848,229.95253164557,1004.58227848101,1152.32911392405,213.664556962025,129.104430379747,584.636075949367,969.370253164557,461.648734177215,330.879746835443,1029.77215189873,130.572784810127,316,21.9631783716914,18.4915563155309,0.539579833061852,0.972307692307692,0.752380952380952,-0.793033300357074,52897.9272151899,33345.4905063291,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_74893,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
75091,4591.04347826087,983.991847826087,1952.73369565217,642.850543478261,1414.25815217391,1946.93206521739,2094.8097826087,254.002717391304,1122.91576086957,6336.97554347826,554.353260869565,121.086956521739,1073.75543478261,3096.08967391304,972.586956521739,844.559782608696,1952.60326086956,3417.34782608696,393.771739130435,243.489130434783,1052.91032608696,2133.33967391304,240.339673913043,308.146739130435,668.451086956522,1210.20380434783,478.698369565217,419.459239130435,1033.51086956522,130.432065217391,368,22.4357199918138,20.9713381147738,0.355359015426129,0.968421052631579,0.796536796536797,-0.805343602365448,53358.6331521739,33553.3451086957,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_75091,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
75104,1494.55263157895,223.330409356725,100.038011695906,619.146198830409,1238.35087719298,1346.92105263158,1679.4649122807,252.248538011696,1108.02046783626,2135.90935672515,634.111111111111,116.432748538012,1073.21052631579,5166.17543859649,1141.11403508772,362.347953216374,7593.61403508772,6595.21929824562,378.146198830409,233.5,1066.16081871345,5185.18128654971,238.166666666667,229.850877192982,741.099415204678,888.865497076023,482.502923976608,245.912280701754,1011.14035087719,127.66081871345,342,21.8606489083642,20.1936843074929,0.383005944984294,0.95,0.814285714285714,1.05878142337529,54174.9269005848,32820.1198830409,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_75104,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
75282,4104.19662921348,1354.69382022472,108.60393258427,630.311797752809,982.390449438202,249.842696629213,256.710674157303,227.915730337079,1072.93539325843,6003.60674157303,738.949438202247,117.643258426966,1096.32584269663,855.72191011236,628.719101123595,288.685393258427,3163.24438202247,1637.10674157303,302.0,227.081460674157,1018.05898876404,1034.05898876404,202.092696629213,143.075842696629,585.662921348315,1295.6797752809,484.407303370787,259.466292134831,1039.99157303371,130.280898876405,356,25.2214209206725,18.4724018487729,0.680864669491435,0.949333333333333,0.674242424242424,0.663165714347669,53386.4915730337,33393.3707865169,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_75282,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
75481,4310.63815789474,197.815789473684,68.0559210526316,611.069078947368,746.161184210526,799.861842105263,430.638157894737,262.111842105263,1120.25328947368,7359.86842105263,899.046052631579,123.305921052632,1080.71052631579,836.667763157895,458.167763157895,274.503289473684,1505.92434210526,1011.46052631579,213.006578947368,217.246710526316,1188.45394736842,705.835526315789,140.924342105263,104.881578947368,585.720394736842,1288.63157894737,468.934210526316,267.569078947368,1035.1875,131.092105263158,304,21.6973182062453,17.9674537740413,0.560586901862185,0.955974842767296,0.727272727272727,-1.1206090356583,53842.2598684211,32731.2565789474,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_75481,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
76620,619.707692307692,1588.77307692308,356.980769230769,609.05,90.3153846153846,856.380769230769,1194.60769230769,258.407692307692,1085.92692307692,1350.13076923077,710.303846153846,119.030769230769,1064.92692307692,617.319230769231,426.773076923077,268.242307692308,1400.88846153846,858.123076923077,254.107692307692,217.257692307692,990.015384615385,827.426923076923,189.696153846154,118.569230769231,588.907692307692,569.403846153846,360.976923076923,204.303846153846,989.807692307692,129.7,260,20.3792514096258,16.2609040202945,0.602770396957547,0.962962962962963,0.8125,-1.27000701030379,53766.7269230769,32662.4384615385,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_76620,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
77229,3381.43506493506,602.813852813853,146.140692640693,646.056277056277,1913.08441558442,2721.14285714286,391.296536796537,272.876623376623,1101.80952380952,5485.21645021645,1608.17748917749,130.296536796537,1073.04545454545,3455.4632034632,674.512987012987,306.813852813853,1807.67965367965,3814.86796536797,390.919913419913,241.62987012987,1053.1038961039,2924.44155844156,249.298701298701,189.056277056277,2964.39177489177,1258.61038961039,505.214285714286,390.082251082251,1052.77489177489,131.335497835498,462,35.1439240311218,16.9716639893611,0.87566510008219,0.937119675456389,0.6015625,0.99915043534002,53589.4718614719,32757.6623376623,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_77229,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
78173,2338.0293040293,145.362637362637,107.968864468864,662.571428571429,2446.48901098901,849.673992673993,293.47619047619,247.437728937729,1086.08058608059,3850.24725274725,489.998168498169,129.377289377289,1075.78388278388,795.346153846154,467.494505494506,286.794871794872,1486.82051282051,1572.21978021978,317.461538461538,240.250915750916,985.17032967033,1528.84249084249,233.285714285714,239.811355311355,632.456043956044,1105.00366300366,439.862637362637,217.617216117216,1042.57142857143,131.261904761905,546,30.2985220117386,23.217427231269,0.642495923569672,0.956217162872154,0.75,-0.524465393755017,52523.1501831502,33436.9413919414,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_78173,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
78672,4877.51533742331,962.40490797546,1552.66257668712,657.815950920245,2037.26687116564,1201.99693251534,350.748466257669,245.834355828221,1111.09202453988,6621.30981595092,678.733128834356,120.80981595092,1069.73926380368,2127.22085889571,529.751533742331,296.769938650307,1663.16257668712,1429.55828220859,311.993865030675,231.088957055215,1018.9509202454,1277.91411042945,229.88036809816,190.239263803681,657.834355828221,1150.13190184049,477.325153374233,312.625766871166,1052.19938650307,130.383435582822,326,22.1109723415948,18.94857767453,0.515355939770776,0.947674418604651,0.740909090909091,1.08341662859501,53801.3588957055,33658.8742331288,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_78672,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
79285,4199.10946745562,862.41124260355,1452.63609467456,622.233727810651,1063.79585798817,341.227810650888,352.988165680473,249.860946745562,1079.90236686391,6368.76923076923,591.866863905325,122.476331360947,1084.19526627219,763.970414201183,520.937869822485,278.278106508876,1435.08284023669,1175.31656804734,297.582840236686,228.46449704142,983.511834319527,1067.02071005917,219.289940828402,134.48224852071,583.686390532544,2002.21597633136,536.363905325444,245.133136094675,1059.90532544379,130.949704142012,338,22.4400879739139,19.4179302623593,0.501214167457394,0.962962962962963,0.731601731601732,-1.01453595790435,53009.7426035503,33276.4792899408,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_79285,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
79433,2802.98678414097,288.4140969163,196.667400881057,687.781938325991,4875.76651982379,438.801762114537,310.751101321586,250.387665198238,1117.28634361233,4989.10792951542,583.900881057269,127.224669603524,1073.10572687225,598.154185022026,354.438325991189,267.136563876652,1435.8127753304,853.856828193833,192.892070484581,206.088105726872,1023.58370044053,788.017621145375,157.775330396476,121.325991189427,1005.02643171806,1079.13876651982,473.079295154185,243.132158590308,1047.48237885463,130.892070484581,454,29.17041339805,19.9538480020867,0.729440692911743,0.97008547008547,0.782758620689655,-1.37803576736364,53404.8193832599,33083.9207048458,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_79433,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
79914,2235.73618090452,469.133165829146,215.075376884422,703.3391959799,5068.47989949749,1582.20351758794,428.439698492462,267.592964824121,1094.32412060301,4234.11055276382,4165.93467336683,129.91959798995,1066.79648241206,2629.48492462312,508.467336683417,322.934673366834,1872.11055276382,2378.84924623116,279.560301507538,215.85175879397,1030.98994974874,1354.43969849246,174.402010050251,124.040201005025,3003.17336683417,1267.62311557789,461.557788944724,416.85175879397,1066.87939698492,130.723618090452,398,27.9029555362301,18.2213676540041,0.757335111900508,0.963680387409201,0.723636363636364,-0.972714499300041,53901.1381909548,32358.7060301508,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,7,FAAGSCC_12_79914,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
79932,3149.68362831858,543.134955752212,175.676991150442,675.053097345133,3230.2389380531,285.840707964602,326.004424778761,266.013274336283,1080.97787610619,4559.0,1388.49778761062,131.809734513274,1068.51991150442,709.08185840708,528.068584070796,271.913716814159,1380.47123893805,935.25221238938,271.287610619469,222.62610619469,975.342920353982,916.712389380531,207.201327433628,123.349557522124,588.026548672566,1086.42699115044,462.639380530973,351.017699115044,1065.03097345133,129.650442477876,452,31.3210486629297,18.5720372062823,0.805234074405692,0.961702127659574,0.792982456140351,-1.38813144044908,52786.8274336283,32700.9889380531,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_79932,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
80148,2111.62295081967,177.209016393443,128.926229508197,652.930327868852,2260.61475409836,1656.45491803279,1549.34426229508,259.565573770492,1087.73360655738,3950.72131147541,546.143442622951,124.688524590164,1066.84836065574,3373.0,1213.98770491803,1920.93032786885,1862.54098360656,3035.7131147541,316.614754098361,226.610655737705,1027.52868852459,2256.92213114754,216.340163934426,1914.10245901639,840.418032786885,1384.63114754098,435.860655737705,213.360655737705,1046.64344262295,130.315573770492,244,20.4263906737066,15.213481312817,0.66729292561015,0.960629921259842,0.7625,1.12472319767134,52822.9221311475,32302.512295082,FAAGSCC_12,AG,1,M2 macrophages,,TIM3+,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_80148,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
80323,2765.77697841727,330.23381294964,140.956834532374,650.953237410072,2391.48561151079,281.946043165468,296.363309352518,251.474820143885,1072.79136690647,4247.91007194245,554.104316546763,124.028776978417,1090.12589928058,802.179856115108,532.672661870504,276.097122302158,1412.67625899281,1198.07194244604,307.122302158273,229.787769784173,1007.5,1189.79856115108,228.791366906475,177.76618705036,586.410071942446,1108.21942446043,471.215827338129,223.553956834532,1032.42086330935,129.597122302158,278,21.7034083034366,16.3549408645814,0.65737276975388,0.952054794520548,0.778711484593838,-1.24043075840176,52890.1978417266,33141.9316546763,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_80323,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
80661,4763.26517571885,857.207667731629,131.980830670927,640.507987220447,1672.696485623,521.488817891374,332.463258785943,243.038338658147,1126.55591054313,7059.22044728435,532.974440894569,119.958466453674,1091.97124600639,1403.1054313099,459.904153354633,285.913738019169,1758.39936102236,3233.75079872204,364.923322683706,244.009584664537,1049.05750798722,2567.92332268371,237.447284345048,188.41214057508,995.172523961661,1090.35463258786,469.485623003195,395.70607028754,1051.92971246006,131.271565495208,313,22.529629193601,17.8564619250839,0.609772072141095,0.954268292682927,0.745238095238095,-1.0425925073838,53812.9169329073,33672.6485623003,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_80661,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
80675,2335.96858638743,551.041884816754,105.397905759162,638.162303664921,1700.79057591623,354.884816753927,1125.28795811518,252.157068062827,1081.35078534031,3332.89005235602,858.340314136126,119.214659685864,1076.30366492147,794.853403141361,1003.13612565445,1170.74869109948,1598.55497382199,1090.16230366492,305.544502617801,238.104712041885,999.769633507853,1015.98429319372,227.575916230366,206.193717277487,646.324607329843,1131.61780104712,490.811518324607,308.366492146597,1027.56544502618,131.471204188482,191,16.1599305108702,15.0792150974102,0.359555351915276,0.936274509803922,0.74609375,1.06694240999044,53406.4607329843,33545.5863874346,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_80675,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
80902,2751.77002583979,567.886304909561,1176.04651162791,636.906976744186,2150.58139534884,281.684754521964,309.485788113695,246.537467700258,1076.67700258398,3854.48062015504,473.369509043928,114.829457364341,1076.58139534884,696.950904392765,440.984496124031,267.798449612403,1410.15503875969,1052.2480620155,252.552971576227,217.095607235142,987.643410852713,938.651162790698,185.421188630491,125.385012919897,582.74677002584,811.961240310078,430.653746770026,246.981912144703,1010.80878552972,128.511627906977,387,24.394574342783,20.5310233864812,0.54006621475313,0.962686567164179,0.767857142857143,0.206998143810877,53688.5994832041,32971.1188630491,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_80902,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
81157,4546.22766570605,743.109510086455,69.0115273775216,642.619596541787,1767.27377521614,698.959654178674,301.046109510086,246.85590778098,1091.68587896254,7516.53025936599,586.628242074928,144.677233429395,1116.64841498559,3077.1613832853,688.07204610951,311.844380403458,1865.21325648415,4334.54755043228,421.651296829971,250.778097982709,1039.1757925072,4776.96829971182,288.334293948127,1426.61959654179,4618.89625360231,1844.08645533141,494.576368876081,234.795389048991,1153.72334293948,132.697406340058,347,27.231568750438,16.2929700459338,0.801263340184836,0.955922865013774,0.688492063492063,0.956283439697766,52828.0489913545,33855.818443804,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_81157,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
82034,3421.76732673267,1074.79702970297,277.054455445545,653.356435643564,2212.59405940594,241.311881188119,436.49504950495,221.470297029703,1068.0495049505,5536.43069306931,1776.20297029703,128.960396039604,1071.97524752475,492.425742574257,317.450495049505,260.925742574257,1476.71782178218,759.094059405941,174.529702970297,207.584158415842,989.024752475248,685.079207920792,146.861386138614,146.30198019802,583.594059405941,1879.26237623762,541.717821782178,607.252475247525,1059.09405940594,132.980198019802,202,18.4053897610406,13.9847335244427,0.650136657199706,0.952830188679245,0.742647058823529,-0.84579814732678,53235.0742574258,33495.3514851485,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_82034,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
82730,2413.26599326599,392.464646464646,169.040404040404,655.845117845118,3307.85185185185,270.47138047138,279.390572390572,247.609427609428,1081.09427609428,4167.9797979798,514.407407407407,122.929292929293,1078.41750841751,1294.23905723906,659.154882154882,292.592592592593,3442.79461279461,2046.50841750842,319.700336700337,230.501683501683,994.919191919192,1594.13468013468,231.0,138.181818181818,587.686868686869,1364.10437710438,500.656565656566,296.158249158249,1051.13804713805,129.377104377104,297,21.6977899564807,17.8517426886557,0.568411015697593,0.942857142857143,0.75,1.42753655203722,54106.1582491583,33156.1279461279,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_82730,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
83753,4737.31896551724,1038.66379310345,1560.50287356322,665.528735632184,1617.13793103448,302.281609195402,426.347701149425,250.551724137931,1081.31034482759,7761.69827586207,629.747126436782,129.798850574713,1087.17528735632,694.362068965517,459.316091954023,275.158045977012,1481.97413793103,981.635057471264,254.985632183908,221.770114942529,986.560344827586,883.841954022988,194.692528735632,128.522988505747,584.695402298851,1685.09482758621,521.494252873563,243.922413793103,1079.17528735632,132.100574712644,348,23.9197091508525,18.575782497766,0.630007585925546,0.950819672131148,0.763157894736842,-1.34130230843873,52940.5287356322,33267.3649425287,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_83753,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
83966,1709.50537634409,730.193548387097,697.007168458781,631.817204301075,1629.40501792115,512.569892473118,332.293906810036,247.05017921147,1097.16845878136,3461.12903225806,452.584229390681,109.989247311828,1067.03225806452,1029.39426523297,685.240143369176,280.143369175627,1887.10752688172,1385.38709677419,293.082437275986,229.978494623656,1044.91397849462,1126.14336917563,219.759856630824,537.921146953405,5064.72759856631,1156.53405017921,467.240143369176,240.688172043011,1031.59856630824,130.064516129032,279,20.1078771767526,17.6809201847204,0.476262460857385,0.958762886597938,0.738095238095238,1.42342204479634,53819.0609318996,33450.5125448029,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_83966,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
84591,2580.97005988024,733.844311377246,2224.64071856287,637.580838323353,1809.76047904192,2667.66766467066,306.958083832335,253.829341317365,1103.25748502994,3980.88622754491,681.347305389222,119.329341317365,1068.57784431138,1432.20958083832,502.925149700599,269.730538922156,2378.52395209581,1318.34131736527,232.251497005988,215.15868263473,993.829341317365,1176.21556886228,188.080838323353,131.206586826347,590.883233532934,1211.28443113772,560.880239520958,262.215568862275,1055.45209580838,129.167664670659,334,22.3212519524866,19.1115177764152,0.516639927550698,0.965317919075144,0.795238095238095,1.16404632556927,54094.8682634731,32956.8113772455,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_84591,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
84623,4095.65263157895,845.221052631579,113.163157894737,638.752631578947,1676.42631578947,788.0,630.634210526316,253.073684210526,1088.06578947368,6335.38684210526,1090.22368421053,126.484210526316,1086.77368421053,1232.62631578947,701.163157894737,326.147368421053,1546.17631578947,2945.37894736842,341.747368421053,233.578947368421,989.905263157895,3256.56842105263,258.021052631579,245.363157894737,619.015789473684,1144.90526315789,466.56052631579,290.910526315789,1036.63684210526,130.697368421053,380,24.3289434215109,19.9319623070886,0.5734085972348,0.95,0.71969696969697,-0.965840631184222,54040.3342105263,32614.5368421053,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_84623,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
84997,592.421383647799,1134.02201257862,251.157232704403,613.286163522013,104.547169811321,3446.04088050314,331.657232704403,270.496855345912,1092.20754716981,1213.46226415094,1333.22012578616,116.317610062893,1060.16352201258,4022.16037735849,675.779874213836,294.952830188679,1548.69182389937,2155.61949685535,358.301886792453,231.430817610063,993.685534591195,1385.18238993711,221.600628930818,131.223270440252,587.182389937107,565.918238993711,358.430817610063,204.150943396226,984.25786163522,129.672955974843,318,21.6055657282695,18.7703697159819,0.495207485528385,0.954954954954955,0.760765550239234,-1.50972982489387,53672.4685534591,32627.5408805031,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_84997,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
85194,1603.5730994152,276.108187134503,142.722222222222,661.266081871345,3383.33625730994,667.745614035088,1056.43859649123,249.298245614035,1094.22514619883,2479.80409356725,596.657894736842,116.93567251462,1065.37426900585,1348.77485380117,987.143274853801,392.412280701754,1661.10233918129,2229.21929824561,288.152046783626,222.198830409357,998.801169590643,1841.80994152047,205.722222222222,138.570175438596,626.514619883041,818.675438596491,427.353801169591,240.657894736842,1038.30701754386,128.453216374269,342,31.7084137670987,13.8065399038154,0.900226477257039,0.952646239554318,0.788018433179724,1.55201786282758,54143.2660818713,32608.5497076023,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_85194,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
85408,2844.53664921466,364.510471204188,214.908376963351,734.083769633508,4821.33769633508,935.753926701571,516.062827225131,233.94502617801,1095.07853403141,4711.86387434555,627.298429319372,126.264397905759,1088.68848167539,2136.90837696335,679.356020942408,590.002617801047,1946.81937172775,2200.10209424084,320.342931937173,232.973821989529,1024.50261780105,2199.06806282723,218.973821989529,384.337696335078,632.497382198953,1561.89790575916,505.612565445026,1087.29057591623,1071.20942408377,130.850785340314,382,22.9996338592922,21.2530091619091,0.38225087061106,0.967088607594937,0.826839826839827,-0.61856719791411,53321.9057591623,33607.0890052356,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_85408,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
85624,1143.5,509.143181818182,157.715909090909,656.793181818182,2422.11818181818,1969.65909090909,305.818181818182,256.963636363636,1091.13636363636,1765.03863636364,979.495454545454,132.693181818182,1065.37727272727,1953.95909090909,539.113636363636,305.240909090909,1782.91590909091,2453.91818181818,279.165909090909,219.356818181818,993.302272727273,2126.625,189.340909090909,248.225,646.754545454545,675.288636363636,367.586363636364,227.686363636364,1019.31363636364,129.454545454545,440,26.6340439528149,21.1145913335384,0.609524791241794,0.973451327433628,0.8,-0.53147806693481,52833.9772727273,32400.1568181818,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_85624,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
85645,2038.21363636364,247.795454545455,140.072727272727,652.877272727273,2519.19090909091,2753.04090909091,353.15,273.186363636364,1154.70454545455,4183.06818181818,517.022727272727,119.259090909091,1060.73181818182,3810.24545454545,629.563636363636,291.472727272727,1605.68181818182,5380.00909090909,370.413636363636,233.054545454545,1025.82272727273,4269.80454545455,235.4,515.090909090909,653.231818181818,1238.60909090909,460.504545454546,228.65,1054.60909090909,129.9,220,22.6511546424468,12.4751483195738,0.83466953138833,0.969162995594714,0.833333333333333,1.5296195590556,53046.55,32751.9409090909,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_85645,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
85681,4144.98260869565,831.898550724638,142.515942028986,671.423188405797,2991.24637681159,2493.74492753623,619.614492753623,252.371014492754,1100.95942028985,7032.04057971014,621.049275362319,133.976811594203,1072.49855072464,2205.50724637681,679.388405797101,1360.1884057971,2384.16811594203,2421.59130434783,330.379710144928,233.023188405797,1031.53043478261,1716.47536231884,241.234782608696,277.640579710145,662.434782608696,2251.54202898551,555.484057971015,259.994202898551,1068.06086956522,132.03768115942,345,22.707698302427,19.7242202747588,0.495489711272411,0.945205479452055,0.75,1.56187624979582,52821.652173913,33467.4028985507,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_85681,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
85688,3378.02476780186,273.839009287926,78.7492260061919,604.015479876161,592.647058823529,273.080495356037,266.990712074303,245.315789473684,1081.13931888545,7487.14241486068,516.108359133127,115.386996904025,1069.15789473684,623.969040247678,486.928792569659,261.755417956656,1471.29411764706,1089.82043343653,261.356037151703,218.736842105263,994.195046439628,971.009287925697,191.882352941176,203.188854489164,599.631578947368,3602.68111455108,513.811145510836,231.631578947368,1028.36842105263,129.393188854489,323,22.861221948723,18.1327915801677,0.60900278542955,0.95,0.734090909090909,-0.553588512026829,53776.3281733746,32945.7925696594,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_85688,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
85793,1787.55837563452,332.368866328257,149.622673434856,658.135363790186,2960.86632825719,4458.31810490694,565.712351945854,274.082910321489,1105.48561759729,3180.45346869712,564.368866328257,119.656514382403,1096.53299492386,4912.74957698816,873.118443316413,494.994923857868,2085.27749576988,5606.179357022,365.61421319797,231.245346869712,1024.39932318105,4748.36886632826,231.126903553299,164.781725888325,617.568527918782,1032.52791878173,458.837563451777,239.020304568528,1035.31302876481,128.741116751269,591,29.1147843681053,25.8940248488979,0.457174178824598,0.968852459016394,0.72962962962963,-1.44112054488977,54116.219966159,32801.7241962775,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_85793,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
86832,3688.21296296296,200.009259259259,88.7731481481482,638.222222222222,1427.64351851852,359.833333333333,713.972222222222,260.083333333333,1087.18055555556,6038.2037037037,574.722222222222,131.685185185185,1076.70833333333,907.351851851852,702.25462962963,289.810185185185,1709.79166666667,1307.83333333333,328.884259259259,227.907407407407,1129.50462962963,1359.43055555556,221.083333333333,944.009259259259,1138.22685185185,1892.58333333333,504.314814814815,229.435185185185,1045.6712962963,129.907407407407,216,20.4751721003651,13.4833195592036,0.752562831955785,0.96,0.668730650154799,-0.631681891025407,52877.0092592593,32818.2638888889,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_86832,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
86926,4127.94524495677,730.227665706052,1085.56772334294,639.71469740634,1606.65994236311,328.521613832853,280.095100864553,242.726224783862,1079.74063400576,5284.87896253602,893.916426512968,117.207492795389,1074.09221902017,837.708933717579,502.092219020173,271.458213256484,1474.43515850144,1153.22766570605,279.276657060519,221.835734870317,996.726224783862,1126.33141210375,212.262247838617,134.319884726225,583.936599423631,1132.90489913545,489.394812680115,272.668587896254,1021.35446685879,129.152737752161,347,23.4530042833497,18.9166054322397,0.591131857019634,0.961218836565097,0.788636363636364,-0.466177668939519,53666.7146974063,33214.8213256484,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_86926,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
87382,1325.32415254237,305.021186440678,155.690677966102,645.540254237288,2324.40254237288,336.921610169492,341.648305084746,263.76906779661,1085.24152542373,2174.10169491525,606.48093220339,130.387711864407,1072.28813559322,800.847457627119,584.408898305085,275.724576271186,1461.33262711864,1250.65466101695,324.847457627119,233.709745762712,980.309322033898,1179.76906779661,244.51906779661,143.247881355932,593.781779661017,1258.03601694915,545.618644067797,232.040254237288,1038.77118644068,129.925847457627,472,27.4460758176501,22.0163240358229,0.597100344185013,0.955465587044534,0.766233766233766,1.36747938724374,52676.7394067797,33273.811440678,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_87382,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
87567,2942.27638190955,231.21608040201,99.2964824120603,636.092964824121,1741.72361809045,387.804020100502,264.218592964824,230.791457286432,1099.74371859296,4599.26130653266,529.507537688442,118.592964824121,1081.39949748744,807.467336683417,447.12311557789,269.246231155779,1593.89949748744,1204.39949748744,235.125628140704,219.663316582914,1057.23869346734,1131.06030150754,187.276381909548,170.527638190955,1380.68844221106,1245.35175879397,499.158291457286,371.972361809045,1027.41959798995,128.211055276382,398,28.1243521326333,18.3131472943077,0.758949811554304,0.963680387409201,0.775828460038986,1.2919119609836,53861.4170854271,33478.1306532663,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_87567,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
88711,1896.06916996047,152.656126482213,73.2826086956522,609.839920948617,408.685770750988,854.681818181818,355.97233201581,272.96837944664,1108.0256916996,2595.895256917,687.673913043478,118.063241106719,1070.80632411067,1024.19565217391,605.942687747036,272.529644268775,1818.62450592885,1495.72134387352,347.262845849802,232.936758893281,1046.57312252964,1299.75494071146,237.859683794466,256.424901185771,3190.43280632411,895.175889328063,426.264822134387,214.822134387352,1022.41699604743,130.04743083004,506,26.4051090699763,24.5706854124707,0.366221516897234,0.961977186311787,0.810897435897436,1.19908213829916,53109.8577075099,32011.3023715415,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_88711,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
88958,1796.05925925926,116.196296296296,162.601851851852,742.45,7483.73518518519,760.3,461.92037037037,295.966666666667,1146.16666666667,1954.22592592593,1036.47222222222,167.007407407407,1068.41851851852,1131.68518518519,662.046296296296,291.807407407407,1644.98888888889,1111.19444444444,219.677777777778,219.112962962963,1257.7537037037,606.690740740741,135.527777777778,98.762962962963,596.457407407407,820.82037037037,421.157407407407,211.712962962963,1039.00185185185,131.068518518519,540,34.9304197507478,19.9060795674527,0.821729277625308,0.96085409252669,0.771428571428571,1.56478695955091,52753.7296296296,32153.212962963,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_88958,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
89065,3707.78409090909,559.045454545455,130.279545454545,646.665909090909,1603.91590909091,311.504545454545,313.722727272727,256.186363636364,1079.7,6484.40681818182,2429.16818181818,129.925,1073.80681818182,743.193181818182,559.818181818182,280.379545454545,1515.66590909091,1316.08409090909,371.888636363636,241.393181818182,998.709090909091,1267.95454545455,271.577272727273,286.820454545455,584.122727272727,2399.70454545455,538.9,372.931818181818,1111.80909090909,131.325,440,26.9635599487628,20.7937309015681,0.636618384041613,0.964912280701754,0.776014109347443,1.50275185219161,52557.9909090909,33219.9159090909,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_89065,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
89331,3135.03703703704,754.707818930041,165.314814814815,643.74279835391,1756.72427983539,818.545267489712,343.80658436214,261.234567901235,1086.1975308642,4315.08230452675,3557.14609053498,132.742798353909,1066.76131687243,638.224279835391,552.668724279835,270.06378600823,1563.91358024691,964.191358024691,262.08024691358,224.526748971193,992.082304526749,867.868312757202,204.092592592592,122.084362139918,584.20987654321,1175.84156378601,449.222222222222,317.238683127572,1077.54938271605,131.592592592593,486,27.6687154283247,22.3904335765871,0.587488031029192,0.958579881656805,0.754658385093168,-0.0336034199146803,52441.0452674897,32296.0679012346,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_89331,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
89352,3771.55411255411,281.619047619048,137.134199134199,649.878787878788,2607.77056277056,244.354978354978,1299.18614718615,249.796536796537,1085.28571428571,5842.93506493507,612.852813852814,135.419913419913,1075.34632034632,634.549783549784,738.623376623377,361.943722943723,1825.78354978355,884.748917748918,219.792207792208,209.91341991342,997.367965367965,752.025974025974,161.857142857143,119.38961038961,600.982683982684,2144.31601731602,517.103896103896,279.545454545455,1041.35930735931,129.904761904762,231,18.7423502345286,15.7561638814028,0.54154506059291,0.96652719665272,0.759868421052632,1.55968866071829,53203.5411255411,32323.1558441558,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_89352,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
89427,4756.45277777778,271.9,93.3611111111111,636.580555555556,1299.94722222222,3002.56111111111,486.052777777778,265.908333333333,1094.09722222222,8605.73333333333,885.511111111111,136.344444444444,1087.33333333333,2724.41666666667,651.85,473.713888888889,1656.49166666667,1475.46666666667,251.602777777778,217.855555555556,1006.73888888889,1154.05277777778,188.611111111111,197.988888888889,619.675,3120.35833333333,552.280555555556,265.733333333333,1106.93888888889,132.080555555556,360,22.3514573757363,20.6770674567923,0.379752536473298,0.957446808510638,0.779220779220779,0.498331348727862,52444.3027777778,32618.2333333333,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_89427,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
89449,4543.41758241758,236.758241758242,94.974358974359,614.538461538462,967.717948717949,708.010989010989,429.893772893773,246.43956043956,1109.52747252747,7431.64102564103,977.52380952381,123.70695970696,1077.28937728938,1179.336996337,607.065934065934,834.549450549451,4029.20512820513,2123.38095238095,231.029304029304,208.040293040293,1005.5641025641,1739.23443223443,167.794871794872,213.67032967033,647.417582417582,1562.49450549451,490.813186813187,271.285714285714,1025.74725274725,130.6336996337,273,24.0482150388688,14.4651595612935,0.798867845960334,0.957894736842105,0.791304347826087,-1.34322833643787,53952.2344322344,32782.032967033,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_89449,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
90214,2648.5787965616,193.630372492837,123.063037249284,657.530085959885,2713.31805157593,3114.5558739255,807.131805157593,256.977077363897,1095.63037249284,4292.54154727794,494.962750716332,142.630372492837,1082.17191977077,3169.93982808023,869.335243553009,831.432664756447,1973.86246418338,3601.22636103152,349.687679083095,240.12893982808,1035.63323782235,3691.37249283668,243.398280802292,583.535816618911,691.166189111748,1147.31805157593,479.498567335244,244.060171919771,1044.37535816619,130.676217765043,349,27.6628307029446,16.2131354330721,0.810240022185374,0.956164383561644,0.718106995884774,1.24010686663693,52856.4498567335,33815.8395415473,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_90214,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
90701,2503.78846153846,279.899572649573,116.606837606838,652.399572649573,2107.00854700855,876.893162393162,405.303418803419,244.690170940171,1090.39102564103,4277.23504273504,524.632478632479,132.549145299145,1137.68162393162,1795.24145299145,719.25641025641,515.929487179487,2066.02564102564,2142.57905982906,339.356837606838,242.155982905983,1048.20512820513,1659.25213675214,220.311965811966,275.380341880342,730.450854700855,1550.80555555556,477.508547008547,344.566239316239,1053.33547008547,130.042735042735,468,31.3169538277261,19.1268347851508,0.791823359921236,0.962962962962963,0.71889400921659,0.329196756307176,52652.7094017094,33737.061965812,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_90701,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
90921,2105.7982832618,660.613733905579,569.412017167382,624.944206008584,1039.26180257511,715.652360515021,1127.84549356223,264.163090128755,1087.71673819743,3752.45064377682,529.128755364807,118.330472103004,1073.7339055794,1004.41630901288,556.600858369099,317.80686695279,1647.24892703863,1460.42489270386,299.326180257511,223.81974248927,1094.77682403433,1062.12875536481,197.845493562232,278.31330472103,2266.15021459227,764.545064377682,408.128755364807,218.450643776824,1002.69098712446,130.210300429185,233,18.1452699299425,16.5838810245635,0.405825371017815,0.951020408163265,0.719135802469136,-0.555448374826805,53828.8798283262,32307.8283261803,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_90921,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
90966,2996.81468531468,597.104895104895,442.258741258741,662.797202797203,2471.38111888112,267.737762237762,501.699300699301,247.255244755245,1085.74475524476,5681.95804195804,1299.81118881119,126.08041958042,1071.44755244755,630.475524475524,640.541958041958,276.895104895105,1466.65734265734,1092.04195804196,300.034965034965,236.20979020979,991.0,1041.03146853147,234.846153846154,184.804195804196,623.367132867133,1976.34265734266,487.381118881119,257.398601398601,1068.95804195804,131.391608391608,286,19.6782039876739,18.5727139860631,0.330455422256252,0.962962962962963,0.752631578947368,1.22606758064873,52598.6678321678,32311.7727272727,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_90966,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
91132,4986.5859030837,517.118942731278,180.986784140969,637.418502202643,1680.88986784141,373.766519823788,1469.59911894273,259.127753303965,1092.88986784141,7075.3127753304,674.511013215859,132.185022026432,1086.30837004405,2066.12334801762,1496.93392070485,313.480176211454,1880.20704845815,1864.66079295154,298.026431718062,224.154185022026,993.594713656388,1232.3436123348,190.052863436123,231.26872246696,638.79295154185,2620.40088105727,521.281938325991,226.986784140969,1066.16299559471,130.022026431718,227,18.043590537039,16.0751184749571,0.454190409443714,0.961864406779661,0.788194444444444,1.47877925176961,53526.0044052863,32191.8149779736,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_91132,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
91659,3796.72916666667,273.596354166667,92.171875,665.8203125,2007.625,750.5859375,977.020833333333,257.283854166667,1080.69270833333,5738.90885416667,892.169270833333,129.638020833333,1088.5625,739.359375,599.200520833333,684.424479166667,1574.15364583333,1259.359375,283.723958333333,228.065104166667,1000.61458333333,962.291666666667,214.716145833333,229.184895833333,633.65625,1307.25520833333,510.888020833333,457.294270833333,1082.3203125,132.049479166667,384,23.6684911173235,20.6810452232906,0.486322086757191,0.955223880597015,0.761904761904762,0.0485840548383259,52418.7369791667,33296.3489583333,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_91659,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
91850,3187.5,492.593406593407,501.881868131868,668.782967032967,3440.92307692308,1022.29945054945,4297.8021978022,248.535714285714,1095.01098901099,5316.30494505495,3386.60439560439,124.546703296703,1097.77197802198,1089.04945054945,510.046703296703,482.486263736264,1536.23351648352,1083.26098901099,290.958791208791,226.60989010989,990.928571428571,1033.00824175824,221.961538461538,175.021978021978,627.728021978022,1952.53296703297,524.502747252747,460.162087912088,1059.16758241758,129.277472527473,364,24.2661196242238,19.1360845984181,0.61491590169141,0.973262032085562,0.798245614035088,1.26563077642551,53530.489010989,33547.771978022,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_91850,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
92115,2015.76351351351,264.916666666667,127.752252252252,676.864864864865,3200.81981981982,1776.5990990991,952.171171171171,249.119369369369,1086.59009009009,3529.47072072072,1258.65540540541,119.018018018018,1078.54504504505,986.405405405405,579.009009009009,539.099099099099,1623.8018018018,1238.26351351351,290.173423423423,228.432432432432,997.166666666667,1450.59009009009,225.164414414414,191.189189189189,595.027027027027,1400.84234234234,496.45045045045,669.556306306306,1069.84009009009,131.84009009009,444,27.3017702341315,20.8307984584974,0.646418035478682,0.958963282937365,0.755102040816326,1.47712015575804,53555.518018018,33553.509009009,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_92115,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
92469,5617.72791519435,1027.96466431095,142.975265017668,651.04593639576,2020.85865724382,2467.93286219081,740.742049469965,254.950530035336,1153.43462897527,8583.31095406361,654.91519434629,148.749116607774,1095.34275618375,4523.66784452297,851.109540636042,555.268551236749,13251.1307420495,5775.31802120141,435.448763250883,248.123674911661,1056.98939929329,5494.8480565371,299.901060070671,398.678445229682,714.703180212014,2821.20848056537,543.265017667845,264.293286219081,1058.09893992933,131.713780918728,283,20.8539153357464,17.3512152395214,0.554721138029652,0.959322033898305,0.714646464646465,-1.48806810561546,52851.3992932862,33598.3886925795,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_92469,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
92869,1784.14,281.285333333333,122.292,673.297333333333,3302.87466666667,508.042666666667,554.952,263.809333333333,1091.072,3228.73066666667,661.648,125.274666666667,1087.72,790.453333333333,577.5,280.630666666667,1421.364,1173.17066666667,348.988,240.602666666667,982.390666666667,1152.12933333333,269.544,130.24,585.033333333333,967.757333333333,566.854666666667,231.869333333333,1017.80266666667,130.765333333333,750,33.5100300796003,28.5579952544497,0.523179829251729,0.965250965250965,0.757575757575758,0.413668920501014,52283.5906666667,33161.052,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_92869,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
93018,3340.44549763033,376.13981042654,230.931279620853,707.755924170616,5734.5308056872,2579.42180094787,480.234597156398,257.312796208531,1100.75118483412,5044.11137440758,585.409952606635,129.130331753555,1080.7654028436,3187.27962085308,740.099526066351,547.151658767772,1702.52369668246,3694.60426540284,378.222748815166,240.976303317536,1050.43127962085,3455.40995260664,297.338862559242,1047.163507109,851.971563981043,1071.13507109005,461.092417061611,297.706161137441,1036.37914691943,128.718009478673,422,30.0131892337594,17.9449707650461,0.801568591251788,0.96127562642369,0.781481481481481,1.52020935648153,53466.2417061611,33634.2559241706,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_93018,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
93542,2711.38541666667,506.152083333333,2830.63125,615.125,840.670833333333,278.645833333333,290.027083333333,246.675,1083.83541666667,3346.5,518.122916666667,117.608333333333,1070.11875,700.977083333333,526.339583333333,306.639583333333,1721.59375,1126.16458333333,290.966666666667,224.666666666667,983.416666666667,1070.0125,229.852083333333,122.0125,598.15,846.277083333333,479.375,245.652083333333,1019.40416666667,128.389583333333,480,29.8608454017667,20.4726455898437,0.727976884813323,0.973630831643002,0.745341614906832,-1.08249727143788,54050.31875,33110.2104166667,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_93542,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
93550,4354.28911564626,1128.47619047619,120.350340136054,629.15306122449,1490.54761904762,280.69387755102,301.394557823129,255.863945578231,1078.31292517007,7462.64965986395,572.551020408163,128.091836734694,1077.53401360544,656.887755102041,443.227891156463,288.414965986395,1448.24489795918,949.632653061224,262.340136054422,231.438775510204,981.809523809524,859.574829931973,198.418367346939,126.08843537415,589.581632653061,2093.42176870748,498.904761904762,234.537414965986,1067.70408163265,129.731292517007,294,19.6929456246469,19.3012992634394,0.198443383652672,0.948387096774194,0.735,0.914213945334846,52670.8401360544,32739.9931972789,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_93550,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
94091,3212.36585365854,325.292682926829,127.09756097561,638.443902439024,1983.77073170732,775.131707317073,332.882926829268,265.039024390244,1106.92195121951,5848.30243902439,560.551219512195,127.49756097561,1071.89268292683,1797.21463414634,752.560975609756,313.829268292683,1500.80487804878,1658.77073170732,385.707317073171,242.170731707317,984.59512195122,1483.14634146341,286.941463414634,169.443902439024,593.214634146341,1909.18536585366,509.692682926829,232.960975609756,1047.72195121951,129.873170731707,205,18.5880008416456,14.0608684390636,0.65405306803423,0.949074074074074,0.770676691729323,1.53135778690466,52982.1219512195,32749.3756097561,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_94091,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
94511,3614.8198757764,241.416149068323,72.2670807453416,627.416149068323,682.049689440994,291.484472049689,2461.70807453416,247.552795031056,1084.76397515528,3696.37888198758,931.385093167702,129.086956521739,1080.67701863354,604.236024844721,437.509316770186,523.080745341615,1448.62732919255,950.416149068323,226.465838509317,215.211180124224,997.726708074534,941.590062111801,184.937888198758,203.124223602484,779.739130434783,753.633540372671,395.919254658385,214.217391304348,1022.52795031056,129.391304347826,161,14.929452740708,13.7167295433334,0.394793805434145,0.987730061349693,0.821428571428571,-0.633929230383356,52716.6211180124,32876.4782608696,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_94511,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
95144,6175.8544973545,1077.64285714286,1905.31746031746,638.029100529101,1618.89682539683,281.962962962963,571.198412698413,242.619047619048,1090.31746031746,9610.93386243386,592.314814814815,128.230158730159,1084.81216931217,817.835978835979,573.222222222222,269.441798941799,1664.80952380952,1089.34126984127,257.865079365079,221.269841269841,1002.46296296296,966.57671957672,192.34126984127,147.230158730159,587.325396825397,2069.46296296296,513.965608465609,254.613756613757,1053.1746031746,129.751322751323,378,23.5090344141592,20.492895496305,0.490034594937279,0.976744186046512,0.782608695652174,1.13629346259636,53869.9576719577,33179.9523809524,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_95144,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
96953,2975.55940594059,469.777227722772,75.8366336633663,621.212871287129,1681.87623762376,480.539603960396,316.559405940594,257.069306930693,1100.19306930693,6386.48514851485,516.143564356436,117.262376237624,1065.29702970297,814.20297029703,447.80198019802,276.79702970297,1525.53465346535,942.579207920792,205.118811881188,209.40099009901,1113.16831683168,624.495049504951,134.29702970297,104.272277227723,585.648514851485,1810.78712871287,482.009900990099,233.014851485149,1051.64851485149,130.965346534653,202,20.4894412999253,12.5699091803813,0.789708484936835,0.952830188679245,0.776923076923077,1.41948884822826,53676.7376237624,32741.6138613861,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_96953,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
97003,4198.10038610039,664.555984555985,95.7142857142857,656.162162162162,1792.13513513514,1576.23166023166,826.108108108108,257.254826254826,1106.49420849421,7480.01544401544,656.015444015444,145.660231660232,1082.74131274131,1198.23938223938,780.895752895753,489.53667953668,3611.98455598456,1789.14671814672,326.015444015444,233.019305019305,1011.74903474903,1837.35521235521,220.459459459459,315.826254826255,634.895752895753,3968.64478764479,567.486486486486,322.359073359073,1075.21235521236,130.401544401544,259,19.3785533783937,17.0545571159253,0.474836925729113,0.970037453183521,0.757309941520468,0.572202384468589,53433.9420849421,33773.9961389961,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_97003,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
97055,2610.890625,304.802083333333,147.03125,641.8671875,2641.953125,293.143229166667,310.622395833333,257.375,1076.2265625,5126.15625,695.8125,122.263020833333,1107.6171875,642.6328125,502.463541666667,272.643229166667,1372.83072916667,1026.2578125,302.1015625,226.645833333333,976.348958333333,932.78125,221.244791666667,121.057291666667,586.5625,2049.171875,521.0234375,251.489583333333,1067.72916666667,130.484375,384,29.0629478739915,16.8786103423514,0.81407451344149,0.964824120603015,0.761904761904762,-1.29211081797926,54075.2161458333,32494.7604166667,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_97055,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
97271,2545.95333333333,204.846666666667,93.6233333333333,634.67,1625.31666666667,299.47,301.616666666667,249.17,1079.02666666667,5771.75666666667,519.596666666667,120.673333333333,1071.9,1225.45,528.96,314.816666666667,1504.19666666667,1469.35666666667,335.596666666667,231.04,985.58,1209.80333333333,237.826666666667,164.733333333333,587.88,2909.55,523.84,325.84,1042.05666666667,130.076666666667,300,24.1450629850667,15.862871398417,0.753906275275904,0.955414012738854,0.75,1.51876516968591,53574.5533333333,32970.52,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_97271,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
97403,1808.41608391608,345.657342657343,156.744755244755,676.213286713287,3379.16433566434,738.65034965035,389.010489510489,266.982517482517,1090.38461538462,3492.82867132867,495.940559440559,128.671328671329,1069.73426573427,821.762237762238,563.304195804196,355.583916083916,1555.22377622378,1029.46503496503,280.472027972028,221.793706293706,1026.03496503497,930.70979020979,199.590909090909,187.821678321678,754.160839160839,835.77972027972,437.510489510489,227.164335664336,1014.1048951049,129.51048951049,286,19.8028154864762,18.4804813180558,0.359292651070602,0.966216216216216,0.752631578947368,-0.786804662056227,53099.1503496504,32838.9405594406,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_97403,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
97683,2216.30652173913,531.378260869565,1373.82608695652,649.421739130435,2266.78260869565,1417.28260869565,710.358695652174,255.291304347826,1089.55,3025.37826086957,1040.07173913043,123.367391304348,1070.62608695652,738.410869565217,705.617391304348,907.419565217391,1588.75217391304,1199.05,265.026086956522,221.710869565217,1024.35652173913,1148.50217391304,198.202173913043,544.447826086957,732.376086956522,1003.43260869565,460.367391304348,235.110869565217,1050.24130434783,129.754347826087,460,27.5651396951118,21.408241170986,0.629942403851645,0.956340956340956,0.774410774410774,-0.0470803572365437,52698.9152173913,32494.8326086957,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_97683,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
98582,2282.3511627907,253.413953488372,104.611627906977,633.753488372093,1938.86046511628,262.674418604651,284.504651162791,255.537209302326,1079.09302325581,3115.51860465116,549.162790697674,138.995348837209,1092.72558139535,514.246511627907,386.344186046512,264.651162790698,1450.69534883721,809.706976744186,211.272093023256,209.63023255814,979.904651162791,731.755813953488,156.448837209302,179.279069767442,604.362790697674,1168.70930232558,502.748837209302,276.593023255814,1021.83255813953,128.841860465116,430,27.3059506306297,20.3503831470094,0.666759631670116,0.966292134831461,0.746527777777778,0.812314835920612,53786.9813953488,32424.7209302326,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_98582,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
99002,4002.56725146199,950.178362573099,163.809941520468,672.883040935673,2918.10526315789,1461.04385964912,2072.81578947368,247.456140350877,1103.69883040936,6665.36257309942,559.657894736842,133.076023391813,1091.07602339181,1558.8216374269,782.038011695906,1035.41520467836,4776.65789473684,2173.83625730994,324.178362573099,237.964912280702,1042.58187134503,1902.07894736842,230.011695906433,228.555555555556,765.543859649123,2651.58479532164,522.72514619883,241.479532163743,1061.32456140351,131.116959064327,342,24.7663312048092,17.6232490977327,0.70260413744187,0.957983193277311,0.75,1.21959174879003,52871.2660818713,33610.1900584795,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_99002,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
99275,3169.00526315789,366.855263157895,180.702631578947,687.2,4111.36578947368,357.139473684211,303.355263157895,254.644736842105,1074.63421052632,6049.58421052632,824.257894736842,135.431578947368,1077.46842105263,665.663157894737,487.0,275.234210526316,1452.69473684211,923.615789473684,273.007894736842,226.442105263158,981.010526315789,894.252631578947,201.931578947368,148.863157894737,593.126315789474,1671.79736842105,501.842105263158,316.813157894737,1078.98947368421,129.928947368421,380,31.5003524024411,15.4714011264542,0.871074958070038,0.954773869346734,0.703703703703704,-1.23845090140332,52472.1447368421,33224.1421052632,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_99275,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
99746,5693.20557491289,1230.81881533101,178.372822299652,674.212543554007,2309.26132404181,2212.61672473868,895.515679442509,249.303135888502,1101.05226480836,8793.62717770035,1205.70034843206,144.623693379791,1086.30662020906,1130.02090592335,857.348432055749,922.533101045296,1973.87804878049,1249.56445993031,308.052264808362,223.836236933798,1046.04181184669,1130.29965156794,215.731707317073,397.062717770035,623.393728222997,2568.55400696864,539.515679442509,446.369337979094,1068.08362369338,130.8606271777,287,23.8576300235449,15.4901983820426,0.760552453191557,0.940983606557377,0.779891304347826,-1.54896455082843,53578.8675958188,33779.3449477352,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_99746,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
100564,2313.33689839572,469.256684491979,82.7219251336898,634.524064171123,2154.3743315508,339.68449197861,864.283422459893,238.390374331551,1078.5614973262,4088.90909090909,1805.08021390374,111.262032085562,1077.6256684492,925.647058823529,649.540106951872,699.604278074866,1689.31550802139,1465.46524064171,324.973262032086,234.764705882353,1042.01604278075,1288.34759358289,263.363636363636,267.20320855615,628.080213903743,1473.2513368984,483.737967914439,479.51871657754,1047.0,128.951871657754,187,17.4662383993076,13.6949451753681,0.620658545322042,0.949238578680203,0.733333333333333,1.17507435392674,53432.8823529412,33650.0695187166,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_100564,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
100933,2699.20677966102,424.769491525424,200.089830508475,691.472881355932,3723.75084745763,538.986440677966,273.867796610169,256.53220338983,1087.46610169492,2696.21525423729,914.796610169492,140.298305084746,1102.06610169492,601.076271186441,588.533898305085,262.713559322034,1677.7813559322,865.354237288136,242.877966101695,216.332203389831,994.18813559322,748.459322033898,173.179661016949,140.41186440678,583.752542372881,937.074576271186,473.438983050847,218.340677966102,1046.06610169492,132.222033898305,590,30.3105910520527,24.8499940431542,0.572585163148881,0.975206611570248,0.782493368700265,-0.53515813856012,53374.0169491526,31988.4423728814,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_100933,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
101565,876.090909090909,512.876733436055,72.0046224961479,612.838212634823,873.041602465331,309.453004622496,454.693374422188,252.257318952234,1078.96302003082,1312.16640986133,535.020030816641,112.451463790447,1069.40677966102,698.500770416025,569.2218798151,278.060092449923,1613.51309707242,1280.41448382126,333.097072419106,240.171032357473,991.020030816641,1290.82280431433,258.950693374422,170.721109399075,603.651771956857,1128.57164869029,555.839753466872,357.277349768875,1045.60400616333,129.563944530046,649,30.795710351356,26.9515488196924,0.483811599168972,0.96577380952381,0.772619047619048,0.42971860649973,52290.5716486903,33290.7026194145,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_101565,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
101608,3912.92113564669,312.451104100946,179.558359621451,681.917981072555,4037.5047318612,516.252365930599,293.375394321767,240.712933753943,1093.81072555205,7700.29022082019,659.858044164038,123.98738170347,1083.57097791798,1151.16719242902,702.362776025237,780.694006309148,2787.06309148265,2230.41640378549,303.659305993691,227.369085173502,1027.09148264984,1575.09779179811,206.1261829653,662.328075709779,786.643533123028,2936.15141955836,535.523659305994,392.968454258675,1050.8738170347,128.854889589905,317,23.8522221524045,16.9462970165961,0.703727119129283,0.954819277108434,0.725400457665904,1.144252470372,53453.5520504732,32767.4195583596,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_101608,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
102655,2415.01265822785,112.028481012658,68.2373417721519,617.373417721519,899.939873417722,1309.25949367089,574.091772151899,258.21835443038,1085.11392405063,4763.90506329114,617.835443037975,115.841772151899,1082.60443037975,3469.37025316456,932.006329113924,338.354430379747,1494.52215189873,3001.48101265823,317.091772151899,232.534810126582,987.594936708861,1960.33544303797,225.594936708861,238.272151898734,636.753164556962,1488.26265822785,475.237341772152,241.348101265823,1304.69620253165,129.284810126582,316,23.223104827727,17.3628536597783,0.664088157877184,0.969325153374233,0.797979797979798,-0.359940881524281,53011.8987341772,33306.7658227848,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_102655,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
103086,1682.51966292135,218.441011235955,123.845505617978,686.842696629213,4071.19662921348,804.662921348315,282.10393258427,234.039325842697,1085.19943820225,2878.06741573034,641.033707865169,134.727528089888,1069.14325842697,698.030898876405,399.935393258427,295.205056179775,1769.19662921348,1383.91011235955,248.457865168539,224.275280898876,1006.73314606742,1422.95224719101,196.581460674157,171.331460674157,603.058988764045,1102.43539325843,459.160112359551,265.567415730337,1077.54213483146,131.52808988764,356,25.064007044536,18.2260648668836,0.686445973162495,0.946808510638298,0.749473684210526,1.52464115947443,52951.8651685393,33752.3033707865,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,9,FAAGSCC_12_103086,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
103097,2942.28139534884,180.993023255814,128.209302325581,676.786046511628,3447.53023255814,1668.66976744186,470.181395348837,255.767441860465,1196.96976744186,4750.19302325581,600.688372093023,131.937209302326,1079.41860465116,1252.38837209302,685.855813953488,854.83488372093,1733.82325581395,1617.21395348837,317.9,229.390697674419,1037.28604651163,1292.31395348837,216.367441860465,593.779069767442,710.33023255814,1902.00697674419,527.504651162791,366.3,1052.00465116279,131.274418604651,430,29.5009764695682,18.6966207066754,0.773527468986895,0.957683741648107,0.693548387096774,0.131415386895172,53478.2604651163,33712.8209302326,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_103097,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
103601,1860.97014925373,244.892537313433,128.522388059701,665.728358208955,3201.88358208955,283.84776119403,310.620895522388,257.435820895522,1084.3671641791,3745.0447761194,944.69552238806,128.331343283582,1079.83880597015,650.411940298507,618.429850746269,264.54328358209,1439.79402985075,901.946268656716,241.84776119403,215.280597014925,988.113432835821,776.528358208955,172.349253731343,114.217910447761,582.471641791045,1567.46567164179,489.220895522388,414.173134328358,1075.65671641791,132.191044776119,335,24.7594662121482,17.4358005225481,0.709994274454097,0.971014492753623,0.766590389016018,-0.538742324851505,53598.071641791,32438.223880597,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_103601,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
104114,3577.66,524.715,136.3275,665.9425,3034.16,1041.195,455.08,243.825,1086.9175,5602.57,581.48,121.1375,1108.7175,1720.08,688.24,306.5425,1716.62,3678.14,383.0525,239.425,1099.36,3937.595,251.98,812.805,998.5375,1498.9575,494.4625,383.655,1042.9725,130.3275,400,24.9190721451104,20.5040201771941,0.568295727404011,0.961538461538462,0.757575757575758,1.00760455261405,53514.1875,33666.6625,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_104114,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
104157,2643.59770114943,266.913793103448,88.5114942528736,638.557471264368,1671.70114942529,249.540229885057,258.327586206897,244.735632183908,1072.68390804598,3657.80459770115,2394.44252873563,125.408045977011,1074.40804597701,578.862068965517,421.729885057471,266.195402298851,1384.59195402299,967.298850574713,293.971264367816,227.385057471264,971.545977011494,964.333333333333,227.333333333333,124.98275862069,588.218390804598,962.034482758621,471.333333333333,282.902298850575,1038.83333333333,128.954022988506,174,18.8903716943127,11.9066676161099,0.776348815383631,0.956043956043956,0.69047619047619,-1.10602532074905,52901.4367816092,32666.7126436782,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_104157,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
104326,616.861788617886,1062.9593495935,241.260162601626,615.271002710027,108.075880758808,316.379403794038,287.983739837398,249.260162601626,1082.79674796748,1374.53658536585,1117.41463414634,123.211382113821,1068.81571815718,617.972899728997,449.20325203252,267.485094850948,1353.84552845528,898.479674796748,266.607046070461,219.327913279133,976.116531165312,854.907859078591,193.040650406504,117.967479674797,592.758807588076,562.352303523035,356.517615176152,204.222222222222,985.084010840108,129.533875338753,369,23.0741547095108,20.4364459305553,0.464285543766266,0.963446475195822,0.802173913043478,1.2965099768937,53191.9701897019,32660.647696477,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_104326,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
104496,1861.15778019586,434.504896626768,119.508161044614,624.394994559304,529.618063112078,1885.31664853101,1964.61044613711,260.981501632209,1088.08269858542,3160.78019586507,768.020674646355,139.985854189336,1066.63873775843,1895.71490750816,683.865070729053,1504.82480957563,1640.3112078346,1819.14581066376,267.984766050054,219.35690968444,1016.50816104461,1291.44831338411,193.22633297062,291.389553862894,679.248095756257,1136.35038084875,474.784548422198,224.949945593036,1065.359085963,130.010881392818,919,49.3103178978982,23.9024490859458,0.874660929218346,0.972486772486772,0.607804232804233,0.679345236165582,52769.4483133841,32470.2285092492,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_104496,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
105466,4240.44117647059,319.770588235294,123.917647058824,643.570588235294,1971.55294117647,241.7,239.294117647059,242.435294117647,1078.72352941176,7187.37058823529,601.447058823529,127.852941176471,1065.61764705882,645.282352941176,436.694117647059,261.670588235294,1415.85882352941,1146.49411764706,293.341176470588,221.505882352941,983.011764705882,1008.78235294118,197.764705882353,109.476470588235,582.905882352941,2695.23529411765,531.282352941176,425.723529411765,1049.82352941176,129.217647058824,170,16.1334261720624,13.4257060958471,0.55452498261528,0.955056179775281,0.80952380952381,0.521504336338683,53654.5411764706,32539.0941176471,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_105466,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
106133,2764.82397003745,378.501872659176,78.9475655430712,632.865168539326,699.823970037453,394.022471910112,670.041198501873,246.310861423221,1088.67415730337,3942.91011235955,1139.68164794007,121.715355805243,1070.19101123596,643.059925093633,404.913857677903,266.224719101124,1634.9063670412,871.479400749064,207.393258426966,211.861423220974,1002.33707865169,794.902621722846,160.554307116105,166.179775280899,674.779026217228,1053.66666666667,479.014981273408,429.876404494382,1024.38202247191,132.524344569288,267,19.3812117693637,17.6046406471952,0.418242525665847,0.978021978021978,0.780701754385965,0.647876398132144,52892.6891385768,33588.670411985,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_106133,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
106171,1448.5696969697,142.727272727273,70.7060606060606,634.1,1531.73333333333,285.781818181818,300.8,262.224242424242,1073.0696969697,3117.90303030303,578.99696969697,117.8,1066.80909090909,662.039393939394,449.821212121212,272.830303030303,1391.7696969697,1041.71515151515,293.490909090909,230.824242424242,983.924242424242,1019.15454545455,223.342424242424,145.351515151515,641.318181818182,1145.32424242424,434.072727272727,231.509090909091,1026.35757575758,129.606060606061,330,22.3585755534527,18.8453489072838,0.538118897339162,0.962099125364432,0.789473684210526,-1.44732418855892,52815.9090909091,32719.4696969697,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_106171,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
106258,4734.49035812672,1342.54269972452,1528.21212121212,642.476584022039,1789.56749311295,455.286501377411,388.137741046832,248.308539944904,1079.44903581267,7689.53994490358,591.413223140496,123.892561983471,1064.35812672176,1052.39393939394,580.484848484848,347.418732782369,1732.62258953168,1222.29201101928,270.36914600551,266.933884297521,990.143250688705,1239.01377410468,202.280991735537,191.600550964187,590.404958677686,2493.34435261708,558.426997245179,259.468319559229,1063.14876033058,129.520661157025,363,26.6991116606821,17.5960003840828,0.752100740764284,0.955263157894737,0.698076923076923,-1.14203832675072,53895.3085399449,33000.741046832,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_106258,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
106339,4924.43624161074,657.503355704698,1685.10402684564,649.137583892617,1801.95637583893,687.090604026846,2518.58389261745,232.38255033557,1077.15100671141,7743.88255033557,692.285234899329,127.969798657718,1105.44966442953,2907.09731543624,878.369127516779,1560.56711409396,1865.01006711409,3730.61744966443,424.08389261745,250.127516778523,1091.05033557047,2682.31879194631,288.963087248322,739.090604026846,806.177852348993,2120.80872483221,533.278523489933,462.845637583893,1061.39932885906,131.053691275168,298,21.5200462254095,17.6812635762049,0.570038056502377,0.964401294498382,0.788359788359788,-0.164970380742463,53379.1610738255,33578.9798657718,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_106339,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
106854,2362.40347071584,374.492407809111,199.399132321041,685.073752711497,4542.93926247289,416.787418655098,375.503253796095,275.518438177874,1086.52277657267,3809.568329718,536.676789587852,133.665943600868,1081.75488069414,718.019522776573,605.425162689805,278.284164859002,1476.13015184382,1008.98915401302,314.370932754881,226.574837310195,987.017353579176,889.726681127983,216.097613882863,132.941431670282,583.520607375271,1724.33622559653,582.772234273319,238.008676789588,1070.11062906725,131.75704989154,461,26.7463103461568,21.9845434707427,0.569537330885625,0.970526315789474,0.805944055944056,-0.0628992137486671,53500.6247288503,32553.6160520607,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_106854,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
107165,4352.68965517241,756.413793103448,74.0094043887147,630.210031347962,1416.43260188088,346.564263322884,329.677115987461,256.877742946708,1078.89968652038,7145.22884012539,631.131661442006,123.573667711599,1082.65830721003,803.065830721003,491.438871473354,280.382445141066,1366.52351097179,1149.24137931034,305.175548589342,227.912225705329,980.056426332288,1093.23824451411,233.266457680251,129.043887147335,587.194357366771,1545.22570532915,495.598746081505,251.288401253918,1041.44200626959,132.109717868339,319,20.9128718316989,19.4641841009392,0.36571354014717,0.972560975609756,0.799498746867168,0.310375034352169,53054.1661442006,33318.9780564263,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_107165,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
107407,4371.65060240964,454.683734939759,195.957831325301,673.777108433735,3202.82530120482,590.219879518072,366.85843373494,263.924698795181,1124.45180722892,7542.26204819277,783.548192771084,129.599397590361,1090.93975903614,726.542168674699,406.545180722892,271.807228915663,1439.24397590361,799.5,183.144578313253,207.617469879518,1042.08734939759,681.186746987952,140.418674698795,124.21686746988,599.340361445783,1585.93373493976,498.900602409639,239.909638554217,1063.64759036145,132.674698795181,332,23.2816838274587,18.224274455592,0.622307292143646,0.96231884057971,0.718614718614719,-0.667812997494778,53273.921686747,33100.3885542169,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_107407,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
107700,1652.74540682415,187.923884514436,80.9632545931758,626.703412073491,650.950131233596,259.716535433071,234.729658792651,225.498687664042,1090.62467191601,3075.23359580053,473.246719160105,106.706036745407,1078.53018372703,849.821522309711,452.118110236221,272.280839895013,1787.35433070866,1322.69553805774,268.459317585302,224.706036745407,1035.71391076115,1049.03412073491,195.918635170604,140.716535433071,675.916010498688,992.186351706037,449.186351706037,696.524934383202,1035.98687664042,128.291338582677,381,32.1183083900911,15.1381682178552,0.881959496313725,0.967005076142132,0.76969696969697,-1.48998543700357,53825.5905511811,33477.7795275591,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_107700,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
108221,4631.45454545455,911.70979020979,168.660839160839,674.874125874126,3771.6993006993,1651.40559440559,538.867132867133,256.045454545455,1125.83566433566,7071.58741258741,799.146853146853,136.444055944056,1077.58741258741,2160.60839160839,818.269230769231,625.160839160839,1937.47552447552,5384.84615384615,373.489510489511,242.178321678322,1032.64685314685,5428.9965034965,274.010489510489,388.755244755245,604.541958041958,1975.48601398601,543.27972027972,291.625874125874,1078.54195804196,131.416083916084,286,22.7198657535491,16.0572653329567,0.707463373139008,0.947019867549669,0.731457800511509,-1.37358838873167,53019.965034965,33629.5699300699,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_108221,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
108282,4188.9375,474.897321428571,265.879464285714,701.28125,5478.86607142857,225.816964285714,265.366071428571,251.080357142857,1081.86607142857,5889.88392857143,688.116071428571,144.008928571429,1094.07142857143,498.544642857143,440.897321428571,255.276785714286,1560.14732142857,834.580357142857,220.513392857143,212.723214285714,986.165178571429,718.147321428571,161.392857142857,125.830357142857,583.526785714286,1913.5,516.919642857143,226.553571428571,1076.00892857143,135.75,224,25.5649234818798,11.3254440205931,0.896518075992298,0.96551724137931,0.746666666666667,-1.36574037767809,52495.9955357143,32206.8973214286,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_108282,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
108512,4638.01538461538,505.166153846154,94.2861538461538,615.289230769231,599.932307692308,1332.35384615385,316.009230769231,245.52,1088.44307692308,7799.24615384615,640.692307692308,126.187692307692,1094.71692307692,3676.28615384615,775.670769230769,324.793846153846,12424.0646153846,5169.60307692308,448.412307692308,247.56,1211.51076923077,4106.22461538462,557.766153846154,233.153846153846,667.781538461539,2031.29846153846,487.498461538462,241.4,1053.43692307692,132.489230769231,325,21.241793330042,19.4983991642888,0.396751112669205,0.95307917888563,0.773809523809524,-1.043361806158,52738.3969230769,33509.1353846154,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_108512,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
108694,1816.14117647059,184.223529411765,83.9529411764706,651.913725490196,2222.77647058824,1925.76470588235,915.972549019608,257.294117647059,1099.38823529412,3418.12941176471,555.309803921569,127.298039215686,1072.78431372549,4859.57647058824,897.239215686275,818.658823529412,2308.23921568627,6903.94117647059,468.211764705882,248.086274509804,1054.56470588235,7105.25490196078,282.666666666667,600.686274509804,749.341176470588,1507.49803921569,490.509803921569,341.423529411765,1041.38431372549,130.705882352941,255,18.8995759578987,17.2058295113296,0.413769287598239,0.965909090909091,0.745614035087719,1.4873005429166,53455.0,33871.0901960784,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_108694,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
108907,1897.13274336283,129.849557522124,100.761061946903,662.676991150443,2954.69469026549,4954.97787610619,892.16814159292,269.141592920354,1234.69911504425,3008.68584070796,535.446902654867,123.982300884956,1067.48672566372,955.911504424779,560.115044247788,293.088495575221,2043.1592920354,1090.3407079646,302.703539823009,227.278761061947,990.725663716814,1020.38495575221,216.853982300885,136.433628318584,600.12389380531,1147.7389380531,500.79203539823,230.690265486726,1045.11946902655,131.252212389381,226,20.2025806687544,14.2570790117466,0.708504959628338,0.961702127659574,0.792982456140351,-1.21533805170515,53141.8761061947,33072.2433628319,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_108907,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
108963,5174.14117647059,1001.42352941176,170.894117647059,631.36862745098,1990.4431372549,1937.48235294118,2124.40784313725,253.945098039216,1100.43921568627,7076.03137254902,577.752941176471,125.003921568627,1081.79607843137,2098.39607843137,1080.53725490196,682.580392156863,1868.57647058824,3068.83921568627,381.164705882353,233.513725490196,1070.01176470588,3203.37254901961,234.705882352941,395.18431372549,702.039215686274,2025.91764705882,578.462745098039,246.803921568627,1045.4431372549,129.898039215686,255,21.2326626665717,15.3235321448666,0.692209926610336,0.940959409594096,0.758928571428571,-1.38188567157092,53942.3450980392,33511.1137254902,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_108963,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
109220,3282.06223175966,311.703862660944,100.296137339056,632.06652360515,1061.21030042918,294.201716738197,307.678111587983,261.30686695279,1080.50858369099,6507.0321888412,1485.28755364807,124.62017167382,1073.36266094421,740.083690987124,714.991416309013,276.416309012876,1471.52360515021,1049.07725321888,305.248927038627,227.957081545064,983.298283261803,927.622317596566,207.830472103004,130.929184549356,582.663090128755,2410.52360515021,538.894849785408,450.987124463519,1101.32618025751,131.935622317597,466,26.2817026263101,22.6910424955752,0.50455774507052,0.962809917355372,0.779264214046823,1.16634949518211,53390.2725321888,32647.2854077253,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_109220,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
109762,3138.0990990991,225.708708708709,143.963963963964,655.72972972973,2378.60660660661,4011.31531531532,1206.63963963964,265.81981981982,1122.50750750751,4056.24324324324,675.660660660661,128.207207207207,1092.78378378378,3454.4954954955,744.843843843844,555.990990990991,2190.07507507507,2999.03003003003,305.333333333333,226.687687687688,1037.02702702703,2167.9009009009,201.636636636637,276.906906906907,708.453453453453,912.078078078078,446.372372372372,275.912912912913,1040.32732732733,131.831831831832,333,22.8716569552364,18.779123320404,0.570834313329147,0.954154727793696,0.762013729977117,-1.55350439578149,53000.4444444444,33589.7927927928,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_109762,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
111203,4262.53691275168,659.939597315436,1470.85234899329,631.442953020134,1145.10738255034,3250.94630872483,445.187919463087,267.503355704698,1095.93288590604,5723.30201342282,570.644295302013,136.241610738255,1076.93959731544,4754.35570469799,679.234899328859,438.771812080537,2765.8322147651,4449.55704697987,355.530201342282,240.228187919463,1038.1677852349,3669.20134228188,246.389261744966,293.315436241611,680.422818791946,1195.73825503356,473.684563758389,294.201342281879,1031.91946308725,129.771812080537,149,16.1863875944935,11.7425597117679,0.688265439467903,0.961290322580645,0.776041666666667,-0.270384024797063,53512.677852349,33830.6979865772,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_111203,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
111663,3864.48484848485,155.272727272727,59.2393939393939,652.090909090909,2436.00909090909,716.090909090909,1228.87878787879,244.312121212121,1074.58181818182,6396.32424242424,948.521212121212,131.690909090909,1084.98484848485,3724.42727272727,674.169696969697,711.284848484848,1856.75454545454,4476.31515151515,402.357575757576,240.809090909091,1055.79090909091,3905.46060606061,263.706060606061,784.021212121212,874.993939393939,2080.15454545455,511.751515151515,329.1,1058.29393939394,129.59696969697,330,21.5014249398994,19.5718802363355,0.414037813065741,0.962099125364432,0.785714285714286,-0.164910430974689,53582.0333333333,33729.2454545455,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_111663,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
111998,1893.89858490566,272.417452830189,298.818396226415,744.205188679245,8506.31367924528,731.620283018868,468.525943396226,293.764150943396,1147.56367924528,2800.08490566038,1523.45283018868,246.707547169811,1071.76650943396,1204.68632075472,708.264150943396,294.60141509434,1677.97877358491,1150.74056603774,230.525943396226,216.445754716981,1289.31839622642,606.575471698113,134.268867924528,98.188679245283,590.61320754717,837.686320754717,422.464622641509,211.216981132075,1031.9858490566,131.264150943396,424,26.4827975988621,20.532296283725,0.631584655610236,0.946428571428571,0.709030100334448,0.481357115011623,52848.2122641509,32207.0400943396,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_111998,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
112511,4815.75769230769,1148.01730769231,1120.55,656.498076923077,1974.74230769231,394.821153846154,322.109615384615,244.75,1101.04230769231,7123.74423076923,648.838461538462,122.259615384615,1085.74615384615,952.8,466.330769230769,273.944230769231,1829.71538461538,1313.09615384615,261.896153846154,225.561538461538,1072.11538461538,1032.93076923077,196.203846153846,143.978846153846,659.948076923077,1676.53269230769,509.125,525.038461538462,1043.03269230769,130.163461538462,520,32.2529635907894,20.6356633032777,0.768535843583756,0.964749536178108,0.75036075036075,-1.56292793874566,53776.7807692308,33475.2884615385,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_112511,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
112900,2550.09873417722,750.093670886076,101.539240506329,641.306329113924,1845.83544303797,508.116455696203,253.706329113924,224.754430379747,1071.97721518987,4703.25316455696,1663.99746835443,115.521518987342,1086.05316455696,2704.11139240506,748.040506329114,343.73670886076,2330.25569620253,2715.30126582278,376.759493670886,240.205063291139,1023.79240506329,1510.61012658228,238.812658227848,190.316455696202,597.060759493671,1912.16962025316,500.969620253165,327.291139240506,1051.10379746835,130.686075949367,395,26.3272896588514,19.1935595877877,0.684474640531666,0.961070559610706,0.759615384615385,-1.33410326536279,53481.8962025316,33483.964556962,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_112900,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
112972,2156.72784810127,329.148734177215,101.142405063291,632.101265822785,1247.99683544304,592.810126582278,296.212025316456,257.009493670886,1077.84810126582,3795.76898734177,1341.79430379747,119.819620253165,1064.87974683544,973.262658227848,742.098101265823,2008.12341772152,2045.03164556962,1665.97151898734,275.724683544304,219.819620253164,1046.04113924051,940.95253164557,170.373417721519,330.272151898734,680.917721518987,1108.23734177215,426.525316455696,240.806962025316,1049.73101265823,131.136075949367,316,21.1429169988471,19.0970536510761,0.429143198443056,0.969325153374233,0.79,-0.693651980293442,53215.3449367089,32179.1772151899,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_112972,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
113627,2500.17068965517,160.508620689655,91.4413793103448,710.605172413793,1594.7224137931,294.518965517241,308.277586206897,260.996551724138,1082.38103448276,5173.98103448276,740.901724137931,152.863793103448,1075.05689655172,673.077586206897,549.920689655172,276.66724137931,1387.80172413793,1051.79827586207,311.770689655172,229.562068965517,981.839655172414,987.684482758621,220.21724137931,122.21724137931,588.187931034483,1855.56551724138,506.506896551724,253.756896551724,1080.95,131.603448275862,580,31.6594348555674,23.7838231594316,0.660029521549078,0.950819672131148,0.692951015531661,0.459647199126225,53036.2793103448,32677.5603448276,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_113627,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
113887,3712.93841642229,249.844574780059,102.964809384164,612.791788856305,647.061583577713,1039.38416422287,1186.93841642229,261.656891495601,1091.04398826979,7345.41055718475,561.114369501466,121.58651026393,1082.47214076246,4381.86803519062,1132.1348973607,485.510263929619,1694.92375366569,3629.4780058651,318.395894428152,228.615835777126,1007.39882697947,2098.41642228739,201.117302052786,244.598240469208,623.961876832845,2020.25219941349,482.196480938416,232.137829912023,1036.12316715543,130.926686217009,341,22.5171060200767,19.4075173973599,0.507076497398654,0.96056338028169,0.775,-0.744305331189966,53410.064516129,32723.6158357771,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_113887,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
114375,3781.82445141066,1001.84952978056,100.354231974922,631.786833855799,1345.07523510972,2201.68652037618,1497.68338557994,260.382445141066,1091.49843260188,6398.68338557994,631.526645768025,125.454545454545,1336.32915360502,2587.25705329154,848.905956112853,1062.99686520376,1897.65830721003,1564.05956112853,317.793103448276,232.652037617555,1034.51724137931,1210.97178683386,218.07210031348,609.244514106583,659.012539184953,2002.08777429467,493.050156739812,267.746081504702,1062.68338557994,129.921630094044,319,23.447093169688,17.3593354467369,0.672208445345296,0.957957957957958,0.725,-0.630916408818523,53324.1724137931,33697.6394984326,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX+,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_114375,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
114410,4856.08562691131,1100.75535168196,1520.22629969419,642.896024464832,1939.93577981651,398.48623853211,631.626911314985,261.645259938838,1096.39449541284,7884.07951070336,661.235474006116,128.590214067278,1076.84403669725,2706.85321100917,569.978593272171,316.05504587156,1691.05810397554,3074.47400611621,312.024464831804,219.354740061162,1120.61162079511,2734.50764525994,198.183486238532,869.666666666667,1487.28440366972,2242.44648318043,576.547400611621,268.743119266055,1074.45871559633,130.840978593272,327,23.1376224041747,18.0429559352854,0.62601590911114,0.958944281524927,0.748283752860412,1.38465926955217,53209.1529051988,33217.1437308868,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_114410,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
114449,1529.367003367,261.030303030303,113.612794612795,624.700336700337,1336.29292929293,937.639730639731,1166.82491582492,251.414141414141,1092.47811447811,2229.11111111111,555.653198653199,120.373737373737,1066.10101010101,2440.64983164983,1122.40067340067,2308.07744107744,4875.65993265993,5012.42424242424,412.050505050505,238.013468013468,1056.30303030303,4413.97306397306,274.255892255892,741.680134680135,816.858585858586,1036.22558922559,524.111111111111,240.777777777778,1034.26262626263,129.989898989899,297,26.6828437737024,14.2839061433224,0.844648236404134,0.964285714285714,0.713942307692308,1.29785411443591,53365.1178451178,32850.2693602694,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_114449,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
114614,2784.03595505618,1003.24494382022,491.620224719101,649.552808988764,2004.41573033708,2240.0202247191,1608.22921348315,274.375280898876,1113.95056179775,5398.24943820225,992.52808988764,120.25393258427,1081.86516853933,4785.09662921348,1519.09662921348,2955.99325842697,1868.08539325843,4307.81348314607,376.325842696629,241.910112359551,1023.18426966292,2993.91235955056,271.743820224719,1173.63146067416,948.489887640449,1967.64269662921,492.47191011236,415.191011235955,1066.01573033708,130.768539325843,445,28.4144419566128,20.2071986744896,0.703030759398731,0.967391304347826,0.730706075533662,1.53726368396144,52440.7438202247,33322.8674157303,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_114614,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
115655,2819.76049382716,461.377777777778,132.795061728395,636.646913580247,1617.80987654321,254.387654320988,389.118518518518,247.861728395062,1085.95061728395,2785.13580246914,944.449382716049,125.303703703704,1074.65185185185,786.543209876543,836.123456790123,355.876543209877,2167.68888888889,1773.11358024691,334.19012345679,221.876543209877,1035.57530864198,1294.03209876543,190.832098765432,262.212345679012,623.743209876543,775.466666666667,402.037037037037,221.36049382716,1016.65925925926,130.076543209877,405,24.2415461905021,21.3681495399286,0.472243578602283,0.971223021582734,0.767045454545455,0.602785435571459,53259.8419753086,32104.9728395062,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_115655,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
115940,3669.05235602094,357.908376963351,157.274869109948,669.861256544503,4121.21989528796,392.167539267016,619.510471204188,247.662303664921,1081.96073298429,6615.34554973822,731.596858638743,125.332460732984,1102.0890052356,1376.76963350785,638.568062827225,292.38219895288,1767.58115183246,1758.09947643979,259.596858638743,218.696335078534,1036.63612565445,1150.23821989529,179.285340314136,144.397905759162,3102.98167539267,1571.26178010471,485.217277486911,236.465968586387,1058.20157068063,131.659685863874,382,24.8044625787741,19.6597145769944,0.609757795857644,0.969543147208122,0.790890269151139,-0.944447449036704,53994.7931937173,32723.8507853403,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_115940,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
116081,2355.57357357357,559.012012012012,116.512012012012,633.165165165165,1289.08108108108,399.234234234234,309.160660660661,249.358858858859,1077.73873873874,3734.17867867868,3360.14864864865,122.132132132132,1071.00750750751,818.555555555556,508.142642642643,322.785285285285,1375.42642642643,1218.13963963964,315.576576576577,230.602102102102,988.594594594595,1122.71921921922,230.432432432432,134.024024024024,591.728228228228,1382.45645645646,541.468468468468,391.794294294294,1043.04054054054,129.668168168168,666,34.9718540559447,24.3417530052614,0.718004567628116,0.966618287373004,0.720779220779221,0.551618108175667,53784.0435435435,33174.7567567568,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_116081,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
116096,3279.7299270073,186.990267639903,84.5839416058394,617.036496350365,422.30900243309,2944.69586374696,496.936739659367,257.143552311436,1110.92214111922,6088.16545012165,1064.77615571776,122.07299270073,1076.61313868613,2479.84184914842,879.248175182482,290.961070559611,1950.47688564477,2679.94403892944,330.564476885645,230.649635036496,1024.65936739659,1960.34063260341,223.888077858881,166.69099756691,579.671532846715,2399.39416058394,514.435523114355,349.815085158151,1059.199513382,129.778588807786,411,25.248675832112,20.788284783898,0.567546151493205,0.958041958041958,0.714782608695652,-0.971231273764724,52907.7639902676,33362.5742092457,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_116096,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
116686,5086.41025641026,766.564102564103,402.586538461538,708.038461538462,3841.69871794872,921.070512820513,330.285256410256,249.150641025641,1091.77884615385,8309.58333333333,642.673076923077,125.833333333333,1660.38782051282,2521.48717948718,583.217948717949,286.772435897436,1791.65705128205,2769.16346153846,315.198717948718,238.766025641026,1017.25641025641,2136.44551282051,228.525641025641,352.583333333333,3480.8141025641,2326.41346153846,572.442307692308,966.461538461538,1086.71474358974,131.615384615385,312,22.1355260538922,18.0036452165682,0.581792672759209,0.948328267477204,0.753623188405797,-1.50610772030823,53722.375,33477.6121794872,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX+,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_116686,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
116990,2891.53287981859,361.569160997732,141.455782312925,662.018140589569,1949.14285714286,1006.56009070295,414.090702947846,246.267573696145,1108.89569160998,4523.46485260771,549.802721088435,118.777777777778,1087.63945578231,823.519274376417,434.24716553288,283.326530612245,1605.07936507937,1498.81405895692,285.62358276644,227.587301587302,1054.26757369615,1673.97505668934,208.857142857143,191.24716553288,2495.67800453515,1031.54195011338,466.90022675737,613.02947845805,1036.55782312925,129.968253968254,441,28.6749288601266,19.6865750864582,0.727089090996299,0.956616052060738,0.742424242424242,-1.08832821144803,53762.5124716553,33660.6961451247,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_116990,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
117020,3839.57097791798,581.643533123028,166.236593059937,651.03785488959,1914.88958990536,446.362776025237,335.365930599369,263.13880126183,1088.7476340694,7040.29968454259,2754.48895899054,135.119873817035,1086.53943217666,1323.84858044164,761.10094637224,284.539432176656,1860.8738170347,1616.66246056782,315.003154574133,227.394321766562,1098.78864353312,1250.14826498423,203.83596214511,413.438485804416,3374.08517350158,2198.7665615142,551.492113564669,490.501577287066,1075.82649842271,131.779179810726,317,24.4147560772829,16.5714908496151,0.734370355150013,0.966463414634146,0.776960784313726,-1.2967528973508,53213.9558359621,32806.7634069401,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_117020,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
117626,3554.38095238095,967.120181405896,166.775510204082,665.605442176871,2987.28117913832,696.079365079365,615.732426303855,243.233560090703,1084.61678004535,5557.5306122449,556.646258503401,124.777777777778,1076.26077097506,1048.61224489796,549.662131519274,437.399092970522,1539.96371882086,1609.80952380952,301.020408163265,226.102040816327,991.349206349206,1354.70975056689,216.657596371882,132.807256235828,589.501133786848,1285.27437641723,528.807256235828,233.179138321995,1033.99319727891,134.1179138322,441,26.7844488009917,20.9812500569286,0.621597239112835,0.97136563876652,0.770979020979021,-0.406172076996637,53608.2857142857,33052.4126984127,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_117626,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
117819,2235.10609480813,280.392776523702,137.841986455982,673.295711060948,3385.65688487585,1753.38826185102,1520.47855530474,263.171557562077,1095.02708803612,4061.61173814898,649.505643340858,121.600451467269,1077.86455981941,1146.89164785553,498.23927765237,309.966139954853,1522.04063205418,1156.15349887133,275.304740406321,220.295711060948,1012.15349887133,1036.1309255079,202.3769751693,233.483069977427,693.702031602709,994.386004514673,435.79683972912,231.410835214447,1041.93905191874,130.568848758465,443,28.3140063257926,20.0442796059708,0.706284546070632,0.954741379310345,0.745791245791246,0.286964972507158,53800.2595936795,32300.6275395034,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_117819,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
117938,4201.43806646526,441.842900302115,141.407854984894,632.250755287009,1354.41087613293,1051.07552870091,318.740181268882,255.749244712991,1084.2749244713,6473.22658610272,702.85498489426,122.858006042296,1083.95468277946,4396.64652567976,773.444108761329,295.36253776435,1671.6253776435,5443.26586102719,323.377643504532,233.07250755287,998.930513595166,5056.01208459214,242.039274924471,211.68580060423,622.851963746224,1509.46827794562,533.238670694864,285.770392749245,1042.80664652568,129.918429003021,331,24.3911978654567,17.3983799483847,0.700853057848633,0.951149425287356,0.79951690821256,-1.30709259944251,54119.1359516616,32951.9848942598,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_117938,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
117982,2543.31558935361,172.003802281369,87.2585551330799,633.087452471483,1651.72243346008,845.163498098859,2567.74904942966,250.395437262357,1086.13688212928,4329.02661596958,580.946768060836,121.847908745247,1072.19011406844,1733.71102661597,960.973384030418,1933.82509505703,2144.85931558935,2404.08365019011,303.904942965779,224.399239543726,1029.21292775665,1617.08745247148,201.509505703422,473.665399239544,863.54752851711,1257.59695817491,435.171102661597,222.239543726236,1047.91254752852,131.250950570342,263,25.0882528365864,13.38397978418,0.845815227670659,0.942652329749104,0.722527472527473,1.50057966916364,52532.6958174905,32679.7376425856,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_117982,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
118766,4610.85542168675,426.028112449799,93.8152610441767,641.417670682731,1598.07228915663,1325.26104417671,1318.44176706827,254.429718875502,1099.95180722892,7579.14859437751,872.746987951807,142.55421686747,1088.36546184739,5553.96385542169,991.401606425703,635.21686746988,1993.99598393574,4754.99598393574,391.839357429719,239.10843373494,1015.55823293173,3169.73895582329,232.261044176707,179.144578313253,600.915662650602,2651.4578313253,539.867469879518,266.192771084337,1132.75903614458,133.710843373494,249,20.1188416036095,15.8262490914275,0.617414254890123,0.950381679389313,0.732352941176471,1.28644862785708,52878.4899598394,33734.8313253012,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,9,FAAGSCC_12_118766,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
119312,4237.95166163142,1034.76132930514,108.87915407855,647.404833836858,1997.58912386707,1634.00302114804,490.407854984894,247.31419939577,1086.62839879154,7195.16616314199,846.694864048338,138.474320241692,1094.03625377643,2633.46827794562,602.003021148036,374.92749244713,2105.12084592145,2444.69486404834,320.084592145015,234.601208459214,1037.72809667674,1947.92145015106,217.703927492447,200.404833836858,623.486404833837,2139.67673716012,512.719033232628,273.628398791541,1079.583081571,133.075528700906,331,24.2429203613957,17.4454979114016,0.694376324589728,0.973529411764706,0.766203703703704,0.323864330160427,52858.8429003021,33732.9728096677,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,9,FAAGSCC_12_119312,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
119350,3730.48156182213,805.095444685466,1313.75488069414,647.785249457701,1363.66377440347,563.51409978308,310.386117136659,232.696312364425,1073.22993492408,5502.52277657267,605.804772234273,120.212581344902,1086.79609544469,894.331887201735,452.590021691974,409.132321041215,1916.60086767896,1024.74837310195,251.114967462039,221.22125813449,1009.43383947939,953.572668112798,199.394793926247,189.299349240781,589.633405639913,1161.98481561822,473.0715835141,564.199566160521,1037.10845986985,131.145336225597,461,27.1409040113384,21.7704846357952,0.597151858084964,0.960416666666667,0.742351046698873,1.38396797114796,53381.8958785249,33632.5271149675,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_119350,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
120320,3792.51657458564,825.425414364641,111.378453038674,620.030386740331,973.331491712707,331.411602209945,466.657458563536,247.704419889503,1079.66574585635,7553.15193370166,613.475138121547,124.290055248619,1066.83149171271,637.798342541436,436.602209944751,275.07182320442,1397.82044198895,948.232044198895,286.218232044199,225.71270718232,980.39226519337,914.867403314917,214.687845303867,124.281767955801,595.306629834254,2404.88397790055,512.395027624309,237.030386740331,1055.73204419889,129.524861878453,362,24.4022140545793,18.991967402709,0.627906603486863,0.960212201591512,0.749482401656315,-0.613027183045477,53372.6436464088,32710.1270718232,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_120320,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
121438,4938.09584664537,802.693290734824,2962.88817891374,652.549520766773,2155.15015974441,3926.86261980831,636.626198083067,267.645367412141,1132.01277955272,7241.44728434505,1033.86581469649,125.872204472843,1096.29392971246,3827.41214057508,875.533546325879,355.255591054313,7254.44728434505,2552.52715654952,382.191693290735,240.817891373802,1015.7571884984,1418.61980830671,241.29392971246,150.990415335463,591.993610223642,1568.47923322684,497.846645367412,516.654952076677,1049.79552715655,133.303514376997,313,22.691860994651,17.6935446014145,0.626114817305477,0.969040247678019,0.756038647342995,1.3976193734156,53361.9808306709,33397.3769968051,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_121438,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
121787,3250.31220657277,251.565727699531,97.8615023474178,636.194835680751,1691.84976525822,793.328638497653,383.056338028169,275.556338028169,1120.92253521127,5828.07981220657,1897.32629107981,132.049295774648,1071.12910798122,1041.57276995305,706.772300469484,280.988262910798,1915.72769953052,1347.51877934272,308.037558685446,226.558685446009,1119.2441314554,1111.45070422535,202.835680751174,381.007042253521,4592.63849765258,1736.94600938967,485.110328638498,222.462441314554,1066.06572769953,129.913145539906,426,28.1159380745942,19.6335213010029,0.715799605824534,0.946666666666667,0.712374581939799,-0.532401622935117,52817.0704225352,32515.9107981221,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_121787,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
121908,3944.1608040201,518.3391959799,121.844221105528,639.168341708543,1933.00502512563,477.655778894472,630.198492462312,254.964824120603,1089.72361809045,6202.32412060302,675.045226130653,123.492462311558,1081.04773869347,709.344221105528,657.733668341708,652.718592964824,1559.94974874372,1091.59045226131,277.020100502513,222.924623115578,995.79648241206,951.582914572864,199.793969849246,379.527638190955,628.060301507538,1069.57035175879,459.261306532663,255.577889447236,1037.80904522613,130.542713567839,398,24.0087349255392,21.2543646526087,0.465065399911428,0.959036144578313,0.786561264822134,-0.576434729023145,53483.5502512563,32747.932160804,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_121908,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
122063,3535.93838862559,330.177725118483,574.312796208531,616.902843601896,802.485781990521,364.336492890995,421.471563981043,251.220379146919,1086.90047393365,5771.21090047393,557.158767772512,118.670616113744,1076.58293838863,1022.49052132701,568.241706161137,288.042654028436,1507.47630331754,2855.06872037915,367.163507109005,242.781990521327,1021.05450236967,3351.02132701422,261.957345971564,177.777251184834,597.5663507109,1486.84123222749,489.002369668246,235.530805687204,1038.163507109,131.881516587678,422,25.5904661475281,21.0717517818177,0.567429534372268,0.963470319634703,0.799242424242424,-1.03479933428586,53813.6350710901,33312.4881516588,FAAGSCC_12,AG,1,Unknown,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,Other,Other,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_122063,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
122073,4348.11666666667,629.316666666667,133.483333333333,655.333333333333,2405.86666666667,554.0,812.791666666667,242.295833333333,1091.04583333333,6888.03333333333,1503.40416666667,140.275,1562.0125,1454.42916666667,747.695833333333,314.254166666667,1865.21666666667,2950.99583333333,391.158333333333,243.029166666667,1026.70833333333,2769.19583333333,250.304166666667,171.954166666667,586.4625,1917.04166666667,587.045833333333,583.329166666667,1081.9375,130.154166666667,240,18.9652802242272,16.1554198478709,0.523799027905353,0.952380952380952,0.743034055727554,-1.16104240774453,52858.0541666667,33419.1458333333,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX+,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_122073,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
122139,1730.61025641026,216.584615384615,101.533333333333,626.369230769231,1462.99230769231,1357.5641025641,267.528205128205,244.541025641026,1081.9358974359,2752.62564102564,636.630769230769,117.789743589744,1077.24871794872,2796.71025641026,563.053846153846,281.961538461538,1573.98974358974,4055.84871794872,345.8,237.041025641026,1022.88717948718,3908.47948717949,242.566666666667,560.651282051282,758.597435897436,1128.88461538462,519.033333333333,295.161538461538,1027.98717948718,129.217948717949,390,23.7606484711674,20.92606689944,0.473669485097524,0.975,0.770750988142292,0.628929399359816,53568.1307692308,33252.9256410256,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_122139,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
122321,3219.79948586118,616.385604113111,160.686375321337,675.94087403599,2574.15681233933,1050.71208226221,2281.43701799486,241.532133676093,1085.21850899743,4728.59640102828,2249.97686375321,128.565552699229,1083.55269922879,1442.96915167095,841.077120822622,1853.56041131105,2285.18766066838,1862.21079691517,264.79177377892,226.375321336761,1040.03598971722,1574.23393316195,194.974293059126,323.192802056555,717.52442159383,1252.46015424165,486.884318766067,1057.48586118252,1059.06940874036,132.370179948586,389,26.7982919348588,18.5489034072584,0.721737018403713,0.951100244498778,0.712454212454212,0.419149967210749,52766.8277634961,33684.6580976864,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_122321,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
123080,3020.92842942346,365.135188866799,157.222664015905,659.079522862823,2191.96222664016,191.679920477137,217.431411530815,243.113320079523,1076.99801192843,2967.31013916501,703.556660039761,129.373757455268,1089.70775347913,520.504970178926,403.797216699801,257.534791252485,1497.85487077535,923.982107355865,265.0,220.043737574553,983.524850894632,807.984095427435,183.021868787276,130.606361829026,580.825049701789,902.487077534791,422.437375745527,209.707753479125,1040.52286282306,133.502982107356,503,30.1365092030788,21.5551019444013,0.698869915514734,0.965451055662188,0.718571428571429,0.576372125054793,53354.055666004,31922.1729622266,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_123080,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
124343,1935.2,296.4,100.687719298246,627.375438596491,1017.78596491228,1823.95087719298,1842.10175438597,254.382456140351,1123.81754385965,3604.14736842105,626.856140350877,130.322807017544,1070.50526315789,4226.92280701754,978.494736842105,2191.99649122807,2078.7298245614,4104.19298245614,399.698245614035,239.768421052632,1083.6350877193,2822.97543859649,274.922807017544,559.4,823.719298245614,2003.17543859649,534.252631578947,559.673684210526,1044.54035087719,131.017543859649,285,22.0138108137342,16.5904465977863,0.657289594720415,0.953177257525084,0.798319327731092,1.30411111884055,53226.6210526316,33919.3894736842,FAAGSCC_12,AG,1,dendritic cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,dendritic cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_124343,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
124507,3690.91032608696,265.326086956522,185.298913043478,659.913043478261,2421.64130434783,535.701086956522,356.448369565217,259.095108695652,1115.5625,6371.72282608696,735.190217391304,131.432065217391,1081.66847826087,834.633152173913,461.836956521739,278.380434782609,1507.89945652174,1015.46739130435,205.763586956522,213.233695652174,1331.3125,624.5625,140.076086956522,125.625,586.470108695652,1721.10597826087,528.103260869565,303.410326086957,1072.38043478261,132.301630434783,368,23.3331135253467,20.1051143786193,0.507493005912101,0.970976253298153,0.796536796536797,0.679366813202854,52622.1032608696,32968.1739130435,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_124507,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
124837,4832.3875432526,911.757785467128,157.103806228374,652.245674740484,2209.55017301038,2609.1107266436,2013.91349480969,260.162629757785,1109.06574394464,7878.35294117647,574.235294117647,128.837370242215,1092.06228373702,4429.06574394464,1258.92387543253,531.539792387543,1636.18685121107,5071.41868512111,377.114186851211,243.217993079585,998.743944636678,4793.51903114187,257.57785467128,376.377162629758,693.80276816609,1454.12456747405,486.01384083045,226.089965397924,1066.00346020761,132.148788927336,289,21.7351015647748,16.9742764884768,0.624579226114368,0.944444444444444,0.764550264550265,-1.39785027181818,52715.955017301,33442.3633217993,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_124837,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
125056,1735.70491803279,205.573770491803,124.459016393443,678.008196721311,2090.0,337.844262295082,327.180327868852,255.22131147541,1087.97540983607,3562.79508196721,642.426229508197,121.270491803279,1066.22131147541,852.516393442623,645.762295081967,292.860655737705,1834.5737704918,1289.45901639344,330.860655737705,230.418032786885,1053.15573770492,1183.06557377049,219.024590163934,522.106557377049,2183.45901639344,1776.55737704918,502.877049180328,237.459016393443,1067.58196721311,130.475409836066,122,13.2256560772444,11.752374308887,0.458674690988173,0.938461538461538,0.72189349112426,-0.880618485786241,52887.0901639344,32841.6147540984,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,1,FAAGSCC_12_125056,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
125069,4427.50537634409,939.704301075269,625.717741935484,647.244623655914,2111.60752688172,1201.82795698925,331.102150537634,249.298387096774,1081.87096774194,7054.23387096774,569.422043010753,123.083333333333,1088.37096774194,791.809139784946,411.916666666667,317.266129032258,1444.88709677419,1087.25,260.532258064516,218.268817204301,988.83064516129,1145.20698924731,196.344086021505,164.290322580645,602.569892473118,1708.09677419355,493.110215053763,233.411290322581,1043.77688172043,130.451612903226,372,24.0966602472872,19.6910009408952,0.576400667459661,0.953846153846154,0.738095238095238,1.14002268434285,53520.1370967742,33039.1801075269,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_125069,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
125097,3834.27807486631,283.965240641711,107.320855614973,628.98128342246,995.114973262032,632.716577540107,1001.50267379679,253.080213903743,1076.74064171123,6351.98663101604,731.042780748663,122.245989304813,1077.34759358289,1187.20053475936,844.171122994652,455.034759358289,1572.92245989305,2013.52139037433,311.304812834225,230.112299465241,1017.13636363636,1650.87967914439,207.687165775401,257.534759358289,664.048128342246,1173.71122994652,432.794117647059,257.379679144385,1042.8128342246,130.195187165775,374,22.3881780539768,21.4126128154473,0.291978170121544,0.968911917098446,0.772727272727273,1.02028912029984,52674.9465240642,32439.3155080214,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_125097,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
125171,3105.05281690141,617.968309859155,84.7288732394366,630.295774647887,1189.63028169014,3540.38028169014,524.514084507042,258.348591549296,1113.96126760563,5294.36971830986,1070.61971830986,119.098591549296,1083.26056338028,2775.89084507042,823.816901408451,1945.69014084507,2032.71830985915,3097.13028169014,344.130281690141,236.348591549296,1064.9014084507,2242.5,244.718309859155,429.042253521127,727.894366197183,1439.4823943662,470.68661971831,284.397887323944,1048.7323943662,129.394366197183,284,20.6005056154997,17.6152944077172,0.518478951075095,0.959459459459459,0.788888888888889,0.404408652211975,52979.9507042254,33586.25,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_125171,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
125219,3509.40566037736,430.732704402516,79.503144654088,615.61320754717,346.150943396226,463.399371069182,303.547169811321,252.591194968553,1086.61949685535,6956.2641509434,576.248427672956,120.455974842767,1092.30503144654,798.116352201258,592.537735849057,300.75786163522,1402.66981132075,1067.26729559748,241.74213836478,216.314465408805,1000.55974842767,922.647798742138,197.172955974843,131.537735849057,626.531446540881,2219.40566037736,510.462264150943,232.952830188679,1031.72955974843,128.701257861635,318,21.8042479073835,18.6355786756276,0.519160909401831,0.963636363636364,0.757142857142857,-0.639618319690993,54196.2767295598,33090.8710691824,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_125219,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
125237,3512.58528428094,289.638795986622,138.170568561873,631.943143812709,2032.62876254181,542.682274247492,410.314381270903,256.150501672241,1141.35451505017,6312.67892976589,523.197324414716,120.826086956522,1071.6856187291,1430.35451505017,856.889632107023,332.280936454849,1612.20735785953,1971.86287625418,319.923076923077,231.458193979933,996.056856187291,1546.33779264214,228.441471571906,223.434782608696,587.297658862876,2218.45484949833,536.207357859532,239.989966555184,1065.37123745819,129.869565217391,299,22.5842345330002,16.9866843313535,0.658994349668162,0.955271565495208,0.799465240641711,1.38306785704505,53587.9531772575,33156.2809364549,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_125237,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
125672,4292.8538961039,402.918831168831,88.5779220779221,642.448051948052,1835.15584415584,3518.88636363636,421.435064935065,255.935064935065,1121.16883116883,6926.69805194805,623.470779220779,137.097402597403,1091.33766233766,7066.75324675325,969.935064935065,515.198051948052,9451.16883116883,8512.55194805195,516.909090909091,262.327922077922,1078.16883116883,7188.66233766234,308.37987012987,417.87012987013,737.37987012987,2245.66233766234,526.704545454545,245.185064935065,1070.80519480519,129.448051948052,308,27.2384987206246,14.4762125524999,0.847082467422123,0.950617283950617,0.675438596491228,1.03164907733707,52835.5032467533,33741.8766233766,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_125672,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
125675,3870.79591836735,427.892128279883,167.166180758018,677.475218658892,4111.58309037901,1805.91836734694,388.97084548105,252.247813411079,1128.92419825073,7488.16618075802,3868.27988338192,132.839650145773,1075.58017492711,744.985422740525,750.104956268222,283.096209912536,1691.02915451895,1329.28571428571,267.376093294461,216.618075801749,1019.19241982507,1033.22448979592,193.880466472303,187.620991253644,2884.44897959184,2348.27113702624,532.967930029155,464.892128279883,1070.97376093294,131.67055393586,343,24.8732158369638,17.6653880985267,0.703982522677598,0.96078431372549,0.762222222222222,-1.455888348361,54172.5976676385,32714.9300291545,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_125675,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
125817,2510.78289473684,469.552631578947,90.2631578947368,636.309210526316,1118.19736842105,267.473684210526,314.368421052632,263.151315789474,1084.32894736842,3489.32236842105,3211.86184210526,120.151315789474,1064.82894736842,548.802631578947,406.506578947368,268.421052631579,1362.75657894737,861.842105263158,258.282894736842,223.184210526316,983.532894736842,819.131578947368,209.638157894737,135.802631578947,586.907894736842,1024.85526315789,446.901315789474,371.230263157895,1056.42105263158,130.973684210526,152,18.2585751574423,10.6280505338834,0.81312763733215,0.944099378881988,0.767676767676768,1.30963759775649,52698.5592105263,32287.7960526316,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_125817,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
126582,4236.64686468647,1100.95709570957,134.749174917492,634.881188118812,1685.79867986799,640.590759075908,858.976897689769,250.310231023102,1086.6600660066,6902.18481848185,561.349834983498,120.696369636964,1073.09900990099,1595.39603960396,610.53795379538,366.749174917492,1484.6204620462,3665.25082508251,284.521452145215,224.122112211221,1000.19141914191,3209.9900990099,273.155115511551,290.485148514851,626.260726072607,1868.05280528053,503.93399339934,271.39603960396,1038.09570957096,129.729372937294,303,23.4909633928394,16.6149173469321,0.706923776875945,0.946875,0.731884057971015,-1.29368180389073,53965.795379538,33001.399339934,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_126582,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
126744,4441.32389937107,522.132075471698,100.477987421384,638.805031446541,1758.76100628931,2563.76729559748,2927.39937106918,255.119496855346,1108.31446540881,6736.43396226415,1095.79874213836,136.937106918239,1067.11635220126,3713.2106918239,1147.45597484277,1997.30817610063,4091.66981132075,5848.08490566038,442.342767295598,248.98427672956,1473.41823899371,5518.15408805031,279.905660377359,263.455974842767,735.006289308176,1947.70440251572,531.622641509434,361.883647798742,1061.97169811321,131.022012578616,318,23.978908057625,16.9142165990643,0.708830416791985,0.954954954954955,0.768115942028985,0.279416315868283,53232.5471698113,33808.8899371069,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_126744,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
127094,3065.47945205479,993.994520547945,1680.8904109589,647.438356164384,2120.45753424658,2059.55068493151,1345.78082191781,268.095890410959,1109.63835616438,3467.32876712329,895.323287671233,123.345205479452,1066.5095890411,1307.03561643836,1010.60273972603,300.016438356164,1654.38630136986,3003.92328767123,336.983561643836,231.194520547945,1020.66575342466,2678.1698630137,230.923287671233,735.635616438356,692.906849315068,836.106849315069,423.608219178082,236.465753424658,1031.59178082192,130.821917808219,365,25.3278508246594,18.4244501389032,0.686173039191659,0.965608465608466,0.800438596491228,-0.291174577773527,52641.7424657534,32342.7150684932,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_127094,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
127269,3675.1512605042,389.445378151261,117.235294117647,653.596638655462,1819.03361344538,2745.19607843137,1599.78711484594,260.33893557423,1172.84593837535,5678.57983193277,932.686274509804,128.96918767507,1077.21288515406,4733.6862745098,1200.82352941176,883.579831932773,4161.24089635854,4902.44817927171,384.686274509804,241.112044817927,1075.65266106443,3692.80112044818,273.439775910364,256.868347338936,633.095238095238,1584.64145658263,502.607843137255,593.579831932773,1088.15966386555,130.680672268908,357,22.4597755684556,20.2763651803229,0.430090573882078,0.967479674796748,0.772727272727273,-1.21411299316935,53169.8879551821,33693.3697478992,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_127269,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
127451,2907.17917675545,366.375302663438,145.036319612591,664.55205811138,3296.12590799031,635.101694915254,852.692493946731,258.145278450363,1089.28571428571,4968.34382566586,559.331719128329,133.745762711864,1074.66828087167,784.145278450363,605.912832929782,506.801452784504,1500.31719128329,1048.94915254237,257.433414043584,216.600484261501,1001.09443099274,945.820823244552,187.457627118644,165.648910411622,653.745762711864,1523.08474576271,477.818401937046,263.670702179177,1070.96852300242,130.648910411622,413,32.0312897697858,16.4956365944914,0.857199135964848,0.949425287356322,0.619190404797601,0.609809528809137,53754.3728813559,32253.602905569,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_127451,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
127502,3273.08648648649,712.47027027027,1290.01891891892,627.489189189189,812.424324324324,283.821621621622,270.635135135135,248.848648648649,1081.99459459459,4318.87567567568,914.745945945946,122.427027027027,1074.15945945946,634.959459459459,432.172972972973,263.697297297297,1439.06216216216,1123.64594594595,297.656756756757,227.3,1011.89459459459,1111.67027027027,221.543243243243,205.691891891892,582.82972972973,965.391891891892,469.754054054054,301.832432432432,1038.2027027027,152.732432432432,370,25.8536445638548,18.4185282210841,0.701758253050374,0.973684210526316,0.699432892249527,0.817542296357784,52827.1837837838,33193.2918918919,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_127502,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
128223,1900.36809815951,373.143149284254,366.940695296524,607.067484662577,531.278118609407,3449.83844580777,1378.79141104294,268.862985685072,1113.67280163599,4132.85071574642,489.468302658487,108.462167689162,1066.33946830266,3681.59304703476,812.646216768916,356.80981595092,1940.47034764826,3624.80777096114,364.261758691207,229.509202453988,1021.50511247444,2634.51124744376,212.216768916155,226.732106339468,594.319018404908,1611.96523517382,484.638036809816,233.940695296524,1023.20245398773,130.685071574642,489,26.4992708682514,23.5668318219488,0.457248685145139,0.97410358565737,0.817725752508361,1.37688839206129,53620.7914110429,32979.7689161554,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_128223,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
128417,2837.74303405573,927.66253869969,2279.66873065015,660.467492260062,2230.70588235294,314.913312693498,318.544891640867,257.582043343653,1080.68421052632,3388.98142414861,680.904024767802,126.777089783282,1070.0,778.758513931889,527.287925696594,311.238390092879,1726.56037151703,1138.62848297214,315.743034055728,233.712074303406,985.520123839009,1013.9040247678,235.034055727554,144.157894736842,586.61919504644,877.650154798762,447.811145510836,230.551083591331,1028.64086687307,131.625386996904,323,23.4429416869073,17.6788354981604,0.656734478029212,0.967065868263473,0.739130434782609,1.08550050078296,52589.133126935,32357.386996904,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_128417,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
128699,3999.26463104326,656.379134860051,102.022900763359,625.0,967.147582697201,1128.40203562341,919.865139949109,245.862595419847,1098.2010178117,7339.97709923664,605.699745547074,125.972010178117,1079.12977099237,1521.80661577608,572.521628498728,275.450381679389,2432.6641221374,1271.27735368957,281.419847328244,225.740458015267,990.221374045802,1270.93893129771,200.783715012723,132.055979643766,597.376590330789,3192.50381679389,540.17048346056,233.748091603053,1053.16284987277,131.496183206107,393,26.3370938161746,19.1149305876582,0.687927094348139,0.946987951807229,0.755769230769231,-1.50222874322839,52776.0254452926,33416.7124681934,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_128699,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
130418,3405.03157894737,1037.71052631579,107.189473684211,623.557894736842,481.026315789474,4026.6052631579,504.157894736842,276.721052631579,1126.53684210526,5618.9,651.163157894737,119.357894736842,1081.49473684211,1968.11052631579,630.478947368421,354.073684210526,2507.11578947368,3227.63157894737,374.378947368421,650.8,1037.88421052632,3814.04210526316,477.836842105263,359.184210526316,613.215789473684,1462.77368421053,476.657894736842,329.673684210526,1060.62631578947,130.673684210526,190,19.1285522962411,12.6549032273119,0.749882174383965,0.964467005076142,0.698529411764706,0.846962212564941,53269.8842105263,33399.4736842105,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_130418,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
130443,5019.89099526066,1628.6327014218,174.834123222749,693.824644549763,3360.36255924171,2167.76303317536,1239.07345971564,259.241706161137,1101.57109004739,7752.07582938389,683.883886255924,146.018957345972,1091.58767772512,4492.46208530806,827.454976303317,405.943127962085,6370.40047393365,2691.68720379147,375.109004739337,245.054502369668,1004.85308056872,1958.0355450237,254.447867298578,179.24644549763,602.258293838863,2039.48815165877,517.492890995261,447.895734597156,1088.6018957346,133.831753554502,422,25.9601204907054,20.794952335311,0.598618173449924,0.967889908256881,0.772893772893773,-1.287548192417,52689.2417061611,33747.3744075829,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_130443,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
130494,3918.84615384615,1082.25384615385,117.520512820513,645.161538461538,1744.73846153846,1308.16153846154,291.125641025641,242.664102564103,1094.05897435897,5763.05641025641,563.394871794872,118.241025641026,1086.49230769231,2827.15897435897,598.489743589744,301.528205128205,1882.87948717949,4879.57179487179,395.351282051282,241.146153846154,1059.24102564103,5762.94615384615,262.9,499.397435897436,1275.74358974359,1126.97692307692,480.91282051282,347.64358974359,1044.54358974359,130.858974358974,390,24.1481949017188,20.6921771486631,0.515510972597818,0.962962962962963,0.807453416149068,1.1286650871538,53662.8,33608.3820512821,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_130494,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
130578,2916.15719063545,578.401337792642,277.290969899666,724.759197324415,6678.28428093645,3652.84280936455,1775.29765886288,306.254180602007,1097.71571906355,4918.94983277592,551.157190635451,135.428093645485,1086.11705685619,1391.54515050167,947.692307692308,1047.91304347826,1538.52508361204,1187.48494983278,265.789297658863,223.217391304348,994.374581939799,963.615384615385,201.190635451505,125.725752508361,632.096989966555,1025.97324414716,446.434782608696,719.852842809365,1067.48829431438,131.876254180602,299,23.1719095467861,16.5513593818251,0.699854413959836,0.955271565495208,0.715311004784689,1.13921048252555,52725.9431438127,32760.1371237458,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_130578,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
130689,4034.37676056338,638.492957746479,540.714788732394,608.598591549296,707.176056338028,400.549295774648,284.514084507042,254.281690140845,1080.51056338028,7615.55281690141,804.904929577465,117.982394366197,1069.34154929577,758.901408450704,476.683098591549,262.429577464789,1427.47887323944,1099.89788732394,276.387323943662,222.679577464789,990.985915492958,1036.34154929577,193.359154929577,118.570422535211,582.038732394366,2167.35915492958,494.721830985916,264.901408450704,1041.77112676056,132.035211267606,284,29.8797276209499,12.1432521343345,0.913693318961267,0.93421052631579,0.728205128205128,1.49671131494928,53823.3767605634,32570.6584507042,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_130689,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
131324,4294.60563380282,607.861971830986,84.6478873239437,644.338028169014,1959.15774647887,1681.99436619718,333.183098591549,246.033802816901,1107.24507042254,6804.52957746479,648.569014084507,120.352112676056,1085.35211267606,2041.57464788732,536.335211267606,314.912676056338,1784.60845070423,1735.83943661972,378.104225352113,246.769014084507,1042.98873239437,1948.81971830986,227.777464788732,206.166197183099,765.90985915493,1697.07323943662,527.394366197183,333.811267605634,1052.16056338028,131.118309859155,355,27.7576376049974,16.4117205753955,0.806487878854259,0.956873315363881,0.730452674897119,1.38367858961093,53734.4676056338,33632.9436619718,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_131324,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
131660,1663.59898477157,257.840101522843,55.4314720812183,647.906091370558,2435.81218274112,3011.52791878173,1996.87563451777,259.271573604061,1133.6192893401,3377.7614213198,1800.22335025381,119.492385786802,1073.88324873096,3034.88578680203,1418.29441624365,1895.82994923858,1867.3654822335,2438.04822335025,316.060913705584,258.342639593909,1026.51015228426,1676.40101522843,215.187817258883,280.395939086294,762.319796954315,940.616751269036,428.065989847716,312.119289340102,1047.45177664975,129.459390862944,394,23.8476539738441,21.2589064734132,0.453126060784095,0.951690821256039,0.746212121212121,1.34948053340088,53050.7284263959,33391.8299492386,FAAGSCC_12,AG,1,M2 macrophages,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_131660,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
131960,1667.73113207547,267.575471698113,271.905660377359,765.047169811321,8894.87735849057,239.481132075472,267.702830188679,235.948113207547,1073.6320754717,2536.92924528302,712.962264150943,122.367924528302,1065.24056603774,668.537735849057,438.0,286.27358490566,1425.14150943396,981.919811320755,248.627358490566,218.731132075472,998.646226415094,905.22641509434,200.929245283019,136.688679245283,584.339622641509,959.764150943396,454.287735849057,289.462264150943,1067.53301886792,128.971698113208,212,21.3652021081656,12.8043377488073,0.800518490481695,0.954954954954955,0.776556776556777,1.42531132294441,53770.0754716981,33341.3773584906,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_131960,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
132103,3246.30751708428,665.576309794989,199.678815489749,644.774487471526,2171.48291571754,3202.76537585421,566.48291571754,278.072892938497,1126.6993166287,6362.67198177677,559.776765375854,118.166287015945,1078.50113895216,1480.39407744875,595.824601366743,287.175398633257,1443.39407744875,1093.78359908884,284.940774487472,222.904328018223,979.375854214123,887.200455580866,200.312072892938,120.958997722096,588.138952164009,1802.0569476082,490.963553530752,230.933940774487,1057.62186788155,130.205011389522,439,24.6599674552644,22.8065272453937,0.380356087861339,0.969094922737307,0.763478260869565,-1.04785919197043,54048.0820045558,32566.1230068337,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_132103,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
132422,2364.20779220779,604.649350649351,101.857142857143,642.814935064935,2098.88636363636,1414.01298701299,337.24025974026,262.191558441558,1089.8538961039,3503.51948051948,1669.59090909091,118.603896103896,1093.28571428571,1978.82792207792,734.253246753247,304.402597402597,1897.02597402597,2512.46103896104,376.188311688312,238.483766233766,1009.07142857143,2328.53246753247,256.954545454545,213.022727272727,587.831168831169,996.227272727273,461.123376623377,311.698051948052,1043.58116883117,131.175324675325,308,19.9222370389416,19.8236720736719,0.0993503499132066,0.953560371517028,0.77,0.430972953217142,52838.0064935065,33404.1883116883,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_132422,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
132511,2414.13043478261,238.734553775744,151.727688787185,649.924485125858,2563.5652173913,707.356979405034,294.864988558352,238.871853546911,1077.08009153318,4720.24485125858,517.585812356979,125.295194508009,1082.78718535469,1722.45537757437,521.098398169336,281.995423340961,1711.75057208238,1348.4118993135,295.366132723112,224.855835240275,995.450800915332,1040.22425629291,207.24942791762,127.878718535469,587.219679633867,2347.85354691076,499.295194508009,225.855835240275,1062.86498855835,129.450800915332,437,26.4135790404208,21.1508140934184,0.598991575899927,0.962555066079295,0.763986013986014,-0.310983961456404,52730.3592677346,33192.6796338673,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_132511,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
133530,2762.008,368.005333333333,153.354666666667,668.317333333333,2477.80266666667,1674.39466666667,675.978666666667,246.712,1088.55466666667,4621.952,2558.58933333333,122.565333333333,1080.58933333333,1545.136,707.986666666667,645.882666666667,1741.984,1424.61333333333,303.842666666667,227.512,1002.55466666667,1206.97066666667,214.272,222.349333333333,624.109333333333,1594.96,517.829333333333,655.053333333333,1056.68266666667,129.810666666667,375,26.5121034910976,18.1350760568695,0.729453809884754,0.946969696969697,0.708884688090737,0.710713115812824,53975.8826666667,33237.8666666667,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_133530,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
134169,2745.10104529617,239.428571428571,124.376306620209,654.16724738676,2855.92334494774,822.766550522648,344.95818815331,266.114982578397,1090.93379790941,5447.21602787456,574.937282229965,124.651567944251,1085.27177700348,4013.52264808362,611.334494773519,335.104529616725,1645.89547038328,2771.76655052265,358.783972125436,240.254355400697,994.839721254355,1957.79442508711,243.808362369338,154.372822299652,583.801393728223,2587.35540069686,585.452961672474,262.432055749129,1075.05923344948,129.954703832753,287,20.6806632507583,17.7964632970601,0.509388968715045,0.972881355932203,0.795013850415512,-0.841480046004078,52593.3135888502,33490.9895470383,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_134169,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
134174,3207.79351032448,138.368731563422,201.135693215339,782.946902654867,8277.3215339233,625.22418879056,423.020648967552,280.598820058997,1147.1592920354,5227.65781710914,906.769911504425,201.17994100295,1069.2389380531,984.209439528024,576.834808259587,281.106194690266,1590.36873156342,1021.91740412979,210.333333333333,215.457227138643,1193.89380530973,603.421828908555,133.825958702065,100.091445427729,600.233038348083,897.961651917404,426.489675516224,219.6401179941,1045.52212389381,129.94395280236,339,21.7663493382595,19.8519696304672,0.410082005899287,0.976945244956772,0.807142857142857,-1.18444985606263,52877.7787610619,32250.9174041298,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,1,FAAGSCC_12_134174,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
134381,3520.00923076923,984.452307692308,116.264615384615,628.830769230769,1052.42153846154,818.649230769231,736.006153846154,249.101538461538,1083.81230769231,5255.76307692308,632.784615384615,122.676923076923,1075.44307692308,691.375384615385,546.132307692308,281.673846153846,1549.56,1014.87076923077,266.916923076923,222.196923076923,991.098461538462,899.107692307692,193.827692307692,135.436923076923,585.972307692308,1377.77538461538,520.412307692308,233.710769230769,1033.15384615385,129.929230769231,325,25.0946940549712,16.7486476038987,0.744683401330993,0.928571428571429,0.712719298245614,-1.21625769200976,53903.0276923077,33198.3846153846,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_134381,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
134640,3371.96755162242,287.103244837758,95.2949852507375,667.59587020649,1820.37168141593,675.159292035398,1467.57817109145,245.159292035398,1090.91150442478,5918.71681415929,662.212389380531,135.746312684366,1089.53687315634,784.041297935103,605.687315634218,517.41592920354,1963.64896755162,1445.02064896755,305.94395280236,232.811209439528,1016.85250737463,1468.77876106195,225.808259587021,213.466076696165,605.30383480826,1866.86430678466,493.77581120944,558.206489675516,1066.94985250737,133.277286135693,339,24.8202028049475,17.5807268713784,0.705888209752249,0.949579831932773,0.743421052631579,1.34039848770216,52666.3156342183,33759.5516224189,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_134640,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
134855,4390.10743801653,274.338842975207,83.2396694214876,618.074380165289,404.157024793388,328.98347107438,260.04132231405,239.338842975207,1075.65289256198,7845.79338842975,736.404958677686,128.099173553719,1074.22314049587,889.388429752066,714.421487603306,499.578512396694,1504.92561983471,1185.90909090909,305.487603305785,227.495867768595,1000.28925619835,1027.85950413223,201.826446280992,289.446280991736,632.256198347107,1469.55371900826,497.239669421488,265.272727272727,1086.69421487603,131.661157024793,121,13.6884647420436,11.2545850385046,0.569206157620964,0.9453125,0.775641025641026,-1.16019680621721,53268.0330578512,32950.2561983471,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_134855,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
135037,6797.58448753463,691.739612188366,174.684210526316,681.772853185596,3353.78393351801,691.326869806094,284.05540166205,231.670360110803,1093.08587257618,10406.8975069252,924.509695290859,144.404432132964,1114.63988919668,1510.72022160665,585.90027700831,378.036011080332,2575.0027700831,3674.54847645429,370.581717451524,237.590027700831,1043.54016620499,3923.89473684211,239.664819944598,217.285318559557,604.484764542936,2934.3351800554,562.587257617728,293.656509695291,1095.23545706371,133.457063711911,361,23.2272654863211,19.8428461222147,0.519794883469164,0.970430107526882,0.781385281385281,-0.771240432742489,52753.9030470914,33468.4349030471,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_135037,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
135085,4160.29508196721,570.450819672131,192.27868852459,657.237704918033,2710.18032786885,602.77868852459,383.114754098361,270.704918032787,1120.81967213115,5939.04098360656,1135.2131147541,129.33606557377,1101.91803278689,1099.4262295082,655.631147540984,313.598360655738,1924.41803278689,1621.24590163934,349.434426229508,245.549180327869,1034.98360655738,1264.43442622951,243.532786885246,1575.59836065574,1373.68032786885,1855.99180327869,509.606557377049,483.180327868852,1083.37704918033,129.483606557377,122,15.2628641549899,10.5410519634593,0.723204511092515,0.931297709923664,0.693181818181818,1.42325609527215,52449.5491803279,32951.4016393443,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_135085,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
135319,5623.22194513716,1478.02244389027,362.885286783042,645.86783042394,2006.56359102244,296.189526184539,271.11970074813,245.638403990025,1074.54862842893,7442.26184538653,625.129675810474,128.26433915212,1087.31920199501,812.740648379052,504.476309226933,272.558603491272,1515.03990024938,1269.66832917706,291.31421446384,227.216957605985,996.872817955112,1142.536159601,217.957605985037,151.895261845387,1085.31421446384,1223.94763092269,466.568578553616,241.42144638404,1038.93516209476,130.992518703242,401,23.2971734487673,21.9758598276451,0.331985808749862,0.973300970873786,0.792490118577075,0.862325549289722,53228.6234413965,33348.6209476309,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_135319,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
135339,2046.94246031746,179.099206349206,105.676587301587,634.611111111111,2554.01587301587,1667.4126984127,321.051587301587,265.948412698413,1084.27777777778,4449.33134920635,476.359126984127,123.486111111111,1070.22222222222,1250.59126984127,545.662698412698,283.299603174603,1551.12103174603,1364.02579365079,306.513888888889,225.926587301587,986.950396825397,1119.66666666667,211.819444444444,124.236111111111,663.89880952381,2111.00793650794,480.045634920635,226.22619047619,1041.79166666667,129.25,504,32.1131133810618,20.0899235649131,0.780144989709032,0.96551724137931,0.7875,-0.0924773510962466,53797.6984126984,32505.1845238095,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_135339,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
136523,3678.65100671141,331.838926174497,184.380313199105,670.152125279642,3509.89261744966,1248.89261744966,420.268456375839,250.545861297539,1095.29977628635,6950.53020134228,582.939597315436,126.042505592841,1074.22371364653,2044.34004474273,812.552572706935,751.076062639821,1582.22371364653,4567.23042505593,347.355704697987,232.131991051454,1022.04250559284,4086.43624161074,234.557046979866,745.306487695749,663.565995525727,2947.45637583893,547.203579418344,234.892617449664,1057.65548098434,130.185682326622,447,28.7176280409447,19.9467721616133,0.719412714148199,0.971739130434783,0.747491638795987,-1.07295841866728,53327.9888143177,33216.581655481,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_136523,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
136534,3009.46405228758,323.21568627451,139.02614379085,652.960784313726,2344.66013071895,368.450980392157,309.398692810458,254.294117647059,1083.14379084967,5013.80392156863,608.254901960784,121.777777777778,1062.83660130719,1508.60784313725,641.424836601307,299.385620915033,1534.21568627451,3126.37908496732,413.725490196078,249.718954248366,979.111111111111,2819.98692810458,325.274509803922,325.993464052288,601.483660130719,1551.26797385621,501.771241830065,232.686274509804,1057.44444444444,129.150326797386,153,15.7069106742046,12.6527352651146,0.592524914657771,0.927272727272727,0.683035714285714,-1.40862093823639,52992.1503267974,32758.6078431373,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_136534,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
137430,2325.39220183486,431.598623853211,165.988532110092,658.770642201835,2526.51376146789,272.417431192661,1229.59862385321,245.385321100917,1083.86009174312,4326.43577981651,597.451834862385,133.415137614679,1108.19266055046,639.47247706422,563.988532110092,274.857798165138,1513.84633027523,1084.6628440367,280.213302752294,222.993119266055,1019.69495412844,943.362385321101,221.089449541284,124.516055045872,594.149082568807,1171.16743119266,457.286697247706,219.878440366972,1061.64449541284,132.245412844037,436,27.7850897973571,20.1327233908903,0.689183019626324,0.966740576496674,0.741496598639456,0.0339593677407132,52582.7362385321,32670.0527522936,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_137430,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
137433,4414.99335548173,295.604651162791,125.431893687708,639.385382059801,1182.3122923588,1198.91029900332,308.1926910299,249.006644518272,1097.54485049834,6825.1096345515,1582.83720930233,143.538205980066,1082.34219269103,945.651162790698,458.634551495017,275.355481727575,1939.7707641196,1447.09634551495,307.46511627907,238.634551495017,1023.54485049834,1222.07641196013,215.980066445183,166.109634551495,679.073089700997,2017.18936877076,538.916943521595,381.435215946844,1067.27574750831,130.235880398671,301,22.0747463067282,17.5929120833099,0.604018798880664,0.95253164556962,0.843137254901961,-1.56128161402259,52970.0830564784,33875.1528239203,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_137433,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
137496,4639.63063063063,1133.87387387387,346.369369369369,678.558558558559,3762.11411411411,1125.76576576577,1879.14714714715,250.408408408408,1074.11411411411,7533.29129129129,3132.8048048048,136.732732732733,1076.42042042042,705.384384384384,659.621621621622,974.888888888889,1734.11711711712,1033.40540540541,250.435435435435,217.897897897898,1006.01801801802,902.888888888889,194.459459459459,230.318318318318,684.213213213213,2966.53753753754,543.222222222222,329.303303303303,1065.03603603604,132.318318318318,333,24.349938968692,17.4267103934461,0.698430603295497,0.96242774566474,0.762013729977117,-0.453299464147495,52417.0540540541,32609.3303303303,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_137496,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
137602,3871.98309178744,262.688405797101,87.2705314009662,624.683574879227,802.850241545894,721.722222222222,425.195652173913,280.838164251208,1131.46859903382,6573.47101449275,857.760869565217,121.381642512077,1090.39855072464,851.033816425121,453.272946859903,283.217391304348,1512.34299516908,959.140096618358,202.659420289855,206.437198067633,1096.64251207729,677.760869565217,141.408212560386,109.391304347826,611.557971014493,1119.58695652174,465.444444444444,329.86231884058,1038.55314009662,131.217391304348,414,24.6479576999001,21.4910512719506,0.489648068521674,0.956120092378753,0.784090909090909,-1.16852405980774,53951.384057971,32671.7028985507,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_137602,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
137779,2489.78067885117,320.947780678851,108.422976501305,620.33681462141,574.55091383812,198.671018276762,224.650130548303,243.415143603133,1071.12793733681,1742.21409921671,1350.24804177546,126.167101827676,1068.26109660574,537.770234986945,646.566579634465,259.041775456919,1378.95822454308,812.22454308094,224.135770234987,210.903394255875,983.532637075718,678.725848563969,153.597911227154,104.046997389034,578.88772845953,706.955613577024,404.509138381201,218.67362924282,1016.76501305483,134.879895561358,383,24.0994655630729,20.6008068752628,0.518917672928371,0.950372208436724,0.725378787878788,-0.509193125569947,53322.6553524804,31920.7545691906,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_137779,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
138220,4151.82857142857,513.491428571429,123.408571428571,639.02,1599.20571428571,1196.05714285714,2703.29714285714,236.908571428571,1076.45428571429,5627.67714285714,636.168571428571,123.297142857143,1076.63714285714,1382.09142857143,772.517142857143,1126.10571428571,1687.00857142857,1887.34,344.402857142857,236.674285714286,1032.03714285714,1419.79428571429,240.025714285714,352.708571428571,701.697142857143,1288.06,528.014285714286,369.771428571428,1039.04571428571,130.722857142857,350,24.2047013699786,18.5950704175879,0.640159423912186,0.964187327823691,0.80091533180778,1.08671016874538,53359.6942857143,33577.7142857143,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_138220,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
138401,4765.15873015873,406.89880952381,169.152777777778,689.845238095238,3402.62698412698,2941.37301587302,1952.39087301587,259.964285714286,1117.98611111111,7448.50595238095,621.049603174603,134.10119047619,1130.68253968254,2390.86706349206,908.946428571429,1249.86507936508,3350.02579365079,3104.43452380952,368.402777777778,237.948412698413,1058.75992063492,2226.45833333333,227.416666666667,216.946428571429,624.105158730159,2238.71031746032,563.555555555556,277.22619047619,1085.54365079365,133.253968253968,504,28.3391992732026,22.9055005705051,0.588822881733502,0.954545454545455,0.724137931034483,1.56340075548663,53167.4682539683,33659.0853174603,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_138401,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
138636,1658.20489296636,931.730886850153,644.195718654434,624.305810397554,1647.6880733945,355.155963302752,341.48623853211,253.80122324159,1091.34250764526,2210.56880733945,910.131498470948,115.094801223242,1069.1498470948,2716.76452599388,637.853211009174,540.113149847095,1545.96636085627,2550.61162079511,318.382262996942,228.024464831804,997.948012232416,1960.59327217125,236.443425076453,711.446483180428,664.694189602446,958.672782874618,499.073394495413,285.388379204893,1023.5749235474,129.663608562691,327,21.6589810423764,19.3705038995726,0.447386938767392,0.950581395348837,0.819548872180451,0.332999834711412,53734.8593272171,33042.2568807339,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_138636,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
138791,2399.804,268.696,99.824,622.996,1096.968,2738.852,3428.396,278.424,1099.448,4796.504,685.356,125.484,1078.416,2729.64,2465.552,1080.096,1908.052,2143.564,353.896,236.532,1014.044,1550.432,254.36,436.38,806.504,2337.044,530.756,253.656,1071.86,130.888,250,20.8461851266886,15.364962403593,0.675823483262386,0.961538461538462,0.694444444444444,-0.992234978371215,52382.584,32969.54,FAAGSCC_12,AG,1,M2 macrophages,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_138791,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
139605,2984.51700680272,527.969387755102,81.5680272108844,630.578231292517,1419.6768707483,1145.71428571429,368.795918367347,255.656462585034,1086.81972789116,5489.24829931973,543.959183673469,115.663265306122,1079.95238095238,849.479591836735,579.299319727891,271.479591836735,1601.97619047619,1223.27551020408,287.299319727891,227.034013605442,1030.75170068027,1080.65986394558,211.326530612245,352.261904761905,2121.16326530612,1719.4693877551,503.581632653061,253.901360544218,1042.80272108844,130.904761904762,294,20.6866519513401,18.3217739894635,0.464294321952917,0.96078431372549,0.773684210526316,0.909705694425662,53896.7414965986,33469.2959183673,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_139605,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
139616,2337.99693251534,219.128834355828,139.300613496933,669.895705521472,3610.44478527607,3198.8527607362,350.125766871166,264.398773006135,1094.83128834356,2999.24233128834,491.573619631902,122.944785276074,1071.80061349693,1950.44478527607,875.763803680982,1366.33435582822,1737.64417177914,1764.42331288344,288.693251533742,221.567484662577,1018.34969325153,1530.26687116564,209.539877300613,1212.70858895706,762.733128834356,916.052147239264,471.144171779141,223.039877300613,1029.35889570552,129.110429447853,326,26.4791266150887,15.7362108815048,0.804252762165601,0.944927536231884,0.696581196581197,-1.16857817677762,53175.9754601227,33149.8036809816,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1+,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_139616,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
139962,4166.46627565982,663.873900293255,93.7184750733138,631.366568914956,1853.43695014663,357.659824046921,389.275659824047,256.953079178886,1079.48387096774,6336.29618768328,608.143695014663,122.891495601173,1098.61290322581,807.677419354839,559.539589442815,295.395894428152,1388.85923753666,1223.60703812317,296.234604105572,228.888563049853,985.615835777126,1172.72434017595,217.489736070381,150.325513196481,610.117302052786,1157.9706744868,457.146627565982,238.134897360704,1040.84164222874,130.900293255132,341,25.1170225662313,17.3285367077982,0.723893191996214,0.96875,0.780320366132723,0.467293004345158,53036.715542522,33332.9648093842,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_139962,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
140424,4792.67971530249,308.814946619217,129.711743772242,628.91103202847,1231.62277580071,313.658362989324,327.46975088968,265.462633451957,1083.70106761566,8148.52669039146,639.384341637011,124.750889679715,1075.88612099644,608.711743772242,488.608540925267,265.053380782918,1396.59074733096,952.451957295374,273.665480427046,219.302491103203,979.825622775801,922.800711743772,211.306049822064,118.505338078292,581.348754448399,2527.04270462633,530.555160142349,234.967971530249,1058.33451957295,130.270462633452,281,23.147169230981,15.4522817882327,0.744549905661636,0.968965517241379,0.798295454545455,-1.27472350899115,54104.4590747331,32492.3701067616,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_140424,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
140427,4326.22580645161,806.477419354839,127.338709677419,615.267741935484,1073.92580645161,318.125806451613,362.848387096774,248.6,1077.44193548387,6858.49032258064,566.012903225806,123.393548387097,1063.73870967742,2309.84516129032,713.451612903226,494.412903225806,1621.82258064516,4690.71290322581,343.212903225806,230.912903225806,1002.55806451613,5019.74838709677,243.367741935484,426.767741935484,623.658064516129,2028.68064516129,547.061290322581,236.638709677419,1020.41935483871,130.051612903226,310,23.6823615644759,16.6887210240419,0.709515428700455,0.953846153846154,0.741626794258373,0.538950756749814,53523.5870967742,33190.2,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_140427,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
140839,2588.34722222222,1189.30555555556,978.555555555556,626.548611111111,1209.81944444444,747.645833333333,2276.97916666667,240.513888888889,1105.77777777778,3413.60416666667,475.666666666667,109.354166666667,1060.97916666667,1644.15277777778,623.444444444444,275.694444444444,1685.59722222222,2002.625,293.034722222222,229.027777777778,1020.51388888889,1463.31944444444,211.444444444444,257.979166666667,650.159722222222,840.083333333333,457.819444444444,234.236111111111,1012.60416666667,127.333333333333,144,14.5627305119571,12.5999472284438,0.501394600833661,0.947368421052632,0.738461538461539,1.27415780858477,53837.5486111111,33547.9097222222,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_140839,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
141550,2090.06782945736,136.746124031008,71.1821705426357,645.257751937984,2221.4980620155,1276.65697674419,566.656976744186,240.387596899225,1081.92635658915,3409.18410852713,650.317829457364,114.298449612403,1075.77519379845,4028.93217054264,690.341085271318,438.308139534884,2800.60852713178,5092.70348837209,379.253875968992,235.972868217054,1055.89534883721,4672.81589147287,297.761627906977,277.248062015504,631.079457364341,1190.10658914729,487.102713178295,265.976744186047,1035.47868217054,131.166666666667,516,29.0591337228759,22.6652141145574,0.625818553009244,0.975425330812854,0.808777429467085,-1.49975264548245,53570.1957364341,33601.8236434109,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_141550,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
141775,3585.16,281.523076923077,295.246153846154,769.427692307692,9080.07692307692,314.836923076923,316.541538461538,253.461538461538,1084.12307692308,7141.32,665.018461538462,148.584615384615,1086.92615384615,730.436923076923,512.495384615385,292.4,1385.64307692308,1160.01846153846,326.529230769231,232.593846153846,984.772307692308,1115.51384615385,239.178461538462,255.716923076923,600.753846153846,2667.68,515.956923076923,235.16,1080.90769230769,130.452307692308,325,22.0452035884463,18.8197133186146,0.520785716303125,0.947521865889213,0.703463203463203,1.04369202548586,53058.6246153846,33290.0246153846,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_141775,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
142339,2105.10634920635,132.525396825397,124.585714285714,703.960317460317,4947.41746031746,1986.13015873016,1132.10793650794,252.0,1104.78253968254,3774.57619047619,585.6,131.673015873016,1085.74603174603,4137.62698412698,1254.38253968254,2678.50476190476,3951.98412698413,5635.06666666667,458.071428571429,249.75873015873,1123.06349206349,5192.10158730159,287.444444444444,619.071428571429,780.184126984127,1357.65396825397,469.174603174603,269.41746031746,1076.26507936508,131.355555555556,630,32.7913491246113,24.6148303176651,0.660699924256625,0.967741935483871,0.724137931034483,0.898874989172218,52959.0666666667,33722.380952381,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3+,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,9,FAAGSCC_12_142339,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
143315,3401.11111111111,296.498866213152,150.628117913832,654.997732426304,3151.11337868481,1370.73469387755,718.480725623583,248.485260770975,1103.07936507937,6266.88888888889,511.199546485261,122.630385487528,1070.55328798186,3455.50340136054,1024.27437641723,423.755102040816,3862.62811791383,4249.43310657596,361.75283446712,227.054421768707,1041.56462585034,2606.27891156463,212.095238095238,325.69387755102,678.312925170068,1962.61678004535,531.097505668934,246.337868480726,1045.60997732426,129.952380952381,441,27.4532646804369,20.5303098505665,0.663892940478341,0.96078431372549,0.777777777777778,-1.52742470087875,53993.5691609977,32762.6757369614,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_143315,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
143484,2122.19294605809,301.639004149378,95.649377593361,619.321576763485,1207.622406639,651.705394190871,366.593360995851,264.838174273859,1109.79253112033,4368.23443983402,1484.78215767635,114.257261410788,1079.14107883817,797.726141078838,429.98755186722,274.933609958506,1453.95435684647,1004.6867219917,198.460580912863,209.294605809129,1313.65767634855,678.684647302905,136.497925311203,109.788381742739,585.315352697095,1271.96680497925,465.346473029046,310.298755186722,1039.06846473029,131.06846473029,482,30.3594582126513,20.3940426224115,0.740775640204133,0.956349206349206,0.717261904761905,-1.11466736148506,53763.4024896266,32741.6867219917,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_143484,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
143766,5033.78716216216,1021.36824324324,1207.53716216216,626.456081081081,946.02027027027,1822.60135135135,478.891891891892,263.162162162162,1103.79054054054,8523.91891891892,945.253378378378,129.533783783784,1072.49324324324,869.199324324324,541.266891891892,280.503378378378,1840.5,1285.32094594595,346.706081081081,237.820945945946,978.814189189189,1266.26689189189,257.868243243243,134.030405405405,583.591216216216,2898.9222972973,545.165540540541,327.851351351351,1071.98648648649,130.456081081081,296,21.5676524568699,17.5034742895185,0.584267138383418,0.973684210526316,0.829131652661064,0.205471088112458,52783.7837837838,33322.1993243243,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_143766,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
143847,2813.25933202358,358.730844793713,103.335952848723,664.536345776031,1779.98231827112,285.748526522593,997.768172888016,242.882121807466,1076.33398821218,5035.36542239686,2940.17092337917,122.196463654224,1071.75049115914,851.168958742633,821.387033398821,1034.51669941061,1603.35756385069,1369.20039292731,333.463654223969,231.522593320236,1007.25540275049,1310.95874263261,233.009823182711,734.803536345776,1315.42436149312,1343.24754420432,469.656188605108,540.746561886051,1056.95088408644,129.878192534381,509,35.7997525187106,18.1412374486147,0.862097770817297,0.958568738229755,0.656774193548387,0.970367033765169,53040.3084479371,32794.9489194499,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_143847,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
144477,4242.26358695652,735.39402173913,88.0869565217391,631.752717391304,1187.47554347826,302.663043478261,315.798913043478,254.516304347826,1078.88858695652,7582.54347826087,1186.91847826087,123.614130434783,1073.40489130435,789.103260869565,511.877717391304,278.149456521739,1431.54347826087,1217.8125,334.820652173913,238.1875,985.839673913044,1175.8152173913,248.698369565217,141.565217391304,587.290760869565,3216.52989130435,543.989130434783,337.051630434783,1081.98369565217,132.461956521739,368,23.1286283197714,20.3139794692161,0.478101578030202,0.965879265091864,0.8,0.294557641406746,52720.1793478261,33337.9347826087,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_144477,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
144498,3108.6962962963,138.772839506173,53.4222222222222,610.99012345679,656.693827160494,1405.16790123457,615.350617283951,245.182716049383,1095.42469135802,5352.01728395062,719.367901234568,115.404938271605,1087.49135802469,3884.57037037037,884.814814814815,788.706172839506,6929.21975308642,5665.46913580247,416.43950617284,245.22962962963,1049.68148148148,5623.01728395062,270.148148148148,228.550617283951,661.595061728395,2575.03209876543,497.437037037037,260.703703703704,1042.72098765432,128.204938271605,405,24.2615222089811,21.2745608230384,0.48070052178371,0.961995249406176,0.803571428571429,-0.290732816739361,53071.0345679012,33683.3925925926,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_144498,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
144811,5153.72440944882,590.133858267717,144.55905511811,632.712598425197,1343.52362204724,263.456692913386,281.925196850394,252.354330708661,1080.00393700787,8126.72047244094,955.807086614173,136.507874015748,1081.84251968504,607.366141732283,422.791338582677,280.015748031496,1430.7125984252,992.771653543307,270.700787401575,222.511811023622,987.492125984252,922.795275590551,206.015748031496,120.870078740157,584.397637795276,2865.01181102362,517.771653543307,274.153543307087,1056.09448818898,132.114173228346,254,21.7778239329076,14.8771080506662,0.730295795146461,0.947761194029851,0.711484593837535,-1.05870022215643,52698.6338582677,32675.094488189,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_144811,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
145047,2721.78254211332,714.159264931087,74.8070444104135,629.655436447167,1088.30321592649,392.54517611026,495.94180704441,241.776416539051,1080.21592649311,3894.92343032159,1030.66462480858,121.577335375191,1073.81010719755,982.949464012251,919.580398162328,599.245022970904,1852.53751914242,1419.15773353752,860.823889739663,230.062787136294,1031.32312404288,1486.37672281776,236.033690658499,681.695252679939,611.860643185299,1076.85451761103,534.104134762634,279.943338437979,1017.8315467075,129.90045941807,653,30.3778581348704,27.4533975303459,0.428101795281629,0.967407407407407,0.750574712643678,1.00734583720209,53631.2465543645,33681.9954058193,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_145047,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
145383,1793.02348336595,192.592954990215,110.929549902153,641.655577299413,2209.36790606654,2217.56947162427,776.399217221135,259.956947162427,1120.60665362035,3597.67906066536,704.385518590998,116.847358121331,1085.97064579256,1565.31311154599,795.003913894325,309.391389432485,1542.92563600783,1693.96673189824,251.371819960861,215.203522504892,1006.45988258317,1348.88454011742,187.189823874755,182.45988258317,642.105675146771,1335.37769080235,478.557729941292,264.138943248532,1053.02152641879,130.285714285714,511,32.4967747851416,20.1718591964197,0.784021086772212,0.965973534971645,0.709722222222222,-0.504285550237849,54134.4853228963,32928.4285714286,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_145383,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
145526,3032.01910828025,300.114649681529,139.595541401274,671.101910828025,3187.06687898089,350.305732484076,270.955414012739,245.15923566879,1094.85350318471,4559.67197452229,883.643312101911,141.407643312102,1077.73885350318,702.751592356688,416.917197452229,269.404458598726,1512.8821656051,942.509554140127,204.289808917197,211.81847133758,1220.3821656051,644.605095541401,143.216560509554,129.917197452229,594.691082802548,921.15923566879,445.152866242038,224.984076433121,1027.72929936306,128.207006369427,314,30.6466150951202,13.6440808289999,0.895427787657007,0.942942942942943,0.675268817204301,-1.42485508419355,52654.6687898089,32943.9872611465,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_145526,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
145756,4116.60704607046,1149.85636856369,2226.57181571816,614.794037940379,616.360433604336,334.338753387534,343.425474254743,257.636856368564,1078.69376693767,5693.9810298103,663.181571815718,117.647696476965,1082.39566395664,731.19783197832,537.658536585366,277.371273712737,1382.31436314363,1031.84552845528,304.216802168022,229.457994579946,985.840108401084,978.168021680217,217.552845528455,117.926829268293,584.856368563686,834.111111111111,428.628726287263,237.9972899729,1007.17886178862,130.558265582656,369,23.8141629865908,19.846143650763,0.55270699245217,0.965968586387434,0.763975155279503,-0.942428029156595,53503.2357723577,32726.4254742547,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_145756,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
145982,4120.62459546926,1010.93527508091,2168.53721682848,651.718446601942,2641.04530744337,2897.01941747573,328.436893203883,260.941747572816,1088.08414239482,7417.00323624596,1251.58252427184,127.935275080906,1083.55339805825,2158.32038834951,569.297734627832,294.990291262136,1553.85436893204,2195.8640776699,330.721682847896,234.388349514563,1011.84466019417,1597.13268608414,238.187702265372,322.967637540453,642.508090614887,2185.97087378641,574.10355987055,419.074433656958,1054.06148867314,130.818770226537,309,23.3995952099275,16.8897491889571,0.692105202378177,0.959627329192547,0.790281329923274,-1.40784061497244,53590.4757281553,33232.216828479,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_145982,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
146791,4512.72027972028,205.730769230769,125.814685314685,634.503496503497,1527.00699300699,404.346153846154,284.835664335664,237.741258741259,1077.13986013986,7244.46853146853,1069.32867132867,121.954545454545,1093.01048951049,939.751748251748,586.377622377622,278.143356643357,1722.95454545455,1232.00699300699,272.70979020979,227.93006993007,1025.08391608392,1041.12937062937,202.020979020979,209.562937062937,2199.65034965035,2198.99300699301,556.730769230769,328.489510489511,1069.03496503497,129.405594405594,286,19.3855511013944,19.0312988167645,0.19030011622141,0.966216216216216,0.752631578947368,-1.26390553788776,53847.5314685315,33533.3951048951,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_146791,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
146852,3503.77188940092,675.440092165899,68.2511520737327,636.967741935484,1369.43087557604,771.117511520737,834.693548387097,257.034562211982,1091.02764976959,5424.85483870968,608.486175115207,133.566820276498,1071.00230414747,1102.79032258065,686.47465437788,684.354838709677,1801.01152073733,1583.21889400922,349.716589861751,235.509216589862,1025.60829493088,1727.53917050691,269.626728110599,288.092165898618,658.891705069124,1369.47695852535,486.695852534562,338.304147465438,1063.85944700461,131.357142857143,434,28.449419810667,19.5793887668812,0.725504420098065,0.953846153846154,0.730639730639731,1.08217539772449,53174.8917050691,33812.0552995392,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_146852,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
146989,3686.9708994709,368.701058201058,154.140211640212,682.055555555556,3409.12169312169,916.806878306878,506.015873015873,248.177248677249,1104.3835978836,6546.39417989418,709.944444444444,134.582010582011,1110.2619047619,1674.42063492063,815.603174603175,335.31746031746,4767.24338624339,1752.03703703704,349.018518518519,237.349206349206,1021.32275132275,1325.53439153439,253.452380952381,169.044973544974,595.486772486772,2301.82010582011,512.42328042328,284.687830687831,1086.11904761905,130.891534391534,378,23.4763520409835,20.5413343960249,0.484159380961921,0.97172236503856,0.78099173553719,0.774885766874211,52796.791005291,33491.3386243386,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_146989,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
147244,3312.30769230769,210.671794871795,69.3589743589744,677.123076923077,856.774358974359,712.225641025641,594.025641025641,260.312820512821,1082.14871794872,5987.74358974359,608.34358974359,121.048717948718,1078.48974358974,937.88717948718,720.489743589744,293.023076923077,1658.42051282051,1317.85897435897,305.697435897436,229.069230769231,993.348717948718,1335.25384615385,234.274358974359,335.187179487179,650.558974358974,1701.19230769231,463.535897435897,226.492307692308,1046.67435897436,129.55641025641,390,36.5535720059909,13.7210972722655,0.926875241500872,0.946601941747573,0.517241379310345,0.900403984458571,52756.4512820513,32350.8435897436,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_147244,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
147361,1754.65614035088,280.670175438597,80.5894736842105,636.438596491228,1739.91929824561,462.831578947368,1625.11228070175,248.8,1157.58947368421,2366.28421052632,1153.63157894737,126.136842105263,1071.64210526316,1285.17543859649,1080.93333333333,1168.70526315789,2099.19649122807,3078.84561403509,488.947368421053,235.20350877193,1040.61052631579,3630.02807017544,251.231578947368,1571.9649122807,730.968421052632,883.284210526316,470.280701754386,355.20701754386,1022.45964912281,129.571929824561,285,22.5012215574382,16.1398576139976,0.696776747206237,0.966101694915254,0.809659090909091,-1.37910488874078,53562.7754385965,33843.4701754386,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_147361,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
147641,4445.01587301587,767.171957671958,112.597883597884,659.746031746032,2208.11904761905,3030.98941798942,820.568783068783,260.465608465608,1128.31481481481,6552.4417989418,786.132275132275,141.439153439153,1095.19576719577,4425.21693121693,787.693121693122,466.910052910053,7708.22222222222,5806.57407407407,404.743386243386,244.171957671958,1042.79365079365,5662.6455026455,260.746031746032,231.21164021164,621.560846560847,1950.69312169312,550.756613756614,323.351851851852,1080.0,131.330687830688,378,25.582835511203,19.1169983595779,0.664533160326088,0.956962025316456,0.715909090909091,0.911864274254399,53064.2936507936,33732.8518518519,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_147641,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
147815,3146.75623268698,1071.25484764543,126.473684210526,635.171745152355,1201.93905817175,387.947368421053,302.628808864266,262.429362880886,1080.81717451524,4111.77008310249,1002.24099722992,126.130193905817,1078.30193905817,857.349030470914,588.321329639889,272.313019390582,1783.54293628809,1314.30193905817,346.204986149584,230.490304709141,1014.34072022161,1096.72022160665,227.689750692521,218.739612188366,3374.19667590028,969.963988919668,422.764542936288,268.92243767313,1048.68975069252,131.047091412742,361,23.3206539018695,19.8085918317869,0.527747639163699,0.973045822102426,0.784782608695652,-0.408518513016171,53114.0664819945,32066.163434903,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_147815,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
148086,2504.84827586207,287.034482758621,146.710344827586,665.318965517241,3111.04827586207,769.422413793103,391.758620689655,265.284482758621,1093.8,4603.67931034483,1458.23965517241,131.056896551724,1156.51206896552,1251.62068965517,576.58275862069,298.639655172414,1638.75689655172,1573.54137931034,355.410344827586,240.365517241379,1010.40517241379,1515.63965517241,252.739655172414,158.951724137931,585.943103448276,1511.49137931034,542.5,290.348275862069,1073.01034482759,130.486206896552,580,37.3997242841998,19.8208007680148,0.84801523967463,0.957095709570957,0.726817042606516,-0.148344313073733,52300.724137931,33070.6620689655,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_148086,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
148127,2905.69927536232,747.31884057971,107.532608695652,662.778985507246,2963.61231884058,2883.1884057971,1835.6847826087,261.134057971014,1274.91666666667,5050.40942028986,598.807971014493,127.5,1062.75724637681,3965.69565217391,1274.31884057971,1164.68115942029,2173.33333333333,1901.76449275362,372.858695652174,242.228260869565,1043.51449275362,1380.24275362319,731.376811594203,533.155797101449,645.934782608696,2013.59782608696,501.547101449275,242.95652173913,1083.28623188406,131.684782608696,276,20.5537425386396,17.2415557852295,0.544358971235958,0.955017301038062,0.811764705882353,-1.37178300861381,53049.5108695652,33630.8333333333,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1-,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_148127,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
148136,3387.44846796657,239.314763231198,78.4902506963788,651.481894150418,2076.06128133705,424.181058495822,616.016713091922,259.328690807799,1085.25905292479,5396.15320334262,641.562674094708,144.863509749304,1095.80222841226,1069.98328690808,763.905292479109,351.077994428969,1939.50417827298,1601.57660167131,383.724233983287,245.977715877437,1003.09192200557,1499.03342618384,253.183844011142,193.303621169916,592.643454038997,1809.86629526462,504.685236768802,407.657381615599,1069.38718662953,129.534818941504,359,24.0767858464973,19.1062402058551,0.608499266706997,0.952254641909814,0.780434782608696,1.38353131221973,53456.3036211699,33781.2757660167,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_148136,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
148200,2649.97457627119,565.494350282486,401.06779661017,722.5,5921.67231638418,2175.30508474576,721.573446327684,252.070621468927,1088.13559322034,3639.3615819209,1222.70056497175,128.762711864407,1080.91807909605,1074.85310734463,665.581920903955,590.926553672316,1754.74858757062,1566.62711864407,325.223163841808,234.604519774011,1040.71468926554,1555.04519774011,239.971751412429,547.502824858757,3114.68361581921,1066.57062146893,473.073446327684,431.709039548023,1071.98587570621,130.14406779661,354,23.7990355047152,19.0936543855551,0.596938633596837,0.941489361702128,0.776315789473684,1.43510209933715,53562.384180791,33712.8785310734,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_148200,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
148282,2026.76872964169,139.208469055375,84.1465798045603,644.892508143323,2519.83550488599,760.174267100977,2086.56351791531,239.306188925081,1083.66449511401,3461.25407166124,815.946254071661,116.017915309446,1089.54234527687,919.161237785016,507.656351791531,528.982084690554,1649.61074918567,1578.49511400651,282.048859934853,224.584690553746,1007.41856677524,1771.29804560261,214.610749185668,182.977198697068,592.986970684039,1416.09609120521,499.415309446254,271.628664495114,1051.332247557,129.114006514658,614,33.4010343664741,23.5484569071446,0.709185646430486,0.968454258675079,0.701714285714286,-0.241809272951926,53500.7638436482,33553.6270358306,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_148282,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
148827,1908.93169398907,279.945355191257,96.6338797814208,633.024590163934,793.379781420765,783.66393442623,305.800546448087,256.051912568306,1084.77595628415,4172.13387978142,1734.37704918033,116.486338797814,1071.71857923497,1281.83606557377,445.713114754098,288.677595628415,1434.95628415301,1376.7349726776,300.726775956284,225.647540983606,1021.31147540984,1196.02459016393,205.882513661202,267.535519125683,588.598360655738,1999.80054644809,509.344262295082,457.103825136612,1042.10655737705,129.945355191257,366,29.7030853104781,15.7482833184676,0.847878766464265,0.950649350649351,0.717647058823529,1.39906853398781,53432.237704918,32906.4153005464,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_148827,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
148940,4530.64364640884,686.649171270718,105.610497237569,653.939226519337,2194.98342541436,1656.76243093923,349.814917127072,253.190607734807,1096.45856353591,6868.91988950276,815.516574585635,122.124309392265,1390.08011049724,1107.52762430939,499.92817679558,282.419889502762,1624.17127071823,1155.7955801105,249.599447513812,221.25138121547,1174.24033149171,946.314917127072,184.930939226519,177.908839779006,901.53591160221,1306.38121546961,509.397790055249,633.911602209945,1050.81491712707,131.0,362,23.4592512874094,19.8258364651136,0.534579740231603,0.955145118733509,0.754166666666667,-0.0711252899255607,53745.5635359116,33481.6187845304,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX+,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_148940,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
149271,3323.31234866828,172.508474576271,104.489104116223,652.946731234867,2320.17433414044,321.375302663438,507.084745762712,247.617433414044,1077.14769975787,5855.61259079903,1234.26392251816,122.232445520581,1074.76513317191,746.951573849879,488.556900726392,275.317191283293,1385.6803874092,1166.40920096852,306.261501210654,229.094430992736,985.421307506053,1156.27602905569,239.186440677966,133.80387409201,589.060532687651,1471.35351089588,488.043583535109,342.610169491525,1167.26150121065,131.682808716707,413,24.3673683426854,21.7147442746154,0.453727826878463,0.964953271028037,0.780718336483932,-0.523326566717918,53034.8256658596,33304.6271186441,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_149271,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
149499,1724.55309734513,373.610619469027,133.66814159292,640.287610619469,2333.43805309735,329.243362831858,756.079646017699,234.225663716814,1072.63716814159,2517.25663716814,1486.11061946903,120.911504424779,1076.34955752212,757.469026548673,662.384955752212,790.929203539823,1618.07079646018,1419.85398230089,266.446902654867,226.20796460177,1016.74778761062,1257.8185840708,216.566371681416,226.946902654867,731.495575221239,1061.39380530973,504.938053097345,365.597345132743,1024.60619469027,130.101769911504,226,18.9509145542742,15.2357760709765,0.594683461778946,0.957627118644068,0.743421052631579,-0.16730035536442,53079.9203539823,33491.5796460177,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_149499,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
149778,1353.17,307.2925,120.5375,711.0925,2261.445,416.2875,655.5025,241.0225,1084.0775,2116.0025,2255.19,121.8,1074.6,693.8175,509.9575,320.895,1504.2525,1160.485,286.385,226.685,998.4175,1218.4175,239.5325,229.655,605.275,1099.445,526.7025,1436.6225,1058.0225,130.8125,400,22.91569813038,22.2513702768459,0.23903917974812,0.970873786407767,0.790513833992095,0.513093381212813,53528.27,33335.2425,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_149778,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
150308,3981.9724137931,559.493103448276,1157.88620689655,622.772413793103,719.675862068966,305.98275862069,267.020689655172,247.5,1071.17931034483,7353.53793103448,997.031034482759,117.68275862069,1075.48965517241,674.341379310345,441.110344827586,264.289655172414,1477.78965517241,1057.47586206897,268.103448275862,219.772413793103,984.634482758621,947.2,196.913793103448,147.18275862069,583.013793103448,2084.73103448276,526.341379310345,295.758620689655,1046.76206896552,130.855172413793,290,22.5974607760449,16.3682996968227,0.689440382573007,0.953947368421053,0.726817042606516,-0.928562422029673,53851.1310344828,32950.5034482759,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_150308,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
150311,4281.1724137931,902.637931034483,127.610344827586,648.772413793103,2652.91034482759,1164.36551724138,384.110344827586,270.08275862069,1130.98620689655,7413.40344827586,2236.04482758621,127.78275862069,1089.07586206897,576.327586206897,339.089655172414,259.420689655172,1411.45172413793,794.693103448276,176.841379310345,201.075862068966,1050.54827586207,626.831034482759,132.955172413793,107.706896551724,592.555172413793,1860.58275862069,521.931034482759,414.875862068965,1051.87586206897,131.675862068966,290,21.3186494966861,17.3583572870255,0.58053760204391,0.957095709570957,0.763157894736842,-1.02511549336718,53938.4482758621,32717.7586206897,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_150311,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
150661,2338.38779174147,243.506283662478,182.271095152603,679.387791741472,4373.87612208259,962.822262118492,443.481149012567,264.269299820467,1093.76301615799,3855.6355475763,592.50987432675,122.008976660682,1087.83123877917,647.639138240575,470.859964093357,265.095152603232,1525.078994614,854.904847396768,224.156193895871,218.290843806104,988.992818671454,743.174147217235,172.314183123878,118.868940754039,583.373429084381,1251.84560143627,543.567324955117,228.973070017953,1033.94434470377,128.16157989228,557,30.7928216392466,23.1805610629829,0.658259530268346,0.967013888888889,0.736772486772487,-0.853498294201691,52268.8850987433,33250.2298025135,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_150661,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
150768,1824.50561797753,404.983146067416,135.227528089888,638.769662921348,1418.94101123596,835.443820224719,489.13202247191,297.460674157303,1161.01685393258,2431.73595505618,787.97191011236,126.27808988764,1077.60112359551,1258.32865168539,657.137640449438,289.817415730337,1628.56179775281,1229.57865168539,226.252808988764,216.991573033708,1337.5702247191,608.842696629213,135.36797752809,103.508426966292,592.598314606742,981.095505617978,463.412921348315,238.772471910112,1056.39606741573,130.780898876405,356,28.6423613909972,15.8829454308999,0.832166135036195,0.959568733153639,0.732510288065844,1.23986329985778,52744.808988764,32186.0646067416,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_150768,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
150820,3989.03846153846,222.970414201183,71.405325443787,615.417159763314,756.136094674556,2108.70118343195,392.597633136095,256.278106508876,1218.67455621302,6603.02662721893,534.825443786982,118.532544378698,1076.0,5393.74556213018,807.065088757396,347.778106508876,2051.51479289941,8510.02071005917,513.636094674556,253.849112426036,1103.34319526627,9747.98520710059,301.508875739645,254.51775147929,585.813609467456,1976.02071005917,510.789940828402,259.079881656805,1039.71893491124,130.899408284024,338,24.788652809595,17.4225075571434,0.71134594450821,0.962962962962963,0.751111111111111,0.272728000992267,52943.5680473373,33363.5266272189,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_150820,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
150825,2231.05128205128,329.318681318681,139.827838827839,679.728937728938,2920.32967032967,289.846153846154,297.347985347985,249.29304029304,1077.92307692308,3438.65934065934,663.084249084249,118.802197802198,1078.84249084249,658.421245421245,427.967032967033,271.908424908425,1363.99267399267,968.582417582418,249.659340659341,219.663003663004,978.014652014652,907.113553113553,196.326007326007,124.40293040293,582.699633699634,1193.61904761905,518.446886446886,1061.13186813187,1070.02197802198,130.663003663004,273,20.3718863071005,17.1002382229872,0.543508331485528,0.968085106382979,0.802941176470588,-0.352351838174335,54062.8717948718,33155.2417582418,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_150825,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
151047,3813.71212121212,119.022727272727,83.7689393939394,630.492424242424,1377.85984848485,2624.37121212121,481.136363636364,282.265151515152,1132.61742424242,6550.30303030303,622.757575757576,120.44696969697,1098.31818181818,3249.44696969697,655.916666666667,410.969696969697,1990.11363636364,2851.64015151515,380.253787878788,240.295454545455,1061.68181818182,1745.48863636364,241.746212121212,223.568181818182,612.549242424242,1906.28409090909,477.94696969697,275.94696969697,1044.70833333333,130.909090909091,264,23.8763220720663,14.1078095148173,0.806766566041356,0.939501779359431,0.765217391304348,1.44660706822706,52463.9507575758,33308.3484848485,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_151047,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
151259,5129.31666666667,1244.02142857143,137.966666666667,665.414285714286,2550.05714285714,1618.83095238095,1006.37142857143,249.828571428571,1119.88571428571,7044.15714285714,645.514285714286,145.230952380952,1103.46428571429,4188.64285714286,817.438095238095,727.269047619048,2303.60476190476,4756.12142857143,438.616666666667,252.588095238095,1559.54523809524,3245.9380952381,301.554761904762,255.919047619048,661.116666666667,1701.5119047619,530.861904761905,259.754761904762,1069.3119047619,131.142857142857,420,24.7107018789098,21.656732143118,0.481563779835312,0.972222222222222,0.793950850661626,0.850325871602525,53252.719047619,33763.1857142857,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_151259,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
151512,4100.99117647059,934.029411764706,868.191176470588,665.014705882353,2982.59411764706,1259.05588235294,299.402941176471,257.791176470588,1079.63235294118,6997.41764705882,1107.84117647059,128.026470588235,1094.86470588235,755.897058823529,456.388235294118,267.973529411765,1377.62352941176,1030.24705882353,278.6,218.776470588235,982.002941176471,983.270588235294,203.638235294118,116.176470588235,584.002941176471,1918.48235294118,542.029411764706,320.994117647059,1073.56764705882,131.508823529412,340,24.1119653634874,17.9844063080943,0.66609085979416,0.974212034383954,0.821256038647343,1.34839836233753,53496.1970588235,32919.25,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_151512,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
151546,3548.10106382979,749.441489361702,2581.34840425532,654.409574468085,2381.74734042553,1268.90957446809,554.101063829787,244.204787234043,1086.09840425532,4511.44680851064,577.199468085106,127.853723404255,1076.84042553191,1191.1329787234,571.377659574468,307.595744680851,1797.60904255319,1759.64361702128,327.220744680851,233.276595744681,1042.05319148936,1584.12765957447,225.132978723404,246.156914893617,962.683510638298,1005.75531914894,500.412234042553,306.042553191489,1030.13031914894,129.029255319149,376,24.76117972068,19.6602906894724,0.6079222943408,0.969072164948454,0.817391304347826,-1.15718563571922,53776.3218085106,33721.5345744681,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_151546,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
151699,328.586206896552,705.823754789272,171.862068965517,606.946360153257,111.371647509579,926.91570881226,351.773946360153,262.32183908046,1090.06130268199,878.816091954023,987.329501915709,104.233716475096,1063.21455938697,695.149425287356,439.754789272031,272.275862068966,1404.4367816092,994.134099616858,278.452107279694,223.770114942529,983.91570881226,942.578544061303,211.877394636015,136.122605363985,624.586206896552,567.846743295019,368.55938697318,206.103448275862,981.816091954023,127.459770114943,261,20.2248721937922,16.4516015955342,0.581657024174697,0.952554744525547,0.767647058823529,-1.20274173235596,53322.245210728,33027.9195402299,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_151699,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
152079,2885.35100548446,172.692870201097,187.563071297989,781.963436928702,5221.90310786106,255.685557586837,273.760511882998,253.404021937843,1082.43875685558,4215.07678244973,1146.83729433272,216.034734917733,1072.53016453382,514.294332723949,488.972577696527,257.08592321755,1574.88665447898,819.45155393053,235.806215722121,218.047531992687,990.839122486289,730.36928702011,179.539305301645,118.440585009141,579.329067641682,1345.97806215722,466.226691042048,239.201096892139,1089.83180987203,130.663619744059,547,29.9823815344904,23.2832816481299,0.630036586087189,0.968141592920354,0.779202279202279,-0.69756916117215,53122.1809872029,31926.5831809872,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_152079,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
152650,4014.24382716049,1011.32716049383,1319.02469135802,721.759259259259,6786.98148148148,2438.88580246914,585.672839506173,247.916666666667,1091.20679012346,5807.84259259259,909.108024691358,142.086419753086,1076.53395061728,3594.55864197531,746.453703703704,408.160493827161,9816.61111111111,2991.70061728395,317.589506172839,232.45987654321,1056.42283950617,2272.37962962963,202.265432098765,249.021604938272,643.438271604938,1464.54938271605,563.101851851852,299.447530864198,1065.87962962963,132.645061728395,324,22.3202209014196,18.5203973326772,0.558122307961396,0.964285714285714,0.771428571428571,0.698760721832443,52729.0740740741,33731.1358024691,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_152650,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
152852,2223.48251748252,204.228438228438,147.662004662005,677.170163170163,3517.337995338,2658.21445221445,3401.9627039627,262.969696969697,1090.88111888112,4293.69230769231,663.794871794872,130.613053613054,1099.62703962704,1970.97202797203,653.589743589744,2337.82517482517,1647.79254079254,1251.3006993007,277.032634032634,222.659673659674,1001.65034965035,1061.7296037296,206.958041958042,421.452214452214,1305.22377622378,1443.23776223776,454.312354312354,226.648018648019,1062.52214452214,132.223776223776,429,24.9366554019465,22.0117991328131,0.469920846014527,0.966216216216216,0.777173913043478,1.02344884822866,52506.6317016317,32624.5454545455,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_152852,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
153008,2915.25333333333,590.930666666667,211.925333333333,741.368,6049.21866666667,1506.26666666667,397.346666666667,259.562666666667,1080.88,4487.66666666667,551.757333333333,132.850666666667,1081.78133333333,819.552,469.901333333333,309.645333333333,1617.88266666667,957.208,263.978666666667,223.928,983.650666666667,856.789333333333,198.584,138.592,594.125333333333,1050.128,422.501333333333,212.866666666667,1046.98933333333,130.818666666667,375,24.1166527585841,19.8274297586194,0.569275487066911,0.96401028277635,0.77639751552795,0.558187707036517,52618.5386666667,32371.4373333333,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_153008,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
154080,1907.08620689655,347.151724137931,102.206896551724,630.189655172414,1917.92413793103,964.834482758621,1021.68620689655,259.420689655172,1086.38275862069,3025.3724137931,1895.22068965517,120.958620689655,1066.92413793103,708.720689655172,471.024137931034,323.131034482759,1364.38275862069,990.086206896552,278.106896551724,222.768965517241,986.641379310345,979.155172413793,212.262068965517,142.072413793103,608.78275862069,1034.13793103448,486.506896551724,410.172413793103,1046.37586206897,130.527586206897,290,21.5209642396354,17.1814783783728,0.602180379040795,0.973154362416107,0.812324929971989,-1.31818999597292,53227.1379310345,32843.6413793103,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_154080,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
155697,2912.92475728155,493.5,162.400485436893,682.949029126214,4741.56553398058,421.788834951456,322.131067961165,251.509708737864,1129.8932038835,4806.08252427184,1894.62378640777,127.446601941748,1071.95631067961,733.655339805825,482.830097087379,270.004854368932,1544.31310679612,1080.63834951456,232.009708737864,211.718446601942,1010.64805825243,919.47572815534,176.25,140.800970873786,2469.79368932039,1404.6140776699,529.01213592233,694.567961165049,1062.53640776699,131.123786407767,412,29.3479898323949,17.9870621046566,0.790168963980046,0.955916473317865,0.72280701754386,1.39346695052279,53436.2621359223,33094.0145631068,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_155697,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
156132,3813.54340836013,256.485530546624,85.3151125401929,624.173633440514,935.167202572347,320.691318327974,258.652733118971,240.154340836013,1104.08038585209,6196.39549839228,653.1961414791,131.498392282958,1071.69453376206,524.344051446945,338.72347266881,254.832797427653,1457.59807073955,857.405144694534,207.858520900322,211.88424437299,1000.0578778135,754.810289389068,159.932475884244,247.244372990354,1364.57234726688,1809.35691318328,519.508038585209,243.572347266881,1059.52090032154,131.315112540193,311,28.1837711672164,14.0852631616049,0.866161022946716,0.939577039274924,0.740476190476191,1.52885244328228,52919.463022508,32876.7202572347,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,1,FAAGSCC_12_156132,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
157367,4154.79530201342,1047.97986577181,333.409395973154,679.261744966443,3922.46308724832,867.375838926175,2664.25503355705,241.389261744966,1094.48322147651,6862.92617449664,582.738255033557,134.865771812081,1076.06711409396,1524.68120805369,886.755033557047,889.036912751678,1838.93959731544,3762.63758389262,340.691275167785,234.530201342282,1027.4932885906,4231.24161073826,243.496644295302,411.691275167785,604.835570469799,2540.74496644295,545.385906040268,272.184563758389,1076.36577181208,129.560402684564,298,19.8156615757427,19.2963810492143,0.227429968145145,0.961290322580645,0.745,0.76988464731623,53616.355704698,33728.9429530201,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_157367,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
157491,4644.75675675676,461.219594594595,139.665540540541,636.040540540541,1451.125,1029.72297297297,748.945945945946,245.226351351351,1085.45608108108,7506.68243243243,689.47972972973,135.347972972973,1084.85135135135,745.793918918919,426.743243243243,351.108108108108,2184.22635135135,1309.46959459459,295.567567567568,274.314189189189,1014.78378378378,1124.13513513514,217.067567567568,171.375,599.942567567568,2434.0,574.199324324324,262.27027027027,1057.49662162162,131.293918918919,296,21.3831603215147,17.8391648244247,0.551367745111815,0.961038961038961,0.741854636591479,-0.547754809661461,53151.1858108108,33515.4594594595,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_157491,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
157791,4133.03939393939,648.387878787879,93.5515151515152,655.224242424242,2331.64242424242,3663.67272727273,552.312121212121,249.730303030303,1108.00606060606,6999.78484848485,584.554545454545,119.40303030303,1087.76060606061,3875.82727272727,877.727272727273,346.09696969697,1962.39393939394,4748.44848484848,419.257575757576,252.839393939394,1041.34242424242,3898.36060606061,282.569696969697,238.49696969697,594.687878787879,3150.84242424242,561.924242424242,245.257575757576,1076.73333333333,130.760606060606,330,24.1855282066389,17.454826003202,0.692200356714909,0.959302325581395,0.75,-0.639471078850942,53626.7696969697,33503.8151515152,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_157791,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
157979,1879.61003861004,344.3861003861,116.146718146718,635.84555984556,1460.20077220077,1128.71814671815,385.166023166023,232.694980694981,1087.74517374517,2915.94208494208,524.949806949807,114.752895752896,1090.3861003861,3036.69498069498,833.200772200772,607.030888030888,1859.61776061776,2843.26640926641,422.930501930502,260.285714285714,1057.37065637066,1752.68725868726,277.359073359073,450.250965250965,687.563706563707,1023.61776061776,474.76833976834,293.532818532819,1025.8416988417,128.559845559846,259,19.1284183349547,17.2754310548646,0.42936912530901,0.970037453183521,0.799382716049383,-0.781420227215727,53406.2355212355,33585.2123552124,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_157979,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
158030,2142.21485943775,371.024096385542,121.050200803213,642.753012048193,1903.76506024096,2723.30722891566,826.016064257028,249.096385542169,1098.87148594378,3279.35742971888,2973.48192771084,118.479919678715,1765.50200803213,1323.42369477912,810.650602409639,585.116465863454,1711.26305220884,2854.71887550201,312.85140562249,227.991967871486,1023.50803212851,2706.10040160643,222.504016064257,369.895582329317,621.467871485944,1055.55020080321,505.317269076305,292.773092369478,1048.85742971888,130.720883534137,498,31.3043586186122,20.6546001969006,0.751441693299571,0.957692307692308,0.698457223001403,-1.26175922390772,53370.4317269076,33473.6004016064,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX+,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_158030,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
158084,612.54,1127.3,248.611428571428,612.922857142857,98.16,239.174285714286,247.3,246.011428571428,1080.01142857143,1222.07428571429,834.645714285714,116.362857142857,1059.98571428571,545.58,393.931428571429,262.022857142857,1335.78857142857,839.474285714286,236.845714285714,214.514285714286,983.094285714286,759.591428571429,170.7,113.594285714286,585.528571428571,572.98,357.974285714286,204.045714285714,978.134285714286,128.188571428571,350,22.7653886612412,19.6760690013917,0.502980908098498,0.945945945945946,0.757575757575758,0.730699348137615,53884.3571428571,32605.5,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_158084,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
158323,2280.18227848101,766.050632911392,159.493670886076,663.80253164557,2672.17721518987,1159.00253164557,359.39746835443,238.506329113924,1114.92405063291,3381.6253164557,993.908860759494,125.901265822785,1064.63291139241,3986.26835443038,668.311392405063,404.111392405063,7143.34430379747,7664.67088607595,460.2,254.612658227848,1068.75949367089,7600.82025316456,280.448101265823,236.027848101266,663.075949367089,913.037974683544,438.984810126582,290.362025316456,1045.18987341772,132.739240506329,395,24.7742386809932,20.3453060947164,0.570599743617704,0.968137254901961,0.783730158730159,-1.19934330972694,52753.6911392405,33607.8481012658,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_158323,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
158366,1739.07272727273,325.445454545455,132.036363636364,658.113636363636,2858.45909090909,512.977272727273,512.286363636364,261.618181818182,1089.30909090909,3617.75,3512.98636363636,121.490909090909,1066.87727272727,798.427272727273,523.1,308.586363636364,1487.92272727273,1043.61818181818,286.945454545455,228.222727272727,988.868181818182,944.695454545455,218.109090909091,140.359090909091,588.372727272727,1531.78181818182,481.040909090909,395.940909090909,1077.27727272727,130.236363636364,220,20.224991483045,13.8541863651871,0.728539942655348,0.977777777777778,0.763888888888889,0.959876611711494,52573.3863636364,32371.8272727273,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_158366,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
158696,654.063025210084,1873.31512605042,423.945378151261,625.247899159664,102.046218487395,1940.55042016807,451.445378151261,272.117647058824,1117.02941176471,1147.21008403361,439.176470588235,110.680672268908,1070.89495798319,661.516806722689,437.365546218487,275.617647058824,1382.88655462185,1023.6974789916,280.105042016807,222.088235294118,978.899159663866,936.294117647059,206.882352941176,120.096638655462,591.193277310924,575.420168067227,358.483193277311,205.168067226891,985.789915966386,126.865546218487,238,19.4147497884566,15.6080232625523,0.594729260612821,0.959677419354839,0.782894736842105,1.13501096860306,53914.4957983193,32625.3991596639,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_158696,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
158912,4027.33513513514,305.12972972973,165.905405405405,645.55945945946,2293.88378378378,3529.74324324324,1002.28378378378,258.121621621622,1210.64324324324,6083.0,560.908108108108,125.578378378378,1103.33783783784,3296.39459459459,1362.71351351351,925.85945945946,5347.6027027027,5026.88648648649,407.535135135135,255.894594594595,1083.81351351351,5117.44324324324,307.286486486486,461.3,767.318918918919,1607.41351351351,486.435135135135,243.789189189189,1042.69459459459,130.818918918919,370,26.9574251174301,17.5092401628962,0.760349152683181,0.961038961038961,0.790598290598291,-0.280890690213652,52689.6675675676,33616.0837837838,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_158912,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
159039,1766.63025210084,318.126050420168,85.6260504201681,623.36974789916,1064.21008403361,469.915966386555,464.31512605042,244.428571428571,1085.73529411765,3798.20168067227,817.899159663866,111.626050420168,1073.57983193277,775.268907563025,645.609243697479,306.210084033613,1472.66386554622,1407.46218487395,259.226890756303,223.117647058824,998.189075630252,1316.36974789916,207.512605042017,147.516806722689,597.844537815126,1398.3025210084,468.176470588235,348.466386554622,1021.58403361345,129.970588235294,238,17.8178401498548,17.0372643284635,0.292742436664364,0.967479674796748,0.777777777777778,0.886432370157359,53973.8823529412,33148.5084033613,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_159039,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
159234,4437.70614035088,301.263157894737,131.90350877193,652.456140350877,2560.20175438596,1705.5350877193,334.122807017544,254.552631578947,1104.65350877193,6963.5350877193,627.728070175439,151.789473684211,1073.77192982456,3145.5350877193,839.385964912281,321.05701754386,11291.0526315789,9341.84210526316,442.675438596491,247.140350877193,1044.07456140351,9868.70175438597,291.271929824561,243.065789473684,645.385964912281,2245.00438596491,605.776315789474,243.925438596491,1097.88157894737,130.736842105263,228,20.1993421333928,14.3664650672761,0.702955022131138,0.957983193277311,0.75,-0.465791245096115,53114.100877193,33133.0394736842,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,9,FAAGSCC_12_159234,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
159455,3307.13407821229,930.153631284916,982.807262569832,631.821229050279,1722.2374301676,310.821229050279,315.04469273743,259.606145251397,1086.24022346369,5806.14525139665,470.424581005587,122.206703910615,1085.70111731844,695.642458100559,475.664804469274,272.477653631285,1616.56145251397,1058.71229050279,280.885474860335,221.142458100559,983.416201117318,993.13687150838,213.125698324022,121.374301675978,584.748603351955,1585.34916201117,488.72625698324,236.432960893855,1023.51955307263,129.36312849162,358,23.010315994306,19.8942045865436,0.502499266455672,0.970189701897019,0.811791383219955,-0.783405502198309,54079.2625698324,32880.156424581,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_159455,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
159780,3790.41340782123,213.480446927374,90.4078212290503,622.594972067039,1014.27932960894,292.893854748603,299.458100558659,248.905027932961,1078.34357541899,5733.28770949721,510.421787709497,118.650837988827,1086.08938547486,714.631284916201,466.011173184358,272.706703910615,1414.41061452514,1091.93854748603,283.108938547486,221.645251396648,983.145251396648,1041.38547486034,224.097765363129,123.245810055866,584.974860335196,1787.5,501.067039106145,263.326815642458,1032.51117318436,130.094972067039,358,27.7684982378704,16.4695518483134,0.805127329880853,0.964959568733154,0.724696356275304,-1.15854986097008,54014.8072625698,33072.1787709497,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_159780,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
159905,1384.54174397032,198.333951762523,109.155844155844,635.972170686456,2050.47866419295,2388.04638218924,748.897959183673,255.025974025974,1111.24489795918,2407.25231910946,489.807050092764,112.128014842301,1077.81818181818,1230.0,691.133580705009,298.569573283859,1624.18181818182,1087.92393320965,253.875695732838,218.423005565863,996.142857142857,957.953617810761,198.962894248609,130.30241187384,587.339517625232,839.228200371057,453.580705009276,235.070500927644,1013.76252319109,128.367346938776,539,29.0321665266194,23.7847314619889,0.573430165824192,0.964221824686941,0.712962962962963,-0.896467957670726,53975.5677179963,33081.6326530612,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_159905,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
159973,4814.52861952862,316.986531986532,122.979797979798,628.114478114478,905.141414141414,468.26936026936,372.552188552189,275.124579124579,1105.68013468013,6114.37373737374,756.003367003367,130.993265993266,1078.42760942761,891.690235690236,659.10101010101,278.824915824916,1895.2962962963,1192.07070707071,294.973063973064,225.16835016835,1040.09090909091,969.754208754209,191.989898989899,160.936026936027,1955.90572390572,1010.74747474747,435.569023569024,230.188552188552,1033.01683501684,129.962962962963,297,26.0573608218896,14.5419839553937,0.829789936392301,0.958064516129032,0.651315789473684,0.524282278557035,53075.4781144781,32118.6565656566,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_159973,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
160515,1928.18217054264,158.244186046512,105.953488372093,632.12015503876,1577.68992248062,531.967054263566,338.478682170543,256.527131782946,1084.36627906977,3267.79651162791,408.895348837209,114.335271317829,1071.79457364341,828.251937984496,532.676356589147,286.281007751938,1580.28875968992,1150.50775193798,323.162790697674,238.972868217054,984.782945736434,1108.22674418605,246.532945736434,174.292635658915,615.106589147287,868.073643410853,411.583333333333,217.93023255814,1024.95542635659,237.339147286822,516,35.5169799187768,18.719310747825,0.849832766387736,0.960893854748603,0.661538461538462,-0.683895508253533,52478.730620155,33542.2596899225,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_160515,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
160586,3700.21558441558,1634.51948051948,652.994805194805,637.714285714286,1888.29350649351,242.932467532468,298.38961038961,250.038961038961,1082.14805194805,3935.19480519481,567.838961038961,128.18961038961,1077.07012987013,518.766233766234,367.254545454546,262.623376623377,1404.42077922078,819.18961038961,230.779220779221,212.005194805195,989.111688311688,735.631168831169,170.709090909091,102.898701298701,589.176623376623,764.722077922078,406.025974025974,210.511688311688,1014.61558441558,130.971428571429,385,26.882701401122,18.6690651428674,0.719527565968773,0.95771144278607,0.712962962962963,0.326938886550266,53142.9298701299,32232.1142857143,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_160586,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
162121,2524.32692307692,306.717032967033,149.678571428571,685.398351648352,3979.98901098901,1070.93131868132,397.494505494506,250.376373626374,1107.84340659341,4559.56318681319,2789.99725274725,127.942307692308,1076.26648351648,3637.99450549451,1150.01648351648,352.162087912088,6161.01373626374,3448.71428571429,363.843406593407,240.697802197802,1021.9478021978,2845.93956043956,242.57967032967,416.57967032967,698.664835164835,1879.61538461538,506.887362637363,766.703296703297,1060.20054945055,130.774725274725,364,24.0140893540563,19.384509502883,0.590258869244595,0.970666666666667,0.791304347826087,1.18111473562005,52846.7417582418,33276.5879120879,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_162121,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
162284,1785.4593837535,802.288515406162,200.033613445378,653.991596638655,2866.90476190476,3027.36134453782,357.425770308123,271.268907563025,1132.59943977591,2248.93837535014,4059.02801120448,127.15406162465,1066.70308123249,2407.76470588235,966.361344537815,291.204481792717,2277.22408963585,1917.21848739496,333.473389355742,253.719887955182,999.795518207283,1151.10644257703,211.344537815126,456.843137254902,630.176470588235,1054.46218487395,477.512605042017,394.226890756303,1044.21008403361,131.971988795518,357,24.1402061869589,18.8723656200188,0.623552523798305,0.959677419354839,0.74375,-0.450027391574948,53648.568627451,32165.6610644258,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_162284,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
162387,1322.2070949185,365.979865771812,267.627996164909,643.823585810163,2221.03643336529,549.713326941515,283.09012464046,242.167785234899,1085.12368168744,1293.90412272291,839.287631831256,113.763183125599,1071.31351869607,720.204218600192,537.952061361457,281.083413231064,1543.34324065197,1174.53787152445,295.733461169703,231.087248322148,998.109300095877,1122.75359539789,221.970278044104,284.85426653883,605.896452540748,772.207094918504,440.496644295302,226.525407478428,1016.10067114094,129.520613614573,1043,39.5572505225054,33.6501917012906,0.525699019103482,0.969330855018587,0.766911764705882,0.289255527332999,52314.9434324065,33368.8772770853,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_162387,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
162539,2800.63793103448,184.924137931034,74.6137931034483,624.144827586207,1521.49310344828,667.658620689655,380.548275862069,271.062068965517,1119.72068965517,5379.61724137931,565.168965517241,118.072413793103,1075.3275862069,948.206896551724,491.510344827586,273.351724137931,1488.14827586207,1112.08275862069,217.248275862069,214.048275862069,1190.11034482759,781.275862068965,147.055172413793,107.762068965517,795.162068965517,1550.04827586207,480.151724137931,235.462068965517,1054.68965517241,130.706896551724,290,23.4230212751321,15.7943195030958,0.738450649524868,0.960264900662252,0.78804347826087,1.39048008842392,53642.9655172414,32730.6724137931,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_162539,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
162791,2322.34297520661,649.876033057851,89.400826446281,618.46694214876,1127.19008264463,1255.20661157025,620.090909090909,256.280991735537,1081.49173553719,4449.64876033058,529.566115702479,112.995867768595,1080.64049586777,5955.78512396694,607.210743801653,407.838842975207,1581.71487603306,3986.00826446281,321.487603305785,234.136363636364,1027.09504132231,2607.53305785124,221.95041322314,312.607438016529,610.735537190083,1516.19421487603,490.384297520661,272.657024793388,1037.38016528926,129.338842975207,242,21.1904480160433,14.6329106563064,0.723291562046989,0.9453125,0.720238095238095,1.19529104161679,53658.132231405,33437.4917355372,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_162791,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
163302,2384.44661921708,210.396797153025,89.8665480427046,629.012455516014,1367.11209964413,439.389679715302,677.254448398577,248.507117437722,1082.6103202847,3546.25800711744,2001.18327402135,115.951957295374,1067.99466192171,1509.90213523132,1152.69039145907,1269.53914590747,1579.07651245552,3984.55516014235,322.478647686833,229.14590747331,1008.26512455516,4106.26868327402,271.040925266904,322.133451957295,855.23487544484,871.35409252669,429.628113879004,295.467971530249,1024.60142348754,130.074733096085,562,31.8893548483615,22.5019960581441,0.708583276428913,0.967297762478485,0.740447957839262,1.42632877024756,54095.3185053381,32634.4466192171,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_163302,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
163613,3163.94871794872,688.927738927739,2455.76923076923,631.83682983683,2013.12354312354,2676.96736596737,505.689976689977,269.624708624709,1095.55944055944,5181.75291375291,715.004662004662,121.317016317016,1074.42191142191,1928.75990675991,516.356643356643,378.447552447552,1521.92074592075,1406.64801864802,295.752913752914,280.298368298368,979.167832167832,1249.48018648019,217.344988344988,145.797202797203,591.799533799534,1297.80885780886,504.90675990676,294.09324009324,1049.87645687646,131.948717948718,429,24.5667301331825,22.2712757209189,0.422071647147556,0.966216216216216,0.777173913043478,-1.26695397322685,53728.7948717949,32940.9207459207,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_163613,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
164328,2434.89112903226,417.5,109.165322580645,655.362903225806,1984.93951612903,258.41935483871,222.350806451613,227.342741935484,1075.37903225806,4057.63306451613,2232.02016129032,135.338709677419,1070.05241935484,701.806451612903,389.0,273.645161290323,1754.97177419355,1107.72177419355,246.403225806452,219.399193548387,1035.04032258065,1062.46370967742,199.217741935484,849.350806451613,2335.08467741935,1110.3064516129,471.653225806452,381.536290322581,1072.16129032258,132.850806451613,248,21.5733728968028,14.6656843609977,0.733393014215017,0.950191570881226,0.787301587301587,1.41470695889606,52890.060483871,33876.0766129032,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_164328,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
166049,3246.61336515513,418.386634844869,85.3699284009546,660.193317422434,3399.90453460621,334.589498806683,441.665871121718,239.477326968974,1079.27923627685,4386.97136038186,529.966587112172,121.942720763723,1086.66587112172,668.231503579952,514.343675417661,298.90692124105,1684.54415274463,1032.10023866348,276.63245823389,224.381861575179,985.505966587112,995.835322195704,213.033412887828,132.64200477327,590.384248210024,1028.92362768496,510.042959427208,244.276849642005,1027.47732696897,130.26491646778,419,26.4457792529668,20.2469780161514,0.643312880798947,0.97215777262181,0.798095238095238,0.360688869500043,54053.093078759,33305.8233890215,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_166049,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
166136,2366.90983606557,250.98087431694,159.439890710383,690.68306010929,3957.01366120219,300.300546448087,903.745901639344,262.92349726776,1086.90983606557,3117.82240437158,511.53825136612,130.882513661202,1093.15300546448,792.196721311475,504.849726775956,270.306010928962,1505.29234972678,1800.55191256831,344.404371584699,235.549180327869,1047.84699453552,1947.1174863388,237.117486338798,430.573770491803,794.991803278689,744.734972677596,382.254098360656,204.606557377049,1016.95901639344,127.306010928962,366,25.2895386729469,18.4560182057651,0.683672824554414,0.965699208443272,0.757763975155279,-0.628327547003685,53170.0846994536,32052.1857923497,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_166136,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
166549,3195.2575,404.575,114.57,632.9475,1075.1575,532.9025,338.4525,260.8225,1127.77,5315.62,983.625,124.045,1069.36,739.115,456.4275,272.7725,1556.4825,1044.37,227.0875,215.8575,1061.4025,979.8275,182.3625,263.8025,3170.72,1086.45,439.07,284.41,1062.155,131.255,400,27.9273885302394,18.4723704456426,0.749995602887839,0.959232613908873,0.695652173913043,0.915813746812623,52759.8975,32391.595,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_166549,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
166783,2831.86330935252,184.928057553957,164.226618705036,691.363309352518,5086.58992805755,324.960431654676,375.255395683453,249.507194244604,1085.72661870504,4778.55395683453,593.935251798561,123.424460431655,1082.38489208633,1710.0,806.647482014389,365.097122302158,3551.3345323741,2349.6726618705,349.197841726619,235.420863309353,1022.10071942446,2330.30935251799,233.712230215827,349.431654676259,654.280575539568,1527.34172661871,495.172661870504,291.737410071942,1066.38848920863,130.158273381295,278,25.8675034013425,13.8082333933797,0.845606855019147,0.958620689655172,0.794285714285714,1.37143183851881,53954.6402877698,33375.0179856115,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_166783,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
166925,3006.04050632911,649.53670886076,135.835443037975,620.607594936709,874.116455696202,1475.30886075949,1197.83544303797,261.098734177215,1090.53924050633,3631.86329113924,602.027848101266,118.349367088608,1068.87848101266,1031.79746835443,648.987341772152,627.630379746835,1580.91898734177,1885.50379746835,315.407594936709,228.007594936709,999.194936708861,1356.27088607595,401.06835443038,159.493670886076,588.754430379747,897.367088607595,476.369620253165,240.045569620253,1013.32911392405,129.918987341772,395,24.167406307884,20.8372437350911,0.506560554587997,0.965770171149144,0.783730158730159,-0.0426107492721164,54070.7974683544,33230.5316455696,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_166925,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
167051,1824.57451923077,256.783653846154,195.427884615385,799.245192307692,3163.87259615385,2561.8125,575.569711538462,272.079326923077,1122.93028846154,3638.48076923077,573.177884615385,120.240384615385,1088.45192307692,1561.31730769231,1234.86778846154,656.764423076923,1852.01201923077,1952.99038461538,349.670673076923,237.858173076923,1021.79326923077,1411.37259615385,241.396634615385,464.254807692308,661.908653846154,1328.53846153846,452.598557692308,243.46875,1054.82692307692,130.038461538462,416,34.6400222059855,15.4184927687871,0.895477729999455,0.960739030023095,0.764705882352941,1.3730621541602,52493.8149038462,33300.7379807692,FAAGSCC_12,AG,1,stromal cells,,TIM3+,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_167051,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
167614,4780.97950819672,1048.90573770492,600.922131147541,622.94262295082,1069.33196721311,950.58606557377,2141.4631147541,251.168032786885,1098.74180327869,8335.04508196721,635.094262295082,125.577868852459,1067.55327868852,2034.29098360656,598.799180327869,301.295081967213,1750.50409836066,3110.37295081967,396.295081967213,230.598360655738,1111.5,1771.32786885246,189.41393442623,144.745901639344,1335.06967213115,2430.61885245902,529.176229508197,313.008196721311,1039.68442622951,129.844262295082,244,20.9874846469931,14.9693078594769,0.70091047605065,0.949416342412451,0.774603174603175,1.56560996603557,53897.2295081967,32768.6229508197,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_167614,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
167648,2229.06233766234,217.981818181818,88.1844155844156,627.532467532468,1156.41298701299,741.075324675325,1600.58441558442,259.654545454545,1096.66493506493,4306.63636363636,1142.74285714286,121.371428571429,1069.80519480519,2466.26493506493,1222.12207792208,1309.51168831169,1913.01038961039,2869.83896103896,337.197402597403,225.854545454545,1055.93506493506,2073.27532467533,242.155844155844,504.574025974026,793.88051948052,1426.12207792208,473.096103896104,277.483116883117,1046.98701298701,130.444155844156,385,23.5882320802154,20.9298028301797,0.46119559878903,0.9625,0.763888888888889,-0.168352475150186,52688.5636363636,32333.812987013,FAAGSCC_12,AG,1,M2 macrophages,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_167648,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
168042,4185.25157232704,866.572327044025,88.3427672955975,626.776729559748,832.845911949686,574.921383647799,374.333333333333,240.899371069182,1110.55031446541,6459.60691823899,1682.77987421384,121.98427672956,1079.2358490566,757.977987421384,520.600628930818,294.399371069182,4013.97798742138,960.946540880503,222.88679245283,216.295597484277,995.207547169811,788.22641509434,169.911949685535,139.685534591195,585.172955974843,2009.49685534591,499.949685534591,325.836477987421,1042.94025157233,129.971698113208,318,21.9608329067187,18.535001246016,0.536338998125175,0.969512195121951,0.841269841269841,1.27847117328507,53138.0471698113,33491.5408805031,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_168042,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
168594,2959.12416851441,202.272727272727,84.9711751662971,622.9977827051,1201.33481152993,919.609756097561,1645.26164079823,238.753880266075,1104.16629711752,5193.64523281596,754.390243902439,115.383592017738,1136.22172949002,990.436807095344,517.691796008869,491.490022172949,1729.31485587583,3215.68957871397,321.538802660754,233.767184035477,1036.65188470067,3960.85365853659,253.237250554324,233.354767184035,602.365853658537,2031.33924611973,519.937915742794,263.108647450111,1049.85809312639,130.228381374723,451,25.1419179400459,22.9726910327525,0.406342798386036,0.974082073434125,0.854166666666667,-0.114809879193243,53432.4279379158,33515.1751662971,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_168594,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
168599,2876.33886255924,545.71327014218,135.497630331754,636.46682464455,1302.34360189573,337.014218009479,1207.29620853081,251.469194312796,1080.9644549763,3583.31753554502,2822.93127962085,121.419431279621,1079.03791469194,874.71327014218,638.936018957346,302.260663507109,1513.3317535545,1379.08293838863,282.476303317536,225.07345971564,1076.59952606635,1174.06872037915,200.978672985782,160.609004739336,908.163507109005,892.985781990521,414.699052132701,258.078199052133,1040.11848341232,131.850710900474,422,26.6621018834196,20.2753158731904,0.64939119486441,0.963470319634703,0.767272727272727,0.587282666553418,52672.8625592417,32234.2938388626,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_168599,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
168683,2839.75,668.721428571429,1192.36071428571,615.196428571429,792.1,522.992857142857,346.975,254.528571428571,1108.22857142857,4039.10357142857,491.971428571429,117.935714285714,1077.43928571429,763.660714285714,423.739285714286,272.457142857143,1485.05357142857,933.492857142857,196.282142857143,208.264285714286,1260.03214285714,691.971428571429,147.057142857143,132.075,610.478571428571,812.325,443.803571428571,229.982142857143,1004.01428571429,129.053571428571,280,24.1261818157554,15.0898264137529,0.780260726756442,0.933333333333333,0.729166666666667,-1.30932604105803,53313.9785714286,33140.4,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_168683,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
169061,3251.90528634361,582.420704845815,166.361233480176,650.07268722467,2771.56607929515,289.348017621145,305.944933920705,260.603524229075,1081.06167400881,4644.31718061674,3980.3436123348,123.621145374449,1068.44273127753,628.077092511013,542.715859030837,266.607929515419,1372.43612334802,920.907488986784,283.392070484581,222.561674008811,981.035242290749,956.997797356828,234.284140969163,130.187224669604,585.191629955947,1050.10792951542,462.281938325991,411.04845814978,1022.42070484581,130.361233480176,454,25.8424302232098,22.5030159434129,0.491676650053719,0.965957446808511,0.759197324414716,-1.14707765219672,53396.6343612335,32623.5726872247,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_169061,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
169256,4814.56944444444,796.730555555556,1218.16944444444,662.663888888889,2939.78611111111,4431.275,1155.01111111111,256.661111111111,1116.28333333333,7647.43611111111,704.327777777778,130.302777777778,1085.63611111111,2314.49722222222,651.35,335.086111111111,1831.41388888889,2147.52777777778,373.866666666667,242.483333333333,1071.31944444444,1997.50833333333,229.897222222222,224.908333333333,731.519444444444,1979.70833333333,510.680555555556,281.344444444444,1062.17222222222,130.341666666667,360,23.5007876573161,19.6072867968805,0.551273392105373,0.975609756097561,0.823798627002288,-1.52150189122393,53753.5444444445,33724.8972222222,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_169256,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
169474,2390.79953917051,477.006912442396,149.370967741935,670.693548387097,3072.98847926267,322.608294930876,466.997695852535,260.375576036866,1085.05299539171,4813.81797235023,2584.11059907834,132.096774193548,1074.71428571429,619.566820276498,451.331797235023,269.889400921659,1361.53917050691,878.057603686636,258.612903225806,220.13133640553,982.110599078341,808.668202764977,188.71198156682,117.320276497696,586.039170506912,2227.60829493088,509.225806451613,357.089861751152,1071.54838709677,130.281105990783,434,27.7314539324478,19.9809247554633,0.693439493338218,0.960176991150442,0.765432098765432,-1.26428231954166,53135.0714285714,32568.5668202765,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_169474,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
169758,2294.81603773585,134.320754716981,156.622641509434,728.330188679245,6914.32547169811,2230.54716981132,2349.79245283019,256.061320754717,1100.12264150943,3173.41509433962,755.169811320755,127.820754716981,1077.73113207547,2735.17452830189,705.957547169811,364.952830188679,1711.85377358491,6446.31132075472,417.702830188679,245.556603773585,1021.94339622642,6293.33490566038,264.849056603774,160.882075471698,584.943396226415,966.952830188679,456.094339622641,241.259433962264,1080.16981132075,132.566037735849,212,17.5257654656181,15.4162346113819,0.47565375247389,0.954954954954955,0.779411764705882,1.46788036743247,53030.1179245283,33378.3962264151,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_169758,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
169986,4691.36798336798,636.503118503118,115.83367983368,647.675675675676,1814.72557172557,1162.2972972973,2176.95218295218,262.573804573805,1094.66735966736,7450.16008316008,698.322245322245,133.873180873181,1078.52182952183,819.827442827443,601.419958419958,547.945945945946,1612.06652806653,1657.09563409563,283.908523908524,221.230769230769,1005.60706860707,1677.38045738046,207.259875259875,1109.65280665281,717.837837837838,1318.90436590437,442.704781704782,220.787941787942,1064.12266112266,132.993762993763,481,32.609023281561,19.7154049340068,0.796529491554922,0.926782273603083,0.71577380952381,-1.53511600319262,52844.5488565489,32324.1933471933,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_169986,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
170091,1515.67397260274,417.434246575342,142.487671232877,641.594520547945,2073.46164383562,1689.66712328767,1599.8301369863,263.276712328767,1099.90547945205,2233.53561643836,2546.65616438356,124.009589041096,1064.95342465753,1224.21232876712,711.865753424658,558.424657534247,1755.29315068493,1301.64109589041,250.695890410959,216.653424657534,1011.93835616438,939.968493150685,177.135616438356,139.021917808219,602.013698630137,1022.92602739726,509.746575342466,472.454794520548,1042.81643835616,129.564383561644,730,32.8661884907651,28.3053110367078,0.508217275193693,0.973333333333333,0.760416666666667,1.0405344345744,53169.5643835616,32874.4082191781,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_170091,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
170222,2102.11944869832,389.777947932619,182.105666156202,695.707503828484,4092.47013782542,456.906584992343,754.234303215927,251.977029096478,1082.36600306279,2787.53292496172,702.542113323124,136.854517611026,1095.70444104135,555.332312404288,999.683001531394,260.799387442573,1576.64012251149,819.972434915773,218.001531393568,211.261868300153,988.315467075038,705.090352220521,163.846860643185,165.980091883614,619.738131699847,897.333843797856,419.81776416539,212.007656967841,1035.79019908116,131.243491577335,653,37.1946091753809,22.4116838481416,0.79807967134007,0.968842729970326,0.725555555555556,0.379239405705458,53233.2970903522,31984.8468606432,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_170222,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
170350,4893.64561403509,179.301754385965,94.3473684210526,646.757894736842,1624.18596491228,2920.57894736842,1271.70175438596,254.277192982456,1141.98596491228,7110.70877192982,1034.38596491228,127.729824561404,1095.98596491228,4935.37192982456,1490.32631578947,2026.89824561403,3305.5649122807,8248.17894736842,491.768421052632,261.347368421053,1119.72280701754,9348.80701754386,802.856140350877,465.915789473684,675.831578947368,2160.8350877193,564.964912280702,410.056140350877,1066.66666666667,131.540350877193,285,22.3786120488628,16.2908373742438,0.685614717451812,0.953177257525084,0.809659090909091,-1.50083389814589,53068.6350877193,33642.3614035088,FAAGSCC_12,AG,1,M2 macrophages,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_170350,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
171037,1989.2719665272,355.004184100418,106.426778242678,614.535564853556,875.728033472803,549.305439330544,498.740585774059,257.041841004184,1079.15062761506,3084.30543933054,2086.26778242678,118.539748953975,1071.40585774059,1085.93305439331,565.150627615063,387.259414225941,1518.53974895397,1764.44769874477,302.422594142259,224.338912133891,990.10460251046,1394.8870292887,201.916317991632,279.460251046025,591.594142259414,1040.2510460251,498.108786610879,307.874476987448,1035.67364016736,131.493723849372,239,21.0502378317555,14.5601753859009,0.722197427901748,0.948412698412698,0.758730158730159,-1.54110092434433,53713.1129707113,32915.2761506276,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_171037,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
171167,3929.65588235294,543.220588235294,91.5352941176471,617.385294117647,1028.41470588235,568.911764705882,337.985294117647,246.194117647059,1093.12647058824,6113.75588235294,486.011764705882,117.370588235294,1085.50294117647,1496.61470588235,536.958823529412,432.65,2406.41176470588,2045.00882352941,292.914705882353,224.970588235294,1094.61764705882,1483.00294117647,201.335294117647,165.885294117647,619.388235294118,1573.68823529412,509.541176470588,242.617647058824,1032.25882352941,130.538235294118,340,21.6490035438975,20.0493738795294,0.377251861221267,0.965909090909091,0.770975056689342,-0.736341620519421,53981.3705882353,33190.05,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_171167,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
171697,4580.45519713262,951.645161290323,1006.92831541219,621.494623655914,1063.39426523297,279.483870967742,267.982078853047,237.921146953405,1076.22222222222,7065.53405017921,570.096774193548,123.014336917563,1077.58781362007,655.064516129032,441.204301075269,262.4229390681,1482.08602150538,1129.54838709677,197.329749103943,222.086021505376,999.455197132616,848.136200716846,162.73476702509,142.258064516129,583.939068100358,1948.14336917563,544.78853046595,261.598566308244,1042.96415770609,129.652329749104,279,23.3005609555803,15.3996584410352,0.750461969015178,0.945762711864407,0.758152173913043,0.0846619700256374,54055.4086021505,33423.146953405,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_171697,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
171826,2105.03673469388,524.040816326531,121.657142857143,635.191836734694,1471.67346938776,806.759183673469,484.559183673469,284.29387755102,1126.57551020408,4222.00408163265,1473.3387755102,122.097959183673,1074.35918367347,921.379591836735,633.714285714286,315.6,1586.22857142857,1002.83673469388,288.114285714286,230.751020408163,994.571428571429,882.926530612245,229.624489795918,161.738775510204,597.783673469388,1509.55510204082,462.187755102041,333.048979591837,1060.75918367347,130.910204081633,245,18.8071026820846,16.6601638737647,0.463982709780125,0.949612403100775,0.758513931888545,0.0115844668544886,52429.9469387755,32908.8081632653,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_171826,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
172134,2501.43559322034,319.286440677966,241.783050847458,767.850847457627,6667.27966101695,313.808474576271,360.159322033898,254.196610169492,1077.07118644068,4112.17288135593,646.954237288136,141.145762711864,1084.37796610169,793.659322033898,729.842372881356,308.320338983051,1580.49661016949,1325.15593220339,303.061016949153,233.61186440678,997.523728813559,1221.92711864407,224.667796610169,287.132203389831,1885.46440677966,1405.7779661017,483.905084745763,225.674576271186,1077.94406779661,131.076271186441,590,41.2074729123771,18.4177499324238,0.894558092507603,0.962479608482871,0.756410256410256,-0.192616207223939,52640.6355932203,32592.8440677966,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_172134,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
172595,2353.36222910217,457.238390092879,1303.98142414861,636.157894736842,2152.55108359133,555.53560371517,1138.5479876161,242.232198142415,1076.71207430341,3086.45510835913,2788.12383900929,116.962848297214,1105.92569659443,962.034055727554,595.965944272446,418.365325077399,4221.26625386997,2861.64705882353,312.201238390093,229.882352941176,1027.73374613003,2830.17647058824,232.547987616099,199.009287925697,595.947368421053,947.606811145511,486.653250773994,390.693498452012,1033.26315789474,130.123839009288,323,25.8544626155304,16.325114160785,0.775438210360097,0.947214076246334,0.76,1.41301059098232,53522.3560371517,33532.0681114551,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_172595,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
172682,4828.42131979695,311.845177664975,98.1852791878173,616.946700507614,623.880710659898,3045.34517766497,1333.41370558376,259.626903553299,1111.00253807107,7802.31979695431,693.55076142132,124.946700507614,1066.53299492386,2383.64974619289,1021.06091370558,1351.84771573604,1774.45685279188,1972.64467005076,277.431472081218,221.043147208122,1020.24873096447,1321.27157360406,194.530456852792,250.271573604061,756.302030456853,1991.81979695431,507.616751269036,283.233502538071,1051.62436548223,130.0,394,23.7945025698171,21.2034438713371,0.453793575229726,0.970443349753695,0.778656126482213,-0.469406890205869,54109.8020304569,32725.5989847716,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_172682,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
173330,4557.03779069767,817.869186046512,155.107558139535,707.28488372093,4899.80813953488,1790.5,3879.97674418605,250.415697674419,1094.30813953488,7195.76162790698,576.718023255814,136.514534883721,1090.83430232558,1741.46802325581,903.029069767442,1137.98255813953,1797.23837209302,1457.72674418605,311.372093023256,221.880813953488,1035.77034883721,1023.09011627907,190.081395348837,346.156976744186,626.142441860465,2529.5523255814,559.316860465116,266.770348837209,1079.05523255814,132.06976744186,344,28.2820227989167,15.5755788806387,0.834687641679037,0.958217270194986,0.767857142857143,-1.39812091189384,53617.1656976744,33745.9651162791,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_173330,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
173373,4761.06766917293,732.161654135338,1188.87969924812,627.003759398496,1274.05263157895,280.082706766917,289.657894736842,250.890977443609,1082.36842105263,8240.42857142857,612.285714285714,122.609022556391,1091.71428571429,688.248120300752,508.90977443609,287.116541353383,1363.68421052632,1173.04887218045,286.248120300752,224.218045112782,987.785714285714,1066.4962406015,226.954887218045,180.932330827068,634.898496240602,2415.25939849624,533.353383458647,276.432330827068,1043.6954887218,130.793233082707,266,20.0244820755728,16.9319282733635,0.533878252489266,0.956834532374101,0.782352941176471,0.102663272962302,54165.0827067669,33127.6954887218,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_173373,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
173418,3676.20786516854,804.449438202247,2029.48314606742,630.438202247191,1597.57303370787,2904.64606741573,507.488764044944,257.314606741573,1102.15730337079,5882.61235955056,506.898876404494,118.421348314607,1056.54494382022,820.707865168539,933.848314606742,277.820224719101,2026.39325842697,1245.11797752809,332.443820224719,239.123595505618,981.280898876404,1218.6404494382,262.252808988764,156.932584269663,592.713483146067,2516.34269662921,525.955056179775,310.88202247191,1044.97191011236,131.213483146067,178,16.6027208156848,13.7309148119116,0.562160746613724,0.972677595628415,0.791111111111111,0.786090900513911,52577.202247191,33595.095505618,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_173418,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
173480,3372.86698337292,863.881235154394,113.845605700713,637.916864608076,1899.37767220903,329.541567695962,311.62945368171,254.175771971496,1087.32541567696,4626.45368171021,506.342042755344,114.78622327791,1078.71733966746,677.527315914489,453.315914489311,279.767220902613,1368.66270783848,1024.72446555819,282.589073634204,225.75296912114,984.971496437055,953.422802850356,206.878859857482,124.667458432304,588.527315914489,848.847980997625,442.850356294537,220.589073634204,1021.12114014252,129.420427553444,421,25.7061977017276,20.8630881548106,0.584216867799213,0.963386727688787,0.765454545454545,-0.349382785217581,53697.674584323,33191.2280285036,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_173480,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
173902,1577.95154185022,301.95154185022,69.6563876651982,602.26872246696,232.828193832599,3792.4140969163,674.004405286344,264.462555066079,1131.56387665198,3386.37004405286,522.325991189427,109.31718061674,1067.17621145374,4682.12334801762,822.277533039648,501.220264317181,2064.69162995595,4467.17621145374,432.726872246696,505.859030837004,1042.79295154185,3409.15418502203,344.603524229075,320.31718061674,598.907488986784,2053.66519823789,541.986784140969,248.528634361233,1014.15418502203,131.154185022026,227,18.5957652903761,15.6162272652387,0.542937194584163,0.957805907172996,0.741830065359477,-0.967883072142039,53640.9074889868,33470.9295154185,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_173902,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
173962,3258.86298568507,529.167689161554,141.629856850716,649.366053169734,1839.81595092025,1483.80777096115,2822.98773006135,269.746421267894,1152.76482617587,3669.26584867076,1967.39263803681,127.873210633947,1076.48875255624,2110.96319018405,1489.58895705521,469.237218813906,2399.75869120654,2282.84253578732,353.196319018405,231.742331288344,1039.24744376278,1558.9754601227,220.61554192229,348.732106339468,677.750511247444,806.775051124744,394.098159509203,260.985685071575,1023.75664621677,130.715746421268,489,27.8478682740105,22.6254086285915,0.583010452687722,0.95136186770428,0.78743961352657,-0.113273050954398,53210.7791411043,32033.2985685072,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_173962,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
175938,1472.13669064748,275.302158273381,99.3669064748201,633.323741007194,1799.03597122302,1690.59352517986,1380.60791366906,254.546762589928,1105.41726618705,3222.23021582734,3795.08273381295,112.55035971223,1080.01079136691,3388.81294964029,1460.8273381295,3269.51438848921,1762.23021582734,3273.21582733813,319.223021582734,226.881294964029,1013.47841726619,2445.90647482014,217.888489208633,426.291366906475,823.302158273381,1128.60431654676,446.258992805755,366.003597122302,1055.11510791367,132.298561151079,278,21.0231902023162,16.8481193674456,0.598120194848307,0.965277777777778,0.772222222222222,-0.988141317065798,54067.8597122302,32636.7374100719,FAAGSCC_12,AG,1,M2 macrophages,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_175938,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
176365,4084.83040935672,755.269005847953,1473.97368421053,642.350877192982,1468.72807017544,1861.99122807018,1567.73391812865,252.497076023392,1102.23684210526,6003.50584795322,1216.15204678363,123.883040935673,1077.48245614035,4480.41228070175,1745.51169590643,963.385964912281,13248.7251461988,8880.36257309942,559.342105263158,274.704678362573,1117.52046783626,9292.62573099415,325.269005847953,356.105263157895,810.09649122807,1219.32748538012,469.701754385965,448.707602339181,1049.25438596491,131.426900584795,342,21.9046789275441,19.9908008547563,0.408793353181225,0.947368421052632,0.74025974025974,0.300977432581255,52781.3070175439,33557.1023391813,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_176365,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
176435,1477.19881305638,221.014836795252,84.3857566765579,659.109792284866,2402.04451038576,614.014836795252,3060.78931750742,263.041543026706,1099.0296735905,3217.45697329377,2515.96142433234,133.210682492582,1073.81899109792,3699.17210682493,1407.90207715134,2189.07121661721,2071.60237388724,3851.3590504451,363.783382789317,237.216617210683,1045.30860534125,2494.26409495549,255.955489614243,532.836795252226,894.715133531157,1402.81602373887,470.041543026706,698.032640949555,1074.03560830861,131.275964391691,337,23.0872567871387,18.6015863952233,0.592313004457288,0.968390804597701,0.802380952380952,-0.907032360156976,52401.0979228487,32705.7388724036,FAAGSCC_12,AG,1,M2 macrophages,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_176435,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
176609,2434.32352941176,553.676470588235,957.807486631016,620.401069518717,1030.7807486631,295.877005347594,298.930481283422,251.657754010695,1074.28877005348,5308.85561497326,1139.91176470588,113.898395721925,1067.94919786096,672.350267379679,479.673796791444,272.171122994652,1396.29946524064,1000.1871657754,283.20320855615,223.010695187166,984.280748663102,962.171122994652,214.106951871658,132.294117647059,587.695187165775,2716.16042780749,537.489304812834,270.823529411765,1044.86631016043,131.532085561497,374,23.2669665782764,20.529209938605,0.470625823192334,0.963917525773196,0.774327122153209,0.104788951712907,53495.2192513369,33218.3957219251,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_176609,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
177534,4461.15342465753,772.364383561644,128.890410958904,647.364383561644,1377.40547945205,1385.08219178082,681.978082191781,253.364383561644,1105.27397260274,6038.15342465753,859.47397260274,126.687671232877,1210.11232876712,2395.87123287671,772.41095890411,463.145205479452,1792.01369863014,2279.31232876712,342.350684931507,249.65205479452,1029.15068493151,1629.16164383562,237.65205479452,417.61095890411,660.523287671233,897.21095890411,438.901369863014,265.756164383562,1035.8904109589,130.452054794521,365,23.5002819584933,19.8143275288034,0.53767409086598,0.975935828877005,0.793478260869565,1.24548183316959,53153.7808219178,33578.2,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_177534,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
177586,4749.996,771.548,1097.58,656.68,2502.0,1212.112,1920.976,267.98,1099.644,7649.9,581.728,143.364,1077.536,2401.676,1431.968,1608.04,2937.276,2820.372,450.364,254.432,1048.216,1895.156,255.912,1360.696,807.66,3124.536,572.216,271.184,1084.56,128.24,250,24.9942193898089,12.795985819549,0.859010594148024,0.965250965250965,0.6265664160401,0.891905275729732,53312.328,33826.72,FAAGSCC_12,AG,1,regulatory T cells,,TIM3+,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_177586,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
177745,2348.41975308642,191.12962962963,173.561728395062,696.679012345679,4573.64197530864,465.58024691358,257.185185185185,238.981481481481,1083.4012345679,4269.45061728395,708.740740740741,120.253086419753,1066.77777777778,670.777777777778,407.802469135802,266.907407407407,1403.50617283951,1012.80864197531,236.456790123457,216.462962962963,999.537037037037,1295.57407407407,188.092592592592,130.543209876543,581.802469135802,1464.72222222222,482.425925925926,249.018518518519,1041.82716049383,130.320987654321,162,18.1152014213967,11.4147724315746,0.776496796607318,0.952941176470588,0.75,1.44558939511994,53981.0617283951,33120.2777777778,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_177745,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
178074,4677.94345238095,531.172619047619,143.705357142857,657.776785714286,2510.89285714286,690.380952380952,413.217261904762,276.622023809524,1123.34226190476,8039.77380952381,1365.36904761905,129.455357142857,1082.71726190476,929.916666666667,504.267857142857,289.386904761905,1519.3630952381,958.96130952381,209.889880952381,213.047619047619,1142.85119047619,692.005952380952,140.639880952381,103.946428571429,592.151785714286,1766.50297619048,487.104166666667,266.255952380952,1061.47916666667,131.854166666667,336,23.4827048109689,18.2934961720973,0.626999102668937,0.954545454545455,0.736842105263158,-1.41984585091955,53640.380952381,32759.9672619048,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_178074,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
178726,3248.7886977887,1051.02457002457,127.385749385749,655.071253071253,2162.33415233415,447.678132678133,341.744471744472,251.702702702703,1087.95823095823,3931.08845208845,1202.18181818182,125.968058968059,1071.27764127764,2225.542997543,660.503685503685,377.152334152334,2487.9828009828,3319.71253071253,392.336609336609,233.7542997543,1105.36855036855,2287.47665847666,220.683046683047,341.36855036855,655.31941031941,918.439803439803,434.5085995086,300.240786240786,1046.48648648649,130.624078624079,407,26.2868561335449,19.8224798707028,0.65677875979442,0.959905660377358,0.782692307692308,1.34644998872855,52732.5651105651,32422.8108108108,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_178726,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
179550,1222.89682539683,267.970899470899,189.960317460317,690.970899470899,4960.23544973545,272.148148148148,244.738095238095,236.611111111111,1099.44973544974,2865.14021164021,791.26455026455,125.26455026455,1069.04232804233,665.751322751323,402.994708994709,269.473544973545,1424.14285714286,926.547619047619,199.309523809524,209.775132275132,1213.72751322751,681.968253968254,142.899470899471,127.227513227513,594.230158730159,1177.69047619048,496.375661375661,250.187830687831,1044.48148148148,130.407407407407,378,34.1010956757866,14.1404991454928,0.909974564775085,0.961832061068702,0.741176470588235,-1.41374771882629,53371.6613756614,33099.6931216931,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_179550,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
179989,4263.26298701299,459.996753246753,153.616883116883,653.185064935065,2300.12012987013,263.262987012987,256.12012987013,234.444805194805,1071.75324675325,6110.5974025974,920.954545454546,126.006493506494,1088.33441558442,1104.67857142857,782.155844155844,438.321428571429,3749.57142857143,2203.77922077922,304.474025974026,237.837662337662,1037.10714285714,1628.56818181818,210.581168831169,199.594155844156,721.561688311688,1406.39935064935,551.214285714286,336.373376623377,1041.68831168831,130.941558441558,308,22.4773924123229,17.5636208889773,0.624042375950074,0.96551724137931,0.771929824561403,-1.17265689861254,53308.8538961039,33265.4318181818,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_179989,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
181157,1762.23333333333,227.925925925926,99.3,632.411111111111,1862.35555555556,1283.5,299.925925925926,249.874074074074,1106.43703703704,2534.42222222222,681.277777777778,112.051851851852,1067.1962962963,4911.69259259259,579.222222222222,348.281481481481,2004.3,6140.6037037037,364.192592592593,235.151851851852,1046.57777777778,4965.3,236.807407407407,158.518518518519,583.348148148148,822.474074074074,463.848148148148,264.918518518519,1024.38518518519,132.27037037037,270,20.3022017527336,16.9408792164925,0.551105512319496,0.967741935483871,0.794117647058823,0.339256185218738,53941.7888888889,33077.6481481481,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_181157,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
181360,4525.81229773463,778.886731391586,94.0744336569579,636.320388349515,1676.68284789644,517.990291262136,624.064724919094,241.776699029126,1077.12944983819,6933.44012944984,578.650485436893,120.7928802589,1089.26537216828,1053.7216828479,594.754045307443,326.62783171521,1684.6925566343,1873.07766990291,297.187702265372,232.809061488673,1019.80906148867,2543.23300970874,227.242718446602,196.977346278317,585.200647249191,1890.68932038835,513.067961165049,270.815533980583,1041.6569579288,131.556634304207,309,20.0837628065234,19.598340999537,0.218530420841376,0.965625,0.7725,0.757685102445615,53596.0388349515,33542.4401294498,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_181360,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
181506,4455.76234567901,710.453703703704,102.472222222222,634.796296296296,1443.74074074074,675.157407407407,372.401234567901,234.70987654321,1080.78395061728,6396.11728395062,599.262345679012,123.41975308642,1092.26543209877,1323.11111111111,685.614197530864,376.33024691358,1549.32716049383,1592.60802469136,318.79012345679,233.503086419753,995.481481481482,1703.08024691358,243.873456790123,187.206790123457,603.070987654321,1191.40740740741,492.385802469136,329.469135802469,1026.96604938272,130.348765432099,324,21.7662532354556,19.278051428546,0.464285985112609,0.93371757925072,0.670807453416149,-0.530299973077444,53608.0987654321,33555.8858024691,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_181506,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
181911,3956.74431818182,1023.53977272727,126.005681818182,620.011363636364,844.332386363636,373.920454545455,299.244318181818,235.082386363636,1098.93465909091,5308.55681818182,602.215909090909,125.085227272727,1074.19886363636,1586.05681818182,558.284090909091,287.144886363636,1554.89204545455,2439.24147727273,250.292613636364,218.997159090909,1002.32386363636,2355.76704545455,196.571022727273,144.375,583.454545454545,1254.5,506.704545454545,241.122159090909,1026.61647727273,129.380681818182,352,25.9582750687112,17.2960766487836,0.745681102938332,0.967032967032967,0.733333333333333,-0.53488108417008,53121.5482954545,33434.9630681818,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_181911,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
182637,3526.96457765668,243.054495912807,88.2942779291553,621.621253405995,885.896457765668,2799.05449591281,498.010899182561,258.798365122616,1145.39509536785,5153.70027247956,556.50408719346,116.217983651226,1095.26702997275,3358.73569482289,633.708446866485,353.152588555858,2326.17438692098,3205.55585831063,394.99727520436,239.681198910082,1113.96730245232,2377.37329700272,232.888283378747,217.291553133515,586.138964577657,989.103542234332,430.223433242507,245.787465940054,1026.45231607629,130.852861035422,367,23.9320775602556,19.6438419197566,0.57119210925665,0.963254593175853,0.764583333333333,1.38797792508934,53005.3514986376,33486.3623978202,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_182637,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
182744,3592.59128065395,348.307901907357,124.41416893733,644.730245231608,1953.31607629428,672.08446866485,423.809264305177,274.405994550409,1135.35694822888,5412.55313351499,2623.26158038147,123.844686648501,1076.46321525886,839.945504087194,482.907356948229,286.264305177112,1506.07629427793,958.32970027248,202.959128065395,209.433242506812,1128.48501362398,694.367847411444,148.49591280654,111.544959128065,602.762942779292,1075.96730245232,455.378746594006,532.801089918256,1049.25613079019,130.596730245232,367,23.721513567344,19.7279910737053,0.555300527723369,0.970899470899471,0.804824561403509,0.014131665938398,53973.7438692098,32664.4386920981,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_182744,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
183495,1922.81920903955,195.762711864407,60.3079096045198,626.734463276836,1345.16101694915,443.579096045198,454.437853107345,248.731638418079,1078.9011299435,2784.15536723164,1359.55649717514,126.440677966102,1071.73163841808,1391.64689265537,600.067796610169,370.466101694915,1804.71186440678,2163.8615819209,311.514124293785,230.234463276836,1025.69209039548,1988.87570621469,217.367231638418,289.700564971751,591.923728813559,927.61581920904,451.624293785311,434.779661016949,1029.12146892655,129.271186440678,354,24.679656656347,18.5887467671264,0.657790215107492,0.96195652173913,0.732919254658385,1.00409334720542,53295.1129943503,33865.6751412429,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_183495,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
184041,4523.1170886076,269.376582278481,127.439873417722,663.661392405063,2263.69620253165,709.414556962025,335.110759493671,249.474683544304,1114.5664556962,7746.68987341772,1856.73101265823,132.829113924051,1102.83544303797,2646.29430379747,575.579113924051,349.756329113924,2021.88291139241,4230.20253164557,449.626582278481,247.936708860759,1180.37974683544,3407.67721518987,248.810126582278,267.803797468354,886.132911392405,2757.36392405063,548.613924050633,382.465189873418,1081.68670886076,130.838607594937,316,21.9422407573737,18.431779828733,0.542565401354749,0.96048632218845,0.791979949874687,-1.13903957313532,52858.414556962,33552.0601265823,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,9,FAAGSCC_12_184041,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
184383,2361.36194029851,427.496268656716,120.380597014925,650.619402985075,2621.24253731343,285.89552238806,296.149253731343,245.253731343284,1074.82089552239,4564.23880597015,1208.88805970149,118.813432835821,1075.82835820896,732.962686567164,426.69776119403,301.078358208955,1599.02985074627,1679.80223880597,242.753731343284,212.134328358209,995.317164179104,1504.22014925373,194.772388059701,154.742537313433,638.514925373134,1762.23507462687,615.820895522388,372.335820895522,1074.89925373134,133.328358208955,268,21.3904629445981,16.1623012547799,0.655051245004168,0.95373665480427,0.708994708994709,-0.587638470194926,54110.9179104478,33301.2574626866,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_184383,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
184445,3280.76566757493,153.637602179837,86.6185286103542,652.776566757493,2127.85558583106,1241.23160762943,865.692098092643,263.188010899183,1099.00544959128,6279.13896457766,785.171662125341,125.286103542234,1119.08719346049,880.449591280654,508.190735694823,306.754768392371,1528.2970027248,1959.39782016349,336.950953678474,240.051771117166,998.790190735695,1766.12534059946,241.91280653951,159.795640326975,597.005449591281,1839.40054495913,469.160762942779,298.782016348774,1053.17983651226,130.536784741144,367,24.5328481172024,19.4887732768967,0.607401426993502,0.933842239185751,0.667272727272727,1.25434327703332,52446.2452316076,33297.8855585831,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_184445,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
184490,3681.61452513966,422.969273743017,96.8631284916201,639.804469273743,1312.09217877095,1399.65083798883,748.891061452514,247.776536312849,1093.65921787709,5788.11173184358,1338.33240223464,128.815642458101,1071.22346368715,4228.0530726257,638.254189944134,319.312849162011,1756.89664804469,4369.40782122905,382.055865921788,253.335195530726,1002.48882681564,3547.90502793296,260.139664804469,228.614525139665,592.175977653631,1557.21229050279,512.424581005587,420.075418994413,1090.00279329609,132.346368715084,358,23.8276431806646,19.1677430347686,0.594043358273068,0.967567567567568,0.778260869565217,0.377228392195214,52827.9804469274,33525.7374301676,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_184490,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
184820,3518.71984435798,1003.96887159533,2826.13618677043,655.56420233463,2821.68093385214,776.459143968872,346.774319066148,254.859922178988,1099.50583657588,6362.73151750973,515.859922178988,118.260700389105,1076.46692607004,833.583657587549,597.354085603113,274.27626459144,1683.0233463035,1005.70428015564,214.396887159533,217.665369649805,1105.15564202335,771.494163424125,160.809338521401,136.291828793774,1119.24902723735,2441.66926070039,527.36186770428,238.715953307393,1054.40077821012,130.785992217899,257,19.2704827700205,17.0597415800365,0.465061509068353,0.948339483394834,0.751461988304094,-1.26752669454304,53323.8443579767,33166.8326848249,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_184820,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
185139,3654.20261437908,769.267973856209,254.320261437908,674.300653594771,3450.55555555556,410.875816993464,432.385620915033,258.235294117647,1091.86274509804,6437.96078431373,3424.95424836601,132.666666666667,1079.43790849673,1186.60130718954,552.143790849673,382.692810457516,1584.57516339869,1288.01960784314,289.16339869281,226.81045751634,1029.49019607843,922.411764705882,201.823529411765,274.993464052288,673.339869281046,2432.49673202614,533.647058823529,658.222222222222,1095.54248366013,132.117647058824,153,17.5646315032841,11.4943934964979,0.756143696603502,0.95625,0.683035714285714,-0.619587207527701,52434.5163398693,32956.5751633987,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_185139,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
185830,2407.84047267356,437.261447562777,230.370753323486,733.394387001477,5682.22008862629,311.870014771049,302.364844903988,265.228951255539,1083.01624815362,3912.8670605613,998.1329394387,139.064992614476,1088.7282127031,741.646971935007,571.480059084195,270.636632200886,1446.27621861152,1158.55096011817,319.940915805022,227.314623338257,988.676514032496,1057.44903988183,225.413589364845,118.370753323486,582.757754800591,1442.14623338257,491.623338257016,253.236336779911,1057.37666174298,131.237813884786,677,43.1712610362945,20.1745975519228,0.88409064256235,0.956214689265537,0.593859649122807,0.670695031741597,53643.0192023634,32084.2451994092,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_185830,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
185864,4941.00355871886,629.4128113879,1198.1743772242,643.459074733096,1698.41992882562,1246.08540925267,1303.43772241993,269.747330960854,1086.15658362989,7592.65836298932,576.722419928826,144.252669039146,1089.16725978648,2482.83985765124,617.291814946619,554.857651245552,1711.30604982206,2493.96085409253,332.864768683274,239.640569395018,1004.65836298932,2294.85409252669,227.074733096085,300.259786476868,624.092526690391,2634.51601423488,559.61921708185,433.918149466192,1054.32028469751,129.658362989324,281,20.0525508228451,17.9125176493482,0.449503130648782,0.965635738831615,0.821637426900585,-1.26489353275125,53353.665480427,33825.7046263345,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_185864,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
185923,3140.49585062241,160.232365145228,78.6970954356846,624.04979253112,1035.5643153527,275.356846473029,301.224066390042,253.867219917012,1078.48340248963,5965.46265560166,944.807053941909,119.929460580913,1074.39004149378,587.92531120332,435.5622406639,269.02489626556,1350.54356846473,896.558091286307,262.197095435685,223.313278008299,990.823651452282,907.099585062241,205.371369294606,156.392116182573,587.495850622407,1839.65975103734,499.661825726141,300.639004149378,1082.68049792531,131.126556016598,482,27.2539699159768,23.1403017347696,0.528293713668276,0.965931863727455,0.743827160493827,-0.273761391053761,53391.8941908714,32675.4605809129,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_185923,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
185984,1600.17948717949,122.115384615385,237.901709401709,793.397435897436,9544.35897435898,2016.17094017094,400.991452991453,248.363247863248,1096.67521367521,3024.05982905983,615.991452991453,137.67094017094,1074.92735042735,1450.25641025641,780.393162393162,628.645299145299,2681.52564102564,2052.41452991453,341.700854700855,236.482905982906,1092.39743589744,2353.6452991453,226.991452991453,338.773504273504,708.683760683761,1262.09401709402,463.440170940171,269.858974358974,1079.09401709402,130.034188034188,234,20.2166224033253,14.8116671244786,0.680607794121666,0.955102040816326,0.769736842105263,-1.17307806316576,52921.7307692308,33720.4487179487,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,9,FAAGSCC_12_185984,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
186177,3277.53571428571,312.122767857143,157.892857142857,659.863839285714,3018.53794642857,1356.66517857143,1366.51116071429,252.888392857143,1092.19866071429,6184.03125,561.473214285714,123.796875,1071.22098214286,1042.28348214286,624.314732142857,663.390625,1735.71651785714,1630.47544642857,232.566964285714,209.743303571429,1002.31026785714,1651.47098214286,195.404017857143,259.200892857143,702.752232142857,1911.86607142857,504.546875,271.004464285714,1034.87053571429,129.888392857143,448,25.7972159593216,22.2524089534777,0.505904403053839,0.957264957264957,0.779130434782609,0.441287772953136,54025.8816964286,32766.4866071429,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_186177,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
187534,4882.09342560554,1116.51211072664,136.944636678201,651.020761245675,2011.49826989619,675.820069204152,433.096885813149,258.667820069204,1085.3598615917,7687.53287197232,856.294117647059,152.806228373702,1083.20761245675,3221.58823529412,713.743944636678,486.636678200692,2207.31833910035,2527.95155709342,314.425605536332,235.038062283737,1018.50865051903,2813.02422145329,223.221453287197,246.837370242214,625.989619377163,2927.40830449827,587.349480968858,319.557093425606,1087.53633217993,131.266435986159,289,20.7383462634635,17.8305929759067,0.510650196675802,0.976351351351351,0.800554016620499,-0.925167661692108,53323.0173010381,33797.7058823529,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_187534,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
187822,2470.29020979021,242.328671328671,72.2482517482517,619.737762237762,896.527972027972,930.027972027972,318.097902097902,250.412587412587,1085.06993006993,5180.21328671329,1193.75524475524,120.541958041958,1065.36713286713,623.458041958042,431.601398601399,290.076923076923,1493.26923076923,914.681818181818,247.77972027972,216.202797202797,987.031468531468,860.972027972028,188.643356643357,130.590909090909,605.534965034965,1882.55594405594,488.398601398601,489.318181818182,1043.8006993007,129.800699300699,286,22.9791667546854,16.4997314067427,0.696012140867216,0.92258064516129,0.680952380952381,-0.703389539406845,53037.1538461538,32831.7622377622,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_187822,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
189124,1598.74739583333,229.216145833333,130.145833333333,653.453125,2705.17447916667,1285.0625,491.174479166667,247.971354166667,1089.83333333333,3440.09895833333,540.330729166667,111.953125,1069.73697916667,918.794270833333,556.486979166667,330.434895833333,1672.3359375,2335.63802083333,298.4609375,239.354166666667,1030.85677083333,1203.640625,187.450520833333,225.244791666667,596.604166666667,1676.06770833333,508.364583333333,302.71875,1034.7109375,130.036458333333,384,25.9370111190008,18.9760955083127,0.681710218971209,0.96,0.731428571428571,1.15782670282497,53706.5520833333,33383.9427083333,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_189124,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
189426,2134.9,785.369565217391,98.8521739130435,632.25652173913,760.760869565217,378.308695652174,1275.6652173913,227.647826086957,1081.39565217391,3184.26956521739,570.565217391304,111.234782608696,1066.61739130435,921.265217391304,592.434782608696,1640.78260869565,1621.43043478261,1190.04347826087,260.373913043478,223.678260869565,1005.84347826087,974.204347826087,216.786956521739,234.508695652174,617.152173913043,762.834782608696,420.169565217391,336.5,1024.17826086957,131.05652173913,230,19.2237914199732,15.2658168111656,0.607773257444448,0.966386554621849,0.751633986928105,-0.816499488916953,53214.652173913,33618.7217391304,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_189426,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
189707,3153.32574031891,230.168564920273,143.348519362187,707.396355353075,4265.44646924829,2107.93849658314,389.710706150342,245.025056947608,1081.29384965831,5257.48291571754,576.44874715262,125.280182232346,1079.00227790433,803.066059225513,457.075170842825,348.293849658314,1537.07061503417,1057.78359908884,262.312072892938,223.382687927107,992.75854214123,1054.28701594533,206.963553530752,171.466970387244,623.004555808656,1884.53986332574,508.78132118451,285.343963553531,1049.89521640091,131.466970387244,439,29.0340170754563,19.4037099060318,0.743883317806562,0.969094922737307,0.756896551724138,0.252761078404431,53596.8906605923,33612.291571754,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_189707,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
189800,4404.27762803235,190.423180592992,88.5121293800539,630.975741239892,926.495956873315,3346.47978436658,385.498652291105,258.822102425876,1097.89757412399,6453.17789757412,845.374663072776,124.048517520216,1091.43935309973,1104.43126684636,809.913746630728,953.633423180593,1712.84636118598,1370.01347708895,243.140161725067,214.169811320755,1013.70080862534,1060.03504043127,180.533692722372,189.374663072776,715.830188679245,1446.29110512129,487.266846361186,291.738544474394,1043.95956873315,130.288409703504,371,22.1928777906749,21.3242786170295,0.277029704514663,0.971204188481675,0.768115942028985,0.18026898971994,54129.6118598383,32729.0458221024,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_189800,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
189931,4447.1083032491,1446.58844765343,90.2093862815884,614.115523465704,483.202166064982,2437.06137184116,1740.37545126354,262.725631768953,1104.47292418773,6943.96750902527,630.339350180505,120.967509025271,1086.0,2666.07942238267,658.559566787004,544.13357400722,1770.65703971119,2293.5523465704,295.018050541516,221.606498194946,1010.01444043321,1497.2274368231,202.346570397112,164.429602888087,597.12274368231,2040.29241877256,520.584837545126,258.740072202166,1034.53429602888,129.971119133574,277,23.7331733185852,15.0437339823279,0.773440040058067,0.948630136986301,0.662679425837321,0.943957884887361,53992.1155234657,33216.5848375451,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_189931,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
190614,2896.93726235741,559.060836501901,115.659695817491,648.939163498099,2071.12547528517,924.357414448669,624.294676806084,257.022813688213,1093.50380228137,4266.86692015209,1800.1463878327,126.057034220532,1070.77376425856,2712.11977186312,1239.43536121673,1380.1216730038,1981.99809885932,4369.52091254753,384.891634980989,248.243346007605,1038.17870722433,3631.94486692015,258.849809885932,1696.77756653992,712.598859315589,929.684410646388,428.868821292776,356.87072243346,1051.463878327,131.007604562738,526,31.1442567732877,22.3746517942661,0.695609762373171,0.92280701754386,0.678709677419355,0.124874013199794,52636.0551330798,32440.7661596958,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_190614,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
190866,2289.88288288288,220.25975975976,134.572072072072,681.372372372372,4538.55105105105,562.408408408408,1082.23123123123,249.186186186186,1089.22372372372,4319.59309309309,591.219219219219,124.061561561562,1071.85735735736,1030.88588588589,863.921921921922,352.255255255255,1612.65165165165,2861.25825825826,318.587087087087,230.518018018018,1021.76576576577,3312.2987987988,233.524024024024,316.531531531532,632.213213213213,1605.34534534535,548.063063063063,271.423423423423,1070.71171171171,131.033033033033,666,34.5452503957105,24.5558055571117,0.703363701328961,0.972262773722628,0.792857142857143,-0.0256197430614547,53873.539039039,33319.6471471471,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_190866,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
190903,3897.88461538462,960.764705882353,210.839366515837,748.85520361991,6230.5814479638,202.178733031674,239.219457013575,245.235294117647,1079.64253393665,3501.31221719457,4277.44796380091,155.649321266968,1080.03393665158,437.427601809955,320.662895927602,252.943438914027,1347.42760180995,732.33257918552,204.196832579186,208.196832579186,983.47963800905,603.823529411765,138.085972850679,96.39592760181,578.726244343891,1026.17194570136,453.920814479638,276.787330316742,1087.00678733032,133.536199095023,442,29.4223951994489,19.2094537565655,0.757456657501633,0.962962962962963,0.744107744107744,0.479825703170438,53200.1538461538,31933.5950226244,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_190903,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
191291,2400.51219512195,987.883468834688,164.390243902439,635.257452574526,1156.23035230352,2235.46341463415,2041.30352303523,245.907859078591,1102.10027100271,3262.13550135501,1347.84552845528,136.582655826558,1103.20325203252,2399.35501355014,656.159891598916,327.490514905149,2376.81842818428,3656.57452574526,393.173441734417,242.962059620596,1051.18699186992,3327.14905149051,349.422764227642,198.113821138211,597.631436314363,858.485094850948,468.569105691057,255.856368563686,1022.51761517615,132.617886178862,369,26.8163690571926,17.6550455079501,0.752696001024724,0.9609375,0.788461538461538,1.38084365547142,53351.0948509485,33458.9376693767,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_191291,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
191394,4090.37317784256,886.099125364432,113.947521865889,648.32944606414,1544.67930029155,1373.472303207,2099.11370262391,250.932944606414,1084.10787172012,6213.4139941691,1121.37317784257,123.241982507289,1090.5860058309,1199.84256559767,730.058309037901,1136.86297376093,1950.7084548105,3261.37609329446,371.3527696793,241.766763848396,1066.52478134111,3195.45189504373,261.425655976676,586.431486880466,657.116618075802,1799.02332361516,519.209912536443,301.99416909621,1058.44023323615,130.443148688047,343,24.4424960837003,18.0306954736082,0.675152528007691,0.955431754874652,0.828502415458937,1.51494722911662,53266.1166180758,33628.3906705539,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_191394,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
191488,1229.61006289308,187.022012578616,114.220125786164,654.289308176101,2286.7358490566,533.044025157233,467.606918238994,273.433962264151,1097.80188679245,1566.29245283019,606.783018867925,120.141509433962,1066.08176100629,1370.30188679245,808.955974842767,300.248427672956,2026.01886792453,1690.49685534591,319.399371069182,233.320754716981,1093.72012578616,1065.7641509434,202.839622641509,215.27358490566,2763.98742138365,757.933962264151,401.276729559749,209.323899371069,1022.0251572327,137.707547169811,318,23.0377312741523,17.6098386430056,0.644752759304886,0.954954954954955,0.768115942028985,1.48649722523403,52817.7641509434,32261.1320754717,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_191488,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
191762,2982.94255874674,441.483028720627,202.691906005222,690.467362924282,4664.80678851175,561.639686684073,525.720626631854,259.584856396867,1087.98433420366,5390.66579634465,678.127937336815,132.746736292428,1080.69190600522,1795.40208877285,821.616187989556,619.65274151436,1478.49869451697,2265.28459530026,332.258485639687,233.45953002611,986.313315926893,2100.06527415144,242.911227154047,284.746736292428,811.493472584856,2123.31592689295,544.984334203655,256.78590078329,1106.02349869452,130.830287206266,383,32.5718090181629,14.9886953685925,0.887828818244267,0.950372208436724,0.726755218216319,1.34427392466399,53239.2036553525,32863.7180156658,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_191762,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
191779,3086.31496062992,451.916010498688,124.304461942257,639.564304461942,1384.44356955381,489.650918635171,354.286089238845,260.262467191601,1128.42782152231,5277.08923884514,1061.41207349081,122.548556430446,1063.33858267717,863.92125984252,485.517060367454,291.139107611549,1552.1154855643,922.183727034121,209.272965879265,211.821522309711,1222.48031496063,611.469816272966,139.044619422572,112.687664041995,596.808398950131,1343.77427821522,443.658792650919,403.0,1061.67979002625,130.503937007874,381,26.7174865694527,18.3626229331948,0.726384493295676,0.959697732997481,0.814102564102564,1.49307122501202,52499.8215223097,32542.9160104987,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_191779,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
191781,4064.46101694915,691.579661016949,122.71186440678,661.281355932203,2777.11186440678,1719.77627118644,3444.11525423729,249.067796610169,1102.81016949153,6524.93898305085,781.633898305085,134.064406779661,1104.57288135593,1348.51525423729,1112.43389830508,3786.70169491525,2479.73898305085,1438.2,258.840677966102,221.966101694915,1026.63050847458,1255.94915254237,198.664406779661,378.833898305085,693.413559322034,2309.32203389831,563.894915254237,263.722033898305,1091.17288135593,132.050847457627,295,20.2593409738881,18.6197502321421,0.394094584673218,0.983333333333333,0.817174515235457,-0.878110230933513,53193.3627118644,33648.5288135593,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_191781,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
192320,5146.64306784661,224.035398230089,119.011799410029,677.501474926254,2287.07079646018,2793.64896755162,486.026548672566,253.784660766962,1102.95575221239,7794.16814159292,641.047197640118,140.601769911504,1122.8790560472,2986.13569321534,688.050147492625,375.964601769911,5054.49557522124,2236.1179941003,331.920353982301,237.094395280236,1021.64601769912,1522.9587020649,224.138643067847,241.628318584071,1059.19764011799,2164.67256637168,513.200589970501,283.870206489676,1070.27728613569,131.200589970501,339,22.0790048571936,19.6620831168527,0.454918586897722,0.957627118644068,0.768707482993197,0.830134124569461,52940.1179941003,33606.4631268437,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_192320,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
192321,1477.67796610169,174.830508474576,105.298305084746,664.264406779661,2624.17288135593,346.549152542373,299.450847457627,246.884745762712,1123.79322033898,2126.29491525424,787.701694915254,128.833898305085,1068.4813559322,812.084745762712,545.664406779661,270.437288135593,1714.83050847458,1617.77627118644,313.820338983051,230.691525423729,1047.96271186441,1399.6,220.898305084746,928.159322033898,2096.94915254237,1143.38983050847,522.240677966102,285.233898305085,1063.2813559322,132.24406779661,295,28.1651689369012,13.6949704618894,0.873826515004363,0.951612903225806,0.752551020408163,1.519873840802,52975.8711864407,32860.3084745763,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,1,FAAGSCC_12_192321,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
192457,2942.30573248408,238.777070063694,92.5605095541401,651.738853503185,1625.56687898089,1724.95541401274,322.12101910828,266.184713375796,1103.49681528662,5111.49044585987,868.910828025478,144.547770700637,1070.87898089172,891.71974522293,520.87898089172,292.885350318471,1707.15286624204,1076.17834394904,271.87898089172,232.738853503185,1023.47770700637,940.929936305732,199.350318471338,245.070063694268,1524.77707006369,946.566878980892,422.668789808917,232.171974522293,1044.8152866242,130.165605095541,157,15.9587133670694,12.5464378330237,0.617996259036576,0.96319018404908,0.805128205128205,-1.1260058066463,52711.1719745223,32903.2484076433,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_192457,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
192684,2667.72955974843,661.578616352201,90.3238993710692,638.899371069182,1525.22955974843,2556.56603773585,2564.73899371069,264.481132075472,1089.90880503145,4962.50628930818,722.729559748428,120.836477987421,1065.17610062893,3487.67610062893,1428.88679245283,4324.85534591195,2081.58805031447,2429.5786163522,325.367924528302,225.028301886792,1039.24842767296,1596.11949685535,215.503144654088,497.188679245283,835.474842767296,1667.04088050314,454.591194968554,266.575471698113,1059.91194968553,130.405660377358,318,20.4814109845393,19.8520684267972,0.24598947316103,0.952095808383234,0.757142857142857,-1.15812128980203,52697.6886792453,32362.4308176101,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_192684,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
192693,1423.34716981132,335.056603773585,156.339622641509,666.037735849057,3411.39622641509,238.584905660377,280.08679245283,235.747169811321,1075.52452830189,2898.87924528302,3657.22264150943,116.343396226415,1068.81509433962,565.981132075472,357.467924528302,403.781132075472,1573.16226415094,869.856603773585,200.418867924528,208.230188679245,1001.98113207547,813.0,164.698113207547,126.249056603774,599.422641509434,1125.67547169811,464.532075471698,325.977358490566,1038.00754716981,130.366037735849,265,19.6260715512202,17.226412192286,0.47915365129881,0.977859778597786,0.774853801169591,-1.14119266027437,53536.7660377358,32806.0867924528,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_192693,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
192825,3775.22839506173,671.611111111111,158.530864197531,623.086419753086,768.061728395062,290.777777777778,246.407407407407,235.37037037037,1076.37037037037,6589.71604938272,660.055555555556,142.265432098765,1075.08641975309,1007.43209876543,492.043209876543,274.759259259259,1933.77777777778,1455.20987654321,318.314814814815,231.327160493827,1027.55555555556,1236.77777777778,215.123456790123,183.382716049383,1392.04938271605,3454.48148148148,547.58024691358,286.753086419753,1050.8024691358,129.308641975309,162,16.6013778248369,12.4400265439285,0.662188848040791,0.958579881656805,0.778846153846154,1.34163018764676,52950.2901234568,33865.6234567901,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_192825,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
192847,358.378006872852,741.450171821306,189.39175257732,609.800687285223,113.917525773196,588.931271477663,392.395189003436,274.147766323024,1122.90378006873,1125.88316151203,919.529209621993,116.45704467354,1063.87972508591,988.39175257732,743.86941580756,275.962199312715,1992.78694158076,1257.92783505155,274.374570446735,223.257731958763,1043.98281786942,1040.05154639175,201.151202749141,213.429553264605,2074.80068728522,582.848797250859,363.797250859107,200.680412371134,989.33676975945,129.73883161512,291,20.8113988748723,17.8880335220202,0.51108433795923,0.976510067114094,0.808333333333333,1.23047717686787,52523.9175257732,32459.0171821306,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_192847,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
193063,5023.9866962306,1223.35476718404,746.80044345898,634.053215077605,934.640798226164,1064.22394678492,640.09534368071,249.10421286031,1081.83592017738,7997.39246119734,631.731707317073,124.618625277162,1086.0487804878,970.79822616408,567.146341463415,349.90022172949,1926.75831485588,1791.94900221729,344.988913525499,242.558758314856,1012.0332594235,1558.23946784922,259.29711751663,547.068736141907,651.259423503326,2714.58536585366,562.529933481153,303.157427937916,1048.16851441242,131.292682926829,451,34.9321797294513,16.9346070668067,0.874633190216223,0.947478991596639,0.683333333333333,1.23232199330313,53621.9046563193,33425.4944567627,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_193063,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
193178,507.565916398714,1209.58520900322,272.604501607717,605.990353697749,107.292604501608,319.508038585209,338.675241157556,248.810289389068,1086.98392282958,1130.38585209003,673.926045016077,113.382636655949,1067.66881028939,621.942122186495,435.697749196142,306.887459807074,1399.34726688103,933.273311897106,274.771704180064,223.511254019293,988.51768488746,867.778135048232,204.434083601286,129.610932475884,594.144694533762,567.231511254019,367.263665594855,208.797427652733,988.877813504823,127.327974276527,311,21.1746694952021,18.7394646948218,0.465601597535974,0.95398773006135,0.779448621553885,0.42425117261343,53290.2893890675,33006.0803858521,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_193178,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
193536,2483.07462686567,291.375621890547,114.057213930348,655.365671641791,2178.74378109453,570.067164179104,433.141791044776,257.164179104478,1084.42537313433,3642.71890547264,694.373134328358,131.047263681592,1070.57213930348,712.517412935323,542.425373134328,274.544776119403,1498.1144278607,1017.42537313433,277.072139303483,223.273631840796,992.84328358209,999.07960199005,204.161691542289,131.564676616915,591.286069651741,884.880597014925,411.062189054726,221.360696517413,1056.87562189055,131.415422885572,402,29.8684064982228,17.2394592037168,0.81661666076541,0.957142857142857,0.644230769230769,0.710158319828815,52791.1542288557,32317.3184079602,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_193536,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
193854,2574.61940298507,523.406716417911,128.313432835821,640.970149253731,1570.80223880597,632.212686567164,1805.51865671642,253.712686567164,1089.85447761194,4255.48507462687,1529.64552238806,122.582089552239,1066.3171641791,489.220149253731,436.466417910448,309.544776119403,1420.62313432836,756.526119402985,197.932835820896,209.108208955224,993.09328358209,686.936567164179,158.574626865672,111.134328358209,589.347014925373,1107.37313432836,448.328358208955,270.037313432836,1044.48134328358,130.876865671642,268,21.1434265806334,16.1675641450518,0.644432153518704,0.957142857142857,0.750700280112045,-1.53017100619066,52685.5223880597,32298.1156716418,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_193854,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
193869,5088.7893258427,668.373595505618,149.696629213483,669.806179775281,2766.15730337079,4255.73876404494,1299.17415730337,272.188202247191,1194.99157303371,7778.91011235955,696.016853932584,132.073033707865,1103.23876404494,2402.48033707865,876.766853932584,522.946629213483,4839.51404494382,1527.20505617978,293.258426966292,230.898876404494,1004.1404494382,1154.45505617978,215.23595505618,164.053370786517,597.252808988764,1759.95786516854,491.921348314607,240.522471910112,1071.32584269663,131.258426966292,356,25.4287330299398,17.9557955317165,0.708089890537489,0.954423592493298,0.791111111111111,-0.0218841467723665,52683.9494382022,33576.6769662921,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_193869,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
193881,2341.12676056338,333.242253521127,93.112676056338,637.467605633803,1365.61971830986,582.498591549296,382.346478873239,272.278873239437,1127.21971830986,3796.59436619718,1237.9014084507,122.394366197183,1073.62816901408,1994.09014084507,674.718309859155,307.101408450704,2118.67323943662,2374.78028169014,328.895774647887,228.76338028169,1130.11830985916,1266.11267605634,180.078873239437,194.270422535211,1660.11549295775,998.746478873239,422.329577464789,299.422535211268,1063.65633802817,129.723943661972,355,28.3745200870495,16.0395229480103,0.824899720121508,0.962059620596206,0.792410714285714,-1.54079839242796,52908.7718309859,32338.1183098592,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_193881,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
193927,4054.17109144543,239.598820058997,108.47197640118,645.88790560472,1912.74336283186,301.646017699115,332.589970501475,241.967551622419,1074.93805309735,7375.86725663717,1760.81415929204,123.153392330383,1084.00884955752,1772.41002949853,824.297935103245,405.654867256637,2535.7610619469,3876.70206489676,328.660766961652,229.787610619469,1029.99705014749,3563.26253687316,218.705014749262,628.823008849557,684.469026548673,2954.35693215339,570.017699115044,446.994100294985,1075.51622418879,129.929203539823,339,26.6235521743517,16.5005479365265,0.784781456417538,0.946927374301676,0.6699604743083,0.909241373439872,53934.7640117994,33254.2064896755,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_193927,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
194048,3542.43673469388,451.25306122449,175.848979591837,660.914285714286,2626.19591836735,259.020408163265,280.240816326531,252.636734693878,1084.74285714286,5197.52244897959,3588.82857142857,128.648979591837,1068.39591836735,635.763265306122,384.640816326531,424.020408163265,1421.8612244898,826.820408163265,196.044897959184,209.338775510204,1001.68163265306,705.983673469388,151.436734693878,119.889795918367,629.624489795918,1476.21224489796,462.248979591837,371.265306122449,1051.04897959184,129.885714285714,245,21.0487071586646,15.0751572164125,0.69789152599063,0.953307392996109,0.729166666666667,1.28218904984557,52616.4448979592,32243.0408163265,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_194048,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
194118,1792.38205128205,365.615384615385,109.084615384615,646.317948717949,1896.44615384615,549.525641025641,399.615384615385,272.753846153846,1142.47179487179,2458.63076923077,1195.63076923077,122.053846153846,1065.35384615385,1028.84871794872,611.174358974359,280.861538461538,1751.83076923077,1121.07692307692,238.876923076923,219.061538461538,1146.43846153846,678.061538461538,148.592307692308,112.433333333333,1890.62051282051,860.446153846154,414.346153846154,248.997435897436,1038.0,130.312820512821,390,26.9130029468944,18.4696581910813,0.727344369992669,0.955882352941176,0.706521739130435,0.637752172890234,52838.0102564103,32252.2769230769,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_194118,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
194147,4402.29192546584,496.090062111801,131.195652173913,652.307453416149,1884.00310559006,1459.25465838509,1554.13043478261,251.562111801242,1086.82608695652,7236.28260869565,615.248447204969,128.083850931677,1243.95652173913,842.829192546584,797.195652173913,1341.03416149068,1826.61801242236,1587.12111801242,333.708074534161,234.565217391304,1054.12422360248,1397.72360248447,237.350931677019,272.394409937888,678.689440993789,2445.58385093168,524.978260869565,258.465838509317,1057.73291925466,130.27950310559,322,21.6621395414998,19.0509349651358,0.47597709052248,0.964071856287425,0.807017543859649,0.0428850408604592,53319.8074534161,33678.3167701863,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX+,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_194147,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
194213,3845.57585139319,1058.4427244582,114.473684210526,645.752321981424,1969.87306501548,514.743034055728,338.405572755418,255.752321981424,1133.44891640867,5188.21671826625,673.009287925697,126.659442724458,1078.84829721362,825.749226006192,445.969040247678,282.188854489164,1499.21981424149,1081.04953560372,219.157894736842,213.547987616099,1192.36842105263,1189.23219814241,166.034055727554,132.294117647059,1196.28792569659,931.613003095975,461.356037151703,251.814241486068,1038.32507739938,129.922600619195,323,22.837630878795,18.1121927473771,0.609110392330232,0.95,0.739130434782609,0.430451652079639,53248.5789473684,33067.0835913313,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_194213,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
194259,2165.0303030303,217.468013468013,185.949494949495,700.104377104377,5729.83838383838,533.451178451178,709.814814814815,239.468013468013,1083.39057239057,3814.58585858586,562.676767676768,117.154882154882,1077.60942760943,2753.37373737374,496.680134680135,716.323232323232,1559.3063973064,3771.07407407407,329.710437710438,1557.09427609428,1023.53535353535,2604.95286195286,303.666666666667,423.424242424242,608.565656565657,1109.44107744108,460.996632996633,280.208754208754,1054.86868686869,129.080808080808,297,24.3676504162923,15.5281382126359,0.770662135302779,0.961165048543689,0.7734375,1.31412582329468,53857.5117845118,33432.4579124579,FAAGSCC_12,AG,1,neutrophils,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,neutrophils,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_194259,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
195062,4024.89173789174,164.376068376068,132.860398860399,676.689458689459,3118.68376068376,874.210826210826,800.096866096866,246.831908831909,1094.23361823362,6010.23931623932,672.740740740741,143.792022792023,1099.45014245014,4028.46153846154,803.236467236467,536.695156695157,2174.47293447293,5292.62393162393,411.700854700855,240.205128205128,1149.86324786325,4298.64102564103,248.615384615385,416.581196581197,662.504273504274,1341.43304843305,496.407407407407,254.108262108262,1265.20227920228,130.415954415954,351,23.9492142624986,18.8269582469433,0.618073797242676,0.951219512195122,0.726708074534162,0.468116823453626,53265.2535612536,33737.9943019943,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_195062,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
195443,4135.73214285714,474.4375,75.5892857142857,634.645833333333,1292.22619047619,442.58630952381,319.794642857143,251.214285714286,1097.40773809524,6150.97321428571,555.303571428571,146.008928571429,1088.47916666667,1343.22023809524,646.949404761905,289.425595238095,1859.41071428571,2994.78869047619,353.535714285714,240.625,1059.6875,3038.94642857143,236.104166666667,1959.76785714286,1383.78571428571,1516.29761904762,491.25,236.824404761905,1064.84821428571,130.991071428571,336,23.2004072635795,18.5117027296638,0.602784260546495,0.957264957264957,0.768878718535469,-1.33315578625339,52925.2946428571,33840.8452380952,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,1,FAAGSCC_12_195443,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
196000,3979.06504065041,798.417344173442,101.338753387534,641.785907859079,1605.50135501355,1695.30081300813,529.205962059621,251.978319783198,1162.21138211382,6115.0298102981,679.986449864499,121.50406504065,1085.57452574526,2211.65311653117,772.065040650407,320.355013550135,4074.05420054201,1961.60975609756,359.550135501355,244.628726287263,1066.87804878049,1294.81571815718,235.842818428184,203.588075880759,634.582655826558,1453.20054200542,473.476964769648,236.780487804878,1042.05691056911,131.092140921409,369,26.5247311689031,17.7429390387436,0.743333864018872,0.9609375,0.702857142857143,0.522519096281105,53102.3848238482,33593.5609756098,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_196000,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
196703,3561.12128712871,384.824257425743,149.153465346535,641.757425742574,1632.42326732673,1718.4603960396,774.866336633663,246.794554455446,1119.43316831683,5503.16336633663,816.955445544554,127.745049504951,1103.88613861386,1158.14356435644,793.665841584158,1251.17326732673,4164.11633663366,2225.40594059406,307.487623762376,232.438118811881,1048.21534653465,1902.52722772277,228.413366336634,456.893564356436,718.754950495049,1609.65346534653,500.730198019802,246.920792079208,1245.30198019802,132.279702970297,404,23.8145101641685,21.6574868183007,0.415870182981096,0.968824940047962,0.765151515151515,0.113571420788777,52996.6386138614,33661.2524752475,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_196703,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
196781,4289.79467680608,144.923954372624,63.4562737642586,629.22433460076,1405.25855513308,1654.77946768061,399.737642585551,260.77566539924,1087.23574144487,7756.42585551331,865.665399239544,119.51711026616,1114.69961977186,803.904942965779,641.901140684411,289.45247148289,2519.40684410646,1274.59695817491,321.817490494297,233.48288973384,1005.30038022814,1125.99619771863,232.783269961977,180.699619771863,596.479087452472,2365.94676806084,518.889733840304,258.551330798479,1131.8174904943,132.509505703422,263,28.2033866805354,11.8907738958135,0.906778187350831,0.949458483754513,0.782738095238095,1.51105872967535,53958.1140684411,33392.2433460076,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_196781,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
197203,4787.28428093645,371.652173913043,124.916387959866,630.267558528428,1054.76923076923,1974.6856187291,366.10033444816,265.695652173913,1097.54849498328,5986.88628762542,642.826086956522,127.94983277592,1078.38461538462,622.939799331104,386.491638795987,266.103678929766,1431.17391304348,937.829431438127,263.023411371237,222.494983277592,983.612040133779,889.862876254181,206.605351170569,132.270903010033,595.578595317726,1003.73913043478,469.421404682274,235.678929765886,1033.61204013378,133.066889632107,299,21.5826193695319,17.8142576754572,0.56455081302002,0.961414790996785,0.74937343358396,-0.582807594607825,53184.143812709,33032.0434782609,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_197203,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
197237,2200.28021978022,530.879120879121,159.807692307692,626.285714285714,1524.25824175824,5629.77472527472,559.005494505495,267.813186813187,1117.54945054945,3986.75274725275,658.043956043956,114.961538461538,1070.58791208791,6145.87362637363,963.653846153846,345.681318681319,3252.12637362637,6927.08241758242,390.197802197802,238.708791208791,1034.71428571429,7454.18131868132,560.428571428571,309.357142857143,690.576923076923,1082.76373626374,464.862637362637,291.620879120879,1040.65934065934,130.736263736264,182,18.2456414147996,12.9216503795658,0.706007079390596,0.938144329896907,0.713725490196078,0.476722940846366,53700.4340659341,33579.8791208791,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_197237,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
197344,2316.80867346939,220.479591836735,117.966836734694,643.022959183673,2478.82908163265,232.081632653061,237.954081632653,246.229591836735,1073.32653061224,2747.88520408163,756.423469387755,128.68112244898,1068.5306122449,532.793367346939,373.469387755102,259.017857142857,1411.13520408163,835.265306122449,212.130102040816,211.183673469388,984.341836734694,802.676020408163,173.831632653061,114.744897959184,583.785714285714,951.392857142857,448.270408163265,346.211734693878,1040.28826530612,131.489795918367,392,28.6964727529359,17.8960060618121,0.781718969311539,0.95609756097561,0.777777777777778,-0.0084296547560134,53599.1479591837,32259.0331632653,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_197344,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
197586,1160.68518518519,140.462962962963,107.246913580247,650.197530864198,1979.34567901235,252.796296296296,512.679012345679,240.086419753086,1085.02469135802,2473.32098765432,1084.75925925926,127.327160493827,1066.32098765432,567.376543209877,385.524691358025,262.574074074074,1452.57407407407,942.820987654321,246.759259259259,218.827160493827,987.506172839506,888.617283950617,194.185185185185,139.913580246914,588.518518518518,1154.56790123457,448.351851851852,333.740740740741,1061.35185185185,129.679012345679,162,15.462393173346,13.361877088956,0.503228760719789,0.970059880239521,0.771428571428571,1.17804740387622,52514.3518518519,32339.6358024691,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_197586,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
197603,2887.74093264249,260.694300518135,184.217616580311,697.129533678757,4804.0621761658,4480.30569948187,1160.62176165803,284.430051813471,1118.64248704663,5027.54922279793,907.829015544042,134.761658031088,1072.54404145078,5359.66839378238,976.715025906736,511.953367875648,3738.73056994819,5374.81347150259,468.849740932642,249.067357512953,1086.41968911917,4426.37305699482,278.284974093264,215.554404145078,637.735751295337,2025.84455958549,536.316062176166,281.124352331606,1072.45595854922,131.880829015544,193,22.5232091640217,11.7505761041304,0.853123095657981,0.893518518518518,0.597523219814242,-0.63564336639347,53106.829015544,33093.3419689119,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_197603,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
199551,3750.45454545455,891.093939393939,1115.29090909091,641.875757575758,1532.61515151515,2127.21515151515,3687.0303030303,250.387878787879,1110.02424242424,5528.85757575758,919.566666666667,130.624242424242,1081.87878787879,2457.38181818182,751.387878787879,1707.95454545455,1736.77575757576,1702.00303030303,300.224242424242,228.681818181818,1018.9303030303,1133.92121212121,216.009090909091,279.181818181818,618.09696969697,1442.83333333333,498.4,371.506060606061,1059.75454545455,130.239393939394,330,25.0714297119371,16.8106512183463,0.741900243823411,0.945558739255014,0.723684210526316,0.451823676457044,53197.3121212121,33624.7484848485,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_199551,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
200078,1995.11041009464,406.017350157729,127.011041009464,639.842271293375,1747.95899053628,278.738170347003,659.801261829653,248.556782334385,1090.66561514196,2715.90536277603,1982.54258675079,129.777602523659,1072.53943217666,713.326498422713,586.892744479495,486.518927444795,1662.44794952681,1037.01104100946,251.381703470032,219.391167192429,993.922712933754,875.378548895899,190.654574132492,186.596214511041,593.184542586751,908.853312302839,482.656151419558,306.544164037855,1041.85646687697,129.996845425868,634,31.668794797187,25.7027281007784,0.584198860043425,0.976887519260401,0.754761904761905,0.693813409241906,52380.4337539432,32637.0362776025,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_200078,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
200697,1462.1752265861,133.063444108761,94.6283987915408,645.302114803625,2266.93051359517,453.519637462236,1430.15105740181,248.531722054381,1116.59516616314,2384.23564954683,585.833836858006,112.785498489426,1082.1329305136,752.516616314199,656.166163141994,582.31419939577,1626.65558912387,1142.78247734139,289.223564954683,220.873111782477,1012.1329305136,1186.77643504532,200.456193353474,206.592145015106,592.540785498489,997.688821752266,481.827794561934,294.157099697885,1029.15709969789,128.117824773414,331,25.495514161823,16.5537516711501,0.760548648793453,0.956647398843931,0.778823529411765,-0.285979213623815,53514.1238670695,33594.9546827795,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_200697,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
200794,1969.1455026455,264.861111111111,128.015873015873,722.667989417989,4148.63227513228,284.338624338624,675.978835978836,249.281746031746,1082.21957671958,3851.21957671958,719.730158730159,140.564814814815,1080.34391534392,1259.68783068783,1511.5582010582,979.707671957672,1976.36507936508,2541.23941798942,326.100529100529,229.861111111111,1050.33201058201,2247.13227513228,452.256613756614,2544.48015873016,694.398148148148,1405.8544973545,495.456349206349,246.763227513228,1076.0873015873,131.132275132275,756,39.5123116643662,24.763853382521,0.77923033649453,0.961832061068702,0.745562130177515,-1.43821714215752,52750.6256613757,32866.4801587302,FAAGSCC_12,AG,1,other APCs,,TIM3+,PD-L1+,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_200794,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
201255,2555.28348214286,458.816964285714,101.162946428571,635.696428571429,1244.54017857143,4150.97991071429,580.776785714286,262.002232142857,1216.94419642857,3717.29017857143,1597.90178571429,117.477678571429,1080.23660714286,2044.60491071429,617.111607142857,340.017857142857,2125.12946428571,1052.95982142857,241.758928571429,225.482142857143,997.299107142857,880.948660714286,205.145089285714,173.850446428571,589.323660714286,761.743303571429,413.779017857143,379.245535714286,1026.41517857143,129.816964285714,448,28.2851335475924,20.2683726061819,0.697511755476296,0.957264957264957,0.772413793103448,-1.46163781427558,53203.046875,33557.9174107143,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_201255,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
201522,2009.29209621993,311.419243986254,106.731958762887,631.85910652921,1957.28865979381,348.759450171821,291.446735395189,251.223367697595,1076.80068728522,3461.67010309278,489.419243986254,116.158075601375,1098.23024054983,751.347079037801,499.333333333333,288.518900343643,1847.6116838488,1184.79725085911,272.40206185567,224.986254295533,982.948453608247,1344.55670103093,208.233676975945,129.938144329897,606.508591065292,1122.23711340206,476.508591065292,225.659793814433,1039.35738831615,129.257731958763,291,21.3570440110811,17.5706817610935,0.568459402515073,0.944805194805195,0.692857142857143,-0.583790341893391,53873.5670103093,33072.0962199313,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_201522,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
201670,2786.87654320988,243.732510288066,84.9547325102881,605.888888888889,414.666666666667,1688.78189300412,2442.0,248.090534979424,1119.58847736626,4067.79423868313,717.625514403292,114.283950617284,1076.16049382716,2856.27983539095,969.082304526749,1300.04115226337,1910.78189300412,5692.41563786008,443.263374485597,239.144032921811,1046.1975308642,5255.56378600823,272.189300411523,248.736625514403,626.131687242798,810.958847736626,436.325102880659,226.415637860082,1012.79423868313,130.382716049383,243,21.0118238303309,15.0335267242803,0.698633848479967,0.956692913385827,0.771428571428571,-1.5632477421632,53775.8724279835,33586.0740740741,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_201670,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
202187,4712.91823899371,211.852201257862,96.4213836477988,657.534591194969,1846.99056603774,894.147798742138,1011.68553459119,254.581761006289,1116.23899371069,6840.26100628931,794.883647798742,143.25786163522,1096.27672955975,1559.7358490566,634.647798742138,578.720125786164,1697.4465408805,2576.61320754717,363.522012578616,238.46855345912,1008.63836477987,2536.51886792453,272.03144654088,270.358490566038,657.896226415094,1473.42767295597,510.424528301887,305.216981132075,1055.50314465409,130.877358490566,318,21.1263290233712,19.3246351194173,0.404092606118116,0.952095808383234,0.757142857142857,0.413434447391653,53177.0125786164,33835.0220125786,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_202187,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
202274,1584.25482625483,107.776061776062,89.6872586872587,699.436293436293,3959.93436293436,2718.14285714286,1137.21235521236,252.447876447876,1133.04247104247,2970.36293436293,1089.06563706564,126.274131274131,1075.05019305019,3947.81467181467,1279.9111969112,949.046332046332,5379.138996139,4923.97683397683,434.247104247104,242.891891891892,1099.20077220077,4440.72200772201,264.200772200772,696.710424710425,712.328185328185,1271.76833976834,468.803088803089,603.764478764479,1040.75675675676,130.088803088803,259,20.1369289777991,16.5247433257932,0.571475911344569,0.959259259259259,0.761764705882353,-0.280879493074742,53731.9961389961,33772.0540540541,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3+,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_202274,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
203196,2302.77813504823,207.167202572347,132.221864951768,648.231511254019,2758.45980707395,766.652733118971,283.630225080386,252.054662379421,1076.58199356913,3028.06752411576,680.864951768489,120.070739549839,1074.06109324759,911.71382636656,517.607717041801,274.1961414791,1464.21864951768,1101.81672025723,288.578778135048,224.231511254019,983.40192926045,976.279742765273,207.926045016077,123.408360128617,592.32154340836,887.170418006431,460.909967845659,233.569131832797,1011.12540192926,130.604501607717,311,22.2155412485437,17.8858371237279,0.593132691152647,0.95398773006135,0.706818181818182,-1.09441623519706,53819.5884244373,32913.9742765273,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_203196,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
204690,4002.75649350649,147.847402597403,86.237012987013,621.883116883117,1114.25974025974,627.659090909091,409.587662337662,272.561688311688,1138.72402597403,8121.99675324675,510.022727272727,119.584415584416,1077.64935064935,836.840909090909,472.5,269.272727272727,1519.28896103896,1019.61688311688,215.581168831169,213.123376623377,1157.41558441558,711.084415584416,140.350649350649,109.048701298701,587.863636363636,2502.81818181818,499.711038961039,235.574675324675,1054.32467532468,128.292207792208,308,23.7335422236258,16.5337569711515,0.717419969089692,0.953560371517028,0.736842105263158,-0.948378153157452,53824.5941558442,32722.0519480519,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_204690,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
205154,2862.28191489362,206.617021276596,87.936170212766,643.595744680851,1657.73936170213,289.186170212766,261.265957446808,240.218085106383,1097.44680851064,5279.48936170213,580.393617021277,126.457446808511,1081.04787234043,555.143617021277,322.994680851064,252.234042553192,1424.86170212766,928.085106382979,193.202127659574,210.63829787234,1015.6329787234,856.015957446809,158.925531914894,467.952127659574,2400.34574468085,1760.95212765957,516.760638297872,230.122340425532,1071.0,130.574468085106,188,18.7020939904599,12.8280190366477,0.727683069215,0.94949494949495,0.746031746031746,-0.406151358649642,52930.9361702128,32858.9308510638,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,1,FAAGSCC_12_205154,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
205328,4193.57020057307,276.684813753582,114.512893982808,636.793696275072,1018.9340974212,242.808022922636,260.30659025788,254.541547277937,1075.39828080229,5198.65616045845,1935.50143266476,154.441260744986,1083.1776504298,531.87106017192,424.071633237822,263.478510028653,1400.23495702006,831.378223495702,273.10888252149,222.957020057306,989.808022922636,766.939828080229,204.071633237822,113.36676217765,584.106017191977,867.378223495702,433.461318051576,210.269340974212,1061.82521489971,133.232091690544,349,25.3486899668675,17.5556554188193,0.721353961434724,0.969444444444444,0.80787037037037,0.270288246169486,53032.0830945559,31936.564469914,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_205328,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
205994,2645.66483516484,565.601648351648,103.964285714286,631.678571428571,1911.5521978022,505.192307692308,270.098901098901,243.076923076923,1089.6978021978,3416.28846153846,506.304945054945,115.203296703297,1072.23626373626,1600.01373626374,671.384615384615,283.623626373626,1797.73351648352,2453.74725274725,305.711538461538,223.766483516484,1032.76373626374,1665.33516483516,208.335164835165,190.497252747253,3674.39010989011,769.881868131868,426.112637362637,218.854395604396,1011.02472527473,130.557692307692,364,24.1414167954271,19.3152583932724,0.599882620436811,0.957894736842105,0.753623188405797,-0.430708438847494,54113.5686813187,32675.2664835165,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_205994,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
206083,1884.96396396396,290.117117117117,53.1036036036036,629.644144144144,1321.07657657658,984.779279279279,1313.73873873874,236.40990990991,1092.75675675676,3441.12162162162,508.094594594595,126.315315315315,1068.22072072072,1859.4009009009,849.292792792793,866.355855855856,4686.39189189189,2455.72972972973,355.243243243243,240.990990990991,1046.29279279279,2013.38738738739,256.878378378378,422.563063063063,719.963963963964,1789.47747747748,471.977477477478,258.207207207207,1048.97297297297,130.81981981982,222,19.3465768619269,14.6799651484671,0.651336787945583,0.94468085106383,0.730263157894737,1.3229362965596,53041.8603603604,33894.6126126126,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_206083,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
206209,2147.11711711712,544.756756756757,882.555555555556,638.430930930931,2202.93243243243,284.444444444444,303.983483483483,253.114114114114,1072.56456456456,3058.21921921922,753.539039039039,125.906906906907,1069.36486486486,695.189189189189,505.626126126126,286.046546546546,1469.36936936937,1155.60960960961,299.765765765766,226.3003003003,978.118618618619,751.009009009009,163.570570570571,133.061561561562,585.555555555556,989.468468468468,516.310810810811,238.974474474474,1022.13363363363,129.48048048048,666,32.0092247923254,26.508732592146,0.560493008101398,0.970845481049563,0.76551724137931,-0.651660185408779,53058.0870870871,33021.9459459459,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_206209,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
206359,2414.3842364532,321.083743842365,741.985221674877,634.453201970443,1526.84236453202,1171.63054187192,381.07881773399,264.162561576355,1124.12807881773,2788.62561576355,775.64039408867,127.270935960591,1067.33497536946,629.896551724138,407.009852216749,389.871921182266,1578.72906403941,866.039408866995,211.916256157635,213.615763546798,990.477832512315,737.014778325123,169.541871921182,111.655172413793,594.541871921182,869.812807881773,440.20197044335,216.399014778325,1033.24630541872,131.556650246305,203,18.0512035029159,14.3625640877616,0.605747591359101,0.939814814814815,0.746323529411765,1.00536888711141,52526.5123152709,32357.6995073892,FAAGSCC_12,AG,1,Unknown,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,Other,Other,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_206359,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
206370,4127.04469273743,238.178770949721,191.298882681564,690.846368715084,4274.82960893855,388.58938547486,863.469273743017,235.972067039106,1075.90223463687,6019.17318435754,1857.78491620112,145.234636871508,1081.2374301676,1691.80726256983,621.036312849162,538.279329608938,4182.31843575419,1938.70111731844,299.248603351955,233.974860335196,1022.49720670391,2226.79608938547,212.100558659218,229.276536312849,625.08938547486,1366.36312849162,502.298882681564,465.530726256983,1094.7905027933,133.553072625698,358,25.2090159148312,18.1799463087136,0.69275977254873,0.970189701897019,0.745833333333333,0.45491052325826,52719.8770949721,33750.9413407821,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_206370,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
206375,4002.06752411576,936.360128617363,83.7877813504823,621.800643086817,839.032154340836,2102.85852090032,349.263665594855,246.418006430868,1087.23794212219,6494.92926045016,577.581993569132,117.675241157556,1093.78135048232,2101.2540192926,657.093247588424,282.591639871383,1862.5884244373,2355.57234726688,299.077170418006,223.942122186495,1023.16720257235,1826.84565916399,205.382636655948,185.848874598071,1451.18649517685,1369.23151125402,509.019292604502,249.450160771704,1034.02250803859,128.987138263666,311,23.4409828936774,16.9382914767587,0.691273661209831,0.96583850931677,0.744019138755981,0.914524859435042,53926.3954983923,33467.3311897106,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_206375,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
206392,4725.63806970509,563.056300268096,1140.71313672922,641.71581769437,1297.3672922252,909.87399463807,359.713136729223,242.55764075067,1087.03753351206,7400.29490616622,909.930294906166,126.077747989276,4400.06434316354,2220.45040214477,599.970509383378,299.600536193029,1759.72654155496,2418.30026809651,321.396782841823,234.587131367292,1049.08310991957,2337.87131367292,231.396782841823,246.554959785523,1751.9436997319,1497.70241286863,511.16890080429,520.061662198391,1054.28686327078,132.949061662198,373,27.4429094655123,17.8060991292428,0.760923570476995,0.946700507614213,0.690740740740741,1.20905757194362,53736.6595174263,33499.4155495979,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX+,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_206392,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
207464,3177.55688622754,287.874251497006,103.964071856287,615.550898203593,543.940119760479,1940.83832335329,3231.41916167665,249.14371257485,1131.5748502994,5524.17365269461,695.167664670659,116.820359281437,1080.94011976048,6612.91616766467,849.592814371258,532.652694610778,2173.75449101796,2900.22754491018,376.251497005988,238.502994011976,1025.95209580838,1658.89221556886,231.041916167665,385.664670658683,662.622754491018,1142.16766467066,460.419161676647,272.047904191617,1031.19760479042,128.269461077844,167,17.5353692513985,12.208878061492,0.717806162908035,0.959770114942529,0.818627450980392,1.47393502460281,53777.8443113772,33572.8143712575,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_207464,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
207963,2446.66095890411,132.059931506849,71.9246575342466,636.917808219178,1382.68493150685,312.914383561644,284.409246575342,254.681506849315,1082.01198630137,4856.96061643836,905.407534246575,130.948630136986,1100.95376712329,580.171232876712,413.655821917808,261.219178082192,1365.41780821918,941.376712328767,267.696917808219,222.455479452055,986.438356164384,888.203767123288,194.61301369863,122.03595890411,588.779109589041,1337.49657534247,511.104452054795,254.633561643836,1062.32705479452,131.530821917808,584,33.0248837858678,22.64754991293,0.727816170055143,0.97171381031614,0.804407713498623,-1.51986755293974,53577.6558219178,32674.1438356164,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_207963,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
207993,4527.7037037037,1010.06552706553,573.433048433048,640.660968660969,1638.27635327635,393.806267806268,673.883190883191,250.586894586895,1085.37606837607,7527.39886039886,757.977207977208,127.492877492877,1078.41025641026,1415.73504273504,537.381766381766,290.974358974359,1512.2962962963,2937.68376068376,341.014245014245,231.660968660969,1014.97720797721,2850.88888888889,240.321937321937,799.481481481482,652.396011396011,2980.08547008547,604.074074074074,305.655270655271,1066.06267806268,132.940170940171,351,25.0999007293527,18.0990547331565,0.692851052726822,0.956403269754768,0.738947368421053,0.225525033402197,53552.9886039886,33286.0085470085,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_207993,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
208085,3195.85480093677,315.384074941452,88.1850117096019,635.257611241218,1326.70725995316,827.68149882904,1255.2224824356,243.850117096019,1118.68852459016,4953.46370023419,662.950819672131,134.395784543326,1086.69086651054,2116.36768149883,704.533957845433,657.606557377049,1747.47775175644,3613.91569086651,388.419203747073,240.819672131148,1036.10538641686,3596.27868852459,263.484777517564,720.854800936768,635.744730679157,952.339578454333,441.276346604215,480.906323185012,1023.54098360656,129.533957845433,427,27.1798940444072,20.102464986579,0.673037978097531,0.977116704805492,0.782051282051282,0.386355801334996,53530.5081967213,33837.9578454333,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_208085,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
208218,3058.01401869159,212.238317757009,115.635514018692,631.560747663551,1547.69158878505,2949.65887850467,910.056074766355,255.046728971963,1095.47196261682,4527.2476635514,589.710280373832,126.654205607477,1072.90186915888,3688.17757009346,558.911214953271,495.901869158879,1876.0,2068.03271028037,327.780373831776,235.233644859813,1046.27570093458,1703.27570093458,228.271028037383,415.953271028037,855.476635514019,910.214953271028,451.476635514019,270.443925233645,1024.8738317757,129.883177570093,214,16.93881088959,16.1798644662745,0.2959777871381,0.959641255605381,0.740484429065744,1.45392183883062,52802.6074766355,33613.4158878505,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_208218,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
208297,4808.45541401274,1412.58280254777,187.273885350318,652.423566878981,2181.05414012739,2140.76114649682,1302.08598726115,246.866242038217,1122.04458598726,7773.24840764331,579.359872611465,125.942675159236,1147.26433121019,1379.79299363057,647.789808917197,299.251592356688,4377.75159235669,1148.85987261146,291.691082802548,225.53821656051,1035.4872611465,1063.06369426752,223.03821656051,142.273885350318,609.019108280255,1907.42993630573,491.006369426752,291.843949044586,1041.67197452229,131.363057324841,314,22.5260127299126,17.8498450147985,0.609988426607406,0.957317073170732,0.792929292929293,-1.55331299346776,54011.9203821656,33448.7292993631,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_208297,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
208490,2907.88295687885,598.622176591376,130.032854209446,641.498973305955,1647.52977412731,829.934291581109,520.99794661191,264.509240246407,1154.42094455852,4547.36960985626,789.35112936345,123.474332648871,1088.84599589322,938.876796714579,615.457905544148,298.928131416838,1508.04722792608,1256.27310061602,334.876796714579,236.090349075975,990.696098562628,1152.12320328542,245.934291581109,194.82340862423,590.669404517454,1287.14784394251,535.197125256674,461.00205338809,1043.90759753593,130.069815195072,487,29.0938036838421,21.3965000973432,0.677599061323466,0.975951903807615,0.828231292517007,-0.182991445596327,53610.5544147844,33300.0431211499,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_208490,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
208604,2857.42105263158,272.06015037594,102.067669172932,638.045112781955,1628.88721804511,380.293233082707,297.721804511278,245.804511278195,1138.90977443609,4415.04511278196,602.127819548872,135.067669172932,1067.45864661654,506.338345864662,356.721804511278,252.09022556391,1437.22556390977,969.368421052632,249.007518796992,221.548872180451,998.827067669173,913.609022556391,182.323308270677,507.082706766917,1871.10526315789,1469.59398496241,511.616541353383,230.135338345865,1078.46616541353,129.781954887218,133,14.0674246940602,12.1174101309047,0.50795968801467,0.93006993006993,0.730769230769231,0.289952847035955,52917.2255639098,32860.8571428571,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,1,FAAGSCC_12_208604,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
209057,2543.74055415617,115.954659949622,130.360201511335,681.234256926952,4350.38287153652,694.229219143577,331.324937027708,241.098236775819,1079.7355163728,3860.86397984887,544.536523929471,120.269521410579,1074.37279596977,1313.97229219144,566.947103274559,298.962216624685,2966.1637279597,1751.58942065491,336.798488664987,241.80604534005,995.926952141058,1682.68261964736,254.224181360201,182.944584382872,602.793450881612,1083.13602015113,480.51637279597,319.775818639799,1046.5516372796,129.284634760705,397,32.623021923405,15.6895274552338,0.876756682542634,0.945238095238095,0.63015873015873,1.0487174248474,53666.4231738035,33570.0100755668,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_209057,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
209652,5259.77777777778,878.102222222222,149.697777777778,647.991111111111,2218.91111111111,444.875555555556,821.471111111111,246.711111111111,1091.27555555556,8282.60888888889,722.675555555556,127.724444444444,1092.22666666667,2129.82222222222,688.911111111111,422.582222222222,1739.90666666667,3986.92444444444,356.346666666667,237.164444444444,1041.12444444444,4157.09777777778,255.248888888889,990.462222222222,910.44,2840.86666666667,550.817777777778,310.662222222222,1069.62666666667,130.737777777778,225,19.0687910215359,15.0415908696711,0.614641300193997,0.957446808510638,0.789473684210526,-1.47190723393102,53536.7466666667,33680.9511111111,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_209652,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
209809,4129.19140625,434.18359375,124.65625,613.640625,743.07421875,2216.92578125,612.7734375,259.12890625,1098.37890625,8777.28125,638.6796875,128.90234375,1072.17578125,1945.46484375,1185.08203125,1448.8203125,3834.28125,2100.5546875,340.296875,231.515625,1017.86328125,1517.2890625,218.0625,1083.6875,857.6328125,4032.7265625,557.84375,242.546875,1039.640625,130.30078125,256,21.7740455259674,15.0456929061725,0.722862332564353,0.966037735849057,0.812698412698413,-1.32753652914133,53366.83203125,32825.58984375,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_209809,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
209996,2279.6404109589,105.907534246575,77.25,643.294520547945,2318.88356164384,304.424657534247,305.743150684931,256.969178082192,1084.33561643836,4145.91095890411,538.873287671233,120.33904109589,1067.02397260274,693.797945205479,450.133561643836,276.078767123288,1400.62328767123,971.157534246575,278.318493150685,222.212328767123,978.47602739726,914.229452054794,213.030821917808,129.83904109589,590.020547945206,1406.62328767123,473.133561643836,234.767123287671,1043.38356164384,130.11301369863,292,26.2951533009225,14.4273138920767,0.836040207628407,0.932907348242812,0.640350877192982,-1.06248071838369,52872.8184931507,32703.0,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_209996,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
210071,2364.82065217391,779.201086956522,71.4619565217391,619.413043478261,837.315217391304,321.663043478261,327.423913043478,248.233695652174,1079.20108695652,4469.875,528.320652173913,113.315217391304,1086.11956521739,833.521739130435,677.396739130435,309.021739130435,1604.60326086957,1521.33152173913,332.576086956522,235.201086956522,1005.40217391304,1438.48369565217,231.608695652174,152.467391304348,609.516304347826,1363.16304347826,466.038043478261,240.326086956522,1024.49456521739,129.440217391304,184,16.24652825467,14.6203608385761,0.436082328464148,0.943589743589744,0.71875,-0.947483724324002,53176.7880434783,33394.3695652174,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_210071,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
210908,1904.67254038179,314.71953010279,136.469897209985,636.205580029369,1977.2261380323,325.531571218796,353.290748898678,259.412628487518,1084.76651982379,2970.60058737151,541.079295154185,123.28046989721,1073.17914831131,730.556534508076,508.628487518355,293.167400881057,1490.79295154185,1206.31864904552,278.256975036711,235.227606461087,996.602055800294,1210.65051395007,207.923641703377,166.732745961821,706.306901615272,1303.97944199706,504.116005873715,232.960352422907,1014.31864904552,130.302496328928,681,35.6902140497072,24.3157655424165,0.732003717853753,0.97008547008547,0.788194444444444,0.100754915112937,52587.2936857562,33398.8839941263,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_210908,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
211434,2811.31499051233,243.647058823529,159.081593927894,685.817836812144,3706.32068311195,413.722960151803,1183.97533206831,249.669829222011,1074.28842504744,4603.62808349146,622.99430740038,136.028462998102,1071.46489563567,760.438330170778,606.074003795066,292.265654648956,1809.92789373814,1157.51802656546,280.0,224.891840607211,993.199240986717,1085.33965844402,206.609108159393,286.318785578748,669.722960151803,1148.14611005693,453.182163187856,259.409867172676,1054.07210626186,131.559772296015,527,31.0160251458275,21.8233850891073,0.71057998157434,0.965201465201465,0.723901098901099,0.985399317016866,52805.2599620493,32355.6280834915,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_211434,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
211483,1460.08597285068,185.036199095023,78.737556561086,628.552036199095,874.923076923077,768.941176470588,345.24886877828,252.117647058824,1093.63800904977,2728.9592760181,683.592760180995,104.909502262443,1076.93212669683,4177.25791855204,732.79185520362,389.022624434389,2606.06334841629,3062.28054298643,374.954751131222,255.339366515837,1022.69683257919,1830.74208144796,330.027149321267,149.321266968326,585.081447963801,929.914027149321,421.085972850679,271.153846153846,1038.00452488688,131.615384615385,221,17.3939739945408,16.2083262379375,0.362880414918541,0.956709956709957,0.767361111111111,-1.01606362621784,53252.6153846154,33387.407239819,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_211483,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
211692,3192.35680751174,943.676056338028,164.631455399061,666.673708920188,3073.3896713615,291.232394366197,327.960093896714,262.053990610329,1079.41314553991,6017.88028169014,718.183098591549,130.988262910798,1084.90375586854,801.241784037559,735.12676056338,297.941314553991,1494.64319248826,1207.31690140845,293.746478873239,225.295774647887,988.43661971831,1020.62910798122,204.847417840376,336.673708920188,666.845070422535,2455.92018779343,609.413145539906,266.575117370892,1102.40375586854,131.30985915493,426,26.8404629710322,20.3267920208787,0.65304514668434,0.974828375286041,0.751322751322751,1.26969584720904,54038.7699530516,32485.8145539906,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_211692,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
211865,5295.1775147929,454.961538461538,182.627218934911,655.94674556213,2410.82544378698,1799.64201183432,398.381656804734,262.139053254438,1134.46449704142,8976.19526627219,699.275147928994,134.813609467456,1102.92603550296,1341.31656804734,828.189349112426,1360.2899408284,1795.94082840237,1736.6449704142,336.860946745562,237.653846153846,1004.78402366864,1518.44674556213,263.236686390532,187.289940828402,639.121301775148,2664.13313609467,524.940828402367,251.005917159763,1060.03846153846,132.612426035503,338,21.7057294529372,19.9057896680057,0.39871391089113,0.957507082152974,0.731601731601732,-0.103132152630199,52648.8224852071,33448.2662721894,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_211865,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
212705,3708.02556818182,607.417613636364,157.610795454545,640.002840909091,1672.49147727273,1046.11363636364,351.488636363636,258.553977272727,1096.37215909091,5570.76420454545,1077.16193181818,122.227272727273,1076.125,785.173295454545,467.866477272727,273.298295454545,1651.79261363636,1738.95170454545,282.602272727273,222.573863636364,989.517045454546,1516.375,223.681818181818,136.411931818182,585.329545454545,1509.28693181818,523.755681818182,313.653409090909,1047.0625,130.534090909091,352,23.9121983255285,18.9674043356577,0.608947670586254,0.956521739130435,0.761904761904762,-0.998740816273504,54100.6818181818,33127.4801136364,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_212705,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
212850,3807.17379679144,156.94385026738,115.72192513369,691.965240641711,3593.69251336898,665.465240641711,494.101604278075,247.048128342246,1089.32620320856,6241.56951871658,576.831550802139,144.505347593583,1095.11229946524,2747.24064171123,731.128342245989,331.173796791444,2286.13636363636,5139.42780748663,538.294117647059,262.131016042781,1053.21122994652,4545.41978609626,294.871657754011,356.505347593583,2083.32085561497,2307.9385026738,508.149732620321,243.697860962567,1076.9385026738,129.598930481283,374,23.6004559136629,20.4378235450299,0.500056566436188,0.976501305483029,0.779166666666667,0.0285858635446719,53021.6550802139,33813.3877005348,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_212850,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
213432,3566.88853503185,1022.64968152866,2523.65923566879,650.124203821656,1579.05414012739,253.277070063694,243.156050955414,225.748407643312,1067.37579617834,4557.17197452229,602.063694267516,122.863057324841,1076.56369426752,600.707006369427,422.614649681529,282.614649681529,1438.29299363057,857.652866242038,237.165605095541,220.101910828025,993.831210191083,749.436305732484,171.716560509554,154.93949044586,580.617834394904,1005.57324840764,502.347133757962,402.703821656051,1018.35031847134,131.407643312102,314,21.5540197321628,18.6062020668908,0.504800857293225,0.960244648318043,0.785,-0.626635215726783,53244.5700636943,33521.6401273885,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_213432,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
213856,1175.26369863014,470.025684931507,145.02397260274,633.029109589041,1069.02568493151,594.104452054794,432.852739726027,259.645547945205,1087.15924657534,1615.28595890411,976.871575342466,149.409246575342,1066.00684931507,1938.06506849315,1431.02397260274,333.73801369863,1968.40924657534,2430.3647260274,460.614726027397,245.301369863014,1003.82020547945,1866.29965753425,266.070205479452,200.263698630137,610.419520547945,720.676369863014,402.64897260274,212.73801369863,1017.16609589041,130.868150684931,584,37.3498089666231,19.9589694208527,0.845244716439359,0.958949096880131,0.705314009661836,-0.266437080193089,52408.3150684932,32406.2071917808,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_213856,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
214781,3843.96153846154,180.363905325444,89.3727810650888,628.55325443787,1100.68047337278,505.434911242604,376.508875739645,262.505917159763,1127.63313609467,6761.47041420118,758.730769230769,128.236686390533,1079.36094674556,850.917159763314,595.491124260355,292.257396449704,1785.76035502959,1180.55029585799,269.727810650888,227.85798816568,1116.36094674556,972.979289940828,200.213017751479,240.662721893491,1697.68343195266,1790.36982248521,474.48224852071,232.633136094675,1067.91124260355,130.769230769231,338,22.7037206839013,18.996922696562,0.547613066084495,0.974063400576369,0.804761904761905,0.630688953682148,52433.5621301775,32536.8727810651,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_214781,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
216246,3774.0,250.89367816092,94.1379310344828,654.574712643678,2134.74137931034,881.301724137931,522.594827586207,257.511494252874,1093.10344827586,5827.70114942529,2802.38218390805,137.919540229885,1115.00287356322,2467.24137931034,850.295977011494,774.580459770115,1996.58620689655,3629.76436781609,314.991379310345,233.310344827586,1042.12356321839,3187.64655172414,224.744252873563,456.290229885057,645.155172413793,1684.25287356322,509.14367816092,375.488505747126,1046.20689655172,130.459770114943,348,23.767746806506,18.9097616126724,0.605814424061607,0.961325966850829,0.753246753246753,0.609002166940014,53443.1609195402,33750.5747126437,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_216246,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
216718,2299.43343653251,293.151702786378,71.5696594427245,617.606811145511,1001.53560371517,693.371517027864,407.987616099071,277.897832817337,1131.15789473684,5169.06811145511,602.665634674923,117.321981424149,1077.30650154799,1088.69040247678,522.835913312693,278.681114551084,1587.05572755418,2650.83591331269,329.160990712074,230.130030959752,1030.74613003096,2619.41795665635,211.399380804954,151.910216718266,1128.0959752322,2079.09907120743,489.204334365325,252.328173374613,1046.26625386997,131.811145510836,323,24.5500563255516,16.8199391862848,0.728422381694792,0.955621301775148,0.791666666666667,1.41035006846184,53617.6408668731,32726.0959752322,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_216718,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
216809,4826.84745762712,1144.44552058111,166.227602905569,660.128329297821,3093.81840193705,640.55205811138,344.17191283293,236.602905569007,1091.01210653753,7243.6392251816,557.271186440678,123.019370460048,1083.81598062954,1789.6803874092,551.794188861986,285.11622276029,1659.18401937046,2800.90314769976,354.246973365617,230.394673123487,1079.44309927361,2615.30024213075,231.409200968523,270.835351089588,2347.37288135593,1516.78450363196,526.661016949153,240.338983050847,1048.20581113801,130.767554479419,413,25.5802811862243,20.5927864430451,0.593239794668063,0.964953271028037,0.748188405797101,0.658600632576228,53804.2276029056,33531.3075060533,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_216809,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
217321,1387.01438848921,797.402877697842,124.510791366906,642.755395683453,2008.39568345324,399.467625899281,497.805755395683,254.071942446043,1088.87769784173,2112.61870503597,468.705035971223,115.877697841727,1073.35971223022,1180.84892086331,1147.25179856115,1739.39568345324,1663.97122302158,1533.9928057554,304.338129496403,229.446043165468,1013.77697841727,1434.92086330935,225.165467625899,385.920863309353,981.553956834532,932.690647482014,454.697841726619,221.489208633094,1031.64748201439,129.920863309353,139,14.5988223578915,12.1459816273585,0.554800137772588,0.97887323943662,0.827380952380952,1.25016674485891,52553.8776978417,33324.4388489209,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_217321,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
217824,2837.6,397.95,114.452777777778,634.630555555556,1207.35555555556,2881.65833333333,2092.15555555556,257.352777777778,1106.23055555556,5040.09444444444,1125.03888888889,123.713888888889,1992.49444444444,4982.07222222222,883.741666666667,772.711111111111,5540.24166666667,5257.9,391.775,240.544444444444,1078.49166666667,4467.81388888889,244.938888888889,214.469444444444,596.738888888889,1679.51666666667,509.369444444444,424.4,1083.95555555556,131.113888888889,360,24.2439457497907,18.9834198785064,0.622000396606178,0.952380952380952,0.789473684210526,-0.0434308518054129,53368.2416666667,33690.6888888889,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX+,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_217824,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
217879,2528.37323943662,359.352112676056,121.795774647887,617.228873239437,755.271126760563,1837.21478873239,633.531690140845,253.517605633803,1114.1514084507,3502.41549295775,526.926056338028,121.475352112676,1084.33098591549,2032.04577464789,731.478873239437,658.971830985916,1832.62323943662,4783.03169014085,381.278169014084,230.390845070423,1064.27816901408,4786.4014084507,228.482394366197,671.478873239437,742.161971830986,1195.93309859155,497.616197183099,231.573943661972,1016.67253521127,129.334507042254,284,28.3428322769206,13.1044461458755,0.886694979579747,0.928104575163399,0.699507389162562,-1.50021731653389,53658.3133802817,32833.7147887324,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_217879,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
218672,604.973333333333,1569.33777777778,375.871111111111,636.133333333333,199.991111111111,1700.55111111111,1651.2,257.4,1108.56444444444,1006.06666666667,579.862222222222,107.164444444444,1062.84444444444,2185.02666666667,806.128888888889,376.111111111111,2058.96444444444,1667.52888888889,280.08,224.253333333333,1033.68888888889,1437.10222222222,197.413333333333,177.742222222222,663.76,842.888888888889,424.591111111111,227.968888888889,1048.05777777778,129.977777777778,225,18.5811513625716,15.42119862811,0.557856039010493,0.953389830508475,0.78125,-1.15503086945499,52901.5822222222,33459.5822222222,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_218672,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
219762,3226.2786259542,667.530534351145,1789.67557251908,649.358778625954,1815.20229007634,431.13358778626,327.80534351145,247.019083969466,1080.11832061069,4779.79007633588,999.038167938931,129.461832061069,1068.27480916031,752.526717557252,542.236641221374,289.19465648855,1722.13740458015,1327.99618320611,301.74427480916,229.496183206107,991.564885496183,1276.09160305344,219.606870229008,250.774809160305,584.312977099237,1191.42748091603,490.167938931298,342.389312977099,1044.96183206107,130.977099236641,262,20.9542189117614,16.1372029078141,0.637902506415013,0.966789667896679,0.733893557422969,1.4418855665506,53294.3053435114,33890.3625954199,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_219762,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
220445,4898.071197411,652.540453074434,85.2006472491909,630.796116504854,1639.81229773463,3763.90938511327,1113.26213592233,266.68932038835,1223.79611650485,7418.6213592233,624.543689320388,123.731391585761,1078.88673139159,919.220064724919,787.815533980582,525.216828478964,1698.71197411003,1394.26213592233,362.05501618123,242.88996763754,1008.77669902913,1319.88025889968,269.029126213592,215.7928802589,597.663430420712,2400.49514563107,530.533980582524,245.935275080906,1077.64401294498,131.828478964401,309,21.7671595007889,18.1722575042156,0.55048137371231,0.956656346749226,0.78030303030303,-1.29709237524043,53047.8187702265,33613.3106796116,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_220445,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
220597,3940.04761904762,330.952380952381,111.731292517007,612.680272108843,433.047619047619,286.69387755102,308.795918367347,244.959183673469,1078.0612244898,7004.94557823129,602.112244897959,117.357142857143,1080.04081632653,669.622448979592,527.486394557823,629.003401360544,1386.34013605442,1027.81292517007,270.469387755102,220.795918367347,988.928571428571,949.210884353741,211.21768707483,134.948979591837,627.928571428571,2157.83333333333,500.721088435374,246.738095238095,1036.6156462585,129.547619047619,294,25.1474571833002,14.9958592220685,0.8027489603739,0.951456310679612,0.720588235294118,1.16279318048084,54139.7482993197,33217.9897959184,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_220597,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
220779,4780.6394984326,266.739811912226,107.134796238245,639.316614420063,1452.99373040752,1027.91849529781,685.25078369906,235.761755485893,1083.3197492163,7246.10971786834,863.742946708464,128.739811912226,1089.45454545455,861.467084639498,456.369905956113,486.021943573668,1838.2946708464,1615.61128526646,250.307210031348,219.739811912226,1025.13166144201,1290.32601880878,184.833855799373,195.467084639498,606.241379310345,1856.934169279,509.084639498433,332.611285266458,1058.52351097179,130.739811912226,319,22.3527456821032,18.1950748289283,0.580868643765233,0.966666666666667,0.759523809523809,0.881274927740755,53216.9561128527,33692.2695924765,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_220779,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
220807,2191.17857142857,281.611111111111,88.6746031746032,645.511904761905,1589.28968253968,2709.40873015873,580.900793650794,265.940476190476,1105.55555555556,2704.25793650794,930.321428571429,134.309523809524,1068.83333333333,960.93253968254,521.420634920635,378.587301587302,2232.55158730159,1292.61904761905,347.269841269841,231.813492063492,1033.86904761905,1197.88095238095,268.321428571429,325.333333333333,660.412698412698,856.888888888889,445.123015873016,533.234126984127,1036.62698412698,132.337301587302,252,18.6475193220984,17.203616032342,0.385833065918651,0.958174904942966,0.780185758513932,0.331611624366339,53145.0238095238,33770.3373015873,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_220807,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
220930,2319.42424242424,740.134986225895,311.867768595041,625.31129476584,1334.98071625344,273.068870523416,292.732782369146,254.275482093664,1083.0523415978,3975.74104683196,1478.28650137741,117.944903581267,1075.24517906336,654.735537190083,412.707988980716,269.308539944904,1446.42148760331,976.900826446281,260.658402203857,223.085399449036,978.539944903581,872.666666666667,200.95867768595,118.840220385675,581.848484848485,1611.80991735537,444.253443526171,319.6391184573,1052.36639118457,131.449035812672,363,22.1361626908198,20.8865763675305,0.331230119906439,0.965425531914894,0.785714285714286,-0.539239305850634,52418.9256198347,32308.2066115702,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_220930,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
221090,4026.19461077844,264.547904191617,177.694610778443,702.173652694611,6448.20658682635,307.48502994012,291.365269461078,238.410179640718,1080.05988023952,5962.4371257485,607.437125748503,134.574850299401,1071.78143712575,702.12874251497,423.464071856287,268.688622754491,1501.50898203593,1148.50898203593,306.455089820359,234.937125748503,979.230538922156,1130.35928143713,240.589820359281,150.12874251497,597.868263473054,1417.2874251497,478.820359281437,223.991017964072,1054.67664670659,130.568862275449,334,23.2139811288907,18.3967561435014,0.609890043425051,0.959770114942529,0.806763285024155,0.149694516263235,52582.3502994012,33524.4011976048,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_221090,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
221193,2894.3503649635,357.649635036496,123.956204379562,621.598540145985,1005.63503649635,380.759124087591,368.613138686131,247.532846715328,1085.59854014599,6487.30656934307,590.051094890511,119.832116788321,1070.99270072993,611.262773722628,404.094890510949,266.773722627737,1390.59854014599,937.605839416058,252.773722627737,216.897810218978,982.467153284672,860.700729927007,188.379562043796,120.175182481752,587.197080291971,2956.28467153285,560.817518248175,241.328467153285,1046.19708029197,130.175182481752,137,16.4632530414231,10.6740254571696,0.761338520528966,0.944827586206897,0.702564102564103,0.940984938680254,53892.5328467153,32887.4890510949,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_221193,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
221205,3027.67705382436,413.614730878187,141.943342776204,634.827195467422,1409.54107648725,1428.70538243626,522.498583569405,266.827195467422,1108.04815864023,6078.86402266289,1466.67705382436,124.56657223796,1071.00566572238,3359.46175637394,926.396600566572,336.246458923513,5521.10198300283,1956.60339943343,356.481586402266,238.090651558074,995.019830028329,1396.76770538244,253.99716713881,131.85269121813,593.42776203966,2884.69688385269,524.532577903683,319.912181303116,1058.20963172805,130.903682719547,353,26.0642988303776,17.6876406860749,0.734493581144394,0.936339522546419,0.668560606060606,-0.636972370014478,52796.0821529745,33333.8300283286,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_221205,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
221526,4975.72452830189,236.366037735849,86.6415094339623,611.22641509434,611.42641509434,703.422641509434,439.381132075472,275.230188679245,1137.33962264151,8615.82641509434,592.630188679245,127.384905660377,1075.01132075472,848.716981132075,452.558490566038,280.966037735849,1496.77735849057,993.77358490566,202.577358490566,211.11320754717,1189.75471698113,668.207547169811,137.124528301887,110.867924528302,602.581132075472,2344.60754716981,514.094339622642,252.256603773585,1048.34716981132,129.415094339623,265,19.6999646567075,17.1847107404492,0.488931989419412,0.970695970695971,0.774853801169591,0.943408527407056,53305.7132075472,32749.8452830189,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_221526,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
223320,4492.44964028777,593.219424460432,1177.40647482014,620.629496402878,1101.46402877698,714.26618705036,443.661870503597,242.561151079137,1076.57553956835,7171.32014388489,558.312949640288,120.028776978417,1085.34532374101,1458.73741007194,577.043165467626,329.424460431655,1812.08273381295,2171.13669064748,366.535971223022,241.485611510791,988.737410071942,2463.41366906475,274.294964028777,169.665467625899,590.197841726619,2513.70863309353,551.571942446043,265.017985611511,1067.18705035971,131.08273381295,278,22.0039868559269,16.2634525795787,0.673580463055756,0.961937716262976,0.696741854636591,0.859856837636968,53619.7697841727,33542.9892086331,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_223320,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
223541,3869.88390501319,301.620052770449,113.920844327177,681.612137203166,3654.60422163588,1902.12137203166,377.569920844327,249.997361477573,1114.01319261214,6005.43007915567,593.620052770449,127.815303430079,1088.02374670185,2573.5963060686,650.506596306069,334.406332453826,5247.07387862797,2319.40633245383,380.456464379947,244.35092348285,1031.37994722955,1730.86807387863,246.387862796834,433.89709762533,2482.16622691293,1593.5382585752,508.580474934037,430.757255936675,1055.04221635884,131.271767810026,379,23.1715863145094,21.0199302616527,0.420823623404123,0.949874686716792,0.784679089026915,-0.14448436666557,52945.5092348285,33571.1187335092,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,9,FAAGSCC_12_223541,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
224432,2634.5632798574,535.181818181818,148.860962566845,665.433155080214,2770.67914438503,326.344028520499,283.969696969697,249.383244206774,1086.93404634581,4741.65418894831,3158.35472370767,119.743315508021,1080.1265597148,799.818181818182,502.561497326203,271.853832442068,1539.68983957219,2147.92869875223,312.17825311943,224.098039215686,1016.93939393939,2286.99643493761,216.707664884135,143.969696969697,582.79679144385,1264.14795008913,477.016042780749,434.436720142602,1059.29768270945,130.896613190731,561,34.7722062917403,20.6992163220927,0.803517969424435,0.955706984667802,0.717391304347826,-1.207890940673,53840.4028520499,32933.3796791444,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_224432,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
224610,989.740318906606,88.9908883826879,58.2346241457859,611.51708428246,490.243735763098,668.763097949886,431.927107061503,281.630979498861,1140.89749430524,2466.2277904328,563.266514806378,117.583143507973,1067.86788154897,935.257403189066,539.400911161731,282.726651480638,1642.5444191344,1030.08428246014,231.897494305239,215.69020501139,1111.40091116173,828.628701594533,164.895216400911,128.933940774487,2375.05011389522,1422.42824601367,454.997722095672,216.348519362187,1013.0159453303,128.902050113895,439,31.0157963818314,18.0661321280663,0.812843854678772,0.962719298245614,0.78673835125448,1.50268761155811,52939.5216400911,32472.9908883827,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_224610,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
225520,2390.50909090909,619.00303030303,471.687878787879,625.127272727273,977.587878787879,319.745454545454,1366.33333333333,247.163636363636,1091.94545454545,4244.17575757576,585.139393939394,112.890909090909,1083.66060606061,870.012121212121,518.939393939394,445.921212121212,1557.1,2461.79090909091,283.778787878788,229.093939393939,1018.3,2753.58484848485,211.215151515152,206.024242424242,613.227272727273,1130.27575757576,446.615151515152,275.278787878788,1031.97575757576,131.60303030303,330,21.0126772779493,20.1127682091769,0.289516441034399,0.967741935483871,0.785714285714286,-1.29023949270129,53281.6393939394,33514.5454545455,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_225520,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
227294,3737.20238095238,132.261904761905,89.6071428571429,627.97619047619,1614.6369047619,499.547619047619,968.946428571429,274.970238095238,1088.54761904762,6388.91666666667,517.059523809524,121.970238095238,1077.78571428571,850.214285714286,542.821428571429,285.440476190476,1550.94642857143,1183.91071428571,293.791666666667,226.642857142857,1156.81547619048,1081.1369047619,207.761904761905,322.029761904762,725.047619047619,2155.27976190476,501.22619047619,233.315476190476,1043.3630952381,130.422619047619,168,18.7359193495798,11.4456924158775,0.791711092207599,0.949152542372881,0.803827751196172,-0.0125536741687762,52859.9761904762,32820.75,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,1,FAAGSCC_12_227294,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
227322,3673.28431372549,533.869281045752,93.4281045751634,646.290849673203,1743.8431372549,1495.14379084967,1410.44117647059,247.633986928104,1129.36928104575,5410.42810457516,769.444444444444,127.343137254902,1110.66339869281,3092.33660130719,1172.24836601307,767.035947712418,6465.03921568627,6823.56535947712,458.519607843137,245.173202614379,1078.76797385621,6101.15359477124,294.513071895425,254.993464052288,681.93137254902,1232.59803921569,487.062091503268,348.12091503268,1045.82352941176,131.372549019608,306,23.0627477544498,16.9633810796086,0.677490354904925,0.953271028037383,0.728571428571429,-0.72077283554062,53185.6764705882,33704.1307189542,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_227322,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
227489,3734.5247148289,509.965779467681,180.372623574144,654.114068441065,2624.10646387833,505.954372623574,309.942965779468,247.638783269962,1108.98479087452,5855.4752851711,625.216730038023,126.053231939163,1078.27756653992,1223.46007604563,770.121673003802,286.631178707224,1715.40304182509,1290.90114068441,302.832699619772,231.41825095057,988.821292775665,1141.97718631179,228.520912547528,157.235741444867,585.384030418251,1222.0,523.277566539924,232.285171102662,1042.30418250951,132.410646387833,263,19.3054754698717,17.4316525640071,0.429770271216645,0.966911764705882,0.769005847953216,0.896210940690122,53860.6045627377,33154.0570342205,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_227489,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
227678,5442.12131147541,519.386885245902,128.816393442623,654.580327868852,2082.88852459016,2887.44262295082,808.111475409836,258.318032786885,1133.04918032787,8341.60983606557,642.301639344262,133.960655737705,1090.06229508197,892.416393442623,663.75737704918,343.603278688525,3304.37049180328,1637.63278688525,312.980327868852,304.977049180328,1014.85573770492,2022.41967213115,225.918032786885,196.577049180328,611.081967213115,1442.90491803279,479.593442622951,237.098360655738,1046.08524590164,133.04262295082,305,21.9246075896929,17.7751200551754,0.585408692448336,0.965189873417722,0.726190476190476,0.537789914497829,52661.3442622951,33565.0524590164,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_227678,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
228566,4239.51736111111,440.284722222222,2154.5,661.756944444444,2499.77777777778,827.197916666667,1209.43402777778,251.211805555556,1100.25,5755.74305555556,704.440972222222,141.413194444444,1089.01388888889,733.475694444444,502.541666666667,507.892361111111,1624.64236111111,1122.21180555556,276.274305555556,224.465277777778,1003.47222222222,1047.34375,222.336805555556,212.736111111111,611.836805555556,1423.97222222222,539.892361111111,444.628472222222,1049.84027777778,131.621527777778,288,25.0848155825787,14.6972567996524,0.810381534032364,0.956810631229236,0.654545454545455,0.919259372524103,53274.0798611111,33904.40625,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_228566,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
228802,2824.51,101.866666666667,124.476666666667,705.65,5031.07,415.413333333333,321.736666666667,264.896666666667,1086.66666666667,5256.38666666667,629.93,139.056666666667,1073.27666666667,801.576666666667,522.94,315.856666666667,1414.77,1041.33,298.016666666667,225.54,978.48,958.846666666667,213.323333333333,123.943333333333,607.146666666667,1191.08,476.986666666667,232.876666666667,1047.37333333333,131.596666666667,300,22.7414902777035,16.8524234312063,0.67145751213275,0.961538461538462,0.72463768115942,-1.26252854494883,53333.91,32698.1866666667,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_228802,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
228829,1683.1439688716,430.322957198444,209.599221789883,697.696498054475,4388.39299610895,390.513618677043,297.68093385214,254.634241245136,1080.7859922179,1890.21789883268,671.552529182879,138.050583657588,1074.87937743191,3400.30350194553,925.583657587549,295.482490272374,1920.92217898833,4592.6186770428,396.175097276265,235.311284046693,1017.71984435798,3436.77042801556,250.875486381323,163.984435797665,590.4046692607,973.373540856031,451.268482490272,219.863813229572,1054.48249027237,130.785992217899,257,23.8669562195865,13.7250953363122,0.818106422072968,0.948339483394834,0.730113636363636,1.15766242000141,52509.420233463,32304.4280155642,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_228829,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
229048,3665.00879765396,769.466275659824,84.7741935483871,638.058651026393,1389.82991202346,1278.28445747801,921.533724340176,245.096774193548,1111.75953079179,4918.46041055718,1131.85923753666,135.99706744868,1085.77126099707,3487.85630498534,784.492668621701,363.237536656892,2707.23460410557,6611.21407624633,499.979472140762,254.319648093842,1219.6275659824,6007.29618768328,24520.2404692082,316.445747800587,604.718475073314,1166.80058651026,493.046920821114,368.243401759531,1050.93255131965,131.173020527859,341,23.5357875710765,18.5121710906229,0.617521326728069,0.96600566572238,0.811904761904762,0.657560188437886,53190.2991202346,33760.9237536657,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67+,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_229048,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
232099,4473.16993464052,641.630718954248,138.960784313725,650.885620915033,2312.10784313725,2202.49673202614,1891.40522875817,259.202614379085,1106.16993464052,7003.28758169935,1581.1045751634,124.049019607843,1089.29738562092,3349.98039215686,1002.83333333333,1715.49346405229,1990.69281045752,3434.0,366.519607843137,230.133986928104,1060.77777777778,3108.80065359477,229.470588235294,339.78431372549,676.777777777778,1919.63725490196,560.777777777778,558.071895424837,1065.09150326797,131.529411764706,306,24.1586118441514,16.3362005545857,0.736712507203378,0.953271028037383,0.693877551020408,0.841833860093459,53998.4673202614,33235.2810457516,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_232099,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
232754,4347.84806629834,489.629834254144,145.781767955801,638.665745856354,987.707182320442,4761.01933701657,533.419889502762,269.859116022099,1139.70165745856,6715.52486187845,1161.59116022099,126.502762430939,1078.86464088398,5571.56077348066,2524.93370165746,377.629834254144,9500.57182320442,8135.48342541436,578.486187845304,754.461325966851,1134.05801104972,7675.95303867403,325.632596685083,348.348066298343,642.497237569061,2186.85082872928,538.069060773481,457.276243093923,1050.90331491713,131.756906077348,362,26.3041472758912,17.5950471861352,0.743345452569757,0.952631578947368,0.773504273504274,0.140320852424468,52683.1104972376,33658.1022099448,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_232754,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
232853,2046.64264264264,243.942942942943,71.3333333333333,613.021021021021,854.630630630631,3233.28828828829,573.18018018018,264.162162162162,1087.6006006006,3036.08108108108,1267.18318318318,112.807807807808,1072.05405405405,2458.34834834835,493.144144144144,278.702702702703,2522.57957957958,1648.63963963964,271.279279279279,221.204204204204,995.225225225225,1732.12912912913,204.63963963964,124.657657657658,586.495495495495,949.948948948949,450.912912912913,262.837837837838,1025.24924924925,129.960960960961,333,22.6904965386796,18.7160872724385,0.565362494133546,0.959654178674352,0.762013729977117,-0.206849541022708,54017.1351351351,32887.7207207207,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_232853,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
232935,2537.9190647482,462.537769784173,1077.73021582734,608.834532374101,593.156474820144,2793.02338129496,356.685251798561,265.798561151079,1106.02877697842,5239.45323741007,484.962230215827,113.652877697842,1073.96402877698,1991.53237410072,568.158273381295,289.019784172662,1578.42985611511,1696.98741007194,276.969424460432,222.086330935252,999.5,1705.48561151079,196.35071942446,142.08273381295,585.580935251799,2616.70143884892,561.938848920863,242.43345323741,1034.05395683453,130.043165467626,556,31.4641105506526,23.0423516104974,0.680941716179763,0.963604852686308,0.702020202020202,-1.46574037409266,53634.6600719424,33096.3147482014,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_232935,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
233786,3426.29288702929,1038.48953974895,256.125523012552,702.782426778243,5465.23849372385,371.753138075314,282.644351464435,237.297071129707,1078.82426778243,5921.60251046025,993.435146443515,121.874476987448,1075.08368200837,2430.02510460251,521.497907949791,297.510460251046,3401.34309623431,5509.42677824268,414.284518828452,239.589958158996,1050.03765690377,5859.77405857741,260.117154811715,188.824267782427,611.81589958159,1741.53138075314,499.945606694561,311.991631799163,1051.31380753138,130.083682008368,239,19.1780305875885,15.9743516737148,0.553347389678729,0.937254901960784,0.739938080495356,-1.56869956409007,53907.1589958159,33575.8033472803,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_233786,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
233923,1841.72429906542,168.41277258567,124.805295950156,682.082554517134,3994.57009345794,341.926791277259,453.056074766355,256.261682242991,1083.42679127726,3535.19003115265,674.242990654206,174.5,1071.69470404984,751.906542056075,828.638629283489,1234.4937694704,1583.05295950156,1058.26479750779,271.901869158879,223.048286604361,1004.52180685358,937.604361370717,199.526479750779,360.842679127726,684.277258566978,1238.3769470405,464.901869158879,235.370716510903,1051.10747663551,129.947040498442,642,32.9318846064062,24.8776257216226,0.655233137004634,0.965413533834586,0.778181818181818,-0.109784302113245,52733.5685358255,32904.6619937695,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,1,FAAGSCC_12_233923,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
233948,2788.86910994764,592.458115183246,131.717277486911,640.356020942408,1533.1832460733,359.130890052356,474.761780104712,245.484293193717,1075.53664921466,4961.52617801047,1217.78534031414,120.879581151832,1076.32460732984,831.473821989529,560.321989528796,336.337696335079,1859.28272251309,1140.02617801047,275.05497382199,230.727748691099,995.324607329843,1050.16753926702,209.353403141361,192.921465968586,590.178010471204,1945.57591623037,509.081151832461,349.714659685864,1060.54188481675,131.178010471204,382,27.3920867364617,18.0455870574417,0.752328343985716,0.94320987654321,0.667832167832168,0.540342592017028,52649.7015706806,33691.2356020942,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_233948,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
234111,3585.12043795621,415.63503649635,145.660583941606,631.510948905109,1859.58394160584,289.379562043796,276.481751824818,247.704379562044,1074.06934306569,5786.93430656934,582.124087591241,125.485401459854,1068.79562043796,616.653284671533,446.025547445255,263.777372262774,1419.55474452555,872.255474452555,229.226277372263,213.328467153285,982.069343065693,798.434306569343,174.737226277372,117.711678832117,578.313868613139,1673.97445255474,505.244525547445,244.759124087591,1018.39051094891,128.496350364963,274,21.4483204737903,16.360646634369,0.646641759299039,0.964788732394366,0.732620320855615,0.374292595152398,53867.4671532847,32878.4452554744,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_234111,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
234254,2681.39386792453,535.931603773585,125.075471698113,659.431603773585,1862.59433962264,285.924528301887,300.790094339623,254.028301886792,1081.81839622642,3728.85141509434,1335.13443396226,127.971698113208,1066.98820754717,1489.05188679245,557.292452830189,310.235849056604,1655.48113207547,3490.21933962264,429.877358490566,247.64858490566,1034.79245283019,3950.8608490566,286.110849056604,305.754716981132,591.537735849057,755.365566037736,389.483490566038,217.778301886792,1038.88679245283,131.483490566038,424,31.157572067753,17.4691363834244,0.828038897056644,0.957110609480813,0.759856630824373,0.0384261092916801,52385.5471698113,32460.5683962264,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_234254,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
234440,4234.90662650602,926.189759036145,141.457831325301,653.653614457831,2703.78614457831,311.481927710843,299.171686746988,235.704819277108,1071.65963855422,6177.23192771084,1351.35542168675,127.647590361446,1095.86445783133,688.370481927711,530.265060240964,302.168674698795,1540.18674698795,1028.63253012048,239.171686746988,222.41265060241,1006.14457831325,924.581325301205,184.268072289157,182.939759036144,651.436746987952,1673.92771084337,523.906626506024,419.563253012048,1055.90361445783,131.442771084337,332,23.8540333723883,17.8001163628067,0.665710713089245,0.956772334293948,0.728070175438597,0.441501119796897,53091.8343373494,33508.6265060241,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_234440,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
234653,4293.9527027027,822.648648648649,244.469594594595,699.726351351351,3936.37837837838,235.108108108108,253.618243243243,245.179054054054,1070.91216216216,7231.31756756757,3671.22972972973,144.763513513514,1072.36486486486,545.368243243243,383.952702702703,260.307432432432,1369.14189189189,844.881756756757,238.148648648649,220.158783783784,986.722972972973,793.317567567568,191.932432432432,124.023648648649,583.560810810811,2495.64527027027,547.152027027027,861.445945945946,1098.21959459459,130.64527027027,296,26.3666077954622,14.3332437531301,0.839335672186336,0.957928802588997,0.758974358974359,-1.34718510590058,52727.1216216216,32678.8378378378,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_234653,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
235300,2648.88235294118,261.779411764706,297.921568627451,826.779411764706,9273.29411764706,3571.75980392157,409.808823529412,269.367647058824,1123.39215686275,4254.62254901961,575.5,133.166666666667,1071.75490196078,6886.6862745098,931.926470588235,531.627450980392,7515.87254901961,5797.02450980392,430.857843137255,247.161764705882,1097.40196078431,4739.49509803922,249.622549019608,252.75,787.299019607843,1159.23529411765,455.960784313726,242.03431372549,1063.0931372549,130.705882352941,204,21.5489101264307,12.1035083550453,0.827357195959095,0.944444444444444,0.772727272727273,0.071349995422842,52860.387254902,33689.3774509804,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_235300,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
236501,4516.12063492063,1143.04126984127,1332.08253968254,619.8,981.634920634921,353.730158730159,457.949206349206,251.244444444444,1085.26349206349,7209.0126984127,595.377777777778,124.279365079365,1111.36825396825,687.72380952381,446.6,269.295238095238,1392.95873015873,1193.8,284.638095238095,223.501587301587,979.304761904762,1492.01587301587,211.101587301587,134.371428571429,582.15873015873,1577.46349206349,506.64126984127,240.653968253968,1041.54285714286,132.320634920635,315,24.4418144149709,16.4491865402072,0.739648235021385,0.957446808510638,0.729166666666667,0.343815748676096,53531.2698412698,32954.6825396825,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_236501,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
236839,4111.59223300971,581.019417475728,132.325242718447,637.742718446602,1609.46116504854,287.019417475728,457.18932038835,241.305825242718,1084.28155339806,7131.48058252427,1350.46601941748,126.927184466019,1085.64077669903,723.815533980582,660.174757281553,1063.33009708738,1645.23786407767,1197.52912621359,263.155339805825,221.553398058252,1019.9854368932,1090.86893203884,195.097087378641,430.247572815534,626.354368932039,2135.07281553398,545.669902912621,354.771844660194,1072.02427184466,130.339805825243,206,16.9326503039622,15.5373064316797,0.397517763544552,0.958139534883721,0.757352941176471,1.05346925624745,54011.2718446602,33275.5582524272,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_236839,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
237068,2286.16699801193,232.322067594433,148.872763419483,704.936381709742,4954.21669980119,283.031809145129,281.019880715706,255.666003976143,1082.09145129225,3753.18687872763,639.817097415507,135.652087475149,1073.98807157058,696.290258449304,477.071570576541,267.644135188867,1357.78330019881,1013.68389662028,294.320079522863,224.061630218688,979.093439363817,958.89662027833,207.548707753479,112.558648111332,586.666003976143,988.357852882704,482.570576540755,227.200795228628,1048.70576540755,132.848906560636,503,32.5506082907639,20.2522243371921,0.782876984169677,0.956273764258555,0.748511904761905,1.50588903007952,53190.6799204771,32606.393638171,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_237068,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
237259,3124.45253863135,514.14348785872,127.406181015453,653.845474613687,2060.64238410596,1760.39514348786,386.841059602649,267.068432671082,1114.97792494481,5462.46136865342,2182.86534216336,130.724061810155,1069.18322295806,1280.82560706402,515.251655629139,280.891832229581,1765.32450331126,1041.0353200883,209.543046357616,210.086092715232,1173.50331125828,716.969094922737,149.456953642384,123.370860927152,1015.79690949227,1364.34437086093,472.097130242826,447.686534216336,1077.74392935982,131.534216335541,453,28.8208230896891,20.3681121654571,0.707498200700168,0.937888198757764,0.696923076923077,0.587367382663966,52505.472406181,32591.4194260486,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_237259,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
238120,4814.52887537994,853.683890577508,338.9726443769,706.787234042553,5552.39209726444,528.878419452888,259.51367781155,237.620060790274,1094.24012158055,7445.81762917933,774.452887537994,131.091185410334,1084.19452887538,2066.26747720365,637.158054711246,295.19452887538,1937.80243161094,3220.18237082067,334.118541033435,228.188449848024,1035.98176291793,2174.95440729483,217.705167173252,157.082066869301,583.313069908815,1788.13069908815,530.376899696049,246.887537993921,1060.33130699088,130.404255319149,329,27.4716521090495,15.286788259073,0.830876527516781,0.964809384164223,0.650197628458498,-0.8529751935461,53724.452887538,33287.3069908815,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_238120,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
238321,3810.74761904762,1068.17142857143,121.280952380952,639.619047619048,1621.15714285714,275.104761904762,280.111904761905,244.216666666667,1076.0380952381,5662.4,1132.27142857143,124.778571428571,1090.31904761905,696.338095238095,464.683333333333,275.083333333333,1452.34285714286,1129.90476190476,323.378571428571,234.954761904762,985.711904761905,1086.29761904762,247.045238095238,138.22619047619,582.616666666667,1369.42142857143,501.497619047619,326.845238095238,1071.32857142857,131.688095238095,420,23.890291910847,22.484168933747,0.33801006526999,0.967741935483871,0.793950850661626,-0.938208169471365,52726.4119047619,33363.3595238095,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_238321,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
238343,3107.24090909091,154.2,59.0136363636364,621.872727272727,720.063636363636,1237.83636363636,962.645454545454,259.831818181818,1084.93181818182,4908.12727272727,658.522727272727,131.563636363636,1071.77272727273,1576.00454545455,1224.20909090909,768.968181818182,1590.74090909091,1671.75909090909,333.440909090909,228.931818181818,1011.18636363636,1189.30909090909,220.15,291.022727272727,630.277272727273,1242.45454545455,528.204545454545,237.986363636364,1024.01363636364,130.745454545455,220,25.4675971706654,11.1359965864107,0.899334469992127,0.948275862068966,0.769230769230769,-1.56211911099709,53253.8772727273,32936.4227272727,FAAGSCC_12,AG,1,stromal cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_238343,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
239191,3127.49397590361,391.149397590362,134.26265060241,656.739759036145,3099.7734939759,628.060240963855,522.185542168675,257.961445783133,1086.60481927711,5013.06506024096,599.472289156627,129.90843373494,1070.90843373494,2966.24578313253,942.703614457831,1099.33493975904,1610.98072289157,4338.92530120482,360.544578313253,230.477108433735,996.874698795181,3823.2265060241,253.619277108434,543.573493975904,665.797590361446,1667.19277108434,494.221686746988,239.867469879518,1057.49638554217,130.893975903614,415,34.3297171908992,15.5665037641501,0.891286258299031,0.960648148148148,0.698653198653199,1.27949258985481,53748.2771084337,32283.0843373494,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_239191,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
240066,5402.1519434629,1136.01060070671,166.265017667845,689.501766784452,3855.93992932862,4524.40636042403,401.73851590106,267.229681978799,1149.04593639576,8606.90106007067,597.939929328622,140.512367491166,1079.87279151943,5589.51590106007,790.226148409894,318.851590106007,2047.28975265018,4781.8445229682,373.872791519435,238.575971731449,1019.78798586572,3645.68197879859,717.222614840989,260.180212014134,587.293286219081,2865.03180212014,556.34628975265,271.360424028269,1076.87279151943,129.420494699647,283,20.7586291224324,17.3961503276155,0.545639222054366,0.972508591065292,0.832352941176471,-0.313759081646384,53622.9363957597,33825.6572438163,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_240066,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
240700,4733.11111111111,1571.9873015873,153.84126984127,653.269841269841,2103.20634920635,1212.1873015873,437.114285714286,251.193650793651,1096.58095238095,7291.35238095238,667.438095238095,125.244444444444,1095.27619047619,811.663492063492,642.990476190476,292.031746031746,1725.14603174603,1185.83492063492,295.860317460317,226.64126984127,995.730158730159,1066.21587301587,217.015873015873,137.352380952381,596.139682539683,1892.27301587302,523.092063492064,241.657142857143,1057.57142857143,130.152380952381,315,21.9999338903724,18.3952880543103,0.548497842906244,0.957446808510638,0.75,-1.00686513111593,53187.6698412698,33381.3650793651,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_240700,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
240937,1783.05333333333,883.493333333333,451.22,612.646666666667,426.36,713.213333333333,610.84,243.673333333333,1072.38,2401.04666666667,526.953333333333,114.08,1068.33333333333,1593.13333333333,1163.34,2264.58666666667,1653.6,1173.83333333333,234.56,216.02,1014.57333333333,1059.82666666667,178.106666666667,512.793333333333,757.393333333333,1062.65333333333,495.126666666667,241.026666666667,1027.38666666667,130.346666666667,150,15.4753096036469,12.4160735162193,0.59690082074356,0.961538461538462,0.769230769230769,-0.308687995960047,53728.1133333333,32839.62,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_240937,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
241051,2749.26315789474,263.708771929825,128.498245614035,654.326315789474,2766.28070175439,1824.02807017544,366.61052631579,259.105263157895,1090.05263157895,4368.32631578947,486.99649122807,125.20350877193,1075.84912280702,670.694736842105,457.417543859649,274.79649122807,1473.35438596491,988.498245614035,270.084210526316,220.971929824561,988.768421052632,901.740350877193,200.617543859649,147.785964912281,591.726315789474,1351.20701754386,467.526315789474,218.922807017544,1039.14385964912,130.414035087719,285,24.6421298549369,15.0601382159073,0.791511648522463,0.931372549019608,0.7421875,-1.46281701066188,53832.1368421053,32367.2315789474,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_241051,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
241491,3490.42045454545,122.198863636364,155.255681818182,669.977272727273,3899.84090909091,915.784090909091,831.681818181818,250.227272727273,1090.83522727273,5750.5,531.403409090909,125.471590909091,1078.23863636364,651.948863636364,461.897727272727,278.551136363636,1563.97727272727,1035.17045454545,252.767045454545,218.272727272727,1005.48295454545,993.284090909091,195.840909090909,229.125,707.715909090909,1649.38636363636,483.534090909091,229.051136363636,1044.40340909091,130.255681818182,176,16.6500182557941,13.5135198422914,0.584183064946952,0.961748633879781,0.785714285714286,1.26030950164968,53196.0625,33102.0227272727,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_241491,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
241642,3611.21204188482,453.05497382199,173.623036649215,663.0,3146.87958115183,1409.58638743456,466.13612565445,268.437172774869,1089.35863874346,5004.60209424084,2836.65706806283,132.476439790576,1073.69371727749,1612.83507853403,482.314136125654,287.727748691099,1487.24869109948,1149.5497382199,282.416230366492,219.887434554974,991.746073298429,977.379581151832,189.32722513089,188.866492146597,593.607329842932,1316.7722513089,458.256544502618,327.599476439791,1052.04188481675,130.109947643979,382,28.7560306604404,16.9808760310101,0.807026444523374,0.952618453865337,0.718045112781955,-0.367768744346757,53220.1204188482,32200.7565445026,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_241642,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
242031,3671.71428571429,765.492711370262,135.743440233236,625.131195335277,1638.85131195335,389.107871720117,282.064139941691,245.583090379009,1103.09912536443,7136.52186588921,681.355685131195,118.381924198251,1080.6472303207,1067.41982507289,728.326530612245,268.615160349854,1721.93586005831,2100.21574344023,263.172011661808,218.591836734694,1019.12827988338,2526.96793002915,221.793002915452,253.075801749271,890.137026239067,1861.27696793003,505.758017492711,233.361516034985,1044.34110787172,129.790087463557,343,26.2504609086495,16.7159978956473,0.771038327259465,0.950138504155125,0.747276688453159,1.53560211077013,54133.2565597668,32650.4110787172,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_242031,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
242195,5238.45901639344,692.570491803279,207.049180327869,704.839344262295,4237.1606557377,298.95737704918,309.701639344262,250.15737704918,1081.74754098361,6848.88524590164,628.213114754098,137.773770491803,1097.82950819672,617.098360655738,458.934426229508,278.888524590164,1424.20655737705,914.059016393443,271.272131147541,220.914754098361,988.350819672131,835.95737704918,192.281967213115,137.193442622951,590.36393442623,1185.78032786885,477.583606557377,232.449180327869,1050.05573770492,131.0,305,20.2833943632729,19.1842233725221,0.324722551670289,0.971337579617834,0.802631578947368,0.208618226266319,53155.5606557377,33023.2131147541,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_242195,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
242414,2235.94951923077,205.122596153846,114.576923076923,646.800480769231,2539.82451923077,1061.64423076923,3200.79326923077,242.629807692308,1092.27884615385,3713.15865384615,544.795673076923,118.84375,1086.08653846154,717.826923076923,529.84375,495.387019230769,1501.59134615385,1042.94230769231,295.637019230769,233.536057692308,1000.53605769231,998.064903846154,229.084134615385,188.324519230769,587.223557692308,1502.05528846154,526.776442307692,281.478365384615,1029.21394230769,129.699519230769,416,28.2794842218321,19.9452112703907,0.708919826624293,0.947608200455581,0.7336860670194,-0.237353670241557,53468.8221153846,33563.9567307692,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_242414,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
242434,3754.18559556787,790.614958448753,117.335180055402,637.601108033241,1663.07756232687,1419.43213296399,1083.87534626039,254.717451523546,1093.83379501385,6490.891966759,606.448753462604,120.279778393352,1086.07202216066,4849.59833795014,761.883656509695,572.637119113573,2630.0027700831,6537.92797783933,432.174515235457,253.692520775623,1025.04432132964,6295.49861495845,285.152354570637,498.18836565097,689.81163434903,2460.40997229917,523.92243767313,251.506925207756,1052.96675900277,130.396121883657,361,21.7306202268303,21.3298608145641,0.191165352567656,0.945026178010471,0.745867768595041,-0.654841703469077,53570.2603878116,33426.2880886427,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_242434,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
243237,2875.46979865772,241.640939597315,96.4261744966443,619.164429530201,700.369127516779,442.86577181208,311.674496644295,267.530201342282,1089.54026845638,3790.51677852349,704.862416107383,122.389261744966,1063.79530201342,1027.05033557047,612.513422818792,277.593959731544,1878.3255033557,1755.10738255034,353.667785234899,237.08389261745,1054.93959731544,1361.85234899329,224.714765100671,327.56711409396,4683.26845637584,1089.87583892617,451.020134228188,249.771812080537,1044.09731543624,130.070469798658,298,23.1978512188985,16.5107643952072,0.702446245214382,0.946031746031746,0.712918660287081,-1.09361293681734,53098.6275167785,32050.2281879195,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,1,FAAGSCC_12_243237,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
244240,1705.45054945055,462.915750915751,110.824175824176,609.124542124542,807.07326007326,2428.69230769231,1089.52014652015,258.615384615385,1149.86446886447,3248.45787545788,637.710622710623,110.611721611722,1084.50183150183,6155.25641025641,906.794871794872,390.868131868132,1881.10622710623,8325.91941391941,467.725274725275,255.787545787546,1033.56043956044,6817.19413919414,293.589743589744,217.336996336996,593.582417582418,1454.93772893773,499.783882783883,241.915750915751,1032.61538461538,130.0,273,19.8056950243827,17.5949926115334,0.459107987701713,0.964664310954064,0.798245614035088,0.697625874865151,53317.7692307692,33485.6117216117,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_244240,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
244533,4404.79754601227,1658.3773006135,211.592024539877,688.883435582822,3652.80061349693,655.239263803681,1095.88036809816,255.273006134969,1086.0,7065.88957055215,630.205521472393,133.039877300613,1083.66257668712,886.328220858896,766.638036809816,305.920245398773,1575.97239263804,1277.25766871166,332.291411042945,235.315950920245,986.279141104294,1121.08895705521,238.036809815951,175.374233128834,626.423312883436,1810.73006134969,497.947852760736,227.766871165644,1062.28527607362,131.113496932515,326,24.2251323151985,17.1666126482347,0.705582051087135,0.958823529411765,0.740909090909091,-0.571728640347399,52634.6595092025,33416.245398773,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_244533,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
245021,1898.19565217391,492.760869565217,660.782608695652,646.277173913043,1260.5652173913,3608.58152173913,404.967391304348,254.010869565217,1084.16847826087,3501.67934782609,491.804347826087,112.135869565217,1074.58152173913,1781.04891304348,567.983695652174,305.864130434783,1754.55434782609,2302.54347826087,293.880434782609,229.83152173913,1009.75543478261,2669.53260869565,226.027173913043,162.157608695652,591.885869565217,1546.67391304348,516.869565217391,652.472826086957,1036.25,130.972826086957,184,17.4722457420211,13.4034891345482,0.641491310421952,0.968421052631579,0.766666666666667,0.651334121711094,53642.9945652174,33578.5380434783,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_245021,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
245278,1466.49212598425,438.299212598425,86.3228346456693,624.838582677165,1383.64960629921,289.370078740157,315.44094488189,245.834645669291,1073.16929133858,3280.82677165354,440.38188976378,106.173228346457,1067.12204724409,604.830708661417,669.397637795276,284.153543307087,1649.56692913386,908.015748031496,217.452755905512,209.393700787402,992.326771653543,833.153543307087,175.204724409449,126.905511811024,583.574803149606,1432.44881889764,478.503937007874,226.834645669291,1029.27559055118,129.606299212598,254,19.9899983652466,16.1919614907133,0.586425536142901,0.954887218045113,0.742690058479532,-0.863865399753946,53669.2047244095,33170.6417322835,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_245278,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
245422,5125.4,508.053571428571,190.478571428571,667.828571428571,3053.47142857143,3249.825,863.482142857143,258.25,1130.85357142857,7888.16785714286,599.771428571429,129.171428571429,1106.71785714286,3532.975,1114.79285714286,468.457142857143,1701.85714285714,1747.49285714286,313.557142857143,230.228571428571,999.025,1292.92142857143,219.635714285714,445.339285714286,668.960714285714,1486.86071428571,471.985714285714,295.371428571429,1268.81428571429,133.328571428571,280,19.9631129561017,17.8798894748412,0.444766900628805,0.972222222222222,0.777777777777778,1.36382476287111,52723.4142857143,33424.4357142857,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_245422,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
245832,884.633802816901,266.62441314554,85.6384976525822,624.990610328638,936.516431924883,294.511737089202,304.816901408451,255.643192488263,1085.54929577465,1956.64788732394,1301.86854460094,110.239436619718,1064.05164319249,747.694835680751,502.31455399061,280.469483568075,1413.24882629108,1096.23943661972,313.12676056338,233.0,986.093896713615,1060.82159624413,235.511737089202,148.586854460094,609.8779342723,1249.05164319249,442.178403755868,308.417840375587,1050.37089201878,131.140845070423,213,18.3799615140352,14.790587097243,0.593664542839151,0.963800904977376,0.788888888888889,1.37470383348799,52470.7183098592,33106.9483568075,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_245832,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
245904,1797.83225806452,240.703225806452,112.129032258065,624.625806451613,1792.06451612903,2789.12580645161,571.332258064516,272.58064516129,1104.37419354839,2452.8064516129,490.18064516129,114.061290322581,1065.63870967742,1604.92580645161,600.8,279.667741935484,1494.93548387097,1186.92258064516,280.68064516129,225.732258064516,1003.97096774194,977.670967741935,230.370967741935,124.025806451613,584.845161290323,982.622580645161,500.438709677419,230.787096774194,1014.82903225806,131.022580645161,310,23.5347644754186,16.8835314196692,0.696674999251243,0.950920245398773,0.741626794258373,0.461447522819254,54087.5806451613,33049.0580645161,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_245904,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
246364,4487.31699346405,427.506535947712,107.045751633987,641.02614379085,1629.38562091503,1044.35294117647,337.797385620915,248.058823529412,1082.58823529412,7435.97058823529,662.277777777778,129.16339869281,1091.57843137255,1385.7908496732,1107.87581699346,437.300653594771,4227.01960784314,1970.19934640523,328.460784313725,237.009803921569,1040.31699346405,1907.29738562092,238.421568627451,202.359477124183,646.611111111111,2250.76797385621,541.493464052288,278.43137254902,1081.51960784314,130.915032679739,306,21.6028961739718,18.1161284875952,0.544751977685422,0.950310559006211,0.728571428571429,0.696935634459294,52830.4575163399,33494.5882352941,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_246364,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
246849,1816.84474885845,211.680365296804,132.876712328767,694.054794520548,4231.32420091324,804.990867579909,1989.50228310502,249.552511415525,1106.77625570776,2912.47488584475,960.009132420091,120.013698630137,1073.30136986301,2713.64383561644,1146.13242009132,1280.23744292237,6846.58447488584,3553.77625570776,403.936073059361,248.89497716895,1081.83105022831,1892.53881278539,223.438356164384,466.584474885845,661.406392694064,1144.26484018265,479.050228310502,334.255707762557,1047.32420091324,130.785388127854,219,17.3228265215314,16.1262557805328,0.365209895938663,0.969026548672566,0.805147058823529,0.447236246813174,53022.6757990868,33610.0228310502,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_246849,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
247812,2284.33450704225,699.507042253521,138.285211267606,656.380281690141,2390.62676056338,431.19014084507,1681.27464788732,255.049295774648,1089.2676056338,3214.0985915493,1018.45774647887,118.278169014085,1081.79577464789,766.806338028169,630.052816901409,613.644366197183,1505.71478873239,1210.01056338028,330.345070422535,247.154929577465,1002.44366197183,1112.03873239437,246.080985915493,319.183098591549,672.235915492958,1002.33098591549,479.87323943662,358.05985915493,1065.06690140845,130.320422535211,284,19.2996685635257,18.7472428771902,0.237545487525786,0.96271186440678,0.786703601108033,-1.46003171710873,53412.0176056338,33561.1971830986,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_247812,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
248344,2157.63613231552,159.547073791349,107.656488549618,653.173027989822,2058.25699745547,766.071246819338,869.325699745547,240.165394402036,1095.67684478372,3380.20356234097,539.847328244275,122.435114503817,1074.53435114504,2124.90839694657,716.582697201018,631.867684478372,4066.0,2047.43002544529,285.931297709924,227.211195928753,1023.53944020356,2069.3155216285,216.76844783715,273.936386768448,623.206106870229,1084.71755725191,478.847328244275,269.223918575064,1042.10941475827,131.465648854962,393,23.5894881972345,21.4139278439802,0.419459263334285,0.963235294117647,0.776679841897233,0.84805323800693,52943.0,33471.6106870229,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_248344,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
248573,2253.10266159696,263.292775665399,170.768060836502,697.178707224335,3735.2433460076,428.410646387833,287.74144486692,236.692015209125,1098.45247148289,4318.5855513308,586.159695817491,115.562737642586,1080.06463878327,941.836501901141,476.718631178707,272.93536121673,1856.15209125475,1349.19391634981,266.505703422053,227.680608365019,1035.48669201521,1056.4144486692,198.114068441065,142.589353612167,601.053231939164,1264.22813688213,479.395437262357,879.174904942966,1054.46007604563,130.920152091255,263,21.0831639510858,15.930232701785,0.655044581783412,0.956363636363636,0.773529411764706,-1.22780271776937,53791.6730038023,33490.1634980989,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_248573,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
249419,3402.34131736527,684.409181636727,365.756487025948,628.542914171657,887.862275449102,398.155688622754,513.718562874251,256.337325349301,1082.91816367265,6048.45109780439,680.996007984032,125.253493013972,1083.2255489022,1141.46706586826,550.169660678643,287.714570858283,1498.75648702595,2504.87025948104,345.622754491018,237.716566866267,1038.47305389222,2441.97005988024,238.86626746507,960.4750499002,1634.31137724551,2409.54091816367,534.580838323353,366.73253493014,1050.42315369261,130.213572854291,501,30.6403563911638,21.0511309454105,0.726620198807386,0.959770114942529,0.715714285714286,-0.548845495549695,53585.0299401198,33288.4051896208,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_249419,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
249488,1348.89081885856,440.275434243176,135.627791563275,639.277915632754,1954.06947890819,358.049627791563,355.846153846154,271.483870967742,1090.06699751861,1348.50620347395,3466.65756823821,127.920595533499,1071.53846153846,754.630272952854,566.816377171216,270.439205955335,1512.97022332506,1010.41935483871,281.915632754342,252.51364764268,992.183622828784,893.925558312655,199.074441687345,133.739454094293,589.411910669975,817.290322580645,447.205955334988,264.258064516129,1030.74937965261,131.940446650124,403,24.5411098150442,20.924989919072,0.522481673847307,0.966426858513189,0.799603174603175,0.0330423377391206,53355.2282878412,32041.6550868486,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_249488,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
249593,1284.07531380753,210.548117154812,94.0669456066946,645.598326359833,1705.4309623431,2365.87866108787,1690.10041841004,252.292887029289,1117.65690376569,2670.07531380753,657.832635983264,133.799163179916,1066.05439330544,1932.85355648536,1029.05857740586,1119.69456066946,1968.81171548117,2920.7489539749,395.401673640167,242.192468619247,1041.6359832636,2344.92468619247,284.439330543933,427.125523012552,671.083682008368,1503.89958158996,524.251046025105,545.167364016736,1070.44351464435,130.945606694561,239,20.5659223897661,14.8199347510879,0.693344398162299,0.952191235059761,0.739938080495356,0.902541103998383,53225.6569037657,33897.9037656904,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_249593,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
249732,5083.32413793103,434.144827586207,142.920689655172,651.920689655172,2239.60689655172,3725.6275862069,392.106896551724,269.634482758621,1087.38275862069,8356.68620689655,639.493103448276,148.689655172414,1092.09655172414,2249.79655172414,581.120689655172,341.937931034483,2210.20689655172,2441.68275862069,366.965517241379,243.734482758621,1003.33448275862,2097.37586206897,244.031034482759,205.748275862069,606.137931034483,3568.43103448276,571.958620689655,353.937931034483,1070.13793103448,129.924137931034,290,20.2127404139407,18.5230155413372,0.400256891220254,0.944625407166124,0.763157894736842,-1.32441220065131,53408.0931034483,33848.0965517241,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_249732,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
250031,4173.24473684211,775.342105263158,1322.33684210526,645.539473684211,2151.1,273.984210526316,311.223684210526,240.755263157895,1077.95789473684,6382.51052631579,731.252631578947,122.292105263158,1079.26578947368,695.005263157895,438.581578947368,336.023684210526,1412.82368421053,929.626315789474,239.613157894737,214.163157894737,993.155263157895,835.478947368421,186.468421052632,128.597368421053,583.318421052632,1358.84736842105,508.752631578947,311.968421052632,1043.86578947368,131.468421052632,380,29.1608481440282,16.6839964890018,0.820158154171109,0.957178841309824,0.678571428571429,-1.06954703941763,53745.8473684211,33304.3131578947,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_250031,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
250149,4843.52189781022,257.748175182482,116.642335766423,664.251824817518,2218.59124087591,2744.03284671533,358.919708029197,263.229927007299,1078.76277372263,8256.45255474453,1873.32846715328,136.948905109489,1102.07664233577,1958.54379562044,589.295620437956,570.441605839416,1797.74087591241,1602.63868613139,309.434306569343,225.138686131387,1083.76277372263,1442.27737226277,221.700729927007,887.704379562044,960.85401459854,2018.65328467153,497.080291970803,302.886861313869,1102.11678832117,132.642335766423,274,22.0966774649379,15.871723323493,0.695748460896241,0.964788732394366,0.761111111111111,-0.963143472436842,52425.7445255474,32581.6824817518,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_250149,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
250206,2242.77659574468,845.191489361702,611.563829787234,616.010638297872,1020.60638297872,227.648936170213,263.0,249.898936170213,1082.90957446809,2114.34574468085,590.218085106383,121.526595744681,1055.41489361702,575.728723404255,537.739361702128,264.239361702128,1409.15425531915,931.132978723404,286.409574468085,222.728723404255,977.867021276596,899.218085106383,212.11170212766,118.56914893617,584.898936170213,935.946808510638,505.744680851064,218.037234042553,1016.03191489362,128.851063829787,188,18.7549138000214,12.77629611946,0.73207510184413,0.964102564102564,0.803418803418803,-0.282078306257399,53695.7234042553,32077.3617021277,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_250206,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
250370,4237.24783861671,340.873198847262,205.951008645533,660.677233429395,2838.50432276657,265.184438040346,228.700288184438,230.097982708934,1080.8530259366,7231.59077809798,597.317002881844,142.685878962536,1098.93083573487,976.691642651297,558.037463976945,274.749279538905,1870.76657060519,2073.29971181556,336.510086455331,237.628242074928,1038.23919308357,1964.4121037464,233.172910662824,1384.59942363112,3791.46109510086,2222.43227665706,527.020172910663,317.412103746398,1080.76080691643,130.06916426513,347,22.9357777725823,19.3700921426997,0.53549863506448,0.971988795518207,0.794050343249428,-1.50904472454124,52863.3631123919,33867.6945244957,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_250370,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
250975,3838.97945205479,330.345890410959,180.434931506849,698.335616438356,3878.14726027397,439.284246575342,328.489726027397,241.969178082192,1075.01712328767,7120.97602739726,2363.49315068493,128.753424657534,1085.91095890411,935.380136986301,602.722602739726,317.061643835616,1483.59246575342,1121.79109589041,254.489726027397,228.376712328767,986.904109589041,1020.59931506849,198.458904109589,183.527397260274,612.732876712329,2856.1095890411,576.441780821918,564.866438356164,1099.7602739726,131.174657534247,292,22.3855106328673,16.9330973071448,0.654073338253502,0.960526315789474,0.731829573934837,0.806382267282352,53909.9452054795,33245.7191780822,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_250975,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
251005,1309.61698440208,280.436741767764,104.147313691508,621.998266897747,1047.15251299827,415.334488734835,281.284228769497,250.051993067591,1107.64818024263,2684.70883882149,689.084922010399,118.963604852686,1065.07798960139,602.126516464471,357.431542461005,255.963604852686,1445.87521663778,827.792027729636,178.549393414211,202.774696707106,1039.21837088388,604.095320623917,131.038128249567,101.970537261698,582.927209705373,995.447140381282,452.362218370884,218.913344887348,1036.62218370884,131.126516464471,577,33.65063076439,21.9076270752117,0.759050549257929,0.966499162479062,0.771390374331551,-1.42042055130473,53944.6464471404,32267.5199306759,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_251005,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
251649,1625.38728323699,412.942196531792,143.052023121387,674.468208092485,3691.95953757225,300.653179190751,301.098265895954,251.514450867052,1078.38150289017,3437.82080924855,778.728323699422,122.953757225434,1066.7225433526,732.329479768786,575.06936416185,276.994219653179,1479.1387283237,1071.79190751445,292.468208092486,231.838150289017,983.21387283237,938.341040462428,207.121387283237,131.583815028902,585.127167630058,1571.32947976879,494.21387283237,288.78612716763,1053.1387283237,131.167630057803,173,16.221677694198,13.5914605519967,0.545888418804212,0.955801104972376,0.768888888888889,0.683724132644617,52934.1156069364,33295.8901734104,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_251649,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
252096,2180.8132780083,273.863070539419,168.066390041494,665.697095435685,3924.1908713693,387.655601659751,492.705394190871,243.290456431535,1083.6265560166,3823.4398340249,561.045643153527,115.929460580913,1077.7510373444,1484.07053941909,508.643153526971,314.199170124481,1544.54356846473,2134.7510373444,284.647302904564,326.908713692946,1010.65975103734,1781.1244813278,224.0,247.041493775934,704.887966804979,1181.29045643154,468.165975103734,267.099585062241,1044.55186721992,130.871369294606,241,20.4100318691445,16.2435708688807,0.605477922238386,0.866906474820144,0.654891304347826,1.56634976270693,53875.7385892116,33437.0829875519,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_252096,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
252644,3192.98484848485,153.689393939394,76.020202020202,628.891414141414,1189.23737373737,309.181818181818,665.782828282828,248.835858585859,1087.43181818182,4164.9898989899,895.752525252525,119.684343434343,1074.0101010101,667.840909090909,450.340909090909,267.80303030303,1398.71212121212,1041.60858585859,263.5,222.401515151515,1001.16414141414,947.94696969697,200.641414141414,133.419191919192,979.292929292929,960.265151515152,471.027777777778,245.444444444444,1019.25,129.974747474747,396,26.3992031323257,19.3900206664353,0.678616642223261,0.95421686746988,0.754285714285714,0.350046620897408,53651.0934343434,33272.3535353535,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_252644,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
252993,3904.05089820359,220.679640718563,195.125748502994,716.317365269461,3143.10479041916,844.72754491018,312.200598802395,245.15868263473,1112.17365269461,6150.67664670659,1141.58083832335,132.682634730539,1106.21556886228,1020.70658682635,456.505988023952,279.868263473054,1824.43413173653,1883.09281437126,303.12874251497,235.146706586826,1040.33532934132,1869.33233532934,218.131736526946,196.526946107784,1418.2874251497,1726.15868263473,513.164670658683,348.380239520958,1057.96107784431,130.544910179641,334,22.5199837899879,19.8447259235267,0.472734032648025,0.925207756232687,0.662698412698413,0.254808024145945,52867.6377245509,33567.5958083832,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_252993,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
253721,1514.8014527845,178.641646489104,88.5641646489104,610.832929782082,676.728813559322,783.607748184019,410.823244552058,277.796610169492,1135.20823244552,3223.88619854722,573.549636803874,119.80387409201,1070.24697336562,1013.24455205811,634.983050847458,279.571428571429,1761.5181598063,1127.34866828087,247.191283292978,217.25181598063,1133.34624697337,729.842615012107,156.019370460048,113.900726392252,1599.51331719128,1620.799031477,468.46004842615,219.714285714286,1022.14285714286,129.162227602906,413,23.8813025909068,22.0312609924751,0.385921084722336,0.958236658932715,0.748188405797101,-0.0211214584059342,52802.2615012107,32237.799031477,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_253721,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
253811,1193.14802631579,102.588815789474,74.875,625.776315789474,1528.45065789474,265.648026315789,365.875,248.746710526316,1081.86513157895,2244.91118421053,513.542763157895,115.3125,1077.59539473684,521.088815789474,392.565789473684,264.526315789474,1378.01644736842,887.157894736842,242.322368421053,215.378289473684,986.486842105263,1220.625,210.371710526316,134.983552631579,585.342105263158,867.8125,430.065789473684,216.41447368421,1028.01973684211,130.184210526316,304,25.9860558712128,14.9531934992521,0.817850022988487,0.952978056426332,0.750617283950617,-1.53921628209152,53943.0328947368,32427.9835526316,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,7,FAAGSCC_12_253811,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
254075,1395.62592592593,384.188888888889,114.596296296296,619.748148148148,1803.3037037037,2026.13333333333,618.888888888889,246.462962962963,1087.16296296296,2041.21481481481,1328.26666666667,111.755555555556,1069.25555555556,943.444444444444,620.296296296296,272.492592592593,2063.64444444444,1913.48888888889,263.018518518519,215.959259259259,998.822222222222,1604.57777777778,202.359259259259,154.385185185185,585.033333333333,964.174074074074,474.725925925926,442.274074074074,1010.68148148148,126.918518518519,270,19.8375383448147,17.408739932951,0.479456706435641,0.964285714285714,0.789473684210526,1.03395157865352,54193.4962962963,32978.9037037037,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_254075,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
254360,3354.43430656934,562.124087591241,126.916058394161,643.580291970803,1902.77737226277,318.547445255474,322.434306569343,264.540145985401,1080.40510948905,4387.83941605839,1650.82116788321,121.605839416058,1076.55839416058,682.368613138686,538.211678832117,275.649635036496,1349.79562043796,1018.76642335766,315.686131386861,228.766423357664,980.361313868613,979.233576642336,227.543795620438,113.675182481752,580.178832116788,1129.82481751825,464.138686131387,335.602189781022,1028.66423357664,129.624087591241,274,23.320708167555,15.3043840092657,0.754537216188,0.958041958041958,0.652380952380952,-0.755809027449021,53485.3649635036,32682.3357664234,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_254360,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
255224,5463.20446096654,703.096654275093,713.966542750929,644.710037174721,1909.44237918216,510.163568773234,345.204460966543,253.687732342007,1102.83271375465,8876.94795539033,602.100371747212,126.754646840149,1081.20074349442,688.338289962825,467.237918215613,266.765799256506,1586.67657992565,971.888475836431,215.468401486989,210.527881040892,1020.68401486989,879.60594795539,173.907063197026,469.111524163569,1713.11524163569,3012.67657992565,591.702602230483,314.988847583643,1056.61338289963,129.412639405204,269,21.4525538974203,16.0304581223523,0.664541078021205,0.967625899280576,0.800595238095238,-1.4584336819614,53992.4423791822,32944.9219330855,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_255224,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
255266,1451.30481283422,647.625668449198,114.893048128342,618.534759358289,1044.59090909091,1912.21390374332,386.510695187166,264.505347593583,1103.18181818182,2293.36096256685,1111.04010695187,114.053475935829,1065.09625668449,3362.22994652406,676.542780748663,301.358288770053,1674.56417112299,4157.43582887701,346.791443850267,229.601604278075,1011.97860962567,3421.23796791444,223.355614973262,142.598930481283,586.382352941176,954.213903743316,479.94385026738,334.192513368984,1034.82352941176,132.366310160428,374,25.210702084382,18.9394284416449,0.660022789439684,0.96640826873385,0.757085020242915,-1.38814582816802,53623.7941176471,32957.2727272727,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_255266,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
255385,4004.65122615804,572.288828337875,129.634877384196,656.610354223433,2026.75476839237,736.373297002725,702.474114441417,251.991825613079,1082.73841961853,5535.87738419619,1301.80926430518,146.841961852861,1095.27520435967,3113.06539509537,1004.28065395095,1801.98365122616,5475.55040871935,5345.41689373297,445.986376021798,251.978201634877,1063.18801089918,5002.52861035422,345.743869209809,901.673024523161,754.724795640327,1372.57493188011,508.386920980927,293.724795640327,1057.02452316076,130.989100817439,367,25.1037168870687,18.6552925935226,0.669148510743522,0.953246753246753,0.772631578947368,0.162496902345148,53120.4332425068,33805.9727520436,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_255385,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
255691,4221.44871794872,721.349358974359,102.477564102564,631.75641025641,1393.20512820513,3568.82371794872,544.11858974359,264.195512820513,1199.21474358974,6696.66025641026,1171.49679487179,140.176282051282,1073.30448717949,3915.15384615385,788.153846153846,507.240384615385,1952.1858974359,3818.74358974359,330.583333333333,234.230769230769,1025.84935897436,3351.63782051282,263.320512820513,492.548076923077,615.746794871795,2207.06730769231,544.753205128205,454.740384615385,1056.38141025641,129.301282051282,312,25.8481663420725,15.6277531614802,0.796530661841132,0.96,0.678260869565217,0.97798179193006,53077.7756410256,33862.8461538462,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_255691,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
256390,1618.22580645161,390.834677419355,124.318548387097,634.879032258065,1803.16129032258,1109.70564516129,350.653225806452,249.133064516129,1090.54838709677,3450.33870967742,2018.33467741935,110.463709677419,1070.09274193548,2529.14516129032,830.774193548387,318.334677419355,4254.82258064516,1882.82258064516,276.270161290323,218.54435483871,1001.1814516129,1032.43548387097,179.790322580645,131.483870967742,590.762096774194,1516.24596774194,472.508064516129,374.95564516129,1020.59274193548,129.036290322581,248,19.9227964424898,15.9008693149283,0.602492733207032,0.96875,0.767801857585139,-1.14121496656609,54183.6129032258,32735.8790322581,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_256390,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
257145,2277.51604278075,231.358288770053,109.810160427807,653.417112299465,2245.20053475936,293.406417112299,292.695187165775,252.901069518717,1083.44385026738,3706.07486631016,656.336898395722,119.419786096257,1094.51871657754,676.804812834225,460.22192513369,274.219251336898,1415.19251336898,1040.64973262032,303.622994652406,228.106951871658,982.812834224599,1011.76470588235,229.106951871658,137.508021390374,588.275401069519,1218.33155080214,494.098930481283,285.213903743315,1040.64705882353,130.470588235294,374,25.6123151438233,18.7191638131923,0.682521253435749,0.971428571428571,0.820175438596491,-0.354964904929628,53456.9679144385,33249.013368984,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_257145,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
258046,4448.32565789474,563.960526315789,241.786184210526,693.914473684211,4046.35855263158,299.243421052632,300.990131578947,252.690789473684,1082.07565789474,6938.02960526316,857.256578947368,147.625,1078.63815789474,707.822368421053,483.638157894737,295.342105263158,1479.80592105263,1056.11513157895,298.154605263158,229.213815789474,1009.76315789474,963.174342105263,222.898026315789,205.463815789474,640.115131578947,2340.75,515.743421052632,226.023026315789,1084.66776315789,131.289473684211,304,22.3928101123943,17.4138233889328,0.628694428863308,0.968152866242038,0.767676767676768,-1.36333137587477,52563.1940789474,32150.2039473684,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_258046,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
259059,3367.72572815534,305.344660194175,133.76213592233,637.822815533981,1706.6140776699,307.827669902913,321.082524271845,253.371359223301,1079.93446601942,5176.55097087379,539.56067961165,119.480582524272,1087.22572815534,714.492718446602,441.325242718447,271.436893203883,1354.75485436893,1131.6067961165,308.432038834951,225.570388349515,985.43932038835,1095.49757281553,218.077669902913,138.400485436893,581.446601941748,1547.27427184466,488.483009708738,232.70145631068,1045.18203883495,130.009708737864,412,29.7729666584372,17.9808786369661,0.79703504820006,0.953703703703704,0.710344827586207,1.320232983343,53438.932038835,32944.7524271845,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_259059,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
259519,5912.21611721612,1410.01465201465,146.395604395604,651.307692307692,2219.07326007326,253.0,255.567765567766,242.978021978022,1074.05860805861,9817.10989010989,594.29304029304,137.710622710623,1089.92673992674,469.007326007326,313.886446886447,250.776556776557,1407.27472527473,729.564102564103,179.399267399267,204.450549450549,986.70695970696,659.490842490843,138.391941391941,127.89010989011,586.139194139194,3007.90476190476,557.479853479853,249.615384615385,1067.77655677656,131.234432234432,273,20.3131629295354,17.1998980828791,0.532012374084467,0.968085106382979,0.802941176470588,-1.29977039110871,53147.5494505494,32992.2600732601,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_259519,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
260261,1103.42944785276,300.574642126789,117.39263803681,620.040899795501,1353.45398773006,241.376278118609,309.517382413088,238.997955010225,1076.86298568507,1472.19427402863,525.993865030675,116.748466257669,1070.20449897751,536.509202453988,353.094069529652,367.61145194274,1415.14110429448,969.402862985685,192.21881390593,215.157464212679,1008.28220858896,718.41308793456,148.985685071575,147.80572597137,601.511247443763,923.406952965235,514.977505112474,227.226993865031,1010.89979550102,130.292433537832,489,32.1551476271779,19.3921937538632,0.797679126135455,0.970238095238095,0.751152073732719,1.20599389545432,53564.736196319,32865.7627811861,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_260261,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
261926,2536.66850828729,145.110497237569,57.4088397790055,611.845303867403,612.502762430939,390.281767955801,1199.49723756906,263.17679558011,1091.60220994475,5076.23204419889,631.635359116022,121.911602209945,1082.09944751381,2093.32044198895,1072.05524861878,1767.6408839779,2005.90055248619,2308.96132596685,338.104972375691,230.138121546961,1053.89502762431,1506.86187845304,217.303867403315,598.027624309392,916.458563535912,1416.41436464088,432.988950276243,224.375690607735,1040.90607734807,131.082872928177,181,17.7089164655274,13.0678329831375,0.674883911842387,0.947643979057592,0.718253968253968,1.30880803439948,52856.7348066298,32348.9005524862,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_261926,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
262078,1625.04751131222,246.079185520362,117.766968325792,661.390271493213,2634.1278280543,384.064479638009,303.050904977376,254.447963800905,1078.7092760181,3297.17533936652,929.496606334842,127.201357466063,1074.7850678733,656.899321266968,509.289592760181,272.449095022624,1435.67194570136,1043.86990950226,307.621040723982,235.450226244344,989.438914027149,985.569004524887,236.940045248869,137.412895927602,582.573529411765,749.733031674208,430.388009049774,210.245475113122,1009.73642533937,128.432126696833,884,41.2645379011063,27.3607591874654,0.748568514465505,0.969298245614035,0.708333333333333,1.02879051923644,52275.7171945701,33007.0746606335,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_262078,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
262499,2308.89765100671,133.848993288591,104.805369127517,727.562080536913,2787.06543624161,1780.87248322148,759.845637583893,262.71644295302,1088.04194630872,5621.74832214765,764.320469798658,152.25,1086.18624161074,663.968120805369,477.337248322148,273.672818791946,1468.90100671141,1028.9144295302,298.426174496644,224.906040268456,976.548657718121,987.474832214765,222.434563758389,123.211409395973,596.464765100671,1818.46476510067,516.803691275168,260.18288590604,1075.53859060403,131.31711409396,596,39.5020614593539,19.3916649559007,0.87121445715185,0.962843295638126,0.727716727716728,-1.32696478714861,53074.7281879195,32699.3825503356,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,7,FAAGSCC_12_262499,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
263663,2109.8479020979,285.041958041958,121.643356643357,639.372377622378,1743.72727272727,353.267482517483,370.5,252.746503496503,1078.86888111888,3445.88986013986,531.138111888112,118.596153846154,1124.97202797203,709.036713286713,459.979020979021,271.746503496504,1377.6993006993,1074.25524475524,274.727272727273,221.129370629371,983.332167832168,989.333916083916,199.699300699301,120.384615384615,584.902097902098,1079.37587412587,466.522727272727,230.034965034965,1033.41083916084,129.585664335664,572,38.6179794536541,19.1219960719681,0.868803023400954,0.954924874791319,0.702702702702703,-1.20886399178515,53513.8758741259,32898.0506993007,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_263663,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
264005,2021.51428571429,1258.02285714286,867.862857142857,653.874285714286,2621.61142857143,1481.17142857143,525.491428571429,248.782857142857,1091.71428571429,4653.31428571429,1468.47428571429,118.645714285714,1071.04571428571,599.051428571429,428.834285714286,353.628571428571,1373.74285714286,913.622857142857,225.177142857143,216.36,979.462857142857,858.674285714286,178.302857142857,122.805714285714,597.708571428571,1744.73142857143,498.462857142857,309.857142857143,1054.86857142857,130.822857142857,175,16.3337636664407,13.724600927215,0.542184365944195,0.966850828729282,0.78125,-0.175808916222148,53891.12,32843.0342857143,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_264005,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
264265,1848.65948275862,871.788793103448,129.426724137931,643.012931034483,1625.97844827586,668.965517241379,296.280172413793,241.715517241379,1075.41810344828,2446.46120689655,632.366379310345,111.771551724138,1078.96982758621,841.775862068965,613.948275862069,374.202586206897,1696.0474137931,1203.92672413793,282.629310344828,226.008620689655,993.35775862069,1210.77155172414,219.581896551724,230.228448275862,613.159482758621,858.5,469.73275862069,238.129310344828,1006.13793103448,130.146551724138,232,18.3883909446425,16.5246532571312,0.438674635973815,0.966666666666667,0.718266253869969,-1.19906061633411,53716.8318965517,33429.0948275862,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_264265,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
264321,590.968085106383,1537.1085106383,346.889361702128,629.340425531915,559.487234042553,456.025531914894,319.531914893617,254.057446808511,1108.11489361702,1061.8,1364.0914893617,109.106382978723,1062.82553191489,801.253191489362,452.88085106383,273.082978723404,1470.96595744681,1090.43617021277,232.908510638298,218.008510638298,1249.94468085106,772.582978723404,154.955319148936,126.525531914894,873.285106382979,704.493617021277,407.112765957447,223.865957446808,1020.23191489362,128.848936170213,470,28.2267903218181,21.3598438694907,0.653736371969418,0.963114754098361,0.756843800322061,0.97700401098246,53349.5680851064,33080.485106383,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_264321,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
264533,4575.95136778115,364.410334346505,126.033434650456,649.647416413374,1866.00607902736,2722.90577507599,1274.43465045593,257.820668693009,1160.55623100304,6864.1641337386,851.869300911854,127.355623100304,1072.53191489362,5415.50759878419,1186.39513677812,1147.24924012158,2359.51367781155,5078.80547112462,465.851063829787,257.115501519757,1130.72948328267,4214.85410334346,9831.27051671732,1276.06686930091,641.948328267477,1819.34346504559,516.310030395137,270.629179331307,1085.00911854103,132.501519756839,329,23.2556668579944,18.0700109396687,0.629481605212895,0.948126801152738,0.721491228070175,-0.0294142845856756,53044.0060790274,33650.2705167173,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67+,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_264533,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
264587,1540.09285714286,118.642857142857,60.6214285714286,633.321428571429,1297.26428571429,2491.90714285714,390.685714285714,267.442857142857,1090.25714285714,3257.13571428571,649.307142857143,119.085714285714,1068.4,742.25,531.4,287.65,1442.15714285714,959.457142857143,283.864285714286,226.535714285714,1001.01428571429,891.2,214.428571428571,140.414285714286,582.821428571429,1387.43571428571,523.8,264.657142857143,1063.47142857143,130.121428571429,140,14.9628860487141,11.9878935644927,0.598429830722205,0.945945945945946,0.777777777777778,-0.183966661358307,52423.6214285714,33262.6571428571,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_264587,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
264699,4752.36363636364,1227.64263322884,105.608150470219,649.595611285267,1506.76489028213,492.097178683386,475.388714733542,251.025078369906,1085.08777429467,8162.83385579937,1564.09090909091,130.203761755486,1082.23197492163,1807.42006269592,543.639498432602,282.316614420063,1863.30721003135,2590.19749216301,318.238244514107,229.774294670846,1008.05329153605,1754.05956112853,209.692789968652,143.228840125392,604.062695924765,2376.08463949843,531.94670846395,365.730407523511,1073.11598746081,132.360501567398,319,22.1918375805182,18.3293606411832,0.56374256102064,0.957957957957958,0.759523809523809,0.764095337778556,52893.3667711599,33390.5485893417,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_264699,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
265057,1979.37630662021,258.449477351916,79.2543554006969,626.505226480836,1548.49128919861,909.87456445993,357.003484320558,264.209059233449,1108.67595818815,4048.6724738676,1908.61324041812,113.616724738676,1071.04181184669,2112.0243902439,584.229965156794,286.219512195122,1635.67944250871,2358.05574912892,311.003484320558,233.550522648084,1021.77351916376,2088.31010452962,230.073170731707,331.0,1429.45644599303,1263.66898954704,467.651567944251,337.97212543554,1058.88153310105,130.961672473868,287,21.9497623060487,16.6920606183852,0.649377074176649,0.947194719471947,0.767379679144385,0.196553825032561,54025.0871080139,32630.0801393728,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_265057,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
265182,2918.37873754153,414.053156146179,165.46511627907,644.023255813953,2353.4584717608,303.920265780731,328.019933554817,248.222591362126,1078.28571428571,5122.3488372093,536.063122923588,134.544850498339,1086.89700996678,774.182724252492,947.551495016611,280.604651162791,1537.82392026578,1151.00664451827,332.06976744186,230.418604651163,975.833887043189,871.58803986711,185.348837209302,153.348837209302,602.225913621262,2157.65780730897,602.421926910299,242.936877076412,1075.78073089701,131.694352159468,301,24.7033847994485,15.5652139769738,0.776526768983323,0.955555555555556,0.682539682539683,-0.829513658607961,53585.1395348837,32538.1395348837,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_265182,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
265227,3703.44985673352,286.091690544413,134.865329512894,681.169054441261,3013.44699140401,1406.04871060172,368.126074498567,245.280802292264,1082.69627507163,6314.58452722063,2111.03438395415,125.621776504298,1098.37535816619,899.383954154728,470.343839541547,335.068767908309,2754.23209169054,1568.44699140401,235.286532951289,217.12893982808,1008.23209169054,1356.25787965616,176.747851002865,147.369627507163,627.186246418338,1601.7106017192,493.151862464183,311.785100286533,1073.67908309456,131.876790830946,349,25.0386324343998,17.8073347598066,0.702995411626434,0.956164383561644,0.765350877192982,-0.33540178600344,52763.8796561605,33485.4641833811,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_265227,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
265316,1516.16239316239,125.17094017094,71.4487179487179,623.935897435897,1193.15811965812,2144.46153846154,3082.67094017094,253.735042735043,1095.14102564103,3295.50854700855,449.307692307692,108.786324786325,1080.86752136752,1434.17094017094,1089.47863247863,1205.35897435897,3121.16239316239,1841.97435897436,317.123931623932,237.863247863248,1023.41025641026,1156.48290598291,214.559829059829,190.615384615385,613.846153846154,1093.06837606838,434.307692307692,244.397435897436,1136.26068376068,128.790598290598,234,19.2811903852526,15.5420211166359,0.591817945782254,0.951219512195122,0.684210526315789,0.896891672057479,53459.9188034188,33416.6623931624,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_265316,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
265484,3809.13942307692,144.692307692308,62.3028846153846,619.701923076923,1035.15865384615,283.110576923077,299.649038461538,260.413461538462,1076.95673076923,7050.86538461538,583.947115384615,128.466346153846,1088.67788461538,633.543269230769,465.105769230769,264.519230769231,1371.01442307692,866.591346153846,261.8125,219.552884615385,985.855769230769,870.682692307692,199.072115384615,114.971153846154,586.394230769231,2267.25480769231,492.038461538462,229.129807692308,1057.5,129.182692307692,208,24.2627993804396,10.9490312429663,0.892388344902716,0.941176470588235,0.57617728531856,-0.818690457567123,53034.0528846154,32652.7692307692,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_265484,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
265651,3684.04508196721,736.114754098361,1032.72131147541,680.25,4321.3237704918,974.475409836066,422.438524590164,242.176229508197,1086.10655737705,5666.11065573771,774.188524590164,137.147540983607,1082.5737704918,2847.40573770492,827.385245901639,358.909836065574,2354.00409836066,6612.77049180328,517.569672131148,259.098360655738,1082.31147540984,6434.74180327869,297.422131147541,289.762295081967,605.524590163934,1349.97950819672,509.852459016393,303.450819672131,1051.93852459016,130.811475409836,244,21.6269244103811,14.3789698978495,0.746964166718447,0.960629921259842,0.829931972789116,0.0461695570520098,52850.7172131148,33712.1229508197,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_265651,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
265699,3430.35319148936,161.191489361702,68.4042553191489,623.893617021277,1252.35744680851,1766.37446808511,3977.58723404255,259.208510638298,1099.02978723404,4517.02978723404,639.83829787234,125.991489361702,1067.77021276596,636.757446808511,737.395744680851,540.56170212766,1545.02553191489,908.234042553191,236.68085106383,212.255319148936,1003.21276595745,755.83829787234,164.987234042553,132.23829787234,593.208510638298,1350.83829787234,456.506382978723,223.391489361702,1023.12340425532,129.148936170213,235,21.9468830498196,13.8058064196997,0.777360430749356,0.955284552845528,0.687134502923977,-0.866257374609264,53206.9106382979,32118.2085106383,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_265699,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
265775,3954.06906077348,425.790055248619,72.5635359116022,636.930939226519,1727.76519337017,893.113259668508,346.162983425414,246.966850828729,1086.39226519337,6119.81491712707,600.477900552486,135.773480662983,1097.49723756906,4911.3453038674,868.406077348066,474.654696132597,2578.23480662983,7641.43093922652,463.223756906077,251.074585635359,1068.50828729282,7184.68508287293,616.17955801105,604.563535911602,644.151933701657,1213.92541436464,468.740331491713,253.270718232044,1041.39226519337,130.872928176796,362,26.8708452952391,17.2622073254807,0.766357780059799,0.9501312335958,0.724,1.17437319613658,53397.455801105,33890.3922651934,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_265775,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
265859,3449.00949367089,177.743670886076,90.496835443038,640.132911392405,1394.57594936709,1905.14873417722,1187.0664556962,251.325949367089,1168.54113924051,5354.35759493671,500.664556962025,137.5,1077.39240506329,4555.85759493671,902.25,571.563291139241,8025.98734177215,6935.66455696203,468.300632911392,244.860759493671,1074.59493670886,5881.50949367089,270.177215189873,260.886075949367,661.094936708861,1904.10126582278,496.325949367089,257.012658227848,1044.02848101266,129.620253164557,316,30.343342212771,13.3772458636509,0.897574584804887,0.943283582089552,0.585185185185185,0.983570336576324,53036.4208860759,33912.164556962,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_265859,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
266201,4931.64242424242,691.393939393939,203.278787878788,653.060606060606,2912.26060606061,689.630303030303,949.209090909091,255.663636363636,1091.26060606061,7099.60606060606,567.469696969697,128.706060606061,1085.80303030303,1830.98181818182,972.609090909091,1325.25454545455,1972.69696969697,2938.6,363.515151515152,269.066666666667,1045.88484848485,2565.50909090909,279.418181818182,390.760606060606,758.833333333333,1551.05757575758,495.433333333333,239.784848484848,1173.63636363636,129.593939393939,330,21.4018695084544,19.73028464417,0.387438906833933,0.953757225433526,0.748299319727891,0.69688386071922,53496.8363636364,33427.3696969697,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_266201,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
266232,5152.91634980989,193.882129277566,78.8060836501901,638.140684410646,1739.71482889734,867.532319391635,393.250950570342,257.570342205323,1076.59695817491,8222.14068441065,560.030418250951,121.057034220532,1077.63498098859,2535.536121673,639.555133079848,332.680608365019,3062.03802281369,2654.7072243346,343.505703422053,237.585551330798,1014.84790874525,2379.20152091255,256.399239543726,204.292775665399,596.77566539924,3235.99239543726,587.357414448669,266.076045627376,1093.54372623574,130.813688212928,263,19.4333454130957,17.4741812077709,0.437567763923245,0.952898550724638,0.769005847953216,-0.38098722935358,53611.5323193916,33524.2661596958,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_266232,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
266266,3841.90135396518,431.52417794971,144.936170212766,673.228239845261,3507.68471953578,1487.46808510638,388.733075435203,259.715667311412,1092.95938104449,6870.16827852998,565.139264990329,123.551257253385,1162.9419729207,3173.76015473888,658.208897485493,364.170212765957,1565.66150870406,2566.56092843327,326.456479690522,235.89748549323,1025.90909090909,2003.9419729207,229.690522243714,194.090909090909,599.117988394584,1935.87620889748,527.825918762089,308.228239845261,1061.42746615087,130.36170212766,517,26.2186539998394,25.2730072780601,0.266147579132022,0.955637707948244,0.710164835164835,1.15366084110923,53788.6479690522,33300.3230174081,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_266266,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
266781,4683.34810126582,720.664556962025,138.091772151899,661.268987341772,2097.43987341772,501.933544303797,584.901898734177,241.313291139241,1078.43670886076,6805.80696202532,1041.62341772152,134.553797468354,1084.38291139241,3495.66772151899,919.708860759494,614.496835443038,1984.52848101266,6457.43987341772,515.892405063291,255.71835443038,1094.21835443038,5636.60126582278,291.303797468354,593.259493670886,664.541139240506,1862.61708860759,556.800632911392,296.54746835443,1065.16139240506,128.867088607595,316,21.8994762528874,18.3854829316726,0.543298119034981,0.969325153374233,0.791979949874687,0.366125329137369,53290.5917721519,33688.9113924051,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_266781,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
266809,3234.26877470356,170.735177865613,126.169960474308,664.553359683794,3392.88537549407,442.391304347826,639.438735177866,243.750988142292,1081.66007905138,5956.28063241107,532.822134387352,127.667984189723,1074.17391304348,1128.39920948617,473.446640316206,294.332015810277,2164.1581027668,3042.55731225296,307.446640316206,229.612648221344,1009.77865612648,3492.29249011858,225.928853754941,152.00395256917,611.415019762846,2410.98023715415,518.098814229249,245.308300395257,1060.81818181818,130.822134387352,253,19.2892886741482,16.8361562758004,0.488034904399083,0.951127819548872,0.739766081871345,-1.10992027425972,52821.256916996,33435.2490118577,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_266809,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
266851,2252.78899082569,366.582568807339,107.321100917431,623.082568807339,1013.51376146789,1256.6376146789,486.064220183486,246.912844036697,1075.27064220183,4207.83486238532,513.073394495413,110.344036697248,1077.29816513761,1140.05963302752,531.536697247706,315.825688073394,1477.04128440367,1476.85321100917,320.793577981651,234.279816513761,989.743119266055,1456.61009174312,253.573394495413,163.591743119266,590.93119266055,2015.57798165138,527.977064220183,280.371559633028,1051.49541284404,128.95871559633,218,20.1828633740103,13.8371458011946,0.727988975463561,0.951965065502183,0.717105263157895,0.545870829751725,53635.6788990826,33558.5733944954,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_266851,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
267073,2247.87943262411,535.716312056738,103.13829787234,617.833333333333,1076.32978723404,1877.68794326241,1719.21631205674,260.258865248227,1090.77304964539,4847.54964539007,507.074468085106,116.148936170213,1070.83687943262,2624.8475177305,1207.97517730496,1354.29078014184,1626.8475177305,1777.40070921986,280.659574468085,224.794326241135,997.489361702128,1660.04255319149,212.014184397163,181.666666666667,609.776595744681,2248.24822695035,519.13475177305,234.893617021277,1039.9219858156,131.560283687943,282,21.1636675224366,17.000518870485,0.595590871907819,0.962457337883959,0.742105263157895,0.865773469557644,53946.0531914894,33010.9929078014,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_267073,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
267843,1484.90957446809,305.872340425532,112.457446808511,690.920212765957,2620.71808510638,264.893617021277,302.303191489362,246.170212765957,1078.03723404255,3457.76063829787,530.877659574468,117.303191489362,1080.73404255319,710.526595744681,464.074468085106,277.643617021277,1479.26063829787,1000.65425531915,248.515957446808,221.494680851064,979.398936170213,885.760638297872,191.489361702128,127.085106382979,582.239361702128,1314.6329787234,482.574468085106,234.734042553192,1058.9414893617,132.010638297872,188,20.1277821760118,11.9877540077699,0.803294176641336,0.94949494949495,0.783333333333333,-1.44808692057148,52943.2606382979,33282.4521276596,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_267843,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
267972,2776.41265822785,349.108860759494,123.589873417722,673.708860759494,2153.18481012658,481.301265822785,260.989873417722,250.511392405063,1079.53924050633,5819.82278481013,2981.71898734177,130.967088607595,1072.73417721519,577.435443037975,418.577215189873,259.0,1382.87088607595,912.903797468354,252.544303797468,215.215189873418,972.415189873418,836.853164556962,182.010126582278,108.574683544304,583.713924050633,2544.88607594937,537.316455696203,435.184810126582,1076.72151898734,131.430379746835,395,25.848991505053,19.5055770472061,0.656188265952673,0.97051597051597,0.783730158730159,-0.503566146339047,53542.9721518987,32254.7316455696,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_267972,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
268255,2376.94482758621,491.685057471264,86.5540229885057,645.475862068966,1988.86206896552,1600.11724137931,909.354022988506,243.186206896552,1127.97471264368,3165.51954022989,607.140229885057,126.370114942529,1079.06436781609,824.770114942529,735.616091954023,821.6,1602.20229885057,1116.28965517241,376.464367816092,233.572413793103,1004.41379310345,1082.31264367816,240.765517241379,230.471264367816,591.954022988506,895.763218390805,513.602298850575,299.988505747126,1005.57931034483,128.63908045977,435,26.0927505091189,21.704932820607,0.555018998459948,0.945652173913044,0.760489510489511,0.229836868942374,53634.7655172414,33706.5770114942,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_268255,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
268680,2552.52511415525,169.077625570776,86.0456621004566,643.27397260274,2099.84474885845,253.063926940639,264.817351598174,247.917808219178,1082.16438356164,6000.73059360731,1332.97716894977,123.812785388128,1073.95433789954,659.666666666667,466.611872146119,267.689497716895,1384.25570776256,990.986301369863,259.840182648402,220.2100456621,985.474885844749,847.493150684931,180.707762557078,108.401826484018,586.420091324201,2693.60730593607,548.255707762557,266.493150684931,1050.1598173516,130.899543378995,219,21.8129953130461,12.8465008508334,0.808178250900301,0.969026548672566,0.782142857142857,1.19010509205576,54011.9452054795,32507.1141552511,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_268680,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
268822,2484.65502183406,480.56768558952,86.5152838427948,630.807860262009,1365.28384279476,693.816593886463,1225.68995633188,245.698689956332,1081.30131004367,3439.37991266376,590.803493449782,116.021834061135,1222.99126637555,2775.92576419214,1329.59825327511,2078.6768558952,1849.17467248908,4503.13537117904,475.685589519651,257.034934497817,1062.01310043668,3915.86899563319,294.318777292576,518.89519650655,732.17903930131,905.558951965066,473.489082969432,249.882096069869,1036.48034934498,129.825327510917,229,19.7475913084385,14.8176804299164,0.661036425446791,0.950207468879668,0.70679012345679,-0.718532225007765,53329.3144104804,33660.7161572052,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX+,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_268822,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
269388,2361.67337807606,322.86129753915,128.015659955257,697.03355704698,2676.78523489933,1596.29753914989,916.751677852349,248.561521252796,1073.14093959732,4727.14317673378,1396.47874720358,125.118568232662,1084.84787472036,886.232662192394,420.55033557047,320.982102908277,1570.74944071588,2188.33109619687,268.208053691275,233.134228187919,1007.61744966443,2537.69574944072,263.225950782998,173.995525727069,580.908277404922,2353.53020134228,536.572706935123,1284.42058165548,1098.64653243848,131.015659955257,447,28.7388030397023,19.8927893426016,0.721712741939202,0.971739130434783,0.840225563909774,-0.0586801781385781,52601.2639821029,33699.581655481,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_269388,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
269704,3202.84444444444,456.119444444444,103.502777777778,637.866666666667,1786.9,494.602777777778,342.447222222222,259.833333333333,1118.28888888889,5488.62222222222,809.769444444444,123.655555555556,1071.83333333333,650.980555555556,390.15,264.402777777778,1478.00277777778,901.933333333333,194.55,207.863888888889,1065.13888888889,635.558333333333,139.327777777778,109.938888888889,595.813888888889,1213.96944444444,468.130555555556,333.216666666667,1047.09444444444,129.813888888889,360,27.8809698756774,16.8164245925084,0.797627303631118,0.957446808510638,0.728744939271255,-1.2849560819887,53968.5305555556,32705.75,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_269704,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
269715,2075.11605415861,333.659574468085,152.586073500967,653.177949709865,2788.76595744681,240.882011605416,255.47582205029,248.218568665377,1080.74468085106,3874.90135396518,711.773694390716,170.299806576402,1076.03481624758,660.340425531915,468.630560928433,263.493230174081,1488.62282398453,1184.02707930368,315.208897485493,227.912959381044,986.905222437137,1117.47775628627,225.280464216634,129.16247582205,590.750483558994,1289.02901353965,464.317214700193,224.984526112186,1031.23210831721,129.131528046422,517,30.03369597003,22.2692903823098,0.670978446708316,0.955637707948244,0.718055555555556,-1.25371059153345,53560.7079303675,32407.3675048356,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_269715,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
270124,2191.77224199288,148.451957295374,97.0427046263345,659.163701067616,2277.77580071174,1397.18505338078,1016.15302491103,247.693950177936,1120.03202846975,2772.79003558719,748.437722419929,136.256227758007,1076.38078291815,3946.93238434164,1181.18149466192,907.572953736655,2005.65836298932,3841.51601423488,410.651245551602,240.829181494662,1050.56939501779,3264.99644128114,1460.87900355872,497.996441281139,683.387900355872,954.092526690391,491.754448398577,656.174377224199,1036.51245551601,130.20640569395,281,20.3532425885473,17.6467806958142,0.498263736739776,0.965635738831615,0.739473684210526,-1.2846511036378,53245.7295373665,33897.8540925267,FAAGSCC_12,AG,1,dendritic cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67+,FAAGSCC_12,gH2AX-,dendritic cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_270124,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
270235,1860.79202279202,154.97150997151,74.0911680911681,607.105413105413,192.173789173789,490.239316239316,358.883190883191,255.48433048433,1132.53846153846,2768.10256410256,564.615384615385,116.182336182336,1054.03988603989,768.148148148148,458.019943019943,279.054131054131,1583.5811965812,988.529914529914,213.162393162393,214.247863247863,1315.47863247863,792.991452991453,160.703703703704,160.586894586895,717.34188034188,895.547008547009,452.131054131054,217.105413105413,1013.95441595442,128.606837606838,351,22.8562477124387,19.6642239711978,0.509714700350671,0.956403269754768,0.76304347826087,1.48985103470126,52482.9800569801,33359.8518518519,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_270235,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
270616,3872.3829787234,1034.14095744681,2356.75,630.864361702128,1112.84042553191,306.808510638298,343.670212765957,254.071808510638,1080.36436170213,6385.20212765957,804.742021276596,122.933510638298,1083.89361702128,662.079787234043,437.792553191489,275.718085106383,1433.04787234043,1040.73670212766,287.747340425532,230.164893617021,985.340425531915,980.454787234043,216.132978723404,130.103723404255,579.973404255319,1524.94414893617,514.952127659574,325.928191489362,1048.09042553191,132.034574468085,376,26.4071240118833,18.1940036502987,0.724779512153629,0.961636828644501,0.710775047258979,-0.684482677836573,52910.6223404255,33278.0505319149,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_270616,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
271017,3275.54497354497,170.100529100529,96.0687830687831,634.687830687831,2005.10317460317,246.955026455026,259.685185185185,248.759259259259,1073.72486772487,5820.07671957672,520.68253968254,126.515873015873,1071.48412698413,518.066137566138,346.708994708995,255.669312169312,1420.30952380952,798.904761904762,201.293650793651,206.801587301587,995.468253968254,776.640211640212,157.343915343915,119.486772486772,585.126984126984,2090.0873015873,502.195767195767,296.298941798942,1035.48412698413,129.420634920635,378,28.5675429579054,16.995350405813,0.803786271244935,0.956962025316456,0.692307692307692,0.467062418224823,53812.671957672,32427.8148148148,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_271017,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
271036,3675.55958549223,564.528497409326,204.730569948187,653.015544041451,2436.53886010363,254.756476683938,299.932642487047,246.233160621762,1073.59585492228,6867.9689119171,1923.0,136.647668393782,1068.34196891192,659.326424870466,420.906735751295,276.341968911917,1414.65284974093,1304.75647668394,305.103626943005,235.937823834197,1015.88601036269,1257.38341968912,219.751295336788,325.60103626943,712.730569948186,2966.83419689119,532.704663212435,420.611398963731,1066.47668393782,130.347150259067,193,23.3745645197434,10.6133796620331,0.890972746065077,0.941463414634146,0.674825174825175,-1.20654834563489,52770.3626943005,33002.03626943,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_271036,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
271276,2502.10975609756,217.085365853659,111.341463414634,670.394308943089,3859.13821138211,275.060975609756,286.146341463415,257.443089430894,1079.36991869919,3836.96341463415,793.182926829268,141.126016260163,1066.07317073171,732.373983739837,511.528455284553,271.089430894309,1356.0162601626,1068.39837398374,320.231707317073,227.471544715447,982.947154471545,976.158536585366,220.19918699187,115.19512195122,584.508130081301,1055.94715447154,487.845528455285,229.162601626016,1044.02032520325,130.943089430894,246,27.7086007606958,11.7640893472821,0.905397675626081,0.935361216730038,0.759259259259259,-1.5531514261125,53235.8130081301,32602.1585365854,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_271276,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
271666,3393.09655172414,951.705747126437,122.206896551724,646.593103448276,2508.47126436782,520.370114942529,345.675862068966,248.641379310345,1101.39310344828,5116.29195402299,567.645977011494,121.066666666667,1080.11264367816,1069.69425287356,587.905747126437,295.220689655172,1678.72413793103,1411.31034482759,281.324137931034,228.416091954023,1025.36091954023,1102.90114942529,203.179310344828,301.24367816092,1076.05977011494,1186.83218390805,509.351724137931,250.524137931034,1028.03448275862,129.567816091954,435,31.3143553495303,17.7499912341053,0.823833131753723,0.960264900662252,0.714285714285714,1.14750298612642,53872.9287356322,33463.1747126437,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_271666,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
272749,2465.10288065844,440.753086419753,121.452674897119,636.205761316872,2094.01646090535,1504.17283950617,1063.68312757202,265.395061728395,1114.37037037037,3767.95473251029,553.975308641975,118.045267489712,1087.82716049383,3442.86008230453,1072.65020576132,2096.62962962963,1755.65020576132,2543.27160493827,403.337448559671,252.572016460905,1011.94238683128,1773.3950617284,298.510288065844,207.864197530864,647.641975308642,1189.11111111111,481.843621399177,241.271604938272,1047.23868312757,129.534979423868,243,18.8015902493506,16.5643572999845,0.473100785362115,0.964285714285714,0.75,0.74206029301038,52658.9835390947,33434.1440329218,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_272749,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
272919,4431.7600896861,2196.2735426009,158.27130044843,647.042600896861,2163.5,1695.90582959641,1147.23766816144,255.502242152466,1130.73094170404,5677.66591928251,671.800448430493,145.77130044843,1078.7399103139,829.7466367713,835.103139013453,1289.35874439462,2559.73542600897,1066.26233183856,281.405829596413,229.309417040359,994.733183856502,973.567264573991,209.087443946188,205.699551569507,608.609865470852,1176.28923766816,480.156950672646,238.706278026906,1035.29820627803,130.878923766816,446,29.3157618929737,19.5396713690747,0.745483191975338,0.957081545064378,0.768965517241379,-1.47392101647958,52713.7914798206,33794.1322869955,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_272919,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
273386,3326.33644859813,307.996884735203,120.411214953271,642.464174454829,2077.42367601246,248.679127725857,267.146417445483,246.133956386293,1077.04361370717,5545.17757009346,3527.1277258567,132.940809968847,1078.92211838006,674.239875389408,548.380062305296,266.894080996885,1763.69158878505,1015.57009345794,256.903426791277,219.417445482866,1003.83177570093,936.479750778816,188.190031152648,120.445482866044,585.476635514019,1555.38629283489,472.869158878505,405.78816199377,1085.95950155763,130.775700934579,321,34.3257624272282,12.0695702773823,0.936143412198985,0.927745664739884,0.726244343891403,-1.47530557209732,52500.707165109,32327.3489096573,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_273386,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
273655,1125.4375,149.723958333333,83.671875,638.026041666667,2230.71875,584.625,352.03125,264.479166666667,1119.57291666667,2072.94270833333,641.046875,112.3125,1063.22395833333,884.760416666667,485.171875,275.989583333333,1479.09375,992.166666666667,202.895833333333,210.484375,1223.0625,673.723958333333,136.557291666667,110.427083333333,587.958333333333,831.151041666667,434.958333333333,244.005208333333,1028.09895833333,129.984375,192,18.5492808305388,13.1822052341964,0.703537069947309,0.96969696969697,0.82051282051282,-1.56447326041347,53706.578125,32731.828125,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_273655,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
273920,2629.94871794872,203.468531468531,100.251748251748,638.934731934732,1525.70396270396,546.911421911422,376.736596736597,266.282051282051,1126.37995337995,4503.75757575758,690.445221445221,134.132867132867,1082.43123543124,840.764568764569,504.109557109557,283.480186480186,1530.36363636364,1033.97435897436,214.11655011655,216.179487179487,1387.35198135198,676.638694638695,150.645687645688,133.668997668998,585.449883449883,1167.2703962704,456.937062937063,237.659673659674,1052.24009324009,130.988344988345,429,40.9783147643952,13.3593329314227,0.945366383301643,0.957589285714286,0.825,1.50088722916936,52594.2470862471,32948.9254079254,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_273920,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
274012,4231.67415730337,634.373595505618,117.691011235955,667.421348314607,2604.12640449438,216.331460674157,227.556179775281,235.657303370787,1079.76685393258,6150.13202247191,1305.73314606742,138.26404494382,1081.0,511.918539325843,359.831460674157,260.205056179775,1395.9691011236,790.089887640449,215.823033707865,210.966292134831,982.814606741573,643.769662921348,136.705056179775,117.463483146067,586.193820224719,1831.94943820225,556.379213483146,417.884831460674,1083.4691011236,130.676966292135,356,25.67645717113,17.8122087362646,0.720247161042105,0.951871657754011,0.703557312252964,-0.731608773600973,53103.7668539326,32999.7612359551,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_274012,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
274082,2707.95035460993,197.975177304964,108.354609929078,628.666666666667,1724.3829787234,498.460992907801,608.450354609929,249.946808510638,1086.62765957447,4955.43262411347,557.329787234043,121.875886524823,1070.79432624113,1559.8475177305,546.280141843972,326.301418439716,1746.83687943262,2868.99290780142,368.234042553192,232.925531914894,1049.05673758865,2323.02127659574,222.58865248227,186.613475177305,600.269503546099,1322.70567375887,476.599290780142,239.723404255319,1045.44326241135,130.425531914894,282,26.7242735433803,13.885895095701,0.854410496067414,0.94314381270903,0.723076923076923,-0.152138438941788,53463.5602836879,33039.8262411348,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_274082,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
274308,2604.58237547893,237.509578544061,106.044061302682,658.44061302682,2841.9367816092,877.249042145594,353.312260536398,269.252873563218,1106.53256704981,4430.86206896552,987.141762452107,152.379310344828,1073.77011494253,2434.88122605364,708.180076628352,359.507662835249,1753.62643678161,2019.72796934866,336.446360153257,230.465517241379,1018.64942528736,1261.55363984674,217.637931034483,139.308429118774,600.973180076628,885.222222222222,432.285440613027,224.718390804598,1044.00766283525,131.582375478927,522,34.7023289454884,19.3201939335153,0.830686434583965,0.954296160877514,0.71900826446281,-1.29180205892825,53173.0670498084,32696.2662835249,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_274308,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
274547,2314.29840546697,220.28701594533,129.116173120729,714.842824601367,4002.80182232346,484.091116173121,326.343963553531,243.170842824601,1123.84054669704,4432.27562642369,721.794988610478,117.464692482916,1123.50797266515,785.842824601367,410.642369020501,267.74715261959,1660.569476082,1332.61275626424,326.676537585421,238.526195899772,1032.03416856492,1307.19589977221,213.423690205011,186.293849658314,3936.56264236902,1828.78359908884,528.501138952164,1233.9430523918,1082.06833712984,131.138952164009,439,29.5924380822292,18.9326461407302,0.768558208621805,0.948164146868251,0.731666666666667,1.38227282623772,53694.0159453303,33628.1890660592,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_274547,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
274980,6279.12190082645,295.018595041322,128.107438016529,638.555785123967,1646.20454545455,643.231404958678,284.435950413223,251.311983471074,1087.71074380165,10308.347107438,750.365702479339,136.77479338843,1300.53099173554,746.530991735537,539.580578512397,342.568181818182,1776.70041322314,946.357438016529,221.018595041322,212.297520661157,1006.98966942149,801.876033057851,161.066115702479,216.276859504132,636.539256198347,3609.17148760331,568.940082644628,331.981404958678,1060.73140495868,130.421487603306,484,41.0376285751759,15.4557581885874,0.926366190677846,0.947162426614481,0.672222222222222,1.36803175629564,53185.9318181818,32355.4359504132,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX+,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_274980,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
275135,2020.25573770492,420.314754098361,143.265573770492,669.245901639344,2413.68852459016,1108.77704918033,333.980327868852,258.685245901639,1084.92131147541,4125.13770491803,2328.12459016393,127.662295081967,1087.61639344262,712.170491803279,489.606557377049,274.275409836066,1480.40327868852,956.911475409836,295.416393442623,229.491803278689,989.285245901639,873.35737704918,224.327868852459,133.954098360656,583.901639344262,1052.14426229508,537.072131147541,230.845901639344,1046.91803278689,130.488524590164,305,22.8745554986533,17.1917328452047,0.65965816758825,0.968253968253968,0.7625,-0.776585208483399,52299.5868852459,33034.8426229508,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_275135,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
275443,2281.26590909091,350.988636363636,196.693181818182,675.831818181818,3776.65,439.363636363636,311.920454545455,243.615909090909,1091.85681818182,4049.57272727273,585.136363636364,115.081818181818,1079.10909090909,831.952272727273,545.159090909091,280.281818181818,1603.60909090909,1894.34090909091,296.593181818182,230.6,1030.75909090909,1698.02272727273,433.456818181818,298.479545454545,614.404545454545,1047.33409090909,455.352272727273,259.440909090909,1041.76363636364,128.386363636364,440,40.0223954933492,14.093029440424,0.935951633663729,0.932203389830508,0.626780626780627,1.3198359633964,53795.6,33423.4681818182,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,7,FAAGSCC_12_275443,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
275622,4110.62573099415,499.228070175439,87.8713450292398,639.347953216374,1562.99415204678,675.087719298246,290.59649122807,243.014619883041,1086.11111111111,6108.70467836257,680.111111111111,119.049707602339,1092.59649122807,1161.13157894737,640.087719298246,280.74269005848,1947.64912280702,1659.05555555556,308.602339181287,235.143274853801,1046.57894736842,1335.40935672515,217.204678362573,168.622807017544,1198.06725146199,1184.22222222222,481.59649122807,547.766081871345,1043.94736842105,130.441520467836,342,25.2605216703409,17.4829925223108,0.721794587482166,0.952646239554318,0.76,1.48198383397989,53778.4795321637,33513.6111111111,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_275622,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
275623,2380.93905817175,184.373961218837,69.7396121883657,625.296398891967,1182.6648199446,619.603878116343,394.418282548476,267.102493074792,1132.8864265928,4199.12188365651,533.97783933518,119.576177285319,1074.97229916898,650.501385041551,388.1108033241,262.263157894737,1407.27700831025,851.476454293629,198.199445983379,229.695290858726,1095.06925207756,728.429362880886,151.013850415512,164.756232686981,671.14404432133,1191.03047091413,478.091412742382,228.828254847645,1035.74792243767,130.257617728532,361,28.3268551855456,16.2690392935846,0.81862198038926,0.960106382978723,0.694230769230769,1.06993856732145,53292.2354570637,33084.703601108,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_275623,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
275878,1456.73946360153,330.567049808429,111.436781609195,637.563218390805,1942.02298850575,287.049808429119,591.429118773946,256.007662835249,1080.82375478927,2098.31034482759,843.172413793103,121.842911877395,1071.71264367816,647.911877394636,480.16091954023,274.233716475096,1367.7969348659,1111.46743295019,318.229885057471,229.988505747126,981.23754789272,1073.40229885057,229.287356321839,116.593869731801,585.145593869732,868.371647509579,469.260536398467,246.590038314176,1026.65900383142,130.563218390805,261,20.5151109032823,16.2778435127004,0.608627256224979,0.966666666666667,0.763157894736842,-0.911556105282504,53539.5862068966,32690.1915708812,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_275878,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
276209,5111.53992395437,1508.92775665399,148.178707224335,664.752851711027,2677.09505703422,414.019011406844,966.266159695818,241.444866920152,1079.29657794677,8321.99239543726,645.973384030418,134.825095057034,1097.24714828897,961.779467680608,871.501901140684,588.699619771863,2785.82129277567,1449.66920152091,292.61216730038,229.106463878327,1009.19011406844,1385.72623574144,231.536121673004,185.422053231939,616.847908745247,2051.15969581749,554.444866920152,241.93536121673,1086.58174904943,131.904942965779,263,20.3191524294148,16.7399350217547,0.566807791642892,0.952898550724638,0.769005847953216,0.802716973160116,52814.3536121673,33482.1558935361,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_276209,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
276888,5817.21074380165,1074.6652892562,185.830578512397,614.743801652893,595.54958677686,386.239669421488,264.140495867769,236.851239669421,1074.2479338843,10222.6404958678,906.855371900826,134.954545454545,1069.85950413223,1188.30578512397,624.818181818182,291.066115702479,3378.29752066116,1441.33884297521,310.574380165289,238.615702479339,992.764462809917,1265.7479338843,240.03305785124,175.995867768595,613.739669421488,4650.04958677686,626.276859504132,283.301652892562,1087.30165289256,131.210743801653,242,18.6547727121738,16.5318923401442,0.463299522127042,0.9453125,0.746913580246914,0.814968084890192,52607.0909090909,33658.1404958678,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_276888,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
277098,4018.55337078652,554.398876404494,183.912921348315,662.13202247191,3016.54213483146,255.637640449438,263.157303370787,249.615168539326,1084.09550561798,6723.32303370786,631.75,137.089887640449,1076.40449438202,584.348314606742,405.862359550562,255.058988764045,1428.30898876404,983.508426966292,250.047752808989,216.733146067416,974.216292134831,936.932584269663,187.550561797753,111.612359550562,583.261235955056,1676.50561797753,523.808988764045,238.401685393258,1045.98876404494,129.679775280899,356,23.8653202633392,19.0731210377325,0.601067578880211,0.967391304347826,0.780701754385965,-0.1611269167144,53622.7050561798,32560.6095505618,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_277098,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
278393,1258.42990654206,107.247663551402,77.7453271028037,631.976635514019,1939.35981308411,1561.16822429907,302.670560747664,257.859813084112,1087.1261682243,2844.84345794393,454.378504672897,116.521028037383,1074.2523364486,657.123831775701,397.228971962617,259.364485981308,1415.50934579439,843.053738317757,243.441588785047,215.035046728972,979.93691588785,774.182242990654,177.759345794393,112.502336448598,584.119158878505,1458.92056074766,468.469626168224,222.873831775701,1020.81308411215,130.834112149533,428,27.6271337752714,19.8343502456305,0.696115224837618,0.968325791855204,0.743055555555556,-0.727582228078479,53828.1401869159,32453.046728972,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_278393,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
278714,3374.03797468354,616.613924050633,1049.81012658228,614.645569620253,596.977848101266,422.613924050633,342.003164556962,247.291139240506,1099.69620253165,6366.56329113924,554.522151898734,119.193037974684,1101.4082278481,1134.83860759494,571.332278481013,323.056962025316,1548.55696202532,1530.8164556962,307.085443037975,486.731012658228,1010.48101265823,1319.24050632911,229.079113924051,172.832278481013,592.436708860759,2732.15506329114,546.96835443038,262.53164556962,1038.92405063291,128.575949367089,316,24.3410095639335,16.6679817185095,0.728759691908436,0.969325153374233,0.752380952380952,-0.779810955989987,54004.8955696203,33394.996835443,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_278714,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
279214,2054.44162436548,377.203045685279,1496.9847715736,622.548223350254,962.055837563452,960.553299492386,1666.90862944162,244.131979695431,1109.77664974619,3055.16751269036,1860.8730964467,117.654822335025,1067.34010152284,946.837563451777,1086.17766497462,1295.6192893401,1751.93908629442,1579.39086294416,359.284263959391,233.167512690355,1043.28426395939,1358.3654822335,234.934010152284,694.558375634518,740.710659898477,1113.07614213198,480.081218274112,347.370558375635,1061.71573604061,131.903553299492,197,17.1633143115173,14.6379654477437,0.522133831335528,0.960975609756098,0.820833333333333,0.569806313418506,53257.1015228426,33694.4923857868,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_279214,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
279343,4169.43421052632,699.543859649123,115.793859649123,627.149122807018,1116.7850877193,277.232456140351,291.083333333333,244.644736842105,1078.00877192982,5340.85087719298,1952.89912280702,131.754385964912,2054.7149122807,636.394736842105,425.982456140351,267.241228070175,1349.46929824561,997.5,246.004385964912,216.600877192982,980.399122807018,962.513157894737,196.631578947368,125.263157894737,580.881578947368,1175.92105263158,529.627192982456,361.728070175439,1042.67105263158,130.035087719298,228,19.4747510737442,15.1103359193124,0.630863714198566,0.957983193277311,0.791666666666667,0.605303301164937,54189.5657894737,33128.8026315789,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX+,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_279343,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
279462,2687.9154676259,444.879496402878,165.230215827338,671.987410071942,2118.45143884892,544.224820143885,386.034172661871,264.179856115108,1124.29856115108,4925.42086330935,2637.90467625899,126.01618705036,1080.62949640288,2225.29496402878,575.741007194245,312.778776978417,1730.22122302158,4378.5845323741,391.989208633094,238.437050359712,1130.07374100719,3671.23561151079,241.145683453237,399.61690647482,1902.16726618705,1950.13669064748,510.852517985611,550.271582733813,1064.72841726619,130.160071942446,556,34.9241913499694,20.282489348093,0.814076542328119,0.972027972027972,0.710997442455243,1.18342466152435,52491.1978417266,33330.0215827338,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_279462,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
279574,3016.37406483791,248.600997506234,91.8703241895262,637.907730673317,1225.04738154613,549.034912718205,288.780548628429,242.88029925187,1087.15960099751,4947.10224438903,3188.4289276808,118.548628428928,1134.29925187032,919.401496259352,529.588528678304,285.391521197007,1704.85536159601,1249.15461346633,316.720698254364,232.042394014963,992.162094763092,1173.48628428928,237.438902743142,177.663341645885,611.304239401496,1257.11720698254,483.369077306733,471.997506234414,1061.8927680798,129.780548628429,401,34.0021848572092,15.0188686082148,0.89716131186909,0.966265060240964,0.786274509803922,1.45206240809656,53949.7206982544,33405.1271820449,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_279574,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
280590,1095.36655948553,480.967845659164,110.138263665595,655.051446945338,2289.3922829582,500.173633440514,1255.7845659164,247.784565916399,1087.08360128617,1791.56270096463,4320.26366559486,120.717041800643,1068.18006430868,654.485530546624,421.289389067524,303.237942122186,1562.05144694534,916.774919614148,246.684887459807,223.633440514469,993.35691318328,860.08038585209,187.816720257235,162.012861736334,593.842443729903,951.106109324759,478.131832797428,748.704180064309,1042.65594855305,129.581993569132,311,21.6509938990849,18.2929932189302,0.534919289067071,0.959876543209877,0.744019138755981,0.540601084843799,52620.9967845659,33697.4533762058,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_280590,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
280942,4818.76119402985,784.417910447761,132.676616915423,635.502487562189,1474.21393034826,410.726368159204,291.293532338308,252.303482587065,1116.24875621891,8821.1144278607,1227.85572139303,128.194029850746,1079.67164179104,821.621890547264,441.970149253731,267.383084577114,1498.73134328358,979.323383084577,210.626865671642,210.323383084577,1161.07960199005,644.970149253731,134.641791044776,112.855721393035,590.800995024876,2516.13930348259,542.029850746269,388.407960199005,1082.4776119403,130.014925373134,201,18.1882124761891,14.312392497721,0.617074360828274,0.95260663507109,0.738970588235294,0.792409356379669,53248.7064676617,32744.7313432836,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_280942,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
282130,1305.49206349206,407.349206349206,115.931216931217,638.227513227513,1601.17989417989,1599.01058201058,898.730158730159,249.275132275132,1107.97354497354,2486.65608465608,2157.86243386243,107.830687830688,1063.21693121693,2247.26455026455,919.878306878307,1688.59788359788,2111.19047619048,1875.79894179894,311.84126984127,231.132275132275,1028.24338624339,1328.89947089947,237.661375661376,239.031746031746,610.888888888889,1285.24338624339,483.719576719577,459.931216931217,1040.71957671958,128.984126984127,189,19.4443022365897,12.4099652684525,0.769844537838262,0.949748743718593,0.75,1.19290564414611,53410.8042328042,33663.6402116402,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_282130,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
282415,2037.05574912892,795.118466898955,102.250871080139,618.121951219512,664.759581881533,1020.10452961672,361.843205574913,252.780487804878,1110.87456445993,2790.65156794425,547.348432055749,116.515679442509,1079.42160278746,642.641114982578,435.564459930314,274.313588850174,1533.94425087108,915.98606271777,257.045296167247,223.836236933798,983.682926829268,852.118466898955,202.310104529617,135.752613240418,585.01393728223,904.710801393728,464.501742160279,222.045296167247,1021.24390243902,130.80487804878,287,21.8461866086441,16.7306433023356,0.643033371145616,0.976190476190476,0.797222222222222,-0.576901247359248,52630.3588850174,33471.4878048781,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_282415,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
283460,2775.00381679389,529.480916030534,140.381679389313,632.473282442748,1334.95801526718,1069.10687022901,879.43893129771,257.526717557252,1080.54961832061,5036.96946564885,1008.90076335878,122.408396946565,1066.28244274809,653.118320610687,445.412213740458,288.698473282443,1408.88167938931,957.446564885496,264.664122137405,230.381679389313,978.213740458015,910.977099236641,209.461832061069,128.858778625954,590.748091603053,1434.69847328244,469.148854961832,298.839694656489,1066.26717557252,130.202290076336,262,20.9902602752543,15.9889708278344,0.647891242326422,0.956204379562044,0.727777777777778,0.613141845106459,52689.4580152672,32760.0229007634,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_283460,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
283591,5208.48771929825,1171.01052631579,129.529824561404,648.375438596491,2388.28070175439,374.978947368421,409.856140350877,246.364912280702,1087.10526315789,7389.82456140351,674.487719298246,126.175438596491,1079.0350877193,1363.95087719298,634.350877192982,282.887719298246,1747.27719298246,1980.05614035088,248.045614035088,215.270175438596,1031.96140350877,1331.65263157895,174.922807017544,122.147368421053,871.245614035088,1086.42807017544,463.40701754386,254.024561403509,1040.94385964912,131.319298245614,285,19.7236214186633,18.4897531384781,0.348141212454103,0.972696245733788,0.833333333333333,0.207559203494686,54130.5052631579,32705.7614035088,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_283591,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
284235,1261.54028436019,225.592417061611,62.2843601895735,623.549763033175,1151.85308056872,1063.02369668246,391.412322274881,265.303317535545,1136.35545023697,1618.59241706161,819.658767772512,114.962085308057,1070.1327014218,1954.95734597156,1286.38388625592,600.161137440758,2434.74881516588,5138.20853080569,380.582938388626,240.701421800948,1027.76777251185,4363.5355450237,242.526066350711,661.862559241706,616.407582938389,945.867298578199,488.0,252.876777251185,1036.91943127962,133.123222748815,211,16.8001263929678,16.0203341393114,0.301126685994018,0.972350230414747,0.775735294117647,0.478188829742547,52608.7251184834,32438.3601895735,FAAGSCC_12,AG,1,stromal cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_284235,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
284425,2656.41588785047,202.86214953271,115.635514018692,657.044392523365,2415.55607476636,1003.05841121495,1164.36448598131,261.810747663551,1118.67757009346,4031.23598130841,529.030373831776,132.78738317757,1093.83878504673,1388.45327102804,893.446261682243,712.63785046729,4862.96728971963,2164.86214953271,350.670560747664,242.357476635514,1045.55373831776,1938.83644859813,238.032710280374,761.03738317757,711.60046728972,1255.66121495327,477.532710280374,263.161214953271,1038.31775700935,130.278037383178,428,40.491949373906,13.6661749690805,0.9413242703379,0.924406047516199,0.484162895927602,0.978971420994792,53325.4509345794,33854.3341121495,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_284425,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
284510,4167.94459833795,1576.99445983379,687.961218836565,658.030470914127,3093.7811634349,714.991689750693,1852.81717451524,256.963988919668,1085.62049861496,6733.22991689751,574.15512465374,123.831024930748,1079.78670360111,751.847645429363,479.457063711911,274.808864265928,1367.16620498615,1116.49861495845,285.722991689751,221.706371191136,992.756232686981,1189.81717451524,209.936288088643,135.847645429363,580.470914127424,2051.50692520776,537.14404432133,256.612188365651,1053.75069252078,131.409972299169,361,25.6733153328701,18.015978465665,0.712433666225781,0.96524064171123,0.716269841269841,1.00051678237194,53783.2077562327,33238.811634349,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_284510,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
285390,2665.41263940521,489.472118959108,139.776951672862,718.431226765799,5018.51301115242,1576.02230483271,412.501858736059,259.862453531599,1093.10037174721,4692.99628252788,3408.83271375465,146.089219330855,1079.47211895911,2272.06319702602,695.843866171004,957.130111524164,1900.72862453532,2348.39405204461,320.598513011152,235.371747211896,1015.87360594796,2262.78810408922,228.382899628253,322.442379182156,624.988847583643,2010.09293680297,519.003717472119,500.933085501859,1088.95539033457,130.371747211896,269,19.2605826471251,17.8877699712966,0.37077120568265,0.97463768115942,0.8328173374613,-0.295523696543926,53460.2639405204,33761.7026022305,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_285390,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
285788,4193.09907120743,964.814241486068,158.603715170279,675.904024767802,3344.93498452012,1706.86996904025,2188.31578947368,243.684210526316,1086.04334365325,6897.67182662539,630.975232198142,137.501547987616,1078.52321981424,1152.41486068111,436.798761609907,367.808049535604,2836.50464396285,2125.47058823529,254.390092879257,223.585139318885,1024.04643962848,2378.17027863777,200.108359133127,205.037151702786,599.981424148607,1906.80185758514,517.931888544892,286.442724458204,1056.58513931889,129.910216718266,323,21.8228572377939,18.8924363565855,0.500532375684941,0.984756097560976,0.8075,0.787282516839285,52962.786377709,33632.5696594427,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_285788,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
285966,2731.62358276644,361.086167800453,95.0907029478458,638.174603174603,1422.92517006803,2069.97959183673,1482.62811791383,253.455782312925,1085.1201814059,4937.99546485261,703.46485260771,130.267573696145,1089.87301587302,1406.1768707483,788.045351473923,924.848072562358,1740.60317460317,2925.87301587302,371.018140589569,243.038548752834,1038.09523809524,3252.91836734694,276.72335600907,984.816326530612,723.997732426304,2155.34240362812,521.748299319728,630.501133786848,1070.4716553288,130.226757369615,441,29.6518223785729,19.5436786663754,0.752050506447569,0.950431034482759,0.684782608695652,0.554119576222674,53355.970521542,33730.0702947846,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_285966,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
286328,1937.90513833992,318.549407114625,97.7667984189723,635.98814229249,1460.01976284585,462.241106719368,334.316205533597,262.446640316206,1078.33992094862,3664.45849802372,1190.01581027668,117.849802371542,1075.59683794466,1233.56126482213,600.233201581028,304.573122529644,1723.99209486166,1455.60079051383,315.086956521739,228.442687747036,1018.90909090909,1092.39920948617,228.620553359684,139.399209486166,600.098814229249,1006.94466403162,424.055335968379,280.173913043478,1040.81027667984,131.743083003953,253,19.5195078877568,16.5590208823339,0.529464839462059,0.954716981132076,0.78328173374613,-0.207718527772096,52559.1818181818,32668.9090909091,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_286328,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
286641,2796.87096774194,218.958064516129,178.832258064516,695.654838709677,5554.71935483871,612.564516129032,377.612903225806,268.7,1137.47096774194,4425.91612903226,1202.91612903226,141.945161290323,1070.63548387097,1294.66774193548,655.996774193548,286.996774193548,1864.28387096774,2094.81612903226,322.5,230.461290322581,1041.56129032258,1345.50322580645,214.7,237.970967741935,1839.76451612903,1019.79677419355,472.303225806452,236.641935483871,1063.06129032258,131.029032258065,310,30.0461391299133,13.1613904160426,0.898955812205726,0.933734939759036,0.714285714285714,1.51140093219143,53229.7903225806,32711.3935483871,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_286641,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
286740,2516.26031746032,113.51746031746,106.44126984127,689.980952380952,3471.44126984127,645.488888888889,431.447619047619,282.625396825397,1144.22857142857,4459.98095238095,872.193650793651,168.136507936508,1075.06984126984,955.698412698413,561.936507936508,283.755555555556,1601.23174603175,938.155555555556,199.628571428571,209.04126984127,1107.27936507937,600.279365079365,132.596825396825,95.8126984126984,592.955555555556,839.514285714286,416.533333333333,209.920634920635,1034.44126984127,130.612698412698,315,22.2685260273743,18.3100553040492,0.569142053836053,0.975232198142415,0.75,-0.534844636592144,52930.5492063492,32295.0507936508,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,7,FAAGSCC_12_286740,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
286830,3258.88461538462,116.932692307692,113.776442307692,634.266826923077,1767.875,300.8125,326.264423076923,253.925480769231,1079.6875,5303.88461538462,557.25,125.259615384615,1076.68990384615,728.144230769231,519.834134615385,295.420673076923,1376.60336538462,1160.21634615385,331.439903846154,233.627403846154,997.007211538462,1094.00480769231,240.117788461538,161.545673076923,597.435096153846,1725.44230769231,534.466346153846,263.935096153846,1035.65384615385,130.596153846154,416,28.7116082623068,18.4634029695689,0.765812400686221,0.96969696969697,0.722222222222222,0.762760126357304,53148.0721153846,33276.6490384615,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_286830,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
286907,1307.73099415205,200.906432748538,74.3859649122807,655.333333333333,1871.78362573099,1452.05847953216,1063.76608187135,245.87134502924,1105.05847953216,2078.51461988304,1218.78362573099,111.748538011696,1070.61403508772,1519.61403508772,964.06432748538,478.847953216374,1997.14035087719,1639.10526315789,358.93567251462,231.912280701754,1031.09356725146,1675.94736842105,252.53216374269,515.74269005848,674.391812865497,1018.51461988304,491.438596491228,735.152046783626,1056.9649122807,130.590643274854,171,18.1092805719822,12.0845852172256,0.744776060091483,0.95,0.718487394957983,1.02032403392317,53532.6023391813,33612.1578947368,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_286907,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
287146,673.062827225131,165.586387434555,71.1675392670157,601.989528795812,584.727748691099,2045.96335078534,390.277486910995,260.51832460733,1127.50785340314,1428.28272251309,557.38219895288,107.55497382199,1063.58115183246,583.581151832461,597.083769633508,308.497382198953,1566.67015706806,843.340314136126,221.848167539267,212.062827225131,1018.71727748691,701.439790575916,159.712041884817,112.465968586387,607.03664921466,808.528795811518,443.69109947644,278.293193717277,1015.34031413613,130.497382198953,191,16.7853132535621,14.490660900491,0.504701297361596,0.974489795918367,0.852678571428571,-1.41559120448996,53138.3403141361,32287.3821989529,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_287146,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
287406,3234.33704735376,303.676880222841,221.774373259053,629.91364902507,967.186629526462,358.933147632312,300.214484679666,245.013927576602,1092.78551532033,5614.35933147632,773.206128133705,116.108635097493,1069.38718662953,755.802228412256,476.894150417827,296.311977715877,1583.42896935933,1134.06963788301,292.036211699164,229.325905292479,992.278551532034,1054.09470752089,221.760445682451,154.777158774373,605.300835654596,1952.6573816156,489.462395543175,285.467966573816,1035.13091922006,129.735376044568,359,21.9332574614288,20.906191781484,0.302425154665377,0.962466487935657,0.741735537190083,-0.801071663558195,53922.922005571,33396.2367688022,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_287406,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
288146,2830.17571884984,481.079872204473,114.188498402556,637.757188498403,1612.62300319489,567.153354632588,433.076677316294,275.731629392971,1130.80191693291,4478.70926517572,958.389776357828,124.402555910543,1069.93610223642,844.686900958466,513.220447284345,282.396166134185,1555.72204472843,958.897763578275,201.517571884984,212.926517571885,1213.68690095847,626.546325878594,144.670926517572,123.715654952077,590.539936102236,1170.23322683706,469.715654952077,332.29392971246,1055.38658146965,131.900958466454,313,25.1192752771421,16.0120111718699,0.770500645194185,0.954268292682927,0.677489177489177,0.793793876110406,52537.5623003195,32955.6166134185,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_288146,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
288158,5576.40073529412,798.647058823529,125.522058823529,654.246323529412,2263.20588235294,258.606617647059,264.125,245.830882352941,1076.53308823529,9229.3125,873.742647058824,141.485294117647,1091.70588235294,503.963235294118,363.180147058824,257.216911764706,1446.19117647059,741.378676470588,180.055147058824,205.378676470588,991.827205882353,654.709558823529,139.772058823529,124.3125,583.518382352941,2284.04779411765,524.672794117647,286.158088235294,1078.36029411765,132.253676470588,272,22.6047868001552,15.4915089327557,0.728242207844447,0.931506849315068,0.739130434782609,-1.39987497264983,53141.4007352941,33011.7904411765,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_288158,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
288420,2802.6292834891,265.722741433022,180.778816199377,703.308411214953,6339.13084112149,256.317757009346,277.22429906542,239.457943925234,1073.32398753894,5335.67601246106,582.168224299065,123.348909657321,1074.93457943925,527.978193146417,353.034267912773,276.255451713396,1415.50778816199,794.214953271028,179.043613707165,207.056074766355,1003.79750778816,680.068535825545,149.915887850467,125.021806853583,579.355140186916,1598.36137071651,492.716510903427,260.990654205607,1055.66666666667,129.722741433022,321,26.0765308841116,15.7025125029702,0.798367663559472,0.955357142857143,0.771634615384615,-1.42746268478649,53742.8130841122,33339.5109034268,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_288420,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
289699,2950.79633867277,670.437070938215,128.965675057208,673.732265446224,3387.61784897025,1850.72082379863,1108.84210526316,250.171624713959,1094.88329519451,4582.96338672769,668.524027459954,120.867276887872,1084.83066361556,1279.78489702517,598.922196796339,735.807780320366,1688.66590389016,1299.58581235698,301.576659038902,230.322654462243,1050.83981693364,1173.52402745995,226.414187643021,414.059496567506,649.313501144165,1224.43935926773,482.503432494279,338.102974828375,1050.20137299771,129.421052631579,437,26.8589066181024,20.9665474946939,0.625008359336863,0.964679911699779,0.758680555555556,-0.622235807995016,53511.2128146453,33695.3043478261,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_289699,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
289840,2660.0679245283,318.233962264151,87.8716981132075,664.520754716981,2249.12830188679,364.237735849057,301.02641509434,231.211320754717,1080.10943396226,3798.50943396226,753.558490566038,126.754716981132,1079.42264150943,2731.39622641509,643.105660377359,369.747169811321,7932.28679245283,5067.40377358491,453.37358490566,245.211320754717,1079.4,4086.43396226415,248.690566037736,202.320754716981,631.592452830189,1023.34339622642,474.083018867925,767.732075471698,1057.75094339623,130.622641509434,265,22.0621166145329,15.3499781293486,0.718272585760336,0.953237410071942,0.742296918767507,-0.471139904135103,52942.8830188679,33627.8339622642,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,9,FAAGSCC_12_289840,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
290127,2067.01510574018,245.404833836858,101.743202416918,644.516616314199,1549.79758308157,286.888217522659,307.132930513595,255.833836858006,1076.78851963746,4083.11782477341,993.060422960725,124.646525679758,1073.14803625378,788.413897280967,546.326283987915,280.906344410876,1438.10574018127,1159.89123867069,351.081570996979,243.311178247734,986.574018126888,1071.47734138973,251.978851963746,143.610271903323,585.383685800604,1680.48036253776,491.73413897281,269.311178247734,1075.02416918429,130.534743202417,331,25.1304088141194,16.8828709605791,0.740723116261426,0.959420289855072,0.757437070938215,1.07023223526756,52562.9818731118,33201.1933534743,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_290127,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
290368,4552.59195402299,927.528735632184,183.16091954023,683.505747126437,3991.77873563218,2675.12068965517,1782.22413793103,254.862068965517,1106.40229885057,6630.95114942529,714.387931034483,133.850574712644,1093.15229885057,3274.94540229885,1452.0316091954,1937.92528735632,2452.87643678161,3967.09482758621,331.264367816092,232.758620689655,1023.90804597701,3296.26436781609,225.92816091954,155.221264367816,612.905172413793,1263.94252873563,488.077586206897,241.330459770115,1081.75,132.186781609195,348,22.3940039559386,19.894275631119,0.459118363382543,0.953424657534246,0.753246753246753,0.974933740599172,53027.2873563218,33402.5402298851,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_290368,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
290503,1318.39420289855,318.6,100.234782608696,642.173913043478,2103.62608695652,540.68115942029,557.657971014493,247.513043478261,1078.67536231884,2689.79710144928,1242.45507246377,109.16231884058,1081.38550724638,1155.45797101449,756.852173913043,560.620289855072,1703.2,1830.51304347826,350.776811594203,237.498550724638,1017.38260869565,1132.20869565217,232.907246376812,287.559420289855,611.788405797101,1403.05797101449,492.579710144928,382.634782608696,1050.3768115942,130.455072463768,345,33.9360193815752,13.0042736743331,0.923665503407204,0.950413223140496,0.780542986425339,-1.56706605843428,53515.4927536232,33460.1884057971,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_290503,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
291020,2547.86495176849,710.016077170418,145.128617363344,647.24115755627,2502.9807073955,391.852090032154,314.032154340836,249.061093247588,1079.89067524116,3660.86816720257,608.797427652733,125.372990353698,1224.22508038585,818.022508038585,517.932475884244,288.832797427653,1504.02893890675,2272.65916398714,311.662379421222,233.372990353698,1013.48231511254,2355.38585209003,227.916398713826,146.549839228296,602.04501607717,1025.68810289389,508.199356913183,248.215434083601,1027.0578778135,131.282958199357,311,20.6103832913471,19.331864014892,0.346723932646918,0.951070336391437,0.740476190476191,-1.37043847803484,53281.8938906752,33289.5273311897,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX+,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_291020,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
291489,1866.64802631579,950.493421052632,152.151315789474,622.743421052632,1282.67434210526,1401.55263157895,1651.44407894737,247.506578947368,1083.85526315789,2167.86513157895,622.148026315789,119.677631578947,1067.28618421053,740.661184210526,397.023026315789,421.960526315789,1447.38486842105,935.858552631579,212.8125,207.990131578947,981.467105263158,879.710526315789,172.967105263158,121.210526315789,595.654605263158,983.427631578947,523.220394736842,232.092105263158,1034.69736842105,128.743421052632,304,20.9004531030106,18.6202344433676,0.454197555022337,0.952978056426332,0.8,-0.285448204167151,54155.3125,32854.7434210526,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_291489,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
292252,3730.90288713911,138.942257217848,84.1574803149606,624.02624671916,1462.58005249344,385.018372703412,346.199475065617,254.758530183727,1082.49081364829,5752.96850393701,596.832020997375,121.548556430446,1082.17847769029,1543.39632545932,542.196850393701,293.650918635171,1461.8687664042,4171.6719160105,340.761154855643,234.173228346457,988.196850393701,4701.01049868766,255.551181102362,248.937007874016,653.278215223097,1238.70603674541,471.748031496063,245.866141732283,1069.18372703412,130.225721784777,381,28.1891924876459,17.759356314992,0.776590382803797,0.940740740740741,0.668421052631579,-0.0070408777348755,53017.469816273,33331.6220472441,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_292252,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
292350,2026.81967213115,500.967213114754,163.073770491803,660.081967213115,1771.94262295082,2802.05737704918,2295.08196721311,260.631147540984,1112.22950819672,2182.70491803279,3479.7131147541,138.172131147541,1080.43442622951,6471.46721311475,1559.11475409836,829.581967213115,13771.8360655738,10065.2868852459,601.286885245902,272.877049180328,1151.97540983607,10731.8114754098,343.385245901639,391.786885245902,723.016393442623,835.868852459016,459.467213114754,592.614754098361,1050.0737704918,130.573770491803,122,13.928908961919,11.1343705633597,0.600837305328553,0.968253968253968,0.782051282051282,0.958255377859502,52771.0983606557,33573.6475409836,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_292350,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
292419,4558.68421052632,329.217105263158,136.141447368421,644.753289473684,1989.74013157895,1340.77631578947,3478.0625,255.648026315789,1103.01973684211,7446.92434210526,1461.15789473684,150.569078947368,1089.66118421053,881.786184210526,644.684210526316,669.486842105263,1851.55921052632,1052.18092105263,261.273026315789,224.578947368421,995.27302631579,1053.82894736842,193.115131578947,257.371710526316,612.651315789474,2340.72039473684,581.075657894737,472.713815789474,1077.78289473684,132.052631578947,304,22.4967131262212,17.2951417741347,0.639506999059105,0.941176470588235,0.695652173913043,1.47914261729261,52733.6282894737,33770.9506578947,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_292419,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
292549,5043.12371134021,1079.50171821306,114.26116838488,646.92439862543,1654.24054982818,245.178694158076,288.573883161512,250.986254295533,1080.26116838488,6584.87628865979,732.556701030928,133.257731958763,1082.5704467354,545.522336769759,482.474226804124,267.549828178694,1508.48453608247,838.096219931271,228.350515463918,215.295532646048,989.14089347079,759.591065292096,177.288659793814,114.742268041237,585.209621993127,1318.05154639175,466.855670103093,230.766323024055,1055.2852233677,129.92439862543,291,22.8424025763703,16.2897171942843,0.701026707579414,0.941747572815534,0.77807486631016,0.0152279636419926,52624.8591065292,32271.4879725086,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_292549,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
292988,4875.53053435115,935.416030534351,927.625954198473,617.896946564886,971.011450381679,665.358778625954,297.751908396947,248.980916030534,1096.96183206107,8025.59541984733,573.175572519084,144.767175572519,1065.62595419847,3154.26335877863,672.767175572519,331.927480916031,2010.29770992366,4000.32061068702,424.62213740458,242.339694656488,1051.96946564886,3180.15267175573,245.725190839695,274.125954198473,1512.19465648855,3042.46946564886,582.251908396947,267.606870229008,1076.26335877863,129.259541984733,262,25.3216171601218,13.4193529664817,0.848024892636262,0.945848375451264,0.779761904761905,-1.41378126728061,52974.6603053435,33818.0992366412,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_292988,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
293031,2113.24675324675,225.878787878788,90.9393939393939,639.757575757576,1276.83116883117,294.393939393939,318.229437229437,252.532467532468,1077.5670995671,2899.54978354978,685.393939393939,140.835497835498,1071.83982683983,671.415584415584,573.705627705628,308.519480519481,1564.05194805195,1161.48917748918,250.900432900433,210.415584415584,1012.0,1009.71861471861,168.047619047619,143.606060606061,594.844155844156,825.645021645022,406.506493506493,209.220779220779,1017.16017316017,129.17316017316,231,17.72199118027,16.5908082033218,0.351545861680274,0.978813559322034,0.802083333333333,-1.45657005527266,53254.9090909091,32263.4545454545,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_293031,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
293121,4168.04815864023,292.189801699717,165.223796033994,678.184135977337,3430.61756373938,3228.82719546742,362.084985835694,284.507082152974,1087.24079320113,6560.44192634561,606.175637393768,129.538243626062,1093.21529745042,1073.09915014164,522.645892351275,288.169971671388,1536.43626062323,1163.32294617564,326.99433427762,239.084985835694,983.57790368272,1049.7507082153,233.603399433428,220.062322946176,587.243626062323,1727.11614730878,546.957507082153,249.14730878187,1047.60906515581,130.8611898017,353,25.6059710605247,17.6414260311336,0.724801732288858,0.946380697050938,0.706,0.334225802099239,52587.5240793201,33471.7733711048,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_293121,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
293395,3590.14102564103,626.222222222222,113.57264957265,647.012820512821,1609.51282051282,1647.7735042735,920.662393162393,249.717948717949,1106.92735042735,5896.21367521367,1232.57692307692,138.183760683761,1069.80341880342,2680.32051282051,800.901709401709,2160.02136752137,2005.13675213675,2289.09401709402,342.752136752137,237.465811965812,1062.86324786325,1969.81196581197,242.645299145299,333.581196581197,688.799145299145,1894.94871794872,517.025641025641,544.358974358974,1068.76923076923,130.5,234,19.1315102081922,15.6274028913263,0.576862807456547,0.955102040816326,0.769736842105263,1.30474976805601,53239.8376068376,33837.9700854701,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_293395,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
293719,3161.93425076453,419.98623853211,740.373088685015,644.295107033639,1619.89296636086,447.001529051988,1379.50305810398,245.169724770642,1087.82568807339,4768.11314984709,615.492354740061,123.750764525994,1084.06422018349,1288.65902140673,857.784403669725,555.594801223242,3379.2370030581,1711.61773700306,291.562691131498,281.363914373089,1033.38837920489,1189.70795107034,208.818042813456,295.987767584098,610.061162079511,1004.4495412844,510.191131498471,257.033639143731,1022.99388379205,129.964831804281,654,31.0242493659837,26.8990750198729,0.498249201398691,0.964601769911504,0.756944444444444,0.072961529719986,53635.4892966361,33379.2966360856,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_293719,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
294227,1694.35849056604,587.343396226415,160.188679245283,683.08679245283,3089.07547169811,300.460377358491,273.664150943396,244.667924528302,1074.38113207547,2389.6641509434,3197.35471698113,119.31320754717,1075.63018867925,668.467924528302,463.064150943396,272.207547169811,1475.41509433962,1061.24150943396,246.592452830189,216.324528301887,991.698113207547,1054.10188679245,195.988679245283,144.139622641509,590.358490566038,1128.42264150943,520.494339622642,449.562264150943,1043.83773584906,130.090566037736,265,19.107933568154,17.9437715095452,0.343713901126582,0.939716312056738,0.734072022160665,0.921441883973963,53932.4679245283,33272.0075471698,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_294227,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
294251,4063.26470588235,719.933823529412,95.6740196078431,643.259803921569,1770.51960784314,4543.1862745098,1138.74509803922,263.026960784314,1118.77696078431,6169.35784313726,927.705882352941,124.625,1082.31617647059,3056.46568627451,802.887254901961,717.132352941176,1986.58333333333,1810.71323529412,387.446078431372,242.926470588235,1062.9068627451,1399.85049019608,223.149509803922,413.71568627451,740.458333333333,1138.67401960784,457.531862745098,447.164215686274,1040.65931372549,129.661764705882,408,25.2070810743936,20.7146011677887,0.56980913575085,0.955503512880562,0.777142857142857,0.228175523175791,53732.6911764706,33724.2867647059,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_294251,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
294591,3674.54449152542,346.063559322034,187.569915254237,686.622881355932,4110.3220338983,453.120762711864,643.283898305085,249.425847457627,1086.47881355932,5653.51483050847,610.862288135593,134.258474576271,1087.37288135593,833.978813559322,705.508474576271,697.127118644068,2250.09957627119,1111.70974576271,282.741525423729,222.188559322034,997.459745762712,946.271186440678,192.281779661017,313.745762711864,626.584745762712,1492.51906779661,536.216101694915,253.864406779661,1052.27118644068,132.343220338983,472,25.5838272806316,23.9652032651705,0.350045949189559,0.957403651115619,0.7552,0.796397757205103,53123.3262711864,33053.4046610169,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_294591,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
294596,2864.24022346369,425.212290502793,172.983240223464,704.201117318436,2544.86033519553,374.837988826816,391.692737430168,242.31843575419,1083.76536312849,4343.79329608939,576.139664804469,118.776536312849,1108.78212290503,884.067039106145,670.720670391062,363.27374301676,1666.75977653631,1378.58659217877,328.335195530726,232.424581005587,992.653631284916,1087.62569832402,228.603351955307,157.374301675978,585.625698324022,1199.38547486034,515.22905027933,1189.50279329609,1039.56983240223,130.810055865922,179,22.6981095282362,10.0666717109278,0.89627306108279,0.957219251336898,0.813636363636364,1.48982076835501,53431.3296089385,33444.4357541899,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_294596,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
294597,1983.51076923077,329.661538461538,124.335384615385,632.633846153846,1577.76307692308,543.424615384615,290.347692307692,245.406153846154,1077.87384615385,2739.26153846154,2939.73230769231,118.664615384615,1072.86769230769,1146.07076923077,522.424615384615,294.704615384615,1771.87384615385,2119.36307692308,355.086153846154,226.270769230769,1056.14461538462,1663.63692307692,210.021538461538,177.209230769231,584.344615384615,925.504615384615,460.624615384615,387.473846153846,1033.68307692308,129.209230769231,325,23.3457588196597,17.760375270519,0.649040538753585,0.975975975975976,0.773809523809524,0.89812865038614,53856.8184615385,32915.2676923077,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_294597,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
294664,4100.42469879518,1016.15963855422,122.518072289157,637.885542168675,1387.99698795181,1689.49698795181,1838.73192771084,253.433734939759,1116.64759036145,6212.27409638554,1022.57831325301,133.132530120482,1083.03012048193,3683.24096385542,904.189759036145,2438.70180722892,2159.09638554217,4160.18072289157,389.578313253012,247.472891566265,1047.12048192771,3717.06024096386,272.719879518072,386.777108433735,873.521084337349,1376.99096385542,506.846385542169,316.451807228916,1062.49698795181,132.834337349398,332,22.3261523840599,19.1354288037272,0.515173643852405,0.959537572254335,0.759725400457666,-0.117984986078198,52827.9879518072,33618.7801204819,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_294664,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
294736,2413.61256544503,355.853403141361,211.853403141361,623.837696335079,1012.44502617801,1000.78010471204,323.162303664921,251.680628272251,1089.58115183246,5431.15183246073,558.51832460733,117.246073298429,1071.0,804.413612565445,646.675392670157,417.403141361256,1508.75916230366,1101.03141361257,241.539267015707,214.03664921466,1018.26178010471,1011.64397905759,189.643979057592,306.230366492147,627.267015706806,2548.65968586387,487.486910994764,290.026178010471,1027.14136125654,129.523560209424,191,21.6734162975153,11.2482441713531,0.854781491772199,0.940886699507389,0.682142857142857,1.12343939117424,53938.4293193717,32898.4397905759,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_294736,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
294832,2565.18597560976,560.713414634146,122.079268292683,632.310975609756,1692.63719512195,441.399390243902,347.506097560976,262.646341463415,1083.93902439024,5198.36280487805,1615.07012195122,116.609756097561,1069.15548780488,636.463414634146,469.47256097561,266.496951219512,1402.25304878049,980.762195121951,269.387195121951,220.286585365854,982.085365853659,969.579268292683,222.375,128.52743902439,584.829268292683,1745.25,493.77743902439,273.280487804878,1055.58841463415,130.823170731707,328,22.8277119561253,18.4587615020037,0.588342294929783,0.970414201183432,0.784688995215311,-1.16483086397453,54047.4908536585,32546.1402439024,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_294832,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
297066,1376.98984771574,270.340101522843,52.7766497461929,609.360406091371,653.269035532995,360.558375634518,325.741116751269,239.365482233502,1082.7461928934,2910.15736040609,836.096446700508,107.781725888325,1067.28426395939,972.055837563452,600.324873096447,292.365482233503,2396.52284263959,1447.57360406091,263.675126903553,224.060913705584,1034.16751269036,1010.8730964467,184.43654822335,136.680203045685,590.527918781726,1025.80203045685,438.208121827411,317.380710659898,1034.52284263959,130.48730964467,197,16.6847968388558,15.1127106708813,0.423753979480625,0.960975609756098,0.684027777777778,0.142807900159364,53013.1319796954,33438.3959390863,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_297066,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
297235,3467.15827338129,628.525179856115,98.0023980815348,648.517985611511,2135.75299760192,297.62829736211,248.877697841727,226.729016786571,1072.76978417266,5780.49880095923,1002.73141486811,120.326139088729,1110.77458033573,2583.0,567.68345323741,317.338129496403,2854.29736211031,4475.51079136691,409.297362110312,241.544364508393,1076.62829736211,3095.67146282974,251.640287769784,228.115107913669,603.184652278178,1454.45803357314,477.877697841727,369.940047961631,1045.48441247002,130.0551558753,417,27.3283685480691,19.4831718660436,0.701236766313794,0.958620689655172,0.763736263736264,1.25955312976899,53376.8225419664,33419.7745803357,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_297235,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
297617,1854.46511627907,461.767441860465,33.0837209302326,631.744186046512,1363.6,3150.74418604651,1307.40930232558,261.906976744186,1140.24186046512,3465.37674418605,508.562790697674,124.097674418605,1069.2511627907,2380.35813953488,911.976744186046,311.460465116279,10781.9720930233,2865.0976744186,335.925581395349,233.511627906977,1028.93953488372,2020.82790697674,677.437209302326,177.720930232558,612.013953488372,1622.94418604651,501.055813953488,278.502325581395,1062.48837209302,129.748837209302,215,18.4967235671872,14.8197528122947,0.598383780693098,0.972850678733032,0.790441176470588,0.671001681043883,53002.4744186047,33739.3860465116,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,9,FAAGSCC_12_297617,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
297920,3757.52601156069,221.439306358382,106.612716763006,631.225433526012,1533.20231213873,1521.33526011561,318.35838150289,256.306358381503,1151.17919075145,6293.05780346821,522.306358381503,124.219653179191,1074.19075144509,1549.13294797688,515.797687861272,271.046242774566,1507.36416184971,1120.46820809249,262.832369942197,222.988439306358,979.468208092486,1058.01734104046,206.491329479769,133.560693641618,586.988439306358,2258.31791907514,525.849710982659,236.421965317919,1062.83815028902,130.653179190751,173,19.4565557004266,11.3382159237245,0.81265487334765,0.966480446927374,0.726890756302521,-0.991305847905505,53569.3757225434,33154.6242774566,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_297920,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
298262,2799.45994065282,152.234421364985,94.3620178041543,649.979228486647,2210.46587537092,560.694362017804,306.412462908012,242.347181008902,1083.10385756677,4679.83679525223,521.305637982196,118.836795252226,1076.52522255193,2529.3293768546,721.818991097923,290.80118694362,2326.89317507418,3569.41839762611,368.044510385757,239.587537091988,1023.37685459941,3841.47181008902,240.940652818991,348.311572700297,1401.46290801187,1525.0059347181,501.896142433234,389.157270029674,1039.22255192878,130.192878338279,337,30.6472676720871,14.0449248301835,0.888809643148617,0.96011396011396,0.668650793650794,1.15273823240852,53693.6973293769,33607.6023738872,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_298262,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
298269,3596.20529801324,390.291390728477,139.278145695364,626.668874172185,1262.2582781457,269.940397350993,295.132450331126,247.198675496689,1080.30463576159,7917.8940397351,595.847682119205,126.099337748344,1073.06622516556,644.152317880795,523.841059602649,362.496688741722,1526.3642384106,1002.88079470199,247.854304635762,216.523178807947,984.185430463576,908.69536423841,179.324503311258,174.58940397351,614.655629139073,3744.70860927152,601.006622516556,244.218543046358,1057.98013245033,132.039735099338,151,16.9400644883654,11.3561100679205,0.742027047572507,0.961783439490446,0.786458333333333,1.16844627372358,53712.701986755,32860.3841059603,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_298269,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
299474,2392.6279491833,207.479128856624,190.315789473684,802.468239564428,5819.02722323049,3353.82032667877,1308.94555353902,263.609800362976,1140.43738656987,4819.2722323049,556.987295825771,142.678765880218,1088.40834845735,5453.18693284936,1082.99818511797,373.602540834846,7976.13067150635,7000.75680580762,483.32667876588,257.742286751361,1070.7277676951,6793.54083484573,284.508166969147,240.533575317604,613.611615245009,2164.85299455535,521.058076225045,339.958257713249,1092.90199637024,130.941923774955,551,42.8037280440876,16.4449639261335,0.923252110711555,0.954939341421144,0.531853281853282,0.976907134134769,52825.6805807623,33756.945553539,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_299474,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
300006,2109.05405405405,489.837837837838,316.258258258258,754.018018018018,7815.3003003003,320.720720720721,330.834834834835,253.576576576577,1081.58558558559,3875.38438438438,607.429429429429,134.591591591592,1090.62762762763,654.6996996997,438.813813813814,275.54954954955,1471.67267267267,846.276276276276,214.138138138138,212.561561561562,983.948948948949,985.249249249249,383.312312312312,227.438438438438,604.894894894895,1188.18318318318,460.213213213213,221.564564564565,1065.31231231231,131.537537537538,333,25.3464602893171,16.9997102847902,0.741734461232463,0.96242774566474,0.753393665158371,-1.49251733249839,52575.7867867868,32645.5705705706,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_300006,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
300678,2350.5347985348,196.820512820513,156.798534798535,690.593406593407,3896.58974358974,272.358974358974,309.413919413919,255.959706959707,1082.32600732601,4698.45054945055,558.564102564103,125.96336996337,1071.46153846154,794.846153846154,695.373626373626,277.483516483516,1615.65934065934,1176.21245421245,316.212454212454,226.600732600733,992.399267399267,1074.22344322344,228.644688644689,135.271062271062,834.091575091575,1987.17582417582,488.893772893773,225.615384615385,1064.19047619048,130.241758241758,273,19.9366833386612,17.4619416068163,0.482547252699427,0.954545454545455,0.756232686980609,0.763359666558904,53924.7326007326,32395.7509157509,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,7,FAAGSCC_12_300678,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
300754,2648.24473684211,127.931578947368,67.3263157894737,652.515789473684,2072.98947368421,355.942105263158,667.647368421053,240.802631578947,1084.51578947368,4234.93421052632,597.144736842105,131.726315789474,1079.01842105263,1235.64473684211,731.1,507.713157894737,1814.24473684211,3090.66578947368,374.544736842105,237.765789473684,1049.50789473684,3280.85789473684,871.931578947368,236.881578947368,616.155263157895,1198.76052631579,471.476315789474,1344.93421052632,1062.21315789474,130.607894736842,380,24.1273437464913,20.1015712668228,0.553054900021921,0.962025316455696,0.786749482401656,-1.09200568299275,53260.9947368421,33879.4157894737,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_300754,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
300824,2594.77608695652,572.452173913043,137.545652173913,626.40652173913,765.363043478261,634.254347826087,463.978260869565,282.15652173913,1130.14782608696,3309.55434782609,1833.33043478261,130.813043478261,1068.35652173913,1012.1652173913,573.930434782609,286.936956521739,1548.34130434783,1051.26739130435,208.980434782609,212.760869565217,1276.20652173913,664.432608695652,147.669565217391,125.239130434783,589.413043478261,654.691304347826,366.658695652174,208.75,1015.58043478261,131.639130434783,460,27.592744874768,21.3110170402353,0.63520774799457,0.960334029227557,0.736,0.677527806499967,52540.752173913,32910.6195652174,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_300824,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
301031,3005.61023622047,497.606299212598,137.948818897638,634.515748031496,1117.29527559055,1286.17716535433,2272.72834645669,564.527559055118,1171.90157480315,4912.8937007874,1462.31102362205,125.279527559055,1066.10236220472,1535.57086614173,1204.02362204724,1107.29133858268,1732.31102362205,3161.12992125984,337.003937007874,229.944881889764,1076.53937007874,3230.67716535433,304.342519685039,1068.85039370079,851.96062992126,1270.30708661417,459.433070866142,343.031496062992,1065.13385826772,131.011811023622,254,21.3775813647183,15.1754471955594,0.704325955820584,0.954887218045113,0.747058823529412,-0.441086477361994,52814.3267716535,32808.5472440945,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_301031,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
301059,1844.90789473684,196.219298245614,51.859649122807,627.179824561404,1170.02631578947,2196.44736842105,413.640350877193,254.714912280702,1143.26754385965,3454.43859649123,619.65350877193,128.039473684211,1070.73684210526,1209.8201754386,819.675438596491,311.228070175439,1820.4298245614,1193.06578947368,340.447368421053,241.381578947368,991.600877192982,1097.03070175439,245.228070175439,208.644736842105,608.359649122807,1728.98684210526,474.59649122807,324.59649122807,1105.02192982456,130.513157894737,228,22.0381081186623,13.2673749155251,0.798481244888782,0.962025316455696,0.7125,1.06842719079077,52808.5701754386,33814.0526315789,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_301059,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
301320,3666.25,592.984126984127,90.1666666666667,628.095238095238,993.944444444444,919.531746031746,712.873015873016,254.956349206349,1088.04761904762,6756.6626984127,788.27380952381,118.384920634921,1078.49603174603,4587.88888888889,1117.01587301587,1709.75396825397,1750.2380952381,5390.54365079365,403.238095238095,798.611111111111,1039.73015873016,4341.38095238095,282.93253968254,339.511904761905,753.492063492063,2153.69841269841,522.551587301587,283.65873015873,1041.53968253968,128.642857142857,252,20.646035260332,15.6485955348734,0.65231641771839,0.969230769230769,0.736842105263158,0.662829322796261,54017.2777777778,33372.9761904762,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_301320,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
301900,2137.72368421053,295.223684210526,67.5087719298246,642.644736842105,1316.32456140351,3382.62719298246,3255.80263157895,278.157894736842,1107.02192982456,4412.63596491228,1844.01315789474,130.679824561404,1069.43859649123,2218.98684210526,1304.60526315789,2290.92543859649,2056.2149122807,2926.42105263158,342.407894736842,230.758771929824,1040.35087719298,2147.91228070175,244.894736842105,2197.9298245614,639.19298245614,1815.40789473684,500.390350877193,280.315789473684,1107.0,131.267543859649,228,17.9364548540421,16.2453049782725,0.423888514700457,0.962025316455696,0.788927335640138,0.438386248928519,52416.2719298246,32642.2807017544,FAAGSCC_12,AG,1,M2 macrophages,,TIM3+,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_301900,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
303493,2513.37873754153,171.53488372093,73.8571428571429,631.970099667774,1274.58471760797,2977.23920265781,478.71096345515,261.611295681063,1121.37873754153,3769.12956810631,722.840531561462,121.598006644518,1073.79401993355,1183.86710963455,616.398671096346,336.34219269103,3587.09634551495,1768.34551495017,297.87707641196,229.734219269103,1016.53488372093,2225.92026578073,221.126245847176,201.378737541528,605.717607973422,812.501661129568,419.641196013289,343.102990033223,1021.10299003322,129.823920265781,301,23.2659146657973,16.5732515691221,0.701834109453009,0.967845659163987,0.716666666666667,-0.709398298048222,52967.6112956811,33477.3156146179,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_303493,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
303594,4569.23699421965,457.401734104046,135.156069364162,630.294797687861,1379.98554913295,287.864161849711,335.138728323699,243.549132947977,1080.30346820809,6925.1936416185,1256.95664739884,122.609826589595,1104.42774566474,668.872832369942,460.904624277457,278.190751445087,1420.5289017341,1027.27456647399,263.890173410405,460.21387283237,993.809248554913,951.442196531792,203.063583815029,136.933526011561,583.881502890173,1351.12716763006,487.673410404624,444.64450867052,1062.56936416185,131.722543352601,346,24.9726432582734,17.7931305824877,0.701667138653849,0.947945205479452,0.768888888888889,0.0462062449001963,53924.3930635838,33134.9826589595,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_303594,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
304083,2387.35454545455,1040.34090909091,98.6954545454546,626.672727272727,1628.60909090909,426.2,329.359090909091,258.490909090909,1092.73636363636,2984.95909090909,754.977272727273,120.318181818182,1066.38636363636,963.172727272727,696.945454545455,291.054545454545,1835.49545454545,1140.83181818182,249.195454545455,213.327272727273,1135.95,806.186363636364,154.354545454545,120.072727272727,2629.40454545455,771.963636363636,419.7,247.336363636364,1016.88181818182,130.327272727273,220,19.4304032230572,14.4764245794995,0.667019963242114,0.948275862068966,0.763888888888889,0.467670320685609,53155.4818181818,32791.1,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_304083,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
304350,2470.63310961969,602.778523489933,807.029082774049,671.062639821029,3552.99776286353,357.865771812081,360.736017897092,248.803131991051,1080.13422818792,3730.93512304251,531.41163310962,126.165548098434,1066.19239373602,945.042505592841,520.046979865772,284.261744966443,1448.48545861298,1255.52572706935,313.375838926174,230.252796420582,991.049217002237,1195.42953020134,233.357941834452,135.565995525727,586.34451901566,1252.57494407159,493.834451901566,237.015659955257,1041.18344519016,130.474272930649,447,26.4869089322707,21.4879583935463,0.584675684411264,0.971739130434783,0.776041666666667,0.836872760367212,52983.3243847875,33344.7427293065,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_304350,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
304489,3942.42708333333,159.211805555556,134.399305555556,647.836805555556,2686.39583333333,2728.69097222222,429.680555555556,260.729166666667,1091.84027777778,7957.14930555556,562.670138888889,130.072916666667,1072.85416666667,1767.28472222222,687.194444444444,292.152777777778,1717.02777777778,1802.23958333333,256.815972222222,211.625,1044.31597222222,1033.85763888889,161.736111111111,132.909722222222,3657.33680555556,3413.68055555556,542.659722222222,371.888888888889,1049.17361111111,128.513888888889,288,21.5836345212404,17.0089312556215,0.615614318782342,0.95364238410596,0.757894736842105,0.608391045504701,53958.6493055556,32736.8159722222,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_304489,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
305162,3437.06201550388,539.457364341085,148.736434108527,620.279069767442,435.131782945736,1066.41085271318,300.953488372093,254.488372093023,1086.01550387597,6892.0,803.821705426357,128.790697674419,1078.96899224806,2509.13953488372,895.418604651163,581.341085271318,1862.5503875969,2239.09302325581,363.542635658915,236.263565891473,1018.6511627907,1588.93023255814,230.015503875969,617.666666666667,635.604651162791,1555.6511627907,494.271317829457,255.007751937984,1067.76744186047,131.922480620155,129,16.872818091706,10.547036782247,0.780552355111831,0.826923076923077,0.614285714285714,0.471619080922033,53258.1860465116,32952.3333333333,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_305162,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
306812,1784.38876889849,474.753779697624,129.123110151188,633.019438444924,1596.18574514039,1438.44492440605,523.110151187905,250.166306695464,1108.76025917927,2918.35637149028,2025.48812095032,119.434125269978,1074.1555075594,4212.78617710583,853.539956803456,360.380129589633,7788.85745140389,4751.17494600432,345.686825053996,229.215982721382,1061.85529157667,3565.60691144708,224.855291576674,183.855291576674,648.45788336933,1243.56803455724,498.794816414687,386.431965442765,1037.9524838013,128.950323974082,463,33.5013133144941,17.6492250365577,0.849975706293293,0.958592132505176,0.779461279461279,-0.125964891641231,54155.8984881209,32817.6501079914,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_306812,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
307608,1715.9387755102,211.083487940631,104.628942486085,670.786641929499,3547.98330241187,453.549165120594,834.640074211503,252.556586270872,1083.53988868275,3570.54545454545,858.9573283859,127.474953617811,1070.26901669759,810.461966604824,803.764378478664,334.844155844156,1647.64749536178,1451.27087198516,282.053803339518,223.005565862709,1005.34879406308,1196.11317254174,204.196660482375,440.773654916512,630.283858998145,1537.64935064935,524.385899814471,265.551020408163,1091.97959183673,130.987012987013,539,35.1650215992204,19.6371800136726,0.829552087290357,0.959074733096085,0.720588235294118,0.298592193049409,52608.0705009276,32473.4768089054,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_307608,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
308160,4377.71785714286,735.660714285714,153.067857142857,637.339285714286,1425.49285714286,854.578571428571,843.135714285714,252.325,1097.18571428571,6453.88928571429,1146.85,129.075,1069.78571428571,1401.31785714286,499.15,380.325,1560.97142857143,2696.14285714286,321.521428571429,223.178571428571,1022.88928571429,2479.86428571429,210.007142857143,245.560714285714,614.603571428571,1476.51428571429,457.653571428571,304.996428571429,1066.26785714286,131.05,280,27.2559323452856,13.3154992146804,0.872543840810246,0.949152542372881,0.608695652173913,0.616516717362684,52643.1821428571,32401.4071428571,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_308160,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
308215,3701.69480519481,143.470779220779,110.438311688312,661.405844155844,2489.1461038961,2257.73051948052,1368.33116883117,252.688311688312,1106.74350649351,6357.93506493507,644.090909090909,136.574675324675,1073.62337662338,4872.20779220779,997.675324675325,1265.74025974026,10481.987012987,5463.3961038961,425.438311688312,247.25,1046.35714285714,4340.72727272727,375.519480519481,398.022727272727,678.717532467532,2006.08441558442,507.561688311688,411.805194805195,1051.58766233766,130.792207792208,308,22.6353988213974,17.6447963507668,0.626374574654613,0.959501557632399,0.736842105263158,0.584379733905824,53486.3863636364,33862.6590909091,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_308215,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
308844,1769.85306122449,286.151020408163,153.50612244898,661.081632653061,3046.94285714286,1111.71836734694,369.061224489796,259.179591836735,1123.19183673469,2752.97959183673,500.485714285714,118.751020408163,1083.62857142857,561.787755102041,437.155102040816,270.579591836735,1633.27755102041,836.477551020408,228.885714285714,216.722448979592,999.575510204082,745.473469387755,180.6,147.175510204082,585.167346938775,728.50612244898,389.142857142857,203.975510204082,1008.83265306122,129.942857142857,245,22.345747035067,14.072647862063,0.776782866163957,0.949612403100775,0.720588235294118,0.976892531752365,52368.1387755102,32526.5102040816,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_308844,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
309164,2804.77904328018,478.847380410023,113.820045558087,651.394077448747,1759.51708428246,2518.3416856492,915.375854214123,257.949886104784,1109.53530751708,4548.50113895216,852.068337129841,135.715261958998,1084.42596810934,5316.7562642369,905.879271070615,715.55125284738,5606.89521640091,6258.20273348519,500.653758542141,252.642369020501,1102.32574031891,5246.70842824601,277.031890660592,405.125284738041,661.906605922551,1214.32346241458,470.917995444191,443.924829157175,1058.41002277904,132.0569476082,439,28.4206896113703,19.838123735077,0.716081214183744,0.958515283842795,0.774250440917108,1.27035565256268,53138.7972665148,33895.735763098,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_309164,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
309451,3209.47096774194,730.993548387097,624.051612903226,656.345161290323,2526.94193548387,410.809677419355,311.029032258064,245.577419354839,1078.91290322581,5063.09677419355,1342.88064516129,123.983870967742,1132.58387096774,3479.92580645161,700.683870967742,341.377419354839,1879.1,4822.60967741935,440.612903225806,243.709677419355,1043.43548387097,4236.56451612903,268.845161290323,201.538709677419,590.503225806452,1112.0,479.529032258064,351.241935483871,1043.13870967742,130.18064516129,310,21.5723427618542,18.4288134767971,0.519813693005683,0.950920245398773,0.776942355889724,-1.08946437404574,52863.9064516129,33402.6290322581,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_309451,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
310936,4437.88304093567,244.690058479532,83.7046783625731,632.941520467836,1114.84502923977,3210.24561403509,1151.66081871345,258.245614035088,1113.10233918129,6439.83333333333,740.918128654971,125.701754385965,1095.50292397661,3734.89766081871,983.631578947368,1454.65204678363,6573.40643274854,5540.49122807018,416.716374269006,251.081871345029,1077.84210526316,5374.30994152047,2399.72807017544,720.266081871345,720.426900584795,1809.69005847953,499.637426900585,283.216374269006,1066.98245614035,131.114035087719,342,22.5873829295497,19.417859046103,0.510837587410697,0.960674157303371,0.777272727272727,0.61909198152115,53060.9035087719,33663.9064327485,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67+,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_310936,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
310954,3401.175,566.165625,152.14375,664.303125,2915.96875,4738.690625,759.8375,265.475,1241.16875,5395.640625,612.90625,121.909375,1089.421875,5012.859375,856.703125,562.728125,2246.271875,6467.8,451.14375,246.45625,1059.14375,5406.296875,261.209375,292.034375,628.565625,1618.878125,499.05625,272.48125,1045.11875,128.696875,320,25.8326718459989,16.03653357328,0.783980906381019,0.941176470588235,0.723981900452489,-1.38824749537889,53974.175,33525.471875,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_310954,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
311078,4161.62209302326,1189.15406976744,548.261627906977,692.901162790698,3658.01744186047,2465.09593023256,476.072674418605,264.177325581395,1138.96220930233,6997.38081395349,715.372093023256,137.950581395349,1074.98837209302,3073.14244186047,856.517441860465,401.46511627907,1879.14244186046,3844.1976744186,405.276162790698,246.610465116279,1032.49418604651,3353.5261627907,310.313953488372,269.549418604651,604.976744186047,2389.90697674419,542.834302325581,340.703488372093,1081.75581395349,130.816860465116,344,23.4233354481707,18.8428395567502,0.594023989763753,0.952908587257618,0.747826086956522,-1.18389599617737,53631.0406976744,33789.1046511628,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_311078,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
311470,491.269058295964,842.744394618834,243.641255605381,642.156950672646,1694.31838565022,258.843049327354,256.914798206278,246.708520179372,1074.93721973094,1208.43946188341,1139.10313901345,135.618834080717,1070.30044843049,818.677130044843,552.385650224215,288.228699551569,1641.93273542601,2517.14798206278,369.807174887892,245.560538116592,1020.27802690583,3315.55156950673,283.09865470852,260.188340807175,609.838565022422,834.192825112108,417.215246636771,247.09865470852,1029.41704035874,131.300448430493,223,17.0537057114858,16.6720611908504,0.210373808121791,0.936974789915966,0.72875816993464,1.06779267391252,52412.4932735426,32440.5112107623,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_311470,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
312385,2174.4880239521,343.458083832335,112.14371257485,669.269461077844,1527.76347305389,3570.27245508982,530.922155688623,273.149700598802,1099.36826347305,3297.56886227545,1759.1497005988,139.799401197605,1080.69461077844,4466.58383233533,769.269461077844,396.844311377246,4950.0,3459.6497005988,355.712574850299,238.212574850299,1024.39820359281,3349.2245508982,249.446107784431,195.191616766467,594.302395209581,1286.54191616766,513.865269461078,691.508982035928,1106.23652694611,130.754491017964,334,26.0871133464261,16.9166224766428,0.761243081973894,0.935574229691877,0.695833333333333,-1.03172047132069,53301.7365269461,33741.2305389222,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_312385,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
313698,4096.23622047244,532.496062992126,112.610236220472,631.720472440945,1633.91732283465,263.732283464567,244.220472440945,223.996062992126,1067.9842519685,5789.33070866142,1332.88976377953,125.291338582677,1082.32677165354,604.070866141732,444.677165354331,262.362204724409,1528.45669291339,952.259842519685,230.05905511811,216.795275590551,988.799212598425,836.728346456693,177.271653543307,137.952755905512,579.153543307087,1589.63385826772,493.751968503937,389.334645669291,1036.6968503937,131.074803149606,254,22.585506433911,14.4526241593233,0.768452342942811,0.951310861423221,0.705555555555556,-0.845777971417544,53116.9881889764,33468.1417322835,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_313698,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
314774,3868.18933333333,223.88,148.466666666667,685.357333333333,3372.94133333333,3561.28,1155.14666666667,265.208,1122.26133333333,6469.808,3009.60533333333,132.821333333333,1104.48,6059.93066666667,956.104,412.781333333333,3001.26666666667,7560.936,543.72,261.533333333333,1091.56,7275.63466666667,289.714666666667,223.546666666667,600.621333333333,1993.04266666667,497.096,536.077333333333,1110.28533333333,131.352,375,23.1220023898657,20.6969397022507,0.445827637159163,0.971502590673575,0.815217391304348,0.122406491806923,52828.712,33700.7946666667,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_314774,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
314775,2301.628,196.19,214.482,739.956,6124.054,1027.694,299.33,249.14,1084.05,4148.698,534.788,154.918,1075.056,2227.482,669.826,305.592,1939.452,1790.796,327.646,232.4,1077.144,1405.136,219.264,251.246,3109.59,1428.742,489.136,293.532,1074.536,130.394,500,36.184974161824,18.1199513494968,0.865586753265465,0.93984962406015,0.668449197860963,-1.21423986750677,52921.892,33814.968,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,1,FAAGSCC_12_314775,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
315024,3272.48175182482,271.07299270073,89.5985401459854,616.014598540146,430.51094890511,616.642335766423,416.751824817518,272.656934306569,1122.80291970803,4743.50364963504,866.233576642336,123.211678832117,1063.5401459854,979.759124087591,609.328467153285,282.043795620438,1760.81751824818,1227.30656934307,295.29197080292,228.591240875912,1033.24817518248,1124.87591240876,204.642335766423,421.445255474453,1052.31386861314,794.583941605839,419.875912408759,216.299270072993,1015.13868613139,130.664233576642,137,15.3043900473585,11.4605213581988,0.662752158936138,0.951388888888889,0.702564102564103,-0.525304036532567,53779.4744525547,32693.3722627737,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_315024,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
315491,1476.19230769231,532.337606837607,76.5299145299145,623.811965811966,1610.52991452991,1825.94871794872,362.923076923077,259.235042735043,1102.76923076923,3327.42307692308,1234.09401709402,118.465811965812,1069.0641025641,762.576923076923,419.145299145299,267.354700854701,1465.24358974359,801.128205128205,173.175213675214,205.273504273504,1076.10683760684,644.918803418803,144.132478632479,116.739316239316,617.559829059829,1451.9188034188,466.547008547009,341.705128205128,1029.51709401709,129.188034188034,234,20.3230638553501,14.7457435091034,0.688151580168866,0.955102040816326,0.78,-1.56632332296184,54146.1794871795,32691.5427350427,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_315491,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
315870,2998.93801652893,665.702479338843,95.2107438016529,645.578512396694,1469.77272727273,1900.59090909091,1378.00413223141,253.884297520661,1120.93388429752,3673.70661157025,770.380165289256,125.086776859504,1079.03305785124,1111.64049586777,739.743801652893,309.710743801653,3827.11157024793,1351.07024793388,312.772727272727,233.946280991736,1028.8347107438,1198.0826446281,225.123966942149,154.152892561983,590.028925619835,800.202479338843,457.429752066116,253.330578512397,1013.23553719008,130.702479338843,242,18.4692336878736,16.6981063413753,0.427312678106186,0.949019607843137,0.74922600619195,0.0333431660050383,53036.0537190083,33461.1239669421,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_315870,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
315993,3169.81900452489,317.83257918552,71.4389140271493,644.511312217195,1302.23981900452,2569.30316742081,1043.43438914027,249.113122171946,1093.92760180995,3776.20814479638,840.556561085973,123.049773755656,1085.73303167421,4986.7963800905,840.945701357466,352.162895927602,6939.79185520362,5545.35746606335,445.153846153846,248.678733031674,1170.68325791855,4825.49773755656,272.556561085973,316.185520361991,601.502262443439,814.719457013575,417.796380090498,503.524886877828,1017.36199095023,130.085972850679,221,18.2741535204909,15.4993324459801,0.529746587302569,0.969298245614035,0.8125,-0.65084497719256,53012.3665158371,33508.1719457014,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_315993,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
316389,2923.63257575758,324.598484848485,145.541666666667,655.409090909091,2273.83712121212,278.401515151515,279.450757575758,252.784090909091,1074.56818181818,5030.12878787879,490.537878787879,124.484848484848,1069.6553030303,626.19696969697,420.306818181818,263.621212121212,1403.20454545455,952.314393939394,264.886363636364,217.17803030303,992.219696969697,924.780303030303,201.943181818182,114.401515151515,592.041666666667,1653.35606060606,486.818181818182,225.265151515152,1046.84848484848,130.719696969697,264,29.0445106602696,11.8761963836161,0.912580801357856,0.942857142857143,0.611111111111111,1.18268871957278,53755.7537878788,32514.7007575758,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_316389,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
316806,2279.67578125,478.92578125,293.05078125,615.609375,893.28515625,338.5703125,325.8125,258.328125,1081.1171875,3381.515625,941.375,118.07421875,1077.09375,774.53125,517.51171875,282.94140625,1478.56640625,1206.171875,336.84765625,239.1328125,985.11328125,1132.69921875,247.40625,137.1875,588.515625,1177.859375,472.28125,291.7578125,1040.91015625,130.20703125,256,23.5756648583478,14.0236978256668,0.803845713270677,0.958801498127341,0.727272727272727,1.24726910231726,52910.13671875,33299.76953125,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_316806,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
317246,1483.04128440367,554.077981651376,144.197247706422,647.660550458716,2371.97706422018,2625.00458715596,1593.73394495413,262.678899082569,1104.12844036697,1509.48623853211,3121.33027522936,112.848623853211,1076.8623853211,3332.87614678899,1408.93577981651,2204.06880733945,2039.79816513761,4495.17431192661,430.697247706422,247.0,1042.92660550459,4816.94495412844,1271.0,1151.42201834862,708.155963302752,788.775229357798,425.215596330275,395.596330275229,1024.34403669725,130.087155963303,218,20.3978110714008,13.693127110301,0.741182347462391,0.956140350877193,0.778571428571429,0.0762734862482732,53250.7110091743,33607.6605504587,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_317246,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
317780,2983.14457831325,564.993975903614,126.825301204819,635.307228915663,1445.26506024096,612.753012048193,308.795180722892,251.975903614458,1087.45180722892,4538.92771084337,1930.47590361446,117.415662650602,1071.94578313253,1360.0,627.096385542169,280.246987951807,1586.14457831325,1420.24096385542,286.728915662651,224.801204819277,1028.54819277108,1632.07228915663,206.409638554217,612.222891566265,655.397590361446,1470.30722891566,503.174698795181,426.83734939759,1058.56626506024,129.78313253012,166,17.2868800426616,12.3543350067143,0.699466488712255,0.965116279069768,0.737777777777778,0.68185161870141,53934.6445783133,32922.156626506,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_317780,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
317803,2257.25981873112,432.178247734139,98.9516616314199,625.21752265861,992.755287009063,627.987915407855,407.900302114804,268.882175226586,1149.80060422961,4354.99395770393,1034.2084592145,113.897280966767,1069.09667673716,715.054380664653,411.283987915408,271.930513595166,1445.06042296072,921.564954682779,197.486404833837,205.558912386707,1148.59818731118,664.70996978852,138.208459214502,110.250755287009,597.308157099698,1157.17220543807,448.631419939577,361.882175226586,1031.25981873112,129.885196374622,331,23.1382211319813,18.2522498308829,0.614604410613806,0.970674486803519,0.788095238095238,-0.683552281172943,53912.5196374622,32695.0151057402,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_317803,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
317986,4587.65732087227,475.130841121495,169.82554517134,674.308411214953,3237.04049844237,2748.43613707165,1761.91900311526,264.922118380062,1097.84423676012,6046.7507788162,811.211838006231,158.697819314642,1092.86292834891,1045.29906542056,747.392523364486,782.542056074766,1685.63239875389,1345.34267912773,342.031152647975,239.461059190031,1001.2492211838,1283.35202492212,236.582554517134,372.205607476636,690.613707165109,1333.7507788162,502.735202492212,301.317757009346,1043.61059190031,130.993769470405,321,27.2708575619963,15.1444560472995,0.83162687988705,0.961077844311377,0.771634615384615,1.32561601585307,53438.7352024922,33830.8099688474,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_317986,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
318186,1919.0490797546,525.383435582822,159.41717791411,702.947852760736,3904.99386503067,268.51226993865,280.533742331288,251.233128834356,1084.96932515337,4409.23619631902,4717.53067484663,129.981595092025,1076.49386503067,755.776073619632,563.337423312883,265.662576687117,1523.01533742331,1108.83742331288,296.549079754601,226.159509202454,984.530674846626,1026.60736196319,226.98773006135,133.751533742331,590.895705521472,1982.8773006135,521.306748466258,603.368098159509,1115.28220858896,134.113496932515,326,21.636608365084,19.2412682989179,0.457339349547569,0.964497041420118,0.740909090909091,-0.367871089236101,52916.481595092,32673.8374233129,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_318186,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
318235,2555.31746031746,210.630385487528,101.761904761905,655.646258503401,2247.98412698413,1061.54875283447,1141.44671201814,237.219954648526,1086.38548752834,3919.68934240363,576.52380952381,117.18820861678,1072.27437641723,963.707482993197,683.15873015873,919.294784580499,1689.47845804989,1400.78684807256,280.281179138322,221.498866213152,1009.99546485261,1698.12698412698,213.945578231293,319.873015873016,600.820861678005,1249.61451247166,502.272108843537,366.956916099773,1043.179138322,129.56462585034,441,27.192037148009,20.8400659203235,0.642359745651278,0.962882096069869,0.737458193979933,-0.920407488609402,53568.820861678,33631.7052154195,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_318235,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
318836,4017.91989664083,1105.52454780362,132.093023255814,625.919896640827,1112.52196382429,330.739018087855,319.821705426357,259.870801033592,1083.37726098191,7445.70025839793,540.909560723514,123.080103359173,1066.98966408269,902.400516795866,500.165374677003,280.105943152455,1399.50904392765,1404.06976744186,330.757105943152,232.697674418605,979.713178294574,1245.83204134367,241.15503875969,128.583979328165,581.346253229974,2991.36434108527,563.049095607235,240.180878552972,1057.63565891473,130.989664082687,387,25.3483000460711,19.6170337336134,0.633308571673177,0.955555555555556,0.732954545454545,-0.959337130075148,52860.2428940568,33211.6485788114,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_318836,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
319224,1522.33632286996,166.973094170404,115.358744394619,711.520179372197,2761.72197309417,339.90134529148,308.57399103139,254.766816143498,1078.92376681614,3414.43497757848,527.515695067265,122.959641255605,1075.03587443946,840.403587443946,645.695067264574,278.582959641256,1623.69506726457,1270.85650224215,320.363228699552,230.42600896861,1010.84304932735,1179.93273542601,228.179372197309,428.798206278027,2407.44394618834,1574.84753363229,477.318385650224,227.32735426009,1047.30493273543,130.035874439462,223,20.0138144355713,14.3626955481683,0.696415205687714,0.952991452991453,0.72875816993464,0.640328262913155,52890.4753363229,32861.5829596413,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,1,FAAGSCC_12_319224,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
320173,2034.69429347826,109.830163043478,74.9442934782609,622.222826086957,1352.18614130435,465.959239130435,328.05027173913,257.929347826087,1126.33695652174,2542.32336956522,571.626358695652,118.792119565217,1072.64809782609,607.101902173913,386.978260869565,257.225543478261,1517.0964673913,777.345108695652,179.13722826087,203.722826086957,1007.02173913043,623.8125,135.816576086957,104.652173913043,830.752717391304,761.278532608696,420.402173913043,215.020380434783,1010.81385869565,130.998641304348,736,43.7591386210061,21.5241276408928,0.870664519967453,0.965879265091864,0.621621621621622,0.879112460415356,53857.3641304348,32300.625,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_320173,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
320386,1883.74193548387,182.670250896057,150.064516129032,702.193548387097,4929.91756272401,446.666666666667,1068.73476702509,254.480286738351,1079.46953405018,2888.71684587814,497.469534050179,123.089605734767,1068.49103942652,2299.48028673835,697.534050179211,419.186379928315,1597.81003584229,1504.95340501792,278.84229390681,221.770609318996,986.620071684588,1123.79211469534,195.551971326165,128.093189964158,591.336917562724,949.953405017921,465.215053763441,226.039426523297,1035.82437275986,129.953405017921,279,22.2580624315838,15.9962367682787,0.695349673410605,0.965397923875433,0.792613636363636,0.021039590056401,53931.7240143369,32824.8422939068,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_320386,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
320673,381.84126984127,1158.85185185185,266.886243386243,607.10582010582,200.944444444444,1688.41005291005,392.34126984127,258.661375661376,1089.25396825397,710.113756613757,464.820105820106,98.6084656084656,1059.99470899471,1746.29100529101,885.219576719577,475.402116402116,1543.19841269841,1397.22486772487,297.915343915344,225.626984126984,1033.05291005291,1574.19841269841,222.507936507937,470.738095238095,824.28835978836,566.785714285714,348.428571428571,201.195767195767,983.992063492064,127.328042328042,378,22.7800908956452,21.1548966410578,0.370938951708553,0.956962025316456,0.78099173553719,-0.356778103860815,52912.3756613757,32788.7328042328,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,7,FAAGSCC_12_320673,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
322822,2514.70344827586,278.772413793103,76.7862068965517,631.227586206897,1155.44827586207,682.889655172414,453.855172413793,282.986206896552,1134.81379310345,4102.4275862069,978.703448275862,121.979310344828,1062.48275862069,869.2,489.275862068966,271.91724137931,1619.60689655172,1068.16551724138,216.786206896552,213.889655172414,1366.42068965517,649.806896551724,145.068965517241,123.593103448276,587.034482758621,1131.93103448276,463.427586206896,403.186206896552,1076.98620689655,131.951724137931,145,15.6323217310136,11.9175359681663,0.647147207439379,0.953947368421053,0.755208333333333,1.45710652818948,52564.8482758621,32959.7517241379,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_322822,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
322916,2511.07692307692,294.273755656109,94.8099547511312,677.350678733032,1652.48868778281,3440.08823529412,693.264705882353,262.807692307692,1112.73529411765,4266.27601809955,761.285067873303,114.828054298643,1082.65837104072,4076.61764705882,1152.76018099548,1416.08823529412,2073.77828054299,5256.73303167421,370.061085972851,495.434389140271,1050.21040723982,4339.78280542986,263.613122171946,516.027149321267,628.036199095023,1300.88009049774,485.470588235294,940.029411764706,1045.00904977376,131.08371040724,442,26.6060907738996,21.1738649049321,0.605523095651438,0.980044345898004,0.767361111111111,0.779630629095872,53677.3687782805,33361.1606334842,FAAGSCC_12,AG,1,dendritic cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,dendritic cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_322916,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
323541,1622.55675675676,114.213513513514,46.1297297297297,624.959459459459,752.610810810811,2310.37297297297,672.524324324324,257.075675675676,1091.74324324324,3616.30810810811,1797.76486486486,109.759459459459,1078.4972972973,1647.38108108108,1092.34324324324,373.378378378378,1603.44324324324,2460.53243243243,309.897297297297,228.186486486486,1007.80540540541,1930.67297297297,212.781081081081,160.781081081081,656.181081081081,1381.4,462.102702702703,351.067567567568,1038.12432432432,129.502702702703,370,22.5496045160619,21.1113935778493,0.351414108933066,0.956072351421189,0.731225296442688,1.53454128681269,52870.4,33369.7324324324,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_323541,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
324065,1199.14932126697,191.158371040724,99.9004524886878,641.68778280543,1909.35746606335,647.714932126697,448.16742081448,284.656108597285,1127.08597285068,1961.98642533937,656.41628959276,115.502262443439,1066.58371040724,954.610859728507,573.918552036199,288.380090497738,1607.52941176471,1037.0814479638,223.72850678733,216.588235294118,1232.47963800905,611.850678733032,132.597285067873,94.2398190045249,643.990950226244,888.036199095023,424.235294117647,213.506787330317,1034.06787330317,129.420814479638,221,19.9913575626324,14.0717205779739,0.710308801182949,0.965065502183406,0.789285714285714,-1.37296173985115,52916.8054298643,32319.4479638009,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,7,FAAGSCC_12_324065,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
324147,5134.93801652893,1007.33884297521,956.96694214876,629.165289256198,1023.78512396694,835.776859504132,396.305785123967,263.909090909091,1085.01239669421,8224.26859504132,623.02479338843,124.54132231405,1071.71900826446,1649.64876033058,553.652892561983,312.98347107438,1523.82644628099,1467.44214876033,335.987603305785,228.057851239669,1043.46694214876,1520.0,220.45041322314,134.206611570248,600.933884297521,3028.83884297521,537.644628099174,255.202479338843,1047.17768595041,130.789256198347,242,26.9086564583952,11.6754085370028,0.9009656454344,0.913207547169811,0.645333333333333,1.24914003875295,53369.5743801653,32937.7892561983,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_324147,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
324191,3837.96052631579,824.781578947368,840.728947368421,628.994736842105,1519.31842105263,320.610526315789,299.557894736842,246.021052631579,1077.43157894737,5546.12368421053,736.336842105263,121.286842105263,1075.33421052632,705.186842105263,502.794736842105,454.178947368421,1437.10526315789,1118.72105263158,293.060526315789,226.989473684211,995.676315789474,1011.18947368421,221.610526315789,159.605263157895,599.323684210526,1105.46052631579,503.302631578947,327.715789473684,1041.91315789474,131.360526315789,380,27.0608960271959,18.1047914672423,0.743227409425319,0.952380952380952,0.723809523809524,-1.06437131632489,53760.9394736842,33313.8236842105,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_324191,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
324426,466.45867768595,1207.12396694215,273.169421487603,613.070247933884,115.169421487603,1406.28512396694,414.54132231405,274.198347107438,1122.05371900826,1196.61983471074,773.185950413223,109.309917355372,1066.81404958678,2357.69834710744,881.871900826446,358.756198347107,1540.22314049587,2999.5,334.669421487603,227.47520661157,1015.7479338843,2000.67768595041,207.913223140496,788.256198347107,649.809917355372,580.648760330579,364.669421487603,206.586776859504,981.628099173554,140.54958677686,242,19.5727899248958,15.761427417429,0.592905026150005,0.96031746031746,0.746913580246914,0.908778064550086,53759.2438016529,32682.7355371901,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_324426,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
324481,1386.41509433962,199.788679245283,70.0528301886793,616.864150943396,993.969811320755,661.464150943396,382.467924528302,266.098113207547,1137.8641509434,2016.55094339623,1942.25283018868,114.452830188679,1068.30566037736,1013.25283018868,633.581132075472,289.252830188679,1623.3358490566,1117.83396226415,308.120754716981,227.920754716981,987.792452830189,983.694339622642,210.403773584906,133.962264150943,906.815094339623,834.147169811321,440.215094339623,290.150943396226,1021.2,131.550943396226,265,21.3199587415782,15.8377153959125,0.669448319220517,0.967153284671533,0.742296918767507,0.433320250470335,53214.8528301887,33039.6339622642,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_324481,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
324603,4957.33216783217,369.437062937063,170.332167832168,650.402097902098,1954.88461538462,1912.97202797203,690.93006993007,258.293706293706,1118.99300699301,7589.48601398601,573.440559440559,128.912587412587,1090.51048951049,2481.31118881119,959.164335664336,383.272727272727,2526.61538461538,2125.81118881119,294.552447552448,232.066433566434,1037.55244755245,1516.13986013986,188.073426573427,175.91958041958,628.506993006993,2197.36363636364,500.832167832168,290.625874125874,1063.24475524476,132.227272727273,286,22.3637050501714,16.3402935192948,0.68274012869947,0.972789115646258,0.756613756613757,0.578674306967516,52718.8846153846,33650.486013986,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_324603,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
324782,3296.53355704698,499.459731543624,104.479865771812,611.885906040268,691.46644295302,825.006711409396,476.107382550336,248.929530201342,1089.36577181208,5886.88926174497,545.640939597315,121.469798657718,1085.36577181208,1651.68120805369,962.859060402685,823.744966442953,1665.81879194631,1965.80536912752,286.573825503356,229.607382550336,1012.23154362416,1742.97651006711,204.187919463087,336.526845637584,664.909395973154,2122.8255033557,513.580536912752,234.268456375839,1043.15100671141,129.697986577181,298,23.1976721817769,16.511103239579,0.702425878855814,0.949044585987261,0.762148337595908,1.4623922541815,53927.2181208054,32977.0939597315,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_324782,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
324967,3466.83164983165,972.141414141414,561.653198653199,637.434343434343,1590.2861952862,398.306397306397,293.747474747475,230.074074074074,1067.3063973064,6139.9696969697,475.454545454545,118.121212121212,1091.12794612795,593.074074074074,506.178451178451,271.255892255892,1601.41750841751,900.343434343434,249.329966329966,218.319865319865,999.525252525252,822.262626262626,189.740740740741,140.0,584.818181818182,2473.13131313131,513.501683501683,267.777777777778,1042.36026936027,129.818181818182,297,22.630614540113,16.7606068965967,0.671927954594271,0.961165048543689,0.794117647058823,-0.107672479682933,54026.8855218855,33433.3063973064,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_324967,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
325658,2613.98723404255,134.325531914894,178.555319148936,732.812765957447,5536.1829787234,265.878723404255,265.31914893617,249.176595744681,1073.32340425532,4915.02340425532,720.825531914894,142.376595744681,1072.44680851064,698.714893617021,463.717021276596,268.797872340426,1369.02765957447,1011.66808510638,267.889361702128,219.034042553191,983.195744680851,969.191489361702,199.644680851064,116.868085106383,605.578723404255,1135.86808510638,460.170212765957,226.248936170213,1046.42553191489,129.882978723404,470,36.7122289988685,16.496634256685,0.893355875649556,0.951417004048583,0.746031746031746,-1.35646512484286,53093.7425531915,32634.4978723404,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_325658,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
325829,2399.9594017094,152.168803418803,95.0918803418803,651.732905982906,2518.32051282051,269.130341880342,286.48717948718,251.517094017094,1073.22008547009,4584.12179487179,682.955128205128,133.709401709402,1070.15170940171,579.497863247863,433.188034188034,267.92735042735,1349.69230769231,926.455128205128,287.647435897436,223.264957264957,977.401709401709,898.166666666667,215.053418803419,127.807692307692,584.946581196581,1369.73504273504,499.989316239316,244.487179487179,1075.27991452991,131.839743589744,468,28.5007173829268,21.5735519817939,0.653475481918945,0.945454545454545,0.726708074534162,-1.366110537459,53347.3354700855,32655.8931623932,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_325829,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
326230,3409.81696428571,411.464285714286,130.171875,662.325892857143,2666.25223214286,657.602678571429,331.366071428571,257.810267857143,1077.10491071429,5840.33928571429,771.819196428571,130.470982142857,1100.46875,3801.16964285714,605.694196428571,310.071428571429,1466.31696428571,4573.70535714286,404.705357142857,248.924107142857,1030.20089285714,4452.93526785714,273.765625,600.453125,899.627232142857,2244.49776785714,567.595982142857,276.116071428571,1092.29464285714,130.875,448,35.0353806203983,16.363478095153,0.884227838167151,0.957264957264957,0.646464646464647,0.407522047674093,53118.1004464286,33257.3526785714,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_326230,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
326984,2436.99722222222,223.777777777778,81.7111111111111,635.105555555556,1662.25555555556,283.741666666667,287.591666666667,255.455555555556,1082.51666666667,3403.05,1516.18888888889,127.516666666667,1074.84444444444,732.752777777778,541.3,273.094444444444,1393.98611111111,1058.35833333333,296.95,224.152777777778,977.675,1056.31111111111,219.375,118.488888888889,589.586111111111,927.216666666667,444.375,357.9,1047.19722222222,132.669444444444,360,26.4278787203859,17.3989872465258,0.752705551480467,0.957446808510638,0.711462450592885,-0.750341751083526,53070.9111111111,32623.9444444444,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_326984,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
327925,2797.4406779661,288.957627118644,100.633474576271,645.213983050847,1765.04025423729,2413.33262711864,1343.63347457627,257.877118644068,1104.1906779661,4821.99576271186,848.383474576271,123.949152542373,1084.52754237288,2440.82203389831,632.324152542373,380.574152542373,1813.20762711864,3476.57415254237,350.474576271186,266.33686440678,1029.8156779661,3048.36228813559,261.756355932203,214.650423728814,584.493644067797,1220.27966101695,463.652542372881,413.415254237288,1038.85593220339,130.775423728814,472,27.8566138023033,21.7227728578147,0.626020430332198,0.963265306122449,0.794612794612795,1.3850322524193,53123.4300847458,33547.7415254237,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_327925,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
328133,3506.56329113924,158.174050632911,112.955696202532,660.208860759494,3460.18037974684,1242.91455696203,337.553797468354,259.617088607595,1137.33544303797,6290.24050632911,564.098101265823,124.325949367089,1090.54113924051,891.246835443038,516.772151898734,275.20253164557,1553.60759493671,1019.90506329114,271.196202531646,220.325949367089,998.28164556962,922.113924050633,203.70253164557,139.189873417722,661.617088607595,2331.13291139241,528.585443037975,232.487341772152,1056.9746835443,131.787974683544,316,24.2884010047609,16.71850599902,0.725394920365073,0.946107784431138,0.774509803921569,1.4786594467152,53167.8639240506,33069.5506329114,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_328133,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
329014,4263.9701986755,969.105960264901,109.029801324503,662.814569536424,2304.19536423841,918.394039735099,333.013245033113,242.738410596026,1111.23178807947,7626.09933774834,638.506622516556,130.758278145695,1101.35099337748,1272.92052980132,674.423841059603,334.794701986755,5382.29470198676,5367.2880794702,411.241721854305,252.403973509934,1048.69205298013,6851.45364238411,288.026490066225,230.807947019868,611.715231788079,2082.99006622517,496.506622516556,236.258278145695,1079.65562913907,133.132450331126,302,23.2143612868445,16.6173117869705,0.698284507429342,0.961783439490446,0.722488038277512,1.01272816514759,52672.5397350993,33552.6688741722,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_329014,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
329611,2533.8533916849,233.251641137856,173.64989059081,732.463894967177,6495.86870897155,547.203501094092,432.849015317287,257.606126914661,1097.45514223195,4621.77461706783,597.078774617068,144.693654266958,1073.83369803063,797.137855579869,921.413566739606,344.398249452954,1989.49015317287,1093.47921225383,290.90590809628,227.328227571116,988.770240700219,978.371991247265,213.404814004376,138.382932166302,618.921225382932,2055.17067833698,514.387308533917,244.363238512035,1057.45733041575,130.352297592998,457,28.9153225664944,20.1594365779211,0.716887645288385,0.970276008492569,0.787931034482759,-1.39372600595015,52806.4879649891,33306.170678337,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_329611,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
330210,1254.65408805031,294.559748427673,187.405660377358,686.817610062893,4655.96855345912,1712.11006289308,1482.79874213836,256.861635220126,1093.71383647799,2769.18238993711,792.157232704403,125.091194968553,1065.94025157233,1077.74213836478,975.254716981132,488.591194968554,1542.82389937107,1130.94968553459,274.245283018868,218.672955974843,990.845911949686,1317.05660377358,212.669811320755,133.292452830189,616.735849056604,997.899371069182,440.663522012579,235.833333333333,1042.33962264151,130.154088050314,318,29.1422910069643,13.8952583964649,0.879007824733825,0.954954954954955,0.783251231527094,-1.4789301694146,54104.9622641509,32610.4685534591,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_330210,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
330940,4283.00941176471,518.809411764706,69.7176470588235,627.244705882353,705.044705882353,2656.15058823529,1033.75294117647,254.597647058824,1141.75294117647,6234.19058823529,602.543529411765,135.938823529412,1075.58823529412,5319.19529411765,956.192941176471,1242.07529411765,4165.76235294118,5736.67058823529,484.374117647059,254.501176470588,1223.36470588235,4612.12,449.637647058824,622.997647058824,716.745882352941,1177.89647058824,446.247058823529,400.849411764706,1040.32470588235,131.112941176471,425,29.329328458134,18.5168454348804,0.775504294669667,0.963718820861678,0.684380032206119,0.997469785175182,53186.1364705882,33792.8611764706,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_330940,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
331437,1796.08686440678,83.875,110.307203389831,678.088983050847,3526.86016949153,2838.32838983051,1016.15254237288,252.98093220339,1109.49152542373,3321.28813559322,474.733050847458,113.845338983051,1138.02330508475,4713.59110169491,772.203389830509,376.96186440678,2026.21610169492,6082.76694915254,413.822033898305,242.930084745763,1054.88347457627,5167.14406779661,246.680084745763,275.027542372881,638.224576271186,1142.68008474576,440.158898305085,742.798728813559,1042.70338983051,130.881355932203,472,29.6916934736757,20.2541452511479,0.731213630934782,0.97319587628866,0.786666666666667,-1.51230643408016,52986.029661017,33540.4618644068,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_331437,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
332296,1584.01785714286,406.117857142857,120.989285714286,643.889285714286,1661.42142857143,2410.82142857143,2426.60357142857,252.614285714286,1125.63214285714,2271.475,1483.43214285714,119.225,1077.72142857143,3116.25714285714,1163.01785714286,1720.78928571429,4204.24285714286,3022.03928571429,360.385714285714,236.614285714286,1075.06785714286,2561.94285714286,243.442857142857,485.467857142857,818.442857142857,965.214285714286,490.107142857143,471.967857142857,1051.37142857143,131.75,280,21.5113398647351,16.7069584696165,0.629922251146686,0.955631399317406,0.748663101604278,0.30564211013178,53122.4071428571,33652.5607142857,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_332296,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
332369,3543.7238372093,332.421511627907,142.412790697674,631.398255813953,1609.6773255814,1143.58720930233,409.65988372093,258.447674418605,1085.73255813953,5023.56104651163,545.904069767442,125.084302325581,1082.60174418605,3246.93604651163,570.101744186047,303.331395348837,1553.85755813953,4041.6976744186,329.267441860465,227.607558139535,1029.68023255814,3114.57558139535,238.066860465116,393.107558139535,1049.04651162791,1335.98255813953,513.69476744186,230.921511627907,1016.92441860465,129.709302325581,344,23.9465089081681,18.4124028031235,0.639372465914523,0.96358543417367,0.781818181818182,-1.07808994744101,53944.4098837209,32960.7122093023,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_332369,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
333343,1394.43093922652,582.740331491713,836.917127071823,623.441988950276,1369.85635359116,288.127071823204,634.828729281768,235.502762430939,1074.97790055249,1857.5138121547,621.127071823204,113.834254143646,1098.91712707182,879.906077348066,479.872928176796,304.193370165746,1595.12154696133,2909.30386740332,359.745856353591,237.618784530387,1032.35359116022,3128.64640883978,277.85635359116,261.75138121547,586.14364640884,785.127071823204,472.011049723757,235.756906077348,1002.55801104972,130.259668508287,181,17.2023149277824,13.4249377070524,0.625262387797067,0.973118279569892,0.754166666666667,0.600110333607467,53373.1933701657,33442.6298342541,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_333343,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
334590,5208.42222222222,351.848148148148,93.0740740740741,649.1,1783.82962962963,212.866666666667,224.633333333333,233.97037037037,1068.53703703704,9496.2037037037,682.762962962963,140.496296296296,1101.99259259259,466.133333333333,317.640740740741,255.292592592593,1402.15555555556,736.514814814815,181.533333333333,204.92962962963,977.833333333333,641.962962962963,133.611111111111,120.818518518519,582.733333333333,2711.82222222222,569.840740740741,317.551851851852,1070.57777777778,131.125925925926,270,22.8035689746888,15.4342389867556,0.736135348060035,0.931034482758621,0.681818181818182,-0.604693541847628,53100.4481481481,32983.4296296296,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_334590,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
335221,2316.57142857143,239.355212355212,183.19305019305,702.918918918919,5557.65637065637,567.474903474903,325.405405405405,263.440154440154,1116.02316602317,3300.6332046332,587.72972972973,127.559845559846,1071.54054054054,1820.69884169884,620.749034749035,299.007722007722,2007.66409266409,1468.34362934363,258.65250965251,221.667953667954,1009.50965250965,994.235521235521,187.146718146718,154.621621621622,1565.7722007722,767.119691119691,397.138996138996,211.698841698842,1029.51351351351,131.965250965251,259,24.146149240458,13.7384299706829,0.822358409773562,0.948717948717949,0.685185185185185,0.661536006984559,53770.3397683398,32151.6718146718,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_335221,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
335327,3162.88771929824,167.119298245614,103.821052631579,658.845614035088,2346.01052631579,297.621052631579,917.729824561404,265.364912280702,1093.70175438596,3095.17192982456,1251.78245614035,128.459649122807,1073.16842105263,671.964912280702,915.284210526316,279.554385964912,1496.59649122807,995.235087719298,353.8,238.498245614035,983.936842105263,858.782456140351,224.168421052632,123.291228070175,586.259649122807,842.733333333333,397.150877192982,256.498245614035,1037.54385964912,131.308771929825,285,27.5420316475074,13.2155458052335,0.877360434919073,0.962837837837838,0.588842975206612,0.812005461756698,53198.3649122807,31962.6912280702,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_335327,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
335547,5856.08366533865,937.478087649402,182.812749003984,673.665338645418,3275.2828685259,1258.64940239044,398.525896414343,253.529880478088,1108.58167330677,8754.73705179283,2651.10756972112,138.577689243028,1075.38247011952,819.171314741036,552.561752988048,277.96812749004,1596.47410358566,1196.34262948207,316.589641434263,233.561752988048,1001.18725099602,1098.74103585657,271.099601593625,135.458167330677,583.083665338645,3364.88047808765,621.235059760956,934.274900398406,1090.10358565737,131.988047808765,251,20.7220068995273,15.5079535125732,0.663269233598242,0.969111969111969,0.784375,1.27066861639068,53332.9442231076,33395.2111553785,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_335547,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
335897,6721.3670411985,396.333333333333,178.38202247191,682.921348314607,3164.42696629213,446.033707865168,335.25468164794,227.985018726592,1072.94756554307,10456.1760299625,968.089887640449,145.962546816479,1120.59176029963,3975.95131086142,900.408239700375,407.786516853933,1802.1872659176,6075.76779026217,369.970037453184,236.307116104869,1020.43820224719,4649.01123595506,225.161048689139,193.505617977528,586.749063670412,3125.06741573034,575.404494382022,368.973782771536,1092.97003745318,134.059925093633,267,20.3521176887276,16.7267730641699,0.569676638021373,0.960431654676259,0.785294117647059,-0.28796684693342,52766.9101123596,33451.7565543071,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_335897,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
336293,1338.41573033708,173.089887640449,76.5468164794007,613.419475655431,504.47191011236,987.044943820225,559.494382022472,257.426966292135,1097.85767790262,2908.58052434457,549.865168539326,113.850187265918,1072.59176029963,4717.13857677903,797.610486891386,414.430711610487,9139.25468164794,3299.69662921348,378.475655430712,245.153558052434,1026.55056179775,2395.74157303371,268.176029962547,331.097378277154,642.621722846442,1842.28838951311,556.310861423221,266.988764044944,1022.73782771536,129.460674157303,267,21.4266539277685,15.917661718577,0.669412744773251,0.946808510638298,0.747899159663866,-0.0811519166762969,53597.1535580524,33430.0337078652,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_336293,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
336786,4122.22077922078,420.503246753247,93.6525974025974,652.25,1587.84415584416,1395.69805194805,2056.38636363636,245.808441558442,1097.46103896104,6357.41558441558,612.948051948052,142.753246753247,1079.89935064935,1102.13311688312,612.487012987013,621.13961038961,1800.28896103896,1391.20454545455,283.038961038961,227.399350649351,1014.34415584416,1495.69480519481,212.535714285714,223.831168831169,816.717532467532,1659.52922077922,534.327922077922,249.168831168831,1033.50974025974,129.357142857143,308,21.4334748548208,18.3912653193433,0.513544936363899,0.9625,0.771929824561403,-0.268515482343049,53013.6103896104,33861.6785714286,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_336786,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
336888,2851.79764243615,168.941060903733,133.361493123772,691.888015717092,4066.4184675835,693.483300589391,313.2278978389,232.206286836935,1076.48919449902,4896.721021611,572.895874263261,127.679764243615,1117.37524557957,821.253438113949,570.320235756385,350.381139489194,1695.07072691552,1106.77406679764,253.49115913556,220.797642436149,1020.51669941061,947.662082514735,187.388998035363,235.21021611002,586.330058939096,1194.51277013752,461.206286836935,236.13163064833,1048.64440078585,130.711198428291,509,29.7643508998865,21.9975830531662,0.67364174664521,0.953183520599251,0.73132183908046,-0.45703711757739,52997.3182711198,33394.5343811395,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_336888,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
337318,2948.61013645224,515.062378167641,123.171539961014,652.341130604289,2173.11500974659,312.910331384016,295.16179337232,251.005847953216,1080.89083820663,4724.08966861598,935.892787524366,127.173489278752,1074.67446393762,800.7738791423,550.138401559454,271.567251461988,1593.9649122807,1224.66276803119,296.541910331384,226.754385964912,1042.33723196881,1038.30019493177,204.450292397661,199.730994152047,3361.15399610137,1044.23586744639,450.220272904483,404.489278752437,1049.56725146199,130.559454191033,513,26.6666551832866,24.5024845757483,0.394621969596277,0.962476547842402,0.76,-0.0833078641729119,53140.3586744639,32813.0838206628,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_337318,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
337890,3607.95918367347,418.772959183673,114.716836734694,660.538265306122,2076.2193877551,1935.12755102041,656.007653061224,265.066326530612,1094.60714285714,5953.17091836735,1704.57397959184,131.997448979592,1071.47448979592,836.410714285714,617.002551020408,446.956632653061,1654.23214285714,1226.31632653061,291.033163265306,224.719387755102,1043.30102040816,989.502551020408,195.668367346939,611.25,939.311224489796,1148.66071428571,435.632653061225,345.59693877551,1080.71683673469,129.739795918367,392,29.1504228780081,17.1447014718031,0.808754851286718,0.96078431372549,0.736842105263158,-1.25751605427989,52872.1785714286,32336.1760204082,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_337890,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
337966,1833.21372031662,315.606860158311,100.530343007916,637.145118733509,1328.2691292876,2537.27704485488,739.503957783641,259.166226912929,1122.24274406332,2767.34300791557,1359.44327176781,136.245382585752,1082.00527704485,6330.41952506596,938.002638522427,631.741424802111,8181.22163588391,6381.36939313984,445.812664907652,245.905013192612,1069.68073878628,5555.81002638522,316.406332453826,267.591029023747,654.973614775726,1007.98944591029,484.403693931398,349.934036939314,1043.82849604222,130.018469656992,379,24.5320718642085,19.8520728564613,0.587492842613775,0.959493670886076,0.789583333333333,0.2161922772375,53107.907651715,33885.3113456464,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_337966,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
338213,469.782918149466,1065.73665480427,233.060498220641,599.861209964413,207.512455516014,1343.02491103203,658.772241992883,253.355871886121,1076.57295373665,790.537366548043,533.024911032029,101.103202846975,1066.50533807829,2699.42704626335,533.654804270463,287.562277580071,5681.81494661922,2436.98576512456,309.170818505338,221.775800711744,996.836298932384,1462.47330960854,239.992882562278,129.291814946619,588.754448398577,579.170818505338,358.156583629893,206.505338078292,985.697508896797,127.55871886121,281,20.4150346536605,17.6086849920364,0.505997147981135,0.95578231292517,0.743386243386243,0.385421106239031,54128.0960854093,32583.9679715302,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_338213,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
338716,3523.21052631579,341.43653250774,134.904024767802,630.634674922601,1572.89473684211,448.092879256966,304.56346749226,240.510835913313,1077.61919504644,6844.91640866873,554.684210526316,126.074303405573,1069.0092879257,609.359133126935,413.532507739938,302.393188854489,1425.4427244582,992.089783281734,250.56346749226,217.458204334365,991.102167182663,888.529411764706,186.575851393189,163.216718266254,626.848297213622,2977.27554179567,544.616099071207,234.761609907121,1052.71826625387,129.894736842105,323,26.5409899135405,15.6287299228674,0.808240471390257,0.952802359882006,0.747685185185185,-1.55687273395112,53296.0619195046,33226.9164086687,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_338716,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
339161,5705.73191489362,507.914893617021,372.965957446808,643.514893617021,1453.77872340426,1374.32340425532,735.710638297872,238.212765957447,1099.0170212766,8477.55319148936,697.940425531915,137.029787234043,1081.21276595745,2860.68936170213,810.344680851064,1506.0170212766,2617.57021276596,3335.74468085106,331.540425531915,235.902127659574,1063.85106382979,3016.62553191489,228.442553191489,431.897872340426,768.255319148936,2708.20425531915,553.191489361702,281.429787234043,1054.72765957447,131.387234042553,235,19.0650222822855,15.7035927379053,0.56704612226006,0.959183673469388,0.773026315789474,0.142630931821324,53152.1191489362,33680.8382978723,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_339161,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
339165,3141.70212765957,834.31914893617,411.375886524823,615.070921985816,699.028368794326,515.063829787234,309.411347517731,246.127659574468,1101.85106382979,5155.29787234043,537.297872340426,117.765957446809,1081.50354609929,6985.86524822695,819.602836879433,498.099290780142,2066.43262411347,5212.05673758865,451.113475177305,1183.15602836879,1025.4609929078,3817.02836879433,265.780141843972,264.77304964539,620.645390070922,1682.64539007092,534.482269503546,249.624113475177,1042.09929078014,131.333333333333,141,14.0940652191982,12.8771223562075,0.406489050772153,0.965753424657534,0.774725274725275,1.50469555237592,53852.7659574468,33258.6382978723,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_339165,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
339198,2877.67482517483,255.195804195804,74.6398601398601,614.552447552448,591.36013986014,394.318181818182,452.073426573427,239.846153846154,1074.92657342657,5532.24125874126,724.667832167832,121.660839160839,1079.00699300699,933.832167832168,902.867132867133,399.076923076923,1756.23776223776,1112.37762237762,259.608391608392,219.587412587413,1004.56993006993,1037.21678321678,196.874125874126,139.118881118881,605.933566433566,2207.1048951049,523.381118881119,259.884615384615,1041.84615384615,131.772727272727,286,19.877274667501,18.4146315786998,0.376500741831265,0.979452054794521,0.83625730994152,-0.206247217186906,52782.520979021,33434.6958041958,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_339198,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
339746,2721.61230769231,114.08,97.8830769230769,693.84,3805.34153846154,2402.36923076923,1041.72307692308,252.403076923077,1148.26153846154,4499.55076923077,861.643076923077,131.332307692308,1080.88923076923,4565.87384615385,1321.78769230769,945.92,3359.08307692308,6641.47076923077,471.523076923077,251.009230769231,1074.49846153846,6129.81230769231,278.403076923077,461.747692307692,680.172307692308,1337.99692307692,487.947692307692,640.701538461538,1065.34461538462,130.947692307692,325,22.3894983604996,18.6616320904044,0.552520453387079,0.942028985507246,0.777511961722488,1.31724284433388,53742.0215384615,33756.8830769231,FAAGSCC_12,AG,1,dendritic cells,,TIM3+,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,dendritic cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_339746,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
340175,3784.80674846626,886.834355828221,95.3006134969325,618.389570552147,621.625766871166,533.953987730061,443.337423312883,240.481595092024,1079.04601226994,5719.68404907975,1676.32208588957,122.579754601227,9581.13496932515,764.898773006135,539.585889570552,341.653374233129,1700.33742331288,1071.92944785276,275.061349693252,221.861963190184,997.588957055215,1018.66871165644,218.187116564417,205.230061349693,588.21472392638,1581.43865030675,515.41717791411,409.757668711656,1047.46319018405,129.739263803681,326,22.1889407447669,18.8302557349157,0.528982910732361,0.964497041420118,0.740909090909091,-0.481294683350847,53540.7791411043,33504.9049079755,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX+,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_340175,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
340295,3157.88846153846,1119.86923076923,454.003846153846,702.938461538462,3759.61538461538,584.753846153846,1154.49230769231,238.873076923077,1079.69230769231,5642.48846153846,1074.15384615385,123.380769230769,1088.49230769231,1745.72307692308,605.538461538462,651.311538461538,1986.68461538462,2422.07692307692,294.788461538462,230.25,1033.29615384615,2338.08461538462,210.657692307692,291.480769230769,603.15,2071.63846153846,517.4,353.596153846154,1065.57692307692,129.088461538462,260,22.4345511868601,14.9180809052715,0.746878902349764,0.962962962962963,0.738636363636364,-1.30288412730727,53407.3769230769,33690.0576923077,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_340295,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
340455,3706.25,200.328125,66.84765625,629.12890625,1069.13671875,1448.52734375,412.3671875,272.7109375,1105.6015625,7686.5546875,713.48828125,126.7421875,1080.90625,802.92578125,506.82421875,277.765625,1440.76171875,975.90625,282.06640625,219.08203125,990.08203125,879.53515625,194.14453125,118.65625,672.18359375,2669.37109375,534.55859375,241.421875,1062.234375,131.08984375,256,21.8773372067247,14.9802209291788,0.72879031505558,0.966037735849057,0.709141274238227,0.766474035991028,53581.87890625,32697.39453125,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_340455,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
342230,2006.75272727273,236.258181818182,99.9272727272727,629.585454545455,1110.98181818182,284.283636363636,323.814545454545,252.56,1079.85090909091,2672.93454545455,521.250909090909,123.861818181818,1080.53454545455,765.861818181818,727.487272727273,298.763636363636,1404.03272727273,1064.8,317.069090909091,230.036363636364,980.338181818182,1018.91272727273,228.883636363636,121.029090909091,590.232727272727,928.756363636364,485.949090909091,223.181818181818,1012.86545454545,129.269090909091,275,29.5359347040806,12.2616358971915,0.909756180328052,0.919732441471572,0.654761904761905,-1.36812319479955,53092.9163636364,32603.1818181818,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_342230,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
342862,2470.53794266442,369.016863406408,124.5413153457,691.912310286678,1988.9544688027,2376.51264755481,727.553119730185,257.622259696459,1123.36087689713,3491.88364249578,4238.26475548061,133.693086003373,1088.02529510961,2525.9089376054,649.600337268128,368.10455311973,1890.56661045531,2643.06913996627,292.490725126476,226.387858347386,1018.96627318718,2060.41989881956,205.419898819562,211.743676222597,596.443507588533,1113.6239460371,496.4586846543,576.487352445194,1068.22428330523,130.659359190557,593,39.5023906770137,19.2730708471212,0.872901589961408,0.950320512820513,0.601419878296146,0.910249622418709,53289.5430016863,33715.741989882,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_342862,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
342976,3551.78070175439,156.083333333333,80.4649122807018,631.276315789474,1388.66666666667,2148.2850877193,563.701754385965,253.280701754386,1098.21929824561,5697.8947368421,542.223684210526,120.504385964912,1087.65350877193,2517.56578947368,696.456140350877,429.745614035088,1945.6798245614,3580.83333333333,389.780701754386,245.855263157895,1024.30263157895,3228.65789473684,278.236842105263,274.614035087719,637.684210526316,2353.98245614035,531.486842105263,239.157894736842,1077.48684210526,129.530701754386,228,19.0608468912072,15.3468735852006,0.593068894838748,0.962025316455696,0.791666666666667,0.579779073636092,53606.9692982456,33504.798245614,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_342976,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
343183,3941.69381107492,284.889250814332,161.371335504886,652.381107491857,2348.02605863192,2635.75570032573,926.309446254072,254.091205211726,1133.4983713355,5253.00651465798,560.201954397394,141.162866449511,1077.06840390879,4368.25732899023,1285.1009771987,1608.16286644951,8190.77850162866,4366.53745928339,412.201954397394,243.951140065146,1072.85667752443,3665.15635179153,255.175895765472,585.964169381107,741.267100977199,1280.22801302932,537.153094462541,287.071661237785,1048.1009771987,130.358306188925,307,21.9084067320035,17.9255068895087,0.574930549972346,0.974603174603175,0.812169312169312,0.295683394193359,53180.0195439739,33925.5732899023,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_343183,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
343571,6722.80991735537,403.574380165289,127.896694214876,630.330578512397,1390.15702479339,595.305785123967,276.425619834711,257.239669421488,1085.11983471074,10936.7314049587,676.380165289256,143.590909090909,1072.21487603306,577.495867768595,399.305785123967,314.00826446281,1386.59917355372,880.892561983471,237.648760330579,214.342975206612,983.623966942149,842.198347107438,179.074380165289,199.677685950413,583.438016528926,4234.0826446281,578.842975206612,249.433884297521,1049.28099173554,131.971074380165,242,20.2238212604133,15.4617472550089,0.644586435147526,0.96031746031746,0.711764705882353,0.313327021018454,53541.8305785124,31981.9917355372,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_343571,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
344484,4907.61313868613,1587.14233576642,154.57299270073,654.894160583942,2437.60948905109,1050.51094890511,846.277372262774,248.948905109489,1086.50364963504,7998.51094890511,620.229927007299,137.63503649635,1099.79562043796,1142.20072992701,710.120437956204,368.204379562044,4879.20072992701,2034.25182481752,329.459854014599,241.733576642336,1003.74452554745,2173.18248175182,242.233576642336,187.602189781022,603.051094890511,2636.6897810219,556.78102189781,294.667883211679,1100.74452554745,132.51094890511,274,21.3181702966227,16.479983421593,0.634346701222075,0.948096885813149,0.778409090909091,-0.036401164394271,52696.2481751825,33728.204379562,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_344484,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
345685,2340.58578431373,143.634803921569,227.509803921569,769.25,9501.78676470588,766.014705882353,463.764705882353,290.174019607843,1151.59803921569,4739.08333333333,1143.48284313725,158.446078431373,1076.07598039216,937.377450980392,552.220588235294,284.950980392157,1531.68137254902,966.30637254902,200.252450980392,208.566176470588,1170.25245098039,594.963235294118,129.821078431373,92.2475490196078,586.96568627451,874.551470588235,419.948529411765,222.536764705882,1057.75490196078,129.801470588235,408,27.8986087964234,18.9479674467048,0.733978703012618,0.940092165898618,0.709565217391304,-0.752826705544176,53027.8235294118,32384.1691176471,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_345685,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
345771,2041.93969849246,316.457286432161,44.748743718593,616.678391959799,1078.17587939699,1804.35175879397,2961.50753768844,240.582914572864,1083.98492462312,3581.82914572864,722.045226130653,111.884422110553,1081.46231155779,972.964824120603,754.035175879397,1053.89447236181,1502.5175879397,1269.37688442211,284.246231155779,226.402010050251,1004.04020100503,1269.26633165829,216.291457286432,251.331658291457,611.075376884422,1285.06030150754,457.015075376884,321.597989949749,1022.18090452261,129.356783919598,199,17.0265814758091,14.9632588050213,0.477157934492139,0.952153110047847,0.731617647058823,-0.736350158999388,53348.0703517588,33592.6783919598,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_345771,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
346030,4447.27044025157,787.745283018868,1194.57547169811,686.679245283019,3869.46855345912,1829.48427672956,353.48427672956,255.459119496855,1099.63836477987,6436.48113207547,551.119496855346,131.770440251572,1094.36163522013,2390.64465408805,589.323899371069,295.581761006289,6427.64465408805,2387.0251572327,310.449685534591,224.852201257862,1039.01886792453,1674.76729559748,202.364779874214,171.704402515723,613.940251572327,1142.88050314465,451.210691823899,245.35534591195,1035.94339622642,130.619496855346,318,23.9898903465088,16.9821166257196,0.706326322246597,0.954954954954955,0.768115942028985,-1.45256551897525,52966.6194968553,33452.6163522013,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_346030,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
346032,3080.08312342569,602.083123425693,624.095717884131,623.952141057934,1745.24937027708,3190.60705289672,747.811083123426,258.395465994962,1096.61460957179,4122.98740554156,762.047858942066,123.627204030227,1073.03274559194,1960.17128463476,1305.28715365239,1810.70025188917,2575.5919395466,2675.50377833753,275.403022670025,220.690176322418,1012.35012594458,1985.97229219144,204.178841309824,585.670025188917,811.715365239295,1030.56171284635,471.304785894206,337.347607052897,1024.77833753149,130.672544080605,397,26.6850421980505,19.0977375064716,0.698436531933767,0.973039215686274,0.803643724696356,0.24664343967287,54087.4332493703,32732.9496221662,FAAGSCC_12,AG,1,regulatory T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_346032,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
346318,1938.94186046512,183.343023255814,62.1395348837209,623.052325581395,768.238372093023,410.843023255814,343.220930232558,257.005813953488,1080.51162790698,3931.12209302326,1120.34302325581,115.389534883721,1072.12790697674,1134.61046511628,601.360465116279,291.883720930233,1590.06395348837,1666.02325581395,394.994186046512,247.104651162791,986.453488372093,1580.31395348837,294.383720930233,418.959302325581,597.098837209302,1482.81976744186,456.325581395349,379.738372093023,1035.72093023256,128.848837209302,172,17.2708671920892,12.7234809686015,0.676217631753198,0.955555555555556,0.716666666666667,0.896477917012247,53006.9825581395,32754.7034883721,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_346318,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
346375,2394.70138888889,214.916666666667,280.84375,756.496527777778,8154.55208333333,1688.86111111111,639.701388888889,242.649305555556,1086.85416666667,4372.85416666667,563.138888888889,136.545138888889,1082.29166666667,1129.00347222222,530.430555555556,314.763888888889,2831.46180555556,1196.58680555556,289.753472222222,224.350694444444,1018.07986111111,1065.95138888889,204.826388888889,173.413194444444,591.184027777778,1552.02083333333,483.701388888889,265.072916666667,1072.69444444444,131.635416666667,288,26.0594715984469,14.1745146087072,0.839130937493891,0.956810631229236,0.72,1.23118298695284,52890.9618055556,33433.5902777778,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_346375,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
346864,2267.46428571429,484.092857142857,541.557142857143,620.528571428571,848.914285714286,2255.37857142857,468.721428571429,255.707142857143,1085.7,4010.67857142857,591.307142857143,109.4,1068.00714285714,1188.31428571429,587.114285714286,299.492857142857,1736.91428571429,1666.55714285714,342.921428571429,244.65,1036.09285714286,1802.53571428571,227.142857142857,219.328571428571,1185.72142857143,1116.62142857143,452.15,291.392857142857,1015.52857142857,129.614285714286,140,15.1688134065804,11.7716434550264,0.630680649362686,0.933333333333333,0.714285714285714,0.625225216120193,53694.4642857143,33686.5071428571,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_346864,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
347676,1965.91992882562,111.492882562278,66.5711743772242,634.110320284698,1408.13523131673,268.832740213523,270.709964412811,253.197508896797,1080.11387900356,3798.26334519573,853.745551601423,138.526690391459,1076.49644128114,600.784697508897,453.802491103203,268.720640569395,1367.7384341637,936.572953736655,268.663701067616,228.695729537367,979.868327402135,862.346975088968,191.115658362989,116.980427046263,585.074733096085,1351.69217081851,523.900355871886,246.576512455516,1058.78825622776,129.928825622776,562,32.884336515526,22.0254059197422,0.742555891464816,0.974003466204506,0.720512820512821,-1.00601859919095,53552.9786476868,32660.5943060498,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_347676,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
347928,2349.43347639485,479.261802575107,85.2317596566524,618.768240343348,784.420600858369,388.081545064378,379.690987124464,248.25321888412,1088.18025751073,4278.08154506438,485.158798283262,131.145922746781,1070.54077253219,1740.23605150215,706.416309012876,316.776824034335,5432.68240343348,4245.43347639485,402.811158798283,244.896995708154,1042.71673819743,4172.26180257511,256.952789699571,249.206008583691,683.502145922747,1996.39055793991,513.103004291846,245.206008583691,1049.30472103004,132.811158798283,233,20.6373272304721,14.6746188699626,0.703119528271806,0.966804979253112,0.792517006802721,-1.55976979414544,52864.8240343348,33844.8583690987,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_347928,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
348237,2036.8811369509,371.025839793282,112.720930232558,613.118863049096,489.059431524548,1905.78036175711,948.385012919897,259.656330749354,1082.63824289406,4055.80620155039,1037.45219638243,114.84496124031,1067.39793281654,1426.17571059432,474.069767441861,283.940568475452,1456.00258397933,1360.63824289406,307.989664082687,224.067183462532,991.8165374677,1212.27390180879,220.413436692506,116.165374677003,593.803617571059,1603.68475452196,482.684754521964,260.320413436692,1035.08785529716,131.002583979328,387,27.0402367576755,18.421018219117,0.732055767389465,0.955555555555556,0.737142857142857,-1.13916368684695,53728.645994832,32174.7054263566,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_348237,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
348714,2552.0976744186,241.467441860465,105.46511627907,653.06976744186,2380.17674418605,2174.05581395349,1335.0488372093,256.548837209302,1152.32790697674,3920.44651162791,2102.1488372093,122.516279069767,1072.86511627907,4073.46279069767,912.655813953488,430.323255813953,2071.91627906977,3257.17441860465,394.388372093023,242.416279069767,1031.81627906977,2185.64651162791,558.851162790698,260.302325581395,597.625581395349,1041.58837209302,471.104651162791,355.932558139535,1054.21627906977,131.690697674419,430,30.2758265530118,18.2704365931187,0.797388613923109,0.972850678733032,0.780399274047187,-0.305279589372488,53025.723255814,33651.7558139535,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_348714,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
349265,1845.54564315353,246.344398340249,73.2925311203319,620.763485477178,652.991701244813,215.599585062241,228.767634854772,239.856846473029,1082.57676348548,3287.58091286307,790.126556016598,123.315352697095,1070.86514522822,505.97510373444,376.740663900415,252.174273858921,1405.57468879668,775.659751037344,193.016597510373,205.369294605809,984.92531120332,691.798755186722,148.979253112033,114.298755186722,584.564315352697,902.46265560166,461.96887966805,250.657676348548,1014.47302904564,129.570539419087,482,32.1093755697831,19.3806940654614,0.797299679520101,0.971774193548387,0.73030303030303,-1.1341718422963,53901.5124481328,32549.4294605809,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_349265,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
350854,1920.53200883002,385.037527593819,117.980132450331,635.909492273731,1802.20529801325,336.761589403974,318.079470198675,266.679911699779,1086.05739514349,2386.32450331126,901.291390728477,117.951434878587,1069.84105960265,680.596026490066,494.523178807947,272.600441501104,1370.32671081678,1007.6710816777,308.271523178808,224.845474613686,981.203090507726,952.596026490066,224.222958057395,121.008830022075,581.679911699779,945.039735099338,442.240618101545,319.626931567329,1042.58278145695,130.304635761589,453,28.6365259736079,20.2649901590704,0.706550814249677,0.970021413276231,0.725961538461538,0.608621363745929,53719.9823399559,32121.1059602649,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_350854,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
351776,4560.27147766323,734.797250859106,151.903780068729,666.536082474227,3276.17869415808,355.505154639175,301.123711340206,241.030927835052,1085.71134020619,6669.11340206186,583.453608247423,122.848797250859,1086.84536082474,868.219931271478,538.635738831615,276.567010309278,3264.54639175258,1153.19243986254,279.621993127148,226.044673539519,1020.03436426117,1101.66666666667,212.85910652921,209.061855670103,1421.23024054983,1389.04467353952,508.213058419244,238.295532646048,1057.12371134021,131.034364261168,291,23.0908498078732,16.1085385360279,0.716472179806339,0.944805194805195,0.744245524296675,1.3387508583972,53782.8350515464,33535.147766323,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_351776,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
352891,2992.89096573209,422.517133956386,168.352024922118,645.249221183801,1856.28971962617,627.065420560748,395.221183800623,274.781931464174,1120.68224299065,4322.83489096573,622.760124610592,124.224299065421,1074.39252336449,744.0,421.305295950156,270.676012461059,1441.93457943925,811.414330218069,178.716510903427,205.261682242991,1082.96261682243,610.856697819315,131.271028037383,106.909657320872,585.866043613707,975.781931464174,444.492211838006,219.115264797508,1046.93146417445,130.193146417445,321,29.7603471444895,14.179725215347,0.879194142001131,0.941348973607038,0.614942528735632,1.18005035389737,53889.8940809969,32270.0903426791,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_352891,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
353369,4023.34319526627,316.647928994083,145.949704142012,653.816568047337,2290.44082840237,1188.18934911243,814.059171597633,260.878698224852,1094.89940828402,6264.54142011834,619.378698224852,126.269230769231,1084.9201183432,1601.92307692308,801.612426035503,310.431952662722,1571.30473372781,1102.7426035503,267.556213017751,222.029585798817,989.615384615385,987.544378698225,196.369822485207,130.801775147929,615.991124260355,1206.28402366864,471.041420118343,241.153846153846,1032.99112426036,131.801775147929,338,25.3794880257286,17.1193750592223,0.738242073324944,0.952112676056338,0.751111111111111,-1.26780522012201,52842.875739645,33370.1686390533,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_353369,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
353496,3613.5572519084,392.36641221374,907.117048346056,618.483460559796,849.142493638677,1808.53180661578,1051.24936386768,249.628498727735,1124.0,4820.30025445293,557.333333333333,140.69465648855,1068.4096692112,1313.07633587786,539.725190839695,458.167938931298,1639.46819338422,1652.19083969466,283.936386768448,227.669211195929,1010.70229007634,1789.13231552163,213.020356234097,319.310432569975,651.498727735369,1500.48600508906,530.661577608142,295.793893129771,1026.54452926209,129.95165394402,393,27.849256038033,18.1252219773846,0.759220701254145,0.960880195599022,0.755769230769231,-0.428858396197425,53409.1221374046,33765.3893129771,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_353496,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
353670,3008.39574468085,94.4851063829787,261.978723404255,786.659574468085,10710.9872340426,807.144680851064,493.646808510638,298.76170212766,1171.08085106383,3793.32765957447,948.851063829787,397.953191489362,1068.22978723404,1125.05531914894,644.957446808511,292.863829787234,1626.00425531915,1153.11489361702,239.106382978723,217.548936170213,1216.05106382979,637.668085106383,143.042553191489,103.357446808511,600.302127659574,800.765957446809,423.455319148936,235.812765957447,1024.87659574468,130.314893617021,235,25.3855763834765,12.3421539196479,0.873854428129443,0.936254980079681,0.652777777777778,1.19251939654396,52662.829787234,32133.7404255319,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,1,FAAGSCC_12_353670,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
354203,4422.49044585987,963.949044585987,103.480891719745,642.410828025478,1487.84076433121,446.996815286624,841.057324840764,236.640127388535,1085.24203821656,7234.1974522293,574.614649681529,139.933121019108,1099.04458598726,1941.46178343949,1364.35668789809,1561.41082802548,2532.69426751592,2929.91719745223,376.831210191083,240.503184713376,1067.43630573248,2292.4872611465,256.308917197452,552.433121019108,782.480891719745,2787.25159235669,571.388535031847,250.031847133758,1077.21337579618,131.468152866242,314,21.7048935165336,18.4463754889737,0.526989597396499,0.975155279503106,0.751196172248804,0.108389506070435,53031.4076433121,33761.2802547771,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_354203,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
354311,3159.94579945799,452.341463414634,115.607046070461,635.146341463415,1511.32249322493,1598.07588075881,2316.56368563686,245.411924119241,1094.10298102981,5346.91598915989,546.514905149052,125.853658536585,1085.45799457995,2860.0054200542,723.173441734417,868.563685636856,2021.45799457995,2723.75338753388,299.046070460705,227.046070460705,1034.33333333333,2035.73712737127,214.436314363144,277.460704607046,641.953929539295,1588.972899729,494.50406504065,275.70460704607,1078.46341463415,131.555555555556,369,22.2763053399518,21.2127475288271,0.305300393026107,0.938931297709924,0.697542533081285,1.09384335079203,52980.1680216802,33644.9024390244,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,9,FAAGSCC_12_354311,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
354683,2967.34081632653,271.969387755102,78.5938775510204,628.279591836735,945.734693877551,486.714285714286,298.016326530612,248.451020408163,1094.67755102041,5455.47142857143,1673.65510204082,126.787755102041,1074.92653061224,751.185714285714,492.80612244898,266.328571428571,1664.18163265306,1091.20816326531,250.230612244898,217.659183673469,1022.29795918367,943.048979591837,180.628571428571,463.081632653061,2044.90612244898,1705.48979591837,524.355102040816,348.763265306122,1067.28571428571,130.979591836735,490,32.4922651989085,19.23487931581,0.805950208331526,0.97609561752988,0.831918505942275,-1.36415408656524,52992.0612244898,32879.9775510204,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_354683,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
354730,2523.66430260047,567.0,863.044917257683,646.439716312057,2302.11347517731,437.787234042553,285.234042553192,247.385342789598,1082.79432624113,3604.39007092199,2152.20094562648,115.65011820331,1077.17966903073,1621.00945626478,599.333333333333,300.193853427896,1797.16548463357,1639.94326241135,263.685579196217,214.90780141844,1024.74704491726,1393.95508274232,209.550827423168,495.160756501182,2361.03073286052,845.09219858156,463.052009456265,368.293144208038,1021.8061465721,129.31914893617,423,27.1821912047546,19.9079857243514,0.680884551155809,0.963553530751708,0.774725274725275,-1.22820498846686,54138.0094562648,33275.5957446809,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_354730,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
354757,2491.99612403101,433.748062015504,89.1085271317829,647.596899224806,1396.7015503876,762.868217054264,379.984496124031,247.941860465116,1120.27519379845,4003.24418604651,1776.8488372093,137.232558139535,1072.36434108527,1134.36821705426,719.856589147287,291.337209302326,2052.37596899225,2041.38759689922,338.031007751938,236.968992248062,1018.43410852713,2188.97286821705,243.848837209302,318.360465116279,1972.95736434108,1202.41085271318,486.341085271318,403.77519379845,1046.40310077519,131.186046511628,258,20.8193239628976,15.825118097254,0.649786454613964,0.941605839416058,0.716666666666667,0.514544871228639,52998.3294573643,33876.2674418605,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_354757,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
354851,2000.28287841191,223.85111662531,92.4367245657568,627.059553349876,987.191066997519,585.565756823821,389.967741935484,273.87841191067,1125.12903225806,3502.21091811414,767.208436724566,152.136476426799,1069.44665012407,877.019851116625,507.816377171216,278.233250620347,1551.317617866,1033.32506203474,207.72952853598,213.697270471464,1210.24565756824,743.06699751861,152.334987593052,122.888337468983,867.389578163772,895.426799007444,450.724565756824,218.774193548387,1040.60297766749,129.449131513648,403,28.4740073111248,18.5197610552603,0.759583870317187,0.952718676122932,0.710758377425044,-0.480943749219297,52552.4243176179,32511.8560794045,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_354851,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
355985,2321.88,316.2,81.7733333333333,618.633333333333,709.9,2144.5,1016.52666666667,255.686666666667,1085.84,3922.80666666667,782.933333333333,109.413333333333,1085.34,1435.26666666667,756.36,612.94,1538.88666666667,1109.52666666667,264.333333333333,220.293333333333,1014.96,1013.92,192.406666666667,453.66,660.826666666667,863.0,438.666666666667,273.413333333333,1037.08,130.64,150,14.4916680575218,13.1799342950454,0.415739821153632,0.955414012738854,0.76530612244898,1.11424874877746,53673.5733333333,33425.7133333333,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_355985,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
356108,3559.91911764706,334.700980392157,126.55637254902,637.654411764706,1565.75980392157,1040.73774509804,364.066176470588,240.946078431373,1107.26225490196,5586.90931372549,545.151960784314,123.40931372549,1076.98284313725,3281.94852941176,639.453431372549,348.727941176471,1791.02450980392,4921.75735294118,364.835784313726,240.78431372549,1025.75245098039,3854.44852941176,265.235294117647,192.35294117647,591.122549019608,1460.66911764706,521.732843137255,268.120098039216,1037.02205882353,129.588235294118,408,27.8932929715085,18.7010584167339,0.741954709249986,0.971428571428571,0.708333333333333,0.770713138367718,53119.0759803922,33410.6274509804,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_356108,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
356296,3606.86666666667,397.364444444444,155.088888888889,629.635555555556,841.248888888889,1657.19111111111,348.813333333333,250.951111111111,1179.0,5134.8,663.164444444444,131.804444444444,1068.41777777778,807.862222222222,478.728888888889,275.955555555556,1613.02666666667,948.475555555556,203.448888888889,211.417777777778,1260.57777777778,735.297777777778,151.097777777778,146.822222222222,731.16,1491.13777777778,509.275555555556,224.248888888889,1035.10222222222,131.106666666667,225,18.9012637915435,15.6557946491014,0.560294400951155,0.9375,0.696594427244582,-0.478275105510705,52490.8488888889,33374.4577777778,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_356296,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
356379,1757.69072164948,580.448453608247,106.798969072165,640.711340206186,1960.79381443299,2201.31958762887,1150.54639175258,255.881443298969,1097.46391752577,3415.36597938144,509.742268041237,109.237113402062,1115.85051546392,2828.89175257732,1037.12371134021,1402.69587628866,2037.28350515464,3031.83505154639,355.850515463918,255.453608247423,1050.22164948454,2576.29896907217,258.726804123711,387.829896907216,789.567010309278,1124.12371134021,450.164948453608,262.484536082474,1052.30927835052,129.721649484536,194,18.0789063078143,13.7251537170177,0.650880111185908,0.950980392156863,0.76984126984127,0.227638710239319,53482.2422680412,33435.912371134,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_356379,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
358116,4316.47154471545,810.162601626016,79.8455284552846,642.69512195122,1049.81300813008,1090.79674796748,1441.89024390244,254.516260162602,1097.10569105691,6256.13414634146,684.386178861789,125.154471544715,1087.92682926829,1683.17886178862,1139.17073170732,733.617886178862,2207.76422764228,2918.15040650406,386.308943089431,778.49593495935,1061.56504065041,2236.13008130081,269.085365853659,515.739837398374,751.166666666667,1070.52845528455,456.764227642276,269.008130081301,1026.10569105691,130.658536585366,246,19.7501284616463,15.9047990441848,0.592866115223711,0.964705882352941,0.761609907120743,0.614280665919771,53143.7845528455,33560.5447154472,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_358116,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
359887,4060.9014084507,635.814084507042,1857.78591549296,663.814084507042,2056.46478873239,2448.17183098592,517.442253521127,250.112676056338,1094.40563380282,6013.56056338028,613.574647887324,143.845070422535,1073.67887323944,4096.80563380282,751.839436619718,482.222535211268,2645.31267605634,7003.01408450704,441.298591549296,247.492957746479,1035.68732394366,7507.73521126761,280.453521126761,233.580281690141,613.974647887324,1480.02253521127,523.647887323944,262.366197183099,1097.03098591549,131.180281690141,355,26.2843916755904,17.2975003276416,0.752939108450136,0.951742627345844,0.758547008547009,0.276747216649219,53047.5633802817,33868.3098591549,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_359887,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
359942,2073.9858490566,270.099056603774,80.8584905660377,622.764150943396,1190.56132075472,645.528301886792,366.155660377359,252.438679245283,1138.43396226415,3073.22169811321,943.283018867924,118.245283018868,1075.88679245283,1456.81132075472,763.221698113208,390.915094339623,2381.85849056604,4595.03773584906,417.797169811321,282.665094339623,1054.3820754717,5398.5141509434,309.127358490566,436.72641509434,751.839622641509,1035.36320754717,475.165094339623,400.943396226415,1033.78301886792,131.948113207547,212,17.8219622849979,15.1681432460428,0.525015330288756,0.976958525345622,0.831372549019608,-1.1602020729676,52873.7688679245,33524.8867924528,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,9,FAAGSCC_12_359942,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
360011,4519.09122807018,531.252631578947,85.1684210526316,639.354385964912,1604.08771929825,2273.29122807018,682.99298245614,256.031578947368,1104.50175438596,7334.77894736842,735.533333333333,120.701754385965,1542.13684210526,819.712280701754,535.631578947368,341.010526315789,1583.55087719298,1249.85964912281,316.828070175439,255.557894736842,1003.51578947368,1288.09824561404,240.666666666667,192.101754385965,633.519298245614,1780.65964912281,504.371929824561,315.891228070175,1050.0350877193,129.831578947368,285,21.4098756904792,17.022005178109,0.606538782941861,0.966101694915254,0.791666666666667,0.564780168114314,53725.0350877193,33512.6947368421,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX+,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_360011,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
360097,1873.37668161435,212.152466367713,109.627802690583,675.286995515695,1672.88789237668,340.457399103139,1622.23766816144,257.968609865471,1089.5201793722,4178.79372197309,526.928251121076,118.910313901345,1074.91479820628,857.973094170404,518.650224215247,289.022421524664,1465.11659192825,1304.63677130045,309.587443946188,228.188340807175,979.165919282511,1310.64573991031,230.260089686099,290.650224215247,614.035874439462,1936.11659192825,506.735426008969,232.121076233184,1065.12556053812,129.910313901345,223,20.3117681882655,14.0817468144432,0.720668132560986,0.961206896551724,0.688271604938272,0.753866925246053,53005.9282511211,32775.3901345291,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_360097,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
360105,2841.78931750742,557.566765578635,136.290801186944,660.676557863501,2154.3234421365,1751.96439169139,419.637982195846,253.816023738872,1129.77151335312,5133.37388724036,2498.42136498516,123.771513353116,1115.12462908012,982.890207715134,567.341246290801,392.044510385757,1589.82492581602,1207.3115727003,281.246290801187,223.26706231454,989.011869436202,1003.09495548961,213.608308605341,130.848664688427,580.448071216617,1319.33827893175,500.608308605341,667.406528189911,1066.44510385757,130.281899109792,337,23.6849600403325,18.5287253417398,0.622902848256564,0.962857142857143,0.732608695652174,-1.19331781885733,54178.6676557863,33172.3857566766,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_360105,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
360768,2098.33818181818,173.414545454545,100.152727272727,702.683636363636,4666.93454545455,343.72,279.603636363636,242.876363636364,1072.52,3587.81818181818,657.985454545455,145.381818181818,1075.27272727273,699.676363636364,427.054545454546,265.581818181818,1452.42181818182,1338.08727272727,284.043636363636,223.596363636364,991.76,1255.51272727273,209.905454545454,147.989090909091,628.989090909091,1293.05818181818,508.603636363636,331.298181818182,1054.12,130.127272727273,275,27.8211901068389,12.6223257230577,0.891157194048666,0.948275862068966,0.755494505494505,-1.4861175661105,52844.9781818182,33314.1054545455,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_360768,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
361053,2946.43909348442,305.926345609065,143.42492917847,670.614730878187,2970.42492917847,1124.90934844193,778.229461756374,256.218130311615,1078.29461756374,4936.55807365439,700.096317280453,130.008498583569,1063.76770538244,4494.31444759207,1178.24079320113,308.898016997167,1833.77337110482,4023.81869688385,380.892351274788,238.294617563739,998.937677053824,2644.7223796034,242.14164305949,537.739376770538,708.662889518414,955.294617563739,420.651558073654,220.733711048159,1043.05099150142,129.662889518414,353,29.1885163804103,15.4742334743527,0.847905125593596,0.951482479784367,0.653703703703704,1.05191408103832,52772.6600566572,32338.9121813031,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_361053,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
361583,4682.83278688525,315.862295081967,135.550819672131,644.724590163934,2191.35737704918,258.898360655738,256.2,247.603278688525,1074.06229508197,7222.83606557377,581.445901639344,148.665573770492,1076.1606557377,640.350819672131,508.413114754098,258.64262295082,1482.6262295082,1115.45901639344,283.003278688525,218.006557377049,976.36393442623,1019.12786885246,195.183606557377,112.554098360656,584.659016393443,2339.65901639344,523.64262295082,239.573770491803,1041.25573770492,130.24262295082,305,21.4177287599728,18.2685956801893,0.521966381316211,0.941358024691358,0.729665071770335,0.0513129976723642,53672.662295082,32538.5245901639,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_361583,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
362641,4267.86968838527,206.674220963173,102.334277620397,650.668555240793,2302.84419263456,367.365439093484,1021.70538243626,249.308781869688,1089.03682719547,6325.10198300283,742.419263456091,125.178470254958,1098.03966005666,1204.31728045326,1237.87252124646,332.954674220963,2785.0,2431.45325779037,377.878186968839,246.118980169972,1062.12181303116,2008.43342776204,237.186968838527,343.813031161473,857.685552407932,1313.81303116147,521.691218130312,364.028328611898,1051.62606232295,132.130311614731,353,23.9993747235365,18.7975442681313,0.62170508860119,0.96978021978022,0.774122807017544,-0.365143886940704,53073.1303116147,33551.7875354108,FAAGSCC_12,AG,1,stromal cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_362641,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
362657,1889.33770491803,279.554098360656,413.793442622951,826.875409836066,13661.9049180328,712.511475409836,576.003278688525,248.577049180328,1078.08196721311,3464.11147540984,564.87868852459,151.780327868852,1072.1868852459,809.177049180328,453.744262295082,372.816393442623,1696.22950819672,1005.75737704918,239.167213114754,217.967213114754,987.639344262295,935.268852459016,191.888524590164,128.652459016393,600.193442622951,1000.76393442623,449.304918032787,235.475409836066,1053.85573770492,129.855737704918,305,22.2432043411165,17.7223162954915,0.604306495103833,0.953125,0.693181818181818,0.528213871127419,52701.8721311475,32825.8786885246,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_362657,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
363030,1840.82485875706,198.409604519774,91.8898305084746,636.5,1449.06214689266,2111.67796610169,3615.75423728814,266.420903954802,1097.36723163842,2620.6384180791,606.019774011299,136.533898305085,1070.40677966102,1295.31073446328,1519.28531073446,1226.01694915254,1531.66101694915,1163.02542372881,311.011299435028,229.95197740113,992.93220338983,964.429378531073,212.381355932203,181.983050847458,622.762711864407,969.980225988701,472.960451977401,229.225988700565,1053.43220338983,129.375706214689,354,29.1212397762403,15.539808504465,0.845721489860735,0.956756756756757,0.614583333333333,0.787147053482172,52946.3926553672,32746.5536723164,FAAGSCC_12,AG,1,M2 macrophages,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_363030,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
363755,3881.10454545455,702.377272727273,435.543181818182,670.877272727273,3484.18863636364,406.068181818182,333.111363636364,243.125,1106.41818181818,6981.96363636364,563.545454545455,131.697727272727,1104.85454545455,681.963636363636,494.302272727273,270.404545454545,1469.61363636364,1062.2,292.297727272727,229.488636363636,989.513636363636,993.336363636364,217.161363636364,143.309090909091,581.690909090909,2283.40454545455,526.911363636364,246.411363636364,1053.72727272727,129.175,440,31.2649444476036,18.0405587797316,0.816728648430139,0.956521739130435,0.651851851851852,0.89764689109184,52952.1613636364,33316.4295454545,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_363755,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
364410,1596.06995884774,337.259259259259,105.0329218107,607.111111111111,773.185185185185,1627.40740740741,328.395061728395,241.222222222222,1098.90946502058,3192.8683127572,418.526748971193,105.481481481481,1072.25925925926,8247.64197530864,1303.69958847737,399.695473251029,11164.4773662551,9362.13991769547,484.58024691358,252.201646090535,1115.90534979424,8241.69958847737,286.736625514403,242.399176954732,672.707818930041,943.168724279835,434.98353909465,261.312757201646,1007.3621399177,128.551440329218,243,19.2023293643626,16.1453113548267,0.541346458666116,0.972,0.794117647058823,-0.986367007515163,53970.8024691358,33562.9547325103,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_364410,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
364814,2530.37730870712,481.960422163588,116.620052770449,664.601583113457,1677.42216358839,1338.87862796834,1436.78627968338,245.22691292876,1092.99736147757,4234.10817941953,540.474934036939,114.087071240106,1077.0,2770.31134564644,892.118733509235,618.630606860158,1841.08443271768,4914.88126649077,420.807387862797,247.480211081794,1081.82321899736,3966.38786279683,572.693931398417,1046.20580474934,617.622691292876,1472.76253298153,487.915567282322,686.250659630607,1041.57255936675,129.831134564644,379,30.8638128795586,16.692195909125,0.841129422804429,0.928921568627451,0.67921146953405,-1.46447539856154,53502.4670184697,33619.1556728232,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_364814,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
365132,3687.37845303867,484.295580110497,218.955801104972,676.223756906077,4113.41160220995,306.839779005525,308.870165745856,259.234806629834,1090.30662983425,5216.23756906077,721.21270718232,144.342541436464,1083.26243093923,680.582872928177,698.337016574586,288.174033149171,2073.56077348066,966.85635359116,269.256906077348,223.033149171271,1000.89779005525,843.538674033149,196.812154696133,133.566298342541,597.312154696133,1769.33701657459,479.881215469613,218.21546961326,1061.31767955801,129.939226519337,362,22.1906180358291,20.8508878517989,0.342202361147615,0.970509383378016,0.783549783549784,1.30394716110579,52559.5193370166,32169.3784530387,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_365132,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
365530,3436.89719626168,624.61214953271,71.5046728971963,646.296728971963,1779.32242990654,1959.40186915888,2850.7453271028,254.453271028037,1127.14953271028,5426.7523364486,762.913551401869,123.014018691589,1108.51635514019,2563.30373831776,982.766355140187,1329.61448598131,1822.32710280374,2944.89485981308,352.81308411215,229.331775700935,1051.78504672897,2915.56775700935,224.57476635514,376.429906542056,684.144859813084,1427.1238317757,482.497663551402,263.628504672897,1044.46495327103,129.892523364486,428,26.0588613035037,21.0458810561693,0.589691514813576,0.961797752808989,0.748251748251748,-0.306790293225598,53691.9228971963,33717.8621495327,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_365530,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
365597,3611.56464379947,525.253298153034,1258.37994722955,638.722955145119,1591.58839050132,4517.54881266491,1418.15567282322,263.013192612137,1098.89973614776,5811.85224274406,505.005277044855,122.902374670185,1072.44854881266,3826.28232189974,673.98944591029,395.46437994723,1838.37730870712,3140.13720316623,328.775725593668,228.551451187335,1012.01583113456,2182.74142480211,211.493403693931,225.955145118733,602.530343007916,1773.77308707124,512.461741424802,282.131926121372,1036.02638522427,129.79419525066,379,27.0498334739086,17.8857040197649,0.75019813878554,0.954659949622166,0.779835390946502,-1.51714800737795,53868.4538258575,33664.5540897098,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_365597,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
365644,4695.60102739726,1408.55993150685,425.345890410959,644.184931506849,1453.0,961.433219178082,293.431506849315,237.97602739726,1077.87157534247,7616.85273972603,700.059931506849,129.809931506849,1089.69349315068,1482.9897260274,456.650684931507,290.820205479452,1654.43150684932,3267.77739726027,306.597602739726,229.784246575342,1038.86301369863,3191.33219178082,374.123287671233,176.421232876712,585.215753424658,1906.45890410959,575.537671232877,356.950342465753,1079.68321917808,133.22602739726,584,29.4794231189764,25.5794834215722,0.497077100504535,0.957377049180328,0.772486772486772,-0.587938135567663,53416.2636986301,33390.5462328767,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_365644,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
366625,2661.85090909091,253.254545454545,84.1054545454545,641.36,1760.62181818182,1442.28,445.625454545455,258.123636363636,1114.23272727273,5238.10181818182,614.094545454545,124.04,1121.04363636364,778.141818181818,478.909090909091,281.676363636364,1505.29818181818,1170.63636363636,281.829090909091,228.341818181818,992.661818181818,1289.13454545455,208.996363636364,138.501818181818,744.149090909091,1482.30181818182,497.614545454546,236.149090909091,1050.75636363636,132.221818181818,275,21.6968554619454,16.1912143380642,0.665669094551028,0.945017182130584,0.735294117647059,0.0115715755881104,53290.1163636364,33348.2036363636,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_366625,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
366680,4566.80428134557,1436.51681957187,148.180428134557,670.039755351682,2200.78899082569,614.165137614679,1674.09174311927,244.715596330275,1085.18960244648,7488.85932721713,609.214067278287,127.443425076453,1227.39143730887,1053.47400611621,517.715596330275,302.681957186544,1511.69418960245,1826.4006116208,298.321100917431,226.54128440367,992.318042813456,1696.14067278287,227.645259938838,167.168195718654,921.021406727829,1802.40366972477,492.948012232416,332.492354740061,1039.33639143731,129.730886850153,327,23.1756662848075,18.0129384108928,0.62921045229219,0.961764705882353,0.741496598639456,0.805014438708027,53996.8042813456,33459.7859327217,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX+,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_366680,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
366837,1667.2183908046,256.103448275862,80.9712643678161,618.879310344828,1445.01149425287,302.132183908046,290.367816091954,253.298850574713,1073.83333333333,3106.55172413793,3359.31609195402,115.810344827586,1080.72413793103,728.637931034483,465.666666666667,274.971264367816,1428.94827586207,1042.91379310345,283.264367816092,223.603448275862,979.804597701149,989.925287356322,217.574712643678,130.764367816092,586.137931034483,1179.0,487.948275862069,982.14367816092,1064.27011494253,131.977011494253,174,15.9864745567452,13.8725041540036,0.496974636847374,0.966666666666667,0.776785714285714,-0.307180594819771,53485.316091954,33251.0517241379,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_366837,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
367063,3804.24936386768,967.071246819338,176.407124681934,674.837150127226,3761.89821882952,849.256997455471,315.898218829517,259.844783715013,1080.58269720102,6047.63358778626,558.300254452926,128.091603053435,1386.24427480916,711.0737913486,496.674300254453,284.913486005089,1473.70992366412,1120.0534351145,307.503816793893,246.06106870229,982.944020356234,1039.66921119593,221.554707379135,148.898218829517,587.193384223919,1451.07124681934,521.702290076336,246.412213740458,1048.87531806616,130.572519083969,393,27.7552715356867,18.0600759332507,0.759343534717406,0.958536585365854,0.71195652173913,0.908887100958564,53565.3409669211,32940.0025445293,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX+,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_367063,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
368136,3545.47204968944,874.453416149068,151.236024844721,669.766045548654,3961.24223602484,750.544513457557,285.513457556936,253.703933747412,1080.01035196687,6244.53623188406,2843.07867494824,123.285714285714,1078.75155279503,650.871635610766,457.585921325052,268.679089026915,1350.60248447205,1018.31884057971,309.4016563147,226.238095238095,981.739130434783,1010.4265010352,244.683229813665,121.277432712215,585.482401656315,1806.29192546584,486.03933747412,516.15734989648,1069.50517598344,130.968944099379,483,27.7636650552283,22.2931695546953,0.596030148389793,0.954545454545455,0.75,-0.217381222689241,54115.3209109731,32528.7412008282,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_368136,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
368619,3756.71584699454,740.535519125683,184.486338797814,695.120218579235,4045.87431693989,276.5956284153,291.956284153005,256.928961748634,1081.99453551913,6419.86338797814,6136.78142076503,138.639344262295,1088.5956284153,2760.90163934426,582.918032786885,293.846994535519,1544.31147540984,2608.26229508197,381.885245901639,237.540983606557,1020.24043715847,1879.21857923497,277.109289617486,156.147540983607,591.978142076503,1952.44262295082,549.103825136612,681.071038251366,1093.26775956284,130.825136612022,183,19.655882427816,12.1892279595548,0.784498035962523,0.958115183246073,0.7625,-1.4985594135294,52931.5737704918,32664.7978142076,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_368619,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
368730,1483.14090909091,194.959090909091,98.35,642.668181818182,1868.87272727273,3305.25909090909,3829.06363636364,274.540909090909,1101.58636363636,2309.47272727273,731.686363636364,128.018181818182,1070.43636363636,2386.60909090909,1654.79090909091,2250.86818181818,1825.30909090909,1355.41363636364,279.740909090909,221.481818181818,997.868181818182,1166.14090909091,201.3,259.209090909091,731.968181818182,1017.75454545455,469.786363636364,236.072727272727,1059.95909090909,131.4,220,23.8694747132675,11.857009436635,0.86789732648914,0.944206008583691,0.763888888888889,-0.0505862272770239,52500.9090909091,32654.5,FAAGSCC_12,AG,1,M2 macrophages,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_368730,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
369730,3825.11337209302,1119.14244186047,271.014534883721,653.755813953488,2489.12209302326,457.029069767442,646.447674418605,255.235465116279,1085.53488372093,5098.75581395349,660.229651162791,125.401162790698,1085.50581395349,2700.62790697674,566.177325581395,284.473837209302,1594.05813953488,4390.77325581395,340.479651162791,237.029069767442,1004.85465116279,3822.74127906977,249.093023255814,193.688953488372,1587.72093023256,1121.81104651163,512.241279069767,236.389534883721,1035.99709302326,131.781976744186,344,22.2823686935005,19.9754810218364,0.443103892555545,0.955555555555556,0.712215320910973,1.5702096353949,53325.8459302326,33324.9854651163,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_369730,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
370142,4973.66435986159,236.487889273356,86.4671280276817,617.996539792388,710.204152249135,685.387543252595,974.595155709342,246.539792387543,1088.06574394464,7723.65397923875,566.955017301038,146.961937716263,1108.03806228374,760.553633217993,648.63321799308,360.581314878893,1797.95501730104,1036.75778546713,238.086505190311,220.941176470588,1021.35640138408,934.069204152249,186.304498269896,195.941176470588,673.688581314879,2654.15570934256,547.764705882353,252.179930795848,1060.63667820069,130.491349480969,289,22.7466203951483,16.2727794482536,0.698722012121037,0.963333333333333,0.772727272727273,0.218148096613615,53050.0311418685,33778.9930795848,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_370142,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
370346,5564.63005780347,1473.79479768786,1053.09826589595,724.705202312139,5736.00867052023,273.153179190751,375.898843930636,245.609826589595,1077.3323699422,8608.55780346821,644.945086705202,147.965317919075,1088.89306358382,611.71676300578,403.950867052023,264.034682080925,1420.7225433526,961.245664739884,247.352601156069,221.664739884393,998.083815028902,899.589595375723,184.760115606936,220.320809248555,580.575144508671,1661.24566473988,514.517341040462,228.843930635838,1051.07803468208,132.820809248555,346,22.1949476814584,19.9562961276365,0.43766752392472,0.977401129943503,0.867167919799499,0.329558364896998,52928.0115606936,33244.289017341,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_370346,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
370357,2809.3485915493,710.264084507042,517.183098591549,616.718309859155,575.950704225352,317.978873239437,344.119718309859,251.084507042254,1080.78521126761,6011.72183098592,614.211267605634,123.066901408451,1064.10563380282,655.859154929577,417.482394366197,266.566901408451,1416.50704225352,992.147887323944,268.700704225352,224.883802816901,987.679577464789,940.538732394366,202.947183098592,125.545774647887,584.68661971831,3407.80633802817,573.545774647887,322.197183098592,1058.10915492958,128.394366197183,284,22.9287361998015,15.8882383908431,0.720995257070727,0.979310344827586,0.860606060606061,-0.0491215932698402,52993.6267605634,33242.3028169014,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_370357,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
370566,2295.31940298507,85.6477611940299,101.776119402985,674.349253731343,3816.21791044776,782.683582089552,472.083582089552,300.70447761194,1160.30149253731,3720.85074626866,1213.07164179104,197.101492537313,1067.82686567164,1183.69552238806,682.089552238806,289.137313432836,1590.87462686567,1151.11641791045,228.388059701492,217.970149253731,1248.81791044776,604.179104477612,138.623880597015,99.9701492537314,593.522388059701,791.307462686567,410.232835820896,209.84776119403,1033.36417910448,131.370149253731,335,35.8837763050556,12.0052838929381,0.942374375162181,0.938375350140056,0.757918552036199,1.48891031219923,52712.0179104478,32137.3671641791,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_370566,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
372604,1764.78969957082,594.283261802575,95.4334763948498,627.909871244635,1333.96995708155,445.12017167382,533.673819742489,278.188841201717,1090.94849785408,3494.36051502146,563.781115879828,139.991416309013,1075.30901287554,1519.65236051502,692.811158798283,350.849785407725,2086.61802575107,4757.49356223176,365.978540772532,242.896995708154,1027.48497854077,5675.34763948498,291.609442060086,331.244635193133,594.776824034335,2107.49785407725,548.390557939914,257.090128755365,1076.78111587983,131.914163090129,233,19.9474632209024,15.1302990867557,0.651664389702107,0.951020408163265,0.728125,-1.18841702467799,53332.025751073,33810.1416309013,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_372604,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
372624,2064.18849840256,388.424920127796,156.162939297125,643.575079872204,2323.06709265176,269.680511182109,286.55750798722,254.150159744409,1077.71086261981,4021.38498402556,684.170926517572,136.821086261981,1079.08945686901,670.924920127796,470.709265175719,267.876996805112,1378.62460063898,1037.88817891374,302.111821086262,224.546325878594,978.747603833866,1003.53354632588,222.329073482428,114.333865814696,586.650159744409,2153.29392971246,621.643769968051,247.119808306709,1073.70127795527,130.0,626,44.3707487799383,18.4594898344236,0.909351639306533,0.944193061840121,0.618577075098814,-1.28094059431738,53014.0623003195,32637.4552715655,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_372624,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
372931,2352.6640625,217.8984375,85.79296875,651.421875,2023.6796875,434.828125,300.5859375,243.12109375,1110.03125,4250.734375,525.70703125,133.12890625,1099.8046875,1350.53515625,700.3671875,597.0234375,2455.25,3233.0390625,365.18359375,241.1328125,1048.83984375,3462.13671875,248.92578125,473.0546875,773.0,1898.91796875,492.45703125,234.421875,1059.3515625,129.53125,256,25.554676094516,12.8260992773767,0.864920947428957,0.948148148148148,0.731428571428571,-1.32263460452345,52894.17578125,33749.11328125,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,9,FAAGSCC_12_372931,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
374280,3147.58049886621,482.410430839002,105.21768707483,647.662131519274,1367.40136054422,1237.03174603175,2773.86621315193,255.408163265306,1100.34467120181,5149.3537414966,1260.04761904762,119.412698412698,1080.8253968254,3344.87528344671,1515.820861678,2400.19954648526,2469.179138322,5059.59863945578,402.714285714286,246.328798185941,1066.60090702948,5183.92517006803,277.816326530612,329.038548752834,698.258503401361,1523.54648526077,493.437641723356,511.530612244898,1075.03628117914,132.426303854875,441,29.0279435076261,19.5224540978887,0.740060743043339,0.962882096069869,0.706730769230769,0.868769365834601,52771.0385487528,33653.89569161,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_374280,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
374957,3167.14418604651,818.53023255814,2191.90697674419,621.637209302326,1021.93023255814,1936.21860465116,468.986046511628,245.548837209302,1102.98604651163,4023.24186046512,548.367441860465,122.93023255814,1079.80930232558,3917.67441860465,751.190697674419,328.33488372093,1723.48372093023,3962.58139534884,352.027906976744,252.758139534884,1021.70697674419,2989.14418604651,240.493023255814,327.26511627907,905.66511627907,951.976744186046,503.213953488372,238.981395348837,1017.07441860465,129.116279069767,215,20.3610188916406,13.5650007375835,0.745751632627979,0.938864628820961,0.716666666666667,1.35483863263466,54074.1069767442,33410.023255814,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_374957,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
375088,2923.96568627451,256.09068627451,115.014705882353,642.149509803922,2265.42892156863,333.174019607843,290.34068627451,258.872549019608,1085.51960784314,4978.27696078431,565.914215686274,127.147058823529,1064.29411764706,707.921568627451,566.549019607843,272.796568627451,1610.24264705882,982.649509803922,242.575980392157,211.622549019608,989.166666666667,823.088235294118,173.267156862745,115.838235294118,587.269607843137,1745.85294117647,474.019607843137,220.53431372549,1059.90441176471,129.406862745098,408,26.4964193526159,19.6861677760204,0.669319562030427,0.969121140142518,0.741818181818182,-0.68272904047223,53324.4117647059,32214.1299019608,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_375088,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
375677,2826.5956284153,318.967213114754,116.484517304189,632.788706739526,1232.029143898,1786.02367941712,1377.53369763206,259.553734061931,1113.60837887067,4110.76684881603,1255.51183970856,125.227686703097,1072.68306010929,2424.96721311475,1065.58652094718,1033.75409836066,1821.5956284153,2866.60473588342,311.630236794171,228.540983606557,1015.07285974499,2576.71038251366,252.382513661202,1296.26958105647,873.114754098361,1086.56102003643,455.664845173042,299.28233151184,1062.55009107468,130.262295081967,549,28.9988655101701,24.2973643208109,0.54586532993437,0.963157894736842,0.726190476190476,0.931820208927405,52707.8925318761,32446.2349726776,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_375677,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
375721,2166.9696969697,504.203463203463,137.926406926407,691.0,3984.53246753247,3969.09523809524,484.580086580087,266.099567099567,1124.62337662338,3296.53246753247,556.264069264069,132.666666666667,1072.8354978355,1137.04761904762,596.372294372294,686.311688311688,2294.01298701299,1006.11688311688,251.155844155844,221.770562770563,1017.28571428571,962.969696969697,194.025974025974,199.640692640693,623.056277056277,1056.70995670996,485.922077922078,266.268398268398,1065.39826839827,130.52380952381,231,21.0719639283493,13.9833030515077,0.748089786377071,0.950617283950617,0.675438596491228,0.930277427980303,52804.8744588745,33730.3463203463,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_375721,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
375822,4876.38235294118,170.546218487395,115.079831932773,664.105042016807,2632.86554621849,2934.33613445378,404.373949579832,256.68487394958,1110.80672268908,7725.63025210084,653.063025210084,145.739495798319,1081.18907563025,1405.13025210084,838.121848739496,947.382352941176,2375.63445378151,1665.01260504202,306.819327731092,232.365546218487,1058.6512605042,1358.09243697479,230.096638655462,283.949579831933,1233.6512605042,2703.91176470588,538.382352941176,294.399159663866,1066.74369747899,129.810924369748,238,21.444646882777,14.1572876527823,0.751109039314722,0.955823293172691,0.80952380952381,1.49215320903814,53020.731092437,33887.2226890756,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_375822,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
376717,1352.13265306122,272.229591836735,120.363945578231,666.991496598639,3354.07482993197,819.013605442177,507.464285714286,300.68537414966,1151.29761904762,1787.94217687075,1924.43197278912,163.874149659864,1072.31972789116,1075.7806122449,593.583333333333,286.537414965986,1583.55102040816,1033.06972789116,209.068027210884,213.767006802721,1219.06292517007,661.232993197279,143.610544217687,98.0374149659864,583.913265306122,844.984693877551,442.363945578231,214.875850340136,1037.47789115646,130.093537414966,588,31.7442995419703,23.678477792745,0.666043668412787,0.963934426229508,0.765625,-1.3993757047684,52796.675170068,32166.3962585034,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_376717,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
376820,1986.44558521561,196.359342915811,92.0862422997947,643.854209445585,1382.12936344969,272.195071868583,276.755646817248,255.281314168378,1079.20944558522,2718.50718685832,580.232032854209,126.975359342916,1076.71047227926,622.188911704312,432.958932238193,264.521560574949,1365.01642710472,1050.10472279261,287.055441478439,222.028747433265,977.049281314168,1018.24024640657,211.006160164271,122.2340862423,596.156057494867,887.533880903491,490.798767967146,225.737166324435,1017.08213552361,130.728952772074,487,30.4698202453363,20.3878823588243,0.743156850544215,0.972055888223553,0.785483870967742,1.53901004615158,53157.9178644764,32595.8685831622,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_376820,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
377000,3016.57174887892,461.704035874439,179.307174887892,675.77130044843,3453.80941704036,2723.27578475336,428.381165919283,268.748878923767,1092.85201793722,5489.11434977578,564.459641255605,132.679372197309,1074.08744394619,1987.45067264574,601.818385650224,298.082959641256,1632.0,2242.67713004484,316.282511210762,227.773542600897,1046.39013452915,1914.74887892377,220.006726457399,200.847533632287,639.533632286995,1378.52914798206,453.840807174888,222.739910313901,1021.96188340807,130.334080717489,446,31.4846850060122,18.102674606057,0.818176159873106,0.950959488272921,0.675757575757576,-0.416729748558924,52882.365470852,32897.4932735426,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,1,FAAGSCC_12_377000,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
377210,4574.81684981685,214.575091575092,79.4615384615385,635.465201465202,1147.47985347985,492.571428571429,332.857142857143,251.545787545788,1096.42124542125,7142.18315018315,557.846153846154,144.582417582418,1095.0989010989,2467.17582417582,646.238095238095,416.135531135531,3002.39926739927,3585.85347985348,337.952380952381,235.040293040293,1026.73992673993,4951.67032967033,244.014652014652,393.626373626374,713.468864468864,1841.03296703297,520.794871794872,243.586080586081,1062.48351648352,131.285714285714,273,25.4268989212147,13.6709181477029,0.843164459385107,0.968085106382979,0.758333333333333,-1.26800201708991,52891.5274725275,33845.8205128205,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_377210,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
378010,1505.39419087137,249.96265560166,278.560165975104,741.219917012448,8637.87136929461,690.485477178423,451.49377593361,275.53112033195,1148.81742738589,3133.72614107884,623.406639004149,134.601659751037,1068.85062240664,851.211618257261,487.767634854772,273.385892116183,1500.61410788382,1006.07883817427,197.087136929461,208.228215767635,1134.73443983402,1087.74273858921,151.867219917012,112.580912863071,1248.51037344398,863.585062240664,429.717842323651,244.605809128631,1042.34854771784,130.095435684647,241,31.3803332279342,9.81806315906086,0.949794926758908,0.934108527131783,0.77741935483871,1.56061233990687,53745.2033195021,32715.1784232365,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_378010,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
378321,2538.54401805869,138.406320541761,87.1602708803612,646.081264108352,2352.91422121896,1023.84424379233,986.139954853273,249.257336343115,1094.51015801354,4813.88036117381,544.284424379233,118.232505643341,1086.56433408578,3008.97291196388,785.604966139955,735.397291196388,2069.07900677201,4464.12641083521,414.216704288939,252.252821670429,1056.04288939052,3589.86004514673,281.230248306998,238.97065462754,592.309255079007,2259.25282167043,524.128668171558,248.505643340858,1055.769751693,130.011286681716,443,30.1522304109932,18.8103305374101,0.78154776223842,0.958874458874459,0.803992740471869,-1.47359234969861,53650.8532731377,33495.8126410835,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_378321,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
378505,2616.45679012346,222.212962962963,85.1635802469136,634.530864197531,1411.37345679012,580.611111111111,405.425925925926,275.302469135802,1138.71913580247,4435.50925925926,795.854938271605,127.546296296296,1085.49382716049,979.333333333333,585.478395061728,283.75,1678.37037037037,1053.86419753086,225.092592592592,214.021604938272,1128.31790123457,633.277777777778,140.367283950617,104.601851851852,2150.54938271605,1080.37037037037,437.33024691358,231.274691358025,1038.62962962963,130.203703703704,324,24.5996784345076,16.837098598069,0.729065578135111,0.958579881656805,0.736363636363636,0.637866610412673,52873.6635802469,32276.3580246914,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_378505,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
378621,3856.08580858086,477.280528052805,241.874587458746,740.798679867987,6656.11221122112,3475.75577557756,2858.85808580858,263.465346534653,1120.72937293729,5566.3498349835,697.455445544554,128.940594059406,1085.59735973597,2094.55775577558,710.759075907591,691.83498349835,2940.9702970297,1394.46204620462,297.224422442244,222.831683168317,1010.78547854785,1238.04290429043,206.478547854785,214.372937293729,642.914191419142,1122.42574257426,469.29702970297,254.488448844884,1055.25082508251,132.389438943894,303,21.2819919417135,18.2491168504855,0.514498941566773,0.95583596214511,0.759398496240602,0.128501456571612,53511.0561056106,33063.3201320132,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_378621,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
378810,2886.22047244094,322.925196850394,133.929133858268,638.452755905512,2128.35433070866,317.870078740157,313.393700787402,250.377952755906,1087.22834645669,5189.3031496063,528.03937007874,120.866141732283,1141.66141732283,2263.32283464567,515.669291338583,296.625984251969,2714.00393700787,1791.51968503937,266.086614173228,219.968503937008,992.704724409449,1674.69291338583,187.212598425197,126.972440944882,603.94094488189,2018.05511811024,501.818897637795,229.027559055118,1040.64566929134,128.704724409449,254,31.0533533646053,10.4581983239127,0.94158278847842,0.944237918215613,0.744868035190616,-1.4286232721963,53408.2086614173,32824.3149606299,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_378810,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
379374,3578.81595092025,494.128834355828,108.766871165644,663.435582822086,2385.41104294479,1603.20245398773,1059.08282208589,245.889570552147,1187.1963190184,5499.43865030675,1506.86503067485,135.935582822086,1076.08282208589,1414.37116564417,634.0,905.665644171779,2106.6226993865,1415.96932515337,273.696319018405,226.687116564417,1027.28527607362,1418.18098159509,207.368098159509,383.766871165644,629.076687116564,1528.65030674847,503.641104294479,503.889570552147,1063.26687116564,130.444785276074,326,24.729716713601,16.8206582350531,0.733045151379228,0.96165191740413,0.705627705627706,0.684797756692181,53450.9141104294,33733.6901840491,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_379374,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
379483,2443.70945945946,428.02027027027,138.891891891892,665.804054054054,2912.91554054054,1948.25675675676,311.246621621622,260.851351351351,1092.39189189189,4629.45945945946,4754.9527027027,130.635135135135,1066.87837837838,2507.72972972973,683.327702702703,453.983108108108,1990.47297297297,1774.42567567568,343.081081081081,227.631756756757,1052.09121621622,1099.16216216216,205.591216216216,521.581081081081,707.601351351351,1729.69932432432,468.52027027027,402.246621621622,1062.38513513514,128.496621621622,296,26.5366191620707,14.3121426447934,0.842090934514775,0.942675159235669,0.657777777777778,1.11296329200034,52772.0304054054,32279.3614864865,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_379483,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
379584,2024.55056179775,350.022471910112,116.710112359551,636.256179775281,2093.52134831461,279.719101123596,312.474157303371,259.157303370787,1084.40898876405,3150.1595505618,977.624719101124,120.229213483146,1074.6202247191,657.341573033708,493.516853932584,270.808988764045,1366.6202247191,979.669662921348,288.040449438202,222.815730337079,973.611235955056,901.752808988764,213.247191011236,115.957303370787,592.966292134831,1189.61123595506,497.701123595506,326.132584269663,1063.34831460674,131.523595505618,445,31.5021532977036,18.5938072077936,0.807228364564219,0.930962343096234,0.613793103448276,-1.05492013000147,54065.6426966292,32477.2112359551,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_379584,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
379677,1945.461352657,246.673913043478,93.3695652173913,643.871980676328,1060.34299516908,1302.46859903382,2364.42753623188,249.949275362319,1087.06280193237,3643.67391304348,625.021739130435,112.188405797101,1078.45652173913,1241.91787439614,1074.64009661836,906.434782608696,4368.61352657005,2199.82125603865,343.594202898551,238.857487922705,1034.20289855072,2039.37198067633,233.091787439614,289.42270531401,602.067632850242,1368.09178743961,456.874396135266,629.683574879227,1052.70048309179,130.859903381643,414,30.4359598437998,17.3823953805055,0.820870925500605,0.967289719626168,0.692307692307692,0.685926590119984,52744.6956521739,33686.1135265701,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_379677,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
380174,1308.93092105263,393.542763157895,262.273026315789,697.944078947368,5796.29934210526,2049.42763157895,2194.25,259.180921052632,1090.97697368421,1251.70723684211,493.355263157895,125.875,1068.38157894737,1659.48684210526,701.792763157895,589.907894736842,1508.57236842105,1343.30592105263,305.953947368421,224.41447368421,1019.67105263158,1268.35855263158,209.394736842105,674.611842105263,714.0625,740.223684210526,444.0625,216.832236842105,1002.54934210526,127.177631578947,304,22.5304715391524,17.2673969564844,0.64236132815176,0.944099378881988,0.703703703703704,1.56935150091865,53032.4375,32933.6710526316,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_380174,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
381076,3798.83886255924,700.895734597156,401.729857819905,627.912322274881,1034.5308056872,2464.31990521327,518.109004739336,252.009478672986,1116.55924170616,5948.39336492891,885.516587677725,124.374407582938,2386.163507109,1556.08056872038,708.21327014218,1061.06161137441,2464.36966824645,1996.80568720379,354.907582938389,239.817535545024,1044.52369668246,1717.09478672986,246.571090047393,561.850710900474,725.490521327014,1057.18246445498,465.841232227488,326.609004739337,1036.76303317536,131.229857819905,422,27.9420784026958,19.3535512598702,0.721292049596309,0.970114942528736,0.732638888888889,0.777575531464159,53351.2962085308,33664.8151658768,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX+,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_381076,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
381511,3282.60434782609,300.791304347826,71.4173913043478,613.021739130435,1197.25652173913,573.995652173913,1251.82608695652,248.004347826087,1082.42608695652,6443.17826086956,609.517391304348,117.160869565217,1078.07826086957,1279.85652173913,520.45652173913,499.94347826087,1556.81304347826,3161.18695652174,312.460869565217,227.7,1022.27826086957,2429.82173913043,211.947826086956,503.417391304348,714.086956521739,1233.14782608696,449.05652173913,238.765217391304,1030.63913043478,129.595652173913,230,20.2762959289376,14.5217023287568,0.69790424376566,0.954356846473029,0.766666666666667,-0.271582370369588,54077.3260869565,32659.8652173913,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_381511,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
382750,5054.10561797753,392.880898876405,497.615730337079,695.197752808989,4145.27865168539,934.197752808989,293.247191011236,244.208988764045,1092.46292134831,7993.44719101124,601.975280898876,137.975280898876,8528.05842696629,940.179775280899,533.067415730337,276.649438202247,1528.17303370787,1808.13707865168,307.280898876404,230.238202247191,1026.72584269663,1758.13707865169,237.829213483146,265.878651685393,1279.62921348315,2023.75280898876,512.842696629213,411.896629213483,1070.19101123596,130.375280898876,445,27.5281250888028,20.7504596127422,0.657113964864716,0.963203463203463,0.773913043478261,0.97153009729266,53976.8224719101,33434.6921348315,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX+,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_382750,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
383019,2970.25668449198,173.310160427807,94.2459893048128,628.657754010695,1082.53475935829,289.032085561497,318.588235294118,248.256684491979,1084.7807486631,5362.04278074866,562.812834224599,121.577540106952,1072.91443850267,629.727272727273,450.983957219251,474.406417112299,1578.35294117647,942.935828877005,231.016042780749,214.267379679144,1007.93582887701,869.401069518717,182.294117647059,168.310160427807,600.010695187166,1713.41176470588,539.24064171123,244.411764705882,1042.35828877005,129.641711229947,187,17.6539181227515,13.5520098390292,0.640870698583573,0.963917525773196,0.785714285714286,-1.11457105520934,54031.5561497326,33291.2085561497,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_383019,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
383789,3955.03249097473,1036.23465703971,606.404332129964,623.129963898917,1009.25992779783,443.436823104693,727.068592057762,247.227436823105,1082.63898916968,7470.3285198556,588.220216606498,119.256317689531,1071.64981949458,686.783393501805,439.624548736462,364.570397111913,1391.07942238267,1302.72924187726,258.379061371841,217.750902527076,996.56678700361,1225.59927797834,187.559566787004,699.790613718412,659.303249097473,2203.88086642599,515.039711191336,272.664259927798,1048.1155234657,128.942238267148,277,23.3116103237157,15.1560848341387,0.759804362475969,0.955172413793104,0.732804232804233,-0.522879388199519,53906.4151624549,32812.0685920578,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_383789,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
385276,2953.80204778157,633.590443686007,132.477815699659,646.587030716724,2355.38907849829,1751.21501706485,1785.42320819113,258.320819112628,1093.41296928328,3787.60068259386,515.511945392491,118.310580204778,1077.33447098976,1047.87372013652,498.976109215017,300.737201365188,1515.15358361775,2365.01365187713,297.726962457338,227.853242320819,1004.46075085324,2453.05119453925,227.098976109215,143.610921501706,580.764505119454,870.245733788396,483.402730375427,225.938566552901,1013.55972696246,129.170648464164,293,21.3479801181884,17.5966110579959,0.56618933040975,0.966996699669967,0.775132275132275,-0.35495918041354,53984.8395904437,33311.1092150171,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_385276,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
385479,2964.51965065502,220.698689956332,76.0043668122271,635.414847161572,1458.70742358079,307.947598253275,793.794759825328,247.393013100437,1073.72489082969,5334.44978165939,539.401746724891,119.008733624454,1077.01310043668,794.877729257642,519.615720524017,280.628820960699,1459.57205240175,1561.19213973799,290.248908296943,219.956331877729,993.096069868996,1708.68122270742,207.755458515284,551.227074235808,637.882096069869,1744.50655021834,515.882096069869,236.46288209607,1048.16593886463,129.052401746725,229,22.5701974536481,13.1120110640969,0.813943836832178,0.950207468879668,0.636111111111111,0.650400338312322,53930.2227074236,32864.0655021834,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_385479,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
386120,1545.08,259.592,111.372,612.524,1127.12,904.896,386.848,255.14,1095.644,2258.236,498.304,114.228,1072.492,1404.616,534.688,281.908,1809.492,1519.38,254.052,216.48,1049.24,924.548,159.832,122.26,801.812,952.524,466.856,226.652,1024.88,128.832,250,21.0103412823684,15.4536869127857,0.677494707454856,0.961538461538462,0.833333333333333,-1.50262754491958,53690.652,32810.596,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_386120,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
386255,3394.99619771863,439.87072243346,99.5817490494297,638.657794676806,1628.46768060837,284.281368821293,253.338403041825,248.874524714829,1093.68441064639,5010.2433460076,1170.53992395437,123.098859315589,1073.31558935361,603.718631178707,361.593155893536,260.060836501901,1424.10266159696,795.410646387833,179.916349809886,202.988593155894,1081.97338403042,606.665399239544,128.787072243346,101.281368821293,591.901140684411,1223.55893536122,472.874524714829,397.726235741445,1065.54372623574,131.984790874525,263,27.4402544413698,12.3769594361017,0.892498080367574,0.942652329749104,0.6575,1.17409271412233,53812.6007604563,32234.8136882129,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_386255,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
388311,4722.3868852459,1127.20983606557,1027.33114754098,677.003278688525,3360.15737704918,3467.68524590164,443.724590163934,258.239344262295,1122.23278688525,6508.56065573771,1051.03606557377,130.652459016393,1080.99016393443,3607.82295081967,1415.69836065574,2530.73770491803,2657.80983606557,4471.82950819672,359.688524590164,236.590163934426,1061.55081967213,4247.72786885246,309.186885245902,355.87868852459,847.688524590164,1093.50163934426,464.718032786885,349.872131147541,1047.71147540984,130.898360655738,305,22.0545384352881,17.7734508555529,0.592070296974236,0.950155763239875,0.726190476190476,0.634183796958314,53044.5672131148,33415.8590163934,FAAGSCC_12,AG,1,regulatory T cells,,TIM3+,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_388311,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
389227,1867.5487804878,394.536585365854,128.725609756098,642.213414634146,1892.1737804878,292.30487804878,372.606707317073,257.618902439024,1080.11585365854,2193.90243902439,903.625,124.57012195122,1074.07926829268,693.140243902439,464.628048780488,274.073170731707,1411.01829268293,973.307926829268,274.734756097561,223.237804878049,980.021341463415,885.265243902439,204.265243902439,123.615853658537,588.167682926829,818.576219512195,457.076219512195,229.399390243902,1008.78048780488,128.990853658537,328,29.2413663069072,14.553013646729,0.867357374497817,0.956268221574344,0.732142857142857,-1.35060727126736,52787.8841463415,32680.5609756098,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_389227,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
389856,1804.60454545454,239.172727272727,108.590909090909,657.131818181818,2246.42727272727,481.55,382.909090909091,248.936363636364,1078.2,3646.36818181818,2437.31818181818,132.672727272727,1075.01363636364,886.695454545455,520.763636363636,298.372727272727,1678.29545454545,1283.67272727273,324.077272727273,231.595454545454,1000.72272727273,1247.79090909091,234.786363636364,191.559090909091,606.013636363636,1807.68636363636,500.013636363636,743.090909090909,1076.57272727273,131.054545454545,220,17.584876829335,16.0124396204824,0.413332562289151,0.960698689956332,0.808823529411765,1.29333563745132,53092.2909090909,33918.4318181818,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_389856,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
389864,2218.2784184514,329.41845140033,120.069192751236,652.728171334432,2108.99835255354,666.176276771005,437.986820428336,284.553542009885,1140.73146622735,3947.17133443163,1276.2784184514,139.31136738056,1067.17133443163,1141.98682042834,664.257001647446,294.026359143328,1606.62108731466,1048.79406919275,211.105436573311,212.973640856672,1197.50247116969,605.398682042834,133.70510708402,100.621087314662,590.207578253707,1110.28665568369,437.752883031302,272.153212520593,1042.70675453048,130.026359143328,607,33.7711179702041,22.9836630608324,0.732681599805509,0.97275641025641,0.722619047619048,0.865912537551518,52812.9176276771,32211.9835255354,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_389864,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
390275,3016.43728813559,218.857627118644,109.983050847458,645.003389830508,1997.95254237288,1341.51525423729,359.623728813559,246.691525423729,1099.32542372881,5578.50169491525,529.416949152542,120.803389830508,1081.78983050847,1627.36271186441,687.742372881356,312.11186440678,2043.51525423729,3351.83389830508,437.016949152542,235.518644067797,1174.90847457627,2877.76949152542,229.447457627119,218.786440677966,585.305084745763,1820.1593220339,498.613559322034,320.28813559322,1057.42711864407,129.952542372881,295,22.0980979539844,17.1554133273193,0.630326856410455,0.942492012779553,0.739348370927318,-1.15465768711693,52988.6271186441,33414.9762711864,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_390275,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
390616,3778.16714697406,362.371757925072,96.6340057636888,625.896253602305,1048.48703170029,393.291066282421,724.951008645533,247.971181556196,1085.55619596542,6208.27377521614,583.348703170029,140.461095100865,1080.97694524496,1481.55619596542,1083.1469740634,1074.85590778098,1931.734870317,1708.67723342939,373.446685878963,241.351585014409,1013.2507204611,1603.37463976945,266.789625360231,267.691642651297,650.35446685879,3191.04034582132,600.164265129683,326.345821325648,1085.94812680115,131.089337175793,347,23.7704318781928,18.7022582792533,0.617225064119277,0.950684931506849,0.751082251082251,0.804969259213119,53123.5648414986,33752.9365994236,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_390616,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
390864,1969.22478991597,395.665966386555,107.550420168067,651.525210084034,2334.76260504202,349.783613445378,418.77731092437,253.518907563025,1078.27941176471,3804.18697478992,535.094537815126,122.079831932773,1095.6281512605,691.636554621849,446.756302521008,282.172268907563,1419.93697478992,1013.34453781513,278.197478991597,227.390756302521,982.241596638655,938.308823529412,206.939075630252,133.997899159664,578.243697478992,1076.48739495798,458.674369747899,236.960084033613,1038.71638655462,130.636554621849,476,33.8180501470405,18.6621504334864,0.83395005330615,0.942574257425742,0.631299734748011,0.865985993435112,52968.2037815126,33309.8865546219,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_390864,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
391069,2753.97442455243,116.736572890026,72.9360613810742,642.191815856777,1792.39641943734,401.416879795396,284.363171355499,250.242966751918,1078.41432225064,5119.07928388747,614.332480818414,120.184143222506,1090.5652173913,1130.17647058824,579.780051150895,284.058823529412,1593.73145780051,1264.68030690537,336.352941176471,235.618925831202,1009.96163682864,1127.59335038363,239.245524296675,174.902813299233,587.542199488491,1555.86445012788,460.923273657289,239.227621483376,1047.37084398977,130.764705882353,391,30.1832484933903,16.6021649255868,0.835134581214772,0.963054187192118,0.793103448275862,1.35269349915861,52506.0664961637,33221.1841432225,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_391069,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
391890,2187.7797752809,257.044943820225,145.72808988764,677.078651685393,3435.77078651685,3978.20674157303,644.379775280899,270.044943820225,1118.84719101124,3543.45168539326,528.943820224719,122.858426966292,1075.54382022472,2195.61123595506,775.388764044944,343.303370786517,5739.7595505618,2127.1393258427,368.415730337079,242.150561797753,1025.22921348315,2067.39101123595,242.775280898876,191.492134831461,610.065168539326,1060.96404494382,455.622471910112,260.660674157303,1056.2606741573,131.530337078652,445,35.8826423615496,16.1188601080903,0.893425943705761,0.946808510638298,0.549382716049383,0.86275908517904,52931.191011236,33682.2426966292,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,9,FAAGSCC_12_391890,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
392004,3833.89679715303,368.686832740214,87.3807829181495,635.188612099644,1105.86476868327,3771.96085409253,4304.94306049822,279.416370106762,1132.72953736655,5334.89679715302,680.330960854092,136.903914590747,1078.90391459075,3388.02846975089,829.975088967971,903.046263345196,1910.51245551601,1668.49822064057,352.167259786477,242.113879003559,1010.0462633452,1357.9359430605,252.316725978648,922.925266903915,694.519572953737,1382.23487544484,488.672597864769,339.975088967972,1050.40213523132,128.120996441281,281,20.7274034511956,17.3666677597957,0.545884763857059,0.959044368600682,0.743386243386243,0.242553955452456,53365.0711743772,33868.1387900356,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_392004,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
392807,3828.95441595442,747.564102564103,88.8148148148148,636.60113960114,1966.61538461538,309.732193732194,355.897435897436,244.871794871795,1077.64387464387,6428.39031339031,560.689458689459,120.80056980057,1079.11111111111,800.321937321937,461.37037037037,277.433048433048,1403.8547008547,1268.1452991453,321.965811965812,226.421652421652,982.652421652422,1198.19373219373,240.019943019943,130.809116809117,585.068376068376,1533.17948717949,489.954415954416,232.817663817664,1037.63532763533,129.45584045584,351,26.5395570523524,16.8438819454949,0.772782617390789,0.972299168975069,0.726708074534162,-0.870088499917553,53059.1452991453,33339.0740740741,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_392807,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
393235,2716.45974576271,1211.5593220339,159.228813559322,646.610169491525,2353.46186440678,274.796610169492,314.807203389831,255.169491525424,1077.94915254237,4055.9343220339,602.080508474576,131.78813559322,1079.41313559322,575.364406779661,418.523305084746,268.302966101695,1434.12076271186,909.879237288136,254.78813559322,222.896186440678,982.050847457627,822.205508474576,184.190677966102,138.358050847458,584.406779661017,1192.60381355932,503.175847457627,223.349576271186,1035.48516949153,129.60593220339,472,28.1597469990278,21.4118884693675,0.649487593480962,0.963265306122449,0.766233766233766,1.25328222222412,52608.7118644068,33245.4470338983,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_393235,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
393247,5565.74132492114,1395.59621451104,1758.55835962145,656.564668769716,1917.45110410095,350.971608832808,967.668769716088,243.747634069401,1084.78233438486,8406.32807570978,755.760252365931,135.703470031546,1091.17034700315,1073.62776025237,863.466876971609,397.741324921136,2749.69716088328,1448.58044164038,308.621451104101,232.91167192429,999.958990536278,1217.42902208202,228.883280757098,139.82334384858,627.261829652997,1499.3596214511,540.485804416404,266.078864353312,1055.92113564669,132.990536277603,317,24.45317857351,16.5683267740957,0.735473865124177,0.966463414634146,0.776960784313726,1.3725756218253,53335.2996845426,33346.4921135647,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_393247,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
393278,3422.88888888889,562.222222222222,124.317829457364,623.015503875969,1436.80361757106,305.625322997416,315.320413436692,259.40826873385,1082.96124031008,6950.66408268734,1401.7519379845,120.630490956072,1075.82170542636,697.516795865633,515.638242894057,277.537467700258,1380.3669250646,1006.53488372093,300.578811369509,232.449612403101,982.049095607235,957.449612403101,228.046511627907,122.739018087855,588.927648578811,2533.82687338501,529.511627906977,364.328165374677,1086.2015503876,130.94315245478,387,28.2913574355678,17.6329516387756,0.782012428685481,0.957920792079208,0.727443609022556,1.41912962360275,54070.8914728682,32523.338501292,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_393278,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
393824,3254.01778656126,587.146245059289,114.430830039526,636.652173913043,1617.76877470356,250.138339920949,291.699604743083,243.278656126482,1078.47628458498,4404.11660079051,1012.895256917,126.347826086957,1091.5395256917,642.341897233202,448.729249011858,272.640316205534,1414.22529644269,1023.7766798419,264.316205533597,220.304347826087,1006.45256916996,948.889328063241,203.760869565217,194.966403162055,627.561264822134,948.405138339921,443.646245059289,431.832015810277,1046.67786561265,130.867588932806,506,31.7573522452844,20.3664656645212,0.767277719388369,0.969348659003831,0.793103448275862,-1.17281932876509,53142.233201581,32839.7826086957,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_393824,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
393894,3231.1,462.315625,101.878125,631.196875,1165.809375,1460.428125,1390.64375,251.71875,1091.43125,4906.984375,1266.571875,117.1625,1076.7375,3921.228125,866.478125,695.65625,1880.53125,6263.1875,408.371875,240.909375,1034.628125,4940.0625,259.90625,840.540625,607.05,1328.16875,479.715625,391.965625,1053.284375,129.45625,320,25.6096561454069,16.2044663862782,0.774357533062603,0.952380952380952,0.711111111111111,-1.20825469186947,53449.796875,33615.24375,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_393894,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
394287,2572.56034482759,381.564655172414,169.913793103448,666.883620689655,3333.25862068966,260.155172413793,320.056034482759,243.926724137931,1075.45689655172,4975.61637931035,567.0,121.948275862069,1076.37931034483,597.353448275862,382.073275862069,329.435344827586,1404.59913793103,944.461206896552,221.362068965517,212.530172413793,984.047413793104,937.560344827586,169.663793103448,180.331896551724,636.353448275862,2187.6724137931,556.784482758621,238.987068965517,1081.85344827586,131.797413793103,232,23.2588825189218,13.110536055835,0.825994160108573,0.950819672131148,0.659090909090909,1.05256948581002,53734.8534482759,32861.2025862069,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_394287,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
395243,4576.71739130435,337.710144927536,251.86231884058,681.731884057971,3926.61956521739,5290.04347826087,510.184782608696,271.949275362319,1150.39130434783,7745.10869565217,752.275362318841,129.576086956522,1104.3768115942,2016.30072463768,768.56884057971,304.304347826087,3350.33695652174,1645.38405797101,333.728260869565,235.898550724638,1010.16666666667,1135.3768115942,235.097826086957,142.094202898551,584.692028985507,2866.73913043478,558.402173913043,324.757246376812,1067.72101449275,131.217391304348,276,20.6052168691104,17.1315726151454,0.555645695464355,0.955017301038062,0.726315789473684,0.810840496605977,53347.5253623188,33410.1231884058,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_395243,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
395657,2395.99574468085,200.914893617021,78.8851063829787,685.578723404255,3760.96595744681,2275.05957446808,3751.55319148936,256.787234042553,1128.62127659574,3850.63829787234,2257.00425531915,134.340425531915,1076.65106382979,3497.82978723404,1191.6085106383,1580.72340425532,2473.85106382979,2788.33617021277,387.812765957447,250.076595744681,1045.44680851064,2205.91489361702,258.182978723404,522.242553191489,755.229787234043,1435.74468085106,509.906382978723,512.855319148936,1084.23829787234,129.782978723404,235,24.5499735461917,12.3003797548498,0.865427404053679,0.932539682539683,0.588972431077694,-0.74108204260695,53037.3872340426,33716.0765957447,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_395657,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
395909,2716.62803738318,955.405607476636,1185.70654205607,656.727102803738,2986.32523364486,284.893457943925,292.594392523364,248.426168224299,1085.30841121495,4335.36635514019,634.700934579439,124.502803738318,1079.21308411215,638.054205607477,474.123364485981,276.222429906542,1415.23925233645,984.841121495327,272.284112149533,224.25046728972,990.4,938.042990654206,212.175700934579,145.624299065421,588.891588785047,1416.64672897196,545.491588785047,274.461682242991,1050.24112149533,131.123364485981,535,34.6760686444746,20.1298095546377,0.814253016146801,0.945229681978799,0.67550505050505,-0.440407185794338,53098.2336448598,33284.9738317757,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_395909,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
396200,3740.46723646724,200.97150997151,97.5156695156695,626.908831908832,1241.1452991453,525.293447293447,336.074074074074,244.378917378917,1124.150997151,6486.4188034188,802.925925925926,125.356125356125,1093.51282051282,962.612535612536,426.809116809117,282.934472934473,1797.20227920228,1739.9943019943,246.5698005698,224.709401709402,1013.62678062678,2003.37606837607,199.675213675214,315.994301994302,2121.45299145299,2469.08547008547,519.7150997151,302.470085470085,1079.43304843305,130.245014245014,351,24.0676803455646,18.6472313938688,0.63222716344938,0.964285714285714,0.75974025974026,0.934887679753857,52892.0797720798,33542.1794871795,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,9,FAAGSCC_12_396200,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
396231,2683.20962199313,326.862542955326,125.171821305842,686.900343642612,3883.65635738832,3341.15807560137,1835.51546391753,260.151202749141,1125.18556701031,4390.97594501718,1294.12714776632,127.762886597938,1081.86597938144,6439.39518900344,893.783505154639,753.676975945017,1991.18556701031,5546.29553264605,422.563573883161,240.962199312715,1051.27491408935,3553.74570446735,244.731958762887,245.656357388316,612.264604810997,1352.11340206186,490.147766323024,318.13058419244,1060.07216494845,129.525773195876,291,24.0703222522727,15.4396568833567,0.767173573925642,0.976510067114094,0.808333333333333,-1.52094678346941,53762.8350515464,33740.2989690722,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_396231,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
396593,1428.30960854093,767.487544483986,94.6868327402135,619.024911032029,1105.27758007117,455.597864768683,540.0,256.875444839858,1082.58362989324,1839.50533807829,505.35231316726,112.256227758007,1071.74021352313,1045.42704626335,573.786476868327,280.231316725979,1531.20996441281,1944.92526690391,331.943060498221,237.455516014235,1022.99644128114,1632.90035587189,240.135231316726,157.274021352313,585.508896797153,880.686832740214,485.348754448399,234.213523131673,1009.98576512456,130.217081850534,281,22.3067662544156,16.5543416792808,0.670264841343848,0.936666666666667,0.678743961352657,-1.25204666566924,53842.5551601424,33299.7651245552,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_396593,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
396712,3177.03755868545,733.117370892019,113.934272300469,644.478873239437,1626.26291079812,1549.99530516432,365.323943661972,248.596244131455,1094.83098591549,5446.61502347418,2721.82629107981,125.591549295775,1076.61502347418,3147.70892018779,1239.20187793427,1531.98122065728,6237.09389671362,5393.70422535211,416.366197183099,251.769953051643,1080.11737089202,5869.3896713615,274.93427230047,385.305164319249,779.422535211268,2679.53990610329,555.87323943662,435.774647887324,1077.01877934272,130.408450704225,213,19.4392177907503,14.1580129072647,0.685234883051868,0.922077922077922,0.696078431372549,-0.617559205000164,53089.0845070423,33679.1737089202,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_396712,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
397159,3696.7987804878,730.341463414634,117.69512195122,648.707317073171,1723.37804878049,651.182926829268,1323.92987804878,262.356707317073,1088.41463414634,5086.2987804878,2317.625,131.265243902439,1084.13109756098,980.926829268293,714.454268292683,363.384146341463,1808.18597560976,1335.75609756098,303.469512195122,227.435975609756,1065.58231707317,1082.2987804878,204.80487804878,556.704268292683,4904.38109756098,1097.21036585366,448.615853658537,458.606707317073,1084.75914634146,133.161585365854,328,22.8290977517039,18.3305719691568,0.596049461345224,0.95906432748538,0.745454545454545,-0.872044752052747,52480.5457317073,32602.862804878,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_397159,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
397221,2830.50092421442,206.395563770795,103.86876155268,698.820702402958,865.243992606285,308.687615526802,331.571164510166,271.046210720887,1092.96672828096,3998.7134935305,779.767097966728,132.589648798521,1077.55637707948,650.639556377079,649.920517560074,272.271719038817,1560.68022181146,906.293900184843,283.0,222.110905730129,982.632162661738,920.232902033272,237.417744916821,137.199630314233,584.460258780037,1338.11275415896,491.994454713494,222.460258780037,1073.80591497227,131.887245841035,541,33.1249828017242,21.1298062452631,0.770134715308172,0.95079086115993,0.67625,-1.16486890322609,53153.2846580407,31936.6820702403,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_397221,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
397308,3169.24905660377,99.6452830188679,89.9735849056604,661.509433962264,2969.19622641509,1858.48301886792,539.166037735849,249.818867924528,1092.6679245283,5078.91698113208,494.618867924528,132.97358490566,1129.93962264151,2874.12075471698,884.807547169811,563.384905660377,3062.98490566038,2075.01886792453,325.120754716981,232.905660377358,1066.81132075472,1534.97358490566,215.558490566038,185.935849056604,623.230188679245,1816.08301886792,490.369811320755,239.135849056604,1063.62264150943,130.562264150943,265,26.5440254771691,12.8175487753321,0.875687162226484,0.936395759717314,0.649509803921569,1.12547176583309,52901.7811320755,33732.3396226415,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,9,FAAGSCC_12_397308,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
397344,2613.38888888889,211.5,117.038194444444,647.715277777778,2394.66319444444,602.732638888889,387.104166666667,243.833333333333,1079.47569444444,4901.96527777778,524.548611111111,121.298611111111,1070.875,1662.70833333333,579.756944444444,376.385416666667,1563.01736111111,1270.32291666667,264.079861111111,220.041666666667,1002.60416666667,1059.18055555556,194.364583333333,230.930555555556,608.131944444444,1401.70486111111,463.638888888889,254.121527777778,1020.67013888889,130.579861111111,288,21.6218712641222,17.0452513484417,0.615247805910335,0.976271186440678,0.80672268907563,0.237175542232579,52848.6493055556,32863.6284722222,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,1,FAAGSCC_12_397344,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
398517,1552.13141025641,307.326923076923,123.402243589744,623.519230769231,1450.89583333333,290.857371794872,356.171474358974,258.435897435897,1082.08173076923,1666.34775641026,551.828525641026,116.5625,1070.51442307692,657.791666666667,460.498397435898,279.641025641026,1434.96474358974,1108.08333333333,265.266025641026,218.748397435897,991.022435897436,1064.39423076923,202.402243589744,345.011217948718,648.296474358974,769.80608974359,415.873397435898,213.623397435897,1010.62179487179,129.309294871795,624,32.6844620288084,24.377980542136,0.666104532093686,0.967441860465116,0.77037037037037,0.523872391415623,53680.0416666667,32286.8076923077,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_398517,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
398907,2350.07960199005,394.248756218905,1119.41293532338,632.278606965174,1490.46766169154,1177.1592039801,687.412935323383,236.73631840796,1093.26865671642,3432.19900497512,649.800995024876,118.373134328358,1081.87064676617,4028.1592039801,825.452736318408,691.303482587065,1772.74626865672,5558.58208955224,394.587064676617,244.885572139303,1019.80099502488,4724.80099502488,260.666666666667,312.174129353234,601.333333333333,1071.05970149254,509.771144278607,253.796019900498,1030.25373134328,128.985074626866,201,19.1991436622666,13.5243756308241,0.709777455027411,0.943661971830986,0.738970588235294,0.785538918352143,53612.7611940299,33711.9253731343,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_398907,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
399015,2954.35483870968,167.312903225806,84.0483870967742,640.593548387097,1664.45806451613,767.274193548387,822.306451612903,250.961290322581,1078.48387096774,5032.56451612903,834.729032258065,144.338709677419,1070.08387096774,926.554838709677,712.770967741935,339.467741935484,1587.78387096774,1225.74838709677,270.490322580645,221.651612903226,1022.60322580645,1185.5935483871,197.883870967742,553.967741935484,679.777419354839,809.196774193548,407.509677419355,220.61935483871,1041.66129032258,128.893548387097,310,28.8440886895908,13.7111659270878,0.879794377374574,0.962732919254658,0.691964285714286,1.22799971299652,52875.3935483871,32376.6322580645,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_399015,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
399025,3976.20353982301,193.76401179941,111.991150442478,659.536873156342,2589.18584070796,1938.25663716814,381.648967551622,269.938053097345,1108.34808259587,6281.598820059,756.740412979351,131.799410029499,1085.94690265487,2405.25368731563,675.533923303835,323.238938053097,2013.92330383481,1673.08849557522,299.200589970501,226.873156342183,1107.87610619469,1150.41297935103,207.026548672566,520.973451327434,4383.46902654867,1484.7197640118,461.424778761062,241.120943952802,1063.96460176991,131.902654867257,339,30.4754085108812,14.3562181714187,0.882092896091838,0.946927374301676,0.637218045112782,-1.12589729012351,52447.5457227139,32578.4808259587,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_399025,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
399844,4405.20535714286,782.72619047619,613.973214285714,657.985119047619,2274.60714285714,2881.41666666667,2254.0119047619,261.529761904762,1145.72321428571,6222.22916666667,1173.47916666667,131.767857142857,1096.18452380952,5391.3125,1111.0744047619,2703.95535714286,2681.57142857143,7014.8630952381,492.116071428571,260.729166666667,1120.95833333333,5826.44047619048,307.157738095238,445.946428571429,740.092261904762,1892.01785714286,548.392857142857,333.532738095238,1077.1130952381,131.196428571429,336,23.4683251082114,18.5433561044802,0.612921259787376,0.949152542372881,0.768878718535469,-0.214578713168777,53085.755952381,33630.6220238095,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_399844,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
400313,4681.49146757679,203.119453924915,77.8805460750853,641.938566552901,1402.7337883959,511.430034129693,492.269624573379,231.191126279863,1081.59385665529,7122.67235494881,900.156996587031,127.733788395904,1097.30716723549,1311.48805460751,1167.9385665529,1824.52218430034,6000.66552901024,2281.51877133106,345.191126279863,232.805460750853,1047.59385665529,1716.8976109215,226.22866894198,445.034129692833,835.054607508532,2005.69965870307,509.798634812287,366.80204778157,1062.7747440273,130.563139931741,293,21.7303979047742,17.5265577042328,0.591171827145817,0.951298701298701,0.783422459893048,-1.56303749935896,53203.7030716724,33678.385665529,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_400313,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
400319,4464.10372340426,933.497340425532,1019.19680851064,648.234042553191,1743.07180851064,3358.52659574468,1229.84840425532,261.787234042553,1099.97074468085,7160.84308510638,1644.11170212766,124.678191489362,1072.66223404255,2015.10904255319,1631.32712765957,2549.91223404255,2297.21808510638,2145.46542553192,348.353723404255,231.542553191489,1095.31117021277,1520.46276595745,220.199468085106,270.864361702128,916.962765957447,1585.25531914894,508.614361702128,633.449468085106,1053.35638297872,132.566489361702,376,30.6201018255393,15.8094131569021,0.856402781754028,0.951898734177215,0.648275862068965,-1.11873092712306,53275.9787234043,33175.6356382979,FAAGSCC_12,AG,1,regulatory T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_400319,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
401072,3030.17837837838,481.043243243243,93.8648648648649,643.081081081081,1943.07027027027,1716.16216216216,470.789189189189,267.075675675676,1090.30810810811,5649.65945945946,512.172972972973,135.940540540541,1065.91891891892,4248.08108108108,664.372972972973,445.767567567568,2083.61621621622,2937.26486486486,402.264864864865,242.421621621622,1025.77837837838,2117.0,254.854054054054,265.167567567568,613.086486486486,2397.45405405405,533.367567567568,445.756756756757,1062.27027027027,130.432432432432,185,15.8730035764496,14.9159167554526,0.341990296606577,0.963541666666667,0.822222222222222,-0.993658208213848,53482.4486486486,33809.0216216216,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_401072,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
401284,3118.75418994413,307.13687150838,91.4469273743017,646.351955307263,1929.5530726257,906.673184357542,717.039106145251,250.142458100559,1089.72346368715,4431.52793296089,963.083798882682,136.337988826816,1089.48044692737,3991.37430167598,652.159217877095,521.882681564246,3105.69273743017,6753.04469273743,474.944134078212,248.59217877095,1058.89664804469,6498.40782122905,292.754189944134,267.606145251397,610.662011173184,1059.84636871508,473.530726256983,298.712290502793,1044.78770949721,131.379888268156,358,24.4796796541485,18.7693166069421,0.641969131899134,0.954666666666667,0.716,0.14979600706156,53156.5027932961,33819.0698324022,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_401284,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
401582,3317.04863221884,905.142857142857,152.310030395137,650.617021276596,1944.96960486322,1431.57142857143,1288.42249240122,244.404255319149,1086.26443768997,4578.81458966565,1682.30699088146,120.963525835866,1097.56838905775,1292.56534954407,596.759878419453,509.80547112462,1840.22188449848,2169.04863221884,331.820668693009,236.984802431611,1063.23404255319,2032.79939209726,228.838905775076,233.534954407295,590.568389057751,1328.98176291793,513.018237082067,514.945288753799,1058.0273556231,130.0,329,22.8296191157103,18.4707337049931,0.587713871253363,0.956395348837209,0.747727272727273,-0.896149070709265,53424.3708206687,33695.6200607903,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_401582,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
401846,5391.62546816479,1266.86516853933,176.573033707865,666.659176029963,3023.48314606742,305.494382022472,314.749063670412,263.153558052434,1081.01498127341,9059.91011235955,1961.66292134831,136.299625468165,1081.38576779026,736.98127340824,541.082397003745,279.861423220974,1349.13108614232,1084.98876404494,328.119850187266,230.262172284644,974.711610486891,1026.90262172285,236.269662921348,117.258426966292,585.838951310861,1769.45692883895,514.565543071161,445.033707865168,1064.56179775281,130.917602996255,267,21.1348890199596,16.5370296202943,0.622711292378309,0.953571428571429,0.702631578947368,-0.625803781057997,53494.8539325843,32692.404494382,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_401846,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
403146,2715.80439121756,435.946107784431,193.534930139721,671.397205588822,3563.75648702595,1509.750499002,1767.63273453094,263.067864271457,1091.67065868263,5239.3373253493,663.988023952096,131.249500998004,1080.73053892216,1651.9500998004,764.4750499002,326.754491017964,1880.19560878244,2767.47305389222,346.922155688623,232.75249500998,1095.15568862275,1935.16566866267,213.994011976048,176.786427145709,3492.62674650699,2016.63473053892,531.367265469062,235.341317365269,1057.50898203593,130.397205588822,501,38.1978345020948,16.7909309930636,0.898204378748369,0.938202247191011,0.632575757575758,-1.19606293644843,53254.1836327345,32808.7405189621,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_403146,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
403280,3633.82456140351,626.812030075188,148.06015037594,647.812030075188,1718.21052631579,572.994987468672,414.335839598997,269.203007518797,1150.01002506266,6477.81704260652,1611.27318295739,129.588972431078,1064.56140350877,843.47619047619,467.548872180451,276.165413533835,1538.16290726817,1036.96240601504,206.887218045113,209.661654135338,1387.04260651629,688.370927318296,147.378446115288,125.280701754386,1100.70175438596,1725.42857142857,480.844611528822,338.105263157895,1085.24310776942,131.854636591479,399,29.297333240052,17.5231089342928,0.80141195565893,0.95,0.724137931034483,-1.26950066825645,52486.7819548872,32573.656641604,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_403280,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
403399,3224.81463414634,279.468292682927,94.7219512195122,648.019512195122,2469.41463414634,1074.12682926829,1475.45853658537,247.29756097561,1097.78536585366,6466.40975609756,2255.80487804878,121.580487804878,1078.4243902439,902.360975609756,470.034146341463,291.648780487805,1516.42926829268,1008.93170731707,220.039024390244,209.385365853659,1002.38048780488,909.639024390244,177.239024390244,165.912195121951,773.175609756098,2118.40975609756,507.882926829268,356.639024390244,1051.15609756098,130.741463414634,205,17.2833904995457,15.2328751916974,0.472446784163596,0.971563981042654,0.753676470588235,1.08599424374011,54161.4146341463,32727.7853658537,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_403399,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
403538,4889.03092783505,795.725085910653,132.979381443299,637.226804123711,1817.83505154639,510.817869415808,347.707903780069,260.525773195876,1104.29209621993,7625.80412371134,652.92439862543,127.845360824742,1083.03780068729,789.481099656357,444.27147766323,270.903780068729,1530.31958762887,979.697594501718,209.635738831615,207.824742268041,1091.71821305842,661.292096219931,143.989690721649,110.54295532646,598.886597938144,1276.96219931271,484.13058419244,256.26116838488,1034.31271477663,130.649484536082,291,19.820140130796,18.946251384643,0.293662871692484,0.941747572815534,0.7275,1.20765301294228,53988.3367697595,32696.0756013746,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_403538,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
403603,4710.29761904762,937.265873015873,152.634920634921,635.539682539683,1070.30158730159,2020.89682539683,809.214285714286,256.142857142857,1097.71428571429,7838.70238095238,1149.63888888889,148.507936507937,1101.11507936508,5044.43253968254,796.099206349206,526.722222222222,7472.35317460317,7092.20238095238,453.900793650794,250.34126984127,1052.06349206349,6533.38888888889,281.654761904762,319.992063492063,638.178571428571,3055.72619047619,580.611111111111,295.242063492063,1079.92857142857,132.047619047619,252,22.392265139278,14.3863183111616,0.766312344989458,0.961832061068702,0.698060941828255,0.852388911810544,53080.7420634921,33773.246031746,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_403603,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
404160,2669.14649681529,316.522292993631,78.8025477707006,618.031847133758,626.324840764331,1749.44585987261,990.611464968153,249.942675159236,1155.89808917197,5255.08280254777,506.012738853503,133.299363057325,1075.82802547771,6780.49681528662,952.312101910828,335.254777070064,16413.7898089172,7899.78343949045,461.363057324841,253.726114649682,1064.57324840764,7821.74522292994,323.324840764331,217.605095541401,689.936305732484,3459.97452229299,575.337579617834,319.458598726115,1057.42675159236,128.891719745223,157,18.4667808626346,10.8330389942302,0.809860122170109,0.951515151515152,0.710407239819005,1.03913063804567,53111.1337579618,33852.8535031847,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_404160,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
405570,1197.97570850202,121.967611336032,154.619433198381,725.574898785425,6457.2955465587,356.072874493927,289.987854251012,245.931174089069,1078.44129554656,2137.68421052632,598.688259109312,166.967611336032,1074.7044534413,720.668016194332,433.615384615385,274.935222672065,1536.10931174089,1092.23481781377,279.777327935223,225.736842105263,984.987854251012,976.076923076923,204.78947368421,127.817813765182,590.242914979757,1093.91497975709,499.238866396761,265.449392712551,1032.69230769231,129.404858299595,247,25.266979881661,12.5703029503947,0.867464419733077,0.946360153256705,0.76,-1.50727070138249,52838.5101214575,33328.9433198381,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_405570,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
406078,3431.69787234043,960.651063829787,1573.42978723404,670.965957446808,2966.79574468085,1142.07234042553,710.83829787234,257.012765957447,1119.63404255319,4710.27659574468,892.846808510638,137.459574468085,1071.97021276596,2765.48510638298,920.497872340426,590.744680851064,1834.70212765957,2459.73617021277,341.178723404255,232.072340425532,1054.82127659574,1879.08085106383,244.102127659574,416.136170212766,631.672340425532,1238.70638297872,503.382978723404,462.208510638298,1062.96595744681,131.544680851064,235,22.2396536858391,13.7481938216997,0.786033573423514,0.94,0.734375,-1.04656698918235,53617.0170212766,33780.4808510638,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_406078,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
406172,2277.6511627907,334.717054263566,115.151162790698,617.782945736434,840.918604651163,817.887596899225,2589.56976744186,261.674418604651,1089.04263565891,4638.7015503876,1006.51550387597,120.968992248062,1069.27131782946,2733.76356589147,568.484496124031,421.248062015504,1498.77131782946,2841.32945736434,285.740310077519,220.558139534884,1005.06589147287,2145.98062015504,201.178294573643,174.802325581395,602.232558139535,1806.88759689922,495.910852713178,294.546511627907,1058.22868217054,132.027131782946,258,20.7302417620198,15.9148249860971,0.640796796980534,0.952029520295203,0.722689075630252,-1.38306580470884,53735.496124031,32188.7868217054,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_406172,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
406206,1215.36120401338,253.816053511706,110.76254180602,623.204013377926,1382.9397993311,975.839464882943,369.321070234114,262.769230769231,1116.90301003344,1686.14715719064,573.836120401338,118.695652173913,1067.66220735786,746.1872909699,487.270903010034,284.816053511706,1550.25752508361,854.545150501672,191.260869565217,208.418060200669,1112.2508361204,629.364548494983,140.658862876254,116.013377926421,596.515050167224,817.936454849498,445.551839464883,221.795986622074,1019.8762541806,128.648829431438,299,23.7717999222273,16.0355695253286,0.738217559102437,0.955271565495208,0.715311004784689,0.514039367582278,52555.0668896321,32573.6989966555,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_406206,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
407667,1441.08376963351,312.392670157068,71.0418848167539,632.643979057592,1364.60209424084,3522.13612565445,2016.67539267016,270.235602094241,1131.26178010471,3192.40314136126,718.534031413613,114.560209424084,1076.03141361257,1888.56020942408,824.167539267016,827.523560209424,1603.97382198953,1984.97905759162,331.602094240838,300.240837696335,1022.33507853403,1497.55497382199,237.387434554974,499.225130890052,709.534031413613,1132.34031413613,465.015706806283,273.607329842932,1023.97905759162,129.162303664921,191,16.778778773351,14.5301365315647,0.500073505085218,0.974489795918367,0.795833333333333,-1.17686383262439,54010.2408376963,33356.9319371728,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_407667,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
408117,5656.72596153846,559.365384615385,429.475961538462,610.538461538462,410.581730769231,1608.42307692308,999.524038461538,255.259615384615,1125.08173076923,8291.06730769231,676.778846153846,151.913461538462,5038.20673076923,1627.28846153846,672.375,348.711538461538,2015.73076923077,1660.82692307692,341.899038461538,238.168269230769,1008.25,1500.41826923077,234.596153846154,307.629807692308,643.701923076923,2966.875,577.317307692308,308.177884615385,1075.21634615385,138.956730769231,208,22.0948278808521,12.1698477123404,0.834636769241107,0.954128440366972,0.643962848297214,0.860863836127163,53067.1346153846,33799.1298076923,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX+,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_408117,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
408892,3672.7196969697,448.5,116.420454545455,619.503787878788,815.80303030303,273.143939393939,273.522727272727,249.340909090909,1077.27272727273,6253.21590909091,898.742424242424,123.25,1072.18181818182,755.280303030303,522.284090909091,272.757575757576,1482.44318181818,1168.60227272727,305.132575757576,225.325757575758,987.746212121212,1025.17803030303,207.988636363636,174.719696969697,584.780303030303,1782.73863636364,504.598484848485,316.840909090909,1048.0303030303,129.17803030303,264,24.250755529398,14.1209774483011,0.812981005470226,0.956521739130435,0.628571428571429,0.887298092261053,53477.4810606061,32956.4772727273,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_408892,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
409005,4358.5395480226,757.545197740113,79.4124293785311,626.895480225989,791.166666666667,818.327683615819,1990.97175141243,248.112994350282,1085.91525423729,5825.54519774011,1148.30790960452,124.610169491525,1100.24293785311,666.796610169491,454.474576271186,626.528248587571,1594.90960451977,1924.86723163842,3185.21186440678,1589.87853107345,1161.63276836158,734.790960451977,158.175141242938,175.629943502825,588.381355932203,926.327683615819,449.912429378531,269.838983050847,1031.89548022599,130.435028248588,354,25.9731779494986,18.0411691499677,0.719388737974038,0.917098445595855,0.669187145557656,-0.831557887742086,53242.2344632768,33671.9604519774,FAAGSCC_12,AG,1,tumor cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,tumor cells,Tumor,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_409005,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
409961,3431.71604938272,360.049382716049,107.041975308642,639.614814814815,1681.15555555556,1137.52839506173,2186.73827160494,269.666666666667,1092.0,5628.5950617284,1256.99259259259,137.740740740741,1079.07407407407,854.424691358025,724.624691358025,579.40987654321,1713.96790123457,1254.04938271605,349.111111111111,243.414814814815,1005.12592592593,1247.46172839506,250.404938271605,432.182716049383,618.891358024691,1880.13333333333,510.58024691358,842.548148148148,1078.19259259259,130.471604938272,405,27.4964089838046,18.8841119657349,0.726860940801821,0.961995249406176,0.733695652173913,0.839821000005142,53350.7530864198,33850.375308642,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_409961,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
410816,1676.62288135593,111.156779661017,52.5550847457627,636.330508474576,1223.41101694915,2248.25,2271.75847457627,249.822033898305,1094.3093220339,2444.34322033898,567.334745762712,124.555084745763,1073.80508474576,3041.48728813559,874.694915254237,1439.93644067797,1932.55508474576,2030.93644067797,305.830508474576,230.338983050847,1040.49152542373,1354.94491525424,214.635593220339,428.326271186441,649.843220338983,1171.91101694915,476.012711864407,628.216101694915,1053.8093220339,131.021186440678,236,18.5979729845373,16.2015787798619,0.491021312491574,0.955465587044534,0.776315789473684,-0.0431549025226575,53373.3050847458,33744.3474576271,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_410816,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
410880,4443.36363636364,778.549407114625,1810.89723320158,647.083003952569,1510.03557312253,2460.36363636364,901.529644268775,257.731225296443,1121.01581027668,6470.07509881423,557.04347826087,140.675889328063,1093.7233201581,5358.82608695652,835.695652173913,920.517786561265,2462.93280632411,4071.91699604743,340.893280632411,232.063241106719,1060.10671936759,3369.6837944664,241.086956521739,343.422924901186,681.02371541502,1208.65612648221,474.98023715415,402.703557312253,1035.81818181818,129.790513833992,253,19.8819663447747,16.8711084267455,0.529093755129299,0.887719298245614,0.739766081871345,-1.50498345202037,53515.0039525692,33816.8260869565,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_410880,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
411806,473.278350515464,914.883161512028,206.890034364261,607.491408934708,472.024054982818,533.762886597938,990.635738831615,251.886597938144,1083.78006872852,953.085910652921,581.082474226804,108.123711340206,1063.0,891.219931271478,481.79381443299,266.305841924399,1700.96219931271,2102.60137457045,280.158075601374,222.027491408935,985.371134020619,2808.23367697594,204.618556701031,123.611683848797,584.415807560137,730.865979381443,400.59793814433,215.085910652921,1000.92783505155,131.07560137457,291,20.1797229721992,18.3736947490383,0.41350285115214,0.973244147157191,0.808333333333333,0.0228130484905359,53978.264604811,32853.910652921,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_411806,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
412252,2370.76944444444,324.713888888889,164.694444444444,657.988888888889,2854.07777777778,3835.675,625.05,260.772222222222,1116.25,4349.21388888889,526.641666666667,120.161111111111,1096.06111111111,4169.87222222222,695.897222222222,307.661111111111,4767.18611111111,2099.56111111111,260.547222222222,222.769444444444,1011.63055555556,1378.71388888889,184.233333333333,231.836111111111,1176.6,1632.60277777778,503.591666666667,234.8,1055.6,130.216666666667,360,29.1371234086911,15.7919268313576,0.840387208401583,0.947368421052632,0.659340659340659,-0.957599156520142,53827.575,32818.8611111111,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_412252,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
412733,2846.1975308642,291.162551440329,120.09670781893,649.022633744856,2326.83333333333,816.602880658436,275.695473251029,254.965020576132,1087.52469135802,4686.71604938272,801.187242798354,139.055555555556,1072.83744855967,1618.82304526749,733.730452674897,305.788065843621,1901.02674897119,1968.21399176955,363.059670781893,233.520576131687,998.440329218107,1291.18724279835,222.20987654321,233.502057613169,578.915637860082,1495.69958847737,501.109053497942,224.010288065844,1044.88683127572,131.619341563786,486,25.448588630072,24.5710570606537,0.260338248497669,0.970059880239521,0.81,-0.807264117922333,53536.7366255144,32008.0,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_412733,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
412889,5553.67688022284,1577.66295264624,1295.44289693593,650.818941504178,1792.45682451253,1923.66573816156,641.754874651811,255.314763231198,1090.25069637883,9275.55710306407,667.367688022284,132.459610027855,1101.91922005571,1206.15877437326,494.49860724234,273.682451253482,1500.68802228412,4008.43732590529,335.526462395543,233.130919220056,998.479108635098,5409.01671309192,248.874651810585,153.543175487465,1342.99721448468,1787.33704735376,512.699164345404,271.061281337047,1058.21727019499,134.481894150418,359,22.7148026373749,20.2967739525113,0.448967017465661,0.944736842105263,0.743271221532091,0.0494663624917134,53347.860724234,33330.364902507,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_412889,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
413756,5355.16,404.96,208.673333333333,674.363333333333,2829.22333333333,565.023333333333,818.886666666667,232.856666666667,1088.44666666667,8449.1,643.53,134.913333333333,1101.28,956.836666666667,697.96,945.36,1841.54,1740.94,280.973333333333,231.046666666667,1021.87,1804.54666666667,203.293333333333,435.483333333333,703.613333333333,2093.69666666667,531.333333333333,292.043333333333,1061.6,133.923333333333,300,21.1770658698266,18.0514564826505,0.522880611714168,0.961538461538462,0.789473684210526,-0.84521904025816,52812.72,33645.08,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_413756,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
414308,2015.44081632653,687.326530612245,51.5714285714286,613.032653061224,721.963265306122,640.742857142857,2443.60408163265,234.081632653061,1090.98367346939,3757.86530612245,506.314285714286,121.187755102041,1073.79591836735,2517.17142857143,2229.23673469388,1922.07346938776,7525.22040816327,3610.81224489796,387.991836734694,238.273469387755,1048.00816326531,2861.15918367347,255.697959183673,251.959183673469,668.575510204082,1773.03265306122,493.857142857143,242.991836734694,1050.21224489796,129.702040816327,245,21.2561813853115,14.8286009446597,0.716474202652776,0.935114503816794,0.678670360110803,-0.67699211510106,53018.0285714286,33751.7428571429,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,9,FAAGSCC_12_414308,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
414515,1418.42131979695,345.58883248731,82.3654822335025,649.43654822335,2443.71573604061,626.015228426396,1099.27411167513,258.263959390863,1089.45177664975,2788.5076142132,506.243654822335,127.802030456853,1071.53807106599,1033.47715736041,580.507614213198,536.431472081218,1647.06598984772,1374.86294416244,282.167512690355,227.583756345178,1016.1421319797,1813.8578680203,230.771573604061,658.416243654822,836.908629441624,1544.22842639594,496.573604060914,252.284263959391,1058.86802030457,131.903553299492,197,18.7425215604965,13.4625456562971,0.695744939451791,0.95631067961165,0.781746031746032,-1.16331853599295,53385.0913705584,33810.4314720812,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_414515,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
414543,3685.83828382838,829.501650165016,2131.83168316832,656.36303630363,2070.27062706271,1791.61716171617,424.488448844884,240.26402640264,1097.12871287129,5165.75577557756,922.851485148515,121.105610561056,1073.92409240924,4209.04290429043,764.270627062706,314.465346534653,3355.61056105611,4400.40264026403,383.970297029703,238.811881188119,1071.46534653465,3112.04620462046,228.63696369637,218.039603960396,652.353135313531,939.168316831683,466.389438943894,325.749174917492,1045.97689768977,131.293729372937,303,25.7835138404655,15.1991047879461,0.807776205953343,0.938080495356037,0.664473684210526,0.448279737425395,52964.7425742574,33610.3663366337,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_414543,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
414615,3137.64030612245,495.545918367347,138.061224489796,634.020408163265,1323.58673469388,427.132653061225,324.630102040816,251.244897959184,1119.3112244898,5213.63010204082,1276.40051020408,129.40306122449,1073.73469387755,789.632653061224,440.801020408163,282.387755102041,1527.3443877551,982.267857142857,202.591836734694,212.609693877551,1309.7193877551,673.948979591837,146.196428571429,132.77806122449,592.380102040816,1375.48979591837,468.19387755102,315.507653061225,1068.47704081633,131.168367346939,392,25.3124218753585,20.1271897841731,0.60641188654725,0.944578313253012,0.746666666666667,1.35985192324343,52651.5612244898,32976.4005102041,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_414615,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
414703,2599.96035242291,383.506607929515,99.7004405286344,630.687224669604,1657.36563876652,1302.6563876652,323.643171806167,254.748898678414,1105.37004405286,5167.03524229075,1539.41850220264,119.823788546255,1069.22907488987,5813.80176211454,576.066079295154,296.52422907489,1816.78854625551,4945.47136563877,314.47577092511,222.735682819383,997.15859030837,3558.72246696035,210.392070484581,125.832599118943,590.854625550661,1322.52863436123,468.418502202643,442.973568281938,1062.26431718062,131.660792951542,227,18.0124720369217,16.1126585297344,0.447012149135806,0.93801652892562,0.741830065359477,1.53993766119017,54033.8898678414,32862.8546255507,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_414703,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
415025,3359.44927536232,674.608695652174,703.855072463768,716.07729468599,5763.54347826087,670.142512077295,809.562801932367,250.393719806763,1087.06280193237,4847.06038647343,586.541062801932,143.961352657005,1079.78019323671,1223.11352657005,778.900966183575,563.743961352657,2981.27536231884,2960.87198067633,348.8961352657,235.038647342995,1044.88164251208,3449.85265700483,244.072463768116,616.56038647343,669.746376811594,1397.26570048309,529.019323671498,285.56038647343,1052.35507246377,130.876811594203,414,25.9725448000257,20.3698388700941,0.620402578648542,0.965034965034965,0.784090909090909,0.983310681652919,53592.5458937198,33848.3212560386,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_415025,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
415291,3790.75694444444,930.753472222222,117.482638888889,659.472222222222,2208.73611111111,805.072916666667,410.652777777778,256.190972222222,1140.90277777778,5321.8125,950.149305555556,118.840277777778,1075.67013888889,919.934027777778,404.607638888889,427.475694444444,1566.74652777778,968.159722222222,314.642361111111,304.118055555556,1096.27083333333,757.930555555556,162.940972222222,172.638888888889,619.666666666667,1033.96180555556,477.951388888889,493.913194444444,1052.52777777778,131.993055555556,288,22.0748105908698,16.7574437035005,0.650949996506292,0.966442953020134,0.857142857142857,1.56065848994207,53721.6770833333,33663.9965277778,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_415291,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
415642,2932.23220973783,323.022471910112,131.243445692884,640.40074906367,2010.13857677903,386.539325842697,663.262172284644,255.123595505618,1079.03370786517,5403.74531835206,615.895131086142,126.752808988764,1091.1872659176,1106.13483146067,1168.30337078652,385.539325842697,1553.30337078652,1329.0936329588,288.947565543071,233.026217228464,990.857677902622,1277.47940074906,215.707865168539,235.910112359551,689.494382022472,2193.91011235955,534.213483146067,237.183520599251,1065.75280898876,130.880149812734,267,22.3920386396647,15.5530140183611,0.719417550933127,0.953571428571429,0.706349206349206,-0.995819192848167,52377.468164794,32991.6666666667,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_415642,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
415851,1953.524,449.008,270.492,626.128,560.748,365.16,916.108,254.56,1080.492,3474.204,458.012,106.272,1084.624,784.992,656.692,424.708,1619.896,1068.732,255.54,221.008,1011.396,992.324,182.388,171.648,656.0,1209.62,462.456,553.392,1031.952,132.004,250,19.7662931087295,16.1678899284908,0.575285685242969,0.954198473282443,0.773993808049536,-0.451073731481449,53264.784,33511.284,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_415851,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
415910,3050.48756218905,205.800995024876,86.7412935323383,626.547263681592,1403.93034825871,396.064676616915,313.149253731343,246.383084577114,1110.35820895522,5637.69651741294,500.358208955224,137.502487562189,1074.99004975124,866.641791044776,458.139303482587,270.582089552239,2097.17412935323,1344.58706467662,294.009950248756,231.716417910448,1012.407960199,1230.23880597015,215.582089552239,217.333333333333,2858.53731343284,3110.87064676617,533.731343283582,292.487562189055,1071.73631840796,129.706467661692,201,21.6140544499501,11.9680149937123,0.832706593515633,0.922018348623853,0.736263736263736,1.48790884848352,52932.4179104478,33865.6218905473,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,1,FAAGSCC_12_415910,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
416114,2912.05679513185,422.894523326572,106.505070993915,635.058823529412,1907.00405679513,400.799188640974,292.821501014199,249.196754563895,1075.89452332657,5092.738336714,1777.38539553753,120.748478701826,1107.38742393509,746.732251521298,491.176470588235,272.965517241379,1662.80527383367,1106.10953346856,302.973630831643,229.896551724138,987.675456389452,1043.42190669371,230.697768762677,130.535496957404,691.073022312373,1338.56186612576,492.367139959432,596.131845841785,1057.98985801217,131.547667342799,493,27.6675683422329,23.5891253416498,0.522578456066654,0.94990366088632,0.704285714285714,1.37943991769118,53503.7444219067,33262.8945233266,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_416114,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
416437,4200.09446254072,559.931596091205,723.775244299674,632.28990228013,1945.34201954397,2147.50814332248,347.342019543974,254.390879478827,1102.72638436482,6318.47882736156,555.0,120.560260586319,1131.22475570033,928.250814332248,408.185667752443,268.86319218241,1517.99022801303,889.550488599349,190.084690553746,204.843648208469,1024.44299674267,766.446254071661,159.690553745928,132.550488599349,636.358306188925,1741.667752443,522.055374592834,253.596091205212,1037.02931596091,130.319218241042,307,22.0789061819465,17.9984133301456,0.579199382402254,0.95046439628483,0.741545893719807,-1.53362781060113,53949.7394136808,33456.993485342,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_416437,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
416463,5536.24418604651,1460.37209302326,155.786821705426,643.763565891473,1736.32170542636,958.546511627907,287.651162790698,231.325581395349,1184.79457364341,8238.50775193798,612.899224806202,131.279069767442,1092.02713178295,4037.5,1077.91472868217,926.589147286822,2448.18217054264,2462.57751937984,337.31007751938,234.976744186046,1030.82945736434,1440.37984496124,223.868217054264,167.798449612403,608.980620155039,2245.68992248062,538.961240310078,278.720930232558,1048.45348837209,131.096899224806,258,19.7003406796009,16.7221915184659,0.528669863316835,0.962686567164179,0.798761609907121,-0.424869147207561,53200.8643410853,33471.8604651163,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_416463,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
416856,3338.89117647059,662.097058823529,923.758823529412,633.294117647059,1239.42058823529,325.920588235294,362.144117647059,239.408823529412,1077.64117647059,5158.01470588235,744.055882352941,129.608823529412,1122.47058823529,853.376470588235,624.502941176471,281.65,1781.42647058824,1759.75588235294,366.467647058824,236.082352941176,1010.45,1963.58235294118,246.347058823529,217.452941176471,585.332352941177,1291.72647058824,485.129411764706,307.191176470588,1051.44411764706,130.764705882353,340,22.9421312583039,19.0195618885931,0.559214028974232,0.965909090909091,0.770975056689342,-0.776649531491898,52878.3705882353,33413.8617647059,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_416856,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
416898,4290.63855421687,276.55421686747,106.240963855422,634.415662650602,719.024096385542,298.198795180723,374.638554216867,246.596385542169,1075.89759036145,7059.84337349398,1092.9156626506,130.879518072289,1078.06024096386,647.024096385542,459.626506024096,599.048192771084,1766.51807228916,988.975903614458,238.765060240964,214.132530120482,1014.22289156627,864.343373493976,181.566265060241,215.301204819277,596.102409638554,1634.49397590361,545.602409638554,344.728915662651,1068.31927710843,131.831325301205,166,18.6796907735104,11.802577103697,0.775098785604337,0.882978723404255,0.697478991596639,1.25090792146516,54032.6204819277,33279.6385542169,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_416898,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
417301,3040.16822429907,753.08722741433,385.389408099688,617.532710280374,936.115264797508,659.105919003115,624.464174454829,250.92523364486,1106.16822429907,5114.84423676012,995.613707165109,123.323987538941,1074.52024922118,2000.49221183801,1128.43302180685,1243.69158878505,2074.28660436137,2032.91277258567,353.090342679128,233.233644859813,1062.59813084112,1453.50778816199,248.242990654206,828.566978193146,802.003115264798,1783.99065420561,506.738317757009,293.732087227414,1045.57943925234,130.14953271028,321,23.6128135743888,17.7507023974245,0.659459320501222,0.941348973607038,0.729545454545454,-0.413441818927786,53681.5700934579,33741.1682242991,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_417301,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
417771,4426.18805970149,765.474626865672,139.722388059702,655.871641791045,2008.53731343284,1270.19701492537,341.113432835821,242.85671641791,1084.13134328358,7150.47462686567,629.689552238806,129.119402985075,1082.27164179104,816.158208955224,592.982089552239,377.731343283582,2002.17313432836,1109.63582089552,229.665671641791,218.232835820896,1009.85671641791,1029.47462686567,176.364179104478,180.617910447761,607.489552238806,1784.02985074627,531.555223880597,257.90447761194,1072.54328358209,131.176119402985,335,23.7868855489751,17.9883747305187,0.654304994103111,0.957142857142857,0.766590389016018,-0.206809314187304,53006.447761194,33420.0149253731,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_417771,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
417865,2286.90845070423,539.616197183099,82.6478873239437,622.366197183099,1494.04929577465,380.517605633803,294.957746478873,245.827464788732,1098.75,3259.47535211268,698.760563380282,114.838028169014,1067.99295774648,1050.20070422535,704.926056338028,273.419014084507,1791.84507042254,1194.91549295775,249.781690140845,215.461267605634,991.992957746479,947.570422535211,186.038732394366,169.457746478873,1136.14788732394,830.140845070423,438.584507042254,234.838028169014,1018.48943661972,128.915492957746,284,22.5468961098895,16.1192153796318,0.699206785164384,0.96271186440678,0.747368421052632,0.799224328650773,54163.3767605634,32638.4683098592,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_417865,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
418694,2308.82047244094,327.766929133858,144.885039370079,654.554330708661,2660.9937007874,309.948031496063,329.007874015748,253.988976377953,1083.30078740157,4479.16692913386,2429.83464566929,123.696062992126,1071.95905511811,846.883464566929,650.376377952756,283.242519685039,1542.51496062992,1292.55118110236,336.932283464567,238.768503937008,999.094488188976,1146.98267716535,246.179527559055,152.500787401575,582.763779527559,2067.11023622047,531.941732283465,422.368503937008,1060.24881889764,131.351181102362,635,41.2498662478163,19.7336851742612,0.878145351421621,0.956325301204819,0.737514518002323,0.116825389333692,52702.3732283465,33351.6771653543,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_418694,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
419146,4618.2125748503,1009.47904191617,198.209580838323,671.09880239521,3694.02694610778,380.464071856287,285.275449101796,245.619760479042,1097.59580838323,7425.43113772455,938.368263473054,128.329341317365,1088.54491017964,608.317365269461,356.290419161677,262.359281437126,1419.18263473054,838.874251497006,183.532934131737,204.784431137725,1168.73053892216,685.946107784431,145.494011976048,132.134730538922,596.0,1676.5,535.248502994012,270.044910179641,1052.65269461078,131.350299401198,334,23.4577811104607,18.1775872412941,0.632075868984634,0.946175637393768,0.722943722943723,0.802352100675756,53299.6497005988,33113.4041916168,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_419146,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
419171,4021.16083916084,949.996503496504,716.248251748252,659.241258741259,2379.75524475524,1583.42307692308,2396.98951048951,252.367132867133,1091.23076923077,6921.32167832168,1626.1048951049,140.524475524476,1077.86713286713,876.912587412587,908.29020979021,779.513986013986,1901.91608391608,987.513986013986,233.583916083916,218.884615384615,1017.23776223776,942.828671328671,176.944055944056,201.688811188811,606.884615384615,2307.70629370629,536.276223776224,493.353146853147,1075.35314685315,131.307692307692,286,28.8923448218799,12.7061408488507,0.898107815270268,0.959731543624161,0.814814814814815,0.173357746638135,52757.8321678322,33753.2482517482,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_419171,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
420078,2030.16985138004,371.11889596603,162.430997876858,638.144373673036,2242.4118895966,288.409766454352,281.562632696391,244.942675159236,1076.91295116773,3124.84713375796,487.006369426752,116.065817409766,1092.64968152866,657.864118895966,446.002123142251,268.581740976645,1412.33757961783,997.953290870488,267.938428874735,221.995753715499,986.218683651805,922.753715498938,210.176220806794,131.450106157113,589.036093418259,1084.74946921444,498.825902335456,233.246284501062,1009.93418259023,129.549893842887,471,31.2980666441895,19.6970174832,0.777132870752489,0.938247011952191,0.649655172413793,-0.571214133514609,53394.6857749469,33275.5690021231,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_420078,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
420750,5491.80487804878,1340.625,1909.51524390244,646.219512195122,1593.18902439024,3184.58536585366,1892.32926829268,257.234756097561,1134.68902439024,8709.44512195122,592.310975609756,148.737804878049,1095.78963414634,1778.60975609756,652.32012195122,638.759146341463,1809.85365853659,1800.2256097561,314.481707317073,229.737804878049,1026.28353658537,1406.99390243902,225.003048780488,246.951219512195,611.460365853659,2048.20426829268,547.225609756098,341.47256097561,1081.40243902439,131.262195121951,328,25.2623584497744,16.7074562176534,0.750070625744047,0.964705882352941,0.771764705882353,-1.42987890344841,53505.2164634146,33802.3597560976,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_420750,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
421100,1172.44827586207,663.579310344828,87.1103448275862,625.379310344828,1097.89655172414,465.565517241379,301.951724137931,239.668965517241,1137.57931034483,1766.95862068966,478.931034482759,109.144827586207,1069.81379310345,1489.84137931034,580.075862068966,283.572413793103,1799.36551724138,2462.7724137931,301.565517241379,235.137931034483,1042.49655172414,2182.18620689655,226.496551724138,217.88275862069,3228.8275862069,750.11724137931,434.213793103448,337.544827586207,1008.1724137931,129.262068965517,145,15.3254505570575,12.2073526776607,0.604584259682508,0.960264900662252,0.69047619047619,1.02379881447299,53845.1655172414,33463.724137931,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_421100,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
421120,3750.07876712329,512.825342465753,161.263698630137,674.212328767123,2794.58219178082,1855.03082191781,452.534246575342,254.72602739726,1095.65753424658,6223.52397260274,2136.48287671233,127.33904109589,1080.43493150685,1785.13356164384,481.893835616438,292.243150684931,1747.61301369863,1130.56164383562,279.534246575342,219.654109589041,1063.43835616438,964.674657534246,193.445205479452,120.592465753425,585.815068493151,1340.19520547945,490.530821917808,362.479452054795,1054.55479452055,130.640410958904,292,21.9027977821704,17.2051099198541,0.618834867597844,0.960526315789474,0.772486772486772,1.2561680879132,53517.9178082192,32988.8184931507,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_421120,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
421173,3291.92071611253,357.979539641944,144.803069053708,679.265984654731,3662.46035805627,413.524296675192,628.762148337596,249.411764705882,1092.83375959079,5456.93606138107,555.69820971867,129.754475703325,1087.0179028133,1640.68286445013,764.281329923274,517.135549872123,1793.04347826087,2397.20971867008,332.859335038363,232.552429667519,1031.58056265985,1885.86700767263,235.49104859335,234.884910485934,620.718670076726,1684.83631713555,491.20716112532,270.713554987212,1042.58567774936,129.687979539642,391,30.93485731214,16.2578880010256,0.850761242621042,0.946731234866828,0.70961887477314,1.19292944329465,53656.9462915601,33756.7289002558,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_421173,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
421804,2086.82478632479,279.75641025641,136.529914529915,645.653846153846,2587.29914529915,236.525641025641,274.07264957265,241.978632478632,1081.10256410256,3056.16666666667,489.119658119658,122.064102564103,1067.60256410256,528.649572649573,546.948717948718,276.692307692308,1441.5811965812,806.564102564103,206.850427350427,209.769230769231,973.551282051282,728.32905982906,159.615384615385,118.333333333333,601.333333333333,1207.8547008547,489.75641025641,224.34188034188,1016.16666666667,129.662393162393,234,22.8796281413383,13.1590463388057,0.818053246567515,0.951219512195122,0.688235294117647,-0.526413842892737,53767.8376068376,32413.1666666667,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_421804,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
422229,1622.64985994398,498.03081232493,263.798319327731,691.27731092437,4968.63585434174,335.428571428571,424.778711484594,247.120448179272,1081.61904761905,3034.55182072829,513.910364145658,133.52380952381,1082.50140056022,1095.96638655462,557.789915966387,373.879551820728,1701.80952380952,2852.03081232493,364.075630252101,240.044817927171,999.355742296919,4311.60504201681,270.43137254902,217.50700280112,588.40056022409,1433.83193277311,495.694677871148,286.350140056022,1070.75350140056,131.182072829132,357,25.915420960111,17.8262924612968,0.725839326548539,0.962264150943396,0.751578947368421,0.393150420061938,53448.0504201681,33891.1232492997,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_422229,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
422677,4873.6332046332,1401.20463320463,1728.21235521236,617.305019305019,904.926640926641,418.540540540541,749.888030888031,252.938223938224,1079.45945945946,7600.0694980695,595.953667953668,124.988416988417,1076.45945945946,2138.00386100386,488.725868725869,606.787644787645,1741.62548262548,1894.69884169884,223.54054054054,211.146718146718,982.799227799228,1544.60231660232,176.783783783784,142.03861003861,674.413127413127,1879.99613899614,525.494208494208,237.324324324324,1021.49034749035,130.521235521236,259,23.1509753551591,14.572245664701,0.777045738992462,0.948717948717949,0.649122807017544,-0.870623185085116,54161.861003861,32872.4633204633,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_422677,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
422823,2783.09248554913,468.739884393064,129.105973025048,652.210019267823,2074.56454720617,3791.71098265896,402.269749518304,264.703275529865,1124.4816955684,5196.83044315992,1691.79961464355,123.375722543353,1138.09441233141,3809.03853564547,1064.04238921002,340.626204238921,4437.5105973025,5714.80539499037,444.092485549133,249.707129094412,1041.88631984586,5110.67630057803,275.884393063584,204.672447013487,597.890173410405,1582.48362235067,476.867052023121,326.635838150289,1115.36030828516,131.067437379576,519,28.8578362243595,23.5742694581428,0.576764451723012,0.941923774954628,0.772321428571429,1.3788738732372,52651.6840077071,33514.6743737958,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_422823,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
423496,4121.26244343891,229.307692307692,147.294117647059,673.135746606335,3322.28054298643,784.565610859729,390.072398190045,250.592760180995,1117.86877828054,6444.63800904977,562.977375565611,142.918552036199,1077.06334841629,4394.23076923077,1060.29411764706,890.06334841629,6811.37104072398,8653.64705882353,494.628959276018,255.280542986425,1058.15384615385,8499.7963800905,316.203619909502,348.678733031674,711.294117647059,1715.23076923077,533.79185520362,236.049773755656,1094.4479638009,129.27149321267,221,19.7143933316559,14.3222588306985,0.687179759971698,0.956709956709957,0.767361111111111,-0.510876386067464,53116.9457013575,33114.5656108597,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_423496,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
424002,1163.83045525903,409.571428571429,121.339089481947,621.193092621664,1315.6420722135,1359.13186813187,393.692307692308,266.557299843014,1101.87441130298,1675.84144427002,1058.97017268446,122.888540031397,1067.96389324961,3187.5431711146,662.946624803768,317.558869701727,1942.09576138148,3384.55729984301,358.257456828885,226.929356357928,1156.96860282575,2136.11302982732,195.80376766091,165.331240188383,1017.00784929356,961.078492935636,541.238618524333,299.313971742543,1021.37205651491,130.631083202512,637,32.4965877935474,25.0067393265698,0.638624007572595,0.966616084977238,0.733870967741935,-1.09268754224368,53183.5007849294,32791.2935635793,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_424002,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
424321,1643.61639344262,96.2131147540984,50.0786885245902,613.773770491803,1233.41639344262,369.396721311475,899.550819672131,255.475409836066,1093.62950819672,3381.98360655738,1524.88524590164,111.931147540984,1073.56393442623,780.859016393443,604.029508196721,267.695081967213,1599.02950819672,840.068852459016,179.583606557377,200.413114754098,1028.52459016393,676.304918032787,146.236065573771,116.344262295082,919.606557377049,1214.7606557377,437.704918032787,275.403278688525,1032.25901639344,128.708196721311,305,20.8033314546086,18.8594914242971,0.422074565801808,0.956112852664577,0.764411027568922,-1.41701122172343,54173.4459016394,32697.3049180328,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_424321,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
425033,3285.5498392283,303.311897106109,100.990353697749,633.122186495177,1951.04823151125,1401.58520900322,288.508038585209,249.215434083601,1089.90675241158,5359.54340836013,497.958199356913,126.729903536977,1068.87781350482,2665.36334405145,820.051446945338,773.774919614148,2142.50482315113,2882.32154340836,333.778135048231,226.257234726688,1034.59485530547,2228.89067524116,264.623794212219,1748.1768488746,734.67845659164,1680.72668810289,497.03536977492,224.016077170418,1039.99678456592,129.569131832797,311,28.0556383654348,14.2353880921665,0.861711546074771,0.951070336391437,0.703619909502262,1.24542938830793,53806.7041800643,32391.8585209003,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_425033,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
425100,3324.7701863354,190.04347826087,109.54347826087,681.580745341615,4055.55279503106,4111.95652173913,351.978260869565,263.490683229814,1110.69875776398,5770.46583850932,713.357142857143,136.496894409938,1081.94099378882,2351.94099378882,786.950310559006,277.5,1917.89751552795,1804.24223602484,296.819875776398,231.049689440994,1021.27639751553,1809.8850931677,219.121118012422,169.509316770186,598.341614906832,2183.17701863354,515.888198757764,309.152173913043,1055.00931677019,128.869565217391,322,31.311673109962,13.174694253224,0.907172070502469,0.955489614243324,0.670833333333333,1.21352794765345,52868.0776397516,33295.0776397516,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_425100,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
425175,4475.41516245487,831.028880866426,616.245487364621,647.209386281588,1602.94584837545,1799.07942238267,2012.59927797834,256.021660649819,1097.1083032491,7795.05054151625,672.018050541516,142.758122743682,1073.67509025271,2229.13718411552,777.238267148014,1097.08303249097,1922.23104693141,2057.32129963899,324.548736462094,232.361010830325,1053.63176895307,1978.38989169675,223.234657039711,266.859205776173,653.353790613718,2975.88086642599,594.101083032491,273.021660649819,1075.66064981949,130.898916967509,277,22.9513129940927,15.4087083786002,0.741126864410386,0.958477508650519,0.6925,0.782611165234266,53031.119133574,33871.4693140794,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_425175,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
425322,2319.16363636364,196.181818181818,109.945454545455,668.751515151515,3881.15151515152,557.666666666667,363.215151515151,244.160606060606,1076.43636363636,4008.77878787879,566.806060606061,123.60303030303,1071.11515151515,2411.22121212121,1057.16060606061,1319.77878787879,3178.7303030303,5131.94848484848,384.730303030303,238.133333333333,1061.87878787879,4821.16666666667,335.051515151515,313.184848484848,706.306060606061,1665.05151515152,614.424242424242,320.2,1096.6696969697,130.736363636364,330,25.0791786110605,16.7882752773395,0.742892361111466,0.959302325581395,0.717391304347826,-0.584993585196892,54095.0939393939,33288.8696969697,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_425322,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
425342,2504.3306010929,397.106557377049,186.385245901639,681.986338797814,4881.79508196721,2675.54644808743,343.060109289618,267.748633879781,1093.79781420765,3738.95081967213,567.948087431694,120.562841530055,1065.8606557377,741.628415300546,498.453551912568,395.658469945355,1861.57923497268,976.784153005464,235.579234972678,213.101092896175,990.814207650273,1014.74316939891,219.677595628415,151.393442622951,611.16393442623,853.42349726776,422.169398907104,224.55737704918,1052.57103825137,129.25956284153,366,30.4366152769811,15.6472042604846,0.857735367963626,0.950649350649351,0.635416666666667,-0.789417043735687,54105.781420765,32567.087431694,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_425342,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
426005,2914.80487804878,178.390243902439,75.890243902439,624.052845528455,692.569105691057,2712.81504065041,357.747967479675,271.463414634146,1124.2743902439,5776.15243902439,703.284552845528,122.168699186992,1062.73983739837,2316.97357723577,699.99593495935,297.817073170732,1992.19105691057,1905.10365853659,312.19918699187,226.036585365854,1158.2093495935,1266.17682926829,188.764227642276,170.140243902439,2635.71951219512,1847.73780487805,494.319105691057,254.353658536585,1057.23170731707,129.530487804878,492,33.3375742693856,19.8067758442225,0.804370743626572,0.933586337760911,0.627551020408163,0.793844941240407,53085.4593495935,32777.1930894309,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_426005,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
426178,1533.92459016393,193.977049180328,150.727868852459,675.970491803279,4304.68524590164,1030.33442622951,447.92131147541,249.16393442623,1091.05573770492,2511.51475409836,517.095081967213,118.980327868852,1071.19016393443,1030.21639344262,575.022950819672,336.12131147541,2120.68196721311,1111.75081967213,294.701639344262,256.803278688525,982.193442622951,1026.7868852459,220.304918032787,166.419672131148,587.777049180328,911.406557377049,428.655737704918,238.147540983606,1028.50819672131,128.613114754098,305,25.4812329067595,15.3004984830526,0.799653691967658,0.962145110410095,0.747549019607843,1.21018372247703,52642.9147540984,33649.0,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_426178,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
426441,1310.23214285714,503.098214285714,223.8125,689.982142857143,3339.4375,301.651785714286,313.866071428571,254.098214285714,1086.25,2075.00892857143,2892.19642857143,120.098214285714,1064.33928571429,674.151785714286,500.339285714286,370.464285714286,1456.92857142857,1198.89285714286,275.821428571429,221.25,1011.29464285714,1219.60714285714,215.464285714286,231.625,944.214285714286,1156.4375,481.089285714286,384.517857142857,1078.07142857143,129.919642857143,112,15.5338046216858,9.17798195415546,0.806789281042942,0.973913043478261,0.82962962962963,1.5538202336496,52684.9553571429,33079.7321428571,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_426441,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
426507,3261.30747922438,536.293628808864,103.371191135734,654.908587257618,2285.06925207756,664.947368421053,1575.98891966759,245.991689750693,1103.83379501385,5205.27977839335,571.19944598338,125.06648199446,1081.73407202216,890.927977839335,748.880886426593,335.764542936288,1830.2271468144,1394.01108033241,324.85595567867,234.047091412742,1003.47645429363,1451.59833795014,230.04432132964,147.761772853186,590.138504155125,1252.80609418283,460.864265927978,237.049861495845,1056.10526315789,131.329639889197,361,23.1159827677224,19.9844562431267,0.502581539312948,0.973045822102426,0.820454545454545,1.32064077739444,52904.1329639889,33411.0332409972,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_426507,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
426791,1414.73333333333,282.505555555556,227.794444444444,705.238888888889,6711.67777777778,386.377777777778,467.966666666667,255.3,1083.96111111111,2374.86666666667,511.733333333333,118.422222222222,1062.91111111111,702.283333333333,502.633333333333,305.111111111111,1368.78333333333,1048.16111111111,298.744444444444,225.738888888889,980.394444444444,1028.93888888889,222.85,136.15,586.638888888889,934.9,475.544444444444,228.288888888889,1048.64444444444,130.588888888889,180,20.3057480888747,11.4563929851491,0.825641857910901,0.947368421052632,0.666666666666667,0.969834128835236,53417.1722222222,32970.1388888889,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_426791,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
427240,4760.25239616614,646.801916932907,146.897763578275,648.712460063898,2121.23642172524,721.539936102236,1944.06389776358,248.405750798722,1090.67092651757,7501.9392971246,643.731629392971,133.610223642173,1093.33226837061,1126.41214057508,833.664536741214,1208.28115015974,2348.40255591054,2241.04792332268,342.955271565495,237.996805111821,1021.76996805112,2216.38019169329,239.079872204473,222.217252396166,643.444089456869,3066.57827476038,584.843450479233,306.884984025559,1092.07987220447,131.523961661342,313,22.4724626141226,17.7524527058842,0.613152294531807,0.960122699386503,0.756038647342995,-0.318012659685342,53296.5047923323,33648.0766773163,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_427240,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
427759,2222.62039045553,162.843817787419,145.301518438178,714.32104121475,6038.53145336226,340.383947939262,1828.17136659436,239.822125813449,1091.0694143167,3517.86550976139,639.911062906725,127.190889370933,1083.11496746204,941.360086767896,676.739696312364,921.1431670282,1620.7830802603,1358.45553145336,316.53579175705,227.34273318872,1008.32104121475,1316.86334056399,220.898047722343,311.665943600868,625.9284164859,1235.58134490239,500.197396963124,343.427331887202,1034.34924078091,130.117136659436,461,32.2584496034711,18.6894762731316,0.815066902320835,0.929435483870968,0.686011904761905,1.02855579050365,53463.1236442516,33672.4642082429,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_427759,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
428254,2296.37297297297,295.113513513514,98.3513513513514,639.081081081081,1439.07567567568,477.108108108108,890.308108108108,255.605405405405,1086.77837837838,3742.89189189189,2245.73513513514,115.556756756757,1062.83783783784,938.994594594595,1331.21081081081,355.410810810811,1611.99459459459,1047.17297297297,256.508108108108,213.481081081081,998.572972972973,1382.05405405405,184.778378378378,202.167567567568,665.556756756757,953.189189189189,457.545945945946,355.751351351351,1030.32432432432,130.372972972973,185,24.4471283866949,9.85532021706589,0.915143635448522,0.911330049261084,0.672727272727273,-1.54591764081088,53747.3297297297,32579.1135135135,FAAGSCC_12,AG,1,M2 macrophages,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_428254,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
428529,2646.11805555556,358.232638888889,181.416666666667,679.940972222222,2463.28472222222,724.190972222222,719.798611111111,238.854166666667,1080.44444444444,3948.21875,1251.69444444444,126.434027777778,1089.68402777778,1487.87847222222,1233.07638888889,1064.48263888889,1845.1875,1194.04861111111,315.625,232.965277777778,999.190972222222,1082.52083333333,233.638888888889,193.986111111111,610.232638888889,1228.96180555556,530.482638888889,1257.9375,1049.35416666667,130.430555555556,288,20.9940478886435,17.4753726494458,0.55418048861956,0.966442953020134,0.8,-1.01068610086495,53311.7777777778,33555.3645833333,FAAGSCC_12,AG,1,dendritic cells,,TIM3+,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,dendritic cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_428529,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
428708,1148.59405940594,84.7986798679868,100.887788778878,692.660066006601,4589.88778877888,246.940594059406,253.409240924092,247.184818481848,1083.30363036304,3065.59405940594,715.897689768977,124.122112211221,1071.16501650165,557.663366336634,416.907590759076,260.904290429043,1384.30363036304,849.660066006601,226.287128712871,211.39603960396,972.075907590759,789.194719471947,181.075907590759,114.594059405941,585.83498349835,1567.21452145215,480.808580858086,233.706270627063,1055.54785478548,129.693069306931,303,25.4600202368435,15.330782437018,0.798382050935996,0.961904761904762,0.687074829931973,0.802564569953194,54017.0396039604,32535.9174917492,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_428708,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
428978,3747.56065573771,869.868852459016,151.580327868852,667.196721311475,3031.35081967213,954.56393442623,337.583606557377,251.419672131148,1103.6262295082,6685.75409836066,741.665573770492,126.032786885246,1075.04590163934,665.239344262295,431.859016393443,270.327868852459,1568.57704918033,863.318032786885,192.003278688525,205.927868852459,998.281967213115,735.27868852459,150.304918032787,254.993442622951,736.793442622951,2191.06557377049,526.16393442623,287.940983606557,1050.16393442623,129.852459016393,305,21.0288018192554,18.5545475696345,0.470612983104652,0.962145110410095,0.802631578947368,-0.47668082651595,53186.7836065574,33216.5737704918,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_428978,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
429259,490.832835820896,1006.80895522388,236.280597014925,605.662686567164,99.1253731343284,294.817910447761,419.689552238806,249.083582089552,1079.42686567164,933.029850746269,1821.09253731343,103.373134328358,1063.28656716418,651.985074626866,654.453731343284,549.925373134328,1414.89253731343,991.808955223881,309.414925373134,228.423880597015,982.988059701492,987.226865671642,237.859701492537,137.229850746269,608.788059701493,573.823880597015,364.653731343284,207.8,979.540298507463,128.205970149254,335,22.2792640089898,19.176515767755,0.509055311715564,0.968208092485549,0.801435406698565,-0.0787493051942392,53320.2029850746,33006.6059701493,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_429259,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
429617,1469.17299578059,111.075949367089,73.4810126582279,655.168776371308,2049.29113924051,334.451476793249,372.848101265823,238.666666666667,1082.70886075949,2452.45147679325,698.367088607595,113.949367088608,1078.45147679325,788.35864978903,514.194092827004,281.438818565401,1834.35864978903,1241.37974683544,301.291139240506,236.95358649789,1000.64135021097,1148.38396624473,231.848101265823,195.666666666667,638.253164556962,863.354430379747,434.869198312236,262.784810126582,1031.99578059072,129.540084388186,237,19.5426327596368,15.5559570480933,0.605295183377711,0.959514170040486,0.740625,-0.268517179917813,53098.6708860759,33563.5105485232,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_429617,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
430110,1715.01287553648,192.450643776824,129.952789699571,653.832618025751,1532.65665236051,937.223175965665,1079.59227467811,240.334763948498,1108.70815450644,2927.27038626609,599.858369098713,119.587982832618,1091.9356223176,2168.85836909871,930.304721030043,1037.67381974249,1666.81974248927,4845.82832618026,379.459227467811,243.459227467811,1069.92274678112,3839.98712446352,306.472103004292,489.042918454936,757.042918454936,1139.18025751073,515.167381974249,1188.65236051502,1062.4635193133,132.845493562232,233,20.186909425592,14.8618041456351,0.676753181138809,0.966804979253112,0.766447368421053,-0.527990568285618,53327.8068669528,33566.7596566524,FAAGSCC_12,AG,1,dendritic cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,dendritic cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_430110,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
430579,5230.04182509506,432.346007604563,163.623574144487,661.673003802281,2640.82509505703,4216.92395437262,742.32319391635,265.307984790875,1143.90114068441,8430.06463878327,594.604562737643,146.897338403042,1107.82129277567,4176.88212927757,1018.09885931559,1137.0,5472.3536121673,5474.38783269962,400.93536121673,241.615969581749,1068.95057034221,4698.54372623574,274.285171102662,450.520912547528,621.243346007605,3540.65399239544,574.992395437262,309.022813688213,1092.26235741445,130.623574144487,263,19.5747842344163,17.3250881234269,0.465454653926932,0.963369963369963,0.769005847953216,-1.033503468974,53195.4448669202,33917.8288973384,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_430579,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
431015,2673.8126984127,310.615873015873,143.298412698413,666.701587301587,3595.80317460317,1529.40634920635,707.965079365079,265.406349206349,1085.6,4510.3873015873,516.44126984127,124.660317460317,1067.75238095238,748.425396825397,455.726984126984,287.174603174603,1404.26031746032,910.180952380952,259.949206349206,219.644444444444,981.098412698413,848.828571428571,188.647619047619,108.314285714286,589.549206349206,1573.8126984127,488.707936507936,258.72380952381,1058.46349206349,132.434920634921,315,22.675931295271,17.7124051259822,0.624392974813193,0.969230769230769,0.842245989304813,-0.119551110678589,53725.8476190476,32258.2634920635,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_431015,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
431406,1419.115,90.29,53.92,653.68,1942.82,4706.44,450.085,257.13,1108.445,2623.36,460.22,105.96,1082.285,6034.705,771.415,309.92,6279.865,3521.405,320.295,230.26,1059.855,3045.145,228.735,337.74,640.17,916.43,423.44,887.47,1027.2,128.255,200,17.1241341865607,14.9519907825233,0.487446069655283,0.961538461538462,0.784313725490196,-1.55369621459798,53614.905,33621.69,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_431406,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
431919,597.387409200968,1122.11622276029,258.733656174334,626.266343825666,109.612590799031,577.513317191283,321.789346246973,261.300242130751,1110.70702179177,1412.81113801453,842.869249394673,115.331719128329,1062.21065375303,991.484261501211,559.389830508475,269.593220338983,1622.91283292978,1446.84261501211,290.239709443099,225.26392251816,1023.85714285714,1321.4382566586,198.273607748184,1130.55205811138,815.302663438257,570.82808716707,362.050847457627,205.690072639225,988.351089588378,128.452784503632,413,27.262424324725,19.4020804194407,0.702505342320989,0.956018518518518,0.756410256410256,0.362345233270979,53669.4576271186,32676.4963680387,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_431919,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
433390,4346.70550161812,912.333333333333,255.741100323625,711.142394822007,5079.75404530744,5948.07766990291,958.715210355987,285.252427184466,1174.44336569579,6955.90291262136,652.294498381877,133.46925566343,1078.29126213592,7273.14239482201,1275.85113268608,376.46925566343,13795.3851132686,4558.22653721683,410.809061488673,242.391585760518,1038.23300970874,3069.30097087379,244.472491909385,175.990291262136,616.271844660194,1985.23300970874,544.644012944984,251.411003236246,1069.13268608414,132.058252427184,309,20.9476024378776,18.8446659366352,0.436694885164426,0.965625,0.7725,0.643392011174915,52760.213592233,33546.4595469256,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3+,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_433390,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
433953,1107.08333333333,398.948717948718,90.9807692307692,623.871794871795,725.032051282051,1822.25641025641,643.820512820513,261.320512820513,1090.92307692308,2426.12820512821,2767.76282051282,116.288461538462,1062.30769230769,638.121794871795,434.410256410256,283.070512820513,1396.96794871795,966.269230769231,268.576923076923,221.153846153846,991.711538461538,926.865384615385,205.596153846154,155.788461538462,611.365384615385,1214.6858974359,456.474358974359,471.442307692308,1034.24358974359,128.070512820513,156,16.2994031310846,12.2064507192487,0.662694968835351,0.939759036144578,0.75,1.49649512955072,52664.2884615385,32340.8397435897,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_433953,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
434209,2182.0,605.745843230404,104.767220902613,638.995249406176,1483.66508313539,2174.41567695962,353.681710213777,251.356294536817,1092.99287410926,2792.20427553444,716.641330166271,119.776722090261,1069.3919239905,1686.7458432304,586.503562945368,290.384798099762,1746.53206650831,1608.77434679335,310.294536817102,229.978622327791,1032.10213776722,1629.15914489311,223.249406175772,184.70783847981,3581.86698337292,942.330166270784,532.463182897862,359.076009501188,1022.57719714964,129.926365795724,421,25.5206334629445,21.0195246463178,0.567129493488534,0.974537037037037,0.797348484848485,0.941645558277707,53661.6983372922,33652.6104513064,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_434209,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
434277,4169.19166666667,1005.21666666667,154.758333333333,644.616666666667,1572.7,714.191666666667,835.35,251.725,1091.06666666667,5967.29166666667,650.633333333333,134.433333333333,1080.35833333333,1062.41666666667,1003.90833333333,1895.78333333333,1921.9,1403.025,319.641666666667,233.591666666667,1035.90833333333,1228.45,227.758333333333,214.333333333333,675.9,1643.525,560.825,273.241666666667,1065.625,133.416666666667,120,16.499804917772,9.93622966208454,0.798343108552264,0.869565217391304,0.576923076923077,-0.470896679971661,53305.325,33657.5166666667,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_434277,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
434501,4490.73387096774,935.45564516129,2256.91935483871,726.693548387097,5945.48387096774,664.927419354839,2011.07258064516,246.814516129032,1104.43548387097,6451.26612903226,615.991935483871,136.495967741935,1072.07661290323,3393.875,1237.78629032258,1401.76209677419,2475.87903225806,6630.52016129032,456.193548387097,249.858870967742,1056.64516129032,6430.85887096774,273.616935483871,331.778225806452,702.040322580645,1352.86290322581,491.604838709677,245.447580645161,1055.28629032258,131.165322580645,248,20.535668173827,15.7926426079388,0.639206962356391,0.953846153846154,0.688888888888889,-1.06672117692743,52794.5443548387,33656.0927419355,FAAGSCC_12,AG,1,regulatory T cells,,TIM3+,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,9,FAAGSCC_12_434501,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
435581,2868.90256410256,127.310256410256,197.558974358974,744.820512820513,7994.32307692308,655.397435897436,398.725641025641,273.228205128205,1136.71538461538,4845.43846153846,700.369230769231,142.223076923077,1071.71282051282,1011.42820512821,601.382051282051,277.107692307692,1814.51025641026,1384.08974358974,317.023076923077,234.379487179487,1052.96666666667,1190.33846153846,226.402564102564,487.071794871795,1617.03333333333,923.54358974359,447.717948717949,270.410256410256,1054.67179487179,130.064102564103,390,34.3129775473176,14.5365333312859,0.905828139709664,0.944309927360775,0.696428571428571,-1.43236355092983,53295.4435897436,32705.3717948718,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,7,FAAGSCC_12_435581,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
435961,3094.13099041534,459.067092651757,138.875399361022,643.466453674121,2451.56869009585,1497.72523961661,2005.95846645367,259.153354632588,1089.34504792332,4464.74440894569,1320.74440894569,119.054313099042,1073.11182108626,775.607028753994,523.309904153355,336.581469648562,1411.28434504792,1001.5303514377,279.702875399361,222.162939297125,989.779552715655,920.482428115016,208.91054313099,132.718849840256,598.990415335463,997.300319488818,444.488817891374,324.070287539936,1038.14696485623,130.41214057508,313,23.8347549534073,16.8529087651289,0.707140683427318,0.963076923076923,0.767156862745098,-0.0041888279648142,53444.4984025559,32732.4440894569,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_435961,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
436614,3165.51269035533,369.269035532995,99.9670050761421,626.106598984772,1256.41370558376,3248.57868020305,983.497461928934,260.159898477157,1163.89593908629,4337.65736040609,862.482233502538,117.657360406091,1149.56091370558,4024.34517766498,769.720812182741,758.639593908629,2676.29695431472,5428.1421319797,376.116751269036,237.492385786802,1067.73350253807,4121.53299492386,240.482233502538,355.928934010152,603.944162436548,852.07614213198,430.296954314721,411.11421319797,1026.2614213198,129.682741116751,394,30.3376922102661,16.7881677568084,0.832931199276121,0.953995157384988,0.703571428571429,1.18280509620009,53367.6319796954,33653.9492385787,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_436614,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
436758,4005.30769230769,603.692307692308,74.1083916083916,618.496503496503,752.562937062937,345.22027972028,651.048951048951,242.755244755245,1074.90909090909,6359.87062937063,591.447552447552,128.797202797203,1082.12237762238,731.083916083916,497.93006993007,409.181818181818,1689.01048951049,1152.95104895105,259.017482517483,222.506993006993,1017.14685314685,1125.45454545455,207.681818181818,199.027972027972,642.590909090909,2590.4965034965,535.867132867133,298.737762237762,1064.78321678322,130.13986013986,286,26.0645909484765,14.040558031863,0.842508384578026,0.943894389438944,0.619047619047619,0.708347031561318,53142.3636363636,33720.0979020979,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_436758,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
436767,1580.78313253012,271.66265060241,95.7289156626506,616.16265060241,703.819277108434,1329.85542168675,321.331325301205,269.228915662651,1084.0421686747,2797.16265060241,661.289156626506,118.05421686747,1070.27710843373,1101.75301204819,628.048192771084,279.379518072289,2037.39156626506,1460.14457831325,362.638554216867,234.825301204819,1048.04819277108,1184.87951807229,220.728915662651,200.361445783132,2407.0843373494,1129.25903614458,436.771084337349,224.132530120482,1051.09638554217,130.524096385542,166,15.7922646089685,13.4348833245522,0.525610124611434,0.959537572254335,0.79047619047619,1.22870091325063,53096.2048192771,32067.6204819277,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,1,FAAGSCC_12_436767,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
436869,3954.05538461538,231.538461538462,96.76,626.301538461538,933.126153846154,1034.95076923077,297.926153846154,247.246153846154,1090.50769230769,7087.67076923077,577.304615384615,137.067692307692,1077.43692307692,1040.64615384615,636.443076923077,283.547692307692,1919.65538461538,1953.20923076923,342.421538461538,237.88,1025.07384615385,1961.17846153846,245.624615384615,329.790769230769,1367.42769230769,3102.61538461538,576.418461538462,343.073846153846,1107.08615384615,131.556923076923,325,24.7665548531034,17.0941343550142,0.723608712630374,0.928571428571429,0.722222222222222,-0.0354752318865354,52987.6523076923,33833.52,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_436869,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
437006,5551.40816326531,684.872448979592,144.323979591837,664.104591836735,3199.27040816327,255.849489795918,250.066326530612,235.418367346939,1083.5637755102,10053.9285714286,2510.84948979592,140.339285714286,1077.29081632653,549.323979591837,373.352040816327,264.553571428571,1413.77040816327,917.52806122449,270.5,223.436224489796,977.076530612245,777.06887755102,178.737244897959,139.265306122449,585.857142857143,3621.93367346939,560.397959183673,445.224489795918,1212.83928571429,131.709183673469,392,29.616294923189,17.5192261273791,0.806275577839292,0.91588785046729,0.687719298245614,0.008755397039692,53093.9719387755,33032.7551020408,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_437006,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
437030,3734.69759450172,657.862542955326,69.7628865979381,638.487972508591,1390.80756013746,467.378006872852,358.113402061856,245.642611683849,1214.74914089347,5366.76632302406,643.86941580756,121.189003436426,1079.62199312715,3856.19587628866,911.189003436426,342.666666666667,2576.01718213058,3493.70790378007,380.917525773196,241.594501718213,1026.85910652921,2515.64261168385,233.501718213058,219.171821305842,590.333333333333,810.364261168385,405.481099656357,230.06529209622,1021.50515463918,130.573883161512,291,22.6467768518404,16.3941200654075,0.68989943248776,0.97,0.826704545454545,0.0464449948850594,52716.8659793814,33554.5360824742,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_437030,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
437062,670.833333333333,93.4880952380952,98.7380952380952,652.39880952381,2437.3630952381,1005.2619047619,1282.54166666667,248.565476190476,1094.93452380952,1868.84523809524,526.47619047619,115.607142857143,1068.58928571429,3187.26785714286,1482.69642857143,2399.66666666667,2316.16666666667,3238.77380952381,361.761904761905,237.744047619048,1078.57142857143,2525.45238095238,243.910714285714,488.982142857143,616.779761904762,1233.3630952381,489.845238095238,347.803571428571,1036.75595238095,129.666666666667,168,15.36773682063,13.9116058882696,0.424884571219885,0.954545454545455,0.8,1.25246434752832,53690.9761904762,33339.5178571429,FAAGSCC_12,AG,1,M2 macrophages,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_437062,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
437620,1987.52866242038,835.875796178344,97.2452229299363,627.286624203822,1143.00318471338,2032.13694267516,2391.6050955414,264.031847133758,1089.87898089172,2191.30891719745,659.082802547771,116.070063694268,1079.35668789809,2031.54140127388,755.363057324841,765.595541401274,1511.49681528662,1212.29299363057,251.426751592357,217.570063694268,1000.69426751592,1079.77707006369,188.353503184713,332.417197452229,677.366242038217,746.796178343949,383.608280254777,220.888535031847,1025.92675159236,130.875796178344,314,23.9619325477329,16.7289860573904,0.715953030815896,0.951515151515152,0.712018140589569,-0.715791688776399,52695.703821656,32420.7738853503,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_437620,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
438547,2755.42335766423,234.248175182482,85.2846715328467,624.839416058394,1277.44890510949,824.127737226277,2982.43795620438,256.412408759124,1095.52919708029,5289.7700729927,613.186131386861,112.153284671533,1087.49635036496,1307.07664233577,1144.44160583942,1854.59124087591,1799.05839416058,1704.21167883212,341.149635036496,247.076642335766,1041.37591240876,1411.74817518248,240.237226277372,1145.52919708029,729.981751824817,2383.36131386861,494.029197080292,255.788321167883,1026.83576642336,129.704379562044,274,20.2329554271445,17.6694566433347,0.487181353371089,0.958041958041958,0.761111111111111,1.10350763278284,53553.2189781022,33433.0802919708,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_438547,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
438742,2444.64079822616,282.190687361419,85.5676274944568,636.831485587583,1233.50332594235,743.753880266075,399.822616407982,274.742793791574,1128.53215077605,3712.35033259424,1248.35476718404,122.658536585366,1066.32372505543,1356.81596452328,868.175166297117,291.878048780488,2114.37694013304,2022.07538802661,309.50332594235,227.576496674058,1075.20177383592,1327.26164079823,198.050997782705,203.645232815965,2822.9800443459,929.075388026608,422.773835920177,266.319290465632,1043.67627494457,130.521064301552,451,27.381228081779,21.3816174673973,0.62467356808706,0.953488372093023,0.784347826086957,0.514505123269258,52877.7361419069,32311.199556541,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_438742,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
439421,2865.83673469388,338.913265306122,113.946428571429,659.19387755102,1647.78826530612,2284.41071428571,1599.98724489796,250.479591836735,1127.78316326531,4957.72448979592,1159.79081632653,125.160714285714,1087.37755102041,2865.17091836735,931.844387755102,1124.72704081633,2147.58418367347,4738.75255102041,384.119897959184,245.326530612245,1066.09948979592,4022.22448979592,257.571428571429,395.285714285714,609.34693877551,2060.92091836735,519.540816326531,666.400510204082,1077.62755102041,129.155612244898,392,26.8496954978567,18.6247031106026,0.720297437486721,0.96551724137931,0.710144927536232,0.876864650111021,53398.4821428571,33715.4107142857,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_439421,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
439531,3168.08070175439,571.905263157895,106.533333333333,622.926315789474,1311.69122807018,453.024561403509,771.063157894737,237.543859649123,1094.4350877193,4219.98947368421,630.322807017544,123.564912280702,1088.49824561404,3090.10877192982,1060.96140350877,2439.60701754386,2087.92280701754,5319.75438596491,433.919298245614,250.39298245614,1109.31228070175,4311.21754385965,292.157894736842,449.775438596491,739.084210526316,1042.42456140351,492.361403508772,250.077192982456,1016.50526315789,129.870175438597,285,20.6336420008278,17.7944313394721,0.50622923568449,0.95,0.75,0.726254817641536,53129.1754385965,33698.1614035088,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_439531,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
439541,2094.33505154639,243.175257731959,89.0541237113402,634.394329896907,1767.07216494845,639.247422680412,538.587628865979,244.301546391753,1100.75257731959,3996.69329896907,1086.62113402062,114.180412371134,1068.35567010309,1870.42010309278,859.432989690722,309.34793814433,3329.01546391753,3481.23453608247,333.474226804124,233.494845360825,1025.39175257732,3477.94587628866,244.146907216495,192.270618556701,617.247422680412,1451.38402061856,458.505154639175,353.242268041237,1064.24742268041,131.033505154639,388,29.9156407780995,16.7109687760804,0.829435115196114,0.974874371859296,0.646666666666667,-0.734082586123685,52925.2809278351,33389.412371134,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_439541,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
439795,1674.29249011858,116.600790513834,92.802371541502,638.928853754941,1272.54545454545,2803.41501976285,815.683794466403,251.95256916996,1103.13438735178,2497.27272727273,558.940711462451,127.750988142292,1079.73913043478,4872.52964426877,640.478260869565,526.193675889328,2772.13833992095,6129.82213438735,439.707509881423,240.134387351779,1061.78260869565,4605.37154150198,254.845849802372,212.252964426877,610.312252964427,1068.33201581028,484.513833992095,266.913043478261,1022.77470355731,131.079051383399,253,20.0194860237057,16.4399304372316,0.570645620904301,0.947565543071161,0.702777777777778,0.984483328591366,53195.0750988142,33879.4150197628,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_439795,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
440284,1042.26339285714,246.34375,94.7410714285714,639.21875,1638.53571428571,317.446428571429,271.959821428571,243.616071428571,1104.50892857143,2388.25446428571,2272.55803571429,108.071428571429,1069.66964285714,652.71875,395.133928571429,264.584821428571,1422.86607142857,882.638392857143,202.334821428571,206.5,1143.73214285714,651.241071428571,142.276785714286,123.714285714286,589.397321428571,1191.66517857143,460.285714285714,442.209821428571,1031.75892857143,129.821428571429,224,19.2227065930455,14.870175438246,0.633706650593448,0.96969696969697,0.82962962962963,1.25557520785085,53337.2455357143,33114.0848214286,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_440284,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
440762,1419.5842217484,296.053304904051,105.460554371002,634.808102345416,773.626865671642,606.963752665245,402.464818763326,282.168443496802,1134.00639658849,3137.56929637527,2456.69722814499,212.925373134328,1088.87420042644,1135.55010660981,541.914712153518,298.936034115139,1739.12793176972,1722.08315565032,323.901918976546,300.454157782516,1052.94882729211,1098.96375266525,212.744136460554,182.441364605544,654.865671641791,794.759061833689,392.537313432836,206.473347547974,1038.11513859275,129.023454157783,469,28.4038102689962,21.0482603585843,0.671464738240711,0.96701030927835,0.78956228956229,-1.15928177678549,53036.9296375266,32057.5799573561,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,1,FAAGSCC_12_440762,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
441014,3228.43188405797,901.405797101449,99.2,620.684057971014,772.078260869565,603.08115942029,386.023188405797,255.4,1091.75362318841,4215.15652173913,601.979710144927,125.026086956522,1083.06666666667,2923.55072463768,644.446376811594,296.855072463768,5719.51014492754,3823.8231884058,364.628985507246,237.979710144928,1011.04057971014,2781.27826086957,250.611594202898,180.527536231884,607.405797101449,967.907246376812,487.086956521739,230.188405797101,1030.97101449275,130.034782608696,345,24.3428808658732,18.187210906098,0.6646818954684,0.958333333333333,0.71875,0.512200750795522,53166.5014492754,33371.8173913044,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_441014,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
441261,3065.29616724739,256.466898954704,108.104529616725,699.400696864112,4311.56794425087,671.04181184669,279.365853658537,245.11149825784,1084.09059233449,5017.63763066202,678.229965156794,148.289198606272,1079.66550522648,1368.97909407665,582.310104529617,312.303135888502,1549.81881533101,3067.01742160279,361.278745644599,242.243902439024,1005.49128919861,2550.84668989547,248.261324041812,205.655052264808,671.898954703833,1744.80487804878,531.592334494773,344.188153310104,1074.48780487805,130.090592334495,287,31.0550466186474,11.8379518119735,0.924495675776037,0.947194719471947,0.771505376344086,-1.51214735950945,52842.7595818815,33302.606271777,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_441261,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
441440,3040.09624413146,200.734741784038,70.7441314553991,629.866197183099,1331.14084507042,570.537558685446,370.12676056338,269.558685446009,1129.10563380282,5164.96478873239,627.593896713615,126.514084507042,1067.51408450704,1161.69953051643,601.112676056338,297.053990610329,1852.59389671362,1169.46478873239,274.922535211268,222.786384976526,1022.71361502347,891.279342723005,196.962441314554,141.617370892019,839.619718309859,1374.42488262911,468.044600938967,223.237089201878,1049.45539906103,131.657276995305,426,36.6900665837263,15.0011411395407,0.912596623600306,0.93421052631579,0.57258064516129,1.05140483977144,52426.3920187793,32500.6995305164,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_441440,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
441591,1111.44052863436,211.757709251101,98.5374449339207,617.916299559471,1283.42731277533,529.330396475771,362.845814977974,265.757709251101,1125.70044052863,1708.33480176211,740.977973568282,116.95154185022,1066.31718061674,990.894273127753,530.779735682819,281.850220264317,1569.90308370044,1031.26872246696,211.550660792952,212.73127753304,1231.0704845815,629.105726872247,132.400881057269,98.3480176211454,678.185022026432,833.95154185022,429.753303964758,212.167400881057,1022.57709251101,129.092511013216,227,21.268799922724,13.6098726252714,0.768459460424588,0.94979079497908,0.667647058823529,-0.916308086186899,53071.577092511,32375.3083700441,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,7,FAAGSCC_12_441591,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
441716,2808.79792746114,389.927461139896,152.528497409326,635.331606217617,1965.36269430052,818.020725388601,463.186528497409,243.616580310881,1090.12435233161,4044.76683937824,676.139896373057,126.336787564767,1076.14507772021,629.756476683938,843.59067357513,627.875647668394,1960.63730569948,1128.10880829016,254.860103626943,216.062176165803,1017.73056994819,974.99481865285,186.497409326425,457.165803108808,797.658031088083,1348.54404145078,527.295336787565,231.424870466321,1039.20725388601,129.383419689119,193,19.3556747262951,12.7841829805385,0.750836960706212,0.946078431372549,0.725563909774436,0.411211375113229,53885.8652849741,33028.2487046632,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_441716,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
441740,2200.7,214.477777777778,186.392063492063,718.585714285714,5970.12380952381,574.996825396825,737.928571428571,244.749206349206,1101.96031746032,3962.41587301587,769.471428571429,150.225396825397,1077.1126984127,1938.46825396825,666.430158730159,441.669841269841,2216.55555555556,2489.30476190476,349.246031746032,241.149206349206,1002.44285714286,2581.85714285714,262.893650793651,262.28253968254,604.633333333333,1448.64126984127,510.865079365079,374.463492063492,1083.75396825397,131.547619047619,630,34.1648304147672,23.6665003543291,0.72121115437825,0.963302752293578,0.729166666666667,1.0685535722643,52810.0031746032,33789.5492063492,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_441740,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
441794,3333.2311827957,707.075268817204,196.306451612903,647.268817204301,2225.33870967742,316.440860215054,315.489247311828,266.586021505376,1089.18279569892,3948.10215053763,1067.83870967742,131.258064516129,1076.72043010753,675.005376344086,538.376344086022,274.263440860215,1430.51612903226,1055.55376344086,333.736559139785,227.97311827957,982.069892473118,932.456989247312,223.435483870968,119.317204301075,586.790322580645,773.715053763441,449.338709677419,216.317204301075,1022.37634408602,130.064516129032,186,19.6742574415347,12.0672766549298,0.789808432315101,0.963730569948186,0.753036437246964,-0.406396910212177,53481.9086021505,32063.6344086021,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_441794,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
442063,2070.13875598086,463.492822966507,96.4736842105263,677.99043062201,1779.12918660287,2513.83253588517,991.602870813397,263.535885167464,1159.54545454545,3149.53588516746,1143.91387559809,131.387559808612,1085.90909090909,4086.88995215311,1373.22009569378,2780.83253588517,2340.004784689,6235.05263157895,474.44019138756,257.124401913876,1087.72248803828,5702.65071770335,307.358851674641,1546.50717703349,875.703349282297,1146.81339712919,491.057416267943,1190.1004784689,1050.16746411483,129.703349282297,209,18.0576536820193,14.8077377741664,0.572326884451184,0.972093023255814,0.768382352941177,0.717337758901509,53463.1674641148,33843.1100478469,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1+,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_442063,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
442138,2852.41140529532,374.955193482688,132.922606924644,675.513238289206,2253.64154786151,1857.46435845214,312.281059063136,258.802443991853,1100.92871690428,5629.66395112016,3459.48268839104,119.720977596741,1082.52138492872,2861.69857433809,873.429735234216,305.820773930754,3822.28105906314,5093.20570264766,359.9816700611,230.380855397149,1023.96537678208,4607.89409368635,243.875763747454,161.696537678208,598.792260692464,1714.97759674134,492.130346232179,512.37067209776,1056.8350305499,129.698574338086,491,37.4418556711694,16.7716581118625,0.894064245017378,0.958984375,0.595151515151515,0.557601577644643,54019.8716904277,32833.8961303462,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_442138,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
442196,2009.74608695652,209.166956521739,96.4939130434783,647.213913043478,2067.62782608696,1974.30260869565,324.349565217391,266.266086956522,1081.90434782609,2843.38782608696,1336.71304347826,126.92347826087,1074.81391304348,981.022608695652,508.255652173913,264.08,1445.93043478261,1178.45739130435,300.846956521739,225.845217391304,981.330434782609,1077.04,212.544347826087,120.953043478261,584.144347826087,1027.21043478261,459.817391304348,274.095652173913,1039.64869565217,129.606956521739,575,39.92372225316,18.4520377596293,0.886784935559229,0.968013468013468,0.720551378446115,0.288283095776944,53524.707826087,32270.6434782609,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_442196,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
442415,1782.89098532495,622.75890985325,80.8930817610063,614.857442348008,690.492662473795,288.115303983229,444.494758909853,246.767295597484,1079.45283018868,2068.14465408805,807.974842767296,115.220125786164,1064.72955974843,646.230607966457,481.230607966457,273.094339622641,1459.18658280922,1017.96645702306,273.522012578616,227.329140461216,991.486373165618,953.136268343816,211.989517819706,130.809224318658,632.542976939203,736.647798742138,420.134171907757,231.809224318658,1003.4821802935,128.805031446541,477,26.1450188139191,23.2460025897682,0.457678348846239,0.967545638945233,0.797658862876254,-0.109281470212989,53424.7610062893,33317.7211740042,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_442415,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
443145,1597.30165289256,411.595041322314,99.1570247933884,618.871900826446,652.685950413223,340.107438016529,391.714876033058,262.210743801653,1081.81404958678,3333.77272727273,1173.53719008264,121.330578512397,1065.6652892562,753.528925619835,641.669421487603,275.971074380165,1528.31404958678,1074.7520661157,299.545454545455,225.867768595041,993.293388429752,994.53305785124,221.00826446281,132.293388429752,585.628099173554,1206.45454545455,515.268595041322,343.413223140496,1034.65289256198,130.342975206612,242,19.8718822221822,15.5547609798697,0.622333414643554,0.96031746031746,0.806666666666667,0.005568148134894,53044.7644628099,33168.9628099174,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,9,FAAGSCC_12_443145,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
443578,4739.8375,1032.36875,1095.04375,657.234375,2314.034375,1275.6875,543.565625,253.29375,1083.596875,8359.9125,936.3125,130.528125,1081.115625,3567.346875,627.24375,449.959375,1596.5625,4343.475,378.11875,241.04375,1053.3375,3675.596875,243.575,621.55625,1008.48125,2451.953125,539.934375,273.096875,1074.328125,130.778125,320,23.0328461038854,17.941646743115,0.627074642656102,0.960960960960961,0.76555023923445,-1.08163348043803,53386.921875,32769.378125,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_443578,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
443789,925.798816568047,898.538461538462,407.988165680473,666.047337278107,3544.86982248521,1923.79289940828,795.804733727811,260.076923076923,1113.1124260355,1340.27810650888,589.201183431953,124.284023668639,1073.34319526627,807.733727810651,494.207100591716,290.751479289941,1383.63905325444,1168.28402366864,314.230769230769,233.289940828402,982.621301775148,1082.49112426036,231.094674556213,125.603550295858,584.426035502959,1005.95266272189,521.745562130178,241.360946745562,1015.65088757396,128.958579881657,169,15.9819126847452,13.4866513842829,0.536548208406716,0.949438202247191,0.754464285714286,0.10658107303288,53841.6153846154,33230.325443787,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_443789,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
443972,2354.00722021661,463.783393501805,156.212996389892,652.602888086643,2446.95667870036,4493.71119133574,1285.50902527076,269.440433212996,1173.09025270758,3675.8916967509,546.599277978339,119.768953068592,1114.10469314079,1901.09386281588,1057.60288808664,1417.03249097473,1776.27797833935,1274.20577617329,292.079422382671,228.57761732852,1010.85559566787,1010.80866425993,216.960288808664,157.321299638989,631.613718411552,1231.32129963899,503.321299638989,234.487364620939,1036.15523465704,130.212996389892,277,20.4638699755905,17.3907211834616,0.527063942506664,0.961805555555556,0.732804232804233,-1.43519404059504,53196.274368231,33292.8916967509,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_443972,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
444915,1353.87951807229,252.192771084337,142.171084337349,652.997590361446,2653.83373493976,240.392771084337,265.332530120482,243.443373493976,1077.54939759036,3052.05301204819,560.973493975904,121.580722891566,1082.6313253012,550.250602409639,428.532530120482,275.920481927711,1432.1734939759,883.527710843373,242.95421686747,219.951807228916,983.55421686747,801.055421686747,178.971084337349,147.361445783133,586.163855421687,1792.98795180723,516.510843373494,227.959036144578,1056.36385542169,129.132530120482,415,25.1254276971733,21.3129249064559,0.529578108689096,0.965116279069768,0.754545454545455,0.166299286119725,52854.5108433735,33044.4072289157,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_444915,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
445452,2895.01357466063,406.194570135747,188.502262443439,693.171945701357,4357.47511312217,3001.45701357466,891.185520361991,267.253393665158,1100.09049773756,5552.58371040724,763.203619909502,130.298642533937,1068.99095022624,1305.10407239819,575.339366515837,750.262443438914,1829.2036199095,1322.03619909502,275.68778280543,323.280542986425,1115.30316742081,969.298642533937,189.158371040724,142.407239819005,2984.52036199095,1730.70135746606,482.615384615385,329.307692307692,1074.65158371041,131.009049773756,221,18.0289942726494,15.6675284686533,0.494779700271915,0.956709956709957,0.767361111111111,1.03673734251917,52719.6696832579,32955.1447963801,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_445452,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
445672,528.965417867435,999.345821325648,237.838616714697,617.487031700288,165.827089337176,984.648414985591,371.270893371758,268.821325648415,1110.13544668588,1132.0288184438,2188.00576368876,116.729106628242,1065.87031700288,1342.11239193084,728.123919308357,284.847262247839,1723.2939481268,990.596541786744,265.556195965418,225.71181556196,1007.71757925072,827.936599423631,189.544668587896,172.207492795389,736.328530259366,776.907780979827,396.602305475504,215.553314121037,1039.08069164265,131.510086455331,347,24.6668746031626,17.9481679150538,0.6859779846871,0.955922865013774,0.771111111111111,1.36762750887488,52436.8933717579,32464.7608069164,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_445672,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
446064,2557.41052631579,228.026315789474,144.1,668.789473684211,3504.90526315789,292.705263157895,389.163157894737,257.026315789474,1087.68947368421,3419.44210526316,568.457894736842,142.952631578947,1066.20526315789,714.91052631579,519.478947368421,269.668421052632,1538.19473684211,1148.22105263158,301.468421052632,224.836842105263,987.936842105263,1070.66315789474,215.321052631579,188.042105263158,692.505263157895,1262.09473684211,481.321052631579,220.984210526316,1060.44736842105,131.694736842105,190,19.6492636292118,12.3298957021708,0.778617268092302,0.945273631840796,0.703703703703704,-0.936911761453721,53907.9684210526,32391.2578947368,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,7,FAAGSCC_12_446064,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
446604,2410.35040431267,194.471698113208,122.929919137466,676.482479784367,4115.0539083558,840.716981132075,946.118598382749,245.929919137466,1090.46361185984,3796.22102425876,597.436657681941,119.905660377358,1072.88948787062,1270.99730458221,545.563342318059,393.094339622641,2655.74393530997,1738.8167115903,330.474393530997,232.835579514825,1011.55525606469,1335.7628032345,224.811320754717,189.008086253369,604.123989218329,1118.42587601078,467.819407008086,312.210242587601,1054.01347708895,129.353099730458,371,27.0709731766828,17.6562789282817,0.758028178882246,0.961139896373057,0.701323251417769,0.828251091744838,53866.1320754717,33605.4258760108,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_446604,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
446719,2397.61721611722,647.763736263736,740.027472527473,618.078754578755,794.950549450549,272.538461538462,283.847985347985,258.934065934066,1081.12637362637,2970.48168498168,1177.26923076923,126.64652014652,1071.41758241758,649.765567765568,579.642857142857,270.135531135531,1401.20695970696,1029.67765567766,313.725274725275,228.322344322344,986.970695970696,1034.88461538462,229.080586080586,117.064102564103,586.001831501831,958.736263736264,503.161172161172,255.483516483516,1015.23626373626,131.091575091575,546,29.394726432924,23.724709423741,0.590404263729291,0.969804618117229,0.777777777777778,-0.942262687163557,53264.4157509158,32454.3003663004,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_446719,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
447953,1503.73059360731,263.164383561644,122.34703196347,653.584474885845,3037.74885844749,260.191780821918,276.831050228311,252.287671232877,1085.38812785388,3148.23287671233,607.401826484018,138.611872146119,1066.50228310502,688.931506849315,558.132420091324,273.223744292237,1454.60730593607,984.438356164384,298.068493150685,223.904109589041,983.155251141552,847.543378995434,196.173515981735,125.036529680365,588.675799086758,1572.35159817352,471.050228310502,217.821917808219,1058.85844748858,130.543378995434,219,20.208899518255,13.8261657052003,0.72932986142701,0.960526315789474,0.715686274509804,-0.700362553913865,53394.6803652968,32153.3105022831,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_447953,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
448513,1114.93835616438,444.715753424658,103.924657534247,677.739726027397,1395.41095890411,1981.11643835616,2185.27054794521,259.349315068493,1113.10616438356,1545.05479452055,845.845890410959,112.760273972603,1069.07534246575,2323.97945205479,890.513698630137,888.630136986301,1630.13356164384,2119.66780821918,341.006849315069,236.390410958904,1011.44520547945,2527.84931506849,263.972602739726,201.695205479452,585.547945205479,845.503424657534,431.102739726027,697.623287671233,1040.15068493151,131.815068493151,292,25.8806196122082,14.4357846044637,0.829986433788291,0.957377049180328,0.663636363636364,-0.724227824189441,53236.3219178082,33589.3184931507,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_448513,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
448700,4721.23384615385,200.233846153846,95.8430769230769,637.166153846154,2079.13538461538,647.763076923077,393.169230769231,243.252307692308,1079.18461538462,6820.04307692308,787.264615384615,123.769230769231,1083.18769230769,956.467692307692,700.535384615385,321.729230769231,1663.08307692308,1555.62769230769,258.495384615385,216.393846153846,1020.62461538462,1115.4,183.969230769231,192.649230769231,2770.31076923077,1166.81846153846,447.686153846154,294.046153846154,1025.74461538462,130.56,325,22.7778202375291,18.178196150498,0.602570495194519,0.961538461538462,0.773809523809524,-0.622065508669982,54147.72,32717.0430769231,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_448700,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
449193,5231.47747747748,442.63963963964,150.693693693694,669.585585585586,2584.21921921922,2641.14114114114,1540.32732732733,256.927927927928,1114.95795795796,7548.60660660661,723.555555555556,155.552552552553,1136.31831831832,4520.96996996997,1163.18018018018,2546.65165165165,3102.55555555556,5786.12312312312,424.858858858859,247.144144144144,1022.94594594595,6444.87987987988,319.429429429429,447.159159159159,706.033033033033,1710.95495495495,517.576576576577,287.096096096096,1056.94294294294,133.039039039039,333,26.4388458643476,16.0600721479966,0.794363837922265,0.956896551724138,0.69375,0.617384452785278,53101.3213213213,33792.6696696697,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_449193,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
449435,3399.07446808511,1083.81914893617,603.095744680851,637.691489361702,1180.47872340426,1091.31382978723,323.457446808511,243.117021276596,1086.45744680851,5577.06914893617,1161.56914893617,118.920212765957,1083.00531914894,6086.1170212766,584.164893617021,329.63829787234,1867.68085106383,7988.48404255319,376.739361702128,235.420212765957,1082.1329787234,7492.65425531915,2263.15957446808,221.292553191489,622.164893617021,1607.6170212766,508.654255319149,573.085106382979,1041.60106382979,129.489361702128,188,18.7219274230442,12.9083224677216,0.724308384982226,0.954314720812183,0.803418803418803,-0.0066274111829996,54028.3723404255,33475.8617021277,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67+,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_449435,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
450386,1671.4538606403,171.316384180791,71.7627118644068,620.822975517891,1026.9868173258,912.736346516008,899.188323917137,251.866290018832,1088.84369114878,3702.26553672316,883.902071563088,113.209039548023,1070.38418079096,1125.59133709981,513.225988700565,298.91713747646,1934.01694915254,2008.70433145009,274.723163841808,219.510357815442,988.267419962335,2211.93032015066,208.894538606403,164.661016949153,597.182674199623,1629.87947269303,485.521657250471,257.583804143126,1031.74011299435,130.188323917137,531,37.3505513087688,18.3147526702126,0.871526961659259,0.949910554561717,0.709893048128342,-0.330588542239115,53998.945386064,32882.6911487759,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_450386,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
450433,5199.8972972973,1491.42162162162,473.989189189189,654.07027027027,2362.10810810811,390.659459459459,464.102702702703,254.72972972973,1098.1027027027,8145.84864864865,1124.63783783784,128.389189189189,1081.88648648649,634.027027027027,461.562162162162,318.027027027027,1523.73513513514,956.448648648649,245.924324324324,220.72972972973,997.989189189189,822.216216216216,186.821621621622,149.751351351351,622.12972972973,2792.08108108108,576.345945945946,376.816216216216,1073.13513513514,131.367567567568,185,15.8277052783233,14.9199854631804,0.333782993543412,0.95360824742268,0.770833333333333,-0.535899921724837,54104.7351351351,33352.8432432432,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_450433,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
450446,1030.49872773537,206.020356234097,92.323155216285,625.842239185751,1493.58015267176,953.491094147583,646.737913486005,271.440203562341,1088.72519083969,1495.10687022901,663.974554707379,121.29262086514,1072.17048346056,984.063613231552,1343.03562340967,336.569974554707,1762.45292620865,1256.96437659033,338.483460559796,238.101781170483,1008.30025445293,991.880407124682,243.52417302799,153.508905852417,660.921119592875,1007.01781170483,549.674300254453,233.666666666667,1032.48600508906,130.422391857506,393,25.7145835974615,19.5896598016544,0.647799024571632,0.958536585365854,0.742911153119093,-0.751774058728867,52244.8473282443,32769.8473282443,FAAGSCC_12,AG,1,stromal cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_450446,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
450775,1706.4578313253,783.963855421687,129.307228915663,610.072289156627,994.638554216867,254.909638554217,270.975903614458,242.204819277108,1077.85542168675,2075.67469879518,556.072289156627,113.795180722892,1067.93975903614,1449.06626506024,522.686746987952,309.60843373494,1447.72891566265,5405.12048192771,316.379518072289,224.512048192771,1009.99397590361,5609.3734939759,220.379518072289,197.722891566265,590.349397590361,925.307228915663,476.198795180723,238.301204819277,1012.4578313253,130.265060240964,166,17.0894326171612,12.4572746738978,0.684571130768014,0.948571428571429,0.737777777777778,0.779993243726856,54086.8734939759,32843.2831325301,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_450775,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
450815,1427.71955719557,166.435424354244,78.5867158671587,614.265682656827,877.225092250923,348.125461254613,327.837638376384,252.959409594096,1072.91881918819,3359.34317343173,820.870848708487,108.287822878229,1068.9889298893,786.730627306273,468.881918819188,286.671586715867,1415.91143911439,1510.0258302583,288.594095940959,223.158671586716,1004.0479704797,1886.74538745387,210.357933579336,162.453874538745,612.586715867159,1353.73800738007,454.926199261993,281.656826568266,1045.32472324723,130.431734317343,271,19.6137812710906,17.652896170911,0.435837989622965,0.9644128113879,0.792397660818713,-0.598564141368059,53691.63099631,32945.0184501845,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_450815,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
451361,2506.09803921569,320.190476190476,125.15406162465,655.495798319328,2354.43137254902,4297.34453781513,491.647058823529,268.53781512605,1186.81792717087,3641.08963585434,1214.61904761905,122.070028011204,1072.01960784314,5267.84033613445,978.971988795518,309.873949579832,1892.37535014006,2420.78711484594,321.145658263305,232.005602240896,1003.05042016807,1573.08683473389,222.915966386555,170.652661064426,585.112044817927,956.257703081232,461.918767507003,349.389355742297,1036.06722689076,132.781512605042,357,23.7028864750699,19.2533992020418,0.583266601498404,0.957104557640751,0.739130434782609,1.04524348855025,52928.9579831933,33342.4537815126,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_451361,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
451672,5614.02265372168,1039.15533980583,890.446601941748,647.679611650485,1734.82524271845,525.278317152104,407.543689320388,238.763754045307,1080.33333333333,8731.95145631068,636.242718446602,128.880258899676,1497.58252427184,895.097087378641,558.495145631068,397.592233009709,1485.49514563107,1327.83818770227,341.559870550162,239.776699029126,996.003236245955,1447.08414239482,258.708737864078,165.446601941748,632.012944983819,2329.62459546926,556.53074433657,319.074433656958,1083.27508090615,132.171521035599,309,21.656098705947,18.2665835356153,0.537153518478058,0.953703703703704,0.774436090225564,0.936161176704279,53705.7702265372,33499.1650485437,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX+,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_451672,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
451816,3736.72075471698,544.358490566038,211.403773584906,715.845283018868,5403.90566037736,3342.1358490566,509.384905660377,255.532075471698,1125.05283018868,5677.01132075472,596.362264150943,134.094339622642,1100.69811320755,2086.76603773585,891.841509433962,361.633962264151,2613.58113207547,1954.59245283019,339.924528301887,237.943396226415,1029.89433962264,1438.76226415094,220.716981132075,280.977358490566,593.969811320755,1094.20754716981,462.88679245283,235.196226415094,1087.1358490566,131.150943396226,265,22.1845098743549,15.4718970105915,0.716663689718203,0.963636363636364,0.742296918767507,1.15991390370765,52732.1169811321,33577.7094339623,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_451816,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
452113,2796.5289017341,543.517341040462,684.774566473988,657.063583815029,3004.0289017341,369.138728323699,306.176300578035,247.491329479769,1078.90751445087,4642.63005780347,1271.92774566474,118.557803468208,1086.93930635838,1514.57225433526,639.898843930636,275.190751445087,1668.45375722543,1404.18208092486,274.046242774566,223.482658959538,997.326589595376,1054.78612716763,214.49710982659,203.861271676301,586.907514450867,1717.65895953757,512.092485549133,287.309248554913,1040.78034682081,131.754335260116,346,25.2100058881381,18.0474978047259,0.698216877034316,0.958448753462604,0.683794466403162,-0.749536828084095,53354.2919075145,33248.8757225434,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_452113,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
452142,2800.17313432836,324.450746268657,119.662686567164,636.561194029851,1535.44179104478,267.214925373134,288.128358208955,250.889552238806,1080.13134328358,4308.88955223881,742.567164179104,131.546268656716,1067.21791044776,613.343283582089,431.90447761194,277.474626865672,1384.39104477612,948.582089552239,263.492537313433,224.259701492537,983.928358208955,891.310447761194,208.725373134328,127.376119402985,586.985074626866,778.591044776119,405.85671641791,228.611940298507,1026.62985074627,129.758208955224,335,36.0549496067828,11.9466704372961,0.943509246216347,0.949008498583569,0.459533607681756,0.741622769379127,52655.6089552239,32779.1940298507,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_452142,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
452402,2860.00917431193,456.045871559633,117.165137614679,637.874617737003,1463.47094801223,881.660550458716,323.522935779817,251.581039755352,1093.03363914373,4564.46788990826,843.510703363914,116.770642201835,1071.34250764526,1644.96330275229,447.54128440367,279.743119266055,1585.81651376147,2680.93883792049,305.082568807339,222.672782874618,1042.14373088685,2505.34862385321,214.547400611621,214.755351681957,581.024464831804,1059.07951070336,464.896024464832,275.819571865443,1021.23241590214,128.669724770642,327,25.161176510729,16.5869064916354,0.751944700277669,0.947826086956522,0.675619834710744,-0.735968213513304,53936.495412844,33099.3088685015,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_452402,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
452601,3392.96212121212,220.070707070707,53.4191919191919,653.169191919192,1696.71464646465,4026.01767676768,1894.54292929293,261.661616161616,1111.41161616162,4831.62121212121,1230.4595959596,125.775252525253,1090.7803030303,4146.49494949495,1321.63383838384,1730.65909090909,2150.90151515152,4047.1994949495,437.972222222222,241.032828282828,1073.78282828283,3745.32070707071,257.989898989899,891.252525252525,808.186868686869,863.656565656566,429.381313131313,458.426767676768,1027.96212121212,130.151515151515,396,23.7669545518465,21.6252847520931,0.414852321392959,0.951923076923077,0.717391304347826,0.868386775303693,53717.851010101,33742.7373737374,FAAGSCC_12,AG,1,M2 macrophages,,TIM3+,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_452601,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
452754,1236.90810810811,472.910810810811,90.6594594594595,612.554054054054,809.162162162162,295.605405405405,300.727027027027,246.162162162162,1080.38648648649,2911.80810810811,492.845945945946,113.310810810811,1094.22432432432,805.802702702703,740.416216216216,361.024324324324,1533.43243243243,1106.02972972973,260.381081081081,217.178378378378,999.259459459459,1106.3027027027,188.164864864865,141.748648648649,591.324324324324,1624.35135135135,524.321621621622,369.821621621622,1080.00810810811,132.294594594595,370,29.6310376329101,16.0883872215849,0.839760326428755,0.956072351421189,0.825892857142857,1.4823735595978,53563.2891891892,33076.8648648649,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_452754,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
452897,3823.41620111732,241.215083798883,98.3743016759776,637.178770949721,1717.34078212291,490.125698324022,377.215083798883,250.491620111732,1112.51675977654,6186.20111731844,1070.75139664804,121.27094972067,1103.07541899441,680.513966480447,457.075418994413,273.458100558659,1404.2905027933,1046.64525139665,280.555865921788,224.282122905028,981.787709497207,997.114525139665,222.837988826816,126.698324022346,582.268156424581,1328.53351955307,492.145251396648,384.078212290503,1046.26815642458,129.357541899441,358,24.4472382694384,19.2572133361845,0.616052542675098,0.96236559139785,0.753684210526316,0.22305343289012,54170.9832402235,33155.812849162,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_452897,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
454122,393.374622356495,707.567975830816,190.148036253776,614.755287009063,104.619335347432,526.262839879154,371.163141993958,264.374622356495,1140.96072507553,1260.3081570997,1412.48640483384,121.012084592145,1064.6586102719,869.027190332326,491.323262839879,282.815709969789,1494.10574018127,933.767371601208,207.616314199396,212.921450151057,1231.71903323263,623.296072507553,140.235649546828,121.691842900302,649.220543806647,557.631419939577,342.818731117825,200.326283987915,985.564954682779,129.030211480363,331,21.5042735608237,19.6356876907635,0.407721575022529,0.956647398843931,0.752272727272727,-1.06548054168201,52565.5498489426,32838.3111782477,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_454122,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
454256,4074.90566037736,106.245283018868,62.188679245283,616.166037735849,583.845283018868,2439.29056603774,1762.08301886792,265.577358490566,1130.3358490566,6643.26037735849,563.679245283019,126.694339622642,1079.72075471698,4180.6641509434,929.671698113208,725.211320754717,3645.69811320755,2212.48301886792,330.479245283019,235.68679245283,1007.21509433962,1411.42264150943,230.769811320755,190.698113207547,611.97358490566,2981.93962264151,550.950943396226,268.396226415094,1057.23396226415,129.784905660377,265,22.1680214387078,15.3355946440443,0.722099647401259,0.960144927536232,0.697368421052632,0.730685703611267,53091.3396226415,33720.0188679245,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_454256,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
454970,3967.57994579946,228.132791327913,90.6449864498645,640.517615176152,1610.77777777778,357.783197831978,825.756097560976,242.468834688347,1084.26016260163,5902.05420054201,661.867208672087,121.409214092141,1097.11382113821,823.821138211382,652.452574525745,325.390243902439,3124.9593495935,1364.92953929539,310.593495934959,248.040650406504,1038.37127371274,1102.94850948509,220.783197831978,179.60433604336,620.680216802168,1709.67208672087,508.441734417344,314.560975609756,1055.17615176152,129.807588075881,369,26.9042732384671,17.620812285424,0.755676773089013,0.958441558441558,0.788461538461538,0.152536712451772,53060.4037940379,33578.9620596206,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_454970,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
455720,1148.41450777202,71.2176165803109,73.4611398963731,611.383419689119,356.020725388601,314.823834196891,337.528497409326,232.823834196891,1080.51295336788,1937.17616580311,492.80310880829,100.611398963731,1065.54404145078,1299.64248704663,573.80310880829,312.321243523316,1564.19689119171,1637.81865284974,321.492227979275,236.813471502591,997.943005181347,1495.22279792746,337.378238341969,182.663212435233,583.932642487047,625.321243523316,377.113989637306,238.528497409326,994.181347150259,129.170984455959,193,17.8311255069937,13.8413754895031,0.630427667938883,0.955445544554455,0.756862745098039,0.417177513934762,53201.8601036269,33584.8756476684,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_455720,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
455771,1230.27083333333,357.286458333333,89.6979166666667,624.604166666667,989.473958333333,1916.44791666667,655.53125,255.473958333333,1094.6875,2686.47916666667,1703.15625,114.145833333333,1071.94791666667,2901.21354166667,1168.17708333333,1159.60416666667,1813.41145833333,2026.44270833333,291.494791666667,218.239583333333,1009.421875,1404.203125,207.265625,220.59375,623.682291666667,1164.36458333333,463.645833333333,284.322916666667,1055.77083333333,130.776041666667,192,16.7388197418349,14.7117655498857,0.477004211197912,0.96,0.752941176470588,-0.187698178355044,54099.1927083333,32820.6822916667,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_455771,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
457092,3338.93870967742,175.251612903226,97.8741935483871,708.31935483871,3671.79032258064,354.638709677419,638.003225806452,237.509677419355,1079.60322580645,5493.56129032258,951.370967741936,133.467741935484,1092.84193548387,1221.01612903226,915.483870967742,1551.11290322581,1830.50967741935,1902.68387096774,335.129032258065,233.51935483871,1023.0064516129,1675.02258064516,239.893548387097,1112.17096774194,707.31935483871,1929.36451612903,529.177419354839,1145.90967741935,1104.14838709677,130.638709677419,310,24.2867589501274,16.3272796834874,0.740305292677207,0.96875,0.704545454545455,-0.654728595044973,53545.6967741936,33730.3903225806,FAAGSCC_12,AG,1,dendritic cells,,TIM3-,PD-L1+,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,dendritic cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_457092,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
458530,1852.4359430605,169.014234875445,124.747330960854,669.343416370107,3672.05160142349,1281.44839857651,403.919928825623,257.489323843416,1093.58540925267,3365.17971530249,763.996441281139,127.008896797153,1066.94128113879,2355.45017793594,637.174377224199,388.903914590747,1499.19928825623,3861.25088967972,362.738434163701,233.418149466192,1055.59252669039,3581.01601423488,233.53024911032,907.935943060498,734.0871886121,1385.18505338078,503.389679715302,274.960854092527,1045.21174377224,131.313167259786,562,35.1423271810338,20.5258928499847,0.811696866929682,0.952542372881356,0.751336898395722,-1.34036288428156,53009.1939501779,32857.1298932384,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_458530,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
458852,1637.08917197452,290.227707006369,123.176751592357,615.143312101911,737.474522292994,551.539808917197,293.5,257.154458598726,1077.57165605096,2560.81687898089,632.732484076433,126.033439490446,1075.90923566879,860.574840764331,463.383757961783,270.845541401274,1507.59713375796,1200.02707006369,292.56050955414,224.113057324841,1041.83121019108,996.027070063694,196.665605095541,308.869426751592,1001.08280254777,1105.53343949045,492.232484076433,224.377388535032,1017.86624203822,129.18949044586,628,36.0588027881466,22.3501376933126,0.784740278301636,0.964669738863287,0.700892857142857,-0.967801263062929,52926.8487261147,32560.4124203822,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,1,FAAGSCC_12_458852,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
458891,3473.79474940334,227.009546539379,97.035799522673,625.100238663484,1255.52267303103,290.787589498807,306.778042959427,256.646778042959,1080.9785202864,6241.41050119332,625.276849642005,120.677804295943,1073.88782816229,645.441527446301,458.293556085919,272.613365155131,1359.7923627685,1018.89976133652,305.467780429594,229.45107398568,981.422434367542,975.579952267303,223.871121718377,121.159904534606,585.933174224344,1410.15274463007,459.343675417661,294.832935560859,1025.70883054893,130.431980906921,419,26.4159010260451,20.4768613986671,0.631750495994492,0.963218390804598,0.761818181818182,0.449227168040523,53469.723150358,32694.8186157518,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_458891,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
459054,1952.8,113.28125,57.19375,616.7125,763.8125,2321.3,634.15,252.875,1109.91875,3610.24375,586.18125,128.28125,1066.05,1496.05,591.9625,349.71875,1984.80625,1411.89375,313.19375,231.26875,1010.24375,1306.9375,226.36875,220.33125,687.15,1636.75625,498.2375,260.4,1055.05625,131.9,160,18.0232997028422,11.3536081410946,0.776643320065063,0.941176470588235,0.723981900452489,1.23813311931806,53052.26875,33848.49375,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_459054,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
459190,4989.40336134454,243.029411764706,117.180672268908,614.72268907563,750.714285714286,303.117647058824,313.508403361345,250.415966386555,1079.21008403361,8652.63445378151,628.420168067227,122.970588235294,1075.66806722689,821.941176470588,501.756302521008,278.285714285714,1477.09243697479,1609.40336134454,359.575630252101,229.504201680672,1058.08403361345,1464.34033613445,231.193277310924,207.264705882353,590.768907563025,3321.0756302521,534.605042016807,253.605042016807,1314.42857142857,129.27731092437,238,27.9676493010436,10.8853984948223,0.921147394465256,0.933333333333333,0.678062678062678,1.30379945774315,53398.7394957983,32946.0714285714,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_459190,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
459194,2409.68607594937,349.101265822785,161.850632911392,656.210126582278,2448.21772151899,751.012658227848,441.620253164557,282.956962025316,1145.8,4356.37721518987,578.260759493671,127.06582278481,1070.4582278481,2517.06329113924,609.939240506329,292.521518987342,1791.18987341772,2879.66835443038,368.025316455696,230.121518987342,1070.33670886076,1452.93164556962,208.977215189873,174.883544303797,841.989873417721,814.151898734177,424.230379746835,226.392405063291,1016.96962025316,129.822784810127,395,37.2407552090831,13.6741223973114,0.93014924984239,0.949519230769231,0.536684782608696,-1.01409419536011,53923.2303797468,32651.5240506329,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_459194,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
459304,5107.11538461538,644.452662721893,100.174556213018,655.760355029586,1994.5325443787,1101.79585798817,362.14201183432,234.46449704142,1076.90236686391,8221.46449704142,764.008875739645,136.085798816568,1099.35207100592,820.420118343195,588.319526627219,422.792899408284,2286.21893491124,1364.91420118343,331.201183431953,238.677514792899,1033.23668639053,1283.94674556213,241.689349112426,463.937869822485,5575.7573964497,2379.46449704142,543.89349112426,283.177514792899,1064.04733727811,131.026627218935,338,23.335972581915,18.7324795862682,0.596342970256328,0.952112676056338,0.734782608695652,1.07698536797072,52920.3964497042,33607.3846153846,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_459304,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
459323,3841.27233115468,708.625272331155,385.891067538126,653.400871459695,2059.83442265795,1246.02396514161,489.19825708061,253.786492374728,1114.76252723312,5889.36383442266,800.363834422658,123.82788671024,1099.67755991285,1878.99564270152,677.252723311547,338.409586056645,3334.92592592593,2781.86928104575,362.949891067538,244.409586056645,1028.46187363834,3208.25054466231,254.374727668845,221.995642701525,599.607843137255,1354.24183006536,497.337690631808,310.679738562092,1051.13725490196,131.610021786492,459,28.2587154476192,20.7643320625133,0.678290429958535,0.95625,0.765,0.998218072882433,53167.0283224401,33597.7189542484,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_459323,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
459507,2309.72164948454,294.860824742268,149.675257731959,658.40206185567,2314.02577319588,1520.92783505155,345.876288659794,260.185567010309,1097.76804123711,3890.40206185567,580.670103092784,127.381443298969,1088.91237113402,514.067010309278,358.252577319588,258.252577319588,1471.70618556701,767.922680412371,197.567010309278,210.577319587629,978.226804123711,675.958762886598,198.159793814433,121.335051546392,588.922680412371,1477.43298969072,480.865979381443,222.520618556701,1043.71134020619,130.298969072165,194,18.445443684293,13.4985842165611,0.681507310058783,0.946341463414634,0.713235294117647,0.724821036527012,52639.6597938144,32654.7422680412,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_459507,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
459872,2303.14964370546,258.239904988123,178.294536817102,687.206650831354,4677.84798099762,1696.94299287411,441.085510688836,266.116389548694,1107.67458432304,4089.77434679335,712.555819477435,131.676959619952,1074.2945368171,1554.1757719715,562.334916864608,284.007125890736,1481.71733966746,1210.95961995249,296.641330166271,223.106888361045,990.387173396675,1073.38954869359,214.619952494062,161.907363420428,610.076009501188,1007.23040380048,460.199524940618,249.945368171021,1058.12589073634,130.529691211401,421,37.3220623479312,14.4359303538806,0.922166364760109,0.976798143851508,0.83531746031746,-0.122552470806347,54012.5106888361,32595.6912114014,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_459872,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
459930,1945.78215223097,129.664041994751,80.5380577427822,643.125984251968,1719.47769028871,1016.42519685039,407.446194225722,273.154855643045,1126.343832021,2772.01837270341,633.023622047244,122.994750656168,1076.47769028871,870.488188976378,558.811023622047,289.842519685039,1701.53280839895,1071.84514435696,237.270341207349,217.795275590551,1142.37532808399,881.779527559055,180.283464566929,188.766404199475,3487.73228346457,842.734908136483,411.377952755906,225.671916010499,1033.12073490814,131.868766404199,381,25.7863518759307,18.8772742369402,0.681235264682458,0.962121212121212,0.771255060728745,1.50659747094666,52447.4330708661,32557.8215223097,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_459930,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
460159,2121.49783549784,245.155844155844,86.8917748917749,626.341991341991,1143.1341991342,3482.5974025974,803.78354978355,260.515151515152,1099.41125541126,2724.00432900433,728.714285714286,116.878787878788,1079.53246753247,2699.15151515152,799.099567099567,1107.5367965368,3341.05194805195,2458.15584415584,393.878787878788,241.424242424242,1058.02164502165,1704.2380952381,255.134199134199,468.125541125541,1030.02597402597,799.995670995671,432.792207792208,253.320346320346,1016.11255411255,131.415584415584,231,19.3739449996514,15.2151848784428,0.619061351429248,0.950617283950617,0.759868421052632,1.26485274277689,52892.4329004329,33621.3852813853,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_460159,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
460671,3795.30701754386,571.008771929825,89.6783625730994,636.184210526316,1077.47076023392,1399.79239766082,381.19298245614,257.719298245614,1086.90058479532,6780.35087719298,540.833333333333,136.108187134503,1080.5350877193,4277.59941520468,684.643274853801,381.529239766082,1864.72222222222,3531.93859649123,429.473684210526,252.029239766082,1000.24561403509,2536.76900584795,269.883040935673,258.710526315789,597.116959064327,3484.10526315789,557.005847953216,332.856725146199,1064.4649122807,130.523391812865,342,24.9604736669095,17.513360224913,0.712527932688442,0.95,0.708074534161491,-0.61897401847105,53421.8801169591,33859.9269005848,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_460671,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
460857,1942.39348370927,194.228070175439,107.117794486216,648.268170426065,1557.84461152882,321.601503759398,339.255639097744,241.649122807018,1084.67919799499,4130.55388471178,509.669172932331,115.105263157895,1074.99248120301,1682.95488721805,593.468671679198,294.09022556391,1749.91478696742,3856.8671679198,356.16290726817,234.721804511278,1040.6992481203,3150.77944862155,225.877192982456,216.255639097744,602.571428571429,2219.27819548872,506.288220551378,231.804511278195,1039.75438596491,129.864661654135,399,23.3236212179257,22.1467509415234,0.313640813595928,0.968446601941748,0.755681818181818,-0.228420468118958,52969.4937343358,33360.4686716792,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_460857,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
461259,1370.84164222874,199.205278592375,102.824046920821,649.724340175953,1648.26686217009,611.029325513196,330.217008797654,238.695014662757,1087.81524926686,2070.31085043988,851.196480938416,116.521994134897,1067.7917888563,1242.71554252199,667.114369501466,944.785923753666,1802.95307917889,1628.60997067449,316.454545454545,2536.96480938416,1014.53079178886,1229.65982404692,224.671554252199,312.794721407625,617.492668621701,1070.76246334311,529.126099706745,554.178885630498,1021.16715542522,129.384164222874,341,23.0358055428068,19.0272970965458,0.563687818459556,0.957865168539326,0.780320366132723,-0.0184694032381324,53895.5161290323,33260.3372434018,FAAGSCC_12,AG,1,neutrophils,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,neutrophils,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_461259,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
461425,2430.12757973734,289.206378986867,128.153846153846,658.151969981238,2879.05440900563,1674.79549718574,356.656660412758,268.467166979362,1092.24202626642,4614.32645403377,676.333958724203,132.909943714822,1068.55722326454,697.028142589118,532.803001876173,277.125703564728,1381.66228893058,1099.53470919325,353.065666041276,241.016885553471,985.630393996248,1091.98499061914,282.727954971857,132.478424015009,581.431519699812,1004.5722326454,580.181988742964,230.272045028143,1031.6660412758,298.93808630394,533,32.2609920528536,21.2522056173208,0.752354385176455,0.969090909090909,0.757102272727273,0.128409151812153,52235.2138836773,33187.5666041276,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_461425,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
462353,4739.25219941349,823.853372434018,230.114369501466,683.979472140762,4036.52492668622,2685.3284457478,517.038123167155,258.387096774194,1128.84164222874,7824.26099706745,646.803519061584,132.741935483871,1091.25513196481,1379.75073313783,1127.47507331378,923.627565982405,4835.41055718475,1977.96774193548,297.495601173021,234.055718475073,1023.1495601173,1827.65982404692,218.1642228739,449.099706744868,886.035190615836,2293.74486803519,520.340175953079,256.222873900293,1115.78299120235,133.478005865103,341,24.9681134896752,17.4350350885847,0.715812975943261,0.949860724233983,0.710416666666667,0.531749332912471,52812.1642228739,33669.4428152493,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_462353,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
462800,2368.13812154696,233.024861878453,165.135359116022,724.281767955801,4560.11602209945,447.872928176796,362.53591160221,252.323204419889,1116.31215469613,4790.06906077348,637.146408839779,125.314917127072,1079.32596685083,3129.53867403315,509.237569060774,728.64364640884,1834.27624309392,5007.23480662983,366.110497237569,878.022099447514,1046.05801104972,4311.70165745856,327.190607734807,379.207182320442,2589.5773480663,1164.66298342541,467.439226519337,229.980662983425,1045.59944751381,129.798342541436,362,35.3565546379515,13.123469472257,0.928562928929086,0.947643979057592,0.507713884992987,0.985021367635887,53270.6878453039,33055.7375690608,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_462800,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
463213,1345.75561797753,135.075842696629,75.7724719101124,646.27808988764,2307.45786516854,320.505617977528,340.252808988764,263.370786516854,1083.56460674157,2079.79775280899,1839.78651685393,119.418539325843,1073.78370786517,683.713483146067,549.727528089888,277.758426966292,1391.75842696629,2420.45505617978,374.480337078652,243.258426966292,1003.43539325843,3060.1404494382,273.553370786517,145.474719101124,591.727528089888,1048.1797752809,475.97191011236,462.053370786517,1064.91011235955,130.070224719101,356,25.1025464669043,18.1300453714772,0.691643265001695,0.962162162162162,0.780701754385965,-1.17736324823247,52946.0196629214,32674.2528089888,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_463213,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
463387,1986.89715536105,347.765864332604,116.698030634573,641.212253829322,1968.51422319475,328.061269146608,284.881838074398,248.347921225383,1086.77461706783,2875.41575492341,512.90590809628,118.08533916849,1082.5601750547,799.553610503282,510.035010940919,282.759299781182,1524.14223194748,1169.76148796499,293.312910284464,223.509846827133,984.251641137856,1081.56455142232,227.592997811816,141.571115973742,585.584245076586,941.573304157549,480.603938730853,229.98249452954,1015.46608315098,128.431072210066,457,28.0104833093577,20.8314924978417,0.668509692538498,0.970276008492569,0.805996472663139,0.0870812174936217,54139.409190372,33161.1619256018,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_463387,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
463423,3076.77737226277,173.697080291971,83.456204379562,613.040145985401,537.20802919708,823.204379562044,683.35401459854,251.251824817518,1092.3503649635,5715.47810218978,762.536496350365,116.113138686131,1069.47445255474,1430.58394160584,767.817518248175,451.751824817518,1721.58759124088,2657.55109489051,306.638686131387,226.656934306569,1001.66058394161,2160.17518248175,210.86496350365,147.784671532847,595.317518248175,1919.17153284672,505.540145985402,250.043795620438,1047.91240875912,130.751824817518,274,21.4943447048882,16.2622124288581,0.653900005622406,0.96140350877193,0.76750700280112,-0.206710770119303,53484.3175182482,33007.7189781022,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_463423,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
463493,2683.39207048458,213.533039647577,75.2555066079295,650.555066079295,2281.62114537445,1806.56828193833,782.013215859031,259.47577092511,1107.81497797357,5119.66519823789,1814.47136563877,120.788546255507,1075.22466960352,4251.98678414097,1173.45374449339,617.810572687225,1573.2731277533,2600.66079295154,313.850220264317,224.242290748899,990.713656387665,1769.08810572687,212.418502202643,558.378854625551,623.590308370044,1608.62114537445,492.066079295154,309.488986784141,1044.52863436123,130.387665198238,227,28.088402461404,10.4003623706855,0.928923189691046,0.941908713692946,0.764309764309764,0.156779253265367,53911.6431718062,32848.6740088106,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_463493,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
464619,1404.97278911565,231.840136054422,80.0646258503401,620.761904761905,937.554421768708,556.200680272109,293.568027210884,259.547619047619,1098.36394557823,2798.73469387755,557.051020408163,112.945578231293,1077.14285714286,607.047619047619,445.741496598639,259.799319727891,1621.5612244898,846.666666666667,203.836734693878,207.414965986394,1028.54421768707,715.285714285714,151.625850340136,110.156462585034,1838.59523809524,885.931972789116,433.292517006803,221.176870748299,1019.86394557823,130.792517006803,294,25.8501492079627,14.615400956491,0.824824102378079,0.948387096774194,0.668181818181818,0.958609065644358,53784.8163265306,32225.1054421769,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_464619,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
464718,4355.73162939297,976.025559105431,132.91054313099,676.226837060703,3212.1661341853,748.0,428.102236421725,251.172523961661,1076.81469648562,6693.33865814696,623.702875399361,123.725239616613,1094.20127795527,738.897763578275,442.239616613419,275.054313099042,1423.87539936102,1445.41533546326,289.102236421725,227.220447284345,986.194888178914,1639.51118210863,217.242811501597,148.495207667732,987.571884984026,1623.07667731629,514.766773162939,245.217252396166,1055.07987220447,134.466453674121,313,26.2631772482001,15.3061499095099,0.812616442214527,0.954268292682927,0.736470588235294,0.30456102502531,53271.2012779553,33343.5239616613,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_464718,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
465276,2607.3918128655,626.719298245614,1194.94152046784,643.608187134503,1456.58479532164,2306.02339181287,385.865497076023,242.842105263158,1091.15789473684,4817.88888888889,752.748538011696,139.789473684211,1078.32748538012,4545.0,899.362573099415,779.789473684211,2225.36842105263,2576.88304093567,390.894736842105,240.017543859649,1007.7485380117,1664.77192982456,261.631578947368,233.923976608187,655.456140350877,2047.97660818713,538.27485380117,349.245614035088,1082.6783625731,131.59649122807,171,16.4904913900413,13.390814932454,0.583612217693066,0.934426229508197,0.718487394957983,0.0231365489531254,53134.350877193,33794.701754386,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_465276,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
465834,2388.41666666667,444.968253968254,114.527777777778,644.388888888889,1623.75793650794,921.722222222222,1639.36111111111,247.829365079365,1089.94444444444,3556.61904761905,1190.70634920635,126.019841269841,1067.40476190476,999.329365079365,755.75,698.869047619048,2009.68253968254,1292.80555555556,305.543650793651,230.15873015873,1021.32936507937,1120.59523809524,212.539682539683,294.813492063492,6707.60317460317,1084.9246031746,500.353174603175,426.928571428571,1040.13888888889,129.972222222222,252,21.4447292553704,15.2494461481057,0.703086205799229,0.936802973977695,0.763636363636364,0.0547556314514363,52900.3253968254,33605.1626984127,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_465834,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
466321,1464.64596273292,275.801242236025,70.9378881987578,631.049689440994,1042.17080745342,3855.96273291925,812.962732919255,273.810559006211,1156.86335403727,1891.93788819876,699.503105590062,128.096273291925,1069.36335403727,3196.23913043478,663.981366459627,546.82298136646,3493.08385093168,1964.44099378882,342.298136645963,232.232919254658,1035.95962732919,1636.52795031056,1097.33540372671,214.664596273292,631.295031055901,887.481366459627,478.105590062112,388.018633540373,1021.08074534161,129.773291925466,322,24.0293378708921,17.0856630705554,0.703158182241214,0.949852507374631,0.74537037037037,1.49276384870119,53159.6677018634,33757.4534161491,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_466321,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
466651,4379.26470588235,697.611111111111,4600.50326797386,695.0,4503.10130718954,1324.50980392157,968.637254901961,256.5,1082.14052287582,7209.89869281046,651.418300653595,152.813725490196,1088.99346405229,2416.49346405229,815.398692810458,1256.86928104575,2030.76797385621,4740.50653594771,399.06862745098,243.754901960784,1070.98039215686,4226.17647058824,341.529411764706,950.274509803922,742.869281045752,2442.48039215686,550.709150326797,348.947712418301,1081.02614379085,132.107843137255,306,25.3944534341507,15.4229098850433,0.79444676111151,0.950310559006211,0.665217391304348,0.561309114913119,53385.3888888889,33790.7843137255,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1+,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_466651,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
467543,2484.79036144578,681.730120481928,188.592771084337,737.971084337349,5002.35180722892,293.195180722892,333.556626506024,245.257831325301,1081.53253012048,5281.1156626506,958.946987951807,147.325301204819,1090.46265060241,2109.4,1127.84578313253,1890.31084337349,1854.67710843373,3431.4265060241,376.467469879518,239.968674698795,1041.50120481928,2812.97590361446,284.368674698795,1303.58313253012,880.428915662651,2057.26506024096,545.665060240964,492.910843373494,1113.0265060241,138.915662650602,415,23.9124119446868,22.1663990035127,0.37510337972816,0.958429561200924,0.785984848484849,0.143788991495206,52407.956626506,33320.4409638554,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_467543,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
467655,3932.52173913043,830.869565217391,1227.10326086957,636.967391304348,1655.97826086957,920.527173913044,339.054347826087,253.521739130435,1100.34239130435,6445.50543478261,1761.04891304348,120.25,1082.34782608696,697.896739130435,604.891304347826,318.315217391304,1782.85326086957,1317.57065217391,301.478260869565,225.04347826087,1018.77717391304,1164.50543478261,220.690217391304,184.608695652174,662.097826086957,1752.32608695652,502.179347826087,529.646739130435,1051.92391304348,132.608695652174,184,17.0265113933603,13.7606837180435,0.588919617270082,0.963350785340314,0.773109243697479,1.48589726265882,53344.7989130435,33371.4782608696,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_467655,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
468997,2572.59420289855,149.826086956522,92.3695652173913,636.18115942029,1690.66666666667,322.695652173913,442.579710144928,251.876811594203,1077.08695652174,3860.67391304348,660.413043478261,124.760869565217,1066.80434782609,730.115942028986,516.572463768116,282.246376811594,1366.44927536232,1100.40579710145,309.601449275362,221.246376811594,988.992753623188,1100.94202898551,229.579710144928,130.775362318841,587.920289855072,978.144927536232,478.688405797101,236.905797101449,1029.09420289855,130.282608695652,138,22.6347639958418,8.12329857579519,0.933381423297994,0.901960784313726,0.657142857142857,1.31338592795192,53354.1086956522,32953.9492753623,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_468997,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
469698,2238.84923076923,657.550769230769,236.990769230769,671.249230769231,3761.16923076923,588.258461538462,366.353846153846,265.553846153846,1142.52307692308,2859.42461538462,936.415384615385,128.252307692308,1071.58153846154,704.473846153846,388.889230769231,258.741538461538,1437.10153846154,861.575384615385,180.076923076923,203.812307692308,1132.61538461538,607.270769230769,131.236923076923,100.609230769231,588.501538461538,833.267692307692,413.824615384615,217.913846153846,1033.29230769231,129.886153846154,325,24.2774392257732,17.3488102083344,0.699526899912298,0.955882352941176,0.703463203463203,-0.759551235333969,53956.72,32247.0738461538,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_469698,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
469927,3090.37575757576,856.475757575758,95.7787878787879,631.227272727273,1016.22727272727,301.436363636364,322.045454545455,259.842424242424,1086.24242424242,4507.97878787879,787.363636363636,127.742424242424,1068.83939393939,596.59696969697,463.481818181818,269.690909090909,1472.86666666667,933.639393939394,255.051515151515,221.127272727273,997.593939393939,868.933333333333,193.609090909091,130.348484848485,595.09696969697,1066.24545454545,440.227272727273,297.606060606061,1043.82727272727,132.454545454545,330,21.7782075054941,19.3293412610686,0.460703160156802,0.967741935483871,0.748299319727891,0.845451456929899,52556.1696969697,32324.1848484848,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_469927,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
470909,1096.74375,201.5125,66.75625,604.35,537.8375,557.5,317.15,248.71875,1085.89375,2689.5375,444.85,109.26875,1063.14375,918.01875,713.29375,275.2125,1566.275,1266.725,293.25,219.76875,1013.34375,1232.15,205.025,138.3125,585.50625,1580.8,514.44375,246.64375,1018.7875,131.5875,160,14.5262376312996,14.0437146182559,0.255599869870513,0.946745562130178,0.761904761904762,1.14672386240504,53563.7875,33061.55,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_470909,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
471387,1605.79908675799,324.538812785388,560.406392694064,982.762557077626,19020.3470319635,335.65296803653,254.063926940639,232.447488584475,1083.18264840183,3298.09589041096,643.876712328767,162.059360730594,1076.100456621,794.388127853881,406.936073059361,272.538812785388,2647.99543378995,1073.85844748858,260.041095890411,225.369863013699,998.086757990868,1142.72602739726,219.470319634703,169.812785388128,601.406392694064,1367.30136986301,464.461187214612,256.324200913242,1090.57534246575,128.771689497717,219,23.7417059997282,11.7896131000368,0.867992000807326,0.943965517241379,0.608333333333333,0.743900743111224,52982.5616438356,33760.5662100457,FAAGSCC_12,AG,1,Unknown,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,Other,Other,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_471387,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
471572,3225.79510022272,302.062360801782,174.400890868597,729.169265033408,5592.01781737194,1465.38752783964,334.58574610245,241.846325167038,1098.19599109131,5632.02227171492,752.300668151448,148.349665924276,1433.9131403118,1489.67260579065,756.3429844098,356.530066815145,3575.9153674833,1124.46993318486,283.973273942094,230.307349665924,989.193763919822,1019.35412026726,209.612472160356,206.579064587973,629.104677060134,1247.03786191537,475.167037861915,267.786191536748,1056.25389755011,130.895322939866,449,30.5876419684701,18.9736923670284,0.784360050167497,0.949260042283298,0.664201183431953,-0.765376768834283,52700.3986636971,33496.0779510022,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX+,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_471572,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
471639,1833.87727272727,223.559090909091,133.436363636364,642.372727272727,2523.17272727273,1751.68181818182,495.4,258.395454545455,1098.50454545455,4078.80454545455,497.481818181818,116.363636363636,1071.00454545455,1467.35909090909,519.495454545455,526.190909090909,2652.27727272727,1481.05909090909,235.218181818182,211.3,1003.39090909091,1075.48181818182,165.518181818182,133.086363636364,602.459090909091,1787.95909090909,493.15,226.572727272727,1043.95454545455,128.890909090909,220,25.2255157048582,11.1454234940612,0.897098135050663,0.936170212765958,0.733333333333333,-1.45154921038505,53438.5727272727,32809.5772727273,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_471639,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
471855,984.084175084175,274.313131313131,94.9259259259259,622.313131313131,1301.3164983165,268.868686868687,295.96632996633,254.723905723906,1087.09764309764,1742.43434343434,1408.36363636364,121.03367003367,1071.37373737374,644.249158249158,493.73063973064,275.542087542088,1491.16161616162,1035.92255892256,291.380471380471,232.784511784512,1002.47138047138,956.346801346801,219.915824915825,140.612794612795,582.531986531986,976.606060606061,520.016835016835,282.505050505051,1025.58249158249,129.164983164983,297,20.876563310782,18.1404744194075,0.494917991001826,0.96742671009772,0.781578947368421,-0.464629357857409,52304.0740740741,32796.4915824916,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_471855,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
471949,3249.23880597015,445.63184079602,153.457711442786,663.965174129353,2292.28855721393,1000.07462686567,491.248756218905,246.547263681592,1111.63184079602,5141.81094527363,3896.44278606965,129.626865671642,1078.09950248756,5581.78606965174,873.179104477612,342.457711442786,5017.61691542289,9274.82089552239,544.945273631841,267.71144278607,1040.83084577114,8411.57213930348,318.726368159204,225.771144278607,598.935323383085,1550.17910447761,508.233830845771,524.751243781095,1050.18905472637,131.283582089552,201,18.1779427412223,14.3799568691695,0.611730495592582,0.934883720930232,0.738970588235294,0.829923467397092,53165.2686567164,33614.4328358209,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_471949,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
472509,1316.41796875,249.470703125,160.40625,644.259765625,2253.431640625,328.751953125,330.462890625,251.376953125,1082.107421875,2104.3125,529.490234375,126.14453125,1060.720703125,700.890625,475.095703125,296.4140625,1499.0390625,980.587890625,269.388671875,226.822265625,995.970703125,928.169921875,208.578125,159.533203125,608.3125,1041.404296875,502.208984375,221.48828125,1024.357421875,131.474609375,512,38.6175146770747,17.3306485315841,0.893643829394486,0.946395563770795,0.658944658944659,-0.29295476584461,52462.40625,33487.06640625,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_472509,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
472735,5035.33611111111,809.6,1132.71944444444,651.186111111111,1748.91944444444,633.394444444444,571.655555555556,244.483333333333,1094.49722222222,7532.08611111111,569.338888888889,144.188888888889,1087.29722222222,1685.40833333333,708.947222222222,986.986111111111,4225.68611111111,2614.19166666667,370.172222222222,239.883333333333,1013.13611111111,2001.46388888889,259.186111111111,252.847222222222,624.986111111111,1523.63333333333,540.119444444444,338.672222222222,1052.12777777778,131.013888888889,360,25.3479870569174,18.2574604149735,0.693691133662947,0.96,0.75,0.447625721806047,53502.9555555556,33859.4611111111,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_472735,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
472990,1991.62917933131,314.975683890577,110.279635258359,670.19452887538,3260.36778115502,2424.52583586626,610.911854103343,252.936170212766,1114.79027355623,3661.93009118541,2385.69300911854,125.893617021277,1090.63829787234,6171.60790273556,807.206686930091,533.19452887538,2007.82674772036,6794.11854103343,441.188449848024,248.820668693009,1049.75683890578,6104.17021276596,271.990881458967,313.717325227963,654.151975683891,1701.42857142857,516.644376899696,429.90273556231,1076.99088145897,130.54103343465,329,20.9042373226972,20.6933973562978,0.141669532314534,0.913888888888889,0.712121212121212,0.316090813127939,53054.3951367781,33714.0516717325,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_472990,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
473118,2425.87058823529,207.176470588235,97.5176470588235,624.352941176471,1007.51176470588,382.576470588235,326.876470588235,257.141176470588,1075.04117647059,4683.69411764706,820.970588235294,123.541176470588,1067.61176470588,1449.44117647059,584.452941176471,288.676470588235,1637.22941176471,1393.15882352941,312.452941176471,224.476470588235,995.270588235294,1091.81764705882,205.447058823529,124.876470588235,586.764705882353,1143.05882352941,487.494117647059,235.423529411765,1050.07058823529,131.217647058824,170,22.8204343219508,9.60729748164283,0.9070627804691,0.92896174863388,0.622710622710623,1.16684822724479,53332.8647058824,32952.2764705882,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_473118,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
474839,3342.59130434783,425.521739130435,100.875362318841,646.446376811594,1538.97971014493,950.927536231884,577.626086956522,243.817391304348,1087.11304347826,5745.93043478261,2115.04927536232,125.217391304348,1082.84927536232,2070.23188405797,660.11884057971,320.194202898551,2931.3768115942,3597.34492753623,396.875362318841,246.23768115942,1047.52173913043,3141.58550724638,254.820289855072,245.205797101449,608.808695652174,2227.28405797101,539.220289855072,394.756521739131,1076.21739130435,131.913043478261,345,21.7328888836326,20.4533223309531,0.338064245744377,0.958333333333333,0.681818181818182,0.437823368439459,53097.3420289855,33695.3565217391,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_474839,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
475031,1444.2298136646,548.664596273292,291.683229813665,613.310559006211,560.416149068323,3661.65217391304,1536.74534161491,281.509316770186,1109.60248447205,3059.45341614907,489.142857142857,105.664596273292,1073.49068322981,1024.24844720497,600.310559006211,341.944099378882,1567.5652173913,1166.90683229814,287.409937888199,238.453416149068,999.732919254658,1055.5900621118,207.850931677019,192.919254658385,612.658385093168,1224.47826086957,469.130434782609,249.670807453416,1029.57142857143,130.086956521739,161,16.044544616224,12.8239558108731,0.600969396541806,0.969879518072289,0.766666666666667,-0.954705293378469,53113.7267080745,33337.6770186335,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_475031,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
475574,2642.10846560847,158.219576719577,95.8465608465608,619.330687830688,918.886243386243,308.343915343915,314.888888888889,246.52380952381,1079.64021164021,5332.05291005291,523.777777777778,119.539682539683,1075.81481481481,601.111111111111,451.174603174603,273.756613756614,1405.57671957672,927.634920634921,231.912698412698,212.724867724868,980.822751322751,838.510582010582,180.685185185185,120.100529100529,589.314814814815,2208.34391534392,535.568783068783,254.719576719577,1028.69576719577,129.886243386243,378,26.1408939701354,18.6008370509648,0.702624465447417,0.956962025316456,0.715909090909091,0.684313357764091,54100.5978835979,32869.5582010582,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_475574,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
475899,2615.41846153846,472.286153846154,126.141538461538,623.787692307692,929.323076923077,334.187692307692,1020.36,251.898461538462,1095.59692307692,4117.18153846154,1217.63076923077,124.612307692308,1076.35384615385,843.046153846154,1055.16615384615,433.84,1726.28923076923,1271.99384615385,292.870769230769,229.083076923077,1004.13538461538,1317.74769230769,231.593846153846,282.670769230769,654.166153846154,1032.94769230769,457.913846153846,314.458461538462,1025.24,133.787692307692,325,22.7678942794713,18.2385705676461,0.598576937000652,0.961538461538462,0.738636363636364,-0.616247735651102,52410.3876923077,33437.4953846154,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_475899,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
475994,2010.86666666667,551.309803921569,123.145098039216,655.8,2855.60784313725,3230.19607843137,3001.2,258.996078431372,1107.57647058824,2897.52549019608,560.035294117647,125.937254901961,1069.69019607843,4603.38431372549,1681.61960784314,1152.61960784314,11225.5725490196,4115.49411764706,399.439215686275,248.450980392157,1020.67058823529,2729.40392156863,251.211764705882,220.439215686275,596.294117647059,819.258823529412,431.450980392157,219.211764705882,1030.14509803922,129.235294117647,255,22.5664413040171,14.6473140329366,0.760724377545871,0.947955390334572,0.714285714285714,0.385596962907632,52670.5137254902,33585.4823529412,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_475994,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
477155,3368.97769516729,297.174721189591,127.765799256506,660.776951672862,2602.72862453532,988.68029739777,1467.95539033457,257.936802973978,1093.57249070632,5537.38661710037,633.769516728625,142.513011152416,1072.47211895911,2366.5092936803,1249.6282527881,344.275092936803,1618.18215613383,1761.68029739777,326.944237918216,226.28624535316,1008.08921933086,1149.79925650558,211.620817843866,231.695167286245,659.743494423792,1587.14126394052,526.96282527881,239.263940520446,1057.50185873606,129.903345724907,269,25.0605191532205,13.8966629321274,0.83216763557548,0.95729537366548,0.679292929292929,-0.924163618738238,53177.3977695167,32962.5241635688,FAAGSCC_12,AG,1,M2 macrophages,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_477155,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
477723,3797.57278481013,855.278481012658,813.5,610.626582278481,594.920886075949,273.712025316456,298.367088607595,237.341772151899,1086.00632911392,6046.12025316456,501.848101265823,118.094936708861,1121.68670886076,921.256329113924,582.642405063291,281.332278481013,1554.85759493671,1696.56962025316,301.009493670886,231.46835443038,1008.45253164557,1187.95569620253,227.433544303797,155.626582278481,584.158227848101,2031.21202531646,515.572784810127,245.598101265823,1037.98417721519,128.588607594937,316,24.2091976603489,16.7137936057423,0.723437161486079,0.954682779456193,0.723112128146453,1.09030516770982,54011.8734177215,33413.3259493671,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_477723,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
478066,3837.84020618557,516.175257731959,157.059278350515,659.564432989691,2516.39175257732,1715.51804123711,2147.82989690722,259.229381443299,1084.37886597938,5838.21391752577,1125.54639175258,124.796391752577,1077.88659793814,1306.13917525773,1075.12371134021,1762.15463917526,2666.56958762887,2391.50773195876,336.275773195876,225.744845360825,1089.71134020619,1967.6030927835,214.219072164948,527.239690721649,730.051546391753,1143.88402061856,438.461340206186,443.175257731959,1067.42525773196,132.342783505155,388,27.8301716047194,17.9939878759384,0.762859722764054,0.962779156327543,0.6208,0.81355806247734,52684.881443299,32376.4020618557,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_478066,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
478422,2522.38842975207,1097.45454545455,1363.89256198347,636.586776859504,1513.0,278.661157024793,249.371900826446,232.818181818182,1084.35537190083,3376.14876033058,810.760330578512,140.057851239669,1067.32231404959,830.669421487603,535.570247933884,278.801652892562,1857.66115702479,1378.47933884298,325.504132231405,235.396694214876,1027.94214876033,1264.18181818182,231.280991735537,465.818181818182,2925.57024793388,974.495867768595,509.05785123967,265.297520661157,1048.61983471074,131.611570247934,121,13.8518808003262,11.1490144382142,0.593446156141141,0.96031746031746,0.846153846153846,1.11856081305687,52880.0661157025,33862.8925619835,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_478422,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
478484,3970.90837696335,574.316753926702,117.732984293194,673.062827225131,2531.30628272251,3264.90314136126,695.232984293194,257.005235602094,1107.12041884817,5936.24607329843,678.269633507853,142.513089005236,1085.98429319372,3102.75654450262,578.32722513089,326.29057591623,1918.30628272251,3320.06544502618,333.091623036649,232.484293193717,1026.96335078534,2964.73821989529,263.05497382199,444.53664921466,1895.69109947644,1642.30366492147,518.607329842932,318.931937172775,1054.02356020942,129.526178010471,382,26.0786617927533,18.7255141709503,0.696002160051927,0.969543147208122,0.816239316239316,-0.0678101735742778,53028.6596858639,33844.8481675393,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_478484,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
479531,2110.60194174757,380.805825242718,100.800970873786,664.868932038835,2638.85436893204,4312.45145631068,1562.85436893204,264.509708737864,1138.83009708738,3674.79126213592,3660.29611650486,131.504854368932,1078.84466019417,3701.21359223301,1351.46601941748,1502.34951456311,4879.83495145631,3702.53883495146,401.956310679612,247.956310679612,1072.06796116505,3311.06796116505,305.95145631068,468.995145631068,819.854368932039,1455.71359223301,483.480582524272,598.344660194175,1082.73786407767,133.101941747573,206,17.7430434499666,15.3703070133236,0.499572123576269,0.876595744680851,0.673202614379085,-0.0431997640630208,53046.4029126214,33729.7427184466,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3+,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_479531,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
480316,4305.61904761905,677.734693877551,157.319727891156,629.43537414966,1396.25850340136,606.809523809524,356.816326530612,256.30612244898,1098.48979591837,7612.91836734694,2269.17006802721,127.170068027211,1076.18367346939,1264.15646258503,477.319727891157,290.959183673469,1672.70068027211,969.78231292517,190.795918367347,206.136054421769,1011.26530612245,651.87074829932,136.292517006803,108.285714285714,696.884353741497,2679.30612244898,549.727891156463,721.231292517007,1066.21768707483,129.408163265306,147,17.9700497666826,10.6886738946549,0.80387008591913,0.930379746835443,0.653333333333333,-0.82529094416749,53903.7346938776,32751.4217687075,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_480316,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
482240,3565.04576659039,737.496567505721,601.784897025172,679.544622425629,3603.4347826087,2419.01372997712,624.894736842105,248.45766590389,1088.68878718535,5077.10983981693,567.741418764302,118.775743707094,1079.13729977117,2445.32265446224,491.04347826087,424.798627002288,1792.92448512586,1865.54233409611,287.54233409611,597.816933638444,1056.11899313501,1461.85125858124,238.617848970252,262.146453089245,982.606407322654,1164.79176201373,502.800915331808,328.839816933638,1049.81693363844,129.796338672769,437,30.6554030895234,18.2361124850898,0.803818715374494,0.958333333333333,0.753448275862069,-0.295015373178777,53779.5995423341,33670.0823798627,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_482240,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
482750,3834.5091383812,884.133159268929,660.229765013055,619.694516971279,1004.95039164491,2496.66579634465,402.078328981723,257.77545691906,1111.94778067885,6811.79634464752,501.699738903394,137.535248041775,1080.77806788512,3677.67362924282,768.981723237598,313.55091383812,4318.83289817232,2712.48302872063,336.754569190601,237.109660574412,1025.28459530026,1839.95822454308,378.167101827676,226.704960835509,634.036553524804,2526.11227154047,520.318537859008,248.678851174935,1064.76762402089,131.68407310705,383,35.3335380229739,13.9360002238332,0.9189333657738,0.936430317848411,0.531944444444444,0.970399493993131,52834.2114882507,33829.7023498695,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_482750,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
482788,486.621513944223,986.083665338646,221.581673306773,613.350597609562,108.0796812749,259.824701195219,260.705179282869,246.462151394422,1076.1593625498,1213.0438247012,807.705179282868,115.956175298805,1070.42231075697,570.059760956175,448.195219123506,272.956175298805,1356.47011952191,890.191235059761,268.880478087649,223.924302788845,982.533864541833,880.780876494024,211.856573705179,131.099601593625,589.254980079681,572.93625498008,358.442231075697,203.254980079681,984.466135458167,155.294820717131,251,18.8002062367887,17.085830985937,0.417208437047284,0.936567164179104,0.733918128654971,-1.5461916911187,53231.4501992032,32660.7410358566,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_482788,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
483224,1438.27932960894,1198.86592178771,143.670391061453,644.597765363128,2544.72067039106,289.715083798883,283.743016759777,235.68156424581,1078.35195530726,1777.83798882682,554.391061452514,113.463687150838,1060.06145251397,711.385474860335,617.664804469274,282.944134078212,1628.27374301676,1157.92737430168,250.508379888268,222.474860335196,1005.68156424581,997.519553072626,181.815642458101,162.08938547486,658.860335195531,888.340782122905,474.502793296089,248.95530726257,1019.36312849162,128.491620111732,179,17.9468976538403,12.7158176079248,0.705686162656475,0.952127659574468,0.752100840336134,0.448465763647786,53090.8212290503,33450.1284916201,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_483224,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
483252,2444.872909699,497.227424749164,181.775919732441,664.19397993311,4203.30100334448,2371.8762541806,818.802675585284,260.173913043478,1085.26755852843,4049.82608695652,2960.8762541806,125.428093645485,1077.41806020067,1371.3779264214,746.167224080268,327.732441471572,1535.67892976589,1291.52173913043,319.023411371237,232.471571906355,992.889632107023,1172.67224080268,233.635451505017,165.130434782609,596.595317725752,1595.13043478261,562.722408026756,504.264214046823,1067.31772575251,130.257525083612,299,27.1063754455852,14.1694486319459,0.852495288907562,0.943217665615142,0.655701754385965,0.564189897031311,53568.7123745819,33222.779264214,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_483252,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
484604,2861.98823529412,580.360784313726,88.9450980392157,641.019607843137,1904.98823529412,1332.54509803922,1277.02745098039,253.537254901961,1083.4862745098,4977.7568627451,811.729411764706,116.513725490196,1073.98431372549,3298.76862745098,679.43137254902,695.721568627451,1738.19215686275,4453.88235294118,367.733333333333,235.380392156863,1062.02352941176,3853.67058823529,249.211764705882,434.650980392157,1145.16078431373,1614.71764705882,475.054901960784,272.666666666667,1043.17647058824,128.890196078431,255,21.2531116336992,15.2929695967832,0.694426345546376,0.958646616541353,0.75,0.475621414798746,53579.8784313725,33703.5529411765,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_484604,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
485380,1409.41,105.25,103.655,690.295,3639.045,3986.58,893.99,260.73,1113.085,2677.7,1254.41,121.46,1071.89,3712.905,907.915,1217.305,2220.435,6797.315,429.87,242.29,1068.04,5434.63,275.385,290.725,604.565,1403.795,495.43,310.38,1070.14,129.525,200,17.2917454541372,14.9929963366008,0.498202167444002,0.956937799043062,0.735294117647059,-0.473206428427898,53778.585,33748.225,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_485380,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
485502,3326.48235294118,275.501960784314,126.392156862745,638.243137254902,1959.90980392157,838.180392156863,497.043137254902,302.207843137255,1161.47450980392,5230.37647058823,605.933333333333,129.537254901961,1070.7568627451,1245.35294117647,698.737254901961,288.03137254902,1605.71764705882,1160.98039215686,221.858823529412,214.674509803922,1215.76470588235,630.866666666667,137.262745098039,103.898039215686,585.972549019608,1726.6862745098,466.803921568627,221.443137254902,1054.33333333333,130.074509803922,255,23.6497639786859,14.0210707370606,0.805303313891612,0.951492537313433,0.739130434782609,1.27789605721997,52766.7137254902,32195.1647058824,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_485502,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
485895,3350.56852791878,576.197969543147,107.878172588832,652.741116751269,2109.30964467005,326.568527918782,515.005076142132,252.878172588832,1084.90355329949,4977.82741116751,633.258883248731,122.243654822335,1068.24365482233,746.020304568528,536.319796954315,280.106598984772,1517.5076142132,1066.58375634518,275.131979695431,226.071065989848,989.604060913706,985.705583756345,204.649746192893,136.736040609137,580.213197969543,1028.12182741117,467.248730964467,227.152284263959,1051.79187817259,129.426395939086,197,18.3558186297303,13.7141764431723,0.664678326987782,0.947115384615385,0.740601503759398,1.45478665095533,52946.8984771574,33251.7360406091,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_485895,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
486147,2897.83890577508,357.920972644377,91.726443768997,629.887537993921,1565.95440729483,1101.89361702128,386.677811550152,248.73556231003,1082.54407294833,3886.96656534954,540.22188449848,122.340425531915,1082.90273556231,2754.24924012158,564.516717325228,293.683890577508,1902.99088145897,3423.13981762918,399.462006079027,242.768996960486,1027.65045592705,2468.73252279635,222.161094224924,196.592705167173,816.477203647416,890.838905775076,499.468085106383,279.474164133739,1013.11246200608,129.051671732523,329,25.3898347241371,16.5645231315803,0.757868208164518,0.948126801152738,0.731111111111111,-1.264372621606,53750.282674772,33707.0820668693,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_486147,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
486172,1973.95794392523,460.495327102804,440.635514018692,625.61214953271,1228.51869158879,3305.40654205607,908.191588785047,265.38785046729,1117.60280373832,2857.92056074766,897.238317757009,127.663551401869,1071.84112149533,5249.26635514019,736.523364485981,672.07476635514,2096.91121495327,5177.08878504673,383.635514018692,239.490654205607,1030.6308411215,4612.56074766355,251.322429906542,262.542056074766,611.271028037383,1002.94392523364,470.200934579439,298.219626168224,1041.19158878505,130.981308411215,214,23.0161005507341,11.9253677249639,0.855300942752359,0.951111111111111,0.679365079365079,1.07724406468315,53386.8317757009,33865.5140186916,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_486172,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
486418,2372.64596273292,1196.18633540373,111.378881987578,642.434782608696,1555.52795031056,850.503105590062,681.192546583851,245.428571428571,1080.99378881988,2785.49689440994,626.173913043478,131.639751552795,1068.37888198758,3249.87577639751,1048.36645962733,405.316770186335,7046.67080745342,5685.24223602484,479.701863354037,254.229813664596,1040.12422360248,4186.51552795031,277.27950310559,402.074534161491,617.310559006211,1052.11180124224,505.465838509317,252.515527950311,1039.57763975155,131.111801242236,161,15.7545237356311,13.0458763321754,0.560622106375523,0.952662721893491,0.766666666666667,-0.465518143491486,53281.5962732919,33837.2173913043,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_486418,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
486730,3610.41964285714,456.78125,295.004464285714,654.075892857143,1843.24107142857,427.058035714286,1047.67857142857,255.6875,1093.77678571429,5575.40178571429,1142.10714285714,146.080357142857,1085.10714285714,1348.76785714286,889.044642857143,734.035714285714,1944.29017857143,3613.95535714286,392.044642857143,247.370535714286,1037.58035714286,3920.97321428571,255.946428571429,817.888392857143,658.691964285714,1572.32589285714,495.107142857143,394.46875,1050.87946428571,129.629464285714,224,20.9832175871607,13.608520293839,0.761177962094514,0.953191489361702,0.736842105263158,0.555772407401143,53418.6517857143,33827.0089285714,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_486730,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
487484,2305.51,150.5775,78.3825,615.295,1021.5975,806.34,350.3925,265.3475,1103.5875,4659.795,1909.9675,113.52,1067.5775,999.755,589.4425,276.35,1759.3825,1412.5775,273.0675,222.8675,1046.32,1346.5675,201.5075,220.7875,1674.6675,1314.425,455.655,304.5175,1036.85,129.7675,400,27.7364004274638,18.4370629799701,0.747088636919851,0.97323600973236,0.75187969924812,-1.35641142823377,54021.23,32653.005,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_487484,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
488042,4512.59659090909,274.434659090909,155.377840909091,672.224431818182,3317.32386363636,1397.14772727273,2197.87784090909,256.826704545455,1096.23579545455,6755.15625,615.931818181818,142.625,1093.82670454545,2633.51136363636,1114.34659090909,892.536931818182,3424.53409090909,5426.32670454545,459.784090909091,251.019886363636,1068.80965909091,5875.5,315.622159090909,675.892045454545,694.789772727273,2724.85511363636,591.255681818182,299.431818181818,1094.95170454545,131.840909090909,352,22.8204084644936,19.7131188980137,0.503770984719653,0.959128065395095,0.728778467908903,-1.08956112586802,53098.25,33742.1477272727,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_488042,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
489284,3510.80392156863,623.104575163399,134.0,612.271241830065,603.075163398693,309.552287581699,339.591503267974,263.411764705882,1079.37581699346,7011.52614379085,625.673202614379,127.346405228758,1069.84967320261,731.950980392157,531.316993464052,281.771241830065,1388.99673202614,1054.1339869281,321.624183006536,232.415032679739,985.937908496732,1034.2385620915,236.294117647059,127.287581699346,599.47385620915,2622.11437908497,538.140522875817,255.921568627451,1070.34967320261,129.506535947712,306,23.2482090139988,16.8877226521801,0.687262006392919,0.950310559006211,0.772727272727273,-1.33333443556488,52966.5032679739,32701.7679738562,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_489284,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
489670,2390.71502590674,160.150259067358,80.9948186528497,657.274611398964,1383.22279792746,269.79274611399,267.860103626943,252.616580310881,1070.52331606218,5113.40932642487,651.979274611399,132.79274611399,1136.64766839378,596.502590673575,452.533678756477,260.20725388601,1380.25388601036,940.362694300518,262.077720207254,220.777202072539,1015.59585492228,833.455958549223,186.20207253886,114.937823834197,583.699481865285,2430.41968911917,534.979274611399,238.321243523316,1048.17616580311,129.336787564767,193,18.3043307892698,14.7496067691624,0.592189482631767,0.850220264317181,0.597523219814242,0.834085551652806,53539.1295336788,32648.2279792746,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_489670,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
490035,3013.68813559322,166.905084745763,71.8847457627119,610.142372881356,360.403389830509,317.972881355932,300.91186440678,243.037288135593,1083.82711864407,5187.60677966102,608.908474576271,117.410169491525,1080.6813559322,806.552542372881,671.416949152542,289.15593220339,1736.49491525424,1142.78305084746,279.477966101695,226.403389830508,1010.67118644068,1081.70169491525,223.691525423729,178.24406779661,577.467796610169,1100.40677966102,467.35593220339,225.922033898305,1027.58644067797,128.881355932203,295,26.6548314044693,14.3910768910263,0.841725956139416,0.930599369085174,0.609504132231405,0.720133888479795,53839.0101694915,33330.9898305085,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_490035,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
490417,2691.24475524476,1338.85314685315,132.237762237762,647.503496503497,2302.95804195804,980.202797202797,471.216783216783,237.062937062937,1109.33566433566,4678.86013986014,505.545454545455,114.671328671329,1074.41958041958,1511.01398601399,759.839160839161,298.881118881119,1837.60839160839,1166.9020979021,248.503496503497,220.258741258741,999.335664335664,1192.74825174825,201.783216783217,192.27972027972,630.594405594406,1599.70629370629,495.146853146853,238.020979020979,1036.74825174825,129.153846153846,143,14.9075406311938,12.5719898443713,0.537394614728015,0.94078947368421,0.733333333333333,-1.36792302176011,53816.2517482518,33544.8111888112,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_490417,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
490553,2119.22164948454,216.262886597938,55.8505154639175,644.40206185567,1292.75773195876,550.567010309278,989.752577319588,242.927835051546,1083.65463917526,3124.78865979381,2105.00515463918,126.438144329897,1075.90721649485,1504.76288659794,789.628865979381,1059.46907216495,1763.31958762887,1831.24742268041,302.067010309278,232.809278350515,1013.56701030928,2125.12371134021,232.242268041237,770.484536082474,613.247422680412,1191.31443298969,483.551546391753,1004.28865979381,1064.32474226804,130.417525773196,194,19.8788422774557,12.4814020597564,0.778315250410505,0.96039603960396,0.729323308270677,1.1738646396429,53526.4329896907,33734.1804123711,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_490553,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
490823,584.227272727273,1374.57196969697,305.791666666667,604.950757575758,95.1628787878788,291.102272727273,424.829545454545,253.594696969697,1084.04166666667,1099.11742424242,884.712121212121,115.416666666667,1062.23484848485,627.0,538.416666666667,277.102272727273,1413.24242424242,896.848484848485,252.526515151515,217.685606060606,996.594696969697,845.306818181818,188.69696969697,134.462121212121,586.988636363636,572.416666666667,368.806818181818,207.378787878788,982.30303030303,129.492424242424,264,19.4074454928304,17.3421532374218,0.448899047449021,0.970588235294118,0.776470588235294,0.147571396991984,53300.0454545455,32984.321969697,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_490823,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
491779,3764.54128440367,465.211009174312,1314.78899082569,637.536697247706,1610.33944954128,2829.99541284404,586.954128440367,263.701834862385,1098.53669724771,5521.90825688073,565.045871559633,138.371559633028,1073.83944954128,3095.64220183486,961.793577981651,563.036697247706,2230.22935779816,3779.02752293578,460.683486238532,253.0,1029.68348623853,2430.22018348624,290.454128440367,214.412844036697,599.325688073395,1246.85321100917,506.967889908257,400.788990825688,1065.38990825688,129.275229357798,218,17.2430049489504,16.1590617170361,0.348961074424428,0.973214285714286,0.801470588235294,1.54117160326587,53148.2660550459,33798.5412844037,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_491779,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
492141,2634.51394422311,950.768924302789,1536.0796812749,665.517928286853,2900.32270916335,4389.66135458167,480.398406374502,268.90438247012,1148.73306772908,4117.47011952191,545.406374501992,128.330677290837,1086.33864541833,1604.62948207171,544.00796812749,286.274900398406,3062.07569721116,3203.83665338645,338.828685258964,233.378486055777,1057.66932270916,3271.75298804781,226.462151394422,182.043824701195,610.585657370518,1171.70517928287,490.458167330677,231.633466135458,1053.62948207171,134.430278884462,251,20.5077311231246,15.8280390394613,0.63585517351927,0.943609022556391,0.703081232492997,-0.123577863688218,52742.4820717131,33543.2669322709,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_492141,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
492239,2010.75153374233,226.291411042945,103.426380368098,625.496932515337,1294.34049079755,1920.0981595092,445.539877300614,248.552147239264,1102.3036809816,3531.78220858896,1208.1717791411,110.576687116564,1103.89877300613,6158.22392638037,1026.49079754601,414.156441717791,6136.29141104294,7454.93251533742,456.233128834356,253.312883435583,1056.98159509202,7727.89877300614,313.223926380368,797.10736196319,694.981595092025,1138.9018404908,473.782208588957,412.153374233129,1028.88036809816,130.322085889571,326,26.2931222978534,16.0181815993703,0.793004597349358,0.947674418604651,0.674948240165631,-0.932710096990282,53350.0153374233,33506.027607362,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_492239,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
493404,3351.80838323353,597.550898203593,127.260479041916,643.482035928144,1667.95808383234,677.622754491018,750.838323353293,241.260479041916,1088.23053892216,4903.34131736527,781.769461077844,118.586826347305,1079.58383233533,1003.11077844311,873.796407185629,452.77245508982,1676.10479041916,1333.03592814371,299.404191616766,230.859281437126,1014.9880239521,1263.53892215569,213.808383233533,228.266467065868,657.958083832335,936.883233532934,450.404191616766,274.889221556886,1023.60479041916,129.646706586826,334,26.2112620282204,16.5590215939564,0.775170432300976,0.962536023054755,0.732456140350877,1.12838360133275,53691.374251497,33424.4940119761,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_493404,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
494382,4522.73381294964,947.798561151079,1731.07553956835,637.305755395683,1790.61151079137,385.406474820144,383.830935251799,248.187050359712,1081.62230215827,7191.04316546763,728.079136690647,127.579136690647,1069.38129496403,786.079136690647,481.169064748201,309.165467625899,1451.55035971223,936.679856115108,247.089928057554,214.345323741007,985.143884892086,856.068345323741,183.489208633094,118.658273381295,589.737410071942,1814.31654676259,533.26618705036,269.820143884892,1054.30935251799,132.007194244604,278,20.5459881780136,17.2321890200894,0.544573567072616,0.968641114982578,0.772222222222222,0.416462989809489,53889.4136690648,32862.4460431655,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_494382,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
494422,2197.74637681159,416.565217391304,132.442028985507,663.210144927536,2404.0652173913,433.434782608696,324.86231884058,251.536231884058,1078.84057971014,3443.54347826087,988.586956521739,113.884057971014,1074.23188405797,649.420289855072,448.057971014493,300.369565217391,1483.5652173913,1101.0652173913,292.644927536232,230.31884057971,987.557971014493,1078.54347826087,225.173913043478,165.36231884058,607.333333333333,1091.82608695652,445.572463768116,254.905797101449,1061.23913043478,129.565217391304,138,14.8596226345753,11.8609821895934,0.602389729611278,0.945205479452055,0.707692307692308,1.22283982869134,52812.0797101449,33369.0434782609,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_494422,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
495407,3187.7881773399,724.046798029557,129.302955665025,648.839901477833,1945.41625615764,337.908866995074,346.559113300493,242.684729064039,1090.10591133005,5093.4039408867,1583.76108374384,137.972906403941,1083.89901477833,1031.47044334975,535.633004926108,343.57881773399,2525.4236453202,1502.88916256158,316.487684729064,235.418719211823,999.556650246305,1638.0960591133,237.098522167488,229.721674876847,617.032019704434,1295.65270935961,463.635467980296,364.386699507389,1049.86699507389,132.23645320197,406,30.9479332463403,16.9630880936821,0.836401675382162,0.94199535962877,0.712280701754386,0.179948770143352,52687.2709359606,33777.3103448276,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_495407,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
496697,2523.15329768271,442.254901960784,176.591800356506,732.689839572193,4015.73618538324,1000.9696969697,397.900178253119,249.41889483066,1087.99465240642,3905.72727272727,623.579322638146,121.160427807487,1076.58645276292,1995.14616755793,509.495543672014,310.147950089127,1446.47415329768,2276.72549019608,255.003565062389,221.559714795009,993.269162210339,2147.00356506239,200.058823529412,126.128342245989,585.828877005348,1217.38502673797,496.008912655971,802.393939393939,1060.86809269162,130.636363636364,561,39.9837533820249,18.4764833989569,0.88682794212184,0.942857142857143,0.616483516483517,0.493761553763856,53995.0,33144.5169340463,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_496697,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
497103,3460.30890804598,239.416666666667,122.465517241379,646.010057471264,2162.97413793103,2358.20833333333,770.935344827586,264.541666666667,1128.80316091954,6905.90517241379,627.73275862069,126.038793103448,1075.82471264368,1429.36350574713,1069.16522988506,433.362068965517,1773.64224137931,2081.54022988506,293.814655172414,238.057471264368,1017.37787356322,1736.55172413793,208.764367816092,217.604885057471,587.774425287356,3464.1724137931,567.64367816092,333.270114942529,1046.65948275862,129.78591954023,696,52.395253605976,17.2500797101941,0.944249822969733,0.946938775510204,0.568163265306122,-1.22566835389764,53650.5057471264,33343.275862069,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_497103,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
497121,4154.89637305699,964.466321243523,626.60621761658,692.911917098446,2910.16062176166,279.79792746114,442.476683937824,244.668393782383,1080.9792746114,8071.56994818653,612.829015544041,131.844559585492,1088.20725388601,607.39896373057,404.492227979275,266.124352331606,1417.44559585492,978.284974093264,262.829015544041,222.813471502591,984.766839378238,966.704663212435,201.295336787565,126.554404145078,581.823834196891,2845.23316062176,573.901554404145,244.564766839378,1084.9896373057,132.647668393782,193,17.1769325086682,14.7376039197969,0.513669540654324,0.927884615384615,0.75390625,1.04679027528766,52923.1917098446,33259.7616580311,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_497121,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
497221,3353.80769230769,649.147928994083,170.692307692308,655.751479289941,2156.21301775148,271.355029585799,291.325443786982,252.242603550296,1077.29289940828,5055.06804733728,3738.51183431953,139.508875739645,1076.43195266272,581.505917159763,429.582840236686,265.692307692308,1478.34023668639,1013.85207100592,274.056213017751,224.852071005917,990.591715976331,949.467455621302,205.402366863905,157.754437869822,589.431952662722,1503.70414201183,517.127218934911,771.937869822485,1089.93786982249,130.275147928994,338,28.9786725214913,15.0739128594841,0.854061130652903,0.946778711484594,0.754464285714286,-1.3986257936646,52870.4704142012,32670.1893491124,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_497221,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
497439,3876.67848101266,570.518987341772,149.754430379747,641.807594936709,2014.30886075949,1931.0329113924,386.194936708861,246.46582278481,1095.60253164557,5757.56962025316,594.341772151899,116.093670886076,1082.73670886076,3243.29620253165,711.139240506329,326.807594936709,4047.37721518987,2583.89367088608,356.782278481013,238.835443037975,1028.18227848101,1803.01772151899,233.812658227848,328.273417721519,747.387341772152,1103.53670886076,469.594936708861,284.448101265823,1040.33670886076,129.379746835443,395,24.831751891758,20.5384352332037,0.562049266919514,0.968137254901961,0.715579710144927,-0.624358736828426,53901.5949367089,33557.4075949367,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_497439,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
497712,2367.25862068966,1007.48275862069,108.862068965517,646.043103448276,1397.06896551724,689.137931034483,522.137931034483,228.76724137931,1079.69827586207,3451.37068965517,1085.64655172414,122.646551724138,1084.21551724138,1426.5775862069,525.637931034483,624.025862068965,1787.03448275862,1054.45689655172,251.103448275862,225.448275862069,1009.14655172414,928.112068965517,201.129310344828,176.258620689655,591.887931034483,872.76724137931,457.172413793103,286.862068965517,1044.71551724138,131.129310344828,116,13.2521185011494,11.2932861132732,0.523236973717393,0.950819672131148,0.811188811188811,-0.0102887001953659,53226.4482758621,33705.8189655172,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_497712,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
498418,5490.81318681319,681.750915750916,235.161172161172,631.318681318681,1300.30402930403,659.663003663004,1258.61904761905,244.516483516484,1083.72893772894,8808.3663003663,647.652014652015,143.179487179487,1085.1684981685,2112.32967032967,802.564102564103,1404.39926739927,2099.54578754579,4178.7032967033,386.901098901099,239.549450549451,1096.78021978022,3188.25641025641,292.47619047619,530.875457875458,666.750915750916,2912.90476190476,546.285714285714,311.051282051282,1066.9706959707,131.282051282051,273,21.8320175644971,16.2247435841482,0.669110628780813,0.97153024911032,0.764705882352941,0.167740522319689,53381.7509157509,33763.5641025641,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_498418,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
498820,2891.66261398176,265.826747720365,129.957446808511,636.623100303951,1918.01519756839,1246.78723404255,737.963525835866,257.814589665654,1085.30699088146,5773.6717325228,631.407294832827,120.206686930091,1095.66869300912,2230.22796352584,642.273556231003,462.790273556231,1537.89665653495,2080.43465045593,356.303951367781,232.340425531915,1053.85106382979,1553.65957446809,234.145896656535,1215.81762917933,1333.13981762918,2215.85106382979,518.820668693009,254.48632218845,1060.0,131.823708206687,329,28.7098020629232,14.6967736863373,0.859040354315896,0.948126801152738,0.676954732510288,-1.165265877393,53219.0516717325,33187.4711246201,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_498820,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
499148,983.764492753623,203.286231884058,129.746376811594,669.605072463768,3680.69565217391,4448.92391304348,459.583333333333,267.239130434783,1198.30434782609,2228.90579710145,497.75,111.728260869565,1073.09782608696,2058.84420289855,979.347826086956,300.380434782609,2840.5652173913,1880.63768115942,266.398550724638,219.865942028986,1029.21739130435,1148.3768115942,179.652173913043,146.826086956522,591.481884057971,1207.92753623188,483.076086956522,310.307971014493,1039.40942028986,129.590579710145,276,20.4122863696388,17.3168024314336,0.529432726295827,0.965034965034965,0.766666666666667,1.16638007401156,53700.3586956522,33309.0326086957,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_499148,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
499221,1702.34551495017,163.039867109635,172.681063122924,723.644518272425,7273.95348837209,502.322259136213,434.767441860465,248.598006644518,1079.93355481728,3834.12624584718,568.724252491694,128.019933554817,1081.28903654485,1996.53488372093,587.305647840532,308.627906976744,2960.10299003322,1732.39867109635,282.920265780731,226.495016611296,988.514950166113,1641.87043189369,218.016611295681,138.614617940199,589.710963455149,1604.4219269103,593.023255813953,300.232558139535,1075.02325581395,131.813953488372,301,24.7390622746281,15.5646089180386,0.777282998036687,0.96474358974359,0.727053140096618,1.09081866128928,54063.3289036545,33290.3521594684,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_499221,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
499437,1724.40389294404,182.856447688564,127.486618004866,656.60097323601,3146.97080291971,396.197080291971,338.063260340633,248.94403892944,1077.51094890511,2612.74939172749,724.014598540146,121.56204379562,1069.84428223844,969.883211678832,590.343065693431,276.187347931873,1668.22141119221,1612.65693430657,300.408759124088,225.267639902676,1035.84428223844,1438.0802919708,212.678832116788,211.722627737226,4124.30170316302,1043.47201946472,503.094890510949,237.603406326034,1048.3503649635,130.182481751825,411,35.4190097444439,14.9393656375074,0.906693794013552,0.940503432494279,0.530322580645161,0.602279610196799,53204.8856447689,33087.2676399027,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_499437,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
499567,626.050147492625,1292.72566371681,295.439528023599,619.356932153392,87.5693215339233,290.952802359882,496.315634218289,249.504424778761,1078.40707964602,1462.0383480826,772.598820058997,118.029498525074,1065.20943952802,576.374631268437,431.47197640118,268.587020648968,1380.13274336283,902.873156342183,273.578171091445,222.867256637168,978.498525073746,866.209439528024,197.530973451327,114.530973451327,590.088495575221,574.784660766962,362.504424778761,205.424778761062,988.212389380531,126.920353982301,339,24.5161960583376,17.714301624025,0.691313372340862,0.954929577464789,0.784722222222222,-0.0124767433304895,53789.7728613569,32646.3775811209,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_499567,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
499753,1790.5367965368,215.099567099567,98.017316017316,625.649350649351,987.471861471861,296.904761904762,234.095238095238,223.848484848485,1085.37229437229,2547.22510822511,563.17316017316,114.714285714286,1066.49783549784,564.584415584416,324.900432900433,257.08658008658,1466.82251082251,864.073593073593,196.30303030303,211.666666666667,1035.66233766234,744.584415584416,162.761904761905,148.056277056277,595.943722943723,960.848484848485,511.155844155844,255.5670995671,1014.2683982684,130.406926406926,231,20.2815721188886,14.7764807206741,0.684974724478851,0.9625,0.77,1.40563983931042,53858.7965367965,33497.3376623377,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_499753,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
499918,4254.83279742765,640.588424437299,162.263665594855,650.980707395498,1857.44372990354,515.549839228296,730.057877813505,255.32154340836,1083.80707395498,5206.54019292605,552.655948553055,137.636655948553,1098.5691318328,1979.79742765273,674.32154340836,361.331189710611,2028.77813504823,3923.85209003215,404.810289389068,244.24115755627,1004.86173633441,4434.09967845659,264.414790996785,219.263665594855,587.594855305466,974.228295819936,467.469453376206,285.893890675241,1025.2154340836,130.742765273312,311,22.7524690007501,17.5143378886214,0.638312349729519,0.951070336391437,0.744019138755981,0.382445926547914,53520.0900321543,33857.4115755627,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_499918,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
500706,3659.52340425532,238.770212765957,224.395744680851,642.187234042553,1653.7914893617,2089.46808510638,514.272340425532,253.851063829787,1112.44255319149,5342.26382978723,610.787234042553,140.140425531915,1081.77872340426,3456.08085106383,650.612765957447,618.165957446809,2750.9914893617,4362.9914893617,378.808510638298,241.693617021277,1032.53617021277,4092.05957446808,263.412765957447,329.463829787234,672.489361702128,1242.28510638298,494.791489361702,274.578723404255,1044.8085106383,130.902127659574,235,19.337143444828,15.5418711519374,0.594992175382846,0.959183673469388,0.725308641975309,0.749519416588194,53139.7957446809,33811.429787234,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_500706,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
500931,1042.72448979592,68.4795918367347,43.7551020408163,608.724489795918,450.122448979592,1935.83673469388,1268.82653061224,251.112244897959,1145.79591836735,2141.07142857143,457.30612244898,117.255102040816,1071.36734693878,1617.92857142857,709.020408163265,1127.25510204082,2953.14285714286,3461.65306122449,339.377551020408,241.448979591837,1038.0,4830.77551020408,273.19387755102,373.642857142857,767.020408163265,1207.4693877551,473.857142857143,246.15306122449,1022.5,127.102040816327,98,12.4784104395191,10.0288327410214,0.595041827813662,0.91588785046729,0.742424242424242,1.11863226570306,53137.387755102,33871.9285714286,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_500931,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
503740,3039.9933481153,456.9977827051,162.250554323725,729.434589800443,4364.0133037694,418.181818181818,319.039911308204,266.50332594235,1083.26607538803,4836.17294900222,5199.64523281596,134.241685144124,1082.19512195122,741.740576496674,492.862527716186,271.906873614191,1387.44789356984,1134.92682926829,323.922394678492,228.254988913525,976.113082039911,958.161862527716,205.869179600887,111.155210643016,589.117516629712,1282.9756097561,461.483370288248,312.718403547672,1066.80044345898,130.490022172949,451,40.7462091526449,14.3475335652964,0.935955062463657,0.933747412008282,0.593421052631579,-0.320900781047839,53520.1751662971,32072.9733924612,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_503740,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
504329,3569.01461988304,252.219298245614,193.681286549708,704.578947368421,5667.52339181287,2567.15204678363,3789.12280701754,269.195906432749,1105.16374269006,5815.6052631579,680.883040935673,155.043859649123,1071.89473684211,877.584795321637,599.912280701754,824.444444444444,1640.62573099415,1500.78362573099,262.690058479532,214.283625730994,1023.28947368421,1006.85964912281,166.429824561404,158.172514619883,599.961988304094,1456.4298245614,476.014619883041,226.576023391813,1053.77485380117,130.619883040936,342,23.9892323788608,18.2118837436075,0.650893455927285,0.963380281690141,0.791666666666667,-1.42066665702109,53202.6959064327,32147.4356725146,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_504329,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
504705,1476.48172043011,154.498924731183,101.565591397849,652.234408602151,2329.26666666667,1295.80430107527,426.120430107527,279.903225806452,1098.4064516129,2610.48387096774,731.070967741936,122.240860215054,1085.65806451613,2329.0,762.645161290323,324.040860215054,1847.80430107527,2605.50107526882,416.539784946237,250.754838709677,1021.78494623656,3035.76989247312,289.795698924731,183.724731182796,589.247311827957,1333.62580645161,526.647311827957,411.086021505376,1068.29892473118,128.851612903226,465,34.4155235367305,17.5259111038142,0.860621976454911,0.958762886597938,0.719814241486068,-0.228174841394875,52317.7741935484,33074.2129032258,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_504705,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
505353,3043.3828125,200.505859375,150.720703125,724.06640625,4853.787109375,1736.287109375,365.177734375,255.990234375,1147.8203125,5313.720703125,618.5625,146.087890625,1084.228515625,3441.646484375,728.908203125,335.365234375,2761.515625,3066.1640625,403.267578125,249.458984375,1051.951171875,2665.826171875,264.787109375,293.15625,3909.5625,1983.380859375,520.04296875,251.96875,1083.39453125,129.75390625,512,33.5137503859895,19.5417701644282,0.812402479823275,0.948148148148148,0.738816738816739,-0.179445930949114,53003.41015625,33813.98046875,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_505353,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
505866,1476.01033057851,195.438016528926,93.4545454545454,648.954545454545,2287.60330578512,2447.6694214876,847.743801652893,275.818181818182,1336.01652892562,2221.35123966942,892.904958677686,120.386363636364,1072.29752066116,2244.17561983471,905.316115702479,977.411157024793,1976.77685950413,2633.3367768595,332.522727272727,1113.53512396694,1016.19834710744,1941.11363636364,276.035123966942,401.876033057851,634.010330578512,970.45041322314,486.549586776859,239.417355371901,1049.81818181818,130.851239669421,484,33.7699736720348,18.5520011823821,0.835583276128033,0.947162426614481,0.64021164021164,0.780047634176363,52591.1157024793,32405.9400826446,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1-,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_505866,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
505873,655.604712041885,251.832460732984,97.7329842931937,667.916230366492,1679.2722513089,1641.66753926702,425.560209424084,265.235602094241,1095.34293193717,1312.06544502618,2411.35863874346,114.620418848168,1072.33246073298,1105.97382198953,525.534031413613,305.575916230366,1577.11518324607,1126.21727748691,276.931937172775,223.989528795812,1013.15445026178,954.013089005236,209.929319371728,139.837696335079,585.028795811518,994.544502617801,507.102094240838,1040.28272251309,1042.18586387435,130.096858638743,382,24.623050533033,19.7992238903802,0.59450345773723,0.955,0.757936507936508,1.19116185752668,53557.6518324607,33352.1047120419,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_505873,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
505954,3923.68715083799,532.072625698324,119.899441340782,627.569832402235,1094.27374301676,480.608938547486,314.139664804469,256.715083798883,1111.67039106145,7333.68715083799,1190.25698324022,125.586592178771,1074.62569832402,837.31843575419,446.731843575419,270.329608938547,1512.95530726257,1037.24581005587,215.005586592179,210.162011173184,1162.53072625698,691.011173184358,137.016759776536,111.469273743017,595.541899441341,1974.25698324022,523.68156424581,458.810055865922,1090.91061452514,130.614525139665,179,17.9078110330445,12.9088309115326,0.693091955418221,0.93717277486911,0.69921875,0.643858193427775,53261.8770949721,32744.5195530726,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_505954,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
507528,1924.04600484262,328.036319612591,236.573849878935,735.462469733656,5777.77360774818,1388.69975786925,677.782082324455,262.756658595642,1088.10532687651,2663.14285714286,622.217917675545,139.332929782082,1086.4794188862,2219.26513317191,609.503631961259,312.802663438257,1617.45278450363,1674.39467312349,334.71186440678,235.990314769976,988.887409200968,1377.85472154964,241.157384987893,168.049636803874,589.399515738499,819.573849878935,405.138014527845,208.194915254237,1023.6598062954,130.244552058111,826,50.7439460854313,20.9436111818955,0.910852860469596,0.959349593495935,0.564979480164159,-0.59106912410854,52354.2469733656,32467.2445520581,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_507528,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
508328,2530.95625,478.21875,111.65,618.50625,656.225,464.075,286.2625,244.1875,1090.075,3168.2,557.79375,119.525,1075.21875,793.85,515.7625,276.9875,1486.425,1222.13125,308.20625,232.7,981.76875,1165.775,222.6625,129.0625,584.525,984.06875,523.23125,235.4875,1009.725,127.8875,160,16.8808731717945,13.0446778786518,0.634711731049807,0.846560846560847,0.588235294117647,-0.987490913914769,53848.4375,33146.525,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_508328,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
508336,2177.45161290323,262.090322580645,140.909677419355,649.477419354839,2369.28387096774,590.825806451613,547.090322580645,245.103225806452,1076.77419354839,4412.41935483871,529.012903225806,119.948387096774,1073.58709677419,1849.76129032258,768.664516129032,588.754838709677,1741.43225806452,1925.70967741935,269.677419354839,220.696774193548,1021.78064516129,1432.87096774194,185.064516129032,183.470967741935,636.922580645161,2128.81935483871,545.761290322581,235.574193548387,1025.36774193548,130.554838709677,155,14.9909558872933,13.1918108787052,0.475002145448978,0.962732919254658,0.790816326530612,0.742923320272446,53538.7290322581,33174.3741935484,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_508336,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
508800,2444.49748743719,322.145728643216,64.0201005025126,616.653266331658,1227.14070351759,536.291457286432,331.190954773869,259.21608040201,1122.86432160804,3769.70854271357,826.48743718593,121.010050251256,1072.10552763819,881.72864321608,469.51256281407,272.989949748744,1520.61306532663,980.150753768844,205.251256281407,215.201005025126,1115.25125628141,747.522613065327,141.391959798995,109.763819095477,934.547738693467,1200.22613065327,489.206030150754,345.989949748744,1044.08542713568,130.56783919598,199,24.8816067490866,10.17158476378,0.912624286454171,0.966019417475728,0.753787878787879,-1.34057218884247,53236.4070351759,32732.0351758794,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_508800,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
508898,2187.30379746835,443.936708860759,158.050632911392,641.746835443038,2834.26582278481,2156.75949367089,312.759493670886,256.481012658228,1081.16455696203,3935.26582278481,4249.11392405063,123.658227848101,3763.06329113924,954.455696202532,517.151898734177,278.582278481013,2150.32911392405,1409.59493670886,313.050632911392,233.455696202532,988.73417721519,1226.29113924051,241.20253164557,139.481012658228,944.79746835443,1363.81012658228,523.73417721519,1831.51898734177,1068.50632911392,130.822784810127,79,11.0634774021428,9.1778548739675,0.558412682233627,0.963414634146341,0.797979797979798,1.54028244818893,53519.1518987342,33276.3544303797,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX+,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_508898,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
509843,451.385281385281,780.168831168831,175.281385281385,611.212121212121,103.822510822511,630.017316017316,427.922077922078,280.419913419913,1114.44155844156,1228.04329004329,1468.9696969697,119.917748917749,1064.26406926407,904.316017316017,522.099567099567,282.87012987013,1521.30735930736,1036.53246753247,203.333333333333,209.874458874459,1311.1645021645,690.515151515152,147.060606060606,125.402597402597,591.160173160173,553.090909090909,343.307359307359,198.510822510822,983.930735930736,128.372294372294,231,18.6189524983159,15.8429469947314,0.525320710775758,0.9625,0.799307958477509,-0.941408832097021,52623.7012987013,32882.1558441558,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_509843,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
509919,3356.57489878542,279.623481781377,110.056680161943,658.412955465587,1840.40890688259,304.611336032389,521.178137651822,226.781376518219,1069.74493927126,5383.71659919028,1293.2955465587,119.716599190283,1076.86234817814,944.251012145749,729.2995951417,1382.83805668016,1578.96356275304,1211.19028340081,229.441295546559,215.485829959514,1012.69230769231,1208.08502024291,183.291497975708,261.46963562753,625.336032388664,1365.97570850202,471.02024291498,562.376518218623,1059.10526315789,131.437246963563,247,20.2893995851266,15.5135251250838,0.644490482667848,0.97244094488189,0.764705882352941,-0.531313211379203,53339.9352226721,33611.6842105263,FAAGSCC_12,AG,1,dendritic cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,dendritic cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_509919,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
511108,2037.88122605364,302.697318007663,235.498084291188,643.07662835249,2174.87739463602,1748.60536398467,584.386973180077,259.068965517241,1113.13793103448,3556.25670498084,440.229885057471,119.23754789272,1074.2337164751,2702.05747126437,1343.0,1102.6398467433,1955.31034482759,4184.26436781609,376.892720306513,238.019157088123,1054.49042145594,3264.72413793103,251.222222222222,293.536398467433,618.915708812261,1289.88888888889,446.846743295019,235.524904214559,1017.71647509579,129.448275862069,261,23.3956265108324,14.2662519583218,0.792568525859122,0.956043956043956,0.709239130434783,1.25416542417922,53654.5325670498,33741.1111111111,FAAGSCC_12,AG,1,other APCs,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_511108,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
511494,1591.96951219512,512.664634146341,125.951219512195,663.176829268293,2202.16463414634,4696.74390243902,1534.18902439024,263.432926829268,1233.78048780488,3468.48170731707,492.542682926829,114.664634146341,1077.51219512195,4769.30487804878,990.5,1197.9756097561,2914.59756097561,8629.31097560976,564.274390243902,255.756097560976,1176.16463414634,6990.05487804878,332.975609756098,374.012195121951,585.268292682927,1348.03048780488,465.323170731707,358.396341463415,1179.84756097561,129.878048780488,164,16.6897342141808,12.6095935616421,0.655114142301397,0.953488372093023,0.732142857142857,-0.440952238299898,53995.5121951219,33539.9756097561,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_511494,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
511720,3090.23975409836,238.233606557377,184.485655737705,673.631147540984,4244.23565573771,324.46106557377,299.168032786885,256.606557377049,1079.16803278689,4654.52663934426,553.637295081967,134.704918032787,1073.95696721311,909.34631147541,485.729508196721,269.383196721311,1481.08606557377,1506.31967213115,301.766393442623,220.518442622951,1019.37704918033,1286.20696721311,208.213114754098,180.22131147541,2629.15778688525,1310.5737704918,476.897540983607,219.088114754098,1045.44672131148,129.674180327869,488,35.7439007921126,17.4917552850511,0.872079987612523,0.954990215264188,0.642951251646904,-1.13633045882393,53944.6516393443,32380.9733606557,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,7,FAAGSCC_12_511720,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
511815,2623.71582733813,136.273381294964,80.6007194244604,640.007194244604,1568.02517985612,348.985611510791,359.025179856115,258.010791366906,1084.35611510791,4389.70503597122,626.575539568345,137.165467625899,1068.91726618705,993.453237410072,676.55035971223,284.665467625899,1683.34172661871,2136.4964028777,359.474820143885,236.910071942446,1071.15827338129,2278.48201438849,237.525179856115,533.330935251799,1476.43165467626,1182.14388489209,474.176258992806,235.438848920863,1071.04316546763,130.151079136691,278,30.1234476494096,11.8698531302103,0.919093151717,0.929765886287626,0.551587301587302,0.47755607373736,52895.5863309352,32814.1690647482,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,1,FAAGSCC_12_511815,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
512240,3453.89416058394,1185.46350364963,1045.8795620438,656.065693430657,2377.21897810219,2731.87591240876,420.503649635036,251.850364963504,1102.09124087591,5371.10583941606,659.317518248175,127.843065693431,1075.72262773723,2207.52189781022,649.930656934307,911.580291970803,4013.18248175182,3350.64598540146,393.233576642336,239.394160583942,1059.04379562044,2892.67153284672,235.28102189781,289.189781021898,1798.48175182482,1509.07299270073,513.229927007299,301.886861313869,1049.25182481752,133.091240875912,274,21.1515744137843,16.5864826280893,0.620542921042317,0.964788732394366,0.761111111111111,-1.02788847555034,52958.7591240876,33583.9087591241,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_512240,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
512243,4729.66779661017,318.491525423729,96.9830508474576,642.098305084746,1596.99661016949,1003.74915254237,1631.52881355932,268.705084745763,1095.94237288136,8044.25084745763,3232.44745762712,130.75593220339,1083.45423728814,1094.67457627119,739.630508474576,303.206779661017,1851.85084745763,1899.34237288136,304.179661016949,229.75593220339,1082.47457627119,1667.19661016949,210.433898305085,975.549152542373,2707.75254237288,1997.66440677966,498.098305084746,466.491525423729,1094.10508474576,132.674576271186,295,22.215297788027,16.9413776601749,0.646870790010675,0.951612903225806,0.754475703324808,0.0820194708051866,52464.6881355932,32594.9118644068,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_512243,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
512539,1632.19078947368,518.585526315789,290.381578947368,609.684210526316,493.585526315789,2680.42763157895,325.572368421053,257.960526315789,1087.33552631579,3411.75657894737,534.348684210526,113.052631578947,1062.80921052632,787.710526315789,479.703947368421,267.046052631579,1892.09210526316,1114.60526315789,275.921052631579,219.28947368421,987.5,958.71052631579,197.256578947368,115.572368421053,581.651315789474,1430.84868421053,523.289473684211,262.967105263158,1020.07894736842,130.842105263158,152,16.1761424545448,12.3583107524109,0.645235426887153,0.932515337423313,0.675555555555556,-0.66103402467153,53863.7434210526,32955.9605263158,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_512539,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
512688,3501.265,349.0375,93.6775,631.45,1156.8275,533.9575,986.29,247.7775,1088.745,4923.475,544.16,134.575,1083.8975,1263.53,584.0,528.555,1832.0725,2304.6975,305.08,228.8175,1018.9275,2113.045,225.79,494.9375,633.215,1011.9,492.9125,272.0925,1021.74,129.24,400,28.8116850678895,17.9996084276506,0.780838502064192,0.943396226415094,0.75187969924812,-1.42206861598241,53547.25,33866.2425,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_512688,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
512855,1992.20295202952,84.3690036900369,65.8487084870849,610.520295202952,621.966789667897,424.29889298893,296.571955719557,248.752767527675,1082.40959409594,3972.43542435424,750.686346863469,111.409594095941,1079.21771217712,645.405904059041,421.487084870849,277.546125461255,1387.29520295203,947.055350553506,245.472324723247,223.0,982.878228782288,875.583025830258,194.29520295203,132.132841328413,609.350553505535,1310.29151291513,437.357933579336,282.154981549815,1016.63468634686,130.10332103321,271,19.5849013753946,17.6355121016087,0.434929127692485,0.960992907801418,0.792397660818713,-0.16177921556601,54191.479704797,32894.9335793358,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_512855,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
513008,1763.40293040293,185.783882783883,92.3553113553114,653.289377289377,1980.53846153846,365.241758241758,475.179487179487,257.120879120879,1090.95970695971,3590.98168498168,1169.15018315018,133.194139194139,1071.45787545788,1308.21978021978,982.252747252747,1100.67399267399,2040.90476190476,3058.94139194139,412.531135531136,254.666666666667,1034.73626373626,2796.8021978022,261.406593406593,1266.9010989011,688.483516483516,1941.02197802198,512.556776556777,594.084249084249,1072.10256410256,131.732600732601,273,24.1977811956481,14.4661061738312,0.801624555285634,0.934931506849315,0.689393939393939,0.488209153475819,52789.0842490842,33794.4139194139,FAAGSCC_12,AG,1,dendritic cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,dendritic cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,9,FAAGSCC_12_513008,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
513079,1455.8855721393,335.746268656716,96.0547263681592,621.577114427861,1220.47263681592,380.019900497512,341.223880597015,244.567164179104,1088.62189054726,2199.40298507463,1979.79104477612,110.388059701493,1070.26368159204,731.393034825871,542.343283582089,303.616915422886,1935.80597014925,1185.58706467662,306.597014925373,233.686567164179,1001.95024875622,1140.7263681592,237.497512437811,197.995024875622,589.154228855721,852.611940298507,446.482587064677,287.502487562189,1040.50248756219,130.860696517413,201,17.4026258218401,14.7622974824436,0.529548139147374,0.95260663507109,0.788235294117647,-1.29375019977562,52633.631840796,33627.9502487562,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_513079,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
513125,2331.46693386774,522.086172344689,99.1543086172345,632.482965931864,1173.38076152305,392.539078156313,376.547094188377,257.03006012024,1083.81362725451,3188.98396793587,649.791583166333,117.605210420842,1079.86172344689,848.761523046092,558.194388777555,277.939879759519,1486.44488977956,1741.22044088176,316.803607214429,233.396793587174,1031.85170340681,2151.78557114228,231.75751503006,574.122244488978,1819.42685370741,843.541082164329,461.260521042084,308.066132264529,1012.0380761523,129.521042084168,499,30.2938669852609,21.926097640241,0.690030715015833,0.90562613430127,0.637292464878672,0.814403637500392,53602.5230460922,33274.5691382766,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_513125,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
513304,1597.52479338843,406.198347107438,123.252066115702,648.004132231405,2348.52066115702,1934.55785123967,348.814049586777,265.44214876033,1088.45041322314,2538.88842975207,1572.87190082645,118.838842975207,1067.76859504132,843.797520661157,487.710743801653,286.747933884298,1477.76859504132,1164.14876033058,314.520661157025,231.586776859504,992.438016528926,1072.51652892562,228.892561983471,127.785123966942,653.929752066116,1019.7520661157,464.454545454545,325.884297520661,1058.20661157025,130.446280991736,242,21.7099794681751,14.2194421462856,0.755652609479725,0.956521739130435,0.768253968253968,1.25901876553104,53351.0330578512,32719.9421487603,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_513304,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
513566,2064.26605504587,193.97247706422,76.6697247706422,639.868501529052,2105.57798165138,620.498470948012,422.229357798165,276.382262996942,1142.11620795107,2936.68501529052,915.562691131498,123.767584097859,1068.54740061162,899.37003058104,520.266055045872,286.088685015291,1606.59633027523,1043.7370030581,225.599388379205,215.550458715596,1206.54434250765,749.663608562691,160.850152905199,128.779816513761,1190.49235474006,913.914373088685,428.155963302752,275.920489296636,1050.08868501529,131.727828746177,327,30.2300234234278,13.9646541950769,0.886907780078906,0.961764705882353,0.751724137931034,1.37619507823166,52456.1406727829,32524.4495412844,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_513566,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
513680,4238.89265536723,984.327683615819,146.011299435028,665.406779661017,2148.07344632768,455.389830508475,325.892655367232,246.440677966102,1096.06779661017,7151.68926553672,808.135593220339,119.853107344633,1084.30508474576,1000.53672316384,496.694915254237,280.135593220339,1672.44632768362,1001.15254237288,225.661016949153,212.937853107345,1072.35593220339,802.050847457627,162.203389830508,159.067796610169,644.745762711864,2608.19774011299,565.847457627119,912.446327683616,1071.29943502825,131.45197740113,177,18.9183459346481,12.0549661018542,0.77068991938301,0.936507936507936,0.716599190283401,-1.31338007533469,53897.9209039548,33523.0734463277,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_513680,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
513987,2025.53907815631,253.541082164329,136.12625250501,675.799599198397,3431.39078156313,313.805611222445,293.90380761523,252.36873747495,1088.23446893788,3130.37675350701,662.507014028056,131.743486973948,1068.2625250501,809.400801603206,570.298597194389,341.132264529058,2166.19639278557,1150.85571142285,267.09619238477,224.635270541082,1012.49899799599,915.448897795591,188.647294589178,154.22244488978,639.957915831663,881.975951903808,434.226452905812,235.517034068136,1045.51903807615,130.412825651303,499,34.9035844585559,18.2602736111728,0.852232471802544,0.959615384615385,0.636479591836735,0.761181841306364,52842.3587174349,32364.879759519,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_513987,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
514211,2444.39583333333,172.90625,84.8489583333333,646.338541666667,1717.015625,1547.86197916667,520.989583333333,254.372395833333,1115.78125,4261.78125,1348.609375,116.135416666667,1076.55729166667,1148.91145833333,447.036458333333,417.015625,1640.72395833333,1186.95572916667,341.1484375,267.9453125,1039.0390625,943.776041666667,185.822916666667,168.9296875,712.140625,1455.390625,493.153645833333,343.359375,1048.234375,130.200520833333,384,27.798731204531,17.6452297471005,0.77271800629991,0.941176470588235,0.761904761904762,-0.0071157453730516,53699.4505208333,33665.484375,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_514211,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
514395,3229.28385899814,558.807050092764,149.165120593692,705.985157699443,4854.09090909091,190.593692022263,221.810760667904,242.580705009276,1076.89795918367,3087.94248608534,6210.05194805195,143.73840445269,1080.73098330241,418.801484230056,294.593692022263,244.567717996289,1343.0853432282,677.981447124304,164.153988868275,201.332096474954,977.319109461967,596.647495361781,134.484230055659,93.4786641929499,576.365491651206,839.461966604824,415.150278293135,265.816326530612,1036.4879406308,130.352504638219,539,40.9796658794143,17.1150579943757,0.908609104520984,0.935763888888889,0.644736842105263,0.359242889103108,53215.3265306122,31926.8775510204,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_514395,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
514766,897.723032069971,240.064139941691,125.889212827988,651.177842565598,2380.91253644315,327.454810495627,368.119533527697,259.586005830904,1090.87172011662,2074.36734693878,521.148688046647,126.68221574344,1064.26530612245,1626.80466472303,706.244897959184,290.880466472303,1914.63265306122,2116.49854227405,376.288629737609,235.63556851312,992.448979591837,1371.46355685131,231.772594752187,148.839650145773,607.014577259475,1503.50728862974,620.271137026239,277.110787172012,1054.98542274052,130.612244897959,343,29.955202602312,14.6588637285785,0.872082137705606,0.950138504155125,0.668615984405458,-1.12160858840975,53562.6880466472,32514.6588921283,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_514766,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
515424,1794.42822384428,186.963503649635,92.1581508515815,619.214111922141,1225.40632603406,597.425790754258,330.630170316302,255.270072992701,1081.84428223844,3265.74695863747,863.272506082725,115.476885644769,1080.76155717762,1395.52311435523,866.094890510949,289.058394160584,2467.92214111922,2785.17761557178,333.856447688564,231.026763990268,1010.29197080292,2301.95133819951,238.36496350365,272.737226277372,677.554744525547,1451.13625304136,496.267639902676,292.771289537713,1037.01459854015,128.506082725061,411,28.7895602314877,18.3412640608972,0.770797369934762,0.958041958041958,0.733928571428571,-0.341079913013192,54176.4914841849,32928.8394160584,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_515424,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
515554,1819.93137254902,305.25,148.262254901961,654.546568627451,3136.01225490196,1182.17892156863,244.713235294118,246.026960784314,1084.14215686275,2273.42892156863,516.740196078431,128.651960784314,1064.89705882353,2670.25490196078,612.622549019608,297.399509803922,2478.28431372549,2545.49754901961,319.683823529412,224.296568627451,1003.24264705882,1560.62990196078,204.370098039216,141.610294117647,607.914215686274,929.649509803922,478.419117647059,219.397058823529,1012.67647058824,129.031862745098,408,33.9057642687805,15.535305222803,0.888853924878957,0.951048951048951,0.75,1.3293630836647,53845.4117647059,32392.3039215686,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_515554,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
515823,2567.56603773585,350.424528301887,112.660377358491,631.141509433962,1589.67924528302,325.150943396226,331.924528301887,268.981132075472,1098.09433962264,2747.83962264151,843.22641509434,122.169811320755,1070.19811320755,660.528301886792,663.22641509434,271.056603773585,1453.88679245283,985.264150943396,325.283018867925,228.915094339623,987.952830188679,868.801886792453,209.122641509434,117.037735849057,587.094339622642,838.0,471.688679245283,218.254716981132,1015.59433962264,132.877358490566,106,13.3203572971252,10.1915045151436,0.643902632578616,0.938053097345133,0.741258741258741,-0.452036288854281,53472.7641509434,32058.5,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_515823,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
515872,4472.99248120301,1108.6015037594,1314.3045112782,635.966165413534,1105.63909774436,708.139097744361,394.372180451128,251.176691729323,1089.19172932331,6778.86466165414,621.157894736842,147.285714285714,1503.71804511278,2417.65037593985,524.582706766917,314.87969924812,3247.44360902256,2945.62030075188,296.597744360902,229.229323308271,1001.48496240602,3166.37218045113,224.109022556391,168.135338345865,608.278195488722,1882.7969924812,564.048872180451,273.515037593985,1079.72932330827,138.868421052632,266,22.7458359851717,14.9281431029047,0.754498091482055,0.96028880866426,0.771014492753623,1.43674496650249,53071.5488721805,33785.3045112782,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX+,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_515872,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
516114,2216.86798679868,421.607260726073,114.910891089109,647.752475247525,1988.67656765677,2612.26402640264,418.389438943894,248.798679867987,1113.92079207921,4311.55115511551,3280.09570957096,125.056105610561,1083.95379537954,4527.47854785479,978.39603960396,335.069306930693,2337.00330033003,5637.3102310231,412.775577557756,237.547854785479,1054.41254125413,4911.69306930693,252.73597359736,256.141914191419,671.122112211221,1161.91089108911,462.280528052805,375.036303630363,1042.77557755776,131.039603960396,303,24.4104165276244,15.9634895761475,0.756527228430398,0.946875,0.673333333333333,-0.289431277553588,53060.1287128713,33427.8613861386,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_516114,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
516450,1273.72440944882,148.07874015748,56.6456692913386,614.622047244094,499.51968503937,354.385826771654,352.889763779528,263.866141732283,1084.66929133858,2550.93700787402,506.188976377953,156.291338582677,1063.77165354331,785.811023622047,518.748031496063,279.157480314961,1448.99212598425,1288.11023622047,333.094488188976,236.496062992126,984.181102362205,1220.27559055118,231.511811023622,132.393700787402,582.787401574803,1352.49606299213,441.826771653543,230.464566929134,1014.94488188976,128.503937007874,127,13.7945546878065,11.782476785384,0.520043628001901,0.940740740740741,0.755952380952381,0.216778756469923,52771.8188976378,33306.1653543307,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_516450,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
516859,2237.25252525253,325.107744107744,158.316498316498,673.13468013468,2741.74074074074,1263.73063973064,1277.49158249158,253.939393939394,1080.91919191919,2900.90572390572,616.814814814815,139.521885521886,1072.19191919192,2278.6734006734,802.585858585859,1154.52861952862,1587.33333333333,4424.80808080808,389.774410774411,231.208754208754,1015.46464646465,4007.81818181818,237.178451178451,358.286195286195,632.589225589226,950.841750841751,436.791245791246,214.175084175084,1040.85185185185,128.838383838384,297,22.9493321325778,16.5523211480188,0.692669608987528,0.976973684210526,0.84375,-0.0351734023481753,53235.1784511784,32263.2424242424,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_516859,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
517469,3707.53804347826,491.875,86.9891304347826,625.880434782609,1644.36413043478,1887.16304347826,539.385869565217,247.021739130435,1095.5597826087,6647.85869565217,578.429347826087,117.228260869565,1087.99456521739,4083.28804347826,856.967391304348,340.717391304348,5897.86413043478,2734.02717391304,327.326086956522,325.211956521739,1003.3097826087,2006.11413043478,232.358695652174,183.744565217391,600.842391304348,2423.1847826087,544.244565217391,279.211956521739,1076.20652173913,129.179347826087,184,21.6731667902498,10.8519519938103,0.865615613285628,0.943589743589744,0.645614035087719,1.06889402382129,53747.1467391304,33535.6630434783,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_517469,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
517922,3738.97928994083,640.224852071006,152.455621301775,675.307692307692,3142.23668639053,282.008875739645,249.647928994083,238.387573964497,1098.59467455621,6332.88165680473,2522.0798816568,132.230769230769,1073.61538461538,561.849112426036,337.260355029586,256.065088757396,1493.87869822485,830.979289940828,191.698224852071,205.659763313609,991.819526627219,699.869822485207,146.133136094675,140.284023668639,606.573964497041,1671.04733727811,514.263313609467,492.026627218935,1080.94082840237,131.12426035503,338,24.4991756235482,17.8090992231034,0.68671530421495,0.962962962962963,0.731601731601732,-0.655492621887786,52936.1982248521,32896.7810650888,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,1,FAAGSCC_12_517922,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
517955,2056.30445544554,475.136138613861,1266.55445544554,626.185643564356,1712.20792079208,1314.38118811881,1213.34158415842,265.462871287129,1117.42574257426,2662.26237623762,670.777227722772,121.799504950495,1071.94801980198,3089.00742574257,1112.47772277228,524.126237623762,1820.64108910891,3233.48514851485,394.517326732673,243.707920792079,1014.94059405941,2548.94059405941,264.970297029703,174.566831683168,599.277227722772,888.321782178218,477.428217821782,238.381188118812,1023.29702970297,130.806930693069,404,25.1486925737469,20.8476081083844,0.559287387829219,0.971153846153846,0.801587301587302,-1.45344597915215,53076.3787128713,33104.9727722772,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_517955,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
518084,1499.06181818182,120.534545454545,117.861818181818,726.36,6907.49090909091,587.581818181818,375.989090909091,266.676363636364,1131.69090909091,2588.92727272727,584.261818181818,126.309090909091,1062.60363636364,806.269090909091,456.810909090909,274.454545454545,1486.63636363636,916.650909090909,201.610909090909,213.727272727273,1092.82909090909,661.654545454545,136.298181818182,101.774545454545,813.6,916.956363636364,449.287272727273,229.869090909091,1045.97818181818,130.458181818182,275,28.3585750776593,12.4273773911055,0.898866329411416,0.938566552901024,0.701530612244898,1.33936539562394,53669.3527272727,32723.0072727273,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_518084,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
518152,1714.50318471338,831.503184713376,93.9235668789809,645.477707006369,1746.16560509554,2981.11464968153,723.414012738854,264.286624203822,1127.35668789809,3063.33121019108,456.624203821656,108.789808917197,1093.44585987261,1043.76433121019,641.84076433121,353.184713375796,2023.29936305732,1280.75796178344,307.375796178344,228.031847133758,1002.77070063694,1231.93630573248,213.745222929936,170.745222929936,595.292993630573,1102.2101910828,437.471337579618,229.178343949044,1036.29299363057,130.987261146497,157,17.3122837626267,11.7695990285435,0.733359608246056,0.957317073170732,0.654166666666667,0.84873845972654,52925.3566878981,33645.1337579618,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,9,FAAGSCC_12_518152,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
518559,3474.25874125874,355.933566433566,107.520979020979,646.031468531468,2209.87062937063,2006.36363636364,411.332167832168,264.821678321678,1104.87762237762,6664.1048951049,609.653846153846,122.052447552448,1084.28321678322,832.328671328671,534.772727272727,282.77972027972,1450.63286713287,1082.54545454545,286.674825174825,225.608391608392,974.674825174825,1008.79370629371,220.41958041958,122.325174825175,586.489510489511,2416.39160839161,509.713286713287,274.888111888112,1052.59090909091,128.961538461538,286,24.9069202251274,14.7073082872168,0.807044339488456,0.953333333333333,0.680952380952381,0.657124538195713,54062.3531468531,33188.8811188811,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_518559,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
518886,3242.9501312336,282.590551181102,116.173228346457,653.556430446194,2323.32020997375,359.383202099738,308.433070866142,263.879265091864,1085.35170603675,3480.343832021,563.07874015748,130.561679790026,1081.09973753281,1330.64829396325,564.695538057743,276.9343832021,1733.5249343832,1928.83202099738,355.48031496063,234.829396325459,1039.98950131234,1812.17060367454,229.860892388451,706.346456692913,2841.93963254593,734.346456692913,388.477690288714,205.125984251969,1021.07349081365,129.03937007874,381,23.6530575050306,20.5841424108363,0.492605168000494,0.969465648854962,0.788819875776398,-0.42432342834308,53152.7795275591,32042.5485564304,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_518886,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
519395,1879.18493150685,199.321917808219,131.981735159817,655.972602739726,2262.15753424658,636.7899543379,416.404109589041,278.659817351598,1158.74429223744,3742.15068493151,974.004566210046,145.689497716895,1069.95890410959,971.705479452055,516.303652968037,280.159817351598,1595.38356164384,1015.70547945205,202.51598173516,210.632420091324,1222.55707762557,605.888127853881,133.132420091324,91.7990867579909,594.276255707763,787.566210045662,401.440639269406,212.522831050228,1029.02283105023,130.292237442922,438,34.4053920922244,16.2613435335009,0.88125592591293,0.946004319654428,0.580901856763926,-0.761400309448765,53088.5890410959,32334.0365296804,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_519395,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
521279,2975.67548076923,383.507211538462,96.3629807692308,637.341346153846,1200.98317307692,2520.58894230769,403.579326923077,243.302884615385,1125.52644230769,4975.93990384615,3169.41346153846,120.704326923077,1092.66586538462,1634.59134615385,612.456730769231,290.221153846154,4788.88461538462,1997.51682692308,269.891826923077,221.59375,1030.07932692308,1720.79807692308,195.923076923077,182.365384615385,587.846153846154,1484.35096153846,510.769230769231,421.276442307692,1071.26442307692,130.360576923077,416,27.9606184237448,19.0439640663844,0.732190842786199,0.965197215777262,0.723478260869565,0.595164391322736,53484.6322115385,33514.4639423077,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_521279,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
521329,2328.84838709677,218.703225806452,69.4612903225807,674.983870967742,1725.40967741935,539.154838709677,334.483870967742,247.683870967742,1104.68709677419,3377.28387096774,777.667741935484,109.661290322581,1122.9,948.696774193548,590.535483870968,287.5,1848.58387096774,1416.55806451613,293.541935483871,230.158064516129,1043.09677419355,1221.91612903226,229.393548387097,336.938709677419,4303.75483870968,924.487096774194,459.712903225806,772.470967741936,1037.5,128.464516129032,310,25.6931785515065,15.6692854732418,0.792507861480713,0.939393939393939,0.729411764705882,1.4280740436424,53731.9677419355,33462.8,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_521329,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
521420,2980.79310344828,206.201149425287,150.224137931034,662.252873563218,3722.36781609195,3125.52873563218,2698.02873563218,259.695402298851,1112.22988505747,4545.87356321839,552.971264367816,124.885057471264,1073.63218390805,1690.37356321839,686.522988505747,587.867816091954,1678.20689655172,1189.96551724138,299.465517241379,230.614942528736,1001.51724137931,1113.72988505747,223.718390804598,166.879310344828,590.701149425287,1219.2183908046,477.563218390805,294.534482758621,1041.05172413793,130.591954022989,174,22.757201113329,9.79092481016201,0.902717334649784,0.940540540540541,0.790909090909091,1.48861940762755,53792.5459770115,33564.9425287356,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_521420,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
521543,1623.54385964912,440.625730994152,428.654970760234,613.409356725146,553.865497076023,2019.22807017544,936.53216374269,248.292397660819,1129.54385964912,2659.10526315789,399.421052631579,103.432748538012,1066.42105263158,4667.38596491228,1054.08771929825,359.327485380117,20151.1520467836,7234.64912280702,505.918128654971,250.824561403509,1102.05263157895,6804.35087719298,290.578947368421,255.298245614035,654.023391812865,828.438596491228,409.637426900585,226.842105263158,1006.72514619883,130.187134502924,171,19.494932443506,11.195530387991,0.818659651802226,0.929347826086956,0.75,1.44193164136298,52959.918128655,33675.2807017544,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,9,FAAGSCC_12_521543,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
521894,3970.45896656535,888.349544072948,1284.58662613982,684.592705167173,5079.9726443769,369.452887537994,282.258358662614,237.285714285714,1107.20972644377,6660.44680851064,1692.24924012158,125.422492401216,1403.09422492401,785.534954407295,526.686930091185,273.12462006079,1574.23404255319,1204.7537993921,262.006079027356,220.772036474164,1018.00303951368,1096.23708206687,211.9726443769,372.893617021277,1470.97872340426,1665.59878419453,502.407294832827,391.079027355623,1064.96960486322,130.781155015198,329,23.5183058367953,17.9003790617207,0.648604796583565,0.953623188405797,0.746031746031746,-0.780200956329912,53952.8024316109,33423.9817629179,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX+,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_521894,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
521956,4055.19935691318,644.167202572347,4821.24115755627,679.398713826367,3362.95498392283,2252.77170418006,673.363344051447,251.511254019293,1095.73954983923,6300.34405144695,727.112540192926,129.144694533762,1163.36977491961,3308.40192926045,949.498392282958,1491.07717041801,1991.77170418006,4596.74919614148,394.299035369775,252.212218649518,1096.38906752412,3778.46302250804,283.951768488746,525.504823151125,795.967845659164,1704.59485530547,559.572347266881,670.922829581994,1097.71382636656,133.273311897106,311,22.0817180311372,18.2506171195378,0.562931588571522,0.956923076923077,0.744019138755981,1.29831318070294,53037.2025723473,33546.6591639871,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_521956,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
523175,822.66724738676,647.993031358885,169.780487804878,632.975609756098,1171.02090592335,1148.58013937282,324.512195121951,263.731707317073,1099.83972125436,1417.63240418118,2480.58013937282,132.054006968641,1065.02613240418,1351.43554006969,634.961672473868,281.493031358885,1826.6637630662,1533.71602787456,286.98606271777,218.808362369338,1027.80487804878,1119.07142857143,190.414634146341,215.675958188153,3542.41289198606,642.674216027875,362.65331010453,206.799651567944,1013.9512195122,127.8606271777,574,30.9999016505774,23.6775006375711,0.645461548123494,0.964705882352941,0.771505376344086,0.113339307968192,52828.3362369338,32432.9895470383,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_523175,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
523597,3787.51886792453,615.103773584906,121.814465408805,651.87106918239,2320.87106918239,983.842767295598,1344.04088050314,248.46855345912,1090.02201257862,4953.87735849057,888.679245283019,134.924528301887,1135.3427672956,2174.39937106918,573.424528301887,318.518867924528,1683.45911949686,4274.90566037736,389.779874213836,244.179245283019,1005.66037735849,5236.92452830189,451.235849056604,277.75786163522,588.25786163522,1296.83333333333,469.650943396226,256.811320754717,1029.3427672956,129.578616352201,318,22.7921936090882,17.83367766491,0.622717507145809,0.949253731343284,0.722727272727273,-1.18115467403933,53335.4622641509,33914.9716981132,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_523597,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
524033,1886.88711516534,357.771949828962,386.175598631699,637.639680729761,2169.31470923603,349.453819840365,305.446978335234,251.480045610034,1088.69783352338,3868.25769669327,572.253135689852,114.311288483466,1077.33979475485,906.571265678449,597.224629418472,276.736602052452,1550.71379703535,1345.0661345496,307.410490307868,225.81755986317,992.818700114025,1147.38084378563,217.750285062714,160.209806157355,585.649942987457,1535.52223489168,509.079817559863,236.013683010262,1046.31698973774,130.477765108324,877,40.3896191307609,28.4060603484308,0.710892168122128,0.958469945355191,0.696031746031746,0.677782652746787,53648.6659064994,32940.2998859749,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_524033,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
524409,2879.10691823899,885.100628930818,208.201257861635,652.704402515723,1602.59748427673,1737.94968553459,415.396226415094,257.691823899371,1098.10691823899,4225.44025157233,1382.11949685535,122.163522012579,1068.10691823899,703.37106918239,446.006289308176,272.704402515723,1511.22012578616,1206.48427672956,294.88679245283,231.37106918239,1002.2893081761,1152.16352201258,445.150943396226,142.710691823899,581.59748427673,1355.59748427673,566.842767295597,505.949685534591,1040.22012578616,130.559748427673,159,16.4621328733318,12.5739913202352,0.645437588197251,0.935294117647059,0.709821428571429,0.451433389642177,53318.7106918239,33401.465408805,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_524409,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
525909,1292.65609990394,181.893371757925,182.215177713737,731.63976945245,6593.28722382325,203.71469740634,221.684918347742,222.24111431316,1053.81844380403,1657.84245917387,691.167146974063,120.834774255524,1071.46493756004,750.317002881844,501.179634966379,292.558117195005,1757.8088376561,1063.12295869356,247.414024975985,218.734870317003,1006.20076849183,867.222862632085,192.807877041306,175.926993275696,580.972142170989,772.887608069164,397.271853986551,209.724303554275,1023.23823246878,128.71469740634,1041,43.0275732427991,31.0896814142617,0.691316033314347,0.971082089552239,0.799539170506912,-0.145771944521933,52336.5158501441,33402.6580211335,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_525909,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
526572,3337.14588859416,410.342175066313,130.660477453581,643.074270557029,2144.21485411141,542.679045092838,769.188328912467,247.143236074271,1086.71087533156,4773.09549071618,2129.87798408488,129.684350132626,1068.86737400531,1038.88328912467,442.949602122016,301.275862068966,1831.43236074271,1375.05039787798,240.461538461538,214.819628647215,1010.5198938992,1034.09814323607,171.196286472149,142.538461538462,598.164456233422,1345.76923076923,475.26525198939,421.790450928382,1077.86472148541,131.676392572944,377,24.8323913782271,19.3836434429019,0.625057126469859,0.959287531806616,0.714015151515151,-0.482809587580481,52388.8700265252,32610.3209549072,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_526572,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
526841,1648.39380530973,669.942477876106,96.1725663716814,653.79203539823,2499.45132743363,3134.53982300885,1157.69469026549,249.964601769911,1133.32743362832,2216.38938053097,2177.29203539823,110.424778761062,1068.54867256637,4225.91592920354,820.986725663717,512.823008849557,2002.07522123894,2608.10619469027,332.393805309734,234.676991150442,1035.85398230089,1599.44690265487,215.190265486726,195.858407079646,593.017699115044,773.62389380531,423.787610619469,351.283185840708,1026.28761061947,128.712389380531,226,19.6680802985864,14.8186746725922,0.657519215033139,0.953586497890295,0.753333333333333,1.53581940275581,53922.9380530973,33623.0398230088,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_526841,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
527228,767.047619047619,526.029761904762,248.452380952381,608.666666666667,523.380952380952,1590.89285714286,406.684523809524,250.27380952381,1105.1369047619,1240.34523809524,603.833333333333,109.761904761905,1066.43452380952,4342.0119047619,608.136904761905,503.190476190476,1672.08333333333,7040.1130952381,380.345238095238,792.261904761905,1017.94047619048,6449.54761904762,266.059523809524,230.190476190476,596.380952380952,936.964285714286,523.839285714286,251.333333333333,1010.08928571429,130.267857142857,168,15.206701927559,14.1646650423068,0.363804940488763,0.943820224719101,0.8,1.16016985668649,53645.1130952381,33453.8095238095,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_527228,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
527239,2631.55831265509,338.526054590571,151.732009925558,662.099255583127,3031.57071960298,474.910669975186,329.461538461538,256.93300248139,1122.92803970223,3352.96526054591,589.042183622829,125.325062034739,1068.70967741935,607.446650124069,365.724565756824,260.739454094293,1434.90074441687,758.111662531017,169.496277915633,201.29776674938,1019.89330024814,631.585607940447,133.034739454094,106.302729528536,820.300248138958,771.258064516129,409.138957816377,215.111662531017,1019.18362282878,130.967741935484,403,35.0345458493835,15.0672088354998,0.902796881044804,0.943793911007026,0.516666666666667,0.91825165467438,53793.2481389578,32188.523573201,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_527239,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
527787,4649.03773584906,1002.81132075472,888.455974842767,651.022012578616,1825.02201257862,589.270440251572,353.641509433962,245.849056603774,1132.79874213836,7378.30188679245,1059.51572327044,122.732704402516,1084.18238993711,813.0,384.327044025157,274.625786163522,1556.37735849057,1124.96226415094,343.723270440252,243.415094339623,1045.01886792453,983.169811320755,185.798742138365,170.877358490566,2144.60062893082,1893.75786163522,527.207547169811,524.556603773585,1056.83333333333,132.141509433962,318,25.6089198585334,15.8777170204754,0.784596048562036,0.952095808383234,0.706666666666667,-1.21798890650107,53716.5597484277,33647.8018867925,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_527787,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
529572,3242.04132231405,637.322314049587,259.487603305785,630.363636363636,1868.19421487603,440.351239669421,311.165289256198,244.442148760331,1111.83884297521,6124.64462809917,531.037190082645,125.595041322314,1068.1694214876,715.561983471074,434.185950413223,283.384297520661,1577.02066115702,980.086776859504,213.607438016529,217.570247933884,1453.25619834711,731.888429752066,158.900826446281,160.677685950413,602.070247933884,3459.22314049587,554.074380165289,229.231404958678,1044.65289256198,130.198347107438,242,24.8489416224839,12.4356720495685,0.865764993255874,0.9453125,0.611111111111111,0.951668947850703,52510.6404958678,33369.3719008264,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_529572,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
530584,613.282685512367,1264.63957597173,289.82332155477,625.367491166078,87.5583038869258,778.650176678445,495.480565371025,297.424028268551,1166.83392226148,1642.8445229682,1828.56183745583,144.003533568905,1068.71024734982,1100.46643109541,637.473498233216,288.374558303887,1630.32508833922,1132.12367491166,225.349823321555,214.268551236749,1258.2296819788,602.339222614841,134.494699646643,94.9293286219081,581.501766784452,551.742049469965,327.180212014134,194.466431095406,981.402826855124,130.088339222615,283,20.5736145974152,17.5529917928672,0.521616984185069,0.965870307167236,0.78393351800554,0.766285873254011,52902.9010600707,32172.8127208481,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_530584,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
531402,2088.59504132231,665.413223140496,323.107438016529,615.768595041322,671.115702479339,1681.97520661157,364.561983471074,251.603305785124,1125.99173553719,4235.5867768595,510.429752066116,112.280991735537,1074.28099173554,1962.51239669421,729.876033057851,300.859504132231,1851.06611570248,1549.47107438017,303.487603305785,227.785123966942,1014.80165289256,1214.74380165289,206.595041322314,228.545454545455,611.479338842975,1440.32231404959,504.98347107438,249.96694214876,1048.72727272727,131.96694214876,121,14.0173256384665,11.3540876313094,0.586424568753143,0.909774436090226,0.715976331360947,0.562087837488982,52994.3140495868,33429.3305785124,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_531402,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
531889,3110.54651162791,359.581395348837,167.395348837209,658.228682170543,2988.00775193798,592.449612403101,341.375968992248,244.852713178294,1085.01550387597,4838.43023255814,540.639534883721,128.600775193798,1069.24031007752,1797.37984496124,566.298449612403,332.329457364341,4093.14728682171,1384.77519379845,261.713178294574,218.918604651163,1002.09302325581,901.895348837209,171.953488372093,150.341085271318,617.426356589147,1279.4496124031,478.108527131783,227.678294573643,1053.45736434109,127.65503875969,258,18.5768874217173,17.7592999208859,0.293402527336678,0.938181818181818,0.754385964912281,0.634161830969126,53200.3992248062,33119.2364341085,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_531889,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
533633,3225.71472392638,210.009202453988,76.7269938650307,611.78527607362,465.377300613497,273.969325153374,293.058282208589,259.453987730061,1083.94785276074,5601.04294478528,728.723926380368,118.337423312883,1067.94785276074,561.849693251534,410.923312883436,261.638036809816,1383.47852760736,872.911042944785,251.361963190184,216.346625766871,995.466257668712,815.622699386503,191.524539877301,118.840490797546,583.71472392638,2204.03987730061,469.076687116564,238.466257668712,1028.22085889571,129.638036809816,326,35.067398086706,11.8985532850014,0.940676314026612,0.942196531791908,0.684873949579832,-0.223939171029191,53727.9938650307,32080.1901840491,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_533633,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
534176,4600.1226993865,471.745398773006,117.496932515337,660.092024539877,2154.61656441718,2751.49693251534,1135.00613496933,258.760736196319,1174.78834355828,6925.90797546012,801.846625766871,141.150306748466,1091.30981595092,1110.48159509202,612.840490797546,803.659509202454,1738.41717791411,1903.89570552147,368.539877300614,245.055214723926,1012.49693251534,1848.61963190184,276.134969325153,252.036809815951,669.322085889571,1326.39570552147,501.662576687116,322.420245398773,1054.15030674847,132.079754601227,326,25.3577154663421,16.4454076416226,0.761183436343661,0.958823529411765,0.815,-0.0746968983246771,53193.6441717791,33836.4662576687,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_534176,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
534457,886.214659685864,211.795811518325,119.596858638743,632.82722513089,2387.19895287958,488.005235602094,1250.93717277487,250.884816753927,1075.55497382199,2006.78010471204,524.890052356021,113.717277486911,1072.21465968586,1075.21989528796,969.094240837696,339.329842931937,1979.27748691099,1806.04188481675,264.361256544503,220.44502617801,1013.74869109948,2547.16753926702,206.706806282723,146.534031413613,680.727748691099,1090.22513089005,465.79057591623,225.03664921466,1046.40314136126,127.774869109948,191,17.5701919320281,14.0266641332351,0.602231339959047,0.959798994974874,0.757936507936508,-1.30228285176821,54179.445026178,32840.9633507853,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_534457,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
535206,2659.17989417989,384.322751322751,70.026455026455,623.989417989418,1144.27513227513,192.619047619048,204.021164021164,228.164021164021,1070.41798941799,3528.38095238095,717.391534391534,117.380952380952,1077.42857142857,441.492063492063,295.042328042328,252.915343915344,1405.28042328042,710.560846560847,169.121693121693,202.767195767196,985.925925925926,639.830687830688,134.883597883598,121.380952380952,584.910052910053,949.365079365079,460.095238095238,251.365079365079,1024.09523809524,131.492063492063,189,17.096245574829,14.4323888202437,0.536052426803442,0.940298507462687,0.73828125,-0.58151531149646,53131.0793650794,32990.8253968254,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_535206,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
535843,4507.92779783394,518.064981949458,377.202166064982,649.682310469314,1889.64259927798,2100.30685920578,503.898916967509,256.891696750902,1101.31768953069,8618.02888086643,613.270758122744,124.039711191336,1077.54151624549,1765.72202166065,766.537906137184,306.28880866426,1908.87364620939,2700.99277978339,374.595667870036,242.812274368231,1045.30324909747,2014.2274368231,230.725631768953,1155.13718411552,2172.85920577617,4570.440433213,573.805054151625,283.238267148014,1062.02527075812,129.379061371841,277,23.6642738631731,15.0126710347909,0.773003010187998,0.951890034364261,0.70843989769821,0.391418542740292,54089.6498194946,33395.1227436823,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_535843,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
535970,4087.62948207171,749.840637450199,2280.96812749004,636.310756972112,1489.45418326693,281.645418326693,267.848605577689,243.282868525896,1075.38247011952,7415.37848605578,572.505976095617,127.290836653386,1084.4422310757,626.179282868526,420.159362549801,265.784860557769,1412.22709163347,1004.00398406375,271.04780876494,225.155378486056,984.135458167331,945.402390438247,212.406374501992,130.139442231076,588.059760956175,2087.7171314741,517.525896414343,298.525896414343,1040.07569721116,131.509960159363,251,21.2362708009379,15.1622493214256,0.70016721336068,0.969111969111969,0.738235294117647,-0.4082840880807,53410.7490039841,33276.6374501992,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_535970,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
537429,1952.92962962963,170.274074074074,81.437037037037,635.233333333333,1689.2037037037,965.362962962963,761.0,253.751851851852,1120.89259259259,4075.82592592593,609.674074074074,117.037037037037,1070.04074074074,2517.35925925926,851.688888888889,918.696296296296,1851.58518518519,1590.05555555556,259.344444444444,213.511111111111,1013.93703703704,1047.95925925926,175.981481481481,214.455555555556,667.233333333333,1620.95925925926,508.277777777778,250.477777777778,1035.81851851852,128.811111111111,270,31.2604684712746,11.1051495048174,0.934772932749912,0.944055944055944,0.692307692307692,1.36235075139293,53969.2888888889,32798.9444444444,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_537429,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
539374,929.525641025641,195.082417582418,86.0714285714286,633.203296703297,1678.27655677656,266.454212454212,330.732600732601,252.040293040293,1070.89926739927,1446.5695970696,815.307692307692,122.619047619048,1067.63186813187,635.227106227106,491.957875457875,283.653846153846,1412.01098901099,981.333333333333,292.016483516484,232.79304029304,980.272893772894,939.593406593407,223.970695970696,135.21978021978,599.59706959707,870.434065934066,469.0,230.117216117216,1026.56043956044,128.873626373626,546,31.2331286593739,22.4813369511199,0.694190435950457,0.966371681415929,0.80058651026393,-0.109090781625645,52355.9175824176,32979.5512820513,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_539374,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
539449,3037.995951417,320.506072874494,92.3603238866397,643.097165991903,1633.08097165992,477.991902834008,367.854251012146,243.34008097166,1090.74898785425,4878.98380566802,914.303643724696,123.194331983806,1084.51417004049,1327.00809716599,861.781376518219,306.959514170041,1756.44534412955,1253.22672064777,288.643724696356,234.044534412955,996.425101214575,1049.57894736842,213.327935222672,192.518218623482,596.481781376518,1126.48582995951,455.388663967611,325.315789473684,1043.03643724696,132.554655870445,247,20.5769134284914,15.6260419540628,0.650627788485387,0.935606060606061,0.653439153439153,0.48930974600374,53094.9271255061,33546.5506072874,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_539449,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
540422,1892.08016877637,152.89029535865,102.337552742616,692.194092827004,3815.6582278481,1842.27004219409,388.548523206751,266.476793248945,1111.68776371308,3200.71308016878,599.556962025316,139.012658227848,1071.23206751055,2460.26160337553,965.261603375527,330.223628691983,3786.77637130802,1335.14767932489,291.877637130802,221.801687763713,999.869198312236,920.700421940928,194.957805907173,141.215189873418,616.274261603376,1087.99578059072,486.940928270042,230.540084388186,1042.00421940928,129.767932489451,237,18.1646064858256,16.8956665004687,0.367199595475285,0.96734693877551,0.774509803921569,-1.41173318606681,53080.9789029536,32714.9873417722,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,7,FAAGSCC_12_540422,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
542910,2947.7868852459,670.44262295082,486.368852459016,619.868852459016,1068.68852459016,2558.1393442623,355.729508196721,250.106557377049,1100.05737704918,4420.74590163934,615.008196721311,123.024590163934,1069.04098360656,741.909836065574,622.147540983607,460.713114754098,1487.69672131148,1082.60655737705,266.188524590164,222.008196721311,978.885245901639,1010.10655737705,214.090163934426,153.55737704918,620.262295081967,1423.98360655738,548.073770491803,252.844262295082,1029.94262295082,128.008196721311,122,15.8453148614354,9.81080957820033,0.785263640626303,0.953125,0.813333333333333,-1.29270811174296,54075.0655737705,32961.3278688525,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_542910,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
542911,3047.30731707317,216.848780487805,133.443902439024,656.473170731707,3002.49756097561,346.956097560976,299.126829268293,254.117073170732,1088.71219512195,5946.63414634146,576.492682926829,123.419512195122,1083.25365853659,847.112195121951,515.521951219512,286.180487804878,1422.50243902439,1483.83902439024,310.395121951219,227.619512195122,989.560975609756,1788.33658536585,222.736585365854,201.736585365854,587.370731707317,2691.86829268293,539.009756097561,389.141463414634,1050.30243902439,130.531707317073,205,19.0990005076424,13.7182529486676,0.695763727900009,0.944700460829493,0.709342560553633,-0.838731009474169,53216.2975609756,33331.2097560976,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_542911,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
543150,3546.9853372434,186.548387096774,88.1671554252199,639.865102639296,1851.03812316716,4496.04692082111,4065.44574780059,275.868035190616,1107.34897360704,5469.24340175953,543.131964809384,126.111436950147,1075.90029325513,3954.70674486804,1472.97360703812,2041.28739002933,5440.14076246334,3312.39589442815,384.278592375367,237.486803519062,1030.36070381232,2753.00293255132,238.961876832844,207.214076246334,699.011730205279,1277.0,465.126099706745,226.346041055718,1051.27272727273,130.885630498534,341,29.5990792056879,14.6844208101486,0.868259260228508,0.96600566572238,0.655769230769231,-1.03178958894447,53133.6304985337,33094.2082111437,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_543150,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
543244,3414.33333333333,238.431111111111,101.213333333333,628.137777777778,1373.73777777778,1158.74222222222,639.124444444444,244.835555555556,1086.43111111111,5892.31555555556,588.755555555556,116.013333333333,1073.55555555556,943.271111111111,493.693333333333,359.995555555556,3434.77333333333,3043.55111111111,363.48,231.022222222222,1048.05777777778,3290.68444444444,230.942222222222,178.568888888889,634.551111111111,1890.95111111111,517.746666666667,292.044444444444,1025.41777777778,131.231111111111,225,27.6660226641048,10.4322188411306,0.926181942295659,0.922131147540984,0.489130434782609,-0.722017008031903,53540.9466666667,33158.3733333333,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_543244,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
543349,1510.20422535211,255.035211267606,169.235915492958,674.176056338028,4076.10915492958,1876.67957746479,390.43661971831,251.154929577465,1093.89788732394,2821.98591549296,540.271126760563,116.820422535211,1077.33098591549,4907.32394366197,784.295774647887,340.37323943662,2262.39436619718,4983.10211267606,386.239436619718,237.225352112676,1059.89788732394,4028.23591549296,244.5,232.521126760563,592.320422535211,1139.44718309859,475.848591549296,335.68661971831,1046.07394366197,128.996478873239,284,23.5115623358016,15.6634830975341,0.745770079260996,0.953020134228188,0.679425837320574,0.893637485311614,53790.7992957746,33628.6126760563,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_543349,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
543867,2324.86956521739,452.917874396135,106.874396135266,622.212560386473,1094.74879227053,280.222222222222,225.381642512077,233.961352657005,1084.8309178744,3869.08212560386,1459.74396135266,120.468599033816,1070.04830917874,2073.47826086957,514.338164251208,329.352657004831,1756.09178743961,2340.27053140097,302.628019323671,226.323671497585,1015.95169082126,1398.17874396135,211.289855072464,497.178743961353,1631.51690821256,1235.25120772947,493.202898550725,370.236714975845,1039.73913043478,132.734299516908,207,17.8792054091165,15.0347913969649,0.541175967368146,0.940909090909091,0.761029411764706,-0.37509131019156,53948.7053140097,32924.4444444444,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_543867,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
543948,2491.04201680672,1195.68907563025,260.596638655462,670.983193277311,2528.26890756303,278.033613445378,449.008403361345,231.563025210084,1080.31932773109,4390.05882352941,1322.39495798319,128.53781512605,1089.04201680672,532.495798319328,450.18487394958,301.176470588235,1506.14285714286,756.865546218487,179.033613445378,206.504201680672,986.126050420168,676.90756302521,150.218487394958,141.310924369748,582.924369747899,1589.10924369748,554.478991596639,881.831932773109,1115.73949579832,132.436974789916,119,14.5217588168836,10.4517121285244,0.694256460086428,0.952,0.762820512820513,-0.75533355584764,53243.512605042,33506.2016806723,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_543948,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
544608,1902.30158730159,553.396825396825,217.068783068783,686.407407407407,4062.85714285714,492.544973544974,319.47619047619,253.698412698413,1097.30158730159,2636.31746031746,751.153439153439,122.015873015873,1077.11111111111,745.058201058201,430.507936507937,278.761904761905,1438.0582010582,861.285714285714,188.931216931217,207.915343915344,1124.2380952381,676.539682539683,143.460317460317,121.222222222222,606.169312169312,871.037037037037,455.391534391534,236.592592592592,1025.85185185185,127.719576719577,189,18.1439389378381,13.5570184299296,0.664607473065183,0.935643564356436,0.741176470588235,0.590466435032956,53283.91005291,33115.9047619048,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_544608,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
545521,2636.23428571429,323.914285714286,138.962857142857,633.782857142857,1768.00857142857,522.557142857143,383.522857142857,262.588571428571,1137.53714285714,3509.87142857143,746.085714285714,127.98,1067.71714285714,771.86,439.611428571429,277.74,1528.66,914.714285714286,190.431428571429,208.117142857143,1218.08857142857,614.714285714286,138.157142857143,114.76,597.631428571429,1033.24857142857,469.851428571429,269.168571428571,1024.26571428571,130.248571428571,350,25.8246018912727,17.3425128941513,0.740959189021728,0.945945945945946,0.723140495867769,0.761763229929243,52528.7057142857,32570.4685714286,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_545521,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
546836,475.022641509434,848.932075471698,188.656603773585,605.781132075472,154.083018867925,608.815094339623,385.335849056604,266.781132075472,1110.98867924528,1274.70566037736,873.396226415094,115.464150943396,1061.31320754717,688.554716981132,435.807547169811,264.030188679245,1611.32075471698,1043.60754716981,233.105660377359,217.264150943396,1014.22641509434,944.279245283019,177.42641509434,134.705660377358,2599.39622641509,574.898113207547,363.894339622641,208.075471698113,989.77358490566,130.709433962264,265,19.166175755195,17.6137537559294,0.394252879696705,0.960144927536232,0.774853801169591,0.594360272961128,53698.6113207547,32698.5509433962,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_546836,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
547299,3516.21621621622,684.675675675676,134.646191646192,663.213759213759,2191.91891891892,330.589680589681,588.385749385749,237.493857493857,1077.20147420147,5380.3144963145,661.547911547912,124.312039312039,1090.55773955774,949.560196560197,838.341523341523,1646.44963144963,1620.0171990172,1926.10565110565,280.95085995086,227.371007371007,1044.18918918919,1754.55528255528,211.457002457002,754.938574938575,752.081081081081,1541.59950859951,485.04914004914,583.169533169533,1052.60442260442,131.09828009828,407,31.6725316554781,16.533157663899,0.852943627095194,0.953161592505855,0.701724137931034,-0.360457304067216,53382.3071253071,33606.6953316953,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_547299,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
548016,3079.43728813559,446.88813559322,173.35593220339,647.752542372881,2415.90508474576,772.616949152542,445.749152542373,250.325423728814,1090.73220338983,4929.83389830508,937.162711864407,116.471186440678,1078.83389830508,3301.87457627119,643.206779661017,377.501694915254,2203.48474576271,4714.41355932203,445.837288135593,243.020338983051,1069.12881355932,3842.33898305085,258.342372881356,275.627118644068,592.064406779661,1501.61694915254,494.338983050847,331.237288135593,1038.09491525424,129.484745762712,295,25.9745343075038,14.5211205232752,0.829132461531131,0.960912052117264,0.7375,0.363921418210382,53878.5423728814,33580.7593220339,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_548016,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
548061,2471.37804878049,324.077235772358,110.867886178862,620.260162601626,1093.14430894309,281.355691056911,301.341463414634,259.762195121951,1081.10569105691,4662.82723577236,557.642276422764,128.04674796748,1070.37398373984,624.819105691057,495.270325203252,271.008130081301,1377.7825203252,1023.25406504065,318.282520325203,228.715447154472,986.115853658537,1022.05081300813,229.664634146341,119.932926829268,594.910569105691,2296.50609756098,520.782520325203,229.166666666667,1055.34959349593,131.04674796748,492,37.28575091119,17.2488261146834,0.886560983691738,0.951644100580271,0.689075630252101,-1.21356342128446,53175.7784552846,32475.7906504065,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_548061,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
548826,4638.26719056974,460.349705304519,266.876227897839,639.133595284872,1764.27111984283,1447.65815324165,358.074656188605,259.799607072692,1096.60314341847,7568.98035363458,598.37721021611,124.679764243615,1080.89194499018,813.829076620825,545.646365422397,358.273084479371,1530.39096267191,1137.78978388998,230.807465618861,211.92141453831,998.125736738703,950.005893909627,177.504911591356,278.106090373281,678.862475442043,1358.1257367387,460.958742632613,234.831041257367,1035.5442043222,129.75442043222,509,33.648806980947,19.9806425972447,0.804613093457384,0.956766917293233,0.734487734487735,-1.28926869792282,54098.3359528487,32656.9037328094,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_548826,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
548870,687.13140311804,292.271714922049,164.730512249443,644.071269487751,924.861915367483,1280.24276169265,305.472160356347,254.26280623608,1082.26948775056,1866.05567928731,2129.96659242762,118.913140311804,1068.23162583519,4489.18485523385,490.133630289532,280.207126948775,1456.29398663697,5390.97772828508,287.236080178174,223.645879732739,984.367483296214,5149.33407572383,208.69710467706,168.100222717149,585.189309576837,1286.97995545657,587.296213808463,508.73719376392,1034.33853006682,130.296213808463,449,30.458036805563,18.8826376503772,0.784636707169204,0.965591397849462,0.712698412698413,0.400385184014325,53785.1959910913,33041.3518930958,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_548870,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
550323,2078.08241758242,364.142857142857,259.277472527473,766.744505494505,7392.68406593407,2078.28296703297,373.324175824176,279.574175824176,1110.99450549451,3614.79945054945,2037.65384615385,288.607142857143,1071.07692307692,1084.56868131868,562.013736263736,288.659340659341,1717.97527472527,1070.96153846154,327.818681318681,231.164835164835,995.711538461538,932.554945054945,222.928571428571,125.601648351648,629.956043956044,863.153846153846,422.43956043956,226.409340659341,1053.5467032967,130.225274725275,364,30.1249278418951,15.4732498238958,0.858008145713016,0.950391644908616,0.697318007662835,-1.18285583876463,53074.3708791209,31989.5576923077,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_550323,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
552135,2110.28181818182,119.009090909091,119.990909090909,662.409090909091,2902.77272727273,368.254545454546,489.5,283.418181818182,1087.87272727273,4309.62727272727,505.327272727273,119.581818181818,1080.39090909091,805.818181818182,499.136363636364,290.472727272727,1501.0,1159.22727272727,290.981818181818,220.718181818182,1138.42727272727,1029.67272727273,196.845454545454,264.009090909091,660.227272727273,2005.22727272727,486.263636363636,230.181818181818,1044.31818181818,131.045454545455,110,12.77394241209,11.3839069480284,0.453646036473552,0.901639344262295,0.714285714285714,-0.109637721935585,52863.3727272727,32807.5636363636,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_552135,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
553669,1958.14948453608,299.139175257732,151.239690721649,625.417525773196,1205.59278350515,489.221649484536,1352.09536082474,233.14175257732,1089.76288659794,3339.76804123711,454.110824742268,111.819587628866,1861.94587628866,3620.14948453608,783.231958762887,747.340206185567,2057.80670103093,4879.14948453608,372.399484536082,237.414948453608,1058.55154639175,4390.94845360825,273.046391752577,336.394329896907,617.711340206186,1126.98453608247,474.979381443299,240.520618556701,1020.63917525773,129.914948453608,388,26.4315127552982,18.9319381903141,0.69782951887233,0.955665024630542,0.705454545454545,0.536747392970173,53409.9768041237,33513.706185567,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX+,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_553669,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
554000,1472.81904761905,385.653968253968,81.9206349206349,634.098412698413,1657.06984126984,1562.4126984127,599.355555555556,241.926984126984,1094.6380952381,2133.12380952381,753.514285714286,109.742857142857,1067.14603174603,3496.86031746032,766.571428571429,373.088888888889,1821.29206349206,6645.67301587302,441.35873015873,241.155555555556,1042.23174603175,6709.06666666667,259.653968253968,270.815873015873,842.593650793651,698.288888888889,422.038095238095,260.219047619048,999.447619047619,128.587301587302,315,23.1190252658958,17.3737816057117,0.659741263028716,0.975232198142415,0.842245989304813,1.34120497413365,53637.7047619048,33657.1396825397,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_554000,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
555520,2977.64806866953,433.24034334764,155.875536480687,644.190987124464,2031.25321888412,303.997854077253,406.484978540772,256.384120171674,1076.62446351931,5400.72961373391,2674.12660944206,122.950643776824,1074.51716738197,724.122317596567,860.871244635193,279.148068669528,1392.99141630901,1079.35622317597,306.675965665236,228.843347639485,983.815450643777,1084.76180257511,231.80686695279,164.93991416309,593.652360515021,1623.67167381974,492.667381974249,437.403433476395,1068.31115879828,133.201716738197,466,31.5873657138082,18.8050982946768,0.803476794248382,0.966804979253112,0.69037037037037,-0.841599605229918,53420.9313304721,32674.1266094421,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_555520,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
556178,2055.40265486726,417.066371681416,119.991150442478,631.424778761062,1561.98230088496,373.654867256637,274.70796460177,242.230088495575,1093.77433628319,4134.43805309734,2340.67256637168,113.699115044248,1073.82300884956,635.340707964602,387.464601769911,268.548672566372,1437.11061946903,834.026548672566,181.495575221239,208.092920353982,1081.76548672566,653.08407079646,141.87610619469,126.234513274336,592.871681415929,1406.84513274336,467.588495575221,452.389380530973,1040.94247787611,129.752212389381,226,17.7242335492454,16.3162572470017,0.390596291112622,0.974137931034483,0.830882352941177,-0.226731872428274,53320.7654867257,33114.296460177,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_556178,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
556436,2103.34210526316,182.298245614035,94.921052631579,621.491228070175,955.026315789474,739.798245614035,306.271929824561,248.122807017544,1089.41228070175,2485.80701754386,1573.20175438596,111.745614035088,1055.36842105263,861.157894736842,507.938596491228,271.447368421053,2121.88596491228,1092.30701754386,269.622807017544,221.929824561404,999.21052631579,904.526315789474,189.236842105263,132.578947368421,626.543859649123,860.438596491228,433.09649122807,363.929824561404,1006.81578947368,131.114035087719,114,14.375906718109,10.111168950701,0.710852314260856,0.957983193277311,0.74025974025974,-1.28775270318756,54187.4824561404,32909.4824561404,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_556436,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
556610,4812.64335664336,561.255244755245,160.56993006993,717.461538461538,4723.84265734266,878.171328671329,344.230769230769,246.258741258741,1093.33916083916,7995.69230769231,603.13986013986,133.91958041958,2135.74475524476,1892.46503496503,502.339160839161,278.58041958042,1713.71678321678,1761.18181818182,260.702797202797,220.304195804196,1009.44755244755,1379.28321678322,202.234265734266,176.622377622378,2964.51048951049,2019.13286713287,531.835664335664,293.395104895105,1075.96853146853,131.29020979021,286,23.0978262388852,15.9985430481047,0.721280771352583,0.956521739130435,0.764705882352941,1.20261222510447,53974.027972028,33451.7482517482,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX+,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_556610,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
557226,4877.18303571429,728.830357142857,101.035714285714,647.866071428571,1649.74553571429,420.691964285714,298.223214285714,243.299107142857,1103.42410714286,8021.45089285714,617.308035714286,152.03125,1082.38839285714,2082.19196428571,751.892857142857,298.147321428571,2148.34375,5048.32589285714,407.397321428571,241.950892857143,1063.99107142857,4766.37053571429,257.683035714286,1000.26339285714,1177.1875,3023.99553571429,558.035714285714,250.258928571429,1110.44642857143,132.049107142857,224,17.9202769045782,16.2140840028352,0.425858418884601,0.949152542372881,0.73202614379085,0.507930174752794,52910.3571428571,33849.90625,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,1,FAAGSCC_12_557226,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
557787,4994.68834688347,407.590785907859,90.5826558265583,655.111111111111,1428.20867208672,337.682926829268,295.666666666667,243.349593495935,1079.35230352304,7808.33604336043,1542.42547425474,140.639566395664,8475.53658536585,762.170731707317,629.035230352304,291.842818428184,1915.93495934959,1200.34688346883,318.349593495935,237.327913279133,994.653116531165,1178.23848238482,237.682926829268,156.842818428184,588.485094850948,1591.48509485095,505.181571815718,366.894308943089,1118.31978319783,131.626016260163,369,27.0490868154218,17.4642470066055,0.76363334236246,0.958441558441558,0.698863636363636,0.72244021458757,52680.5230352304,33511.1300813008,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX+,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_557787,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
558113,3961.24838709677,392.722580645161,148.054838709677,631.687096774193,1282.7935483871,457.612903225806,323.493548387097,240.667741935484,1083.26774193548,6726.93225806452,745.209677419355,127.754838709677,1073.13225806452,871.177419354839,592.709677419355,287.329032258065,3082.0935483871,2612.67096774194,338.174193548387,241.293548387097,1042.94516129032,3024.51935483871,248.641935483871,213.264516129032,618.387096774194,2094.18064516129,548.658064516129,253.632258064516,1074.21935483871,131.022580645161,310,25.4917572523019,15.5623090534217,0.79202861560712,0.945121951219512,0.688888888888889,0.317090815795569,52598.435483871,33637.1193548387,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_558113,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
558193,4786.45340501792,239.679211469534,83.7724014336918,629.688172043011,1193.23476702509,1359.44444444444,1372.60573476703,259.76164874552,1097.15770609319,6093.13440860215,638.508960573477,141.073476702509,1076.91218637993,2415.06630824373,934.401433691756,1877.0017921147,1991.96415770609,2294.82795698925,307.338709677419,219.320788530466,1053.79928315412,1267.2311827957,182.344086021505,591.430107526882,711.582437275986,1154.15770609319,444.13082437276,217.397849462366,1023.76523297491,129.824372759857,558,31.0111703537414,23.3632475862633,0.657583489659791,0.934673366834171,0.75,-1.12385751923909,53222.2544802867,32155.7078853047,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_558193,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
558220,3279.42173913043,370.382608695652,121.865217391304,613.626086956522,323.239130434783,2451.81304347826,1998.31304347826,255.078260869565,1101.30434782609,4500.3,633.339130434783,128.195652173913,6981.60434782609,1332.79565217391,490.3,328.113043478261,1520.56956521739,4947.68260869565,380.769565217391,235.121739130435,1022.9652173913,5679.54782608696,241.626086956522,193.073913043478,602.726086956522,1238.2652173913,520.647826086957,247.104347826087,1025.03913043478,130.469565217391,230,20.5461297990532,14.5579368629552,0.705661754567945,0.966386554621849,0.756578947368421,-0.525091344864254,53239.0956521739,33289.9869565217,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX+,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_558220,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
558523,3483.55449330784,902.527724665392,859.833652007648,639.378585086042,1792.49330783939,350.837476099426,269.300191204589,239.971319311663,1085.24091778203,6730.12045889101,638.428298279159,124.015296367113,1072.00191204589,1587.91013384321,558.263862332696,305.827915869981,1678.05927342256,1596.00956022945,254.782026768642,220.65965583174,994.066921606118,1462.78585086042,209.734225621415,148.718929254302,612.110898661568,3005.48757170172,557.812619502868,239.820267686424,1048.57743785851,130.17017208413,523,30.6492461417998,22.0230981902363,0.695472526447192,0.96316758747698,0.81974921630094,0.242378097295574,54079.7667304015,32987.0363288719,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,11,FAAGSCC_12_558523,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
558813,2039.22580645161,284.693548387097,95.7983870967742,636.225806451613,1213.8064516129,1408.83870967742,319.798387096774,261.306451612903,1106.21774193548,3571.18548387097,804.766129032258,148.016129032258,1068.1935483871,2432.39516129032,576.741935483871,312.620967741935,2029.75,1418.84677419355,264.879032258065,234.209677419355,1023.5,1068.99193548387,193.145161290323,300.08064516129,1814.32258064516,967.806451612903,427.306451612903,235.282258064516,1061.33064516129,129.346774193548,124,17.96416533762,8.93394082038686,0.867567115855759,0.898550724637681,0.663101604278075,1.23013138521287,52709.5322580645,32913.5483870968,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_558813,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
559107,1519.70238095238,192.845238095238,70.0198412698413,613.746031746032,659.845238095238,1070.53571428571,393.753968253968,260.944444444444,1079.40873015873,3569.61507936508,831.876984126984,109.559523809524,1067.04365079365,1046.63095238095,458.325396825397,306.031746031746,1386.5,1922.0119047619,289.337301587302,230.595238095238,997.265873015873,2795.20634920635,222.206349206349,158.896825396825,594.25,1529.98015873016,482.293650793651,288.246031746032,1054.93650793651,130.948412698413,252,22.1626855569496,14.9827077547812,0.73687130828636,0.940298507462687,0.8,0.0703336340277333,53705.9484126984,32947.4206349206,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_559107,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
559157,489.147321428571,1188.37053571429,264.0625,617.245535714286,152.071428571429,242.147321428571,253.21875,249.102678571429,1074.77232142857,1380.57589285714,1143.08035714286,121.1875,1068.19196428571,590.147321428571,463.616071428571,266.383928571429,1356.01785714286,909.183035714286,267.348214285714,219.691964285714,979.0625,896.620535714286,199.223214285714,112.758928571429,587.303571428571,659.839285714286,369.325892857143,211.120535714286,1002.75892857143,131.397321428571,224,18.720363878728,15.2498374605943,0.580005953825063,0.949152542372881,0.736842105263158,-1.40180281633744,53184.3973214286,32634.2544642857,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_559157,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
560393,2874.90751445087,313.982658959538,133.901734104046,660.843930635838,2620.63583815029,421.462427745665,576.57225433526,246.554913294798,1084.76300578035,5154.97687861272,626.520231213873,134.491329479769,1066.12716763006,1355.30057803468,668.549132947977,374.612716763006,2430.52023121387,3306.02312138728,323.346820809249,232.381502890173,994.109826589595,3517.7225433526,224.104046242775,251.179190751445,660.64161849711,2208.61271676301,573.953757225433,237.537572254335,1046.4161849711,133.820809248555,173,19.2744296707685,11.6480680603174,0.79673600552115,0.945355191256831,0.720833333333333,0.0654467606159844,53100.7976878613,33151.0115606936,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,9,FAAGSCC_12_560393,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
560528,2705.36097560976,529.951219512195,109.721951219512,658.321951219512,2317.20975609756,296.843902439024,332.20487804878,262.317073170732,1078.51707317073,5007.62926829268,809.458536585366,127.180487804878,1081.11219512195,608.136585365854,620.556097560976,271.985365853658,1516.82926829268,936.126829268293,281.014634146341,223.307317073171,995.448780487805,805.087804878049,188.985365853658,119.224390243902,587.614634146341,1617.69268292683,465.921951219512,270.682926829268,1075.2487804878,129.448780487805,205,17.4442914299543,15.3544531232035,0.474604246195988,0.923423423423423,0.711805555555556,0.565533633799045,52628.8975609756,32288.8731707317,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_560528,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
561555,3282.59408602151,443.258064516129,185.094086021505,685.602150537634,3962.14516129032,1159.61827956989,2449.62903225806,253.913978494624,1095.35215053763,5014.41666666667,3453.73655913978,129.513440860215,1088.90322580645,2855.79569892473,875.094086021505,888.438172043011,1982.63978494624,3177.27956989247,318.408602150538,225.430107526882,1038.45698924731,1884.34946236559,208.139784946236,298.268817204301,641.220430107527,1243.2876344086,484.967741935484,793.301075268817,1051.31451612903,130.72311827957,372,32.5233421825576,14.8817997256357,0.889172114334641,0.956298200514139,0.62,-1.08403558335001,53253.8037634409,33170.8790322581,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_561555,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
561770,536.017441860465,1016.85465116279,241.627906976744,615.415697674419,98.9156976744186,376.604651162791,361.334302325581,252.691860465116,1081.02906976744,1369.11627906977,1244.50581395349,118.543604651163,1064.05813953488,4030.2238372093,752.258720930233,315.30523255814,1605.84302325581,6702.09593023256,432.770348837209,240.956395348837,1003.40697674419,6506.375,254.691860465116,161.918604651163,585.508720930233,574.837209302326,359.901162790698,205.732558139535,984.186046511628,128.130813953488,344,23.4610330189105,18.8136917506825,0.597441719563807,0.960893854748603,0.744588744588745,-0.764363170927669,53688.6598837209,32641.2296511628,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_561770,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
562373,2300.70720720721,179.698198198198,129.554054054054,633.153153153153,1701.8963963964,2037.81081081081,602.747747747748,266.396396396396,1094.49099099099,3670.95945945946,785.783783783784,130.414414414414,1070.0045045045,1900.44144144144,521.518018018018,327.234234234234,1872.2027027027,1378.94144144144,239.103603603604,214.18018018018,992.576576576577,834.545045045045,164.599099099099,167.045045045045,616.198198198198,801.274774774775,416.837837837838,223.54954954955,1037.66216216216,131.414414414414,222,28.7890487266652,9.89033401117176,0.939136213026484,0.94468085106383,0.482608695652174,0.828072336126887,52585.9684684685,32730.1126126126,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_562373,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
562692,1671.25413223141,87.0185950413223,62.8636363636364,643.679752066116,1784.40289256198,1950.81198347107,1737.82644628099,266.280991735537,1102.49586776859,2947.8367768595,848.202479338843,153.49173553719,1073.45661157025,1091.5805785124,883.489669421488,1087.48760330579,2069.0826446281,1186.20247933884,284.75826446281,223.254132231405,1005.94628099174,996.415289256198,199.811983471074,593.392561983471,629.603305785124,1110.11157024793,480.349173553719,246.119834710744,1054.19214876033,130.485537190083,484,33.7619936311582,18.5782806291841,0.834985447575997,0.977777777777778,0.814814814814815,-0.058567642518993,52413.7561983471,32670.1714876033,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_562692,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
564436,1704.86363636364,817.727272727273,128.136363636364,649.790909090909,2791.03636363636,367.863636363636,390.872727272727,241.436363636364,1065.31818181818,3234.55454545455,2153.61818181818,118.872727272727,1072.99090909091,809.963636363636,474.590909090909,348.027272727273,1520.61818181818,1058.90909090909,269.118181818182,225.863636363636,986.872727272727,992.2,204.881818181818,152.8,586.745454545455,1520.88181818182,506.136363636364,287.290909090909,1018.08181818182,131.081818181818,110,12.9153810313477,11.0234704044259,0.52106840412316,0.973451327433628,0.769230769230769,1.23440163769278,53298.6545454545,33490.2636363636,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_564436,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
564611,3546.67111111111,1049.74222222222,215.431111111111,680.373333333333,3498.57333333333,514.626666666667,1147.08444444444,250.977777777778,1080.58222222222,5489.79555555556,899.244444444444,149.297777777778,1089.15555555556,2226.84444444444,795.933333333333,1251.65777777778,1931.52,4539.24888888889,389.862222222222,249.346666666667,1063.24444444444,4492.91111111111,298.075555555556,679.613333333333,743.271111111111,1911.57333333333,574.795555555556,388.555555555556,1088.07111111111,133.528888888889,225,21.6623157179813,13.2251006654408,0.79200711394718,0.974025974025974,0.803571428571429,1.19958392669008,53370.4933333333,33798.5022222222,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_564611,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
564617,3041.73858921162,843.92531120332,909.46887966805,664.800829875519,3613.52282157676,2298.01659751037,371.593360995851,249.439834024896,1083.88796680498,5569.74273858921,1713.82987551867,121.04979253112,1077.39004149378,4490.67219917012,548.439834024896,307.207468879668,1594.3734439834,6922.1244813278,375.464730290456,235.979253112033,1008.17427385892,6803.69709543568,302.178423236515,170.780082987552,595.402489626556,2134.86307053942,509.157676348548,511.9377593361,1050.66804979253,129.788381742739,241,19.8868600794995,15.5711251668517,0.622039824031669,0.952569169960474,0.746130030959752,-0.573683915555328,54022.0041493776,33495.7053941909,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_564617,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
564624,3427.64010989011,873.28021978022,133.186813186813,624.453296703297,1277.45054945055,995.574175824176,1257.17857142857,253.71978021978,1080.8956043956,4745.25274725275,593.563186813187,123.928571428571,1078.79945054945,853.519230769231,529.046703296703,297.131868131868,1458.37637362637,1259.28846153846,269.695054945055,220.464285714286,989.192307692308,1061.06868131868,207.381868131868,131.777472527473,587.065934065934,1133.4010989011,540.118131868132,235.956043956044,1025.35714285714,130.068681318681,364,24.452690723384,19.1742052076321,0.620590565673972,0.952879581151832,0.719367588932806,0.605915610120051,53965.8543956044,33313.8021978022,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_564624,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
564709,3351.74805194805,819.628571428571,145.374025974026,680.857142857143,3025.67012987013,1158.48571428571,314.096103896104,247.012987012987,1143.32207792208,5401.98181818182,1045.23116883117,130.451948051948,1090.28311688312,920.064935064935,507.542857142857,269.285714285714,1404.35584415584,1122.1974025974,281.049350649351,221.527272727273,991.636363636364,1050.22597402597,210.823376623377,137.716883116883,1061.57922077922,951.309090909091,475.792207792208,413.438961038961,1057.53246753247,131.07012987013,385,26.9409990959373,18.3510107590657,0.7321387380522,0.95771144278607,0.822649572649573,-0.0256676065483303,53675.3324675325,33249.438961039,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_564709,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
564712,1155.68382352941,282.154411764706,319.125,785.345588235294,11685.6470588235,357.367647058824,472.036764705882,257.919117647059,1078.36029411765,1827.08823529412,593.198529411765,122.227941176471,1062.0,719.397058823529,594.558823529412,286.779411764706,1609.24264705882,974.169117647059,277.720588235294,221.132352941176,996.727941176471,854.161764705882,203.367647058824,122.058823529412,591.514705882353,814.669117647059,404.213235294118,211.992647058824,1028.0,130.095588235294,136,17.4443548400645,9.94608405454862,0.821533246448859,0.931506849315068,0.727272727272727,0.285516391246531,53750.1102941177,32100.0808823529,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_564712,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
566694,868.688442211055,168.793969849246,126.301507537688,743.643216080402,7190.18592964824,1703.73366834171,2296.41206030151,258.477386934673,1098.8743718593,1525.76381909548,3757.45728643216,123.668341708543,1066.07537688442,1182.42211055276,727.457286432161,637.185929648241,4493.72361809045,2107.13567839196,350.899497487437,240.577889447236,1048.78391959799,1687.07035175879,246.145728643216,186.522613065327,635.86432160804,1036.28140703518,494.763819095477,556.979899497487,1073.77386934673,130.306532663317,199,21.2168688449214,12.0282479305685,0.823773480964074,0.947619047619048,0.654605263157895,1.00549333304777,53027.8693467337,33690.5226130653,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_566694,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
566734,3308.61279461279,1028.14141414141,123.198653198653,665.700336700337,3068.68686868687,684.461279461279,307.451178451178,249.569023569024,1076.2962962963,4456.60942760943,659.006734006734,128.747474747475,1115.81144781145,2025.58585858586,610.451178451178,343.83164983165,1580.50505050505,2047.00673400673,292.996632996633,227.326599326599,1028.64983164983,1560.06060606061,217.52861952862,270.569023569024,809.750841750842,1071.27946127946,511.326599326599,239.841750841751,1055.45791245791,131.03367003367,297,22.6796276167829,17.2031127896012,0.651641463384255,0.942857142857143,0.707142857142857,-0.696228311170369,53275.4377104377,33320.7003367003,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_566734,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
567486,1521.85416666667,468.495833333333,86.1458333333333,619.908333333333,987.5625,2784.45416666667,534.941666666667,268.708333333333,1111.8125,3288.93333333333,1727.66666666667,108.725,1070.82083333333,1679.52083333333,642.970833333333,497.925,1865.0125,1214.48333333333,254.833333333333,220.095833333333,1007.97916666667,1249.05416666667,193.029166666667,1005.20833333333,707.283333333333,895.683333333333,406.820833333333,330.8375,1036.79583333333,131.1625,240,21.7643399833457,14.3742692405719,0.750869586582343,0.941176470588235,0.727272727272727,1.44606588606523,52719.8458333333,32408.5541666667,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_567486,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
567495,2729.02298850575,332.532567049808,107.72030651341,611.471264367816,592.593869731801,1160.16091954023,680.229885057471,275.64367816092,1121.69348659004,5399.04597701149,765.996168582376,120.291187739464,1080.58620689655,2758.87356321839,577.938697318008,702.16091954023,2008.83908045977,1951.8275862069,283.229885057471,671.521072796935,1200.64367816092,874.425287356322,188.295019157088,270.524904214559,748.704980842912,2382.31800766284,493.789272030651,281.555555555556,1049.19157088123,130.417624521073,261,25.4414829273428,13.239849761133,0.853920175037995,0.956043956043956,0.776785714285714,1.32179913767361,52545.7164750958,33005.8620689655,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_567495,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
568524,6102.36796536797,797.577922077922,655.348484848485,658.915584415584,2013.38744588745,3377.70995670996,805.231601731602,273.536796536797,1129.22077922078,9688.46536796537,797.5670995671,140.268398268398,1116.46536796537,1908.8354978355,923.493506493506,365.357142857143,3134.20779220779,1895.30519480519,304.74025974026,233.190476190476,1006.94588744589,2083.12121212121,219.705627705628,193.915584415584,660.97619047619,2612.18398268398,588.878787878788,265.264069264069,1090.86147186147,137.188311688312,462,26.1412843511899,22.5990524455622,0.502638599952316,0.964509394572025,0.77257525083612,-0.375573360538878,53310.6298701299,33347.7943722944,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_568524,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
569110,3012.99305555556,272.979166666667,114.770833333333,656.541666666667,2386.98611111111,2543.27083333333,343.368055555556,257.868055555556,1106.80555555556,5475.4375,1087.20833333333,123.076388888889,1231.51388888889,759.347222222222,541.979166666667,283.416666666667,3346.02083333333,1146.74305555556,309.777777777778,238.395833333333,987.833333333333,1111.77777777778,233.194444444444,161.3125,592.784722222222,1695.47916666667,499.354166666667,352.381944444444,1064.93055555556,132.034722222222,144,14.2382345696407,12.9154237316106,0.420927115298104,0.935064935064935,0.73469387755102,0.34131249582657,52696.7430555556,33534.2152777778,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX+,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_569110,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
569394,1133.39419087137,291.331950207469,163.008298755187,665.497925311203,3696.7468879668,270.244813278008,270.763485477178,246.54356846473,1079.7468879668,1860.95435684647,1287.14522821577,120.477178423237,1068.12033195021,682.099585062241,484.572614107884,274.647302904564,1401.32780082988,1086.2531120332,288.717842323651,222.871369294606,986.336099585062,1014.48132780083,211.622406639004,116.265560165975,587.49377593361,998.282157676349,466.614107883817,234.244813278008,1031.05809128631,129.120331950207,241,20.0330962376901,15.367962511105,0.641493258523028,0.956349206349206,0.803333333333333,-1.42009472037204,53799.3029045643,32927.3319502075,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_569394,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
569495,2812.99618320611,576.809160305344,158.312977099237,721.679389312977,4006.15648854962,1332.29389312977,710.324427480916,263.293893129771,1089.41221374046,3670.20229007634,576.213740458015,137.69465648855,1079.32442748092,978.484732824428,642.709923664122,2220.58396946565,2007.79389312977,2389.8320610687,338.503816793893,237.389312977099,1020.50763358779,2339.46183206107,232.839694656488,284.984732824427,615.12213740458,976.916030534351,468.80534351145,1242.9427480916,1068.98473282443,130.614503816794,262,20.7098442533574,16.6381877015271,0.595446294393447,0.95970695970696,0.693121693121693,-0.401216818306958,53487.2480916031,33786.4809160305,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_569495,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
569561,1826.30769230769,572.466063348416,95.2307692307692,650.909502262443,2051.56108597285,3435.0,1071.82805429864,264.330316742081,1117.43438914027,3411.50226244344,2200.27149321267,122.461538461538,1081.28959276018,8260.70135746606,1378.31221719457,441.656108597285,14117.6334841629,8899.78733031674,551.72850678733,264.859728506787,1086.72850678733,8644.45701357466,314.113122171946,235.850678733032,665.669683257919,1051.07692307692,457.859728506787,553.606334841629,1053.14932126697,132.719457013575,221,17.9352131177755,15.7140821193055,0.482023854610803,0.973568281938326,0.8125,-1.17717983768056,52758.1990950226,33565.7194570136,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_569561,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
570021,2173.105,218.38,115.655,657.895,2254.02,1226.585,436.235,244.885,1086.655,3206.355,1085.025,124.79,1080.24,1817.785,817.555,444.695,2045.865,1712.34,314.78,235.075,1016.075,1363.025,209.765,180.22,590.55,1131.75,504.635,319.98,1050.275,131.55,200,17.8932779311942,14.2590253831403,0.604120661326843,0.961538461538462,0.793650793650794,1.35283586359412,53109.03,33714.605,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_570021,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
571267,1748.12328767123,142.513698630137,58.7465753424658,612.0,684.246575342466,401.109589041096,823.397260273973,254.027397260274,1122.85616438356,3260.62328767123,572.931506849315,111.308219178082,1077.02054794521,789.602739726027,507.815068493151,352.72602739726,2242.78767123288,1057.50684931507,257.397260273973,224.568493150685,1011.87671232877,977.493150684932,190.308219178082,161.58904109589,587.753424657534,1546.86301369863,492.294520547945,266.77397260274,1039.13698630137,129.5,146,15.677847516445,11.8862672159977,0.652072248367184,0.960526315789474,0.760416666666667,1.50048210359633,53044.0753424658,33595.2876712329,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_571267,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
571590,3861.08727272727,929.6,547.323636363636,618.647272727273,758.789090909091,1174.55636363636,326.312727272727,250.770909090909,1116.58545454545,6304.62545454545,531.669090909091,143.021818181818,1072.18181818182,3448.67636363636,684.716363636364,316.04,4034.24,5613.49454545455,437.287272727273,246.072727272727,1051.72363636364,6746.82545454545,298.825454545455,796.385454545455,939.450909090909,2059.73454545454,521.836363636364,244.24,1155.04363636364,130.672727272727,275,23.0641789431416,15.5754386036243,0.737535275351431,0.938566552901024,0.735294117647059,1.22083299599701,52846.0981818182,33848.08,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_571590,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
572005,2434.5868852459,159.031147540984,100.44262295082,690.42131147541,2979.1737704918,1701.09016393443,529.049180327869,243.703278688525,1091.06721311475,4567.31803278688,709.286885245902,121.154098360656,1077.20491803279,4524.19672131148,765.034426229508,628.706557377049,2097.2131147541,5176.42295081967,405.916393442623,303.386885245902,1055.75573770492,4237.23770491803,261.231147540984,261.677049180328,592.822950819672,1820.50983606557,529.306557377049,302.003278688525,1096.07540983607,131.085245901639,610,34.4803083493335,23.2697671588586,0.737935539199577,0.956112852664577,0.702764976958525,-1.02893529576427,53648.5409836066,33523.3213114754,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_572005,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
573073,2560.77363896848,285.902578796562,129.065902578797,675.681948424069,3096.17478510029,3372.08309455587,512.644699140401,257.974212034384,1111.58739255014,4412.29226361031,593.169054441261,130.458452722063,1082.43839541547,4078.1776504298,821.014326647564,328.186246418338,10036.547277937,1836.22922636103,291.232091690544,227.438395415473,1025.21776504298,1385.57306590258,209.916905444126,140.936962750716,594.41547277937,1307.39828080229,480.444126074499,249.971346704871,1070.92263610315,132.011461318052,349,29.6713791323561,14.9868664226816,0.863063729284677,0.953551912568306,0.733193277310924,-0.33213313398811,52845.994269341,33454.4154727794,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_573073,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
573337,995.190721649484,261.855670103093,88.340206185567,660.752577319588,1678.43298969072,405.5,391.030927835052,247.824742268041,1076.53608247423,2155.83505154639,655.592783505155,106.798969072165,1081.0206185567,889.690721649485,510.69587628866,338.927835051546,1462.39175257732,1277.77835051546,310.958762886598,233.345360824742,1003.66494845361,1273.77319587629,226.149484536082,164.721649484536,591.309278350515,951.994845360825,440.623711340206,243.350515463918,1046.57216494845,129.489690721649,194,18.3052670237639,13.5583979462705,0.671854796362524,0.950980392156863,0.76984126984127,1.45214258069534,53313.5824742268,33505.4020618557,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_573337,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
573487,1953.17355371901,732.553719008264,73.2148760330578,634.512396694215,866.628099173554,2394.06611570248,349.495867768595,250.103305785124,1087.5,2934.13636363636,556.103305785124,112.235537190083,1080.42148760331,2759.30165289256,858.50826446281,463.731404958678,3115.01239669421,1755.60330578512,276.44214876033,219.305785123967,1032.92975206612,1906.23966942149,237.904958677686,161.48347107438,624.929752066116,930.214876033058,458.342975206612,584.409090909091,1022.02892561983,130.409090909091,242,19.7689801302207,15.681806931101,0.608891900158366,0.930769230769231,0.711764705882353,0.176375021049359,54015.9958677686,33469.5619834711,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_573487,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
573577,1410.255,310.6,94.025,613.1,603.815,716.145,380.11,265.75,1130.155,3032.315,855.935,120.08,1072.24,781.9,421.97,270.735,1568.235,1010.48,212.725,212.86,1115.575,683.485,137.565,113.12,634.105,1220.975,526.805,248.075,1021.395,130.71,200,23.4507420943501,11.0468771706884,0.882097286358961,0.943396226415094,0.617283950617284,0.79746513058555,53226.885,32771.94,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_573577,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
573805,1228.88194444444,400.840277777778,219.555555555556,610.979166666667,375.638888888889,4844.71527777778,777.333333333333,275.659722222222,1111.54166666667,2734.84027777778,1027.64583333333,116.979166666667,1074.86111111111,1793.74305555556,869.277777777778,763.173611111111,2454.83333333333,2567.16666666667,359.743055555556,279.798611111111,1015.66666666667,2942.20833333333,268.201388888889,204.416666666667,634.465277777778,1795.58333333333,562.4375,331.506944444444,1036.49305555556,131.138888888889,144,16.7492821054885,11.041034833082,0.751972470372991,0.941176470588235,0.685714285714286,0.69857685283949,53609.4513888889,33455.6597222222,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_573805,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
574094,2974.60869565217,266.557312252964,146.233201581028,672.237154150198,2954.20158102767,284.818181818182,321.434782608696,261.636363636364,1078.42292490119,4784.15019762846,761.450592885375,126.106719367589,1094.67984189723,587.600790513834,449.517786561265,270.766798418972,1361.41501976285,889.861660079051,286.648221343874,229.01185770751,990.95256916996,834.695652173913,225.97628458498,135.98418972332,594.055335968379,1270.24110671937,433.719367588933,230.628458498024,1056.42292490119,130.391304347826,253,26.2577666805604,12.7355574513227,0.874502732192471,0.913357400722022,0.75297619047619,1.38277740535216,52653.9881422925,32266.6442687747,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_574094,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
574530,3753.12320916906,197.395415472779,105.037249283668,651.126074498567,1989.14326647564,3376.74498567335,1117.38108882521,255.621776504298,1110.76217765043,5975.64756446991,641.977077363897,139.896848137536,1092.69054441261,3863.22922636103,849.902578796562,769.220630372493,1954.7106017192,4804.14326647564,367.12893982808,240.280802292264,1039.30085959885,3890.23495702006,249.939828080229,590.650429799427,636.234957020057,2244.03438395415,537.997134670487,309.389684813754,1048.98567335244,128.386819484241,349,33.5553093437255,13.4253790523474,0.916472792756773,0.950953678474114,0.523238380809595,0.651083163931334,53507.6418338109,33742.4985673352,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_574530,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
574786,2556.60454545455,263.586363636364,120.272727272727,632.136363636364,1500.94090909091,277.581818181818,290.145454545455,252.359090909091,1070.56818181818,5411.14545454545,553.886363636364,126.759090909091,1071.90909090909,532.431818181818,496.677272727273,315.918181818182,1411.71363636364,854.831818181818,217.981818181818,212.072727272727,992.609090909091,775.722727272727,162.068181818182,146.554545454545,653.318181818182,2692.64090909091,563.7,253.686363636364,1039.11818181818,129.422727272727,220,22.3669834859843,12.6219289753991,0.82556246892064,0.956521739130435,0.698412698412698,-1.13517069257214,53215.65,32338.1090909091,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_574786,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
574969,2626.14937759336,227.804979253112,101.44398340249,653.966804979253,1979.59751037344,509.697095435685,367.618257261411,268.771784232365,1118.1867219917,4350.22406639004,992.423236514523,171.904564315353,1070.80082987552,940.257261410788,590.473029045643,288.946058091286,1814.95435684647,1286.90871369295,291.991701244813,230.112033195021,1068.12033195021,1001.90456431535,213.153526970954,170.834024896266,1621.65975103734,1005.99585062241,449.020746887967,227.116182572614,1066.78838174274,131.688796680498,241,24.7670894129531,12.4629954498177,0.864165373777926,0.956349206349206,0.644385026737968,1.0386241146627,52440.6473029046,32489.2572614108,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_574969,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
575090,368.786982248521,798.96449704142,190.242603550296,601.508875739645,115.147928994083,692.869822485207,371.479289940828,271.12426035503,1104.92899408284,869.828402366864,511.331360946746,100.325443786982,1069.55621301775,1413.8224852071,513.094674556213,295.100591715976,1634.78698224852,2062.72189349112,311.076923076923,229.727810650888,1010.32544378698,2408.65088757396,216.994082840237,255.414201183432,656.887573964497,570.372781065089,369.609467455621,206.940828402367,979.047337278106,130.461538461538,169,15.2102922680412,14.1730382184604,0.362957287193792,0.965714285714286,0.804761904761905,1.22214929184707,53369.6568047337,33045.8165680473,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_575090,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
575476,4395.28358208955,1308.2328358209,163.011940298507,675.516417910448,2623.66268656716,323.235820895522,317.340298507463,233.208955223881,1081.58507462687,6760.23880597015,722.537313432836,126.725373134328,1101.57611940299,1587.8776119403,529.298507462687,451.29552238806,1846.28955223881,1829.25074626866,324.549253731343,231.683582089552,1028.31940298507,1279.57313432836,207.925373134328,217.874626865672,658.170149253731,2153.82388059701,581.970149253731,482.376119402985,1087.8447761194,134.617910447761,335,26.4688722784623,16.1847097093233,0.791273793723332,0.951704545454545,0.693581780538302,-0.946700386126633,53037.1014925373,33565.7731343284,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_575476,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
575788,3500.22045454545,1335.61136363636,127.838636363636,633.702272727273,1721.60681818182,254.55,254.888636363636,239.127272727273,1077.4,5346.01590909091,623.906818181818,123.047727272727,1079.44545454545,663.090909090909,415.227272727273,266.427272727273,1403.66363636364,1117.10681818182,291.102272727273,228.104545454545,981.377272727273,1089.96363636364,225.895454545455,124.575,591.915909090909,1442.51363636364,550.775,244.184090909091,1038.87954545455,129.943181818182,440,32.7808283242252,17.1769696429031,0.851721724031249,0.956521739130435,0.666666666666667,1.08484231275778,53838.7090909091,33158.3840909091,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_575788,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
576788,2811.92482915718,230.127562642369,111.678815489749,639.378132118451,2133.47835990888,1327.40546697039,345.924829157175,263.198177676538,1100.32801822323,4452.74715261959,725.596810933941,125.48291571754,1071.32574031891,762.927107061503,455.175398633257,272.564920273348,1379.03644646925,1028.80637813212,314.0569476082,228.43735763098,983.496583143508,1010.82004555809,235.305239179954,130.366742596811,606.5284738041,917.366742596811,452.20728929385,226.01138952164,1037.20956719818,131.123006833713,439,42.1593477032853,13.3400059915858,0.948619632051415,0.952277657266811,0.45681581685744,0.773832905288427,53231.3644646925,33016.708428246,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_576788,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
576999,2392.1958041958,180.118881118881,79.4125874125874,640.468531468532,1785.73426573427,288.041958041958,248.587412587413,245.055944055944,1098.96503496503,3925.76923076923,557.034965034965,115.601398601399,1070.56643356643,632.72027972028,366.265734265734,260.237762237762,1422.40559440559,804.979020979021,174.391608391608,199.111888111888,1107.25174825175,604.986013986014,128.188811188811,96.8671328671329,589.79020979021,1174.9020979021,466.776223776224,221.699300699301,1035.51048951049,129.538461538462,143,19.8892675784332,9.1509260213033,0.887870384180093,0.947019867549669,0.662037037037037,1.07906961411137,53801.6573426574,32211.5104895105,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_576999,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
577710,1248.66666666667,200.72514619883,79.0526315789474,620.286549707602,898.543859649123,300.321637426901,563.502923976608,264.280701754386,1082.52631578947,2979.74269005848,636.824561403509,124.684210526316,1067.89473684211,702.649122807018,810.777777777778,285.619883040936,1410.50292397661,1084.54385964912,335.12865497076,234.923976608187,977.619883040936,1002.02923976608,239.076023391813,125.076023391813,602.111111111111,1722.30994152047,580.672514619883,250.321637426901,1047.54385964912,131.0,171,15.7507319646887,13.8520252125451,0.475986119030034,0.955307262569832,0.763392857142857,-1.28536798975375,52970.298245614,32663.3391812865,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_577710,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
577757,2582.75318066158,420.519083969466,120.23155216285,661.099236641221,2409.01272264631,3666.28498727735,477.315521628499,261.972010178117,1094.67430025445,4209.48600508906,1261.79389312977,121.40203562341,1085.57760814249,3956.90330788804,693.798982188295,347.552162849873,3599.64122137405,2186.0737913486,343.994910941476,237.687022900763,1005.97709923664,1568.74300254453,233.045801526718,156.727735368957,603.478371501272,1105.06615776081,459.063613231552,681.389312977099,1065.80152671756,131.290076335878,393,25.8486291335843,19.4756842188425,0.657503673394258,0.949275362318841,0.71978021978022,0.0782026419973793,52779.1959287532,33499.4860050891,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_577757,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
577787,3832.98791540785,506.172205438066,770.933534743202,622.435045317221,888.220543806647,789.607250755287,1435.38066465257,248.31419939577,1086.12990936556,5468.19033232628,502.73413897281,120.480362537764,1077.46223564955,3163.82779456193,850.83081570997,2124.81873111782,2867.60725075529,3924.42900302115,338.350453172205,524.688821752266,1079.92447129909,2625.24773413897,242.099697885196,314.160120845921,753.712990936556,1198.41087613293,476.042296072508,244.404833836858,1015.35347432024,128.773413897281,331,25.4934528064,16.5616619004908,0.760238789795191,0.956647398843931,0.725877192982456,0.423871325988868,53958.1117824773,33196.4803625378,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_577787,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
577829,5128.57716049383,1012.28703703704,197.608024691358,688.148148148148,4155.26543209877,531.54012345679,442.938271604938,252.679012345679,1080.71296296296,8844.72222222222,650.524691358025,131.867283950617,1082.04012345679,846.820987654321,606.391975308642,429.243827160494,3801.33950617284,1075.62962962963,244.780864197531,217.25,1012.16049382716,914.635802469136,190.157407407407,220.287037037037,619.91975308642,2327.27777777778,557.348765432099,250.972222222222,1070.77469135802,129.62037037037,324,22.0809621463039,18.7287959349824,0.529696116675147,0.964285714285714,0.73469387755102,-0.715982179088028,54044.4598765432,33255.4012345679,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_577829,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
578404,5968.39484978541,193.304721030043,121.648068669528,638.738197424893,1707.12446351931,491.669527896996,734.738197424893,249.583690987124,1077.5321888412,9126.94849785408,630.463519313305,150.922746781116,1078.45922746781,1126.07296137339,1022.99570815451,883.44635193133,1806.12875536481,2273.2660944206,390.781115879828,243.519313304721,1021.669527897,1848.41630901288,278.06008583691,788.326180257511,656.540772532189,3633.29184549356,641.776824034335,318.068669527897,1109.66094420601,131.841201716738,233,22.2330270391738,13.8168502581435,0.783448987945524,0.939516129032258,0.681286549707602,0.761573807010281,53111.008583691,33760.1802575107,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_578404,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
578578,4780.86384976526,751.896713615023,1976.86384976526,636.586854460094,1324.8779342723,4131.42723004695,556.319248826291,271.478873239437,1135.04694835681,7595.33802816901,631.028169014084,124.004694835681,1079.53051643192,1891.38028169014,704.910798122066,301.464788732394,2083.07511737089,1394.69483568075,307.507042253521,230.699530516432,1003.30985915493,1015.39906103286,220.201877934272,144.112676056338,580.920187793427,2506.51643192488,600.539906103286,369.784037558685,1045.2676056338,130.215962441315,213,21.376417985401,12.862330643803,0.798717241473927,0.946666666666667,0.657407407407407,0.724141699233504,53333.338028169,33413.1690140845,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_578578,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
578666,1435.17401668653,367.342073897497,214.431466030989,679.595947556615,4033.8557806913,252.218116805721,284.674612634088,245.954707985697,1076.22050059595,2104.02145411204,503.374255065554,117.706793802145,1080.4684147795,584.893921334923,441.053635280095,268.202622169249,1453.16567342074,935.116805721096,281.215733015495,229.957091775924,983.404052443385,913.673420738975,223.082240762813,138.637663885578,583.107270560191,1110.80929678188,513.706793802145,226.868891537545,1046.83671036949,129.95947556615,839,54.5349809661786,19.796276541591,0.931788578818359,0.946952595936795,0.541290322580645,-0.452929760150464,52337.6030989273,33279.9761620977,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_578666,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
578801,3075.20175438596,342.277777777778,140.783625730994,668.464912280702,2416.12280701754,2148.26608187134,1357.56140350877,259.304093567251,1107.23684210526,4777.78362573099,3608.42105263158,125.295321637427,1094.46783625731,5216.70760233918,1355.95029239766,1919.90643274854,7316.36257309942,6488.09649122807,450.122807017544,252.152046783626,1145.54093567251,5862.17543859649,295.245614035088,339.491228070175,737.029239766082,1700.78947368421,520.30701754386,859.040935672515,1093.54970760234,132.254385964912,342,22.2723873801116,19.972978372592,0.442517937743431,0.936986301369863,0.74025974025974,-1.10066449861587,53085.0730994152,33660.4619883041,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3+,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_578801,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
579195,1907.13461538462,371.057692307692,175.108974358974,686.833333333333,4430.83333333333,2214.73076923077,2548.07692307692,479.596153846154,1109.92948717949,3349.29487179487,563.647435897436,129.057692307692,1091.32051282051,788.807692307692,741.467948717949,295.532051282051,1422.24358974359,897.294871794872,261.75641025641,221.737179487179,974.179487179487,876.75641025641,208.589743589744,128.108974358974,593.74358974359,949.878205128205,440.153846153846,242.512820512821,1045.21153846154,128.794871794872,156,15.8273359735361,12.8704299543669,0.5820160802652,0.968944099378882,0.8,0.119076774431973,52743.9102564103,32756.7564102564,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_579195,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
579529,1351.63414634146,652.006097560976,70.9329268292683,671.84756097561,2127.74390243902,307.457317073171,630.94512195122,239.042682926829,1080.05487804878,2458.53048780488,4080.2987804878,147.756097560976,1070.7256097561,901.80487804878,700.59756097561,747.530487804878,1656.40853658537,1780.70731707317,299.512195121951,234.469512195122,1010.70731707317,1794.88414634146,231.560975609756,406.890243902439,613.80487804878,1165.05487804878,482.19512195122,581.896341463415,1078.59756097561,132.384146341463,164,16.3298714559064,12.8127417510168,0.619977134175486,0.947976878612717,0.732142857142857,0.986843061834805,53571.4207317073,33745.6341463415,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_579529,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
579591,1302.50996015936,145.513944223108,156.721115537849,697.97609561753,4475.50199203187,322.541832669323,314.07171314741,248.195219123506,1085.67729083665,2745.58167330677,555.09561752988,115.625498007968,1071.19521912351,751.621513944223,507.01593625498,277.972111553785,1617.50597609562,1130.52589641434,286.665338645418,225.868525896414,995.940239043825,1112.02788844622,222.135458167331,132.677290836653,596.442231075697,1356.78087649402,493.760956175299,241.278884462151,1031.29482071713,130.115537848606,251,19.6825085530426,16.3074365454639,0.559953114717426,0.954372623574144,0.777089783281734,0.436677689537636,53972.8685258964,33356.0996015936,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_579591,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
579605,1975.9107505071,139.036511156187,52.8093306288032,623.730223123732,1425.0060851927,582.630831643002,397.245436105477,271.752535496957,1138.97160243408,3891.40770791075,619.030425963489,123.896551724138,1075.74036511156,983.036511156187,529.113590263692,281.967545638945,1578.31237322515,962.336713995943,202.434077079108,211.04462474645,1162.47667342799,610.081135902637,131.557809330629,95.9411764705882,589.158215010142,1275.60851926978,447.610547667343,216.981744421907,1031.40162271805,129.738336713996,493,40.7391106954257,15.8128671553859,0.921596404666065,0.95357833655706,0.665317139001349,-1.28377004725928,53032.1764705882,32408.3935091278,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_579605,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
579642,2768.96564885496,152.793893129771,121.381679389313,657.301526717557,2411.37022900763,2639.61450381679,1205.67938931298,251.358778625954,1102.5572519084,4901.2786259542,544.446564885496,130.648854961832,1079.01145038168,2861.06106870229,669.06106870229,1531.07251908397,2785.97709923664,2017.50763358779,271.385496183206,224.423664122137,1027.41221374046,1673.70992366412,195.511450381679,307.675572519084,659.339694656489,1960.2786259542,492.25572519084,247.793893129771,1044.12977099237,129.763358778626,262,20.2208413597716,16.5322094774275,0.575811233825181,0.963235294117647,0.770588235294118,0.21291610990014,53178.5572519084,33879.8664122137,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_579642,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
580905,1324.55050505051,167.373737373737,72.2070707070707,640.272727272727,1076.26262626263,734.722222222222,1282.79292929293,252.893939393939,1082.39898989899,2395.08080808081,471.459595959596,123.282828282828,1073.5303030303,3997.76767676768,1238.85353535354,1798.68181818182,6068.10606060606,6939.57575757576,461.681818181818,258.30303030303,1051.69696969697,7512.0303030303,343.318181818182,204.510101010101,642.116161616162,1009.31313131313,430.409090909091,674.80303030303,1015.80808080808,130.50505050505,198,16.5831644259765,15.2378678764796,0.39454699452029,0.970588235294118,0.7734375,0.758118511391258,53161.696969697,33788.8080808081,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_580905,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
581120,651.901408450704,638.304225352113,184.940845070423,622.447887323944,78.3098591549296,715.152112676056,468.611267605634,293.507042253521,1147.38591549296,1732.71549295775,2718.14929577465,145.022535211268,1066.14929577465,1167.45915492958,644.343661971831,288.839436619718,1618.96056338028,1095.63661971831,220.887323943662,215.245070422535,1221.51830985915,626.704225352113,140.371830985915,94.9183098591549,581.721126760563,553.056338028169,324.966197183099,192.532394366197,981.332394366197,129.760563380282,355,24.7003412791601,18.3380245031125,0.669934859586523,0.964673913043478,0.778508771929825,1.45666842704218,52849.5887323944,32127.5436619718,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_581120,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
581707,3381.86823529412,629.945882352941,156.764705882353,678.0,4143.94117647059,1089.74823529412,2217.57176470588,252.098823529412,1091.08941176471,6305.24235294118,1530.82588235294,125.828235294118,1081.01176470588,2118.65882352941,1372.97882352941,1904.94117647059,2777.91294117647,3685.48235294118,330.350588235294,228.025882352941,1042.98588235294,3595.93411764706,268.651764705882,617.861176470588,743.517647058824,2297.82117647059,526.562352941176,312.364705882353,1058.01411764706,130.522352941176,425,29.1470678245083,18.6963925577358,0.767164674459191,0.961538461538462,0.710702341137124,0.546983808645822,53496.9811764706,33073.7317647059,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_581707,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
581825,2032.79329608938,247.178770949721,112.256983240223,642.631284916201,2026.69832402235,569.435754189944,485.653631284916,256.642458100559,1106.84357541899,4271.49162011173,694.162011173184,118.391061452514,1066.27374301676,945.162011173184,775.396648044693,288.905027932961,1939.22905027933,1281.45810055866,290.335195530726,237.357541899441,1067.16201117318,1103.54189944134,208.379888268156,248.13407821229,5222.16201117318,1873.18994413408,491.268156424581,323.284916201117,1060.87709497207,129.882681564246,179,17.0413577008744,13.7462336290311,0.591043642193173,0.913265306122449,0.701960784313725,1.434331411884,52728.7877094972,32944.8938547486,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_581825,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
581885,4228.12927756654,869.349809885932,154.292775665399,631.901140684411,1085.83269961977,371.885931558935,261.733840304183,234.847908745247,1073.65399239544,7488.09505703422,659.642585551331,125.342205323194,1069.61596958175,1272.69961977186,679.471482889734,281.06463878327,2879.26615969582,1937.73003802281,306.965779467681,238.67680608365,1008.39163498099,1988.30038022814,244.281368821293,226.863117870722,633.828897338403,2688.7072243346,539.182509505703,371.817490494297,1048.06844106464,131.121673003802,263,23.248243504283,15.0914505389069,0.760665808167195,0.932624113475177,0.695767195767196,0.588421429823119,52598.8821292776,33670.0760456274,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_581885,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
582315,3480.3711790393,256.550218340611,89.7248908296943,650.25327510917,1653.01310043668,576.078602620087,327.427947598253,249.580786026201,1072.72489082969,5373.71615720524,1446.40611353712,139.528384279476,1106.0,793.471615720524,545.266375545851,322.655021834061,1956.91703056769,1225.50218340611,332.441048034935,236.899563318777,999.676855895196,1143.05240174672,234.144104803493,179.397379912664,587.227074235808,1505.96943231441,523.615720524017,708.633187772926,1054.80786026201,129.799126637555,229,22.8431092151674,12.8309380339373,0.827342069951792,0.954166666666667,0.765886287625418,-1.55609056413157,53111.7641921397,33919.5895196507,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_582315,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
582518,1623.84173669468,387.327731092437,184.306722689076,677.68487394958,3405.31652661064,589.840336134454,351.801120448179,268.378151260504,1112.58263305322,2076.18207282913,1036.86834733894,149.649859943978,1069.87394957983,830.670868347339,597.406162464986,553.044817927171,1559.92156862745,1802.3837535014,296.759103641457,226.854341736695,1019.91596638655,1793.21988795518,224.21568627451,518.450980392157,826.97619047619,842.960784313726,419.535014005602,231.46218487395,1047.31092436975,129.180672268908,714,48.4769475449112,18.8840175460148,0.921006866478355,0.96617050067659,0.782894736842105,1.50427690523599,52908.8669467787,32446.4089635854,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_582518,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
583436,3262.3115727003,638.780415430267,712.86646884273,622.121661721068,710.091988130564,392.569732937685,444.228486646884,245.896142433234,1084.87537091988,6080.43026706231,560.679525222552,117.430267062315,1073.69732937685,658.522255192878,479.06528189911,273.056379821958,1404.14243323442,1067.55786350148,288.433234421365,229.258160237389,996.017804154303,999.548961424332,219.080118694362,142.293768545994,584.780415430267,1730.94362017804,497.872403560831,270.394658753709,1055.77151335312,130.181008902077,337,23.0348924562288,18.8763504049464,0.573125365078588,0.962857142857143,0.764172335600907,0.745823876184819,53104.8486646884,33314.7596439169,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_583436,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
584526,1892.47260273973,142.246575342466,87.7397260273973,652.328767123288,2898.34931506849,305.5,412.739726027397,263.671232876712,1085.05479452055,2901.61643835616,656.047945205479,118.520547945205,1069.35616438356,612.328767123288,433.534246575342,268.568493150685,1390.38356164384,1059.01369863014,298.212328767123,230.767123287671,991.075342465754,1051.08219178082,230.698630136986,129.527397260274,590.349315068493,1065.50684931507,464.472602739726,275.006849315069,1031.81506849315,129.034246575342,146,18.8464203936305,9.88727499280787,0.851334355752032,0.935897435897436,0.715686274509804,-0.426258006614518,52844.2534246575,32746.6849315069,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_584526,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
585346,2985.79881656805,244.988165680473,314.573964497041,766.147928994083,8524.30769230769,1562.04733727811,1129.26035502959,245.674556213018,1087.67455621302,4460.72189349112,531.059171597633,127.023668639053,1069.39644970414,5506.27810650888,798.325443786982,489.266272189349,3056.14792899408,7352.98816568047,494.822485207101,250.674556213018,1087.26035502959,7218.43786982248,290.337278106509,258.207100591716,599.01775147929,1351.37278106509,483.041420118343,310.325443786982,1052.2899408284,128.970414201183,169,27.8116056271689,7.81388509927753,0.959720148668443,0.903743315508021,0.65,1.36216950813173,53739.1301775148,33607.5562130177,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_585346,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
585520,2868.32635983264,622.305439330544,114.510460251046,654.912133891213,1452.93723849372,3126.54811715481,436.087866108787,261.163179916318,1161.77824267782,3986.24267782427,628.652719665272,116.912133891213,1117.41422594142,1226.19665271967,568.878661087866,290.405857740586,1565.41422594142,1300.89121338912,283.619246861925,229.945606694561,999.062761506276,1066.49372384937,214.430962343096,138.188284518828,588.924686192469,1227.07112970711,476.836820083682,489.443514644351,1032.10460251046,130.983263598326,239,20.6947847561987,14.7594818142466,0.70096249943606,0.952191235059761,0.758730158730159,0.167363717727273,53985.7782426778,33394.2133891213,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_585520,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
585697,2027.93805309734,188.654867256637,76.4955752212389,618.929203539823,692.70796460177,736.433628318584,1109.8407079646,250.575221238938,1089.2389380531,2636.58407079646,557.513274336283,130.840707964602,1069.04424778761,1067.80530973451,709.991150442478,484.265486725664,1684.50442477876,1461.19469026549,331.805309734513,234.522123893805,1012.85840707965,1366.77876106195,236.495575221239,164.176991150442,595.716814159292,1028.03539823009,509.398230088496,268.752212389381,1032.20353982301,128.212389380531,113,13.138871522831,10.9588549570673,0.551645228744646,0.965811965811966,0.79020979020979,1.232207754163,53133.8761061947,33733.0884955752,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_585697,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
586603,1953.1202346041,345.052785923754,86.0117302052786,632.005865102639,1355.73900293255,814.598240469208,1458.07038123167,260.741935483871,1100.57478005865,3795.27565982405,1331.7008797654,120.33137829912,1079.357771261,1955.75659824047,958.492668621701,2337.48680351906,1897.38123167155,1738.13782991202,290.448680351906,224.900293255132,1037.80351906158,974.718475073314,187.935483870968,284.492668621701,675.073313782991,1106.85923753666,445.384164222874,357.762463343108,1050.00586510264,130.296187683284,341,24.474263091643,17.9718841439444,0.67880596770526,0.96875,0.872122762148338,1.38100361478614,52403.9002932551,32541.0527859238,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_586603,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
586902,4885.13888888889,1344.49691358025,344.641975308642,645.166666666667,1076.47222222222,1019.22222222222,1083.4475308642,233.990740740741,1077.83641975309,6315.43209876543,1999.57716049383,127.811728395062,1076.45679012346,640.003086419753,398.333333333333,368.672839506173,1449.27469135802,946.836419753086,252.45987654321,221.163580246914,990.138888888889,861.793209876543,190.231481481481,165.898148148148,582.333333333333,1397.50308641975,495.021604938272,503.95987654321,1060.71913580247,131.157407407407,324,25.2467054923358,16.3931787980553,0.760515716790091,0.955752212389381,0.72,0.205496177184207,53275.1388888889,33583.1049382716,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_586902,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
588450,1541.36783733826,484.081330868762,114.946395563771,641.658040665434,913.576709796673,771.639556377079,322.654343807763,255.484288354898,1079.98706099815,2031.51386321627,1336.96303142329,133.218114602588,1064.82070240296,599.624768946396,444.1146025878,267.837338262477,1383.39741219963,906.966728280961,264.203327171904,220.940850277264,978.070240295749,878.556377079482,199.804066543438,119.081330868762,589.362292051756,687.118299445471,381.534195933456,214.456561922366,1007.80776340111,130.157116451017,541,30.3357066828113,23.1089719242481,0.647842113124729,0.971274685816876,0.784057971014493,-0.0591808865927941,53090.3234750462,32671.8003696858,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_588450,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
588463,1206.01104972376,513.430939226519,190.425414364641,649.453038674033,1961.44198895028,4359.34254143646,481.508287292818,259.569060773481,1130.6408839779,2458.46961325967,1278.40883977901,126.972375690608,1073.24861878453,3865.82872928177,758.640883977901,414.53591160221,2124.9226519337,5118.88397790055,398.502762430939,241.154696132597,1058.06629834254,3387.53591160221,235.812154696133,326.276243093923,606.740331491713,1337.66298342541,473.348066298342,415.270718232044,1047.11602209945,129.806629834254,181,17.0928967136279,13.5246734779359,0.611498929656402,0.952631578947368,0.754166666666667,0.542557904803565,53531.0386740332,33764.3591160221,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_588463,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
589417,2496.504,290.584,111.56,624.168,1246.696,1753.816,380.928,269.688,1123.192,4171.256,1012.208,122.008,1089.496,621.96,381.824,269.688,1415.016,762.672,170.232,202.168,1015.304,630.712,133.176,108.0,595.576,1506.464,500.968,273.872,1047.392,128.896,125,18.1408299906425,8.92239694536196,0.87068525384993,0.925925925925926,0.668449197860963,-0.458414239655937,53921.288,32730.624,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_589417,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
589784,1434.50149253731,182.080597014925,176.385074626866,718.09552238806,5315.26865671642,308.325373134328,286.55223880597,251.253731343284,1079.68358208955,2419.66865671642,696.788059701493,123.605970149254,1072.45671641791,696.050746268657,453.268656716418,272.841791044776,1422.75223880597,1054.67462686567,285.167164179104,228.817910447761,993.797014925373,997.44776119403,216.638805970149,130.913432835821,587.740298507463,909.020895522388,458.620895522388,628.949253731343,1032.42686567164,131.561194029851,335,30.8885505612583,13.8555372176347,0.893749975449094,0.938375350140056,0.613553113553114,0.978240904245195,53449.471641791,33270.1492537313,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_589784,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
589948,2134.38596491228,292.666666666667,48.5087719298246,606.719298245614,549.789473684211,2845.24561403509,3054.42105263158,272.631578947368,1103.41228070175,3382.20175438596,570.377192982456,129.245614035088,1074.14035087719,1011.84210526316,576.736842105263,501.684210526316,2001.31578947368,1374.44736842105,347.850877192982,239.026315789474,1013.78070175439,1523.66666666667,248.464912280702,329.780701754386,621.666666666667,1471.0701754386,534.991228070175,388.728070175439,1044.56140350877,129.947368421053,114,13.3188842512851,11.1394417387778,0.548173742394295,0.942148760330578,0.674556213017751,0.768269075374968,53372.8859649123,33856.3684210526,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_589948,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
590003,2358.79310344828,138.393103448276,61.0724137931035,612.81724137931,451.244827586207,299.624137931035,305.641379310345,255.386206896552,1075.92413793103,3565.97931034483,787.775862068965,122.475862068966,1068.18965517241,567.751724137931,398.393103448276,266.920689655172,1385.76551724138,819.479310344828,226.279310344828,216.393103448276,975.055172413793,636.931034482759,135.896551724138,126.831034482759,584.448275862069,1372.0,576.789655172414,382.855172413793,1057.23103448276,132.968965517241,290,21.6030749251014,17.1433279620378,0.608492503679225,0.953947368421053,0.732323232323232,-1.42159235277135,53079.4,32996.175862069,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_590003,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
590140,1817.35802469136,71.3744855967078,53.5102880658436,626.337448559671,888.740740740741,1881.2304526749,296.905349794239,258.255144032922,1086.670781893,3525.8683127572,740.288065843621,123.139917695473,1072.36625514403,943.814814814815,542.102880658436,262.106995884774,1543.61728395062,1011.35802469136,257.238683127572,217.489711934156,983.518518518518,946.802469135802,191.057613168724,131.9670781893,586.934156378601,1075.1975308642,465.456790123457,255.181069958848,1030.62962962963,131.333333333333,243,30.8126449112274,10.220983243394,0.943380026802482,0.910112359550562,0.644562334217507,-1.37705458912113,53790.2674897119,32588.0534979424,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_590140,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
590718,3616.26296296296,578.640740740741,1511.6037037037,637.855555555556,1376.08518518519,336.4,261.17037037037,227.681481481481,1072.22222222222,5269.44814814815,1024.08148148148,119.566666666667,1083.05925925926,500.362962962963,339.640740740741,262.7,1554.62962962963,1010.13333333333,225.318518518518,213.737037037037,1009.22222222222,851.859259259259,182.344444444444,162.17037037037,590.633333333333,1062.21851851852,464.474074074074,533.918518518519,1043.46296296296,130.614814814815,270,21.5140409754324,16.1976112915496,0.658151425034977,0.957446808510638,0.714285714285714,-1.17560007577843,53400.8666666667,33411.162962963,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_590718,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
590975,2387.30878186969,384.815864022663,82.9206798866855,660.628895184136,1936.96600566572,1263.26345609065,3117.6402266289,262.396600566572,1098.92634560907,3931.09065155807,1416.24079320113,125.694050991501,1076.4164305949,2548.65722379603,1098.73087818697,1634.24079320113,1756.94617563739,1581.03682719547,255.257790368272,221.903682719547,996.589235127479,994.742209631728,186.311614730878,259.223796033994,628.226628895184,1233.57507082153,549.56940509915,293.416430594901,1091.04532577904,135.524079320113,353,26.2977038490295,17.2986506380977,0.753191945732952,0.956639566395664,0.754273504273504,-0.287280703677848,52398.9915014164,33300.3201133144,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_590975,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
591021,3724.81048387097,241.552419354839,71.6048387096774,624.008064516129,1160.57258064516,2396.01209677419,978.907258064516,248.008064516129,1092.61290322581,6637.49193548387,566.524193548387,118.883064516129,1095.6814516129,807.713709677419,567.467741935484,839.193548387097,1524.05241935484,1235.42338709677,331.306451612903,242.701612903226,1000.75806451613,1182.08870967742,242.927419354839,164.326612903226,594.697580645161,2471.64919354839,525.822580645161,267.254032258065,1044.09274193548,128.689516129032,248,23.3772905846253,14.173352413486,0.795245755960492,0.895306859205776,0.621553884711779,0.559624586614957,53691.0483870968,33502.7459677419,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_591021,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
591151,2876.73346693387,293.793587174349,98.7775551102204,612.124248496994,642.617234468938,1341.77354709419,305.599198396794,251.400801603206,1087.83166332665,4053.28456913828,513.703406813627,116.561122244489,1067.32865731463,1050.90981963928,468.158316633267,268.825651302605,1492.625250501,1011.98396793587,240.312625250501,216.332665330661,981.206412825651,954.094188376754,187.462925851703,126.96993987976,581.044088176353,841.589178356713,453.967935871743,221.460921843687,1009.39078156313,129.072144288577,499,26.5424188953903,23.9813726399208,0.428564486127576,0.968932038834952,0.767692307692308,-0.82482922744006,53919.0661322645,33079.0140280561,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_591151,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
591268,1421.82278481013,261.107594936709,62.2784810126582,616.063291139241,622.759493670886,3569.93037974684,752.860759493671,263.284810126582,1112.32911392405,2444.87974683544,1178.27848101266,108.683544303797,1069.89873417722,2566.06962025316,725.70253164557,493.23417721519,6058.08227848101,3262.32278481013,385.398734177215,243.689873417722,1059.05063291139,2646.08227848101,238.76582278481,293.278481012658,702.341772151899,870.196202531646,435.873417721519,327.012658227848,1038.49367088608,128.481012658228,158,18.3308384595549,11.2608539412724,0.789063224963271,0.946107784431138,0.663865546218487,1.08808301590087,52800.1582278481,33568.0632911392,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_591268,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
591360,3103.44162436548,233.279187817259,79.0964467005076,634.918781725888,1673.42639593909,334.142131979695,873.10152284264,243.060913705584,1080.07614213198,5314.36040609137,993.89847715736,121.715736040609,1067.84263959391,815.873096446701,539.878172588833,342.624365482233,1639.63959390863,2872.27411167513,304.48730964467,221.725888324873,988.593908629442,3016.06091370558,216.705583756345,156.020304568528,592.416243654822,1633.32994923858,497.761421319797,352.355329949239,1046.95939086294,128.761421319797,197,23.8685065517381,10.5663665280021,0.896674366673611,0.951690821256039,0.579411764705882,0.905633158597796,53927.2233502538,32878.0050761421,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_591360,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
591479,2894.75595238095,465.339285714286,106.125,615.184523809524,641.625,1685.71428571429,1669.125,561.815476190476,1122.07142857143,5390.91666666667,1243.76785714286,119.47619047619,1066.58333333333,2129.41666666667,1988.80357142857,1873.42261904762,2077.18452380952,2400.6369047619,352.529761904762,235.196428571429,1052.8869047619,1417.0119047619,236.327380952381,1022.6369047619,942.511904761905,1549.06547619048,463.107142857143,300.482142857143,1061.6369047619,132.029761904762,168,16.6857992564277,13.6777033169609,0.572762744416667,0.879581151832461,0.717948717948718,-0.413239916132531,52813.755952381,32792.9583333333,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_591479,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
592398,4317.0,685.862595419847,122.564885496183,642.858778625954,1407.7213740458,273.18320610687,311.977099236641,254.034351145038,1084.28244274809,6738.92366412214,878.961832061069,134.18320610687,1079.51526717557,790.706106870229,1019.28244274809,285.770992366412,1498.56488549618,1096.69083969466,311.164122137405,232.896946564885,993.053435114504,1005.45038167939,233.324427480916,140.034351145038,609.450381679389,1504.53435114504,460.942748091603,262.442748091603,1047.52290076336,131.595419847328,262,19.4476843703375,17.3636262070838,0.450378510332128,0.932384341637011,0.689473684210526,1.2400614300402,52567.5534351145,32311.5114503817,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_592398,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
592844,3387.20581655481,273.418344519016,103.190156599553,627.252796420582,560.633109619687,2406.84563758389,2051.90156599553,251.832214765101,1090.58389261745,4375.08501118568,2150.47427293065,125.633109619687,5611.91946308725,1338.74272930649,656.302013422819,832.082774049217,1659.62639821029,1412.01789709172,300.03355704698,229.901565995526,1022.36912751678,1403.8322147651,223.422818791946,312.21029082774,645.642058165548,1002.79194630872,450.651006711409,467.955257270693,1037.27293064877,131.731543624161,447,24.8196193954248,23.0571692870875,0.370105726479692,0.953091684434968,0.745,1.14830156403118,53346.5704697987,33685.1073825503,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX+,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_592844,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
592912,5927.59842519685,563.417322834646,137.417322834646,644.314960629921,2484.12992125984,3313.49212598425,676.224409448819,252.610236220472,1106.13385826772,8377.71653543307,700.488188976378,126.192913385827,1175.3031496063,2033.96456692913,716.893700787402,285.681102362205,1926.31496062992,2154.83858267717,288.88188976378,225.429133858268,1046.85433070866,1755.46062992126,203.787401574803,182.53937007874,2553.31102362205,1971.10236220472,526.38188976378,284.913385826772,1041.38188976378,130.413385826772,254,23.5179528900168,13.8800319654438,0.807265261171879,0.951310861423221,0.721590909090909,1.25146662249532,53951.8818897638,33475.1496062992,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_592912,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
592948,3953.99610894942,432.92607003891,197.019455252918,691.400778210117,4463.10894941634,310.544747081712,293.976653696498,246.544747081712,1087.62256809339,4973.29961089494,629.221789883268,126.43579766537,1090.19844357977,751.630350194553,488.31906614786,267.56420233463,1405.88715953307,1106.56420233463,274.392996108949,221.124513618677,984.073929961089,995.649805447471,207.299610894942,129.412451361868,654.494163424125,1397.85214007782,514.673151750973,245.692607003891,1062.80544747082,130.95719844358,257,21.4162705568876,15.3257113577895,0.698499386778245,0.931159420289855,0.687165775401069,-0.12903327698712,53681.8638132296,33223.8093385214,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_592948,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
593050,2756.76102941176,628.992647058824,95.3529411764706,657.411764705882,2064.58823529412,1200.84926470588,324.301470588235,254.393382352941,1093.61397058824,4644.77205882353,2633.36764705882,126.198529411765,1080.91176470588,3489.6875,655.297794117647,330.014705882353,1741.76102941176,3462.72794117647,361.845588235294,235.036764705882,1017.56617647059,2250.98529411765,219.66544117647,235.10294117647,755.503676470588,1161.56617647059,477.022058823529,456.014705882353,1044.51470588235,131.1875,272,26.2775516578143,14.2112632110693,0.841142322801959,0.866242038216561,0.622425629290618,-0.489856062070905,52878.9779411765,33385.1470588235,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_593050,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
594786,3458.57421875,370.6875,119.578125,664.23046875,2838.65625,850.79296875,313.95703125,238.24609375,1083.3359375,5491.3359375,502.12109375,130.49609375,1071.8359375,885.8125,709.61328125,509.359375,1707.35546875,1656.78515625,422.38671875,236.63671875,1016.28125,1417.48046875,259.7734375,608.80859375,590.16796875,1694.140625,486.32421875,244.953125,1055.3203125,128.8125,256,23.0701230360789,14.1667538036968,0.789248755395194,0.966037735849057,0.677248677248677,0.954095959199736,53660.76953125,33815.453125,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_594786,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
595516,1271.64522417154,185.639376218324,103.824561403509,635.51656920078,1821.93177387914,954.362573099415,1285.9044834308,242.167641325536,1079.05847953216,2096.15009746589,513.58089668616,116.387914230019,1083.31578947368,635.937621832359,448.797270955166,274.282651072125,1508.92397660819,957.962962962963,254.820662768031,222.522417153996,983.98440545809,852.09746588694,196.658869395711,148.937621832359,585.456140350877,887.945419103314,494.237816764133,224.896686159844,1030.0350877193,130.423001949318,513,31.9051689977734,20.7176972695768,0.760487667772272,0.955307262569832,0.728693181818182,-0.170037503112721,52374.3138401559,33300.9259259259,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_595516,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
595653,1091.903930131,234.46288209607,61.0524017467249,610.183406113537,689.344978165939,1948.18777292576,751.017467248908,257.519650655022,1092.10480349345,2380.62445414847,648.048034934498,116.200873362445,1070.51528384279,960.480349344978,803.74672489083,333.554585152838,1794.67248908297,929.82096069869,230.227074235808,214.742358078603,995.135371179039,802.375545851528,173.135371179039,137.013100436681,621.436681222707,944.275109170306,427.755458515284,218.323144104804,1032.48034934498,129.589519650655,229,21.5512914430877,13.8235298295827,0.767186028923888,0.938524590163934,0.726984126984127,1.39595197953844,52691.519650655,32512.9475982533,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_595653,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
596013,4127.70769230769,1193.98974358974,1094.70769230769,630.238461538462,773.407692307692,512.871794871795,1914.32307692308,245.566666666667,1078.28461538462,5463.18205128205,903.258974358974,121.161538461538,1104.7,760.812820512821,643.117948717949,416.448717948718,1482.30256410256,1110.21794871795,307.330769230769,229.838461538462,1002.56666666667,1000.42307692308,230.028205128205,167.494871794872,604.741025641026,1203.57692307692,509.533333333333,470.538461538462,1039.93076923077,130.046153846154,390,24.608052155396,20.3449155881166,0.562557045729795,0.965346534653465,0.738636363636364,1.04238237451263,53298.6282051282,33534.6128205128,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_596013,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
596357,2733.3407079646,499.672566371681,225.230088495575,673.769911504425,3892.50884955752,344.044247787611,333.87610619469,259.269911504425,1083.05309734513,5129.70796460177,568.230088495575,135.672566371681,1070.38938053097,1023.72566371681,578.508849557522,473.884955752212,1501.03097345133,1960.44247787611,324.137168141593,229.190265486726,989.898230088496,2576.23008849558,235.570796460177,570.03982300885,686.473451327434,2412.21238938053,573.548672566372,237.119469026549,1051.47345132743,131.092920353982,226,26.328808645707,10.9820922406317,0.908854566085069,0.941666666666667,0.695384615384615,1.31800335061289,53307.7389380531,32859.4336283186,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_596357,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
597030,5194.2578125,908.9765625,1173.375,643.1015625,1918.2265625,1914.859375,473.3671875,258.9140625,1101.0859375,7305.8359375,566.921875,147.6953125,1083.3203125,2475.7265625,587.53125,438.4375,1891.625,4495.3203125,411.90625,246.3515625,1040.828125,3362.625,267.8515625,202.2109375,593.65625,1773.1484375,548.59375,291.9140625,1058.0546875,130.203125,128,17.4180069529219,9.68506756754769,0.831157107464345,0.914285714285714,0.60952380952381,0.836330378148878,53496.125,33812.5625,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_597030,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
597149,2538.48636363636,219.365909090909,101.993181818182,670.913636363636,3028.77045454545,1189.65909090909,1073.69090909091,241.809090909091,1120.29772727273,3828.1,564.215909090909,132.409090909091,1078.78636363636,2670.21136363636,663.95,478.570454545455,1850.87727272727,3174.65909090909,324.563636363636,231.0,1020.45227272727,2825.49772727273,257.520454545455,284.095454545455,601.229545454545,1167.57045454545,495.215909090909,726.977272727273,1041.57272727273,129.052272727273,440,26.0441463691275,21.790623737715,0.547691614985007,0.956521739130435,0.735785953177257,1.286153935929,53700.0681818182,33787.0659090909,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_597149,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
598230,2939.70769230769,999.28717948718,120.635897435897,630.528205128205,1367.23076923077,1654.08205128205,316.733333333333,252.282051282051,1109.34871794872,4611.74871794872,642.769230769231,124.194871794872,1075.72820512821,1531.70256410256,433.266666666667,271.738461538462,1488.32307692308,1518.53846153846,203.384615384615,211.748717948718,1022.05641025641,1309.80512820513,163.830769230769,478.564102564103,1150.0,1719.78974358974,540.764102564103,268.676923076923,1046.03076923077,132.764102564103,195,17.7835589454984,14.5412648792731,0.575672661252811,0.902777777777778,0.637254901960784,1.42826814796794,53197.6461538462,33204.4,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_598230,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
599154,611.59067357513,250.352331606218,135.715025906736,654.974093264249,3169.13471502591,510.782383419689,709.823834196891,269.683937823834,1092.53886010363,1119.35233160622,1190.07772020725,123.829015544041,1067.33678756477,886.533678756477,607.891191709845,486.559585492228,1432.99481865285,1218.31088082902,318.435233160622,226.575129533679,990.373056994819,1087.67875647668,222.829015544041,134.963730569948,606.108808290155,959.284974093264,508.507772020725,351.544041450777,1048.90155440415,127.559585492228,193,16.1935273971428,15.1772885820968,0.348673817379833,0.969849246231156,0.75390625,-1.105521103587,53207.3471502591,32868.8238341969,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_599154,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
599274,2741.75418994413,396.888268156425,168.824022346369,675.54469273743,3168.02793296089,351.994413407821,360.248603351955,244.192737430168,1076.67597765363,4038.98882681564,1169.95251396648,124.966480446927,1105.10335195531,731.178770949721,493.399441340782,314.561452513966,1562.19273743017,1032.19273743017,274.821229050279,232.315642458101,986.935754189944,937.460893854749,208.662011173184,163.131284916201,589.91061452514,927.08938547486,441.871508379888,359.282122905028,1106.04469273743,130.988826815642,358,24.7200784271046,18.7962990151577,0.649495224529863,0.954666666666667,0.71031746031746,-1.09503058767936,53175.9916201117,33573.5335195531,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_599274,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
599390,2378.02083333333,183.151041666667,96.6458333333333,654.901041666667,2932.625,2234.41666666667,457.427083333333,254.020833333333,1085.95833333333,4355.0,476.697916666667,134.145833333333,1082.23958333333,6159.36979166667,838.572916666667,825.921875,5009.48958333333,5650.61458333333,473.822916666667,254.203125,1044.61979166667,3718.69791666667,258.744791666667,1495.96354166667,965.041666666667,1836.78125,506.328125,235.239583333333,1059.921875,130.760416666667,192,25.8625290288221,9.53175842235962,0.929606035883662,0.932038834951456,0.698181818181818,1.45046473768303,52892.7447916667,33829.359375,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_599390,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
599422,2479.77900552486,429.077348066298,79.7348066298343,643.779005524862,1883.70165745856,2263.19337016575,377.651933701658,249.75138121547,1102.96132596685,5429.49171270718,520.353591160221,121.21546961326,1130.25414364641,3497.34806629834,555.502762430939,315.331491712707,1922.50828729282,3504.50276243094,396.348066298342,235.872928176796,1065.86187845304,2344.60773480663,228.331491712707,214.961325966851,1130.04972375691,1799.7955801105,495.193370165746,263.546961325967,1055.63535911602,131.651933701657,181,16.7959918676345,13.8346368011779,0.567045020107752,0.957671957671958,0.754166666666667,-0.864895710466078,53969.7071823204,33471.5359116022,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_599422,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
599948,2168.94607843137,112.588235294118,67.906862745098,617.794117647059,1152.77941176471,258.098039215686,278.039215686275,251.200980392157,1069.81862745098,3970.82843137255,835.039215686274,117.299019607843,1074.80392156863,594.06862745098,516.622549019608,268.882352941176,1459.5931372549,944.274509803922,266.455882352941,221.700980392157,991.112745098039,872.28431372549,198.450980392157,141.867647058824,589.328431372549,1361.75,480.539215686274,337.5,1070.36764705882,129.5,204,21.0439035643311,12.7061981523651,0.79713983675515,0.935779816513762,0.747252747252747,-1.33716177062655,52913.3431372549,32700.2009803922,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_599948,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
600370,2920.25,558.207317073171,115.576219512195,643.594512195122,2079.98475609756,285.231707317073,304.920731707317,251.478658536585,1089.23170731707,5768.36280487805,1284.44512195122,121.725609756098,1074.91158536585,681.131097560976,499.55487804878,278.762195121951,1373.05487804878,1049.65243902439,276.314024390244,224.131097560976,975.25,962.692073170732,209.131097560976,122.728658536585,579.164634146341,1870.53963414634,510.640243902439,507.161585365854,1072.06402439024,129.524390243902,328,22.5159374453941,18.5773258162407,0.565023955636163,0.95906432748538,0.743764172335601,0.546310410107414,54076.1036585366,33180.0914634146,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_600370,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
601260,1642.19871794872,693.5,71.4615384615385,639.570512820513,1246.5,381.948717948718,383.333333333333,248.634615384615,1082.32051282051,3391.25641025641,1197.58974358974,112.378205128205,1080.82692307692,1134.94871794872,612.205128205128,572.141025641026,1729.63461538462,1609.89102564103,299.557692307692,231.025641025641,1012.30128205128,1502.41666666667,224.884615384615,346.115384615385,603.038461538462,1757.48076923077,532.570512820513,355.211538461538,1051.6858974359,130.474358974359,156,15.8435595456209,12.6122845217914,0.605229290177173,0.951219512195122,0.742857142857143,0.93883857360789,53675.5512820513,33468.9615384615,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_601260,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
601463,486.94696969697,1076.70454545455,262.431818181818,633.689393939394,557.670454545455,810.0,489.587121212121,282.117424242424,1143.07196969697,1059.31818181818,676.920454545455,113.299242424242,1065.11742424242,1270.02651515152,553.015151515152,270.026515151515,1666.40151515152,1339.17045454545,272.723484848485,221.030303030303,1013.56818181818,1047.63257575758,193.424242424242,215.337121212121,1262.10984848485,630.458333333333,377.598484848485,211.545454545455,1003.86742424242,129.590909090909,264,19.5893845732828,17.2538851804885,0.473530732197823,0.949640287769784,0.776470588235294,-1.43417477202987,53738.4015151515,32700.4204545455,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_601463,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
603467,2138.83585858586,665.10101010101,220.007575757576,668.368686868687,3479.28282828283,249.929292929293,259.171717171717,250.002525252525,1079.88131313131,3874.62121212121,953.368686868687,131.030303030303,1073.55303030303,571.598484848485,440.888888888889,258.780303030303,1400.00757575758,864.787878787879,244.368686868687,214.234848484848,977.176767676768,800.936868686869,181.126262626263,114.487373737374,582.984848484848,859.449494949495,442.848484848485,247.353535353535,1031.74747474747,129.527777777778,396,31.365126336588,16.3704374124972,0.852987598337779,0.942857142857143,0.63768115942029,-0.981152859067344,53853.7272727273,32581.9671717172,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_603467,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
604249,1941.12244897959,650.418367346939,231.484693877551,619.765306122449,796.326530612245,2229.61224489796,396.627551020408,257.260204081633,1100.23469387755,3578.08673469388,464.933673469388,113.744897959184,1074.35204081633,3151.27551020408,600.418367346939,309.071428571429,1649.29591836735,2775.94897959184,332.969387755102,233.979591836735,1017.42346938776,1885.94387755102,228.275510204082,289.775510204082,577.265306122449,1323.10204081633,466.908163265306,240.551020408163,1037.6887755102,130.479591836735,196,17.2175692557342,14.6642458696256,0.524025706874256,0.946859903381642,0.768627450980392,0.223617184761614,52986.137755102,33446.3469387755,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_604249,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
604532,1416.86451612903,125.512903225806,70.8322580645161,615.064516129032,773.796774193548,549.770967741935,785.703225806452,247.874193548387,1082.18709677419,3094.71935483871,433.858064516129,111.351612903226,1080.35806451613,853.793548387097,450.88064516129,353.341935483871,1447.80967741935,1633.28709677419,276.01935483871,281.183870967742,991.696774193548,1602.0935483871,209.241935483871,290.835483870968,607.441935483871,1110.9,461.961290322581,222.622580645161,1031.94516129032,128.606451612903,310,20.7657205362773,19.1593308826382,0.385656971246122,0.965732087227414,0.776942355889724,-1.39171725805123,53926.2451612903,32995.8,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_604532,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
605021,1129.14285714286,228.136054421769,107.748299319728,647.421768707483,1948.26530612245,250.489795918367,504.918367346939,251.544217687075,1077.04081632653,2022.13605442177,667.278911564626,113.972789115646,1068.80272108844,579.91156462585,606.095238095238,290.387755102041,1507.48299319728,1005.92517006803,250.65306122449,214.945578231293,1017.31292517007,835.0,166.78231292517,285.897959183673,612.802721088435,816.52380952381,387.605442176871,219.87074829932,1030.48979591837,129.673469387755,147,15.4483950326377,12.2514972534163,0.609144109373336,0.942307692307692,0.753846153846154,-0.456292665076397,53264.0068027211,32124.8095238095,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_605021,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
605735,930.917355371901,258.851239669421,94.1239669421488,635.322314049587,1707.3305785124,1257.46280991736,449.446280991736,283.02479338843,1110.19834710744,1864.55371900826,785.363636363636,122.115702479339,1057.12396694215,858.074380165289,539.677685950413,300.462809917355,1551.0,959.859504132232,248.123966942149,221.115702479339,1018.34710743802,727.01652892562,173.03305785124,187.727272727273,614.512396694215,792.115702479339,435.173553719008,248.272727272727,1025.55371900826,131.297520661157,121,13.849366117128,11.1343873387966,0.59467840254036,0.9453125,0.720238095238095,0.487433336556039,52426.4628099174,32863.7272727273,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_605735,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
606028,2258.16,118.085714285714,62.7828571428571,625.142857142857,1193.02571428571,386.511428571429,1192.77142857143,343.882857142857,1097.66,3875.01142857143,511.034285714286,117.78,1067.13714285714,766.837142857143,530.02,309.557142857143,1541.97142857143,1245.58285714286,273.594285714286,221.517142857143,987.128571428571,1090.45714285714,196.094285714286,128.234285714286,595.531428571429,1198.44285714286,447.3,229.12,1030.57428571429,129.594285714286,350,25.6748112203271,17.7441560205662,0.722748201769851,0.958904109589041,0.736842105263158,-0.466036745800543,52845.2542857143,32768.9971428571,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_606028,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
606177,1407.935,460.275,124.665,631.28,1536.285,937.84,350.055,260.03,1112.81,2314.205,1733.885,120.34,1064.09,572.265,350.65,263.97,1446.46,750.29,172.085,201.875,1020.57,633.61,134.265,112.125,596.885,1087.87,481.87,488.305,1019.685,129.645,200,22.0712573657705,11.9644138299342,0.840326106437485,0.91743119266055,0.666666666666667,-1.15824372455231,53903.6,32740.795,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_606177,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
606395,4919.42105263158,1351.98564593301,176.464114832536,650.808612440191,2152.52631578947,232.244019138756,215.033492822967,220.138755980861,1066.34449760766,6368.69377990431,568.803827751196,134.387559808612,1087.1004784689,1947.22488038278,684.66985645933,295.784688995215,2017.71291866029,6766.91387559809,435.66985645933,250.913875598086,1039.65550239234,5776.88516746411,272.684210526316,214.822966507177,608.052631578947,1144.77033492823,499.684210526316,276.574162679426,1032.12918660287,130.148325358852,209,18.7735868284006,14.3545534420385,0.644488116461929,0.967592592592593,0.774074074074074,-0.500883103489077,53207.2631578947,33485.6267942584,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_606395,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
606676,2887.58870967742,627.413306451613,89.0987903225806,627.790322580645,1214.31048387097,2671.1814516129,656.441532258065,263.673387096774,1139.30040322581,4087.92540322581,1041.88508064516,131.711693548387,1069.19153225806,4016.53024193548,1001.42943548387,1265.21572580645,5545.48991935484,4723.17741935484,416.818548387097,245.112903225806,1118.83467741935,3829.66330645161,335.897177419355,377.006048387097,699.516129032258,1075.53830645161,475.639112903226,573.534274193548,1042.05241935484,130.161290322581,496,27.037791106176,23.4180758863195,0.499829437250515,0.966861598440546,0.734814814814815,0.952857896794058,53260.0463709677,33830.7580645161,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_606676,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
606751,1139.39097744361,245.59649122807,87.1503759398496,626.072681704261,1572.29323308271,1567.70927318296,475.431077694236,262.431077694236,1162.39598997494,2525.47117794486,1945.32330827068,110.927318295739,1069.87468671679,3696.45112781955,829.46365914787,302.874686716792,1522.08521303258,2170.81453634085,283.929824561404,222.531328320802,996.674185463659,1332.19047619048,246.621553884712,154.461152882206,605.832080200501,1162.44611528822,467.395989974937,394.586466165414,1040.93483709273,129.09022556391,399,30.1110518697018,17.2497878825269,0.81964462717688,0.959134615384615,0.724137931034483,-0.33140366656628,54152.7619047619,32929.7218045113,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_606751,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
607005,5103.73148148148,1112.21913580247,136.981481481481,643.305555555556,1880.96296296296,621.422839506173,743.256172839506,236.490740740741,1085.57098765432,7857.5524691358,627.012345679012,122.361111111111,1088.74382716049,995.848765432099,626.472222222222,286.611111111111,1775.79938271605,1586.89814814815,301.651234567901,230.966049382716,1033.08641975309,1304.91049382716,214.922839506173,214.166666666667,1703.08333333333,1804.77160493827,525.302469135802,429.015432098765,1062.34567901235,130.361111111111,324,27.2127672749141,15.2576900747392,0.828031681591463,0.944606413994169,0.613636363636364,0.724166956306753,53915.5030864198,33532.1574074074,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_607005,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
607074,3446.05275779377,369.386091127098,128.592326139089,666.486810551559,3710.20623501199,1134.34532374101,356.354916067146,252.529976019185,1084.67146282974,5645.57314148681,605.678657074341,128.064748201439,1268.15587529976,2481.70743405276,792.508393285372,1059.16306954436,1582.0551558753,4728.90407673861,369.484412470024,239.539568345324,1043.51318944844,4501.1175059952,333.465227817746,587.410071942446,714.604316546763,2034.70743405276,547.935251798561,241.503597122302,1045.69544364508,130.757793764988,417,32.1447530508182,16.7681061137169,0.853163471310159,0.963048498845266,0.643518518518518,-0.687469753049889,53257.6258992806,33317.6690647482,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX+,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_607074,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
607270,1465.72222222222,142.833333333333,95.8019323671498,630.067632850242,2004.22222222222,438.62077294686,288.751207729469,252.311594202899,1082.13768115942,3378.30676328502,768.830917874396,114.012077294686,1077.63526570048,677.710144927536,436.091787439614,269.714975845411,1410.26086956522,1018.88164251208,285.053140096618,223.485507246377,978.451690821256,976.582125603865,214.070048309179,122.840579710145,584.190821256039,1537.66183574879,496.231884057971,245.492753623188,1038.22222222222,130.086956521739,414,35.1441873710671,15.3573809727232,0.89947019961161,0.930337078651685,0.597402597402597,-0.426928000186532,53804.2415458937,32951.8937198068,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_607270,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
608444,2542.4652173913,344.182608695652,70.2521739130435,634.539130434783,1170.84782608696,2067.75217391304,1962.08260869565,254.921739130435,1197.69130434783,4094.48260869565,1472.73913043478,129.613043478261,1071.56086956522,4712.87391304348,877.469565217391,561.74347826087,3458.73043478261,3897.51739130435,363.313043478261,238.021739130435,1169.81739130435,3884.0652173913,256.547826086957,261.317391304348,655.25652173913,963.630434782609,447.539130434783,446.886956521739,1035.06086956522,129.678260869565,230,19.8712995771166,14.7633415807118,0.66934917752458,0.954356846473029,0.766666666666667,0.28092123638388,53204.9217391304,33820.3565217391,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_608444,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
608887,1256.66929133858,1105.29921259843,252.346456692913,646.629921259842,1887.12598425197,3316.0,1075.95275590551,256.748031496063,1126.94488188976,2516.14173228346,2193.77952755906,122.826771653543,1075.51181102362,1452.86614173228,1230.79527559055,966.181102362205,2015.55905511811,1746.83464566929,312.291338582677,230.48031496063,1054.25984251968,1171.4094488189,191.771653543307,998.472440944882,667.763779527559,1159.74803149606,476.590551181102,359.44094488189,1105.97637795276,131.251968503937,127,12.9869941795662,12.4964433270487,0.272246544833745,0.933823529411765,0.751479289940828,1.18460641719517,53254.2047244095,33718.6299212598,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_608887,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
609103,3131.4007585335,981.769911504425,135.471554993679,648.625790139065,2226.47661188369,1233.25916561315,1583.3185840708,251.467762326169,1100.46523388116,4446.18963337547,630.834386852086,122.094816687737,1078.37041719343,1172.02654867257,651.630847029077,572.217446270544,2872.7193426043,1469.51706700379,293.142857142857,226.14412136536,1029.90012642225,1083.45512010114,208.734513274336,510.395701643489,605.242730720607,1105.28697850822,487.206068268015,253.346396965866,1027.93046776233,130.682680151707,791,35.1801042883464,28.8633756564515,0.571724032889197,0.968176254589963,0.753333333333333,1.37734097525145,53451.8280657396,33388.7370417193,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_609103,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
610004,1127.87562189055,273.338308457711,133.34328358209,643.945273631841,2499.51741293532,2026.48756218905,366.18407960199,262.646766169154,1076.87064676617,2625.96517412935,633.119402985075,114.223880597015,1061.34825870647,2939.90547263682,1152.95024875622,2308.8407960199,1936.28358208955,2972.81094527363,357.199004975124,233.562189054726,1024.02487562189,2053.74129353234,250.398009950249,416.233830845771,836.492537313433,1115.80099502488,465.651741293532,227.044776119403,1057.92537313433,129.890547263682,201,19.1613760142341,13.4826754407808,0.71055846626833,0.971014492753623,0.744444444444444,-1.05043925564925,54084.9651741294,32581.3432835821,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_610004,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
610012,2364.14285714286,700.165714285714,124.011428571429,638.531428571429,1823.62857142857,270.485714285714,286.108571428571,247.64,1080.44571428571,2461.15428571429,468.651428571429,113.674285714286,1073.08,644.977142857143,456.451428571429,274.862857142857,1386.46285714286,1027.32,277.445714285714,223.902857142857,980.942857142857,989.291428571429,222.542857142857,135.765714285714,583.468571428571,903.302857142857,480.422857142857,225.16,1013.02285714286,128.68,175,21.2226592634215,10.7725747359566,0.861594158144852,0.916230366492147,0.607638888888889,-0.912444392988956,54151.2342857143,33081.8971428571,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_610012,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
610967,3738.38906752412,407.736334405145,169.83922829582,677.067524115756,3105.22829581994,491.951768488746,295.707395498392,240.093247588424,1115.79742765273,5815.37942122186,626.987138263666,126.733118971061,1143.46302250804,742.836012861736,500.03536977492,282.75884244373,2604.90353697749,1861.72347266881,345.572347266881,241.218649517685,1022.20900321543,1808.77813504823,242.0,169.218649517685,615.536977491961,1202.22829581994,467.270096463023,248.742765273312,1066.6463022508,133.350482315113,311,23.6541351549461,16.854872674298,0.701616239790817,0.956923076923077,0.744019138755981,0.48930631861752,52686.8360128617,33543.7459807074,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_610967,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
611229,966.938524590164,199.348360655738,53.8155737704918,610.725409836066,408.69262295082,3620.68852459016,726.262295081967,260.217213114754,1133.10655737705,2006.43852459016,669.536885245902,121.581967213115,1065.25819672131,930.483606557377,1126.01229508197,1949.60655737705,1781.42213114754,1222.88114754098,310.434426229508,234.700819672131,1009.77049180328,1139.08606557377,246.254098360656,235.80737704918,632.405737704918,1456.69262295082,529.622950819672,317.397540983607,1060.62295081967,129.426229508197,244,20.4055409958158,15.2635391500671,0.663687985075975,0.956862745098039,0.7625,1.41263703290877,53162.5450819672,33733.3606557377,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_611229,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
611233,2744.6013986014,538.510489510489,145.426573426573,676.223776223776,3167.35664335664,1232.55244755245,366.482517482517,239.251748251748,1099.3986013986,4114.81818181818,2027.24475524476,126.692307692308,1073.65034965035,2619.42657342657,789.748251748252,343.41958041958,2280.55244755245,4031.7972027972,317.454545454545,232.503496503497,1038.86013986014,4224.34965034965,229.839160839161,185.524475524476,587.104895104895,1402.44755244755,521.664335664336,418.076923076923,1079.93006993007,130.118881118881,143,15.7096406541077,13.1990442969012,0.542295954026069,0.86144578313253,0.595833333333333,-0.231539352029838,53110.1398601399,33701.9440559441,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_611233,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
613852,2114.82419659735,410.406427221172,236.754253308129,699.175803402646,5186.65784499055,1069.53686200378,323.313799621928,251.714555765595,1085.89035916824,3290.63894139887,871.759924385633,131.007561436673,1076.20604914934,1606.45557655955,629.542533081285,290.153119092628,1608.56899810964,2714.13043478261,333.432892249527,231.232514177694,1009.6427221172,2220.49338374291,240.421550094518,159.068052930057,588.090737240076,1013.0056710775,522.576559546314,256.389413988658,1037.08506616257,132.89224952741,529,36.6679010903706,18.7049546084119,0.860104455892328,0.958333333333333,0.687012987012987,-0.345607943375132,53589.2684310019,33041.6124763705,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_613852,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
614407,3592.75918367347,361.689795918367,115.89387755102,637.057142857143,1443.13469387755,3196.98367346939,466.559183673469,265.302040816326,1123.89795918367,5751.47346938776,1230.47346938776,122.232653061224,1078.48163265306,2156.11428571429,509.702040816326,283.130612244898,2332.62448979592,6368.17959183673,382.551020408163,234.844897959184,1005.58367346939,6676.89795918367,251.032653061224,154.563265306122,588.514285714286,1310.63265306122,484.05306122449,323.967346938776,1035.0693877551,129.130612244898,245,20.784939991637,16.5511687903872,0.604894232786797,0.865724381625442,0.655080213903743,-0.323966004916284,54042.8571428571,32874.0163265306,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_614407,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
615097,2220.79983036472,249.685326547922,105.871077184054,671.623409669211,2567.11704834606,608.223070398643,646.603901611535,252.777777777778,1104.03816793893,3184.51569126378,1290.81085665819,127.144189991518,1076.18490245971,776.40288379983,478.147582697201,281.76844783715,1450.18405428329,1067.07888040712,285.111111111111,226.36641221374,991.891433418151,1007.19168787108,251.995759117897,136.472434266327,645.899915182358,902.380831212892,483.432569974555,402.044953350297,1022.90076335878,130.346904156064,1179,47.8353686511839,31.973436028036,0.74379683885289,0.97037037037037,0.668367346938776,0.807667703865986,53472.6887192536,33306.8312128923,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_615097,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
616821,1825.62146892655,407.64406779661,69.1412429378531,617.418079096045,740.689265536723,366.581920903955,426.881355932203,244.915254237288,1085.84745762712,3444.50282485876,790.197740112994,126.949152542373,1061.82485875706,1741.4011299435,618.322033898305,306.909604519774,2520.46892655367,5089.66666666667,419.519774011299,247.542372881356,1022.45197740113,4913.99435028249,275.915254237288,284.683615819209,600.090395480226,1803.16384180791,500.474576271186,262.203389830508,1048.39548022599,130.491525423729,177,15.8931063515081,14.3631664021052,0.428091018438749,0.956756756756757,0.786666666666667,0.855809959103086,53091.4802259887,33894.2881355932,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_616821,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
618394,2287.47931034483,244.68275862069,145.165517241379,655.055172413793,3192.99655172414,424.448275862069,320.503448275862,250.613793103448,1081.98965517241,3739.25862068966,639.368965517241,129.979310344828,1084.0724137931,843.4,446.6,292.703448275862,1489.54482758621,1697.63448275862,294.572413793103,223.241379310345,1026.33103448276,1557.4275862069,202.303448275862,171.034482758621,617.237931034483,1014.24137931034,474.196551724138,232.713793103448,1064.36896551724,130.527586206897,290,26.803267442939,13.7951749537352,0.857380800738585,0.96989966555184,0.627705627705628,-0.792788550104789,53451.175862069,33063.7344827586,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_618394,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
619775,2900.32075471698,703.494339622642,118.883018867925,633.188679245283,1510.78113207547,5736.03773584906,491.237735849057,270.939622641509,1112.65283018868,3671.47547169811,640.645283018868,121.8,1081.90943396226,4695.84528301887,801.62641509434,1062.74716981132,2153.69433962264,5694.50566037736,421.490566037736,1590.44905660377,1037.14716981132,3802.9320754717,315.928301886792,440.932075471698,642.083018867925,916.271698113208,504.456603773585,288.935849056604,1015.16226415094,129.184905660377,265,21.2202281850236,15.9324423844027,0.660513800275868,0.956678700361011,0.742296918767507,-0.25013281940472,53869.9283018868,33259.0339622641,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_619775,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
620002,5066.05555555556,871.818713450292,109.795321637427,645.111111111111,1262.43859649123,743.75730994152,256.37134502924,227.827485380117,1081.79532163743,7589.87134502924,727.62865497076,130.74269005848,1103.43859649123,3002.40350877193,721.347953216374,302.891812865497,7853.1052631579,3587.14912280702,356.956140350877,235.593567251462,1054.25730994152,2796.29239766082,229.587719298246,189.409356725146,613.850877192982,1702.15204678363,509.634502923977,235.24269005848,1055.19883040936,132.134502923977,342,22.7300989528788,19.4682929976176,0.516149706955465,0.957983193277311,0.814285714285714,-0.55042447859325,52739.7602339181,33489.8099415205,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_620002,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
621534,2145.04825737265,350.790884718499,116.86327077748,612.959785522788,892.782841823056,277.638069705094,318.139410187668,245.753351206434,1080.74798927614,3433.70241286863,1931.50134048257,113.683646112601,1071.36193029491,1033.01876675603,532.56836461126,807.117962466488,1537.19571045576,2152.97587131367,346.970509383378,1545.78016085791,1014.91420911528,2272.76139410188,239.316353887399,263.573726541555,592.71581769437,1021.41286863271,477.005361930295,440.774798927614,1021.80428954424,128.447721179625,373,29.3257704792458,16.6165559590629,0.823979516471109,0.93483709273183,0.740079365079365,-0.0944732016633761,53907.3806970509,33125.5656836461,FAAGSCC_12,AG,1,neutrophils,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,neutrophils,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_621534,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
622432,580.018404907975,1644.84355828221,366.610429447853,616.978527607362,683.849693251534,289.484662576687,279.791411042945,248.837423312883,1078.07055214724,903.711656441718,524.30981595092,108.015337423313,1059.13496932515,1413.09202453988,458.800613496932,263.769938650307,1395.62576687117,2439.84662576687,278.858895705521,220.865030674847,972.092024539877,1879.9509202454,236.79754601227,126.187116564417,585.558282208589,632.91717791411,372.030674846626,216.365030674847,1002.15644171779,128.180981595092,326,22.1189884149167,19.1421366807323,0.501053239263811,0.950437317784257,0.739229024943311,1.0808559823027,54145.7668711657,32557.5674846626,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_622432,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
622865,2092.18059299191,151.016172506739,62.989218328841,623.320754716981,842.44204851752,2231.64959568733,2249.75202156334,267.102425876011,1112.14285714286,3267.27493261456,910.989218328841,132.582210242588,1074.22641509434,2686.08894878706,1175.474393531,2118.05121293801,1960.04312668464,3738.61994609164,333.592991913747,230.390835579515,1045.47978436658,3311.22641509434,232.4474393531,1072.11859838275,726.326145552561,1163.11859838275,485.822102425876,236.905660377358,1073.32075471698,132.905660377358,371,27.1635697690957,17.5203560951742,0.764187118968877,0.971204188481675,0.781052631578947,1.24626520410987,52438.1132075472,32636.9380053908,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_622865,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
623093,1387.58823529412,453.315294117647,154.122352941176,664.882352941176,2961.06823529412,267.802352941176,285.604705882353,260.957647058824,1079.99764705882,2677.54823529412,3337.51764705882,165.609411764706,1077.13176470588,571.432941176471,489.028235294118,267.049411764706,1390.32470588235,926.023529411765,295.447058823529,227.969411764706,981.592941176471,891.823529411765,221.287058823529,117.776470588235,585.442352941177,881.065882352941,419.637647058824,222.221176470588,1057.57647058824,130.811764705882,425,31.6901065965951,17.4580341689787,0.834572210090181,0.959367945823928,0.737847222222222,-1.53800820148595,53062.9764705882,31952.8235294118,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_623093,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
623485,1237.36842105263,430.447368421053,66.2543859649123,612.280701754386,822.263157894737,281.508771929825,244.017543859649,224.921052631579,1090.91228070175,2477.5350877193,574.745614035088,111.035087719298,1071.85964912281,778.40350877193,419.017543859649,281.745614035088,1527.0,1008.73684210526,223.675438596491,215.728070175439,1237.27192982456,810.885964912281,168.087719298246,163.815789473684,629.368421052632,1241.47368421053,503.578947368421,247.280701754386,1021.05263157895,131.552631578947,114,16.5198670035376,8.86700037397247,0.843742805854767,0.942148760330578,0.7125,1.23042618461581,53886.4473684211,33498.850877193,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_623485,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
623626,3157.16438356164,794.239726027397,414.541095890411,647.458904109589,2381.0,1004.41095890411,1376.64383561644,244.77397260274,1099.55136986301,4172.04452054795,795.83904109589,134.982876712329,1074.27054794521,2263.9897260274,638.188356164384,373.66095890411,1738.47260273973,1988.8698630137,322.640410958904,236.202054794521,1007.80136986301,2231.07534246575,247.684931506849,197.794520547945,608.078767123288,1210.42465753425,506.171232876712,390.154109589041,1054.22260273973,130.808219178082,292,22.1269139267205,17.1852844525726,0.629909137395443,0.960526315789474,0.731829573934837,-1.00685394285161,53370.2465753425,33911.6198630137,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_623626,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
623995,3183.56825396825,566.704761904762,167.333333333333,686.063492063492,3770.19047619048,2621.45079365079,547.161904761905,248.047619047619,1131.26666666667,4607.67936507937,562.533333333333,124.565079365079,1071.03174603175,2613.3873015873,958.006349206349,1375.86984126984,7461.25396825397,2692.08253968254,333.669841269841,239.701587301587,1094.20952380952,2194.27619047619,251.44126984127,316.009523809524,757.64126984127,954.130158730159,438.101587301587,233.279365079365,1041.4126984127,129.68253968254,315,22.6345713253413,17.7740758763621,0.619163223029612,0.954545454545455,0.753588516746411,-1.01919877914492,52942.0412698413,33450.3714285714,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_623995,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
624435,2113.11872146119,259.534246575342,121.995433789954,657.098173515982,2564.04109589041,716.063926940639,409.486301369863,271.452054794521,1137.94748858447,4263.16666666667,728.547945205479,125.735159817352,1069.62100456621,1885.78310502283,632.933789954338,312.527397260274,1688.7100456621,1290.41324200913,276.075342465753,221.563926940639,1002.15753424658,1025.99315068493,196.399543378995,237.399543378995,714.171232876712,894.869863013699,433.51598173516,229.132420091324,1037.34474885845,130.107305936073,438,37.1286695933931,15.0825711937564,0.91377335492273,0.960526315789474,0.5703125,-1.01969361450656,53874.9155251142,32672.0068493151,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_624435,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
624497,2986.69791666667,311.586805555556,176.690972222222,669.541666666667,3925.15625,894.020833333333,541.986111111111,240.138888888889,1084.01041666667,5043.12847222222,640.027777777778,121.166666666667,1086.32291666667,2753.53819444444,879.128472222222,603.142361111111,1889.95833333333,4755.10763888889,399.097222222222,236.90625,1057.11111111111,4712.06944444444,260.270833333333,195.222222222222,598.142361111111,1207.94791666667,466.277777777778,251.899305555556,1036.70138888889,130.53125,288,28.2358474498072,13.1370108698167,0.885174059948758,0.944262295081967,0.571428571428571,0.812917406578532,53741.1875,33403.6736111111,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_624497,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
624711,2484.49519230769,374.701923076923,122.072115384615,629.682692307692,1464.19711538462,533.0,471.283653846154,238.879807692308,1093.84134615385,3489.82211538462,525.024038461538,119.802884615385,1075.97596153846,844.807692307692,717.961538461538,547.985576923077,1597.59134615385,1350.41346153846,338.947115384615,237.206730769231,990.980769230769,1222.57211538462,254.086538461538,164.5625,632.951923076923,936.543269230769,447.293269230769,222.009615384615,1021.91826923077,129.860576923077,208,21.79439711261,12.6645749490407,0.813837051771312,0.916299559471366,0.684210526315789,-0.558640682952939,52637.5961538462,33438.4855769231,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_624711,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
624734,3931.10074626866,921.742537313433,501.593283582089,625.832089552239,1024.5,3810.33208955224,530.406716417911,253.320895522388,1113.2723880597,4965.73507462687,594.305970149254,163.041044776119,1072.88432835821,2427.04104477612,749.977611940299,1162.05970149254,1769.92537313433,2292.49626865672,309.757462686567,228.861940298507,1014.99626865672,2930.54104477612,240.19776119403,337.085820895522,616.100746268657,874.731343283582,448.492537313433,291.242537313433,1011.5,128.384328358209,268,20.5808108643394,16.8232081756722,0.576039257748547,0.971014492753623,0.829721362229102,-1.21216000994167,53899.6753731343,33641.4626865672,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_624734,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
624759,1325.34210526316,518.436090225564,220.921052631579,666.360902255639,1231.25939849624,1128.29323308271,313.646616541353,248.684210526316,1088.68045112782,2288.72932330827,516.778195488722,110.436090225564,1073.09398496241,893.864661654135,396.906015037594,280.033834586466,1606.93609022556,1174.21052631579,223.815789473684,582.451127819549,1008.74436090226,1010.25187969925,226.943609022556,273.84962406015,634.800751879699,759.917293233083,419.857142857143,851.857142857143,1014.16917293233,129.601503759398,266,21.6336459083034,15.6758264423368,0.689165464638919,0.94661921708185,0.755681818181818,-0.0815932873600528,53796.9097744361,33707.5338345865,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_624759,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
626232,1199.75757575758,718.315151515152,135.921212121212,672.418181818182,4145.7696969697,273.030303030303,366.866666666667,237.248484848485,1077.02424242424,1762.9696969697,828.648484848485,113.630303030303,1065.49090909091,701.278787878788,449.436363636364,267.733333333333,1473.7696969697,1093.49090909091,298.50303030303,229.29696969697,1015.45454545455,1025.09696969697,228.218181818182,175.163636363636,590.957575757576,836.648484848485,435.181818181818,261.133333333333,1034.42424242424,133.30303030303,165,15.3031676032102,13.9497044794432,0.411174464098729,0.926966292134832,0.733333333333333,1.3841540196566,52716.5393939394,33378.0848484848,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_626232,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
626284,1951.93670886076,155.04641350211,53.6877637130802,629.738396624473,1223.93670886076,554.654008438819,2133.92827004219,249.122362869198,1090.67510548523,3078.59493670886,485.075949367089,115.0,1076.26160337553,803.029535864979,753.911392405063,1592.75949367089,1916.29113924051,1086.29957805907,283.354430379747,224.042194092827,1003.19831223629,1026.73417721519,202.464135021097,204.962025316456,689.73417721519,1011.21518987342,442.261603375527,236.008438818565,1028.71308016878,130.649789029536,237,21.975522471526,13.8929975886373,0.774802556210495,0.955645161290323,0.752380952380952,-0.28027379231418,52846.6540084388,33658.6033755274,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_626284,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
626556,3032.61170212766,1034.79255319149,120.515957446809,632.946808510638,1211.91489361702,354.11170212766,280.920212765957,244.505319148936,1079.02127659574,4664.64361702128,668.228723404255,120.797872340426,1100.6914893617,675.436170212766,438.590425531915,279.218085106383,1470.32978723404,2162.95744680851,307.824468085106,242.521276595745,1022.63829787234,2574.21276595745,230.574468085106,183.675531914894,620.239361702128,1089.94680851064,531.473404255319,261.904255319149,1040.72340425532,132.473404255319,188,17.236478124822,14.5989938457861,0.531620909002932,0.878504672897196,0.61437908496732,-0.856494227066586,53297.7872340426,33283.3670212766,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_626556,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
626741,5853.271875,1277.703125,152.51875,666.059375,2953.50625,739.45625,396.378125,277.465625,1123.7625,10590.703125,708.1375,137.48125,1082.64375,1605.1,683.3625,282.553125,1718.665625,1619.159375,346.440625,233.553125,1028.8125,1312.775,229.025,205.096875,1600.478125,3284.521875,599.821875,262.84375,1068.840625,131.95625,320,25.5699428542392,16.0258694360381,0.77922330541278,0.960960960960961,0.662525879917184,1.00402998973731,53581.065625,32718.45625,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_626741,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
627746,2201.6091954023,616.252873563218,123.35632183908,646.695402298851,1657.22988505747,608.206896551724,362.270114942529,262.235632183908,1091.23563218391,4423.41954022988,573.0,120.666666666667,1082.95402298851,830.787356321839,480.195402298851,270.396551724138,1500.68390804598,1006.70114942529,210.281609195402,206.666666666667,1178.27011494253,694.304597701149,144.074712643678,112.028735632184,644.5,1219.18965517241,459.620689655172,223.98275862069,1028.43103448276,129.419540229885,174,18.1693675112289,12.5336747810806,0.723976632977457,0.910994764397906,0.73109243697479,-0.236836612912207,54002.6781609195,32700.4252873563,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_627746,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
628301,2087.81027667984,336.774703557312,356.814229249012,655.498023715415,1852.85770750988,344.126482213439,547.415019762846,251.901185770751,1073.91304347826,2566.02371541502,677.881422924901,115.268774703557,1115.18181818182,787.739130434783,670.177865612648,544.264822134387,1595.93280632411,1168.28063241107,327.901185770751,232.853754940711,1003.13438735178,1091.82213438735,242.901185770751,660.624505928854,602.110671936759,885.96837944664,478.367588932806,595.106719367589,1022.02371541502,130.632411067194,253,18.6528483617686,17.9132128975411,0.278806436051698,0.926739926739927,0.66578947368421,-0.0901383753990256,53544.95256917,33473.138339921,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_628301,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
628364,5282.91232876712,910.958904109589,123.241095890411,655.772602739726,1762.19452054795,2004.59178082192,994.25205479452,264.268493150685,1148.01917808219,7582.18356164384,597.550684931507,150.164383561644,1082.95890410959,4376.42465753425,1193.72602739726,1666.10410958904,5938.6,5029.08767123288,434.180821917808,243.950684931507,1082.58356164384,4392.98630136986,592.049315068493,409.569863013699,766.394520547945,1823.79452054794,517.775342465753,329.295890410959,1076.77534246575,130.238356164384,365,31.5104884395276,14.9328710664555,0.880577803580077,0.940721649484536,0.662431941923775,1.21110871290981,53231.0246575342,33865.6082191781,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_628364,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
628950,2332.23076923077,224.086247086247,63.8904428904429,636.876456876457,1659.81118881119,2960.88811188811,463.447552447552,259.247086247086,1102.78088578089,4010.06060606061,1481.53146853147,132.142191142191,1070.75990675991,1519.11421911422,564.606060606061,291.300699300699,1660.77855477855,1332.65268065268,303.062937062937,230.862470862471,992.764568764569,1220.24009324009,228.198135198135,174.156177156177,582.328671328671,1272.82750582751,462.013986013986,331.128205128205,1034.43356643357,129.452214452214,429,31.8322633633653,17.2462469010244,0.840517028019841,0.947019867549669,0.680952380952381,-1.20920012713899,53310.5337995338,33909.9044289044,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_628950,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
629007,1126.74242424242,309.863636363636,111.040404040404,658.424242424242,1884.67171717172,2698.09090909091,1537.65151515152,255.00505050505,1105.95454545455,2299.90404040404,1047.91919191919,110.712121212121,1067.18686868687,3324.56565656566,988.717171717172,436.782828282828,1988.60606060606,2543.29292929293,365.641414141414,235.313131313131,1056.01515151515,2051.62626262626,264.969696969697,611.747474747475,649.207070707071,1227.20202020202,485.636363636364,837.242424242424,1059.54545454545,130.353535353535,198,22.2395382882436,11.5354516387816,0.854961691135951,0.938388625592417,0.613003095975232,0.918966014072934,53526.7171717172,33635.904040404,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_629007,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
629749,3005.5775862069,841.936781609195,1205.50862068966,647.051724137931,1655.44827586207,408.048850574713,326.939655172414,239.543103448276,1091.3908045977,4383.36206896552,542.761494252874,122.974137931034,1079.68965517241,648.948275862069,532.33908045977,274.433908045977,1671.08620689655,1028.22988505747,244.33908045977,216.497126436782,1013.02298850575,925.471264367816,184.19540229885,198.189655172414,583.385057471264,1155.71264367816,522.98275862069,247.474137931034,1035.7183908046,130.25,348,26.3535286221364,16.8515327393409,0.768839979600458,0.96398891966759,0.773333333333333,-0.288549846736342,52983.1005747126,33375.224137931,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_629749,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
630166,2246.89722222222,229.688888888889,205.736111111111,702.608333333333,4716.52777777778,2850.30277777778,820.261111111111,261.627777777778,1118.70277777778,3761.6,545.436111111111,126.4,1086.85555555556,2403.53055555556,1266.40833333333,507.711111111111,6547.04166666667,3989.14444444444,383.186111111111,245.038888888889,1096.83611111111,3312.275,248.830555555556,250.991666666667,704.283333333333,1140.80277777778,458.444444444444,260.980555555556,1066.16111111111,131.430555555556,360,30.5514364261116,15.1930492215007,0.867582026980016,0.949868073878628,0.602006688963211,0.708495196632592,52854.1527777778,33490.1361111111,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3+,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_630166,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
630334,4013.73333333333,308.614035087719,110.101754385965,605.863157894737,373.319298245614,2400.88070175439,568.610526315789,260.431578947368,1100.63859649123,7829.41403508772,621.122807017544,121.743859649123,1075.33333333333,1007.77192982456,535.663157894737,281.585964912281,1535.04561403509,1750.18245614035,301.887719298246,225.175438596491,1019.09122807018,1392.94736842105,215.929824561404,252.508771929824,1061.57543859649,3138.72280701754,547.084210526316,256.614035087719,1043.38596491228,128.838596491228,285,22.013152823377,16.6568226045122,0.653790146937028,0.953177257525084,0.714285714285714,0.93170180083127,54036.8666666667,32688.8771929825,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_630334,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
630763,2376.03832752613,400.282229965157,133.303135888502,666.937282229965,3176.65156794425,1229.81881533101,1238.57839721254,246.466898954704,1095.54703832753,4126.36236933798,930.146341463415,120.954703832753,1085.89547038328,3574.51916376307,906.344947735192,492.756097560976,1887.5574912892,4442.91289198606,389.871080139373,249.362369337979,1044.7212543554,3739.62020905923,244.536585365854,193.937282229965,585.348432055749,1192.28222996516,474.637630662021,325.229965156794,1046.16724738676,130.250871080139,287,24.8809875752768,14.7249361619025,0.806073983835976,0.953488372093023,0.747395833333333,1.25074930843737,53123.3902439024,33566.4668989547,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_630763,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
630840,1362.79104477612,387.44776119403,210.651741293532,700.407960199005,5581.45771144279,316.412935323383,393.074626865672,251.019900497512,1080.37313432836,2873.75621890547,662.621890547264,122.746268656716,1070.00497512438,988.517412935323,720.019900497512,1003.77611940299,1536.50746268657,1617.17412935323,359.601990049751,229.985074626866,1016.407960199,1371.75124378109,245.039800995025,642.427860696517,651.890547263682,1214.71144278607,477.412935323383,260.238805970149,1070.03482587065,130.054726368159,201,24.173548683494,10.610405688257,0.898523079677014,0.939252336448598,0.624223602484472,1.15620286632803,53918.5671641791,33370.3233830846,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_630840,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
630944,4552.58609271523,1120.3642384106,102.566225165563,642.043046357616,1557.65562913907,2030.5761589404,1026.76490066225,250.03642384106,1125.09933774834,6520.88741721854,729.149006622517,128.572847682119,1090.25165562914,2966.00993377483,787.059602649007,637.132450331126,2174.7880794702,1865.96688741722,289.331125827815,221.788079470199,1032.37086092715,1287.30132450331,197.67880794702,180.486754966887,597.129139072848,1411.65894039735,488.317880794702,268.056291390728,1044.79801324503,130.996688741722,302,28.9774933143608,13.5965661460853,0.883085949160891,0.923547400611621,0.657952069716776,1.25662644822265,53210.5927152318,33712.1754966887,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_630944,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
631252,2183.79872204473,197.830670926518,70.9361022364217,620.287539936102,443.88178913738,1020.01916932907,395.444089456869,264.773162939297,1112.62300319489,4541.90415335463,974.603833865815,122.031948881789,1068.10223642173,4304.76038338658,741.290734824281,298.779552715655,1487.84984025559,4695.49840255591,307.424920127796,225.079872204473,993.996805111821,2866.92332268371,202.961661341853,135.137380191693,638.108626198083,740.680511182109,395.610223642173,214.456869009585,1003.79872204473,130.373801916933,313,24.1884185277857,16.5236458639927,0.730304080113662,0.966049382716049,0.756038647342995,-0.428950791529407,53840.5591054313,32666.1309904153,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_631252,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
631328,1895.98888888889,1070.48888888889,829.355555555556,635.4,1701.22222222222,478.411111111111,692.355555555556,427.222222222222,1101.43333333333,1459.33333333333,873.611111111111,103.966666666667,1063.71111111111,679.688888888889,472.588888888889,273.377777777778,1394.87777777778,1009.04444444444,280.2,223.222222222222,988.311111111111,913.166666666667,199.944444444444,125.388888888889,588.822222222222,726.844444444444,399.455555555556,241.888888888889,999.055555555556,130.344444444444,90,14.5963649472721,7.84535449270269,0.843272118458522,0.967741935483871,0.803571428571429,-0.239882261583325,52748.6555555556,32728.6555555556,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_631328,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
631600,5249.46411483254,669.076555023923,134.239234449761,660.995215311005,2461.46889952153,527.052631578947,1217.66985645933,243.105263157895,1092.09090909091,8432.12918660287,1039.6985645933,134.181818181818,1085.39234449761,2749.94736842105,1066.13397129187,345.909090909091,2066.77511961722,5049.33971291866,408.933014354067,245.8995215311,1056.95693779904,4187.14354066986,245.052631578947,347.358851674641,711.956937799043,2591.95693779904,568.751196172249,335.885167464115,1072.46411483254,131.937799043062,209,18.5143048156903,14.4052495870334,0.628189327372624,0.954337899543379,0.774074074074074,0.316543723816196,53069.971291866,33531.2822966507,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_631600,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
632407,1925.9932885906,349.255033557047,146.880872483221,686.93288590604,3314.01845637584,366.791946308725,494.093959731544,245.71644295302,1087.7533557047,3451.37751677852,3270.99832214765,127.248322147651,1075.61912751678,1045.78523489933,568.755033557047,288.364093959732,1573.09395973154,1171.52348993289,313.203020134228,238.145973154362,985.26677852349,1125.40771812081,242.441275167785,166.577181208054,584.302013422819,1433.70637583893,523.659395973154,595.780201342282,1071.34899328859,130.427852348993,596,43.1852631184229,18.1279227006487,0.907630032634432,0.9536,0.555452003727866,-0.583272784994608,52568.4765100671,33697.6761744966,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_632407,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
632787,2544.50341685649,635.29840546697,142.596810933941,628.73576309795,1122.53075170843,336.717539863326,461.239179954442,230.236902050114,1081.04328018223,3346.23006833713,782.699316628702,111.888382687927,1067.8132118451,716.407744874715,449.674259681093,297.576309794989,1959.9271070615,1108.72209567198,246.154897494305,251.173120728929,1022.569476082,973.658314350797,195.355353075171,222.908883826879,602.587699316629,769.152619589977,425.69020501139,319.384965831435,1013.77448747153,129.763097949886,439,25.5174322451668,22.3786549404939,0.480499897563092,0.948164146868251,0.734113712374582,-0.100925488331862,53190.9453302961,33534.2300683371,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_632787,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
632967,631.665369649805,1248.83657587549,287.47859922179,616.785992217899,102.04280155642,288.4046692607,1033.61478599222,244.377431906615,1086.44357976654,1420.15175097276,1194.84824902724,117.334630350195,1058.58365758755,632.52140077821,621.673151750973,300.377431906615,1616.92996108949,1080.30350194553,273.350194552529,219.455252918288,994.466926070039,1015.36964980545,195.233463035019,122.128404669261,586.284046692607,570.79766536965,358.501945525292,206.287937743191,990.019455252918,130.112840466926,257,20.530513081264,16.1389711396371,0.618103375194471,0.958955223880597,0.755882352941176,0.360608794552721,53713.1556420233,32660.0505836576,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_632967,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
633365,1467.24299065421,405.177570093458,126.96261682243,647.439252336449,2619.16822429907,962.831775700935,1391.06542056075,263.971962616822,1089.45794392523,2331.83177570093,2341.8691588785,123.327102803738,1073.18691588785,990.345794392523,560.411214953271,384.672897196262,1387.36448598131,1114.16822429907,286.906542056075,221.065420560748,987.672897196262,1072.45794392523,212.084112149533,189.514018691589,642.18691588785,1014.92523364486,485.504672897196,531.224299065421,1051.1308411215,131.373831775701,107,14.359369906739,10.5358961146726,0.679441486359677,0.829457364341085,0.587912087912088,-0.418342388935464,53240.0747663551,32847.0373831776,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_633365,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
633726,994.744310575636,247.223560910308,134.061579651941,670.520749665328,3457.56224899598,257.547523427041,291.327978580991,251.724230254351,1080.63855421687,1830.49799196787,706.463186077644,132.5046854083,1072.10441767068,595.307898259705,504.25702811245,274.945113788487,1398.4203480589,935.740294511379,292.647925033467,232.410977242302,980.28781793842,915.776439089692,235.874163319946,138.472556894244,585.539491298527,1030.37483266399,476.091030789826,221.619812583668,1048.11111111111,128.492637215529,747,40.8917841936016,23.8181070591894,0.812854486518401,0.956466069142126,0.655263157894737,-1.07196837143798,52321.3962516734,32992.1204819277,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_633726,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
634887,1693.62711864407,309.875706214689,243.203389830508,726.19209039548,6318.0790960452,312.610169491525,321.694915254237,247.084745762712,1081.13559322034,2843.00564971751,630.570621468927,122.0,1069.42372881356,709.276836158192,419.231638418079,268.16384180791,1374.16384180791,961.564971751412,235.197740112994,213.039548022599,988.757062146893,858.632768361582,184.700564971751,127.762711864407,577.16384180791,1019.44632768362,464.06779661017,298.276836158192,1048.80225988701,129.994350282486,177,26.9428623269625,8.59688814392587,0.9477282889764,0.931578947368421,0.756410256410256,1.4628361506093,53843.2937853107,33360.3333333333,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_634887,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
635160,1691.20625,252.0625,283.74375,778.5625,8859.84375,2722.35,1049.15625,259.56875,1103.51875,2773.9875,675.0375,146.9375,1074.6,2965.3875,989.33125,3383.66875,3250.4875,3050.5125,368.19375,239.25,1072.2125,2241.15,235.93125,764.11875,869.2,1253.35,513.2125,381.7,1110.24375,131.23125,160,18.738254790599,10.89921132021,0.81343514354415,0.930232558139535,0.683760683760684,1.26885904142649,52787.6625,33740.9375,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1+,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_635160,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
635417,1445.77586206897,699.163793103448,208.98275862069,678.103448275862,3357.68965517241,288.681034482759,658.922413793103,233.215517241379,1079.75,2192.02586206897,5286.3275862069,133.137931034483,1075.66379310345,561.586206896552,380.715517241379,265.293103448276,1514.56896551724,918.353448275862,218.224137931034,216.758620689655,994.060344827586,843.784482758621,183.75,139.0,577.784482758621,1076.89655172414,497.844827586207,504.715517241379,1082.28448275862,129.896551724138,116,13.7697926947633,10.7377866626768,0.626019465363131,0.950819672131148,0.753246753246753,1.46320272198194,53135.8017241379,33468.4137931034,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_635417,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
636491,2089.69194312796,149.258293838863,76.0189573459716,619.293838862559,897.85308056872,330.118483412322,260.789099526066,248.476303317536,1101.27488151659,3421.8981042654,1577.21090047393,119.64691943128,1068.8009478673,585.154028436019,352.592417061611,257.665876777251,1424.28199052133,708.196682464455,162.812796208531,199.447867298578,987.42654028436,610.279620853081,131.793838862559,102.699052132701,587.400473933649,1369.50473933649,495.239336492891,364.078199052133,1037.45260663507,129.772511848341,422,35.3894571053386,15.326057828806,0.90136102951468,0.94407158836689,0.538952745849298,0.84825928411285,53845.2464454976,32261.4739336493,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_636491,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
636812,1908.56837606838,243.217948717949,72.1025641025641,602.867521367521,201.397435897436,757.217948717949,416.67094017094,278.581196581197,1085.24358974359,3786.80341880342,777.782051282051,110.277777777778,1068.02564102564,1137.27777777778,539.735042735043,309.752136752137,1680.36324786325,1330.64957264957,326.213675213675,231.559829059829,1045.76923076923,1066.57692307692,220.153846153846,155.350427350427,591.358974358974,1668.73931623932,463.905982905983,246.512820512821,1024.93162393162,128.551282051282,234,22.2218378673772,13.5278001259806,0.793353259123033,0.932270916334661,0.65546218487395,-0.527930635381385,52532.5512820513,33199.047008547,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_636812,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
637537,1825.48046875,237.02734375,113.23046875,622.890625,1393.59765625,223.625,396.5078125,242.9375,1079.94140625,4284.31640625,550.484375,127.9921875,1070.046875,2135.02734375,1446.40625,2316.0078125,1816.8359375,4455.3515625,433.24609375,236.86328125,1040.0859375,3070.6953125,256.15625,1687.6875,786.06640625,2515.6171875,513.76171875,225.80859375,1040.7421875,129.3828125,256,21.1705862821628,15.5197195977046,0.680143123834112,0.962406015037594,0.812698412698413,1.55351845658953,54033.0859375,32350.66796875,FAAGSCC_12,AG,1,other APCs,,TIM3+,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,1,FAAGSCC_12_637537,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
637837,2195.16574585635,225.92817679558,78.1381215469613,610.872928176796,768.977900552486,403.342541436464,295.033149171271,246.867403314917,1100.31491712707,4548.08839779005,759.955801104972,117.254143646409,1062.2044198895,860.110497237569,449.32044198895,278.972375690608,1473.03314917127,1018.1546961326,209.696132596685,210.60773480663,1200.11049723757,694.055248618785,141.033149171271,110.138121546961,599.060773480663,1573.92817679558,487.563535911602,275.386740331492,1043.70165745856,129.662983425414,181,20.6360652277148,11.3012103389133,0.836711670187974,0.947643979057592,0.754166666666667,1.41081517496913,53275.7513812155,32755.4309392265,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_637837,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
638208,2153.67450980392,524.670588235294,192.470588235294,672.909803921569,3686.62941176471,322.898039215686,827.578431372549,255.939215686275,1081.28431372549,4005.92156862745,5157.04117647059,134.974509803922,1074.66078431373,750.325490196078,549.466666666667,353.63137254902,1498.3862745098,1137.1568627451,312.101960784314,236.243137254902,990.088235294118,1013.68039215686,228.229411764706,135.78431372549,587.533333333333,1457.42352941176,490.554901960784,601.564705882353,1080.16862745098,130.750980392157,510,39.1069511194604,16.8697716680362,0.902172585976812,0.946196660482375,0.590277777777778,0.480859514596395,52373.0117647059,32888.831372549,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_638208,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
638503,3169.40669856459,291.066985645933,153.397129186603,652.306220095694,2690.8038277512,267.980861244019,262.933014354067,247.430622009569,1076.34928229665,6024.29186602871,507.564593301435,129.172248803828,1074.01913875598,858.909090909091,507.641148325359,271.966507177034,1477.29186602871,1236.8995215311,327.287081339713,226.583732057416,979.755980861244,1060.74641148325,223.138755980861,115.928229665072,585.44019138756,2597.64593301435,516.947368421053,227.913875598086,1044.77511961722,131.038277511962,209,26.1220891503929,10.238230666933,0.919991774714228,0.937219730941704,0.76,1.43104747671147,53687.2679425837,32525.7033492823,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_638503,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
639237,2882.37419354839,485.764516129032,106.925806451613,647.093548387097,1442.60967741935,562.122580645161,377.390322580645,246.858064516129,1095.65161290323,4684.72258064516,1292.9064516129,125.329032258065,1081.93548387097,1270.13225806452,673.929032258064,319.567741935484,4875.76774193548,2805.9,352.867741935484,234.525806451613,1043.76774193548,2623.78709677419,231.793548387097,166.290322580645,616.254838709677,1083.28387096774,473.729032258064,403.238709677419,1042.11290322581,132.674193548387,310,22.0207197451711,18.0547748426989,0.572507623216177,0.945121951219512,0.738095238095238,-0.857142968627563,53028.7774193548,33445.0741935484,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_639237,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
641574,2106.00282485876,207.440677966102,116.014124293785,662.522598870057,2464.10734463277,1112.92937853107,379.406779661017,261.35593220339,1096.87005649718,2260.43502824859,1257.74858757062,202.728813559322,1071.17231638418,734.454802259887,485.810734463277,289.680790960452,2280.48870056497,993.053672316384,253.559322033898,219.573446327684,1049.64124293785,852.234463276836,180.994350282486,163.056497175141,665.228813559322,828.954802259887,412.305084745763,217.624293785311,1057.66666666667,129.985875706215,354,40.3841072428988,11.4167666777019,0.959207066299197,0.934036939313984,0.422939068100358,0.700315183162975,53089.5169491526,32192.6836158192,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_641574,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
641630,1581.69348659004,125.586206896552,102.241379310345,657.490421455939,2693.60153256705,1336.4061302682,1882.66283524904,243.030651340996,1096.91954022989,2955.07279693487,538.2030651341,111.743295019157,1073.2183908046,1388.25670498084,739.467432950192,1329.50957854406,1906.32567049808,3732.33333333333,356.973180076628,240.977011494253,1056.36781609195,4185.70881226054,253.245210727969,281.386973180077,807.019157088123,1237.29118773946,458.586206896552,236.026819923372,1045.19540229885,128.950191570881,261,27.4940812107589,12.5277414306017,0.890157839095945,0.91578947368421,0.604166666666667,0.316072750285402,53109.2298850575,33626.3218390805,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_641630,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
641743,2366.17333333333,1103.7,1672.77333333333,711.113333333333,5434.55333333333,587.133333333333,388.62,256.373333333333,1132.7,4756.10666666667,563.526666666667,119.76,1072.12666666667,631.84,380.193333333333,265.313333333333,1474.47333333333,879.513333333333,188.146666666667,208.62,1132.31333333333,678.72,147.82,121.82,635.226666666667,1886.76666666667,518.586666666667,239.033333333333,1079.03333333333,129.293333333333,150,15.7887450114338,12.7501450042966,0.589803975071289,0.914634146341463,0.669642857142857,-0.109459884189868,53337.04,33161.38,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_641743,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
642772,2950.648,635.56,109.32,690.132,3674.788,1359.932,374.528,246.62,1082.836,4912.392,840.188,126.576,1085.804,1165.368,609.124,294.088,1920.508,1535.648,346.64,240.168,1056.228,1388.164,245.544,463.988,2139.772,1532.884,483.612,287.48,1054.676,132.996,250,23.9434608993722,13.5265176656903,0.825134879206467,0.93984962406015,0.668449197860963,0.436645531289321,52931.44,33580.18,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,9,FAAGSCC_12_642772,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
643608,1177.90714285714,576.35,108.078571428571,681.464285714286,3298.72142857143,455.35,316.828571428571,247.392857142857,1088.86428571429,1952.95714285714,5278.72857142857,111.771428571429,1086.07142857143,1123.57857142857,538.921428571429,280.271428571429,1894.02142857143,1524.66428571429,288.485714285714,235.9,1051.25714285714,1231.33571428571,215.692857142857,164.171428571429,815.742857142857,976.178571428571,463.471428571429,859.678571428571,1047.6,130.442857142857,140,14.137333995872,12.6891031404734,0.440892669677896,0.958904109589041,0.714285714285714,-0.485851764759168,53765.5071428571,33498.3714285714,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_643608,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
644053,1770.65853658537,78.5060975609756,53.4451219512195,614.05487804878,370.829268292683,1347.64024390244,403.780487804878,243.780487804878,1094.44512195122,3198.82926829268,523.591463414634,127.810975609756,1080.09756097561,3772.5,730.25,367.115853658537,7637.89634146341,6081.06707317073,408.975609756098,245.451219512195,1050.35975609756,6356.09756097561,275.548780487805,228.073170731707,645.243902439024,1800.90243902439,488.65243902439,254.908536585366,1037.87804878049,130.841463414634,164,17.7572213429366,11.8749160137083,0.743498784038403,0.976190476190476,0.728888888888889,0.781031320616039,53059.4756097561,33761.4451219512,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_644053,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
644650,3344.79847908745,572.969581749049,218.813688212928,646.437262357414,1867.21292775665,1117.43726235741,1522.65779467681,249.574144486692,1090.38022813688,5922.43726235742,638.422053231939,126.513307984791,1084.14448669202,2428.73003802281,855.942965779468,543.851711026616,1823.89353612167,2324.57414448669,356.254752851711,241.619771863118,1051.74524714829,1654.09125475285,230.885931558935,282.072243346008,646.768060836502,2415.44486692015,552.038022813688,304.768060836502,1080.95057034221,129.787072243346,263,22.1673173757085,15.447923738917,0.717189343092272,0.910034602076124,0.664141414141414,0.564967890482399,53295.2091254753,33672.1330798479,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_644650,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
644663,2901.27325581395,151.912790697674,41.8604651162791,607.726744186047,362.872093023256,3224.12790697674,2460.40697674419,264.616279069767,1111.76744186047,4912.35465116279,539.360465116279,126.255813953488,1069.49418604651,2242.47093023256,1718.17441860465,2107.03488372093,6860.13372093023,4830.16860465116,476.71511627907,258.267441860465,1119.66279069767,5101.41279069767,8076.53488372093,378.656976744186,621.023255813953,1291.12790697674,451.186046511628,288.203488372093,1021.36046511628,128.052325581395,172,20.4996007640706,12.4379262500097,0.794900410261402,0.807511737089202,0.661538461538462,1.5064188938406,53179.7325581395,33777.9186046512,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67+,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_644663,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
645663,1526.28636363636,492.990909090909,321.9,685.759090909091,2064.57272727273,654.159090909091,339.140909090909,246.509090909091,1132.75454545455,2296.58181818182,614.218181818182,110.604545454545,1073.29090909091,644.9,339.981818181818,261.936363636364,1514.95909090909,1290.20454545455,282.45,228.472727272727,999.690909090909,1611.30909090909,197.4,167.563636363636,875.513636363636,892.386363636364,486.277272727273,586.677272727273,1021.41818181818,128.768181818182,220,21.7261746265159,12.9115662376686,0.80425362064528,0.969162995594714,0.681114551083591,0.865942045028586,53677.5681818182,33642.0409090909,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_645663,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
646004,3026.96713615023,518.023474178404,99.8732394366197,619.140845070423,893.004694835681,1748.6103286385,340.037558685446,263.68544600939,1107.30985915493,4103.92488262911,706.230046948357,122.474178403756,1073.83098591549,3433.61502347418,559.69014084507,296.798122065728,1957.2441314554,2387.2441314554,320.586854460094,229.338028169014,1053.50704225352,1332.46009389671,209.69014084507,189.971830985915,1417.19718309859,976.098591549296,466.253521126761,249.075117370892,1021.779342723,130.492957746479,213,20.674098293753,13.8989794187258,0.740288331854867,0.91025641025641,0.747368421052632,1.47812780855749,53332.9107981221,32733.3849765258,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_646004,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
646574,1137.18835616438,236.342465753425,158.883561643836,649.684931506849,1736.28424657534,301.657534246575,288.428082191781,251.294520547945,1072.81849315068,1750.75,557.873287671233,112.366438356164,1073.11643835616,657.465753424658,446.482876712329,270.25,1417.13356164384,987.883561643836,270.900684931507,226.068493150685,985.993150684932,924.47602739726,209.08904109589,123.092465753425,589.037671232877,868.715753424658,491.407534246575,398.116438356164,1018.03424657534,129.243150684931,292,21.8904765070856,17.1569133240774,0.621061886318385,0.963696369636964,0.731829573934837,1.00612308510749,53426.3869863014,33265.345890411,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_646574,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
646809,1645.28472222222,676.208333333333,618.979166666667,618.763888888889,788.972222222222,251.826388888889,262.972222222222,232.256944444444,1070.10416666667,2278.52083333333,803.895833333333,115.243055555556,1073.05555555556,488.083333333333,320.506944444444,260.027777777778,1461.36805555556,751.131944444444,179.145833333333,207.618055555556,986.243055555556,679.652777777778,149.666666666667,144.611111111111,579.513888888889,797.611111111111,450.354166666667,281.722222222222,1014.77083333333,129.791666666667,144,14.8864932454001,12.4015395436288,0.553162664936289,0.935064935064935,0.738461538461539,-0.188708561857153,53227.5486111111,33508.9930555556,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_646809,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
647106,2519.05483870968,783.706451612903,122.477419354839,667.374193548387,3159.8064516129,524.596774193548,357.683870967742,260.325806451613,1119.04838709677,3706.25806451613,1063.67096774194,127.438709677419,1077.17096774194,942.88064516129,510.770967741935,281.429032258065,1702.58064516129,1233.05806451613,260.216129032258,223.316129032258,1023.68387096774,1129.81935483871,201.241935483871,180.609677419355,1159.30322580645,1084.32580645161,493.238709677419,338.670967741935,1039.4064516129,131.287096774194,310,22.5182577425246,17.7792836684318,0.613686621653164,0.94224924012158,0.782828282828283,-1.28446556505582,52918.2096774194,33565.4225806452,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,9,FAAGSCC_12_647106,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
648218,2422.53454545455,495.116363636364,196.32,633.101818181818,1464.57818181818,888.636363636364,922.436363636364,245.04,1111.21454545455,4078.52363636364,462.443636363636,123.741818181818,1070.2,1709.05090909091,800.305454545454,500.869090909091,1727.75636363636,2530.29090909091,421.894545454545,237.523636363636,1014.92,2933.97818181818,262.876363636364,588.443636363636,607.036363636364,1860.42181818182,501.701818181818,270.116363636364,1036.61090909091,128.96,275,22.7287137454309,15.472864583535,0.73250385929346,0.961538461538462,0.6875,0.848536597135651,53672.7818181818,33807.2181818182,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_648218,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
648960,1124.33727810651,104.408284023669,57.7514792899408,611.059171597633,620.384615384615,1063.02366863905,444.177514792899,244.544378698225,1112.27218934911,2405.78698224852,615.98224852071,103.988165680473,1101.3550295858,828.289940828402,633.337278106509,420.934911242604,1611.72781065089,1362.7573964497,307.662721893491,227.89349112426,1040.01183431953,1261.14792899408,220.461538461538,433.591715976331,794.686390532544,1112.25443786982,458.976331360947,306.508875739645,1026.13609467456,129.112426035503,169,16.0699325778404,13.4115494245217,0.550895708224862,0.954802259887006,0.754464285714286,-0.579664443264065,53936.4911242604,33538.426035503,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_648960,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
649371,460.408695652174,741.875362318841,192.542028985507,608.794202898551,95.7942028985507,395.284057971014,1016.3652173913,255.939130434783,1086.11014492754,1352.62028985507,883.892753623188,116.197101449275,1061.91304347826,679.486956521739,471.385507246377,271.057971014493,1458.6231884058,971.211594202899,278.628985507246,219.24347826087,981.066666666667,904.171014492754,199.495652173913,110.950724637681,588.371014492754,566.771014492754,359.31884057971,206.979710144928,980.68115942029,128.089855072464,345,23.6028453016617,18.6168049034936,0.614710812076094,0.966386554621849,0.784090909090909,0.9642525493299,53732.7072463768,32652.484057971,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_649371,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
650223,1321.12658227848,373.784810126582,160.79746835443,667.645569620253,2851.44303797468,289.683544303797,282.518987341772,251.481012658228,1079.49367088608,1645.78481012658,2956.03797468354,122.177215189873,1063.55696202532,703.455696202532,442.253164556962,267.050632911392,1370.11392405063,975.139240506329,274.379746835443,218.506329113924,978.518987341772,981.582278481013,198.329113924051,125.987341772152,582.164556962025,960.962025316456,476.012658227848,485.443037974684,1026.40506329114,129.506329113924,79,11.4752674555915,8.8028315863072,0.641511505077021,0.929411764705882,0.718181818181818,0.708695842184269,53461.9746835443,32926.6075949367,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_650223,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
650810,4777.92832764505,1245.33788395904,121.757679180887,647.174061433447,1616.39590443686,3247.39590443686,3110.34470989761,268.174061433447,1138.80546075085,6897.62116040956,667.252559726962,136.358361774744,1091.54607508532,3955.49488054607,1298.83959044369,3277.8976109215,9159.32081911263,4003.16723549488,377.962457337884,245.928327645051,1060.0409556314,4249.75085324232,267.447098976109,427.651877133106,738.952218430034,1561.47440273038,502.873720136519,239.440273037543,1071.21501706485,132.180887372014,293,24.352614204797,16.0406833621325,0.752419472166963,0.904320987654321,0.670480549199085,0.528470001002813,52835.9897610921,33603.0546075085,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_650810,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
651867,1868.91707317073,476.287804878049,147.907317073171,655.678048780488,2277.01951219512,900.551219512195,270.468292682927,255.712195121951,1084.04390243902,4001.76097560976,802.751219512195,128.034146341463,1068.97073170732,960.624390243902,710.985365853659,290.873170731707,1604.85365853659,1620.46341463415,287.029268292683,219.258536585366,999.307317073171,1658.78536585366,207.009756097561,665.409756097561,685.234146341463,966.087804878049,450.990243902439,231.643902439024,1032.50243902439,130.49756097561,205,27.586587692703,9.64814178549536,0.936846686599097,0.907079646017699,0.632716049382716,1.35293140456499,53745.9219512195,32598.4390243902,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_651867,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
651994,2001.29,232.53,101.86,642.58,1607.77,258.73,255.04,252.55,1078.68,3257.41,510.85,149.12,1056.58,719.19,606.79,262.88,1623.49,983.83,283.96,217.25,991.28,901.05,194.26,109.94,586.16,1162.84,460.02,220.08,1015.15,128.41,100,14.695645291235,9.19180120945855,0.780241891388731,0.925925925925926,0.641025641025641,0.681948396328804,53689.93,32545.87,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_651994,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
652495,1382.95360824742,273.479381443299,132.515463917526,631.469072164948,2129.72164948454,286.603092783505,264.432989690722,246.072164948454,1074.67525773196,2202.36597938144,541.268041237113,121.396907216495,1079.50515463918,616.036082474227,430.201030927835,270.639175257732,1394.30927835052,985.39175257732,276.221649484536,224.670103092784,979.484536082474,928.10824742268,198.134020618557,118.237113402062,583.345360824742,1062.01030927835,507.010309278351,227.278350515464,1023.61855670103,129.628865979381,194,19.005141604949,13.106383112906,0.72416855283499,0.96039603960396,0.76984126984127,-1.18095467425282,53595.1288659794,32942.1340206186,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_652495,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
653935,3870.4440433213,973.050541516246,106.397111913357,616.306859205776,803.787003610108,369.545126353791,294.628158844765,245.678700361011,1075.96750902527,5247.40433212996,537.227436823105,121.270758122744,1093.98916967509,627.949458483754,406.494584837545,265.270758122744,1377.67509025271,982.772563176895,248.620938628159,219.902527075812,985.72202166065,887.111913357401,203.823104693141,126.595667870036,582.624548736462,1252.76173285199,495.667870036101,231.530685920578,1021.75812274368,129.505415162455,277,24.1621725468744,14.6037255896944,0.796677608419484,0.968531468531468,0.69949494949495,-0.586505789445659,54174.5126353791,33103.7328519856,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_653935,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
654756,4386.53284671533,1584.06569343066,2489.35766423358,652.167883211679,1639.28467153285,624.817518248175,511.627737226277,257.248175182482,1114.55474452555,7121.67883211679,713.36496350365,132.094890510949,1091.39416058394,5030.91240875912,1103.85401459854,320.109489051095,9350.89781021898,3266.40145985401,351.817518248175,244.255474452555,1025.00729927007,1910.75182481752,246.832116788321,293.875912408759,641.518248175183,3063.67153284672,611.861313868613,275.175182481752,1089.89781021898,134.350364963504,137,15.3271540536037,11.8344457629313,0.635473300242619,0.931972789115646,0.702564102564103,1.01761177339832,53313.5839416058,33365.4233576642,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_654756,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
655619,2146.14102564103,146.894230769231,61.349358974359,636.772435897436,1357.59935897436,1618.1891025641,712.125,248.689102564103,1087.16346153846,3613.81730769231,579.224358974359,112.849358974359,1075.23397435897,3296.74358974359,643.25641025641,403.282051282051,1695.0608974359,4330.61538461538,382.246794871795,244.028846153846,1059.72756410256,4762.53205128205,263.641025641026,748.060897435897,925.673076923077,1293.05128205128,490.022435897436,608.660256410256,1030.97115384615,129.108974358974,312,31.4969566705715,12.7872609003528,0.913880178312938,0.925816023738872,0.632860040567951,1.26577460030805,53465.4967948718,33654.5865384615,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_655619,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
655841,5042.52397260274,397.469178082192,119.212328767123,669.623287671233,2922.61301369863,225.900684931507,229.380136986301,234.630136986301,1075.26712328767,8629.18835616438,1667.04794520548,138.493150684931,1081.09931506849,466.013698630137,317.52397260274,254.804794520548,1389.87671232877,753.845890410959,193.746575342466,207.958904109589,987.667808219178,639.369863013699,137.893835616438,121.044520547945,587.366438356164,2287.8801369863,530.486301369863,380.708904109589,1120.95547945205,132.174657534247,292,23.9758427867408,15.6267216325713,0.758417165391002,0.963696369636964,0.737373737373737,-0.534498602991587,53121.3287671233,33010.3561643836,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_655841,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
657557,1765.34920634921,174.809523809524,90.7460317460318,646.640211640212,2140.89947089947,303.037037037037,301.243386243386,254.338624338624,1082.73544973545,2893.95238095238,566.449735449735,132.042328042328,1070.36507936508,674.497354497355,650.15873015873,279.37037037037,1429.80423280423,1511.68253968254,347.185185185185,234.57671957672,1001.57142857143,1335.26455026455,240.925925925926,179.296296296296,649.809523809524,1155.96296296296,498.624338624339,247.439153439153,1076.19047619048,130.42328042328,189,20.3221798451751,11.9207332200673,0.809885982098863,0.954545454545455,0.675,1.15741852434962,53176.2169312169,32986.4603174603,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_657557,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
657616,1734.51540616247,548.672268907563,143.347338935574,652.627450980392,2599.38095238095,625.47619047619,370.893557422969,264.056022408964,1145.74509803922,3113.93837535014,1818.73669467787,120.212885154062,1070.57142857143,665.386554621849,372.924369747899,272.406162464986,1431.6918767507,853.571428571429,188.501400560224,226.826330532213,1120.12885154062,766.467787114846,150.649859943978,175.498599439776,645.577030812325,1102.96638655462,471.834733893557,395.980392156863,1065.37535014006,130.725490196078,357,27.5475340318234,16.6826133526179,0.795773999112728,0.962264150943396,0.722672064777328,-0.408936229994375,53263.5770308123,33084.0196078431,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_657616,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
658035,2362.76712328767,590.83904109589,158.332191780822,637.143835616438,1394.53424657534,1768.99315068493,2351.15410958904,261.914383561644,1085.75342465753,3109.36301369863,1160.42123287671,134.931506849315,1070.78424657534,664.921232876712,509.291095890411,274.325342465753,1476.24657534247,953.208904109589,243.989726027397,217.893835616438,989.178082191781,875.558219178082,181.243150684931,124.376712328767,592.140410958904,917.626712328767,454.260273972603,218.321917808219,1028.57534246575,130.147260273973,292,27.1970153558985,13.7401346153387,0.862997936508048,0.948051948051948,0.648888888888889,-0.475834231280535,52433.2979452055,32374.698630137,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_658035,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
661212,3567.98494623656,1130.34408602151,175.32688172043,632.587096774194,1228.59784946237,868.051612903226,644.286021505376,247.978494623656,1092.81935483871,5153.04946236559,607.217204301075,122.834408602151,1086.25376344086,3536.07741935484,969.03440860215,412.722580645161,7697.09032258065,6238.0,419.718279569893,247.202150537634,1036.77634408602,6174.07096774194,264.939784946237,324.290322580645,636.410752688172,1189.90967741935,462.574193548387,238.916129032258,1031.11827956989,131.060215053763,465,26.4127778508884,22.4725371187408,0.525456184898865,0.970772442588726,0.775,-0.980463809887533,52904.7849462366,33643.0731182796,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_661212,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
661591,1965.55387523629,221.950850661626,52.3667296786389,630.198487712665,1139.42155009452,933.818525519849,617.741020793951,257.531190926276,1114.86389413989,2766.30434782609,1289.09829867675,133.512287334594,1070.32514177694,993.640831758034,883.792060491493,376.546313799622,3074.96219281664,1930.55387523629,348.500945179584,235.741020793951,1028.70888468809,1882.78827977316,235.189035916824,257.47258979206,1011.76748582231,902.587901701323,442.143667296786,280.574669187146,1032.17391304348,130.648393194707,529,36.6013231606919,18.8111977834343,0.85782099823388,0.960072595281307,0.629761904761905,0.8552962925998,53020.1323251418,33782.8506616257,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_661591,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
661694,5066.3670886076,1635.39873417722,192.113924050633,697.981012658228,4574.9746835443,754.544303797468,1390.58227848101,251.613924050633,1127.39240506329,7689.11392405063,807.221518987342,138.164556962025,1091.3417721519,3645.50632911392,1479.8164556962,480.537974683544,2448.60126582278,4432.03797468354,414.259493670886,252.151898734177,1056.22784810127,4035.21518987342,252.417721518987,283.208860759494,748.563291139241,2228.01265822785,615.139240506329,480.354430379747,1076.86708860759,133.405063291139,158,18.1173013127409,12.1656524000486,0.741010328313196,0.863387978142076,0.593984962406015,-0.088386996983624,53061.4746835443,33541.1265822785,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_661694,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
661872,2701.24060150376,202.345864661654,144.165413533835,684.5,2543.24436090226,1570.10526315789,313.093984962406,254.296992481203,1085.46240601504,4863.6992481203,881.270676691729,119.09022556391,1084.36842105263,723.575187969925,480.477443609023,272.789473684211,1424.08646616541,1099.73308270677,274.473684210526,224.135338345865,982.424812030075,1049.42105263158,207.496240601504,174.894736842105,585.496240601504,1396.05263157895,473.330827067669,230.654135338346,1036.24812030075,130.240601503759,266,26.1768639758721,13.0785799289298,0.866242589282387,0.956834532374101,0.78698224852071,1.46791553486381,53512.969924812,32973.2819548872,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_661872,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
662639,550.917910447761,1021.27985074627,244.951492537313,618.694029850746,110.902985074627,3119.69402985075,2926.11567164179,269.138059701493,1089.29850746269,1273.36194029851,886.731343283582,120.481343283582,1065.21268656716,3845.88432835821,1489.24626865672,1861.05970149254,3726.50373134328,5093.89552238806,503.317164179104,240.981343283582,1068.83208955224,3408.38805970149,236.227611940298,308.09328358209,709.873134328358,559.906716417911,338.041044776119,193.996268656716,983.089552238806,126.018656716418,268,20.437431256139,16.8179147591874,0.568189588769488,0.95373665480427,0.788235294117647,-0.398322059455563,52874.3843283582,32422.5970149254,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_662639,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
663125,1763.27433628319,258.017699115044,103.247787610619,615.601769911504,674.920353982301,445.70796460177,463.53982300885,251.761061946903,1098.54867256637,3652.3185840708,483.973451327434,121.061946902655,1079.42477876106,2547.27433628319,618.176991150443,336.044247787611,1937.75221238938,1934.59292035398,315.221238938053,235.265486725664,1110.81415929204,1247.13274336283,205.628318584071,223.176991150442,4913.32743362832,2135.78761061947,487.637168141593,224.70796460177,1019.16814159292,130.522123893805,113,19.1387024684111,7.66923229386439,0.916201221090492,0.91869918699187,0.660818713450292,-1.32227334774401,52651.3451327434,33036.0442477876,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_663125,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
663490,2369.6365914787,793.794486215539,1628.78195488722,653.551378446115,2116.07268170426,654.012531328321,286.927318295739,237.588972431078,1090.5037593985,3629.45112781955,805.285714285714,116.115288220551,1078.2380952381,688.471177944862,350.854636591479,275.593984962406,1536.36090225564,850.967418546366,224.213032581454,221.095238095238,1028.90476190476,738.275689223058,159.488721804511,165.152882205514,597.152882205514,1070.65664160401,483.0,666.190476190476,1049.33834586466,129.451127819549,399,23.7710963348611,21.4109516734937,0.434413242709969,0.956834532374101,0.791666666666667,0.120152740818973,53759.8145363409,33685.3709273183,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_663490,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
664383,1369.2347826087,236.591304347826,118.973913043478,628.713043478261,1049.11304347826,274.565217391304,279.069565217391,248.547826086956,1074.75652173913,2752.68695652174,613.24347826087,145.652173913043,1080.11304347826,623.913043478261,414.217391304348,266.573913043478,1412.39130434783,1007.8347826087,283.35652173913,228.034782608696,986.486956521739,959.147826086957,217.55652173913,132.313043478261,583.286956521739,1222.6347826087,470.826086956522,220.304347826087,1010.24347826087,127.182608695652,115,20.6268937740744,7.12487494803314,0.938449389950932,0.912698412698413,0.71875,-1.43049737887386,52488.6086956522,33135.7130434783,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_664383,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
664778,6864.30368098159,1770.18404907975,600.628834355828,650.855828220859,1856.57668711656,338.527607361963,303.509202453988,246.990797546012,1079.37423312883,9747.34969325153,740.518404907975,136.355828220859,1089.65337423313,2744.69938650307,723.533742331288,320.975460122699,2963.86503067485,3578.51840490798,391.947852760736,266.947852760736,1040.36809815951,2594.79754601227,1194.23926380368,332.141104294479,597.601226993865,2418.80674846626,560.923312883436,263.726993865031,1044.07668711656,131.325153374233,326,24.0139680310226,17.5644088407954,0.681922238994131,0.96165191740413,0.78743961352657,0.384820026864578,53307.7914110429,33383.3098159509,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_664778,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
664905,1513.98557692308,231.759615384615,111.427884615385,631.379807692308,1800.17307692308,597.572115384615,381.110576923077,270.048076923077,1127.95192307692,3501.76442307692,2172.14903846154,119.370192307692,1078.78365384615,861.884615384615,467.418269230769,277.139423076923,1500.42307692308,1025.65865384615,211.735576923077,212.466346153846,1110.11057692308,864.682692307692,167.927884615385,118.591346153846,600.495192307692,1113.68269230769,442.947115384615,419.206730769231,1047.09615384615,130.567307692308,208,20.7403405899754,12.9482596906516,0.781182176742079,0.949771689497717,0.8,0.0598828492570912,53989.1730769231,32665.4759615385,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_664905,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
665324,3194.18928571429,228.885714285714,97.6107142857143,642.775,1652.92857142857,1909.22857142857,2319.96785714286,251.821428571429,1121.95714285714,4645.91428571429,1622.99642857143,138.035714285714,1080.17857142857,3458.36428571429,873.342857142857,1031.77857142857,2391.4,7665.7,449.578571428571,249.210714285714,1178.13928571429,7882.50357142857,296.078571428571,261.753571428571,692.353571428571,1012.17142857143,463.714285714286,586.539285714286,1049.89642857143,132.092857142857,280,22.0139449744992,16.3365591675613,0.670288650660561,0.955631399317406,0.736842105263158,-0.523650178296338,53218.4464285714,33829.0,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_665324,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
666099,1674.32589285714,222.915178571429,159.133928571429,687.040178571429,3923.31696428571,1176.90625,290.410714285714,250.397321428571,1104.88839285714,3323.67857142857,670.357142857143,125.348214285714,1078.63392857143,2823.18303571429,561.138392857143,304.629464285714,1850.96875,3463.63392857143,360.852678571429,234.017857142857,1025.09375,2343.66071428571,216.892857142857,1379.28571428571,1856.94196428571,1153.72321428571,463.660714285714,226.674107142857,1040.65178571429,129.321428571429,224,22.5669493898398,12.9720687708473,0.818275683454024,0.945147679324894,0.711111111111111,1.20465252697455,52913.4017857143,32906.8794642857,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,1,FAAGSCC_12_666099,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
666598,2294.26617375231,190.541589648798,103.907578558226,639.634011090573,2063.07578558225,321.543438077634,744.990757855822,240.051756007394,1077.16451016636,4512.18669131238,680.040665434381,118.720887245841,1085.60443622921,1035.90388170055,759.445471349353,580.486136783734,1931.85212569316,1995.0258780037,380.735674676525,243.090573012939,1028.27171903882,1849.28096118299,244.510166358595,632.743068391867,610.31977818854,2273.31608133087,543.844731977819,259.695009242144,1057.2033271719,130.950092421442,541,35.6758384140755,19.8259778455481,0.831365757095164,0.945804195804196,0.647129186602871,-0.155372330797344,53457.9907578558,33544.7024029575,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_666598,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
666716,1350.59375,275.645220588235,158.262867647059,658.639705882353,2947.52022058824,283.623161764706,348.073529411765,252.229779411765,1079.10477941176,2313.21139705882,1079.99080882353,275.428308823529,1108.69117647059,801.154411764706,495.972426470588,269.571691176471,1412.93382352941,1157.22977941176,292.689338235294,226.84375,977.415441176471,1058.67647058824,220.834558823529,157.875,586.818014705882,1010.73529411765,483.689338235294,220.551470588235,1026.01470588235,131.055147058824,544,28.6973592925384,24.3628021470949,0.52846315693226,0.951048951048951,0.747252747252747,1.14187426819678,52515.1617647059,33117.9595588235,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_666716,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
668446,2742.70854271357,416.603015075377,520.582914572864,615.8391959799,620.145728643216,445.934673366834,432.336683417086,241.587939698492,1076.79899497487,4902.14070351759,577.603015075377,137.422110552764,1079.91959798995,1705.8743718593,827.718592964824,1495.81909547739,2018.45226130653,3020.13065326633,368.35175879397,240.869346733668,1083.74874371859,2003.41206030151,260.643216080402,782.437185929648,695.924623115578,2516.66331658291,545.050251256281,320.060301507538,1043.5527638191,130.497487437186,199,18.93860422958,13.761044277463,0.68704651644755,0.952153110047847,0.731617647058823,0.605794129686338,53393.1005025126,33756.3668341709,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_668446,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
668651,2292.09360730594,460.276255707763,110.51598173516,629.022831050228,1454.66210045662,663.08904109589,621.376712328767,259.294520547945,1089.96803652968,4729.22831050228,553.216894977169,117.011415525114,1068.59360730594,2427.85844748858,626.819634703196,307.545662100457,3803.01826484018,2721.07305936073,320.62100456621,228.385844748858,1002.94063926941,2100.98401826484,214.111872146119,129.141552511416,595.029680365297,1918.36757990868,522.438356164384,238.575342465753,1039.19178082192,130.050228310502,438,24.9466111597313,22.6221453534517,0.421512950683913,0.958424507658643,0.732441471571906,-0.0925193338212872,54038.4292237443,32897.5821917808,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_668651,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
669492,2541.10119047619,187.988095238095,63.1398809523809,633.800595238095,1422.24702380952,2327.87202380952,374.095238095238,264.46130952381,1103.4255952381,5170.68154761905,953.895833333333,134.982142857143,1070.72916666667,2504.10119047619,1036.09821428571,1907.52083333333,2125.87202380952,2330.90773809524,318.785714285714,228.238095238095,1042.36607142857,1621.35416666667,222.895833333333,563.97619047619,863.547619047619,1976.55654761905,511.235119047619,348.845238095238,1098.27083333333,131.46130952381,336,26.4869618588927,16.5598517995065,0.780458432659191,0.954545454545455,0.736842105263158,1.13728472497697,52469.3214285714,32621.2232142857,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_669492,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
669859,3661.06808510638,307.36170212766,195.978723404255,686.157446808511,3739.05106382979,1791.53191489362,393.11914893617,261.085106382979,1103.89787234043,6375.52340425532,2430.18723404255,124.374468085106,1076.10212765957,823.008510638298,513.736170212766,284.923404255319,1772.40425531915,1232.5829787234,318.391489361702,233.404255319149,993.285106382979,1115.25957446809,240.191489361702,144.370212765957,619.110638297872,2324.88085106383,525.514893617021,628.957446808511,1072.30638297872,131.446808510638,235,22.7997410584576,13.8072720674735,0.795777594619375,0.883458646616541,0.628342245989305,1.11578257857049,53340.2595744681,33384.8255319149,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_669859,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
670649,2524.66028708134,244.511961722488,135.99043062201,643.057416267943,2427.95215311005,1231.48325358852,368.617224880383,252.066985645933,1090.13875598086,4677.93301435407,588.406698564593,119.416267942584,1090.04784688995,2144.35406698565,1513.70813397129,379.435406698565,2214.34928229665,3389.15311004785,337.822966507177,234.631578947368,1035.83732057416,2479.8947368421,224.531100478469,869.291866028708,771.464114832536,1481.14354066986,521.822966507177,229.44019138756,1055.26794258373,129.11004784689,209,22.6311921574979,11.779395830884,0.853865431641994,0.945701357466063,0.791666666666667,-0.115821283693785,53871.4449760766,33034.1818181818,FAAGSCC_12,AG,1,stromal cells,,TIM3+,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_670649,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
671153,1147.84649122807,241.048245614035,485.381578947368,893.429824561404,16143.2587719298,513.232456140351,361.706140350877,240.328947368421,1072.62280701754,2552.61403508772,587.197368421053,136.995614035088,1069.95614035088,1548.07456140351,624.385964912281,643.30701754386,1737.9298245614,2825.37280701754,341.359649122807,237.478070175439,991.837719298246,2985.22807017544,263.390350877193,288.315789473684,638.605263157895,1263.19736842105,475.276315789474,350.627192982456,1080.17543859649,130.377192982456,228,22.7557401205861,12.9740699715204,0.82154412730802,0.946058091286307,0.633333333333333,-0.68796687428152,53882.4605263158,33631.1622807018,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_671153,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
672127,3018.32958801498,425.385767790262,322.898876404494,655.367041198502,2649.0074906367,621.823970037453,388.149812734082,247.883895131086,1088.85393258427,4591.16479400749,492.756554307116,117.730337078652,1097.05992509363,4439.0861423221,752.87265917603,767.325842696629,6743.24344569288,5691.55056179775,394.056179775281,242.370786516854,1036.63670411985,4983.35580524345,336.0,210.037453183521,680.940074906367,952.228464419476,466.655430711611,256.468164794007,1022.01872659176,130.037453183521,267,22.6172370003024,15.4485057188431,0.73037980369612,0.956989247311828,0.674242424242424,0.446075013740442,53952.4531835206,33575.5093632959,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_672127,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
672150,2836.2472826087,548.728260869565,94.0135869565217,650.801630434783,2109.39945652174,3508.09510869565,825.58152173913,259.83152173913,1119.48641304348,4140.03260869565,1825.82880434783,135.369565217391,1078.89673913043,2817.86141304348,767.290760869565,984.45652173913,6864.63586956522,3722.90760869565,342.475543478261,238.451086956522,1507.70108695652,3821.99184782609,278.698369565217,246.347826086957,666.654891304348,1121.21195652174,473.04347826087,439.872282608696,1041.91576086957,130.059782608696,368,23.3959233517221,20.8496220428434,0.453679842144824,0.941176470588235,0.761904761904762,0.386728493477899,53208.4076086957,33790.1657608696,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_672150,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
673113,980.986666666667,885.473333333333,222.666666666667,657.856666666667,2097.13333333333,289.776666666667,299.24,259.05,1078.98333333333,2949.11,1104.86666666667,138.483333333333,1067.72,639.58,470.54,266.55,1343.77333333333,1059.98666666667,314.69,230.056666666667,974.14,1045.2,233.41,120.57,589.696666666667,1040.91666666667,451.813333333333,229.343333333333,1068.18,129.74,300,25.4947453319457,15.0840373468596,0.806192886068037,0.952380952380952,0.75,-1.29483992311676,53243.64,32613.5966666667,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_673113,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
673526,816.214285714286,236.038961038961,199.38961038961,728.837662337662,6288.91558441558,276.831168831169,273.272727272727,235.655844155844,1081.87662337662,2097.8961038961,561.974025974026,119.753246753247,1072.15584415584,1324.8961038961,595.941558441558,303.902597402597,1597.36363636364,6526.14285714286,449.298701298701,246.279220779221,1094.4025974026,2448.03246753247,213.863636363636,170.837662337662,590.519480519481,1260.98701298701,498.967532467532,291.655844155844,1053.48051948052,128.512987012987,154,16.4701359564994,11.9505049099368,0.68813118661777,0.956521739130435,0.733333333333333,-0.674187154710961,53720.3831168831,33342.2532467532,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_673526,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
673699,891.225352112676,242.746478873239,50.2957746478873,609.971830985916,795.450704225352,901.760563380282,2348.43661971831,257.140845070423,1082.49295774648,1268.76056338028,2303.74647887324,107.802816901408,1076.15492957746,715.619718309859,483.788732394366,309.183098591549,1711.08450704225,985.028169014084,250.028169014085,218.704225352113,1022.22535211268,915.323943661972,194.56338028169,173.014084507042,678.352112676056,719.985915492958,374.577464788732,249.887323943662,1014.70422535211,128.154929577465,71,10.2169912022111,8.84661319854066,0.500264492287841,0.946666666666667,0.71,0.850092291517957,52805.3802816901,32280.0563380282,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_673699,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
674213,1445.73262032086,330.941176470588,88.6631016042781,624.561497326203,1296.67379679144,736.994652406417,337.090909090909,244.727272727273,1111.20320855615,2294.43315508021,793.080213903743,115.181818181818,1072.90374331551,2847.49197860963,594.090909090909,352.657754010695,1889.27272727273,2899.60427807487,369.181818181818,385.561497326203,1030.05347593583,2706.58288770053,279.636363636364,1041.96256684492,1111.7486631016,974.0,455.866310160428,388.326203208556,1039.3743315508,130.122994652406,187,17.5827754710415,14.0045481979363,0.604648452618148,0.949238578680203,0.785714285714286,-1.52413854564233,52889.5454545455,33525.5935828877,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,9,FAAGSCC_12_674213,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
674333,1675.40666666667,340.323333333333,136.903333333333,668.28,3602.23666666667,2022.09666666667,319.553333333333,246.656666666667,1135.55,3667.46,542.663333333333,116.466666666667,1091.57333333333,3179.04,830.28,308.223333333333,2541.17333333333,3300.66333333333,326.33,228.513333333333,1052.22,2508.26333333333,210.223333333333,173.986666666667,582.27,1563.69333333333,505.556666666667,264.19,1041.69,130.266666666667,300,26.9322556803187,14.5936456329058,0.840465564843883,0.923076923076923,0.631578947368421,1.09399703102063,53716.4733333333,33303.47,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_674333,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
674343,2732.58050847458,374.885593220339,202.728813559322,685.809322033898,4332.98305084746,289.046610169492,293.35593220339,256.550847457627,1078.39406779661,4894.44915254237,543.233050847458,131.292372881356,1117.18220338983,735.059322033898,516.419491525424,275.944915254237,1415.51694915254,1125.13559322034,330.21186440678,236.817796610169,985.813559322034,1043.18220338983,237.885593220339,146.258474576271,586.682203389831,1869.02966101695,506.588983050847,223.665254237288,1067.07203389831,131.186440677966,236,17.9691717068769,16.8181972322517,0.352140177705523,0.955465587044534,0.728395061728395,-1.09237225618872,52705.4194915254,33107.2966101695,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_674343,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
674782,766.169014084507,105.556338028169,67.9014084507042,639.056338028169,1532.49295774648,405.042253521127,1123.4014084507,231.471830985915,1078.99295774648,1410.96478873239,855.295774647887,107.330985915493,1064.64788732394,871.584507042254,661.746478873239,1071.1338028169,1694.59154929577,1070.73943661972,314.697183098592,219.87323943662,1022.38028169014,973.570422535211,195.767605633803,721.415492957746,599.394366197183,804.380281690141,451.87323943662,326.295774647887,1023.69014084507,130.661971830986,142,14.1046885947642,12.9900711810844,0.389620735759964,0.972602739726027,0.78021978021978,1.12364675524677,53583.5,33641.6126760563,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_674782,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
675664,1237.11042944785,387.573619631902,151.398773006135,655.871165644172,2744.9509202454,1119.61963190184,708.748466257669,260.435582822086,1085.67484662577,2801.50613496933,3235.26073619632,119.125766871166,1084.61656441718,1514.73926380368,1010.8036809816,310.205521472393,1745.65644171779,1269.83128834356,269.242331288344,225.926380368098,1000.86503067485,1001.09202453988,199.981595092024,151.533742331288,630.015337423313,1312.68404907975,464.527607361963,429.110429447853,1044.49386503067,129.435582822086,326,27.9814166777708,15.0743278469231,0.84248078136816,0.926136363636364,0.727678571428571,0.0241360944542499,54171.9325153374,32905.1901840491,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_675664,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
675702,1207.40977443609,72.9398496240601,54.7706766917293,634.041353383459,1150.6954887218,198.357142857143,225.962406015038,243.823308270677,1076.74060150376,1143.24436090226,4041.42857142857,120.759398496241,1065.26315789474,418.624060150376,293.996240601504,245.601503759398,1344.45864661654,676.466165413534,162.624060150376,202.537593984962,985.860902255639,601.432330827068,136.781954887218,95.5413533834586,579.31954887218,709.913533834586,391.0,236.808270676692,1009.76691729323,131.575187969925,266,23.3181773210172,14.6550539319106,0.777824156289591,0.95,0.703703703703704,0.558836720567526,53226.992481203,31912.7894736842,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_675702,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
676484,2578.34,607.372,122.912,654.572,1940.64,782.592,2552.796,244.78,1110.088,3805.788,3101.544,118.548,1097.888,735.6,553.612,539.344,1492.792,976.02,270.208,227.336,997.02,930.448,208.876,160.516,584.824,1118.964,460.448,501.944,1052.628,128.296,250,22.4078094373316,15.5732127777229,0.719019000586973,0.886524822695035,0.661375661375661,0.358608246188573,53288.764,33580.932,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_676484,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
676825,1549.79813084112,304.52523364486,96.1607476635514,611.452336448598,674.357009345794,324.564485981308,310.979439252336,260.736448598131,1082.9214953271,1900.85607476636,1625.03364485981,114.863551401869,1065.31588785047,698.43738317757,526.08785046729,276.85046728972,1355.65981308411,1068.80186915888,348.485981308411,235.966355140187,977.076635514019,1019.60934579439,253.299065420561,127.590654205607,584.710280373832,826.495327102804,463.207476635514,245.902803738318,1014.25046728972,130.218691588785,535,31.4540741285311,21.7313179237816,0.722959509393817,0.965703971119134,0.784457478005865,-1.40993602245672,53444.308411215,32648.5495327103,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_676825,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
678658,6454.17699115044,1792.57079646018,1774.88938053097,646.455752212389,1869.13274336283,2615.29646017699,594.137168141593,267.384955752212,1129.13274336283,10053.7699115044,684.557522123894,132.911504424779,1107.05752212389,2049.85840707965,836.544247787611,365.889380530973,3355.82743362832,1712.34955752212,314.442477876106,289.37610619469,1013.88053097345,1157.3982300885,229.234513274336,201.340707964602,606.96017699115,1415.99115044248,490.973451327434,233.730088495575,1020.64159292035,133.057522123894,226,20.3888810914102,14.6800904547457,0.693969174346661,0.896825396825397,0.660818713450292,0.715173789811207,53300.0,33365.5530973451,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_678658,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
678738,1838.21304347826,645.408695652174,103.613043478261,637.8,1937.9347826087,261.160869565217,256.847826086957,228.05652173913,1080.0347826087,3622.91739130435,522.821739130435,115.086956521739,1075.34347826087,566.060869565217,422.830434782609,268.226086956522,1477.87826086957,855.426086956522,195.147826086957,209.417391304348,996.808695652174,750.65652173913,162.347826086957,135.104347826087,653.791304347826,1681.12608695652,482.691304347826,248.765217391304,1046.43043478261,130.073913043478,230,20.9741706988772,14.1530309290042,0.738015448670603,0.958333333333333,0.751633986928105,0.674682137350063,53105.747826087,33450.7608695652,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_678738,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
678888,665.63436123348,100.118942731278,69.568281938326,622.788546255507,1016.64317180617,2135.14537444934,403.171806167401,248.25550660793,1091.78414096916,1387.61674008811,520.370044052863,100.960352422907,1081.96475770925,1027.11894273128,427.894273127753,278.039647577093,1689.0,2786.45814977974,311.383259911894,232.850220264317,1081.39647577093,2421.85022026432,213.63436123348,197.832599118943,973.04845814978,801.171806167401,436.969162995595,230.132158590308,1020.92070484581,129.700440528634,227,23.1145405001195,12.5466203311912,0.839860653603248,0.965957446808511,0.66374269005848,-0.7121431262514,52498.0484581498,33640.8854625551,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_678888,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
679180,3080.04166666667,757.868421052632,157.717105263158,676.84649122807,3338.57456140351,846.866228070175,431.550438596491,237.440789473684,1082.78947368421,4977.92543859649,1119.5350877193,122.309210526316,1087.26754385965,2451.9298245614,705.747807017544,332.910087719298,5680.09649122807,3023.93859649123,326.160087719298,231.348684210526,1035.03289473684,2356.97587719298,214.445175438596,214.304824561404,612.756578947368,1513.05043859649,527.434210526316,517.532894736842,1078.4649122807,132.583333333333,456,26.5362369212057,22.6993365165562,0.51795308883105,0.95397489539749,0.7296,-1.06078177768584,53463.225877193,33510.2807017544,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_679180,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
679253,3794.66336633663,469.940594059406,99.3069306930693,628.336633663366,759.787128712871,311.99504950495,342.816831683168,266.663366336634,1086.75742574257,7379.08415841584,1363.55940594059,127.089108910891,1083.16831683168,1061.74752475248,681.386138613861,298.658415841584,1681.80693069307,1415.27227722772,358.707920792079,233.910891089109,1061.39603960396,1133.74752475248,233.737623762376,160.643564356436,583.990099009901,2994.89603960396,535.762376237624,278.935643564356,1080.65346534653,131.564356435644,202,21.1064935577375,12.7568446132235,0.796678143040317,0.922374429223744,0.625386996904025,-0.79007180585456,52542.801980198,33204.4059405941,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_679253,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
679567,2807.36028119508,419.15992970123,109.355008787346,641.31985940246,1801.62917398946,370.602811950791,379.077328646749,245.256590509666,1088.47451669596,4201.89806678383,1201.0913884007,118.899824253076,1083.90509666081,774.799648506151,567.082601054482,333.613356766257,1676.61159929701,1214.1072056239,287.678383128295,229.891036906854,1013.9525483304,1112.21616871705,208.961335676626,242.420035149385,605.530755711775,973.966608084358,440.151142355009,364.506151142355,1031.97188049209,130.369068541301,569,33.0688448131369,22.5597019772721,0.731161778828677,0.961148648648649,0.727621483375959,0.09623151086172,53121.9173989455,33590.3901581722,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_679567,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
679956,1336.95562130178,192.724852071006,109.757396449704,656.334319526627,2707.36686390533,417.772189349112,342.301775147929,246.41124260355,1137.83136094675,3247.44970414201,540.263313609467,112.582840236686,1070.44378698225,797.579881656805,947.819526627219,279.721893491124,1503.83431952663,1262.09467455621,282.269230769231,224.038461538462,994.109467455621,1024.57100591716,193.668639053254,144.834319526627,594.988165680473,1573.86982248521,481.038461538462,230.795857988166,1042.12721893491,128.804733727811,338,26.8859559739648,16.1333473678896,0.799950514985486,0.957507082152974,0.670634920634921,-0.696422476167278,53757.4467455621,32930.375739645,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_679956,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
680204,1618.37,256.79,114.98,632.77,2164.36,279.69,281.16,244.01,1072.84,2731.24,532.73,114.95,1068.96,1362.58,532.15,365.19,1485.99,2577.98,276.32,223.79,1002.35,2566.83,203.83,185.22,615.61,1172.38,519.35,236.44,1022.58,130.75,100,12.4131115609497,10.3852713674423,0.54775736646527,0.943396226415094,0.699300699300699,1.30818405438088,53546.38,33184.62,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_680204,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
681315,2367.61494252874,394.373563218391,151.913793103448,636.51724137931,1832.2183908046,674.465517241379,344.367816091954,263.120689655172,1086.55747126437,2749.12068965517,588.166666666667,126.080459770115,1078.99425287356,890.477011494253,680.264367816092,273.545977011494,1787.95402298851,1263.17816091954,280.304597701149,219.275862068966,1112.86781609195,925.465517241379,171.735632183908,136.01724137931,1254.84482758621,924.281609195402,443.17816091954,216.19540229885,1012.35632183908,129.229885057471,174,24.2458256173971,9.21316679773206,0.924990670375326,0.93048128342246,0.687747035573123,1.30013564833776,52827.2011494253,32564.8505747126,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,1,FAAGSCC_12_681315,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
681687,2877.33928571429,421.053571428571,204.353571428571,678.967857142857,4237.89285714286,541.242857142857,450.692857142857,246.939285714286,1089.76785714286,4645.69285714286,532.096428571429,120.825,1097.975,1639.45714285714,531.189285714286,413.582142857143,2042.21071428571,3831.84285714286,346.246428571429,235.107142857143,1018.68214285714,4548.375,329.489285714286,214.785714285714,607.557142857143,1019.33928571429,463.864285714286,247.107142857143,1023.36428571429,130.296428571429,280,22.5653003738981,16.2453784528577,0.694049358219756,0.955631399317406,0.736842105263158,0.805981420462689,53938.7464285714,33579.3857142857,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_681687,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
682910,1640.05633802817,451.605633802817,147.098591549296,650.830985915493,2795.74647887324,325.281690140845,297.183098591549,248.492957746479,1083.40845070423,2185.45070422535,957.084507042254,123.521126760563,1057.76056338028,683.450704225352,455.859154929578,318.521126760563,1602.69014084507,1137.30985915493,305.169014084507,229.816901408451,991.211267605634,1097.53521126761,229.887323943662,134.619718309859,597.957746478873,977.028169014084,475.056338028169,245.169014084507,1035.42253521127,129.394366197183,71,9.86203959219697,9.21313267275124,0.356745657382202,0.91025641025641,0.71,-1.21984855126923,52801.8873239437,33363.4084507042,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_682910,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
683687,2201.95024875622,452.009950248756,162.089552238806,665.587064676617,2818.30845771144,1389.18407960199,1454.16417910448,239.238805970149,1094.83084577114,3084.55721393035,2646.93532338308,140.422885572139,1075.54726368159,1162.19402985075,596.308457711443,699.517412935323,5886.1592039801,4149.60199004975,320.139303482587,235.945273631841,1077.67661691542,5094.34328358209,228.651741293532,424.761194029851,625.781094527363,1041.22885572139,511.686567164179,540.07960199005,1053.02487562189,132.149253731343,201,19.0173453493248,13.4942594234639,0.704628508210445,0.966346153846154,0.797619047619048,1.16809065730072,52741.6915422886,33756.1990049751,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_683687,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
683772,1645.7905982906,475.136752136752,848.794871794872,664.700854700855,2672.05555555556,2817.92307692308,1530.97008547009,263.683760683761,1135.51709401709,2320.91025641026,530.222222222222,132.923076923077,1071.07692307692,2557.47863247863,639.910256410256,344.74358974359,2028.92307692308,2686.90598290598,333.457264957265,235.132478632479,1031.34188034188,3919.38034188034,239.410256410256,242.888888888889,586.149572649573,948.123931623932,488.65811965812,401.564102564103,1041.14102564103,137.649572649573,234,22.4906035221364,13.4323923210453,0.802059127742448,0.955102040816326,0.709090909090909,-1.26921164607138,53543.9743589744,33797.0384615385,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_683772,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
684194,1764.53801169591,273.795321637427,101.982456140351,616.526315789474,652.514619883041,1121.61403508772,856.245614035088,236.058479532164,1092.01754385965,3214.59649122807,547.953216374269,114.081871345029,1071.08771929825,2747.72514619883,1916.40350877193,338.988304093567,10839.9883040936,6362.87134502924,435.140350877193,255.438596491228,1067.73099415205,5617.71929824562,264.222222222222,313.093567251462,695.730994152047,1458.3918128655,455.637426900585,229.485380116959,1022.52046783626,129.327485380117,171,17.5696440403582,13.0010374562123,0.672638122851906,0.977142857142857,0.773755656108597,0.083006514654428,52707.8245614035,33636.1111111111,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_684194,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
684851,2382.49132947977,148.251445086705,78.8468208092486,720.268786127168,2560.21387283237,4286.35549132948,467.598265895954,273.251445086705,1127.59537572254,4661.8063583815,942.618497109826,122.040462427746,1071.84393063584,3883.48843930636,793.167630057803,973.482658959538,2610.26589595376,2273.87572254335,329.71676300578,235.768786127168,1030.89595375723,1697.36994219653,214.413294797688,183.890173410405,638.841040462428,1935.23988439306,490.973988439306,290.606936416185,1059.19653179191,129.381502890173,346,28.1207966786858,15.6886462507117,0.829906895936963,0.955801104972376,0.772321428571429,0.12974811415007,52843.7196531792,33684.9595375723,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_684851,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
685112,3779.95435684647,371.699170124481,105.143153526971,630.03734439834,941.170124481328,2046.41286307054,1463.59128630705,254.08091286307,1094.67634854772,6375.98755186722,601.350622406639,133.607883817427,1076.78008298755,2752.86307053942,912.759336099585,1535.23236514523,7680.44605809129,5076.99170124481,414.251037344398,246.921161825726,1098.97925311203,5496.08921161826,264.572614107884,378.809128630705,709.923236514523,2094.21369294606,515.508298755187,252.354771784232,1070.11410788382,130.313278008299,482,28.0800723823237,21.8910392142805,0.626285976510941,0.967871485943775,0.782467532467532,0.161225043754619,52814.3423236514,33597.7199170125,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_685112,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
686231,5368.47197640118,1566.63421828909,373.778761061947,673.421828908555,2618.35693215339,2556.02359882006,464.106194690266,257.985250737463,1115.28908554572,8496.18879056047,633.684365781711,130.964601769911,1089.00294985251,1320.45722713864,659.457227138643,308.864306784661,2984.74926253687,3616.17994100295,341.191740412979,236.52802359882,1034.28613569322,3623.93510324484,226.637168141593,201.507374631268,586.085545722714,2021.2389380531,558.115044247788,234.141592920354,1074.1592920354,132.533923303835,339,26.6200528348187,16.4919149468089,0.784973169185371,0.954929577464789,0.724358974358974,0.305902341376485,52732.0825958702,33556.3303834808,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_686231,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
687217,2828.08018867925,139.349056603774,74.4669811320755,634.86320754717,1489.87735849057,703.264150943396,398.844339622641,242.919811320755,1094.83490566038,4350.14622641509,582.316037735849,119.240566037736,1072.76886792453,2183.68867924528,609.448113207547,490.278301886792,3535.98113207547,1764.14150943396,330.707547169811,367.570754716981,1008.73113207547,1390.65566037736,227.349056603774,188.929245283019,588.537735849057,835.759433962264,420.617924528302,217.061320754717,1021.93867924528,128.547169811321,212,22.6733923384135,12.3782880338693,0.837824958770661,0.938053097345133,0.656346749226006,-0.592372970698783,52648.6037735849,33557.6933962264,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_687217,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
687784,1564.52027027027,380.121621621622,141.47972972973,624.087837837838,1203.9527027027,279.540540540541,283.702702702703,252.358108108108,1076.33783783784,3622.93918918919,639.851351351351,132.506756756757,1070.82432432432,1861.09459459459,477.047297297297,283.013513513513,1523.70945945946,2874.0472972973,351.067567567568,229.304054054054,1104.16216216216,1924.80405405405,204.175675675676,817.412162162162,804.189189189189,1687.40540540541,522.648648648649,226.013513513514,1045.90540540541,130.871621621622,148,17.9973569795974,10.4788649182016,0.813013628976744,0.961038961038961,0.79144385026738,-1.28294304927706,53034.2905405405,32509.9324324324,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_687784,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
688061,1499.89928057554,105.647482014388,320.280575539568,890.618705035971,12449.1942446043,978.223021582734,384.676258992806,275.726618705036,1134.36690647482,2500.89928057554,798.482014388489,200.323741007194,1073.68345323741,2130.58992805755,804.676258992806,308.532374100719,2191.02158273381,2095.67625899281,369.122302158273,229.453237410072,1077.21582733813,1099.73381294964,197.381294964029,156.410071942446,6490.62589928058,802.309352517986,410.525179856115,213.697841726619,1031.3309352518,129.769784172662,139,22.082782567644,8.26550812919537,0.92730908188514,0.939189189189189,0.702020202020202,-0.140974641888828,53104.4028776978,32292.4604316547,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_688061,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
688126,5365.8253968254,638.138888888889,908.305555555556,638.40873015873,2029.90079365079,1737.96825396825,512.452380952381,256.218253968254,1096.78968253968,7947.91666666667,582.559523809524,121.428571428571,1073.81349206349,2758.80555555556,672.269841269841,980.134920634921,1986.90873015873,2374.85714285714,388.365079365079,228.071428571429,1074.19841269841,1506.60317460317,214.460317460317,440.484126984127,608.384920634921,1967.10317460317,548.75,321.956349206349,1053.06746031746,130.492063492063,252,19.6960783164651,17.8173878199762,0.426227487046737,0.875,0.63,1.16579014039741,53862.1587301587,33578.8253968254,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_688126,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
689526,1161.65185185185,276.948148148148,90.7925925925926,629.540740740741,1853.31111111111,3513.87407407407,365.348148148148,275.755555555556,1093.79259259259,2689.08888888889,532.125925925926,119.977777777778,1064.91851851852,2397.2,806.059259259259,513.488888888889,1770.57777777778,4236.31111111111,363.903703703704,229.177777777778,1029.0962962963,2876.51851851852,214.740740740741,216.237037037037,633.725925925926,1370.91111111111,498.792592592593,233.340740740741,1065.58518518519,129.911111111111,135,17.5738767637798,9.81007612043542,0.829693486029978,0.964285714285714,0.767045454545455,1.18474895750435,53964.4592592593,32810.8592592593,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_689526,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
689776,2011.83505154639,682.123711340206,135.958762886598,645.752577319588,1932.51546391753,2850.38144329897,2865.62886597938,268.20618556701,1111.70103092784,2588.44329896907,1100.62886597938,117.731958762887,1079.53608247423,927.030927835052,784.432989690722,956.257731958763,1609.14432989691,1219.61855670103,321.639175257732,239.164948453608,1011.34020618557,1036.09278350515,231.412371134021,202.340206185567,633.855670103093,952.051546391753,474.587628865979,355.711340206186,1042.53608247423,130.546391752577,97,13.803195466011,9.14753206098688,0.748875077520091,0.941747572815534,0.734848484848485,0.551424936542409,53401.3195876289,33568.8041237113,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_689776,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
690266,2533.36569579288,184.987055016181,99.6278317152104,673.53074433657,3643.47572815534,2287.95469255663,976.21359223301,251.760517799353,1098.54368932039,4310.24595469256,526.980582524272,120.288025889968,1092.60194174757,1430.8284789644,1054.67313915858,909.809061488673,5549.91262135922,1563.66343042071,302.831715210356,227.368932038835,1033.73786407767,1183.071197411,220.462783171521,371.278317152104,676.618122977346,1253.26860841424,463.834951456311,233.148867313916,1057.18770226537,131.21359223301,309,28.998039878181,13.9330749167861,0.877003856624137,0.939209726443769,0.613095238095238,0.878579404168103,52914.0388349515,33433.1585760518,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_690266,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
690397,4831.82075471698,896.037735849057,160.320754716981,672.330188679245,3452.71698113208,2802.68867924528,1279.22012578616,264.509433962264,1154.35849056604,7034.74842767296,685.251572327044,136.314465408805,1092.43396226415,3241.82389937107,1247.90251572327,978.779874213836,3235.77672955975,4158.07232704402,377.971698113208,244.367924528302,1052.18553459119,3669.44968553459,253.040880503145,350.619496855346,640.0,2052.52830188679,546.783018867925,353.443396226415,1057.29559748428,132.323899371069,318,25.1516971506668,16.2862147686606,0.762048867357221,0.954954954954955,0.691304347826087,-0.442994078668539,53052.4150943396,33530.0880503145,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_690397,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
690709,1006.65536723164,279.64406779661,134.0,652.45197740113,2749.93220338983,1172.49717514124,332.316384180791,270.248587570621,1079.9604519774,2275.23728813559,592.395480225989,120.977401129944,1065.55367231638,787.542372881356,515.932203389831,283.16384180791,1535.02259887006,1013.92655367232,267.71186440678,230.175141242938,988.937853107345,914.966101694915,198.310734463277,128.276836158192,588.598870056497,1310.41807909605,454.734463276836,217.813559322034,1033.4802259887,130.649717514124,177,18.0585441886292,12.5593257322836,0.718547093115385,0.941489361702128,0.743697478991597,-1.20261760446604,52653.395480226,32733.1638418079,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_690709,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
690864,2896.28,597.049230769231,218.08,655.886153846154,1960.43384615385,748.476923076923,341.944615384615,229.627692307692,1093.63384615385,4971.21230769231,3679.44,125.547692307692,1077.34153846154,1391.74153846154,509.473846153846,390.64,1606.13230769231,1710.92,343.575384615385,235.790769230769,1017.52307692308,1516.55692307692,245.96,266.0,636.963076923077,1586.14769230769,516.252307692308,405.116923076923,1076.46461538462,130.710769230769,325,22.353766459833,18.85853943641,0.53690870181416,0.95307917888563,0.820707070707071,0.165115281980046,53272.9230769231,33693.8153846154,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_690864,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
691990,1659.2722513089,218.51832460733,56.2879581151833,643.162303664921,1424.79581151832,699.130890052356,331.706806282723,246.513089005236,1127.9057591623,3119.80104712042,487.890052356021,107.371727748691,1082.34031413613,1719.43979057592,399.900523560209,446.03664921466,1828.76963350785,3690.44502617801,336.015706806283,1769.9057591623,1050.88481675393,2730.51832460733,475.910994764398,446.937172774869,627.628272251309,971.031413612565,449.942408376963,749.319371727749,1025.20418848168,129.869109947644,191,19.1207577943608,13.8251852011155,0.690800008123382,0.834061135371179,0.591331269349845,-1.18041874205534,53790.5706806283,33694.5497382199,FAAGSCC_12,AG,1,neutrophils,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,neutrophils,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_691990,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
692800,1909.45454545455,170.212121212121,88.1404958677686,621.074380165289,982.33608815427,646.95041322314,301.457300275482,256.198347107438,1109.03856749311,2122.07438016529,441.754820936639,115.462809917355,1068.30027548209,845.578512396694,529.123966942149,279.479338842975,1626.62258953168,878.096418732782,240.140495867769,215.30303030303,991.31955922865,768.539944903581,180.512396694215,112.231404958678,591.801652892562,802.539944903581,450.077134986226,218.482093663912,1019.61157024793,130.876033057851,363,34.3245310139211,14.1364530586987,0.911253037396471,0.912060301507538,0.557603686635945,-0.462968756798998,53163.9972451791,32277.6666666667,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_692800,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
693153,4149.27184466019,867.441747572816,127.558252427184,680.606796116505,2521.02912621359,715.344660194175,887.247572815534,237.155339805825,1093.35436893204,7446.46601941748,611.708737864078,121.281553398058,1092.47087378641,1087.26213592233,584.140776699029,292.077669902913,1810.49029126214,1849.79126213592,308.0,229.368932038835,1042.07281553398,1500.59223300971,211.800970873786,256.165048543689,997.077669902913,2433.49029126214,542.76213592233,1042.41747572816,1072.18446601942,129.927184466019,206,18.8008897896868,14.1003102039594,0.661459366377224,0.962616822429906,0.762962962962963,1.16434841992826,53902.4077669903,33538.4514563107,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_693153,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
693831,1464.66911764706,230.794117647059,73.2132352941177,604.014705882353,248.345588235294,2080.27941176471,381.691176470588,279.669117647059,1117.97058823529,2331.61029411765,743.514705882353,117.161764705882,1069.44117647059,1123.20588235294,826.845588235294,284.198529411765,2007.19117647059,1877.90441176471,338.772058823529,231.867647058824,1077.41911764706,1744.625,226.970588235294,161.257352941176,2812.30147058824,698.433823529412,397.985294117647,212.183823529412,1005.13235294118,128.919117647059,136,16.9015248448442,10.2792437651212,0.793795776180159,0.957746478873239,0.772727272727273,-1.31186466904954,52611.7132352941,32144.1617647059,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_693831,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
693887,1517.6171875,111.42578125,116.765625,667.70703125,3626.03125,343.671875,300.36328125,252.43359375,1071.2890625,3087.95703125,518.65234375,114.90234375,1074.62109375,832.36328125,522.5703125,282.03125,1414.07421875,1392.10546875,328.0234375,231.25,980.37890625,1359.51171875,231.26953125,149.71875,601.32421875,1681.046875,503.39453125,241.56640625,1030.76953125,129.60546875,256,22.0991119363623,14.8353628826027,0.741176358845301,0.941176470588235,0.727272727272727,-1.19079020552732,53196.55078125,33340.125,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_693887,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
693984,2849.49520766773,1315.08945686901,1189.93290734824,728.725239616613,5698.29073482428,428.843450479233,439.166134185304,242.683706070288,1080.36741214057,3910.61022364217,1699.95207667732,134.667731629393,1066.8338658147,1833.37699680511,648.223642172524,322.85303514377,2753.63897763578,2900.00638977636,356.022364217252,235.226837060703,1064.17252396166,2609.58785942492,227.645367412141,167.610223642173,605.629392971246,1104.70607028754,478.124600638978,422.223642172524,1070.16293929712,131.274760383387,313,28.5907000721281,14.4317111063104,0.863254210621577,0.934328358208955,0.601923076923077,0.517670860180318,53047.7092651757,33445.6741214057,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_693984,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
694203,3083.6170212766,237.059101654846,67.5271867612293,621.248226950355,1058.95508274232,1913.52718676123,2519.08510638298,247.879432624113,1091.97399527187,4272.01891252955,911.262411347518,118.120567375887,1075.23877068558,2045.66430260047,855.146572104019,1513.9598108747,5739.81560283688,2536.71631205674,339.283687943262,233.860520094563,1043.87470449173,2006.45390070922,218.919621749409,220.860520094563,770.63829787234,923.018912529551,436.163120567376,14773.401891253,1106.02836879433,131.874704491726,423,29.4580503438476,18.6300334228591,0.774620878772989,0.937915742793792,0.729310344827586,0.131892871431788,52966.4349881797,33560.0236406619,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_694203,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
694621,2317.275,161.4625,102.9875,639.0625,2850.475,1278.2875,333.6125,258.9625,1107.025,4582.55,516.2625,124.6875,1090.6,1274.05,764.8,281.875,1844.6,1961.6,341.65,240.775,1022.9125,1727.625,239.7125,193.775,2029.6,1674.85,517.9,226.9875,1063.7375,131.8125,80,11.6995475457738,9.13280281316626,0.625016393403489,0.869565217391304,0.727272727272727,-0.0563173485136695,53183.4625,33072.325,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_694621,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
694806,619.978494623656,89.8960573476703,60.4659498207885,608.114695340502,358.555555555556,442.268817204301,313.870967741935,255.082437275986,1109.76344086022,1583.54838709677,506.043010752688,111.136200716846,1068.34050179211,645.372759856631,365.856630824373,262.731182795699,1406.81362007168,749.749103942652,169.94982078853,204.032258064516,1018.33691756272,605.953405017921,131.566308243728,100.340501792115,590.648745519713,1090.50537634409,462.469534050179,215.078853046595,1011.52688172043,129.89247311828,279,24.9073698146881,14.2729524734004,0.81952646528484,0.958762886597938,0.713554987212276,-1.08135808730938,53963.8960573477,32282.8028673835,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_694806,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
695558,2638.16666666667,341.35119047619,153.357142857143,656.5,2022.31547619048,595.136904761905,372.130952380952,268.630952380952,1108.67857142857,3938.3630952381,730.505952380952,125.494047619048,1071.97619047619,1246.55952380952,959.071428571429,278.60119047619,2016.20833333333,2534.35714285714,357.160714285714,233.404761904762,1061.75595238095,3570.24404761905,239.428571428571,794.25,3881.94642857143,956.285714285714,452.89880952381,235.202380952381,1066.54166666667,128.845238095238,168,20.5372022338581,11.2035623649974,0.838094387622842,0.823529411764706,0.466666666666667,0.608904623269248,53061.880952381,32760.6726190476,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_695558,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
695791,1992.9298245614,580.912280701754,131.608187134503,639.672514619883,2281.02923976608,333.812865497076,280.678362573099,244.491228070175,1077.98830409357,3054.01754385965,640.894736842105,122.900584795322,1106.64912280702,6379.65497076023,1096.56725146199,541.099415204678,6006.00584795322,6570.59064327485,392.315789473684,252.25730994152,1077.87719298246,4285.91812865497,242.573099415205,210.005847953216,692.432748538012,936.649122807018,505.286549707602,236.730994152047,1012.66081871345,130.046783625731,171,20.1195621884007,10.8851277077226,0.841008377802981,0.929347826086956,0.633333333333333,-0.671113913336067,53290.0467836257,33268.3976608187,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_695791,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
695879,3109.42175066313,426.289124668435,124.305039787798,643.039787798408,1296.77188328912,1051.42705570292,392.832891246684,264.48275862069,1093.94694960212,5859.18832891247,733.381962864721,131.636604774536,1075.60212201592,802.912466843501,560.941644562334,276.023872679045,1463.54111405836,1008.43236074271,288.40848806366,234.058355437666,988.050397877984,911.098143236074,219.384615384615,136.007957559682,584.275862068965,1685.32095490716,520.835543766578,277.721485411141,1083.07161803714,130.554376657825,377,29.0586795741888,16.7196847637197,0.8178885914246,0.956852791878173,0.673214285714286,-0.500020236174936,52439.5039787798,33253.9469496021,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_695879,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
695966,2550.97315436242,213.848993288591,112.093959731544,654.520134228188,2449.95637583893,1526.19463087248,1177.36912751678,245.570469798658,1096.84563758389,3620.06040268456,568.624161073825,118.88255033557,1072.84899328859,5538.63758389262,847.144295302013,605.902684563758,2713.85234899329,6003.81208053691,417.459731543624,880.926174496644,1061.54362416107,4360.60402684564,248.053691275168,320.553691275168,604.053691275168,1032.42281879195,467.446308724832,262.057046979866,1056.05033557047,130.295302013423,298,29.4129530200635,12.9634530422366,0.89763500833462,0.949044585987261,0.613168724279835,1.11233093313434,53735.2013422819,33542.1744966443,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_695966,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
697019,1515.51097178683,283.978056426332,63.2037617554859,638.097178683386,1430.3605015674,1345.05642633229,1718.24137931034,253.228840125392,1103.01567398119,2832.86206896552,2143.79310344828,127.680250783699,1066.32601880878,1319.70219435737,789.206896551724,667.943573667712,2989.07210031348,2164.12225705329,369.915360501567,243.557993730408,1034.58620689655,2376.14420062696,267.197492163009,254.808777429467,614.824451410658,1440.70846394984,502.76802507837,496.802507836991,1044.48275862069,129.523510971787,319,28.0700231402419,14.5929401533887,0.854241545779909,0.949404761904762,0.671578947368421,1.06242054200441,53155.4576802508,33839.0595611285,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_697019,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
697046,3231.19811320755,1129.2358490566,206.858490566038,611.943396226415,688.877358490566,265.556603773585,880.103773584906,230.943396226415,1083.14150943396,6607.66981132075,499.094339622641,116.462264150943,1073.18867924528,1017.18867924528,1422.2358490566,427.311320754717,6700.08490566038,1528.62264150943,287.443396226415,222.566037735849,1039.58490566038,1014.57547169811,197.301886792453,144.660377358491,613.830188679245,3117.29245283019,546.358490566038,241.122641509434,1030.96226415094,132.028301886792,106,12.8653297636529,11.1237506738649,0.502409078749424,0.868852459016393,0.627218934911243,0.621445653745811,53879.8490566038,33009.6886792453,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_697046,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
697998,4081.3202247191,948.455056179775,93.1011235955056,669.174157303371,3057.86516853933,386.904494382023,447.185393258427,251.005617977528,1076.95505617978,6441.10674157303,679.876404494382,121.758426966292,1113.89325842697,946.185393258427,529.691011235955,355.960674157303,1456.84269662921,1302.69662921348,318.331460674157,233.331460674157,1028.10112359551,1242.33146067416,229.466292134831,282.056179775281,638.050561797753,1762.35393258427,528.47191011236,295.269662921348,1071.33146067416,130.426966292135,178,17.6871093062573,12.8664156606728,0.686165009583385,0.962162162162162,0.760683760683761,-1.37773225296994,53692.2808988764,33485.691011236,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_697998,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
698276,3487.23461538462,405.261538461538,124.019230769231,618.407692307692,638.038461538462,700.184615384615,461.934615384615,278.430769230769,1136.59230769231,5730.87692307692,898.392307692308,124.461538461538,1067.77307692308,921.161538461538,507.480769230769,278.603846153846,1618.37692307692,1555.45384615385,276.003846153846,225.226923076923,1059.96153846154,1199.41538461538,191.111538461538,140.696153846154,2603.97307692308,813.15,426.930769230769,223.826923076923,1023.65384615385,129.65,260,21.7484662078321,15.4446200540091,0.704052876773989,0.942028985507246,0.65,-0.836352394312463,53790.0038461538,32702.1,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_698276,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
699839,1271.25654450262,307.298429319372,102.602094240838,632.17277486911,1735.10994764398,2693.78010471204,608.429319371728,248.0,1097.10471204188,2386.83769633508,1383.62827225131,107.759162303665,1313.86387434555,5198.11518324607,1080.12565445026,443.801047120419,8273.75392670157,5811.59162303665,430.30890052356,243.507853403141,1082.16230366492,5188.86910994764,527.094240837696,775.230366492147,745.397905759162,1072.0,453.465968586387,426.722513089005,1037.31937172775,130.523560209424,191,21.4959574870597,12.2488458784694,0.82176890910433,0.856502242152466,0.591331269349845,0.482742726612217,53365.5078534031,33502.612565445,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX+,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_699839,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
700743,445.560402684564,880.570469798658,204.298657718121,607.704697986577,99.8187919463087,305.781879194631,290.912751677852,250.714765100671,1083.55033557047,1169.96308724832,597.161073825503,113.88255033557,1066.75838926174,593.375838926175,421.036912751678,264.979865771812,1351.06711409396,872.352348993289,261.906040268456,217.543624161074,981.573825503356,810.56711409396,196.120805369128,116.902684563758,590.637583892617,567.677852348993,359.91610738255,205.510067114094,982.302013422819,128.667785234899,298,21.3504090521403,17.7851094074753,0.553257568428391,0.964401294498382,0.788359788359788,1.40206061807412,53913.9697986577,32605.5805369128,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_700743,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
700940,2932.8449197861,326.144385026738,90.6951871657754,624.374331550802,1025.14973262032,4136.44385026738,635.133689839572,261.588235294118,1097.96256684492,3982.75401069519,638.165775401069,118.689839572193,1082.32620320856,1640.61497326203,484.652406417112,271.887700534759,3198.01604278075,1602.41711229947,242.983957219251,217.219251336898,982.705882352941,1330.55614973262,178.529411764706,129.92513368984,600.935828877005,1097.08556149733,462.903743315508,236.850267379679,1031.29946524064,132.967914438503,187,20.3842165055964,12.189458191679,0.801507201465629,0.916666666666667,0.757085020242915,1.45166402504611,52778.2032085562,33402.7326203209,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_700940,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
701126,1933.65762711864,399.898305084746,110.040677966102,662.433898305085,3207.32542372881,1309.02711864407,310.932203389831,241.630508474576,1087.49152542373,3637.82033898305,521.827118644068,111.637288135593,1088.36949152542,2806.38983050847,569.901694915254,310.969491525424,1932.93559322034,3042.18305084746,357.796610169492,232.362711864407,1081.18983050847,2113.89152542373,222.820338983051,191.752542372881,786.003389830508,1015.23389830508,446.132203389831,252.559322033898,1023.56610169492,130.186440677966,295,27.6640951616374,14.4715240814924,0.852261641049905,0.904907975460123,0.58300395256917,0.854978712607313,53814.3966101695,33519.7525423729,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_701126,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
701582,1982.89788732394,252.538732394366,100.792253521127,638.771126760563,1808.80985915493,385.672535211268,287.017605633803,249.37323943662,1075.6514084507,2935.49295774648,1574.02816901408,115.37676056338,1076.29577464789,639.683098591549,417.968309859155,266.080985915493,1380.33098591549,983.573943661972,268.535211267606,221.257042253521,986.732394366197,968.109154929578,202.119718309859,179.996478873239,588.338028169014,967.866197183099,455.915492957746,301.602112676056,1046.21478873239,131.359154929577,284,25.4167126373449,14.6074890710546,0.818350232610274,0.925081433224756,0.788888888888889,1.49113712355168,53487.8978873239,32974.5563380282,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_701582,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
701684,2758.59340659341,421.785714285714,75.1648351648352,630.67032967033,1357.31868131868,472.346153846154,485.423076923077,236.730769230769,1066.76923076923,3863.05494505495,1318.28571428571,120.631868131868,1073.41758241758,1239.59340659341,746.285714285714,310.164835164835,1892.27472527472,2445.52747252747,321.626373626374,238.802197802198,1016.04945054945,1918.78571428571,208.230769230769,278.587912087912,702.879120879121,990.961538461538,455.67032967033,410.186813186813,1030.66483516484,133.384615384615,182,21.4547624177176,11.4584306547575,0.845437738057978,0.90547263681592,0.598684210526316,0.689155100625512,53078.6923076923,33523.5659340659,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_701684,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
702056,1609.29347826087,170.076086956522,77.6739130434783,612.902173913043,978.467391304348,276.586956521739,244.989130434783,233.880434782609,1081.40217391304,2434.38043478261,576.184782608696,111.054347826087,1065.40217391304,754.076086956522,646.336956521739,270.923913043478,1762.75,1261.07608695652,294.847826086957,227.847826086957,1004.55434782609,1096.94565217391,219.021739130435,141.619565217391,581.315217391304,858.967391304348,503.565217391304,246.228260869565,1017.8152173913,128.195652173913,92,12.3293827058203,9.55184484080407,0.632301922065675,0.92,0.696969696969697,-0.61661451922059,53721.6956521739,33272.8260869565,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_702056,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
702151,3644.41914191419,632.399339933993,80.009900990099,633.046204620462,1137.30363036304,3710.12541254125,1979.75247524752,266.811881188119,1129.67326732673,5749.66336633663,1208.60726072607,135.76897689769,1106.59405940594,2471.29702970297,796.927392739274,607.739273927393,2894.04290429043,5650.53795379538,443.554455445544,255.036303630363,1385.70297029703,6644.22442244224,433.468646864686,756.643564356436,627.389438943894,1678.16171617162,519.950495049505,411.877887788779,1076.99669966997,132.831683168317,303,21.999244113478,17.597446831701,0.600118074331587,0.97741935483871,0.848739495798319,1.46345498432744,53211.1254125413,33756.2739273927,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_702151,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
703207,3551.82258064516,385.245967741935,187.254032258065,684.883064516129,3662.39112903226,560.665322580645,776.298387096774,256.95564516129,1094.07258064516,5850.97983870968,635.129032258065,136.197580645161,1074.14919354839,1426.36290322581,554.483870967742,295.754032258065,3488.87903225806,1772.43548387097,293.149193548387,226.709677419355,1000.66935483871,1492.03225806452,207.685483870968,140.653225806452,605.217741935484,1943.10080645161,573.846774193548,248.564516129032,1045.33467741935,136.931451612903,248,24.5728071341984,13.4766144509107,0.836192470001417,0.946564885496183,0.708571428571429,-1.56248762247946,53122.2217741935,33157.6612903226,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_703207,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
703215,1902.32735426009,226.161434977578,110.331838565022,616.52466367713,857.22869955157,564.085201793722,728.515695067265,256.309417040359,1109.56950672646,4127.70403587444,491.479820627803,113.260089686099,1069.93721973094,3114.70852017937,777.448430493274,397.439461883408,8507.24215246637,3887.10313901345,360.304932735426,230.497757847534,1034.73094170404,2591.7533632287,217.165919282511,328.887892376682,726.829596412556,2261.10762331839,518.053811659193,231.390134529148,1026.69058295964,130.600896860987,223,32.3148893098065,8.93430744629259,0.961020679157627,0.933054393305439,0.774305555555556,1.54256323270127,53503.0448430493,32839.869955157,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_703215,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
704162,2432.21602787456,321.045296167247,116.898954703833,623.390243902439,768.707317073171,358.348432055749,574.707317073171,260.198606271777,1086.07317073171,2371.00696864111,822.1393728223,127.163763066202,1071.8850174216,562.954703832753,408.191637630662,258.114982578397,1429.87108013937,815.010452961673,205.480836236934,209.686411149826,987.449477351916,659.783972125436,146.954703832753,101.351916376307,578.090592334495,906.191637630662,453.470383275261,212.836236933798,1028.41463414634,135.648083623693,287,25.1847156174353,15.1094597272106,0.800040785042661,0.937908496732026,0.693236714975845,0.366237302908222,53321.4459930314,31979.3763066202,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_704162,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
704229,2403.78873239437,579.647887323944,80.6478873239437,611.549295774648,626.042253521127,886.971830985916,522.183098591549,249.957746478873,1086.87323943662,4539.56338028169,566.12676056338,117.535211267606,1084.40845070423,1741.9014084507,646.971830985916,1088.6338028169,1546.29577464789,4875.85915492958,380.507042253521,1709.22535211268,1041.08450704225,5680.14084507042,348.69014084507,613.521126760563,789.084507042254,1669.40845070423,511.12676056338,241.323943661972,1024.38028169014,128.676056338028,71,10.4350538072971,8.98388157395378,0.508718457918735,0.922077922077922,0.645454545454546,-0.922258263253876,54026.5492957746,33383.0563380282,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_704229,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
704649,1559.14516129032,82.6048387096774,60.5,608.717741935484,798.806451612903,565.08064516129,336.475806451613,249.870967741935,1145.56451612903,2027.6935483871,626.137096774194,104.217741935484,1068.31451612903,1571.54032258065,635.991935483871,290.403225806452,1724.57258064516,3812.53225806452,382.16935483871,241.725806451613,1026.86290322581,2667.47580645161,262.766129032258,209.217741935484,4014.25806451613,942.088709677419,453.08064516129,274.491935483871,1069.79032258065,130.177419354839,124,24.7330252228218,6.59554308707166,0.963788039985849,0.885714285714286,0.708571428571429,-0.0106864385151183,53897.8951612903,33416.0725806452,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_704649,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
704747,1021.08163265306,145.775510204082,60.3333333333333,602.142857142857,326.170068027211,471.768707482993,2496.91156462585,253.809523809524,1120.62585034014,2438.16326530612,714.367346938776,108.047619047619,1069.77551020408,1944.58503401361,1233.83673469388,1139.48979591837,1901.12925170068,5549.72108843537,383.659863945578,235.707482993197,1051.76870748299,4657.72108843537,259.12925170068,637.374149659864,724.789115646259,1309.74829931973,486.850340136054,283.591836734694,1030.01360544218,130.78231292517,147,14.3792245202045,13.0620426128886,0.418108978942269,0.954545454545455,0.807692307692308,0.600603771595365,54052.6870748299,32723.2789115646,FAAGSCC_12,AG,1,M2 macrophages,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_704747,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
706617,2021.29861111111,713.701388888889,314.25,627.666666666667,787.277777777778,2313.73611111111,329.409722222222,252.284722222222,1097.60416666667,4053.01388888889,1645.29861111111,121.194444444444,1075.22222222222,1586.90972222222,517.819444444444,291.770833333333,1766.88194444444,1092.82638888889,253.534722222222,218.645833333333,1037.45833333333,812.729166666667,173.354166666667,185.506944444444,669.736111111111,2415.8125,584.416666666667,688.173611111111,1049.03472222222,127.395833333333,144,18.84858844365,9.85473208900686,0.85243291761315,0.947368421052632,0.727272727272727,1.33837568840563,53877.2986111111,33521.8194444444,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_706617,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
707184,912.292517006803,164.333333333333,100.380952380952,625.993197278912,1185.36734693878,1669.74829931973,631.646258503401,264.537414965986,1094.41496598639,1580.63945578231,523.265306122449,115.136054421769,1069.80272108844,1212.93197278912,481.761904761905,343.734693877551,1640.93197278912,1924.39455782313,327.054421768707,228.537414965986,1047.61904761905,1262.34693877551,205.285714285714,278.285714285714,748.170068027211,706.795918367347,393.891156462585,206.510204081633,1020.10204081633,129.394557823129,147,16.1388144613296,11.6005426094728,0.695219300596578,0.96078431372549,0.75,-0.759466153276188,53134.8503401361,32101.4761904762,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_707184,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
707726,2228.63253012048,277.584337349398,66.9036144578313,620.548192771084,1175.56626506024,1579.73493975904,380.55421686747,255.969879518072,1123.16265060241,4051.9578313253,507.204819277108,126.981927710843,1073.80722891566,2449.24096385542,708.463855421687,319.578313253012,1838.93975903614,2818.83734939759,386.168674698795,240.012048192771,1012.0421686747,1932.16265060241,279.843373493976,205.89156626506,586.44578313253,1878.88554216867,495.55421686747,271.331325301205,1036.64457831325,128.734939759036,166,18.2744919879108,11.9198576524101,0.757988836555458,0.932584269662921,0.697478991596639,1.1699485375943,53629.686746988,33812.5421686747,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_707726,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
709027,862.561538461538,362.553846153846,170.646153846154,670.215384615385,3480.33076923077,5156.01538461538,648.430769230769,273.184615384615,1115.27692307692,2002.65384615385,531.969230769231,117.161538461538,1055.38461538462,1162.98461538462,554.330769230769,402.284615384615,1634.83076923077,1861.18461538462,255.046153846154,215.853846153846,1019.42307692308,1368.54615384615,177.784615384615,128.261538461538,591.284615384615,1140.93076923077,471.853846153846,227.184615384615,1054.87692307692,129.815384615385,130,14.2147301557208,11.6283535534209,0.575147754878242,0.977443609022556,0.833333333333333,0.620610294560307,54130.4615384615,32788.0846153846,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_709027,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
709322,3087.30803571429,260.147321428571,137.459821428571,651.977678571429,3131.83035714286,376.5,799.665178571429,251.714285714286,1082.8125,5326.29910714286,515.183035714286,125.321428571429,1087.41964285714,639.834821428571,530.276785714286,328.375,1485.60267857143,1088.46875,282.459821428571,227.75,1020.95535714286,1007.58035714286,207.486607142857,318.424107142857,661.174107142857,1837.67857142857,498.857142857143,231.924107142857,1037.20089285714,157.540178571429,224,27.210044187583,11.330760593001,0.90917313631069,0.899598393574297,0.56,-1.16102208007636,53236.2633928571,33241.3035714286,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_709322,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
710855,1909.75655430712,407.996254681648,133.947565543071,627.374531835206,1679.75280898876,2513.34831460674,413.797752808989,263.779026217228,1088.45692883895,2807.67415730337,1041.46816479401,119.408239700375,1069.29213483146,3766.52808988764,664.385767790262,305.831460674157,1684.03370786517,4069.76029962547,369.239700374532,233.876404494382,1042.71161048689,3273.59550561798,244.49063670412,455.887640449438,1877.45692883895,928.25468164794,450.943820224719,263.262172284644,1037.1872659176,130.333333333333,267,22.4919174658074,15.9540344941033,0.704883588975712,0.940140845070422,0.644927536231884,-1.0949058202264,53370.7041198502,32764.9101123596,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_710855,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
711285,1235.15254237288,521.847457627119,69.4971751412429,627.248587570621,1138.31638418079,999.389830508475,555.813559322034,246.881355932203,1073.76271186441,2477.61016949153,547.254237288136,130.265536723164,1067.75706214689,1429.58757062147,648.576271186441,356.135593220339,3697.67231638418,2658.34463276836,342.841807909605,239.220338983051,1042.38983050847,2199.70056497175,236.406779661017,295.508474576271,592.203389830509,1361.99435028249,514.700564971751,254.050847457627,1032.72316384181,130.028248587571,177,19.0446550259559,12.0164147549815,0.775815396919029,0.946524064171123,0.702380952380952,-1.02715444295071,53288.1807909604,33849.5649717514,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_711285,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
711742,5184.71923076923,663.069230769231,170.426923076923,656.461538461538,3131.52692307692,276.861538461538,376.426923076923,241.203846153846,1076.01923076923,7928.05384615385,1075.00384615385,128.534615384615,1093.4,610.853846153846,517.192307692308,804.326923076923,2212.44615384615,1304.48846153846,259.203846153846,218.307692307692,1028.05769230769,1045.48461538462,192.780769230769,389.626923076923,641.126923076923,2147.26153846154,626.065384615385,358.419230769231,1098.86538461538,133.169230769231,260,24.5419630362851,14.9498563261247,0.793051286615825,0.828025477707006,0.590909090909091,0.594724672712505,54030.3961538462,33260.7307692308,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_711742,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
712358,1727.37073170732,253.243902439024,89.8829268292683,632.868292682927,1449.71707317073,410.692682926829,402.639024390244,222.931707317073,1076.52682926829,3217.58048780488,1222.56585365854,114.619512195122,1079.19024390244,807.180487804878,515.70243902439,843.156097560976,1492.10731707317,1597.47804878049,225.273170731707,214.468292682927,994.682926829268,1447.49268292683,180.478048780488,446.819512195122,679.321951219512,1331.79024390244,504.160975609756,616.375609756098,1049.57073170732,130.10243902439,205,22.7415266093074,11.625014781407,0.859473648948518,0.931818181818182,0.632716049382716,-0.771790310573363,53348.8487804878,33620.9512195122,FAAGSCC_12,AG,1,dendritic cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,dendritic cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_712358,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
712596,3442.81911262799,991.938566552901,98.5255972696246,639.156996587031,1902.91467576792,1936.84982935154,324.928327645051,249.563139931741,1098.55972696246,6172.80887372014,540.938566552901,122.976109215017,1083.72013651877,1120.54266211604,464.310580204778,294.040955631399,2371.69965870307,1229.795221843,274.174061433447,227.310580204778,1003.36518771331,1174.26962457338,205.460750853242,177.170648464164,611.808873720136,1894.30034129693,484.18771331058,253.703071672355,1048.99658703072,131.505119453925,293,25.9396252561598,14.9482463088901,0.817258873784427,0.909937888198758,0.704326923076923,-1.54160159305064,52970.7508532423,33438.5324232082,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_712596,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
712852,1438.15270935961,173.950738916256,65.4679802955665,604.019704433498,334.128078817734,3283.26600985222,345.192118226601,247.748768472906,1217.72906403941,2120.00492610837,536.684729064039,117.48275862069,1072.11822660099,814.325123152709,531.423645320197,271.428571428571,2908.12315270936,2163.70935960591,309.044334975369,228.738916256158,1028.5960591133,2372.2315270936,230.714285714286,208.532019704434,609.128078817734,917.246305418719,478.995073891626,224.827586206897,1016.80295566502,130.970443349754,203,17.8352490947264,14.5667293520122,0.577008407738937,0.953051643192488,0.751851851851852,-0.0901011962514951,52751.0689655172,33428.1724137931,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_712852,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
713211,4491.8,531.142857142857,134.55,658.185714285714,2604.36428571429,765.707142857143,403.992857142857,278.835714285714,1114.1,7502.07142857143,687.671428571429,134.642857142857,1071.48571428571,1199.60714285714,759.121428571429,285.692857142857,1726.74285714286,1604.44285714286,361.564285714286,231.564285714286,1015.57857142857,1292.75714285714,236.878571428571,200.578571428571,1773.96428571429,1662.41428571429,499.75,234.45,1034.87857142857,132.178571428571,140,17.7064772375682,10.1934678242715,0.817667008571295,0.945945945945946,0.666666666666667,0.723464122137103,53569.3785714286,32725.9428571429,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_713211,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
714116,6421.49275362319,802.565217391304,169.31884057971,662.876811594203,2379.14492753623,393.731884057971,317.152173913043,243.166666666667,1080.9347826087,9208.60144927536,632.54347826087,130.224637681159,9421.84057971014,1695.71014492754,576.18115942029,286.86231884058,1657.02898550725,3162.6231884058,333.623188405797,237.275362318841,1004.82608695652,3680.86956521739,239.644927536232,220.492753623188,704.086956521739,2373.51449275362,574.478260869565,399.739130434783,1078.50724637681,133.173913043478,138,15.0276671604258,14.0110651434336,0.36155364360257,0.737967914438503,0.558704453441296,-0.863625863711026,53719.7971014493,33493.615942029,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX+,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_714116,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
714195,1590.75438596491,263.824561403509,78.0789473684211,620.438596491228,1707.77192982456,523.30701754386,341.210526315789,253.078947368421,1127.34210526316,2485.20175438596,860.043859649123,112.675438596491,1072.79824561404,537.614035087719,326.438596491228,255.385964912281,1407.58771929825,795.043859649123,179.070175438596,205.657894736842,1017.77192982456,685.456140350877,143.385964912281,138.114035087719,664.035087719298,1425.34210526316,491.517543859649,330.728070175439,1039.31578947368,130.675438596491,114,13.5012978837208,10.8882780283249,0.591286495186828,0.934426229508197,0.674556213017751,-0.62572939596836,53177.4824561404,33204.7192982456,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_714195,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
714693,2139.576,735.744,124.264,630.52,1755.584,267.224,750.392,239.704,1077.312,3101.6,1080.296,120.304,1077.304,597.232,451.888,550.704,1620.648,986.456,238.248,218.92,993.76,816.584,191.776,154.288,621.4,1076.456,506.824,249.352,1015.64,128.488,125,17.0495410469152,9.46238014928345,0.831854852445576,0.932835820895522,0.735294117647059,1.41502751261253,54107.216,33336.376,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_714693,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
715169,1188.90419161677,365.85628742515,182.940119760479,688.059880239521,4265.60479041916,1756.28143712575,600.74251497006,260.053892215569,1093.61077844311,2786.64071856287,1110.16167664671,120.041916167665,1072.23952095808,1811.33532934132,716.928143712575,600.077844311377,1520.31137724551,1711.97604790419,341.233532934132,230.239520958084,1050.4251497006,1284.55089820359,219.97005988024,761.994011976048,781.335329341317,1604.82035928144,494.239520958084,313.317365269461,1048.8502994012,131.467065868263,167,18.4385122632258,11.6299158156338,0.775993856071641,0.948863636363636,0.695833333333333,-0.898610228844786,53213.0119760479,33175.0658682635,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_715169,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
715928,1551.12735849057,323.896226415094,200.792452830189,688.146226415094,3921.36320754717,310.929245283019,336.63679245283,257.254716981132,1075.00943396226,3017.2641509434,982.047169811321,126.575471698113,1067.90094339623,657.995283018868,416.566037735849,274.910377358491,1497.92452830189,998.231132075472,240.518867924528,217.415094339623,988.103773584906,852.957547169811,184.518867924528,123.334905660377,589.966981132075,1179.6320754717,442.433962264151,225.547169811321,1047.57547169811,129.353773584906,212,27.978989160029,9.76877293071884,0.937068061575913,0.925764192139738,0.490740740740741,0.955054410395204,52554.3490566038,32352.6981132075,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_715928,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
716344,1453.91034482759,315.703448275862,237.020689655172,704.703448275862,4897.2,320.910344827586,308.731034482759,254.213793103448,1070.80689655172,3244.08965517241,667.606896551724,134.462068965517,1070.35862068966,703.903448275862,457.11724137931,269.268965517241,1435.34482758621,1993.17931034483,303.11724137931,229.206896551724,1005.30344827586,2452.02068965517,235.820689655172,164.31724137931,587.524137931034,1255.99310344828,445.986206896552,226.696551724138,1049.68275862069,128.241379310345,145,20.5967587147465,9.01490502504628,0.899128078514451,0.92948717948718,0.725,1.42276191988834,52512.9793103448,33235.4689655172,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_716344,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
716538,1894.41414141414,608.464646464646,120.515151515152,636.757575757576,2359.09090909091,3496.52525252525,445.59595959596,263.323232323232,1131.55555555556,2518.54545454545,2202.9595959596,116.767676767677,1071.93939393939,1065.0101010101,507.717171717172,272.676767676768,1494.71717171717,1038.0,265.626262626263,219.151515151515,993.010101010101,931.252525252525,198.767676767677,127.737373737374,579.181818181818,979.050505050505,468.707070707071,395.878787878788,1034.32323232323,132.79797979798,99,12.7509449314482,9.92966164674003,0.627347700454628,0.933962264150943,0.761538461538461,0.174422555943258,53504.6666666667,32993.1717171717,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_716538,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
718937,2687.48916408669,321.56346749226,156.498452012384,656.510835913313,2954.25077399381,409.346749226006,847.826625386997,275.043343653251,1082.65015479876,3107.59752321981,730.297213622291,132.250773993808,1068.42724458204,2657.96594427245,754.433436532508,310.523219814241,1739.38699690402,4532.88544891641,453.414860681114,238.235294117647,1013.28482972136,4793.60681114551,261.616099071207,215.659442724458,585.405572755418,1152.98142414861,504.012383900929,230.510835913313,1044.32507739938,130.188854489164,323,27.4334792301963,15.2108595373305,0.832208125137989,0.952802359882006,0.672916666666667,0.951887472736595,53550.9628482972,32113.8452012384,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_718937,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
719731,2262.27384615385,291.209230769231,109.076923076923,632.778461538462,1488.63692307692,318.224615384615,296.169230769231,248.098461538462,1073.6,3700.32307692308,749.006153846154,117.138461538462,1078.66769230769,737.655384615385,461.267692307692,271.784615384615,2025.81846153846,986.184615384615,249.095384615385,218.341538461538,988.350769230769,905.775384615385,195.046153846154,118.209230769231,581.2,1408.33538461538,521.596923076923,348.006153846154,1026.55692307692,127.803076923077,325,28.9658126066834,14.6120780279484,0.863435381903395,0.928571428571429,0.65,0.462997379667968,54046.7815384615,33156.7784615385,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_719731,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
719947,4271.26633165829,1293.76381909548,2240.36683417085,640.020100502513,1516.56281407035,309.195979899498,474.130653266332,243.447236180905,1077.57788944724,6883.97487437186,623.618090452261,124.050251256281,1099.8743718593,643.060301507538,421.778894472362,376.929648241206,1454.51256281407,906.949748743719,225.78391959799,218.51256281407,1008.09547738693,808.090452261306,175.030150753769,153.683417085427,590.86432160804,1902.13567839196,537.005025125628,291.849246231156,1045.96984924623,129.231155778894,199,18.9567139370647,13.8986647674245,0.680035689142021,0.929906542056075,0.698245614035088,1.47602743182927,53306.0050251256,33521.2914572864,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_719947,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
720041,888.0234375,218.1484375,60.890625,603.7109375,257.015625,4749.296875,412.453125,272.625,1167.65625,2084.9765625,538.8828125,102.21875,1066.1640625,1291.3828125,1689.515625,510.234375,3620.703125,1186.9453125,301.015625,234.53125,1018.3671875,1049.234375,210.09375,234.671875,708.515625,1473.4375,458.453125,232.2421875,1014.53125,130.34375,128,15.6338862396832,10.4444942634693,0.744100505162485,0.941176470588235,0.703296703296703,-0.651099384368004,52849.0703125,33257.1015625,FAAGSCC_12,AG,1,stromal cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_720041,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
720119,2366.99509803922,797.519607843137,233.367647058824,683.985294117647,4256.57352941176,329.308823529412,333.813725490196,263.421568627451,1081.68137254902,4772.9362745098,1471.71078431373,133.348039215686,1075.14215686275,719.838235294118,556.598039215686,269.828431372549,1565.25980392157,1091.19117647059,305.960784313725,229.245098039216,990.808823529412,1020.63725490196,225.196078431373,141.524509803922,582.916666666667,2060.01960784314,510.813725490196,369.31862745098,1088.61764705882,132.519607843137,204,21.7335060117733,13.0285511076286,0.800398388585893,0.846473029045643,0.6,-0.782618211965248,52568.6470588235,33231.9019607843,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_720119,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
720364,1134.50694444444,441.4375,81.9861111111111,645.611111111111,1597.34027777778,667.590277777778,388.333333333333,268.638888888889,1119.4375,1637.65277777778,841.354166666667,116.486111111111,1063.24305555556,1711.0,554.520833333333,292.972222222222,1744.47222222222,5168.72916666667,399.166666666667,236.972222222222,1053.72222222222,4311.19444444444,240.236111111111,182.270833333333,1132.57638888889,780.722222222222,460.8125,239.145833333333,1002.75694444444,128.708333333333,144,15.8280900368908,11.6052334025339,0.680007759751179,0.941176470588235,0.738461538461539,1.3714989185269,53611.0277777778,32770.9166666667,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_720364,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
720933,1894.38872403561,192.151335311573,67.2106824925816,628.884272997033,1211.80712166172,739.014836795252,358.937685459941,245.237388724036,1089.0237388724,3417.37388724036,1529.20178041543,118.899109792285,1088.9881305638,808.421364985163,611.961424332344,347.649851632048,1765.09198813056,1102.54302670623,245.100890207715,217.860534124629,999.504451038576,1097.30860534125,184.810089020771,153.480712166172,587.827893175074,1144.50741839763,456.86646884273,343.560830860534,1048.59050445104,131.73590504451,337,23.8399028000948,18.0688700798,0.652341127979538,0.962857142857143,0.732608695652174,1.21153881562999,52783.762611276,33470.4955489614,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_720933,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
721315,2030.91082802548,110.694267515924,140.143312101911,669.12101910828,3665.75477707006,1630.76751592357,400.920382165605,265.707006369427,1242.46496815287,3732.8025477707,758.630573248408,147.203821656051,1071.93312101911,3576.33121019108,1144.76433121019,1453.73885350318,2174.39808917197,4908.06050955414,403.687898089172,552.627388535032,1045.26433121019,4620.78025477707,324.853503184713,2366.50636942675,773.955414012739,1058.71974522293,511.917197452229,238.46178343949,1070.15605095541,131.71974522293,314,32.7742842550004,12.2973182072939,0.926938858171249,0.94578313253012,0.534013605442177,0.594448534252298,52573.127388535,32416.9044585987,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1+,PD-1+,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_721315,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
721634,2074.71951219512,162.469512195122,78.0670731707317,661.94512195122,2659.2987804878,357.69512195122,371.243902439024,246.725609756098,1085.50609756098,3449.69512195122,1209.17682926829,130.80487804878,1075.81707317073,1202.98780487805,682.012195121951,310.634146341463,1946.68292682927,2358.32926829268,379.810975609756,237.40243902439,1026.59756097561,2316.2256097561,258.878048780488,309.128048780488,586.329268292683,1066.60975609756,457.512195121951,1184.35365853659,1061.53658536585,129.786585365854,164,21.0783175970986,10.7748387790385,0.859472992376339,0.845360824742268,0.719298245614035,0.0230350975206714,53275.9634146341,33877.243902439,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_721634,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
721931,551.897959183673,1216.37755102041,275.683673469388,621.65306122449,90.7704081632653,267.989795918367,295.469387755102,247.989795918367,1075.4693877551,1453.76530612245,764.34693877551,118.510204081633,1069.65306122449,600.183673469388,431.571428571429,268.795918367347,1383.40306122449,1009.82653061224,283.260204081633,220.69387755102,978.688775510204,1090.40306122449,208.65306122449,118.561224489796,580.035714285714,571.127551020408,360.520408163265,207.316326530612,985.55612244898,129.25,196,17.4453786443676,14.345947250771,0.5690034953956,0.95609756097561,0.768627450980392,0.606838014515777,53770.9591836735,32644.306122449,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_721931,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
722262,1539.86571428571,159.765714285714,84.6257142857143,651.46,2221.66,3230.91428571429,1831.82571428571,268.588571428571,1113.23714285714,3940.98571428571,863.44,147.428571428571,1064.20571428571,3461.96571428571,1203.39428571429,520.314285714286,7475.09428571429,3919.59142857143,380.58,232.665714285714,1076.86571428571,2309.96,230.402857142857,282.934285714286,660.8,1147.86,427.817142857143,235.057142857143,1083.88571428571,130.125714285714,350,24.0611264574352,18.7050504400993,0.629010108025119,0.945945945945946,0.729166666666667,0.272620543155364,52466.7542857143,32666.2828571429,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_722262,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
723645,1202.77477477477,643.18018018018,58.8918918918919,619.297297297297,857.846846846847,295.612612612613,314.135135135135,246.990990990991,1070.13513513514,2532.65765765766,670.585585585586,106.963963963964,1080.61261261261,619.117117117117,503.117117117117,286.378378378378,1426.82882882883,1033.84684684685,277.216216216216,221.801801801802,984.477477477478,914.720720720721,219.216216216216,123.873873873874,582.81981981982,957.63963963964,426.801801801802,236.873873873874,1026.64864864865,128.081081081081,111,13.3712696773857,10.6597170522977,0.603701385608146,0.948717948717949,0.776223776223776,1.56427937613143,54086.7207207207,33198.6756756757,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_723645,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
723821,1238.48559670782,175.839506172839,75.5432098765432,640.493827160494,2172.95061728395,359.75720164609,327.024691358025,252.275720164609,1082.12757201646,2537.53497942387,641.341563786008,130.62962962963,1066.58024691358,1065.80658436214,643.802469135802,280.666666666667,1553.15637860082,1096.66255144033,253.748971193416,216.798353909465,995.934156378601,983.131687242798,188.62962962963,164.316872427984,613.975308641975,851.41975308642,443.592592592593,220.082304526749,1026.60082304527,129.679012345679,243,26.5169835037109,11.752088691267,0.896427202279121,0.934615384615385,0.6075,-1.11151474054164,53939.6296296296,32525.6666666667,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_723821,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
725347,1135.34482758621,265.945812807882,149.246305418719,675.330049261084,3543.28571428571,275.492610837438,281.369458128079,256.251231527094,1080.61083743842,2009.60098522167,574.172413793103,121.512315270936,1065.89655172414,536.758620689655,381.655172413793,255.344827586207,1418.07389162562,769.532019704434,196.605911330049,207.246305418719,986.733990147783,718.566502463054,159.379310344828,111.118226600985,579.945812807882,917.162561576355,441.285714285714,215.369458128079,1035.45320197044,131.093596059113,203,18.7949122269282,13.7913275299455,0.679387340659641,0.971291866028708,0.796078431372549,-0.524942561915972,53612.3596059113,32279.1527093596,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,12,FAAGSCC_12_725347,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
726013,1752.23015873016,251.730158730159,91.4206349206349,663.809523809524,1832.97619047619,6514.74603174603,889.452380952381,275.801587301587,1115.80158730159,3773.70634920635,608.269841269841,134.301587301587,1087.22222222222,6944.35714285714,673.936507936508,1182.19047619048,1930.15079365079,6693.64285714286,427.420634920635,2099.11111111111,1047.85714285714,7003.46825396825,389.253968253968,782.309523809524,613.674603174603,1585.54761904762,483.706349206349,660.452380952381,1090.04761904762,132.769841269841,126,16.4114437712036,10.0005977834026,0.792888043092031,0.947368421052632,0.715909090909091,0.286385946896893,52607.6666666667,33732.0555555556,FAAGSCC_12,AG,1,neutrophils,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,neutrophils,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_726013,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
726272,2120.25358851675,219.693779904306,114.186602870813,650.746411483254,2509.77033492823,283.827751196172,288.334928229665,250.363636363636,1088.66028708134,3884.88516746412,630.377990430622,125.531100478469,1073.32057416268,634.301435406699,486.712918660287,306.315789473684,1501.31100478469,1036.67464114833,273.531100478469,219.799043062201,979.765550239234,889.607655502392,189.081339712919,137.904306220096,642.578947368421,1518.35406698565,460.282296650718,217.430622009569,1074.39234449761,129.803827751196,209,25.8584352185046,10.3445646092062,0.916495044120497,0.933035714285714,0.730769230769231,1.499974432881,53313.9186602871,32195.7559808612,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_726272,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
726326,3555.97872340426,1259.03546099291,1641.47517730496,641.574468085106,2334.31205673759,474.085106382979,1317.51063829787,249.269503546099,1083.7304964539,4631.43262411347,587.503546099291,126.964539007092,1083.02836879433,1198.17730496454,659.248226950355,347.219858156028,1654.85106382979,1331.84397163121,298.822695035461,221.22695035461,1045.63829787234,1407.59574468085,215.90780141844,316.943262411348,957.723404255319,1307.65957446809,551.801418439716,253.390070921986,1028.14184397163,132.425531914894,141,16.4706989878819,11.2892392746125,0.728154068754317,0.933774834437086,0.677884615384615,0.99385019506686,54005.0567375887,32937.6879432624,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_726326,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
726391,2311.9561752988,200.011952191235,161.908366533865,716.027888446215,4223.46613545817,1301.96812749004,309.366533864542,249.139442231076,1096.11155378486,3820.37848605578,616.426294820717,142.019920318725,1066.67330677291,1344.81274900398,618.011952191235,302.91235059761,2148.1593625498,1380.67330677291,322.438247011952,232.159362549801,1004.98406374502,1170.69322709163,219.07171314741,207.816733067729,2368.45418326693,1309.16334661355,481.673306772908,321.505976095618,1077.06374501992,130.418326693227,251,29.9252849073189,10.9539409818228,0.930597939039718,0.933085501858736,0.508097165991903,-0.931834082744207,52972.1593625498,33799.3266932271,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_726391,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
726407,3363.63636363636,390.537549407115,106.501976284585,646.110671936759,1778.00790513834,1707.58893280632,648.272727272727,242.525691699605,1106.41501976285,5247.98023715415,873.557312252964,128.920948616601,1077.74308300395,1076.81027667984,870.758893280632,750.940711462451,2016.15019762846,2346.18181818182,278.403162055336,225.766798418972,1101.90118577075,1884.73913043478,198.466403162055,195.470355731225,635.660079051383,1113.50197628458,483.201581027668,262.01185770751,1047.32806324111,131.628458498024,253,19.5161438393826,16.5618234447659,0.529000175552617,0.973076923076923,0.826797385620915,0.859936950879014,53235.4782608696,33724.9723320158,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_726407,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
726781,4867.2874015748,1074.49212598425,1249.14173228346,649.169291338583,2053.48818897638,3395.14960629921,636.291338582677,256.531496062992,1114.86220472441,7782.66535433071,2231.40551181102,142.46062992126,1111.25196850394,1677.42125984252,550.397637795276,314.488188976378,1717.34645669291,3090.88976377953,388.783464566929,247.55905511811,1005.03937007874,2787.32677165354,369.590551181102,240.346456692913,615.043307086614,2297.94488188976,562.232283464567,475.271653543307,1073.99606299213,130.685039370079,254,21.0568591774905,15.4058361357488,0.681701627095189,0.958490566037736,0.742690058479532,0.795371728624447,53349.4212598425,33902.0354330709,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_726781,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
727784,1770.98507462687,323.089552238806,90.4328358208955,619.820895522388,840.820895522388,540.029850746269,372.34328358209,271.880597014925,1115.44776119403,2670.53731343284,811.283582089552,118.970149253731,1077.80597014925,1103.70149253731,699.791044776119,275.89552238806,1798.97014925373,1675.74626865672,327.089552238806,229.492537313433,1086.59701492537,1306.67164179104,218.850746268657,157.388059701493,1536.50746268657,998.716417910448,437.253731343284,230.641791044776,1007.71641791045,129.313432835821,67,10.1867598812871,8.44686621610866,0.558951302540349,0.943661971830986,0.761363636363636,0.293239014280474,52615.4029850746,32134.1641791045,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_727784,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
728090,2820.61754385965,145.175438596491,65.0456140350877,620.670175438597,963.098245614035,716.859649122807,440.845614035088,280.084210526316,1139.31578947368,5413.38245614035,538.915789473684,122.045614035088,1076.02456140351,855.582456140351,449.301754385965,275.757894736842,1465.11929824561,1029.90877192982,211.547368421053,211.063157894737,1078.10526315789,983.891228070175,167.319298245614,119.740350877193,3846.97192982456,1394.41403508772,479.424561403509,229.052631578947,1033.99649122807,129.901754385965,285,29.6346357244142,12.6946088198797,0.903603102787005,0.904761904761905,0.620915032679739,-1.16623135159372,53948.0526315789,32656.5789473684,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_728090,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
728217,3380.75355450237,767.042654028436,72.563981042654,620.184834123223,683.630331753555,261.42654028436,613.620853080569,238.464454976303,1075.03791469194,6694.56872037915,567.023696682464,117.379146919431,1076.72511848341,1119.68720379147,806.056872037915,1607.37440758294,5824.87203791469,1554.81042654028,280.559241706161,218.9336492891,1043.74407582938,1048.28909952607,199.924170616114,322.137440758294,628.748815165877,1961.94786729858,518.905213270142,276.251184834123,1041.45971563981,130.791469194313,211,22.9984142031702,12.2129662710048,0.84734979345755,0.857723577235772,0.685064935064935,-1.44609148836649,54025.345971564,33246.5355450237,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_728217,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
729122,1296.86111111111,236.111111111111,127.925925925926,655.805555555556,3377.72222222222,970.953703703704,306.435185185185,258.703703703704,1083.81481481481,2916.07407407407,474.314814814815,119.009259259259,1068.64814814815,1191.67592592593,458.805555555556,274.305555555556,1437.49074074074,1056.52777777778,278.398148148148,215.907407407407,982.12037037037,986.111111111111,205.37037037037,117.546296296296,1436.08333333333,1585.99074074074,470.685185185185,220.398148148148,1028.71296296296,130.981481481481,108,15.2026744848607,9.08220073898361,0.801937387239348,0.964285714285714,0.692307692307692,0.836745872253939,53772.962962963,32505.5,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_729122,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
729990,3201.48509485095,414.233062330623,140.10027100271,633.19512195122,1466.38482384824,683.151761517615,605.620596205962,254.425474254743,1083.87533875339,5713.94037940379,612.655826558266,132.241192411924,1110.43902439024,2580.17344173442,1038.83739837398,293.428184281843,1514.46341463415,2163.82384823848,309.119241192412,229.056910569106,988.092140921409,1369.53116531165,209.593495934959,175.292682926829,610.813008130081,2308.35230352304,540.70460704607,231.780487804878,1069.27371273713,129.317073170732,369,22.6076518285398,20.9877283157369,0.371716665728783,0.963446475195822,0.798701298701299,0.248968881959629,52785.8401084011,33088.3550135501,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_729990,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
730874,864.764411027569,152.067669172932,67.8395989974937,630.238095238095,1247.34837092732,285.516290726817,258.255639097744,243.864661654135,1076.91979949875,1493.44611528822,605.842105263158,118.042606516291,1066.60902255639,654.546365914787,492.521303258145,265.19298245614,1427.96741854637,1037.04761904762,292.809523809524,224.949874686717,986.699248120301,992.385964912281,220.902255639098,129.09022556391,585.741854636591,896.706766917293,519.661654135338,234.370927318296,1008.13533834586,127.872180451128,399,28.3824709522679,18.102840859433,0.77018741112083,0.966101694915254,0.693913043478261,-0.576199276848414,53614.1679197995,33207.1979949875,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_730874,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
730954,1378.33834586466,415.052631578947,96.2556390977444,637.330827067669,2389.51127819549,486.240601503759,351.225563909774,261.443609022556,1131.52631578947,3062.07518796992,649.654135338346,115.466165413534,1070.66165413534,823.360902255639,451.864661654135,276.481203007519,1523.12781954887,1046.9022556391,214.383458646617,214.18045112782,1157.1954887218,888.443609022556,147.699248120301,117.473684210526,696.428571428571,952.323308270677,430.789473684211,271.135338345865,1025.04511278195,128.473684210526,133,18.3018517491402,9.26731876917409,0.862322405622895,0.956834532374101,0.633333333333333,-0.811858803209561,53862.969924812,32707.3082706767,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_730954,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
732020,1034.12096774194,119.459677419355,69.008064516129,620.193548387097,875.66935483871,252.895161290323,251.096774193548,246.645161290323,1081.11290322581,1728.63709677419,696.185483870968,124.58064516129,1065.83064516129,676.088709677419,503.241935483871,271.161290322581,1431.8064516129,1220.07258064516,325.806451612903,225.653225806452,980.774193548387,999.314516129032,203.572580645161,118.064516129032,581.637096774194,922.620967741936,473.048387096774,221.540322580645,1030.39516129032,129.822580645161,124,19.0859504380364,8.28399171713958,0.900895473236886,0.946564885496183,0.815789473684211,1.55252524608746,53604.6935483871,32592.4435483871,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_732020,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
732120,2319.31232091691,143.472779369628,82.2378223495702,643.951289398281,1766.35243553009,1906.10028653295,1198.36962750716,257.312320916905,1116.31805157593,4518.7994269341,858.335243553009,145.398280802292,1074.32378223496,1194.31232091691,734.094555873926,660.813753581662,3132.68194842407,2435.86819484241,349.948424068768,227.452722063037,1057.52435530086,2374.48424068768,212.169054441261,194.492836676218,611.593123209169,1275.3553008596,460.616045845272,253.679083094556,1083.52722063037,131.74212034384,349,23.3539754448075,20.3110409158734,0.493574027519697,0.911227154046997,0.632246376811594,0.324890925235625,52478.435530086,32653.6991404011,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_732120,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
732431,1607.92397660819,213.374269005848,81.0818713450292,643.485380116959,1500.53801169591,477.146198830409,341.976608187135,255.929824561404,1124.95906432749,3072.50292397661,907.286549707602,113.842105263158,1064.21052631579,801.771929824561,459.029239766082,277.046783625731,1513.0,958.122807017544,200.672514619883,214.824561403509,1309.07602339181,624.912280701754,140.005847953216,125.286549707602,590.017543859649,1172.36257309942,471.900584795322,415.456140350877,1055.16374269006,129.760233918129,171,20.1072477562646,12.39770275013,0.787293198165884,0.846534653465347,0.5625,-1.03321459699081,52605.485380117,32978.6023391813,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_732431,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
733814,1495.30882352941,572.196078431373,90.6225490196078,652.299019607843,2024.64705882353,1145.20588235294,1327.71568627451,243.176470588235,1109.28921568627,2834.78431372549,2569.79411764706,133.911764705882,1068.82352941176,3402.52450980392,1140.8137254902,2670.10294117647,5121.42647058824,4156.91176470588,423.31862745098,256.21568627451,1493.08333333333,3152.21078431373,281.514705882353,558.352941176471,863.387254901961,1379.72058823529,506.117647058824,570.745098039216,1082.51960784314,133.0,204,17.2676125417813,15.3349966255369,0.459691697091371,0.948837209302326,0.75,-0.211084195325871,53234.9166666667,33782.612745098,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_733814,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
734748,2465.67400881057,817.740088105727,696.422907488987,676.15859030837,3860.94273127753,363.722466960353,301.73127753304,240.325991189427,1077.6872246696,3327.80176211454,1101.859030837,122.929515418502,1076.11453744493,1242.78854625551,496.581497797357,335.405286343612,3353.21585903084,2736.03083700441,330.925110132159,231.11013215859,1025.95594713656,2848.16740088106,236.722466960352,184.215859030837,616.982378854625,1012.92070484581,475.114537444934,316.621145374449,1039.58149779736,130.057268722467,227,20.4127526080779,14.8181418383674,0.687773123990432,0.88671875,0.746710526315789,-0.221858496632809,53921.6343612335,33577.0572687225,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_734748,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
735379,1093.28484848485,326.072727272727,73.5393939393939,640.969696969697,1234.77575757576,3679.84848484848,1300.30909090909,259.484848484848,1146.12121212121,2119.15757575758,825.50303030303,109.50303030303,1077.29090909091,3117.01212121212,754.812121212121,337.654545454545,2348.98181818182,1443.58787878788,243.412121212121,219.690909090909,1023.55757575758,1338.13333333333,173.139393939394,204.872727272727,626.812121212121,956.345454545455,421.442424242424,378.745454545455,1052.01818181818,132.072727272727,165,17.9991355631268,11.7656130202532,0.756774044701639,0.9375,0.746606334841629,1.24423743641052,52767.8909090909,33629.296969697,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_735379,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
736366,4448.39700374532,444.74531835206,94.4831460674157,696.861423220974,3304.28464419476,894.546816479401,356.801498127341,246.340823970037,1079.44194756554,7710.12734082397,1764.85767790262,122.546816479401,1101.27715355805,2183.83146067416,654.550561797753,587.790262172285,1714.31835205993,4374.13483146067,370.408239700375,237.49063670412,1100.05243445693,4203.82397003745,249.441947565543,902.917602996255,669.239700374532,2578.52808988764,552.760299625468,570.951310861423,1078.80149812734,130.696629213483,267,21.4866186266673,15.8853440943235,0.673361540198167,0.95017793594306,0.794642857142857,-1.55626848870098,53694.9550561798,33469.4382022472,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_736366,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
736849,1922.6393442623,172.229508196721,299.090163934426,840.598360655738,12826.631147541,1019.58196721311,285.418032786885,241.83606557377,1074.86885245902,3110.76229508197,542.77868852459,133.254098360656,1074.00819672131,5649.82786885246,982.33606557377,349.83606557377,5161.82786885246,9335.46721311475,555.286885245902,266.024590163934,1128.7131147541,10303.5819672131,300.491803278689,251.55737704918,630.713114754098,937.459016393443,441.590163934426,248.5,1086.55737704918,129.704918032787,122,15.3707073945228,11.0744661167528,0.693463627374891,0.818791946308725,0.508333333333333,1.08292507972668,52867.7459016393,33702.4098360656,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_736849,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
737315,1633.42134831461,252.297752808989,86.8932584269663,633.196629213483,1408.73595505618,1691.48876404494,348.005617977528,260.865168539326,1100.70786516854,3338.1404494382,1490.83707865169,115.02808988764,1068.06179775281,1840.88202247191,519.747191011236,282.292134831461,1518.0,1081.23033707865,272.752808988764,223.016853932584,994.449438202247,964.612359550562,200.865168539326,135.129213483146,609.803370786517,1536.81460674157,480.825842696629,336.438202247191,1083.23595505618,131.713483146067,178,24.4104130806259,9.30024549185906,0.924577095203015,0.917525773195876,0.595317725752508,1.19857511526803,53177.808988764,33051.3764044944,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_737315,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
737993,3250.49771689498,722.559360730594,131.689497716895,644.771689497717,1814.95662100457,1265.64383561644,652.794520547945,260.369863013699,1098.48630136986,4915.85844748858,649.924657534247,126.915525114155,1078.29223744292,3604.62100456621,791.415525114155,433.87899543379,2956.85844748858,4051.7100456621,388.858447488584,247.070776255708,1047.33105022831,3252.64611872146,251.920091324201,287.675799086758,622.239726027397,910.063926940639,492.51598173516,234.552511415525,1012.13698630137,129.860730593607,438,27.3038349816642,20.9188877201782,0.642659409166257,0.937901498929336,0.705314009661836,0.329810728138718,53619.7534246575,33396.904109589,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_737993,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
738054,578.243303571429,1210.84151785714,247.78125,618.408482142857,124.160714285714,710.611607142857,315.888392857143,255.819196428571,1082.20089285714,1129.14955357143,580.345982142857,112.522321428571,1065.578125,654.674107142857,499.350446428571,274.506696428571,1408.546875,988.607142857143,309.0625,228.953125,984.167410714286,928.868303571429,224.270089285714,135.129464285714,596.305803571429,578.738839285714,370.379464285714,207.9375,986.540178571429,128.729910714286,448,30.1640700607395,18.9826124575264,0.777152724120113,0.96137339055794,0.785964912280702,1.44603344143941,53264.7209821429,33005.3348214286,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_738054,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
738150,739.116600790514,1041.45652173913,253.458498023715,662.505928853755,2507.03359683794,1569.07312252964,496.9604743083,282.130434782609,1121.81027667984,1740.6442687747,996.306324110672,136.559288537549,1060.59486166008,2105.30039525692,635.416996047431,362.357707509881,1768.10079051383,1736.19565217391,337.766798418972,234.438735177866,1038.63636363636,1389.70948616601,226.51976284585,303.812252964427,1114.1581027668,859.883399209486,465.266798418972,221.666007905138,1023.73320158103,130.990118577075,506,29.1020835858634,22.4686325953307,0.635546395542188,0.961977186311787,0.74962962962963,1.11258702402528,52424.9150197628,32763.4861660079,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_738150,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
738448,2903.97520661157,618.02479338843,85.3636363636364,612.165289256198,736.842975206612,383.140495867769,289.805785123967,248.107438016529,1103.14049586777,5798.56611570248,630.855371900826,120.442148760331,1073.17355371901,796.929752066116,434.971074380165,271.169421487603,1518.11570247934,1010.07851239669,211.057851239669,211.074380165289,1175.88842975207,645.603305785124,133.227272727273,110.714876033058,592.632231404959,2068.22314049587,517.144628099174,240.438016528926,1034.0,130.0,242,24.1279746093451,12.986781584334,0.842787892967563,0.949019607843137,0.751552795031056,1.35557954861822,53250.6033057851,32757.7066115702,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_738448,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
738508,1139.90753424658,144.530821917808,60.9931506849315,620.821917808219,688.712328767123,525.606164383562,709.904109589041,253.479452054795,1188.95205479452,1843.53082191781,483.366438356164,113.25,1082.5,4209.00342465753,1423.95205479452,420.119863013699,3027.3904109589,5951.1301369863,472.794520547945,257.921232876712,1062.68493150685,5205.12328767123,305.195205479452,494.818493150685,605.469178082192,799.130136986301,439.907534246575,237.907534246575,1023.73287671233,129.222602739726,292,23.1276362287792,16.1167524721742,0.717206009247914,0.957377049180328,0.737373737373737,0.441921231063653,52714.4143835616,33593.3869863014,FAAGSCC_12,AG,1,stromal cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_738508,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
739043,476.493917274939,711.043795620438,175.637469586375,609.936739659367,105.223844282238,239.922141119221,259.649635036496,245.48905109489,1074.89294403893,1323.68369829684,995.768856447689,120.077858880779,1069.13868613139,605.579075425791,482.717761557178,262.535279805353,1388.61070559611,950.304136253041,264.155717761557,221.440389294404,975.32603406326,918.931873479319,199.189781021898,115.479318734793,585.557177615572,576.659367396594,358.272506082725,203.98296836983,987.83698296837,129.165450121654,411,25.0739627075738,20.949556494134,0.54947463936584,0.944827586206897,0.718531468531469,0.203851911975029,53213.3357664234,32647.9951338199,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_739043,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
739106,2869.01282051282,769.166666666667,672.294871794872,647.230769230769,1741.23076923077,542.871794871795,354.948717948718,244.153846153846,1109.92307692308,4117.5,542.794871794872,127.166666666667,1079.0641025641,806.75641025641,579.692307692308,282.0,1811.42307692308,1933.5,322.782051282051,229.564102564103,1034.88461538462,2204.9358974359,232.038461538462,287.320512820513,591.769230769231,1238.42307692308,542.461538461538,269.576923076923,1027.5,131.705128205128,78,13.5908016666533,7.84951567821097,0.816347599825089,0.876404494382023,0.619047619047619,-0.254681216106144,52971.3846153846,33375.9102564103,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_739106,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
739215,2134.78134110787,203.419825072886,108.137026239067,624.489795918367,1576.84256559767,2252.87755102041,718.32361516035,256.384839650146,1093.00874635569,4031.75218658892,556.422740524781,116.696793002915,1091.60932944606,1600.89504373178,948.026239067055,1113.76093294461,1725.9416909621,3038.73177842566,320.959183673469,227.793002915452,1025.68221574344,2537.15160349854,228.32944606414,209.020408163265,674.067055393586,1801.38775510204,520.583090379009,244.912536443149,1046.69970845481,130.935860058309,343,41.4303571453809,10.6412046590432,0.966452451615972,0.937158469945355,0.394252873563218,-0.763567736524299,54121.5685131195,32918.2274052478,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_739215,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
739955,2629.25806451613,707.820276497696,123.276497695853,709.861751152074,5659.44239631336,3151.88479262673,373.760368663594,256.645161290323,1099.62211981567,4902.60368663594,638.529953917051,125.889400921659,1097.75115207373,3944.52534562212,930.649769585254,961.460829493088,5230.81566820276,4398.31797235023,318.68202764977,227.129032258065,1046.61751152074,3927.59447004608,214.94930875576,167.069124423963,656.373271889401,1380.02764976959,484.110599078341,233.728110599078,1065.46082949309,130.976958525346,217,24.5189098439912,12.6066333047484,0.857694518941702,0.800738007380074,0.543859649122807,0.951243734035274,53024.7465437788,33416.7188940092,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_739955,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
741191,1949.35379061372,331.978339350181,78.5090252707581,607.173285198556,320.689530685921,276.281588447653,302.046931407942,243.516245487365,1074.16245487365,4107.59927797834,500.981949458484,113.884476534296,1066.53429602888,768.794223826715,515.646209386282,277.039711191336,1430.09025270758,1235.53068592058,321.747292418773,229.501805054152,980.436823104693,1192.15884476534,235.057761732852,122.29963898917,581.090252707581,2105.47653429603,489.916967509025,234.960288808664,1028.40072202166,128.837545126354,277,24.0140252646609,15.1061331331583,0.777361117011919,0.945392491467577,0.70843989769821,-1.26735212264033,52866.5306859206,33225.6895306859,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_741191,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
741876,800.762237762238,185.503496503497,88.7482517482517,629.811188811189,1770.81118881119,686.902097902098,367.587412587413,249.608391608392,1084.62937062937,1238.81818181818,463.524475524476,114.475524475524,1068.8041958042,2851.74825174825,1151.74125874126,1400.42657342657,3839.74125874126,5750.22377622378,417.867132867133,232.776223776224,1056.04895104895,4917.16083916084,239.594405594406,281.566433566434,903.951048951049,795.797202797203,449.321678321678,221.181818181818,996.685314685315,128.881118881119,143,14.9629779060011,12.2046443306785,0.57853704517008,0.947019867549669,0.733333333333333,-0.248604240349522,53854.9090909091,32837.4055944056,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_741876,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
742139,1417.5,96.8623188405797,77.963768115942,646.405797101449,1708.25362318841,511.094202898551,322.884057971014,244.311594202899,1090.71014492754,2723.23913043478,504.717391304348,107.550724637681,1078.58695652174,958.13768115942,466.13768115942,273.442028985507,1827.23913043478,1319.21014492754,266.492753623188,231.702898550725,1033.25362318841,1029.60144927536,191.608695652174,146.913043478261,598.949275362319,912.31884057971,433.797101449275,675.826086956522,1027.27536231884,131.586956521739,138,18.4193401715524,11.2360400753794,0.792391275330504,0.766666666666667,0.541176470588235,-0.340697217972754,53803.5579710145,33493.268115942,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_742139,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
742340,1637.09426229508,303.770491803279,99.3360655737705,631.155737704918,1367.34016393443,641.290983606557,877.516393442623,245.696721311475,1114.78278688525,2678.3237704918,2520.95491803279,118.979508196721,1079.72131147541,801.094262295082,1110.95081967213,483.647540983607,2269.76229508197,993.774590163934,250.815573770492,220.614754098361,1005.04508196721,872.741803278689,187.766393442623,129.045081967213,616.422131147541,1042.70491803279,515.606557377049,357.454918032787,1032.66803278689,131.754098360656,244,26.659347505195,11.6933849161022,0.898671496322287,0.934865900383142,0.695156695156695,1.43801343811606,53305.3196721311,33250.4016393443,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_742340,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
742559,1796.80769230769,209.230769230769,132.980769230769,649.480769230769,2521.16346153846,325.182692307692,357.115384615385,259.471153846154,1081.61538461538,2932.5,559.942307692308,116.682692307692,1070.76923076923,639.778846153846,407.980769230769,267.028846153846,1418.98076923077,1177.76923076923,271.278846153846,224.990384615385,998.971153846154,1284.79807692308,234.240384615385,153.759615384615,585.115384615385,1118.24038461538,533.009615384615,234.432692307692,1016.70192307692,127.884615384615,104,17.6423508651294,7.80269641446368,0.896881569842976,0.936936936936937,0.764705882352941,-1.4862224883034,53561.5673076923,33192.7115384615,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_742559,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
743572,2145.52222222222,180.127777777778,422.95,608.511111111111,508.294444444444,531.772222222222,689.633333333333,254.533333333333,1075.50555555556,3071.56111111111,657.022222222222,132.572222222222,1059.83333333333,2419.07222222222,722.894444444444,470.477777777778,1997.85,4885.56111111111,386.244444444444,250.694444444444,1022.8,5596.20555555556,260.994444444444,476.122222222222,635.383333333333,905.2,480.461111111111,257.166666666667,1009.27222222222,128.977777777778,180,20.7051505209455,11.3210369537185,0.837280267681494,0.927835051546392,0.676691729323308,-0.368334100071397,53405.7666666667,33824.9111111111,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_743572,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
743753,905.99375,115.14375,134.19375,678.7375,4812.76875,589.0375,313.1875,244.55625,1089.2375,2440.0,610.94375,124.0,1079.45625,979.65625,481.81875,280.19375,1572.49375,2201.56875,324.0875,227.5125,999.25625,2028.7375,221.24375,554.66875,591.625,1393.48125,543.61875,247.09375,1051.69375,128.75,160,17.4879907976863,11.7742909705867,0.739388834816294,0.941176470588235,0.723981900452489,0.425284427464132,53679.58125,33043.85625,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_743753,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
743927,1849.99604743083,214.97233201581,101.217391304348,642.351778656126,1811.19367588933,800.541501976285,273.616600790514,246.98418972332,1101.2766798419,3999.44664031621,2727.70750988142,116.723320158103,1081.86166007905,775.588932806324,496.090909090909,274.422924901186,1797.77865612648,1787.33992094862,299.312252964427,223.830039525692,994.98418972332,2767.20158102767,221.549407114625,140.130434782609,632.739130434783,2097.55731225296,542.02766798419,457.241106719368,1054.16205533597,131.158102766798,253,25.9945430632247,12.5627431137754,0.875463711722467,0.954716981132076,0.748520710059172,-1.46363109578824,53564.628458498,33137.7351778656,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_743927,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
744028,1095.45821325648,193.391930835735,69.7233429394813,629.953890489914,1270.12968299712,800.585014409222,336.85590778098,249.377521613833,1080.01729106628,2678.52161383285,738.766570605187,122.602305475504,1069.09798270893,1069.61959654179,597.893371757925,291.945244956772,1722.72622478386,1052.56772334294,260.36023054755,220.406340057637,1016.66570605187,941.665706051873,188.161383285303,214.270893371758,641.414985590778,1424.98270893372,491.279538904899,234.296829971182,1072.91930835735,129.93083573487,347,30.62578308728,14.6415961191381,0.878315908336092,0.950684931506849,0.578333333333333,-0.821562525563181,52747.8731988473,32440.4178674352,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_744028,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
744106,2953.71117166213,535.694822888283,130.74931880109,642.653950953678,1976.27247956403,523.937329700272,1500.70572207084,238.506811989101,1090.37602179837,3970.41961852861,530.817438692098,121.956403269755,1080.1689373297,1588.15803814714,819.607629427793,382.66757493188,1605.22070844687,2056.22615803815,329.820163487738,234.852861035422,1004.41144414169,2172.93460490463,254.891008174387,235.539509536785,645.58310626703,825.193460490463,433.910081743869,217.076294277929,1009.60217983651,130.825613079019,367,23.5300696625374,20.0420478570233,0.523926922722961,0.953246753246753,0.728174603174603,0.481647225954426,52703.4877384196,33458.4795640327,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_744106,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
745564,2398.14285714286,382.387012987013,131.766233766234,658.358441558442,2294.45974025974,264.246753246753,297.537662337662,247.111688311688,1081.68051948052,4260.4025974026,703.672727272727,123.52987012987,1081.23636363636,660.724675324675,563.096103896104,405.58961038961,1473.30909090909,838.335064935065,226.677922077922,217.155844155844,994.109090909091,785.683116883117,176.322077922078,165.231168831169,596.051948051948,1460.32467532468,509.233766233766,231.820779220779,1037.58441558442,129.942857142857,385,36.3062608332189,13.5721014605798,0.927500215933967,0.941320293398533,0.566176470588235,-1.13063708793445,52458.6441558442,33207.5272727273,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_745564,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
745946,2303.70967741935,715.075268817204,110.172043010753,613.365591397849,1010.93548387097,967.763440860215,618.440860215054,252.064516129032,1114.60215053763,2821.77419354839,716.258064516129,115.451612903226,1065.94623655914,4227.08602150538,674.666666666667,961.043010752688,2053.60215053763,3012.32258064516,368.612903225806,691.752688172043,999.021505376344,1724.24731182796,246.967741935484,194.354838709677,599.903225806452,960.94623655914,522.860215053763,292.397849462366,1014.2688172043,127.752688172043,93,12.1663019030902,9.92780341681595,0.578040174311737,0.93,0.704545454545455,-0.435572195586251,53861.3870967742,33249.8602150538,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_745946,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
746035,1437.72916666667,239.409722222222,173.263888888889,603.131944444444,391.159722222222,2364.83333333333,1439.86111111111,261.493055555556,1094.65972222222,2585.59027777778,490.048611111111,121.444444444444,1093.13194444444,1811.84027777778,814.0625,393.083333333333,2156.38888888889,1640.43055555556,374.229166666667,249.069444444444,1043.63194444444,1394.59722222222,261.173611111111,548.354166666667,2588.19444444444,1372.125,470.819444444444,234.090277777778,1021.58333333333,130.548611111111,144,16.1548837284868,11.3499528302956,0.71161365129975,0.979591836734694,0.791208791208791,0.716705824827141,53046.0486111111,33800.5555555556,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_746035,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
746938,1660.02339181287,129.912280701754,137.099415204678,691.12865497076,4101.6783625731,590.461988304094,663.461988304094,240.619883040936,1082.14619883041,2930.54385964912,545.795321637427,119.847953216374,1081.18128654971,872.33918128655,730.853801169591,567.461988304094,1816.21052631579,1864.93567251462,321.538011695906,236.754385964912,1015.80701754386,1620.94736842105,244.391812865497,344.643274853801,680.74269005848,926.567251461988,463.134502923977,254.280701754386,1025.91812865497,130.543859649123,171,19.8841133869576,10.9889264052515,0.833414411702215,0.934426229508197,0.75,1.38150253240174,53640.0877192982,33412.9064327485,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_746938,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
747501,2706.68794326241,374.014184397163,101.460992907801,653.234042553191,1753.0780141844,3318.32624113475,2503.90070921986,261.418439716312,1107.63120567376,4987.43971631206,3269.72340425532,143.177304964539,1107.02836879433,3445.12056737589,1226.02836879433,2809.05673758865,2151.59574468085,5503.24822695035,440.070921985816,252.120567375887,1033.66666666667,5367.90070921986,308.312056737589,391.780141843972,692.68085106383,1774.97872340426,540.702127659574,500.375886524823,1082.21985815603,130.730496453901,141,18.6924404136014,9.64278463920228,0.856669605190652,0.979166666666667,0.671428571428571,0.830386562245494,53108.2553191489,33782.2695035461,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_747501,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
747504,3249.38213399504,476.581885856079,637.775434243176,643.849875930521,1851.29776674938,2245.59925558313,740.426799007444,264.465260545906,1147.25930521092,5251.12406947891,695.900744416873,128.585607940447,1083.25930521092,2535.63275434243,710.81141439206,510.686104218362,2340.19478908189,2261.99255583127,310.908188585608,233.06699751861,1021.78287841191,1465.01240694789,230.286600496278,248.455334987593,587.068238213399,1603.09925558313,560.578163771712,295.488833746898,1046.91563275434,130.923076923077,806,40.1292231284217,25.7502269827758,0.766970242524435,0.950471698113208,0.765432098765432,-0.281737785316385,53610.929280397,33368.5248138958,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_747504,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
748124,3635.0938215103,569.057208237986,541.054919908467,639.160183066362,1843.06636155606,1664.30892448513,1646.89931350114,254.764302059497,1090.99771167048,5816.69107551487,598.37299771167,122.594965675057,1069.32036613272,1088.40961098398,662.009153318078,519.368421052632,1603.9061784897,1269.07322654462,258.95652173913,217.537757437071,1034.58123569794,1109.26315789474,201.132723112128,254.286041189931,2673.35011441648,1402.83752860412,490.695652173913,267.700228832952,1034.62929061785,129.622425629291,437,31.4908590093374,17.8737435135996,0.823314710587574,0.962555066079295,0.655172413793103,-0.988586827380431,54098.3707093822,32708.3775743707,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_748124,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
748768,1222.43875278396,305.853006681515,87.0489977728285,638.004454342984,1771.52561247216,1860.24276169265,1566.13140311804,255.015590200445,1087.61692650334,2320.8574610245,510.32293986637,130.614699331849,1083.3140311804,1063.72605790646,582.93986636971,554.389755011136,1705.36080178174,1384.15590200445,297.013363028953,228.902004454343,1175.08240534521,1399.83518930958,213.233853006682,214.084632516704,614.271714922049,1173.4008908686,467.102449888641,248.846325167038,1058.72383073497,130.363028953229,449,31.5948149840303,18.2919344084403,0.81536043333542,0.965591397849462,0.738486842105263,0.17828406425817,53274.6414253898,33766.293986637,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_748768,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
748905,2416.20192307692,392.173076923077,187.096153846154,697.865384615385,4653.26923076923,3093.55769230769,595.394230769231,248.548076923077,1171.09615384615,4842.26923076923,620.538461538462,124.365384615385,1087.82692307692,3242.15384615385,914.971153846154,2183.57692307692,2637.27884615385,3237.72115384615,364.375,244.125,1074.68269230769,2027.00961538462,248.346153846154,369.788461538462,908.480769230769,1439.625,478.413461538462,233.596153846154,1047.73076923077,129.509615384615,104,16.0666302225364,9.05952160733764,0.825862252153668,0.852459016393443,0.577777777777778,-1.16293003039455,52938.3557692308,33439.1538461538,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_748905,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
749247,1562.45138888889,292.708333333333,91.8611111111111,627.090277777778,820.048611111111,188.826388888889,204.326388888889,239.25,1074.20138888889,3601.55555555556,2139.05555555556,124.597222222222,1072.54166666667,502.104166666667,365.868055555556,255.055555555556,1411.95833333333,915.972222222222,261.972222222222,218.604166666667,973.743055555556,913.152777777778,198.631944444444,124.444444444444,582.263888888889,2087.06944444444,544.284722222222,509.666666666667,1079.86805555556,131.402777777778,144,17.0940912841179,11.2126433248695,0.754815825612051,0.9,0.705882352941177,0.15131373153521,53557.0555555556,32247.4652777778,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_749247,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
749299,1015.40707964602,216.345132743363,184.58407079646,703.309734513274,5326.30973451327,286.725663716814,326.769911504425,249.424778761062,1077.38053097345,1422.61061946903,824.734513274336,160.575221238938,1068.73451327434,610.486725663717,445.902654867257,271.902654867257,1507.62831858407,960.522123893805,260.973451327434,220.247787610619,973.212389380531,921.778761061947,214.991150442478,116.610619469027,595.557522123894,886.106194690266,471.920353982301,228.973451327434,1038.73451327434,131.283185840708,113,12.1994649774147,11.7970567598637,0.254722192243531,0.949579831932773,0.784722222222222,-0.728178010762416,52465.185840708,32342.3274336283,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_749299,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
749435,1551.12056737589,552.425531914894,230.368794326241,679.234042553191,5123.24113475177,282.042553191489,322.042553191489,243.936170212766,1086.08510638298,3439.3829787234,531.539007092199,126.843971631206,1071.79432624113,595.397163120567,421.09219858156,268.879432624113,1440.07092198582,983.41134751773,243.808510638298,216.241134751773,983.879432624114,954.219858156028,200.049645390071,138.255319148936,582.099290780142,1224.89361702128,490.063829787234,256.446808510638,1076.50354609929,127.794326241135,141,15.0340276134454,12.4078229863477,0.564671196584768,0.886792452830189,0.677884615384615,0.634506653901339,54132.695035461,33178.2836879433,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_749435,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
749712,1674.85501858736,257.338289962825,98.3382899628253,637.42750929368,1164.86617100372,3393.50185873606,343.89219330855,264.520446096654,1088.61338289963,4248.70260223048,1447.34200743494,129.691449814126,1063.5092936803,742.996282527881,548.788104089219,268.263940520446,1470.72118959108,1476.18587360595,266.899628252788,218.899628252788,981.758364312268,1866.08178438662,195.981412639405,113.349442379182,583.739776951673,1497.5092936803,484.60594795539,241.520446096654,1082.11152416357,130.624535315985,269,29.7175937288915,11.7223308232402,0.918914141001502,0.937282229965157,0.622685185185185,-1.17244689742852,53587.0520446097,32620.0334572491,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_749712,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
750360,3811.98538011696,626.514619883041,793.611111111111,653.83918128655,2226.65789473684,2326.16666666667,2400.52339181287,251.304093567251,1151.95614035088,5390.61695906433,751.59649122807,122.304093567251,1079.26900584795,2902.65497076023,1076.57602339181,1619.26315789474,1951.76315789474,4133.21637426901,462.090643274854,244.994152046784,1091.71052631579,3735.9649122807,260.80701754386,727.994152046784,731.891812865497,904.388888888889,447.374269005848,427.915204678363,1034.61403508772,128.953216374269,342,28.8305985857854,15.2610436879076,0.848412931520875,0.94475138121547,0.619565217391304,-0.855129536652581,53710.716374269,33723.6052631579,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_750360,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
750400,1759.88505747126,298.66091954023,73.6264367816092,651.66091954023,2127.52298850575,4326.67816091954,2205.27011494253,259.137931034483,1160.54022988506,2705.05747126437,566.028735632184,116.32183908046,1071.52873563218,1269.82183908046,669.793103448276,558.408045977012,3516.44252873563,2885.37356321839,398.620689655172,399.316091954023,1033.01149425287,2467.24712643678,259.034482758621,273.844827586207,602.942528735632,819.689655172414,449.770114942529,219.977011494253,1018.69540229885,130.413793103448,174,19.7259452735412,11.6001804745446,0.808812106563379,0.861386138613861,0.602076124567474,0.714355682040006,52650.1609195402,33574.4942528736,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_750400,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
750804,1940.17894736842,393.042105263158,99.0,621.684210526316,809.157894736842,1565.51578947368,307.652631578947,250.568421052632,1095.66315789474,3088.83157894737,1071.16842105263,111.452631578947,1059.42105263158,1490.2,556.863157894737,283.452631578947,1621.25263157895,1208.58947368421,266.442105263158,220.652631578947,1054.55789473684,1085.01052631579,191.768421052632,556.168421052632,761.084210526316,1167.25263157895,502.126315789474,314.010526315789,1025.53684210526,131.842105263158,95,12.3369888976699,9.78953770252067,0.60855576980315,0.94059405940594,0.791666666666667,1.31169921478638,53941.4842105263,32912.5894736842,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_750804,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
751713,1658.75490196078,242.43137254902,93.4313725490196,631.862745098039,1638.89215686275,323.774509803922,306.862745098039,257.78431372549,1072.42156862745,3846.93137254902,569.450980392157,117.009803921569,1069.93137254902,712.607843137255,570.78431372549,387.519607843137,1647.60784313725,984.127450980392,260.666666666667,218.539215686275,1006.5,860.117647058824,184.745098039216,186.294117647059,643.274509803922,1596.3137254902,477.637254901961,236.274509803922,1061.87254901961,132.725490196078,102,13.7780624180736,9.56483279396979,0.719775031026879,0.918918918918919,0.708333333333333,0.733256389829034,53139.862745098,33048.1274509804,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_751713,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
752043,718.956790123457,200.592592592592,144.845679012346,674.41975308642,3311.96913580247,379.061728395062,2199.96913580247,263.574074074074,1103.51851851852,921.783950617284,1301.4012345679,133.635802469136,1066.5987654321,436.567901234568,489.487654320988,245.246913580247,1414.72222222222,680.777777777778,164.469135802469,202.030864197531,979.901234567901,594.91975308642,137.611111111111,94.3518518518518,581.320987654321,757.098765432099,424.796296296296,214.283950617284,1028.56790123457,128.259259259259,162,17.2160327439668,12.0199087305003,0.71592118798859,0.931034482758621,0.680672268907563,-1.07123641857849,53240.1111111111,31955.8209876543,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_752043,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
752229,1569.67142857143,136.8,74.5428571428571,646.657142857143,2016.32857142857,2819.02857142857,680.6,251.628571428571,1102.08571428571,2708.61428571429,528.771428571429,125.971428571429,1068.68571428571,1896.88571428571,676.757142857143,349.028571428571,1800.81428571429,1248.17142857143,340.128571428571,239.242857142857,986.342857142857,1219.65714285714,258.1,195.8,583.271428571429,1012.32857142857,488.328571428571,546.8,1026.87142857143,130.285714285714,70,10.3657327259594,9.11763000404762,0.47572625068316,0.853658536585366,0.636363636363636,-0.252577594556353,53684.3714285714,33781.5285714286,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_752229,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
752311,474.740046838408,1057.29274004684,254.058548009368,612.023419203747,97.8711943793911,586.639344262295,389.060889929742,268.983606557377,1112.07962529274,1212.36768149883,889.946135831382,118.674473067916,1058.18969555035,937.819672131148,562.629976580796,303.833723653396,1541.80093676815,1229.40983606557,226.791569086651,217.625292740047,1133.75644028103,987.065573770492,166.96018735363,148.580796252927,894.3981264637,558.943793911007,343.889929742389,198.112412177986,986.667447306792,127.955503512881,427,30.5793076936979,17.9432485109519,0.809748239827085,0.96606334841629,0.724957555178268,-1.34330107821259,52605.9929742389,32853.868852459,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_752311,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
753294,1935.68987341772,860.854430379747,1002.98101265823,630.208860759494,1702.83544303797,501.23417721519,2081.31012658228,255.259493670886,1092.54430379747,2740.39873417722,578.088607594937,115.924050632911,1066.4746835443,767.746835443038,533.569620253165,1196.18987341772,1570.57594936709,1327.10759493671,267.816455696203,219.512658227848,1002.91139240506,1939.48734177215,214.069620253164,149.46835443038,592.645569620253,1079.57594936709,545.848101265823,257.405063291139,1028.14556962025,130.050632911392,158,22.1679702729522,9.52452881653449,0.902994206313067,0.877777777777778,0.548611111111111,0.615095873235488,54088.753164557,33310.3797468354,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_753294,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
753313,2982.38461538462,306.753846153846,132.96,616.464615384615,626.058461538462,1957.50153846154,328.0,263.504615384615,1090.88,3724.20923076923,610.286153846154,122.56,1081.28307692308,1824.95076923077,581.344615384615,290.476923076923,1503.66153846154,1232.97846153846,278.403076923077,223.489230769231,992.369230769231,1032.68,212.636923076923,126.378461538462,609.169230769231,898.415384615385,506.526153846154,233.510769230769,1011.49230769231,130.563076923077,325,26.0892121516853,16.6606533205535,0.769536226637633,0.902777777777778,0.65,-1.19676960857748,53346.4584615385,33298.7353846154,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_753313,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
753906,1127.41111111111,334.622222222222,134.144444444444,639.655555555556,1873.13333333333,274.777777777778,257.511111111111,231.688888888889,1074.36666666667,2354.22222222222,959.488888888889,118.177777777778,1071.46666666667,622.155555555556,554.611111111111,286.366666666667,1831.8,1066.36666666667,302.5,235.022222222222,1007.04444444444,1066.97777777778,229.822222222222,164.6,604.022222222222,1392.42222222222,515.933333333333,334.244444444444,1072.68888888889,127.188888888889,90,11.2960005367793,10.1570568557947,0.437593656472325,0.967741935483871,0.818181818181818,1.18618641406572,52612.8,33633.3222222222,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_753906,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
753990,931.328767123288,109.013698630137,103.554794520548,649.424657534247,2285.57534246575,367.650684931507,340.267123287671,253.794520547945,1087.35616438356,1477.03424657534,431.458904109589,115.027397260274,1065.43835616438,749.678082191781,453.417808219178,283.924657534247,1491.65068493151,1106.82191780822,311.623287671233,236.86301369863,995.72602739726,1060.55479452055,237.739726027397,158.287671232877,596.27397260274,754.383561643836,404.616438356164,204.513698630137,1027.94520547945,131.143835616438,146,20.4581617594671,9.0867632170512,0.895945882672186,0.948051948051948,0.811111111111111,-0.0113930523455058,52492.0890410959,33516.6095890411,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_753990,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
754150,967.771739130435,241.880434782609,122.760869565217,649.673913043478,2353.80434782609,490.032608695652,363.195652173913,256.652173913043,1118.34782608696,2204.88043478261,601.847826086957,112.152173913043,1055.20652173913,654.804347826087,391.228260869565,269.358695652174,1439.48913043478,904.880434782609,199.076086956522,210.684782608696,1202.5652173913,691.510869565217,145.402173913043,123.217391304348,596.141304347826,1000.70652173913,474.684782608696,233.065217391304,1038.90217391304,131.0,92,13.3924013209277,8.81477723111936,0.752849732005337,0.929292929292929,0.696969696969697,0.955332774827239,53320.4239130435,33086.9347826087,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_754150,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
755226,1756.63725490196,503.362745098039,86.0882352941177,655.039215686274,2398.63725490196,1416.41176470588,850.970588235294,253.78431372549,1100.51960784314,2463.12745098039,1143.78431372549,119.06862745098,1074.94117647059,4191.78431372549,1284.64705882353,474.911764705882,15582.5,7469.35294117647,500.607843137255,260.813725490196,1075.6862745098,6590.21568627451,300.098039215686,435.911764705882,760.019607843137,992.892156862745,487.450980392157,288.598039215686,1037.51960784314,130.676470588235,102,15.5098667177757,8.41050617821794,0.840205505935753,0.953271028037383,0.713286713286713,-0.600570057337756,52879.2058823529,33650.2254901961,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_755226,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
756965,3666.75925925926,867.953703703704,90.3425925925926,639.203703703704,1518.50925925926,761.106481481482,427.902777777778,280.62037037037,1134.77314814815,8198.86111111111,655.842592592593,129.064814814815,1075.79166666667,1469.25462962963,616.578703703704,278.402777777778,1744.93518518519,2393.04166666667,346.814814814815,236.328703703704,1051.2037037037,2007.73148148148,231.541666666667,235.675925925926,3700.49537037037,2736.49537037037,540.074074074074,258.421296296296,1071.73148148148,130.763888888889,216,21.3152949071058,15.7172626651173,0.675488882153372,0.757894736842105,0.568421052631579,-1.04662262111999,53589.1064814815,32731.3333333333,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_756965,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
757417,614.883620689655,837.262931034483,199.290948275862,627.855603448276,156.094827586207,627.043103448276,454.681034482759,280.476293103448,1144.3599137931,1496.92887931034,1835.95905172414,125.426724137931,1072.91379310345,818.586206896552,517.734913793103,288.924568965517,1590.44396551724,1105.25431034483,251.206896551724,223.463362068966,1142.18103448276,936.883620689655,187.234913793103,186.859913793103,3399.72413793103,938.82974137931,449.502155172414,221.540948275862,1066.71551724138,130.629310344828,464,29.6827920401936,19.9743631461872,0.739708561747484,0.974789915966386,0.842105263157895,-0.0626110615386261,52448.9073275862,32804.3706896552,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_757417,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
757877,1718.27368421053,103.368421052632,58.6210526315789,626.452631578947,1101.14736842105,1369.29473684211,816.263157894737,246.526315789474,1099.84210526316,3058.22105263158,1666.44210526316,111.642105263158,1066.72631578947,6031.42105263158,1192.98947368421,434.957894736842,10343.5473684211,7239.55789473684,560.031578947368,264.768421052632,1089.53684210526,6429.29473684211,305.568421052632,282.547368421053,668.789473684211,821.726315789474,407.315789473684,364.747368421053,1025.73684210526,129.526315789474,95,14.5785453032269,8.88665968983113,0.792731411866635,0.84070796460177,0.678571428571429,1.46384606531819,52756.6736842105,33576.747368421,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_757877,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
757993,1139.74479166667,231.317708333333,120.083333333333,668.614583333333,3087.48958333333,888.447916666667,352.411458333333,267.645833333333,1087.88541666667,2176.25,634.5,129.28125,1067.88020833333,4764.63020833333,639.807291666667,312.708333333333,1687.453125,3915.30729166667,412.671875,243.109375,1006.93229166667,4723.45833333333,261.239583333333,135.375,581.838541666667,1154.953125,519.385416666667,239.026041666667,1027.13541666667,130.609375,192,18.8355774984198,13.1131598508233,0.717856579069547,0.945812807881773,0.761904761904762,1.24005226433481,53554.9895833333,32099.421875,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_757993,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
758682,5389.8320610687,1515.90839694656,217.618320610687,655.198473282443,2813.67175572519,300.175572519084,724.862595419847,244.931297709924,1086.0534351145,9352.61832061069,1119.56488549618,134.091603053435,1083.41221374046,633.893129770992,442.854961832061,319.885496183206,1513.61832061069,950.57251908397,240.389312977099,214.488549618321,977.93893129771,809.381679389313,183.12213740458,140.740458015267,605.893129770992,3742.45801526718,624.396946564886,311.381679389313,1072.01526717557,131.473282442748,131,18.5988178013013,10.8714059287004,0.811378334384733,0.779761904761905,0.55982905982906,1.0286462171326,54113.3053435114,33346.572519084,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_758682,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
758834,1389.57575757576,147.787878787879,104.954545454545,610.121212121212,863.227272727273,1953.07575757576,404.636363636364,258.606060606061,1110.75757575758,2785.75757575758,450.69696969697,102.151515151515,1058.72727272727,979.757575757576,686.121212121212,279.712121212121,1925.80303030303,1249.12121212121,300.666666666667,225.848484848485,1062.54545454545,1186.0,220.060606060606,1266.72727272727,858.787878787879,1574.56060606061,469.257575757576,255.69696969697,1016.81818181818,130.318181818182,66,10.5255821115926,7.9553390657505,0.654791118646057,0.942857142857143,0.814814814814815,0.785398163397448,53863.8787878788,33552.1212121212,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_758834,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
760056,592.646808510638,1429.49361702128,316.889361702128,616.246808510638,105.897872340426,361.953191489362,272.110638297872,254.991489361702,1071.7829787234,1513.67659574468,738.987234042553,118.787234042553,1065.99574468085,1213.14468085106,511.714893617021,270.412765957447,1525.63829787234,1353.68936170213,267.570212765957,216.527659574468,976.740425531915,1158.29361702128,189.770212765957,120.455319148936,586.255319148936,578.91914893617,363.714893617021,207.03829787234,983.96170212766,128.378723404255,235,18.3523308042008,16.3132751295381,0.458113100186877,0.955284552845528,0.76797385620915,1.4596039626223,53754.5531914894,32625.0808510638,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_760056,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
760384,1478.48199445983,195.371191135734,100.130193905817,626.149584487535,1298.25761772853,308.947368421053,354.506925207756,253.736842105263,1082.35457063712,2899.35457063712,555.02216066482,116.180055401662,1077.59833795014,634.174515235457,563.509695290859,273.168975069252,1487.4404432133,977.15512465374,282.196675900277,225.141274238227,983.853185595568,895.047091412742,208.8891966759,134.024930747922,588.213296398892,1366.49861495845,448.711911357341,218.157894736842,1045.32409972299,129.373961218837,361,32.5756556379428,14.6053863272605,0.893856682698835,0.9328165374677,0.56055900621118,0.914695296119766,52614.8587257618,32299.0166204986,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_760384,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
760386,1596.09285714286,232.171428571428,186.764285714286,681.007142857143,4820.19285714286,284.385714285714,308.478571428571,249.235714285714,1088.49285714286,3451.59285714286,570.564285714286,122.171428571429,1078.47857142857,579.871428571429,455.728571428571,267.592857142857,1424.50714285714,874.6,231.292857142857,217.864285714286,986.185714285714,814.657142857143,180.55,140.835714285714,593.0,1652.35,489.721428571429,229.614285714286,1048.05714285714,129.535714285714,140,22.2477879256568,8.0967626288573,0.93142410320393,0.933333333333333,0.606060606060606,-1.16343541708996,53264.6142857143,33227.8928571429,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_760386,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
760976,1438.97222222222,533.902777777778,97.4305555555556,634.583333333333,1116.125,653.527777777778,333.763888888889,236.958333333333,1085.44444444444,1899.73611111111,898.083333333333,129.902777777778,1068.81944444444,5310.72222222222,811.375,405.0,2129.18055555556,8703.5,555.013888888889,265.722222222222,1087.13888888889,6421.22222222222,358.055555555556,499.958333333333,637.75,956.222222222222,489.402777777778,439.444444444444,1051.88888888889,129.916666666667,72,10.7663504461165,8.50304342304119,0.613390789430645,0.947368421052632,0.8,-0.901073168194947,53081.4861111111,33833.9861111111,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_760976,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
761099,1170.6338028169,68.0281690140845,59.6478873239437,628.380281690141,1355.12676056338,333.183098591549,358.521126760563,247.056338028169,1072.83098591549,1697.78873239437,795.014084507042,121.098591549296,1068.04225352113,959.084507042254,632.070422535211,412.549295774648,1491.2676056338,2988.81690140845,314.830985915493,229.394366197183,994.281690140845,5197.64788732394,233.676056338028,159.380281690141,594.028169014084,784.859154929577,411.338028169014,209.366197183099,1018.53521126761,129.197183098592,71,10.3582184239904,8.74639444697238,0.535726170088396,0.93421052631579,0.788888888888889,-1.18203302386366,52983.6338028169,32809.8873239437,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_761099,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
762544,4599.30729166667,526.744791666667,193.114583333333,693.244791666667,4084.05208333333,1562.375,1648.21875,255.46875,1116.60416666667,6217.02083333333,719.78125,145.817708333333,1081.61979166667,5048.09895833333,950.833333333333,1688.02604166667,2926.70833333333,4508.46875,371.994791666667,236.458333333333,1083.33333333333,2939.44270833333,246.286458333333,513.557291666667,720.46875,2025.16666666667,557.317708333333,348.484375,1091.015625,131.989583333333,192,21.4122347319969,12.5922177092609,0.808799006213377,0.849557522123894,0.6,-0.845687534008802,53207.9635416667,33922.078125,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_762544,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
762991,2268.90118577075,182.462450592885,71.2173913043478,630.158102766798,1322.87747035573,827.292490118577,410.450592885375,281.731225296443,1140.9604743083,3767.71541501976,760.03557312253,122.664031620553,1071.32806324111,1732.97628458498,564.557312252964,288.130434782609,1748.84584980237,1968.99604743083,332.312252964427,233.138339920949,1040.20948616601,1494.71936758893,222.99604743083,211.99604743083,1888.9604743083,1103.70750988142,475.628458498024,255.794466403162,1025.53754940711,129.098814229249,253,27.5577693468211,11.7899324198481,0.903861076541211,0.947565543071161,0.554824561403509,0.942832578858867,53614.7075098814,32709.8932806324,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_762991,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
763086,2542.94047619048,291.214285714286,65.0952380952381,611.261904761905,1015.19047619048,327.02380952381,228.75,226.0,1074.86904761905,4724.2380952381,889.869047619048,132.916666666667,1083.41666666667,3984.7619047619,668.035714285714,319.095238095238,1968.35714285714,6939.41666666667,503.321428571429,250.52380952381,1142.97619047619,7049.80952380952,273.952380952381,1118.64285714286,1547.65476190476,2041.32142857143,486.02380952381,283.690476190476,1160.2380952381,131.702380952381,84,11.3820689138217,9.50591076333882,0.549998784327823,0.954545454545455,0.763636363636364,0.72833790821116,52844.2023809524,33860.9880952381,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_763086,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
763475,1083.90540540541,336.662162162162,189.466216216216,603.810810810811,468.195945945946,1224.07432432432,342.087837837838,264.148648648649,1099.62837837838,2478.81756756757,486.790540540541,109.851351351351,1064.5472972973,915.108108108108,686.385135135135,316.587837837838,1520.20945945946,1131.83108108108,258.851351351351,221.317567567568,988.189189189189,998.817567567568,194.736486486486,130.898648648649,593.155405405405,1190.08783783784,471.837837837838,229.648648648649,1005.18918918919,128.641891891892,148,16.3198152288932,11.5546944881763,0.706196134418506,0.954838709677419,0.711538461538462,-1.14572678641874,53881.0472972973,32952.7972972973,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_763475,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
764338,1178.80898876404,436.23595505618,100.730337078652,635.662921348315,400.292134831461,506.393258426966,654.516853932584,238.022471910112,1079.30337078652,2721.32584269663,595.651685393258,123.921348314607,1070.38202247191,634.730337078652,582.595505617978,767.438202247191,1494.47191011236,924.202247191011,227.685393258427,220.157303370787,1010.02247191011,811.550561797753,187.123595505618,183.584269662921,601.269662921348,1118.38202247191,516.842696629213,427.325842696629,1020.96629213483,130.651685393258,89,11.3917925679131,9.98039081573199,0.48212283736025,0.946808510638298,0.741666666666667,0.104896569229195,53261.4382022472,33578.4494382022,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_764338,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
764496,2789.47703180212,299.466431095406,147.795053003534,658.16961130742,2122.55830388693,1779.02826855124,380.720848056537,272.378091872792,1098.59010600707,2396.14487632509,677.911660777385,134.575971731449,1079.10954063604,1109.4628975265,531.180212014134,276.381625441696,1587.90106007067,1714.35335689046,351.837455830389,235.650176678445,1040.68551236749,1265.59010600707,236.134275618374,187.349823321555,709.120141342756,723.544169611307,380.639575971731,203.798586572438,1012.56183745583,128.939929328622,283,25.5698891350569,15.5149605671605,0.794879874152708,0.881619937694704,0.584710743801653,0.893545972901507,53168.0565371025,32007.4204946996,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_764496,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
764516,4075.01807228916,357.728915662651,123.048192771084,647.0,2043.51807228916,2112.40361445783,3110.07831325301,262.439759036144,1090.75903614458,6740.97590361446,2138.96385542169,133.759036144578,1080.26506024096,1808.31927710843,624.120481927711,726.222891566265,1621.73493975904,4728.87951807229,368.21686746988,233.78313253012,1091.92771084337,5238.25903614458,247.343373493976,1054.10240963855,742.307228915663,1667.9578313253,501.16265060241,402.066265060241,1111.87951807229,131.740963855422,166,17.4311842704889,12.4586680933632,0.699395918149615,0.922222222222222,0.691666666666667,0.808877908882306,52451.1204819277,32603.5421686747,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_764516,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
764525,918.13698630137,556.13698630137,87.0,620.630136986301,1107.98630136986,394.342465753425,1268.28767123288,260.013698630137,1080.6301369863,2032.71232876712,541.643835616438,110.342465753425,1074.21917808219,1057.79452054795,1326.2602739726,1333.94520547945,1820.58904109589,1670.8904109589,341.753424657534,238.150684931507,1054.72602739726,1371.52054794521,234.86301369863,1899.54794520548,737.945205479452,1254.86301369863,511.931506849315,245.13698630137,1021.91780821918,127.068493150685,73,10.4886966680696,8.8558652304267,0.535831943208874,0.948051948051948,0.811111111111111,1.01071778586366,53558.3835616438,33455.2191780822,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_764525,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
765767,2995.1797752809,1180.51685393258,165.044943820225,662.640449438202,1047.70786516854,1341.85393258427,357.662921348315,242.370786516854,1087.34831460674,3778.13483146067,620.123595505618,136.539325842697,1080.02247191011,964.61797752809,624.516853932584,361.887640449438,2728.32584269663,1180.83146067416,301.595505617978,225.76404494382,999.337078651685,1199.29213483146,249.303370786517,192.494382022472,592.651685393258,973.629213483146,451.988764044944,759.370786516854,1049.55056179775,130.573033707865,89,11.9965553297939,9.65276937050533,0.593778666154376,0.936842105263158,0.674242424242424,-0.572058060122298,53592.6179775281,33785.0449438202,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_765767,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
765840,1420.93596059113,221.674876847291,110.576354679803,635.049261083744,1787.13300492611,731.35960591133,438.733990147783,280.665024630542,1139.33497536946,2348.31034482759,682.551724137931,112.985221674877,1065.52709359606,813.92118226601,479.581280788177,274.399014778325,1543.96551724138,1425.73399014778,264.07881773399,221.024630541872,1075.85221674877,1630.3645320197,190.551724137931,258.108374384236,1965.6354679803,850.753694581281,427.507389162562,237.536945812808,1034.68965517241,129.177339901478,203,27.7899302710902,9.42251122953108,0.94076400547051,0.922727272727273,0.464530892448513,-0.901916505085834,53811.960591133,32702.4088669951,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_765840,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
766433,582.90625,996.09375,209.194444444444,619.642361111111,98.2638888888889,272.947916666667,259.229166666667,247.059027777778,1084.09722222222,1423.72222222222,871.253472222222,121.482638888889,1061.30902777778,619.763888888889,446.743055555556,265.409722222222,1371.80208333333,875.986111111111,242.534722222222,214.899305555556,982.291666666667,796.149305555556,182.447916666667,120.173611111111,592.555555555556,568.1875,354.899305555556,205.461805555556,980.375,131.517361111111,288,20.6142026817595,17.9202962202777,0.494253293698183,0.95049504950495,0.761904761904762,1.20824829384453,53939.8819444444,32587.7534722222,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_766433,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
768121,1849.89637305699,159.0,92.3937823834197,634.316062176166,1408.52849740933,3641.46113989637,466.849740932642,273.523316062176,1097.77202072539,3410.89637305699,1124.17616580311,131.072538860104,1074.83937823834,2796.31088082902,782.321243523316,662.321243523316,6243.25388601036,2017.62694300518,328.088082901554,232.129533678756,1043.01554404145,1780.76165803109,227.373056994819,406.549222797927,677.922279792746,1562.62176165803,490.917098445596,324.937823834197,1023.99481865285,129.492227979275,193,18.1574412664874,13.8537534341903,0.646422812660133,0.955445544554455,0.75390625,0.790739234283137,53391.2797927461,33843.3730569948,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_768121,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
769445,542.619718309859,1156.88450704225,265.118309859155,624.36338028169,118.529577464789,251.605633802817,276.954929577465,247.96338028169,1078.94366197183,1338.22816901408,854.721126760563,118.056338028169,1060.23943661972,552.374647887324,422.408450704225,261.0,1389.06478873239,876.478873239437,246.442253521127,216.867605633803,983.983098591549,826.923943661972,184.811267605634,114.332394366197,587.129577464789,567.087323943662,358.611267605634,205.771830985915,986.030985915493,129.070422535211,355,26.9684115641823,16.9562442856841,0.777611840587725,0.951742627345844,0.643115942028985,-0.832863410644865,53850.7267605634,32614.8056338028,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_769445,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
769468,2414.95348837209,353.360465116279,108.063953488372,709.511627906977,2159.05813953488,3707.27325581395,1204.63953488372,263.831395348837,1093.22093023256,4837.72093023256,707.412790697674,132.901162790698,1083.62790697674,2328.65697674419,487.127906976744,748.837209302326,1762.91279069767,1113.6511627907,274.0,324.220930232558,999.668604651163,1054.1511627907,218.610465116279,168.779069767442,588.011627906977,2142.64534883721,545.779069767442,1686.13953488372,1113.79069767442,131.976744186047,172,17.8520952694515,12.8930300117603,0.691669856752887,0.905263157894737,0.682539682539683,0.62750613565347,52598.011627907,33719.0058139535,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_769468,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
770031,619.642487046632,1478.60103626943,294.756476683938,617.067357512953,697.782383419689,628.378238341969,409.233160621762,267.331606217617,1113.64766839378,1257.75647668394,784.839378238342,115.834196891192,1065.51813471503,723.466321243523,414.533678756477,268.647668393782,1452.10880829016,947.683937823834,196.295336787565,207.212435233161,1053.10880829016,914.077720207254,149.062176165803,116.367875647668,874.663212435233,662.580310880829,382.010362694301,210.227979274611,1005.00518134715,128.880829015544,193,18.040443459011,13.7298209300376,0.648684025009662,0.946078431372549,0.765873015873016,-1.41439433777003,53679.7098445596,32708.4611398964,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_770031,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
770045,1894.625,462.325,73.7666666666667,633.641666666667,1596.35833333333,2240.175,1070.99166666667,252.033333333333,1152.175,3682.14166666667,796.008333333333,129.091666666667,1077.625,3331.48333333333,960.45,1115.775,1990.875,4025.05,344.8,240.3,1043.01666666667,4196.35833333333,275.933333333333,1143.05,693.65,1452.35833333333,488.25,423.808333333333,1061.725,131.791666666667,120,18.1850046900689,9.27428008466638,0.860176758411414,0.845070422535211,0.535714285714286,0.534000431518095,53461.75,33729.4,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_770045,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
772975,3896.10204081633,463.832653061225,150.775510204082,624.604081632653,767.359183673469,1032.18367346939,1296.16734693878,257.710204081633,1092.45306122449,6707.52244897959,761.428571428571,134.677551020408,6972.97142857143,817.008163265306,526.555102040816,338.840816326531,1458.84081632653,1418.95510204082,276.669387755102,225.889795918367,991.963265306122,1665.06530612245,213.10612244898,160.432653061224,606.212244897959,2252.28571428571,538.379591836735,254.820408163265,1062.29387755102,132.648979591837,245,21.9231113156776,14.6749037612804,0.742919721640302,0.921052631578947,0.720588235294118,-1.04057849808484,53254.9265306122,33288.1020408163,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX+,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_772975,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
773691,2064.14114832536,162.129186602871,66.1578947368421,627.657894736842,1697.56459330144,1767.97846889952,313.55023923445,258.409090909091,1090.26315789474,3663.75598086124,1037.16507177033,114.724880382775,1094.81818181818,2087.71531100478,966.700956937799,514.997607655502,5759.6961722488,2464.87081339713,280.086124401914,219.710526315789,1023.90669856459,2271.48325358852,200.153110047847,229.767942583732,682.224880382775,1138.58373205742,459.959330143541,406.854066985646,1038.52153110048,129.562200956938,418,39.1760328847603,13.6531120360132,0.937306269454605,0.954337899543379,0.580555555555556,0.407280999962624,54000.95215311,32833.5023923445,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_773691,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
774197,2078.22023809524,259.678571428571,98.4047619047619,623.470238095238,1414.54166666667,456.910714285714,323.27380952381,252.410714285714,1088.0,3362.92857142857,2725.95833333333,115.494047619048,1065.01785714286,1034.5,659.488095238095,283.714285714286,1552.625,1361.875,303.607142857143,222.214285714286,1037.19642857143,1204.72619047619,212.690476190476,260.434523809524,3002.25595238095,1396.5,467.595238095238,559.666666666667,1050.64880952381,130.797619047619,168,15.6228541273362,13.883325383371,0.458576628625693,0.976744186046512,0.8,-0.281161729816995,54038.6666666667,32666.4345238095,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_774197,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
774817,2088.85384615385,318.476923076923,659.215384615385,620.292307692308,1336.70769230769,646.553846153846,2345.92307692308,252.107692307692,1087.56153846154,2628.43076923077,485.092307692308,108.923076923077,1064.3,2331.4,738.107692307692,795.615384615385,10411.9692307692,1518.65384615385,260.192307692308,881.884615384615,1012.55384615385,928.053846153846,188.753846153846,133.953846153846,591.038461538462,812.338461538462,440.015384615385,225.7,1003.36153846154,128.238461538462,130,16.7980035300485,9.9317362579151,0.806491973586092,0.928571428571429,0.764705882352941,0.185238513339864,53954.7230769231,33169.9153846154,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_774817,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
776160,2130.05263157895,401.87969924812,171.240601503759,643.834586466165,2282.7969924812,1152.18045112782,440.481203007519,247.135338345865,1094.47368421053,4644.46616541353,596.233082706767,121.045112781955,1063.24812030075,756.639097744361,466.240601503759,272.706766917293,1494.57142857143,955.466165413534,240.052631578947,216.639097744361,971.932330827068,862.624060150376,182.609022556391,118.338345864662,588.037593984962,2086.51879699248,534.992481203008,238.360902255639,1038.29323308271,129.954887218045,133,16.0883426043218,11.988121849383,0.666904307955558,0.820987654320988,0.639423076923077,-0.825150247255915,53897.5338345865,32897.3233082707,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_776160,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
776698,845.444015444015,300.559845559846,121.664092664093,630.23166023166,2125.63706563707,650.911196911197,314.733590733591,246.173745173745,1078.57528957529,1469.89961389961,2335.9305019305,118.015444015444,1057.55984555985,698.683397683398,441.104247104247,338.749034749035,1397.64478764479,1072.81081081081,287.258687258687,223.602316602317,992.88416988417,1027.82239382239,208.903474903475,127.247104247104,593.243243243243,1030.2471042471,521.911196911197,538.490347490348,1032.13513513514,128.181467181467,259,26.0529826802498,12.6771667560996,0.873629473427612,0.948717948717949,0.587301587301587,-0.802724345850332,53756.8571428571,32998.8262548263,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_776698,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
777575,571.646869983949,121.91974317817,92.6661316211878,628.375601926164,1978.75601926164,236.987158908507,252.823434991974,237.874799357945,1073.9036918138,966.463884430177,469.529695024077,116.040128410915,1062.01284109149,492.910112359551,407.321027287319,279.263242375602,1393.73354735152,811.252006420546,208.741573033708,213.422150882825,980.040128410915,882.91974317817,187.430176565008,411.518459069021,639.650080256822,790.956661316212,452.181380417335,220.964686998395,1015.50401284109,129.951845906902,623,30.373361035172,26.1337991084923,0.50958822008862,0.965891472868217,0.769135802469136,-0.505011584303224,53002.0144462279,33007.746388443,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_777575,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
777874,2537.54240631164,326.358974358974,65.422090729783,636.313609467456,1662.23865877712,985.110453648915,627.005917159763,262.242603550296,1091.68639053254,4081.90532544379,660.201183431953,125.579881656805,1076.36489151874,3415.13017751479,650.25641025641,438.717948717949,1844.30769230769,5247.3057199211,369.978303747535,242.207100591716,1023.15187376726,5585.25049309665,255.625246548323,206.506903353057,602.611439842209,1104.29585798817,523.562130177515,273.311637080868,1016.21499013807,130.011834319527,507,29.8648930232928,21.8801582311831,0.68061841489886,0.942379182156134,0.724285714285714,0.918832844834868,53596.3214990138,33396.573964497,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_777874,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
778169,990.932515337423,169.361963190184,80.8834355828221,613.368098159509,1010.38036809816,917.478527607362,354.282208588957,256.503067484662,1089.8282208589,1797.13496932515,533.110429447853,112.687116564417,1066.55828220859,4586.73619631902,585.552147239264,315.932515337423,1511.76687116564,2560.53374233129,333.067484662577,233.153374233129,1023.0245398773,1467.05521472393,233.570552147239,210.435582822086,604.496932515337,901.374233128834,485.871165644172,249.361963190184,1007.49693251534,129.441717791411,163,15.3070911862232,13.6879404551949,0.447623382085287,0.947674418604651,0.776190476190476,-1.11840943876339,53550.9079754601,33256.3312883436,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_778169,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
778491,1758.03821656051,227.095541401274,140.936305732484,667.216560509554,2942.47133757962,296.171974522293,294.700636942675,253.859872611465,1071.6178343949,2038.24203821656,571.490445859873,124.178343949045,1072.34394904459,800.044585987261,487.573248407643,263.968152866242,1495.53503184713,1420.54777070064,322.452229299363,225.898089171975,985.904458598726,1085.29936305732,213.146496815287,119.917197452229,589.955414012739,851.375796178344,396.821656050955,208.815286624204,1027.47133757962,130.554140127389,157,18.6606200334805,10.9794808175257,0.808586687499569,0.91812865497076,0.615686274509804,-0.687926601671255,53581.3949044586,32065.1910828025,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_778491,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
779469,2169.43209876543,1107.45679012346,106.543209876543,639.691358024691,1424.98765432099,1492.48148148148,577.246913580247,251.333333333333,1103.27160493827,2862.61728395062,792.654320987654,132.234567901235,1075.8024691358,3437.27160493827,914.728395061728,370.604938271605,5981.77777777778,5826.14814814815,457.925925925926,247.320987654321,1057.83950617284,6437.75308641975,283.913580246914,304.086419753086,605.666666666667,997.728395061728,473.901234567901,335.098765432099,1062.71604938272,133.987654320988,81,11.2241466393364,10.0883129060845,0.438349822852839,0.852631578947368,0.566433566433566,1.25180606028158,53272.4197530864,33843.6913580247,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_779469,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
779555,2233.70857142857,471.36,122.954285714286,646.508571428571,2053.25142857143,516.771428571429,510.485714285714,267.16,1094.82857142857,3214.11428571429,2822.92571428571,122.52,1074.91428571429,882.348571428571,596.451428571429,295.502857142857,1376.28,1168.41142857143,343.514285714286,232.131428571429,988.542857142857,1036.72,228.76,123.765714285714,587.857142857143,1036.72571428571,461.125714285714,321.194285714286,1078.57142857143,131.834285714286,175,17.0707705579216,14.1370779212196,0.560513522601392,0.845410628019324,0.68359375,0.277970731022015,54063.5485714286,32546.7371428571,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_779555,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
779631,508.733840304183,684.577946768061,170.19391634981,616.471482889734,110.551330798479,433.722433460076,312.961977186312,256.32319391635,1102.42585551331,1369.44106463878,1316.59695817491,116.349809885932,1067.40684410646,757.885931558935,586.041825095057,273.714828897338,1730.76045627376,1006.33079847909,258.80608365019,215.730038022814,1004.66920152091,862.920152091255,176.61216730038,131.441064638783,774.509505703422,570.190114068441,360.657794676806,204.828897338403,977.296577946768,130.300380228137,263,20.806845612042,16.1245060043919,0.6320083429009,0.952898550724638,0.728531855955679,-0.719282394018964,53689.4752851711,32680.9505703422,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_779631,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
780586,1338.53881278539,156.48401826484,147.913242009132,672.671232876712,3818.47488584475,764.593607305936,790.86301369863,251.009132420091,1080.22374429224,2324.13698630137,538.977168949772,119.712328767123,1062.92237442922,807.876712328767,465.584474885845,280.525114155251,1457.61187214612,1103.43378995434,278.876712328767,220.356164383562,1008.20091324201,1005.64840182648,196.525114155251,424.598173515982,776.264840182648,1090.71689497717,504.228310502283,227.771689497717,1058.15068493151,130.086757990868,219,18.7613960802927,16.4157127347891,0.484171934055892,0.823308270676692,0.651785714285714,0.0659420732563002,53214.4200913242,33107.9863013699,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_780586,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
782415,1030.48387096774,339.812903225806,90.3935483870968,634.883870967742,1184.1935483871,301.477419354839,303.01935483871,255.877419354839,1075.98064516129,1674.82580645161,732.006451612903,114.864516129032,1071.09677419355,684.870967741935,425.251612903226,270.967741935484,1366.27096774194,1080.85161290323,252.870967741935,218.290322580645,986.832258064516,1008.89032258065,199.741935483871,125.870967741935,575.535483870968,956.987096774194,520.116129032258,437.464516129032,1023.8,126.658064516129,155,19.3087819351164,10.3800934873667,0.843210159336423,0.939393939393939,0.662393162393162,1.05564453659348,54074.0580645161,33141.2258064516,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_782415,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
782818,1640.97115384615,191.096153846154,78.1923076923077,614.538461538462,915.355769230769,702.211538461538,413.115384615385,272.307692307692,1125.88461538462,2538.29807692308,592.769230769231,117.817307692308,1076.18269230769,609.75,364.432692307692,275.403846153846,1417.97115384615,783.230769230769,174.163461538462,201.461538461538,1018.36538461538,622.846153846154,132.230769230769,113.932692307692,588.0,998.538461538462,479.721153846154,233.432692307692,1004.89423076923,129.336538461538,104,14.8065278671782,10.0582851114084,0.733847513975663,0.8125,0.722222222222222,0.149463181935542,53922.8846153846,32717.5,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_782818,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
782819,1557.96842105263,360.284210526316,62.9368421052632,620.147368421053,768.684210526316,1404.58947368421,1678.72631578947,251.894736842105,1101.21052631579,3859.75789473684,457.8,106.526315789474,1075.03157894737,2937.31578947368,1335.46315789474,2234.52631578947,3074.87368421053,3390.41052631579,381.463157894737,284.294736842105,1048.13684210526,3261.96842105263,289.789473684211,367.842105263158,769.421052631579,1469.88421052632,461.968421052632,239.189473684211,1146.23157894737,131.136842105263,95,13.8832514265672,8.83809026441859,0.771193427260654,0.88785046728972,0.659722222222222,-0.724686217533734,53484.6736842105,33419.7157894737,FAAGSCC_12,AG,1,M2 macrophages,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_782819,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
782961,1413.23456790123,170.111111111111,128.617283950617,636.358024691358,2159.22222222222,295.567901234568,1873.83950617284,241.851851851852,1083.79012345679,1815.33333333333,522.506172839506,114.913580246914,1058.28395061728,518.123456790123,389.851851851852,264.864197530864,1405.8024691358,851.851851851852,254.864197530864,216.061728395062,981.728395061728,758.962962962963,172.827160493827,104.024691358025,587.320987654321,921.395061728395,456.123456790123,216.716049382716,1019.96296296296,126.617283950617,81,13.1511551687206,7.89513788141675,0.799746406107836,0.952941176470588,0.692307692307692,-1.06382385541305,53190.5925925926,32308.8271604938,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_782961,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
783160,916.324324324324,156.945945945946,82.945945945946,645.702702702703,1395.32432432432,1333.56756756757,2578.45945945946,253.378378378378,1173.62162162162,1574.12162162162,670.783783783784,111.945945945946,1067.04054054054,816.108108108108,592.351351351351,588.378378378378,1600.7972972973,1035.90540540541,277.283783783784,232.27027027027,997.189189189189,988.581081081081,218.972972972973,168.675675675676,579.918918918919,889.932432432432,462.432432432433,597.77027027027,1023.06756756757,127.932432432432,74,11.4034797403624,8.24568548630869,0.690759031702707,0.936708860759494,0.74,0.649818870111248,53300.0810810811,33573.4594594595,FAAGSCC_12,AG,1,M1/M0 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M1/M0 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_783160,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
784865,896.54,121.68,56.32,597.87,147.79,1048.92,352.84,259.11,1085.78,906.11,589.03,107.55,1063.72,1206.29,889.62,400.68,2455.45,2079.47,334.2,222.3,1068.89,1510.87,219.74,578.64,673.1,804.27,444.87,221.71,1021.66,128.4,100,12.5853756344203,10.1496955688601,0.591278513981292,0.934579439252336,0.699300699300699,-1.5409603070444,52743.94,32526.28,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_784865,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
784937,2319.85438596491,184.882456140351,122.894736842105,692.81052631579,3019.41754385965,818.575438596491,1260.01929824561,232.440350877193,1080.60175438597,4054.73859649123,700.361403508772,138.517543859649,1070.77192982456,2139.09122807018,766.822807017544,2185.71754385965,1871.21403508772,3163.73684210526,389.726315789474,240.540350877193,1099.31754385965,2091.3649122807,249.171929824561,594.045614035088,711.59649122807,1285.33859649123,505.084210526316,247.350877192982,1097.97719298246,132.240350877193,570,35.8635031524091,20.4828736662736,0.82085669283424,0.971039182282794,0.708074534161491,0.284407440487058,53217.8824561404,33652.1631578947,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_784937,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
786551,1009.18888888889,109.366666666667,76.5296296296296,628.396296296296,1017.43333333333,265.9,272.677777777778,244.585185185185,1072.04074074074,2252.58888888889,661.914814814815,108.833333333333,1068.31481481481,646.233333333333,480.588888888889,264.955555555556,1421.22962962963,950.503703703704,255.733333333333,219.659259259259,981.011111111111,909.951851851852,201.92962962963,131.296296296296,590.340740740741,1208.57407407407,454.344444444444,245.988888888889,1019.03703703704,129.6,270,30.4245540784842,11.3771631990899,0.927450174493146,0.940766550522648,0.555555555555556,-1.07368249722882,53383.0333333333,33248.6666666667,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,15,FAAGSCC_12_786551,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
788038,978.204081632653,245.744897959184,116.224489795918,635.255102040816,2559.83673469388,1772.54081632653,943.387755102041,250.15306122449,1103.14285714286,1678.36734693878,455.908163265306,111.826530612245,1080.44897959184,1438.0,1536.66326530612,1156.09183673469,7929.05102040816,1210.67346938776,250.367346938776,215.234693877551,1012.40816326531,1072.22448979592,192.571428571429,152.469387755102,665.448979591837,1040.25510204082,480.030612244898,222.326530612245,1025.26530612245,128.173469387755,98,13.3079062014141,9.43303228944342,0.705380172915072,0.91588785046729,0.685314685314685,-0.358984594055065,54174.9387755102,33007.2448979592,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_788038,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
788207,2770.41258741259,572.0,115.216783216783,657.426573426573,1767.1048951049,2027.28671328671,279.027972027972,235.384615384615,1126.57342657343,4471.18881118881,656.664335664336,126.237762237762,1076.96503496503,1984.08391608392,689.755244755245,292.27972027972,3531.58741258741,2123.41958041958,339.874125874126,234.195804195804,1044.95104895105,1870.28671328671,231.944055944056,211.258741258741,637.20979020979,1096.01398601399,489.426573426573,229.041958041958,1044.62937062937,130.867132867133,143,16.5292316948838,11.3019979344682,0.729708644221011,0.916666666666667,0.6875,-1.02897024567271,52735.3006993007,33475.8951048951,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_788207,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
788312,1272.90163934426,281.55737704918,116.475409836066,629.254098360656,1366.87704918033,312.581967213115,349.05737704918,258.762295081967,1080.48360655738,2785.1393442623,537.172131147541,111.377049180328,1087.95081967213,808.745901639344,1353.73770491803,297.172131147541,1545.41803278689,1406.67213114754,323.803278688525,234.434426229508,989.975409836066,1221.31147540984,233.311475409836,640.852459016393,749.393442622951,1389.37704918033,469.245901639344,225.16393442623,1039.16393442623,128.795081967213,122,19.4465701290644,7.99961059438297,0.911471343386411,0.938461538461538,0.616161616161616,-1.1491955654749,52467.5327868852,33081.7459016393,FAAGSCC_12,AG,1,stromal cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_788312,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
788760,1135.08695652174,300.811594202899,101.521739130435,662.942028985507,1829.26086956522,2749.11594202899,1397.72463768116,262.217391304348,1136.39130434783,1666.27536231884,4641.78260869565,127.449275362319,1068.05797101449,4625.14492753623,933.449275362319,725.652173913043,2162.1884057971,7311.02898550725,553.927536231884,259.188405797101,1068.07246376812,7492.08695652174,298.898550724638,535.666666666667,687.695652173913,910.927536231884,458.536231884058,649.652173913043,1026.47826086957,128.260869565217,69,10.1002899275662,8.7806295496603,0.494206915702755,0.932432432432432,0.766666666666667,0.557917354992825,53458.6956521739,33853.8695652174,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_788760,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
788951,2775.92366412214,601.511450381679,95.7671755725191,627.381679389313,1160.25572519084,998.110687022901,856.828244274809,242.935114503817,1089.41984732824,4626.6679389313,1073.14885496183,115.137404580153,1082.53435114504,1675.30916030534,752.389312977099,542.354961832061,1745.09160305344,2357.36259541985,339.099236641221,228.423664122137,1008.59541984733,1868.74427480916,232.958015267176,227.480916030534,684.19465648855,834.748091603053,437.713740458015,339.614503816794,1028.80534351145,131.114503816794,262,24.2162684719101,14.6103259764332,0.797493988826794,0.912891986062718,0.759420289855072,1.5591436278327,53694.1755725191,33438.4312977099,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_788951,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
789831,748.434108527132,662.372093023256,60.5348837209302,632.666666666667,410.914728682171,377.891472868217,441.751937984496,231.658914728682,1072.93023255814,1473.05426356589,898.395348837209,100.519379844961,1069.21705426357,1122.90697674419,534.744186046512,505.798449612403,1575.74418604651,1120.02325581395,259.472868217054,220.604651162791,1008.10852713178,974.023255813954,195.410852713178,181.162790697674,587.387596899225,673.511627906977,386.899224806202,448.899224806202,1018.72868217054,129.217054263566,129,15.283432298322,10.8751381213228,0.70262142674181,0.941605839416058,0.716666666666667,-1.30030344936264,53228.0930232558,33606.4496124031,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_789831,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
790735,2936.70588235294,405.411764705882,113.710784313725,638.299019607843,1648.73039215686,268.700980392157,704.401960784314,238.191176470588,1084.04901960784,6571.66176470588,1504.57352941176,123.294117647059,1085.08823529412,824.509803921569,967.901960784314,1966.81862745098,1755.64705882353,2176.98039215686,322.382352941176,228.803921568627,1057.53431372549,2064.95588235294,228.563725490196,702.671568627451,652.588235294118,2623.25490196078,561.102941176471,457.421568627451,1084.22058823529,130.696078431373,204,23.6966237390454,11.9014201961681,0.864727587270919,0.85,0.565096952908587,0.786740961326544,54018.3137254902,33266.6911764706,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_790735,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
791190,1262.76635514019,451.056074766355,98.4018691588785,614.915887850467,795.280373831776,1937.26168224299,325.831775700935,248.102803738318,1127.33644859813,2473.35514018692,499.682242990654,112.271028037383,1072.22429906542,4293.67289719626,909.018691588785,298.719626168224,8932.72897196262,2185.10280373832,317.859813084112,238.411214953271,1011.5046728972,1980.51401869159,235.81308411215,215.981308411215,617.485981308411,1257.40186915888,496.308411214953,242.682242990654,1031.14953271028,129.467289719626,107,15.4586775583856,8.8250843463477,0.821031958775574,0.946902654867257,0.694805194805195,-0.55675964698684,52592.9439252336,33574.6168224299,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_791190,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
791803,895.294117647059,194.435294117647,186.364705882353,693.588235294118,3975.44705882353,1490.65882352941,426.658823529412,288.976470588235,1104.95294117647,1227.41176470588,955.670588235294,119.494117647059,1062.44705882353,1036.03529411765,812.141176470588,285.623529411765,2080.81176470588,1171.96470588235,287.929411764706,226.376470588235,1083.75294117647,942.976470588235,196.2,278.529411764706,1485.72941176471,771.858823529412,410.776470588235,244.552941176471,1029.90588235294,129.882352941176,85,12.4211747933383,8.75349983228941,0.709481572106812,0.965909090909091,0.787037037037037,1.35258093843963,52787.8588235294,32256.6,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_791803,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
792112,1306.84931506849,1060.98630136986,471.602739726027,649.575342465753,1899.13698630137,981.876712328767,328.095890410959,247.301369863014,1073.80821917808,2346.82191780822,569.712328767123,121.342465753425,1067.08219178082,2423.90410958904,568.876712328767,297.684931506849,1933.05479452055,2534.87671232877,329.808219178082,236.342465753425,1004.3698630137,1614.46575342466,215.520547945205,221.931506849315,980.328767123288,811.684931506849,434.41095890411,373.0,1023.42465753425,127.465753424658,73,10.6483680218853,8.99077658977406,0.535817604131519,0.890243902439024,0.663636363636364,1.00773465780869,53793.3698630137,33721.1095890411,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_792112,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
792255,618.602150537634,875.639784946237,224.884408602151,621.989247311828,625.612903225806,1938.04569892473,345.08064516129,267.833333333333,1092.40591397849,1264.02956989247,1081.6747311828,135.376344086022,1065.54569892473,1353.94623655914,603.537634408602,286.970430107527,1939.3064516129,1277.12096774194,282.180107526882,219.908602150538,1031.17204301075,1221.38440860215,188.680107526882,148.779569892473,805.916666666667,618.10752688172,356.034946236559,202.736559139785,996.994623655914,128.411290322581,372,29.1015562067456,16.4141288430129,0.825754811171105,0.958762886597938,0.65034965034965,1.00963732699751,52852.1935483871,32441.2043010753,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_792255,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
793257,2009.15525114155,363.205479452055,93.5844748858448,629.365296803653,1157.12328767123,781.374429223744,313.689497716895,252.735159817352,1088.85388127854,4075.43378995434,883.72602739726,113.082191780822,1072.1095890411,1834.98630136986,509.223744292237,278.566210045662,1514.96803652968,1808.50228310502,281.050228310502,221.520547945205,1020.81278538813,2053.35159817352,202.908675799087,168.812785388128,584.397260273973,1056.21461187215,449.62100456621,332.753424657534,1032.35159817352,129.739726027397,219,23.4268191995441,13.4257902200256,0.819489020366868,0.839080459770115,0.579365079365079,-0.625955481423067,53945.9680365297,33107.5433789954,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_793257,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
793545,1123.85321100917,350.761467889908,266.100917431193,748.128440366972,6883.4495412844,683.330275229358,331.779816513761,258.825688073394,1095.51376146789,2420.3119266055,618.880733944954,130.192660550459,1068.79816513761,2107.29357798165,631.660550458716,313.623853211009,1894.79816513761,5291.22935779817,433.155963302752,236.935779816514,1055.28440366972,6062.87155963303,262.706422018349,171.165137614679,1107.88990825688,970.449541284404,465.642201834862,258.605504587156,1058.24770642202,130.366972477064,109,14.9094481062819,9.31015480721567,0.781067468935302,0.956140350877193,0.698717948717949,0.707014623798272,53056.752293578,32784.9357798165,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_793545,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
793575,2361.82291666667,883.125,42.21875,636.291666666667,1062.15625,3501.67708333333,1137.875,262.9375,1160.4375,4343.35416666667,600.791666666667,127.895833333333,1079.54166666667,3745.5625,890.697916666667,566.21875,2827.25,3288.28125,368.0,234.927083333333,1414.48958333333,1707.92708333333,212.59375,238.083333333333,705.677083333333,1599.9375,495.635416666667,293.770833333333,1149.36458333333,129.572916666667,96,12.3060289145618,9.99674528248365,0.583176682765371,0.96,0.793388429752066,-0.895933704567497,53247.25,33745.3645833333,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_793575,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
793603,584.071770334928,1050.00956937799,255.44019138756,622.631578947368,79.1818181818182,786.555023923445,501.287081339713,304.162679425837,1174.75119617225,1450.11483253589,1940.95215311005,144.755980861244,1077.97129186603,922.612440191388,537.138755980861,300.181818181818,1567.88995215311,998.406698564593,210.913875598086,211.205741626794,1180.77990430622,610.942583732057,137.392344497608,96.0526315789474,579.416267942584,549.516746411483,328.617224880383,194.913875598086,980.521531100478,127.248803827751,209,16.6938117683105,16.0366676869534,0.277811981215775,0.963133640552995,0.768382352941177,1.17093199629349,52942.4497607656,32167.9282296651,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_793603,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
794108,2165.74418604651,309.875968992248,128.662790697674,656.341085271318,2888.26356589147,343.662790697674,1173.53875968992,244.697674418605,1085.86434108527,4251.57364341085,2063.26744186047,117.468992248062,1075.6511627907,3035.40697674419,1207.68604651163,1282.86434108527,1954.41085271318,3497.86821705426,370.934108527132,229.507751937984,1071.77519379845,3224.58139534884,231.937984496124,622.480620155039,804.093023255814,1412.37209302326,487.217054263566,426.147286821706,1028.3992248062,128.635658914729,258,20.424020624993,16.25840505998,0.605239657088116,0.955555555555556,0.754385964912281,-0.631514178143373,53518.3565891473,33088.2945736434,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_794108,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
795261,4368.42715231788,410.665562913907,1595.31125827815,688.751655629139,3796.53642384106,3953.5,465.46357615894,268.311258278146,1119.05629139073,7391.36754966887,1729.23841059603,135.91059602649,1088.35761589404,3539.03642384106,958.420529801324,451.360927152318,3439.62913907285,1983.26158940397,321.413907284768,234.933774834437,1032.03973509934,1601.82119205298,219.162251655629,259.526490066225,695.523178807947,2418.77483443709,528.854304635762,331.14238410596,1216.56622516556,131.185430463576,302,20.7389933640761,19.6071327999545,0.32584398828159,0.929230769230769,0.684807256235828,1.23074763931359,52812.6920529801,33689.3443708609,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_795261,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
795373,5524.85344827586,855.629310344828,291.206896551724,671.413793103448,3324.40517241379,2220.97413793103,361.137931034483,255.672413793103,1105.02586206897,9987.87068965517,615.98275862069,134.905172413793,1225.53448275862,1335.51724137931,552.586206896552,283.931034482759,1874.38793103448,1236.94827586207,229.568965517241,215.103448275862,1017.11206896552,1045.81034482759,181.129310344828,139.137931034483,722.206896551724,2550.68965517241,560.689655172414,274.905172413793,1069.08620689655,130.137931034483,116,15.5720427550652,10.6261829954473,0.730989689728289,0.87218045112782,0.591836734693878,0.856588729045977,53965.5086206897,33460.0517241379,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX+,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_795373,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
796492,404.542253521127,478.481220657277,135.6220657277,607.286384976526,115.431924882629,534.607981220657,392.525821596244,265.396713615023,1136.12676056338,1315.68075117371,759.021126760563,124.953051643192,1062.5,974.140845070422,518.382629107981,288.260563380282,1587.51877934272,1174.45774647887,237.208920187793,219.051643192488,1035.75117370892,1110.18309859155,185.136150234742,242.697183098592,3597.69483568075,587.380281690141,347.058685446009,200.382629107981,995.854460093897,129.382629107981,426,27.2225833725325,19.9785170144966,0.679262962800011,0.961625282167043,0.78021978021978,1.20091656623903,52466.7957746479,32773.3849765258,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_796492,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
796906,1856.64230769231,684.1,217.542307692308,661.184615384615,2485.45769230769,222.861538461538,246.138461538462,247.796153846154,1074.07692307692,2345.65,3067.66153846154,135.465384615385,1071.97692307692,518.738461538462,371.457692307692,255.223076923077,1372.58076923077,828.75,227.230769230769,214.45,983.184615384615,758.407692307692,168.957692307692,116.157692307692,590.9,1215.35,533.453846153846,387.373076923077,1055.75,129.180769230769,260,26.4265670615097,12.870906028038,0.873377326286973,0.921985815602837,0.628019323671498,-1.04242809839177,53104.5461538462,32504.9846153846,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_796906,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
796998,2211.65060240964,402.265060240964,88.421686746988,613.33734939759,1078.65060240964,520.132530120482,1744.78313253012,245.33734939759,1096.77108433735,4543.51807228916,548.168674698795,114.867469879518,1075.9156626506,612.518072289157,394.590361445783,270.89156626506,1384.97590361446,925.33734939759,248.156626506024,230.963855421687,977.192771084337,852.024096385542,185.192771084337,128.192771084337,593.084337349398,2397.92771084337,515.397590361446,229.180722891566,1034.26506024096,132.409638554217,83,14.3068507951323,8.15154658441554,0.821807487673942,0.855670103092783,0.614814814814815,1.27270370736252,53283.9759036145,33234.6626506024,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_796998,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
797005,1026.26811594203,261.268115942029,70.5652173913043,615.898550724638,677.826086956522,578.63768115942,360.239130434783,261.673913043478,1118.25362318841,1306.25362318841,2312.02898550725,106.007246376812,1069.73188405797,908.985507246377,460.130434782609,278.739130434783,1493.3768115942,977.992753623188,196.231884057971,206.913043478261,1153.65217391304,698.282608695652,137.615942028986,107.304347826087,601.376811594203,721.913043478261,427.797101449275,245.95652173913,996.586956521739,131.615942028986,138,17.7672541122854,10.174592319229,0.819793111039193,0.926174496644295,0.624434389140271,-1.08048024296723,53644.0217391304,32779.0507246377,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_797005,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
797560,891.477611940299,286.761194029851,108.194029850746,631.402985074627,1366.97014925373,217.417910447761,222.791044776119,235.014925373134,1074.4328358209,1838.83582089552,589.462686567164,118.119402985075,1075.23880597015,511.761194029851,341.89552238806,303.373134328358,1364.17910447761,912.268656716418,221.34328358209,215.761194029851,989.55223880597,875.298507462687,169.850746268657,146.358208955224,594.850746268657,1092.38805970149,484.477611940299,232.701492537313,1034.92537313433,127.582089552239,67,9.84490289605889,8.68554944281325,0.470803305653708,0.930555555555556,0.744444444444444,-1.41306896183423,53182.776119403,32835.4029850746,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_797560,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
797758,970.22480620155,223.131782945736,156.418604651163,673.325581395349,5219.18604651163,546.472868217054,391.891472868217,270.333333333333,1131.25581395349,2032.85271317829,755.240310077519,123.806201550388,1060.78294573643,972.503875968992,539.813953488372,302.573643410853,1515.2480620155,1030.59689922481,208.53488372093,213.945736434109,1306.58914728682,691.131782945736,151.480620155039,139.906976744186,614.348837209302,870.348837209302,419.728682170543,212.286821705426,1065.36434108527,130.100775193798,129,21.7643506839366,7.67001395446919,0.935845032420868,0.895833333333333,0.477777777777778,0.926035639384415,52499.023255814,32916.1085271318,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_797758,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
798544,556.541984732824,1199.87404580153,287.18320610687,623.324427480916,118.160305343511,563.519083969466,369.698473282443,264.347328244275,1124.09160305344,1343.3893129771,896.076335877863,118.923664122137,1062.11832061069,625.698473282443,519.167938931298,284.496183206107,1465.56106870229,887.603053435114,220.63358778626,212.076335877863,999.889312977099,802.515267175572,155.446564885496,259.343511450382,686.641221374046,563.400763358779,358.12213740458,204.419847328244,980.751908396946,128.064885496183,262,22.9784552326498,14.5925821342952,0.77246694985776,0.952727272727273,0.759420289855072,-1.52424285054834,53712.0877862595,32682.427480916,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_798544,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
798781,1496.140625,344.453125,164.03125,647.109375,3051.75,287.0390625,387.640625,244.0078125,1082.9140625,2181.3203125,523.3515625,122.03125,1079.2890625,662.4375,559.0703125,269.65625,1422.6015625,935.734375,236.34375,214.5859375,989.1875,886.078125,176.40625,126.28125,591.3359375,1062.7421875,500.8828125,228.125,1025.5,130.8203125,128,21.4233845775149,7.70136703328679,0.933151194247158,0.907801418439716,0.518218623481781,-0.538536459082017,53814.4375,32860.6015625,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_798781,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
799321,411.184905660377,776.098113207547,182.449056603774,616.898113207547,115.860377358491,794.664150943396,514.494339622642,271.252830188679,1121.63396226415,1200.17358490566,1019.4679245283,114.705660377358,1060.72075471698,712.841509433962,907.784905660377,372.324528301887,1544.2679245283,999.566037735849,245.935849056604,215.841509433962,991.196226415094,885.007547169811,176.588679245283,246.864150943396,634.909433962264,564.456603773585,362.332075471698,203.437735849057,984.015094339623,131.905660377358,265,19.8630471690947,18.9778441041516,0.295202597171303,0.830721003134796,0.602272727272727,-0.833682285915553,53727.7811320755,32676.2,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_799321,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
801007,1814.03314917127,872.602209944751,934.944751381216,625.066298342541,976.425414364641,414.657458563536,439.569060773481,243.060773480663,1080.24861878453,2493.86740331492,629.182320441989,124.331491712707,1073.39779005525,1235.93370165746,656.425414364641,1534.77900552486,2126.35359116022,3134.09392265193,350.629834254144,242.226519337017,1104.14917127072,2635.33149171271,269.204419889503,489.734806629834,690.325966850829,906.104972375691,507.585635359116,251.46408839779,1010.1270718232,130.149171270718,181,18.0025006646446,12.8705597627471,0.699194219404947,0.947643979057592,0.754166666666667,0.803095343776963,53145.7513812155,33695.5690607735,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_801007,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
801076,520.069124423963,1192.40092165899,283.023041474654,614.557603686636,998.516129032258,2605.30875576037,324.290322580645,268.387096774194,1085.51152073733,1141.55299539171,613.571428571429,113.354838709677,1067.65898617512,709.516129032258,589.05069124424,273.903225806452,1419.97235023041,1014.4930875576,322.769585253456,228.534562211982,978.589861751152,972.009216589862,221.516129032258,121.0,583.705069124424,592.004608294931,367.746543778802,207.516129032258,991.152073732719,127.0,217,18.9766276769362,14.5611468512444,0.641264332893138,0.96875,0.815789473684211,-1.5673109513905,53674.0,32607.4470046083,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_801076,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
802043,1182.10126582278,382.430379746835,319.556962025316,645.354430379747,1878.51898734177,2340.12658227848,844.79746835443,257.316455696203,1175.56962025316,2122.44303797468,2085.22784810127,124.873417721519,1062.13924050633,3618.46835443038,842.873417721519,502.025316455696,2299.3417721519,6845.55696202532,470.53164556962,253.848101265823,1057.83544303797,6355.55696202532,273.848101265823,502.379746835443,679.683544303797,1046.50632911392,447.594936708861,343.050632911392,1026.21518987342,130.974683544304,79,11.6109230069191,8.63826201250459,0.668205000544818,0.951807228915663,0.797979797979798,1.17442305511769,53317.7848101266,33871.8734177215,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_802043,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
802588,3962.36333333333,117.806666666667,147.993333333333,671.213333333333,3329.59666666667,1097.62,313.116666666667,228.246666666667,1108.73,6469.73,598.093333333333,130.04,1103.29666666667,4548.30666666667,842.643333333333,351.726666666667,1951.91333333333,3840.78,393.553333333333,238.266666666667,1038.84333333333,2562.39,223.68,191.073333333333,628.59,1552.97333333333,491.193333333333,243.233333333333,1040.97,131.756666666667,300,27.4257608546078,14.5529499640785,0.847603142946494,0.920245398773006,0.619834710743802,-0.813265868708066,52747.0466666667,33454.0166666667,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_802588,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
802815,2237.5067264574,339.304932735426,223.85201793722,690.269058295964,3994.0,495.869955156951,437.663677130045,272.139013452915,1083.2466367713,4467.11659192825,561.013452914798,129.717488789238,1076.73542600897,787.556053811659,808.77130044843,307.372197309417,1443.42600896861,1331.9730941704,355.57399103139,242.349775784753,971.57399103139,1297.23766816144,264.618834080717,160.219730941704,652.201793721973,1567.37668161435,554.941704035874,235.448430493274,1045.52914798206,129.497757847534,223,23.8154595979748,12.7189583848754,0.84544461442867,0.910204081632653,0.633522727272727,-1.08533963764011,52401.2242152466,33034.7578475336,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_802815,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
803518,1379.38938053097,191.973451327434,90.1150442477876,615.256637168142,1113.33628318584,328.185840707965,293.982300884956,256.044247787611,1087.67256637168,3349.00884955752,550.309734513274,124.920353982301,1063.74336283186,568.628318584071,419.16814159292,267.823008849558,1397.6017699115,904.840707964602,228.41592920354,212.176991150442,985.283185840708,808.371681415929,165.646017699115,170.610619469027,617.858407079646,1993.0796460177,535.486725663717,241.017699115044,1037.3982300885,130.690265486726,113,13.9619400347357,11.1232184827008,0.604399440956394,0.856060606060606,0.627777777777778,0.223544877879558,53227.3185840708,32329.2300884956,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_803518,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
803805,385.078616352201,763.918238993711,184.820754716981,603.185534591195,96.2578616352201,507.377358490566,360.679245283019,266.487421383648,1129.17924528302,1144.56289308176,1293.52201257862,113.663522012579,1061.53773584906,806.232704402516,489.977987421384,280.75786163522,1512.21383647799,915.899371069182,207.732704402516,216.0,1149.00628930818,703.078616352201,149.581761006289,120.559748427673,634.314465408805,553.575471698113,343.74213836478,198.650943396226,985.943396226415,130.430817610063,318,22.6199547053766,18.2126985766945,0.593056697383051,0.929824561403509,0.688311688311688,-0.891214280860516,52581.2201257862,32846.320754717,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_803805,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
803988,1314.38036809816,152.368098159509,82.1226993865031,636.411042944785,2173.75460122699,614.067484662577,493.662576687116,235.742331288344,1076.09202453988,2677.44785276074,1206.42944785276,111.98773006135,1069.53987730061,1524.88343558282,615.760736196319,384.01226993865,2346.71165644172,1681.95705521472,266.441717791411,224.754601226994,1016.88343558282,1795.61349693252,209.411042944785,185.993865030675,587.920245398773,1320.31288343558,499.723926380368,304.944785276074,1037.58282208589,130.441717791411,163,20.2310120272065,10.3683227948235,0.858689315501764,0.936781609195402,0.63671875,0.732010698866549,53481.773006135,33532.0674846626,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_803988,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
804545,2252.84196185286,346.493188010899,57.1907356948229,645.656675749319,1711.310626703,327.32970027248,2337.89918256131,242.179836512262,1086.05722070845,3630.57220708447,610.400544959128,121.373297002725,1075.90190735695,817.411444141689,1148.88010899183,950.207084468665,2209.59945504087,1527.92370572207,273.66757493188,437.899182561308,1023.38147138965,1271.24523160763,220.297002724796,308.634877384196,658.455040871935,883.204359673025,491.065395095368,312.370572207084,1020.98092643052,131.190735694823,367,27.6179525754897,18.9155551905044,0.72863641430148,0.839816933638444,0.543703703703704,-0.785186366125346,53650.3160762943,33392.8991825613,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_804545,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
804905,415.097719869707,796.781758957655,198.384364820847,614.00325732899,109.42345276873,615.13680781759,400.742671009772,276.198697068404,1138.44299674267,1120.07491856678,1120.26058631922,123.315960912052,1068.39413680782,1230.92833876221,722.084690553746,298.628664495114,1784.06188925081,2485.83061889251,329.755700325733,232.788273615635,1040.85342019544,3362.09771986971,240.592833876222,781.022801302932,840.801302931596,578.14983713355,342.361563517915,198.00651465798,983.527687296417,128.052117263844,307,24.1201863424275,16.2565171999495,0.738749818554636,0.965408805031446,0.73444976076555,-1.03042155023357,52515.4755700326,32440.0521172638,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_804905,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
805536,679.287581699346,127.771241830065,49.5424836601307,607.477124183006,596.692810457516,507.967320261438,377.156862745098,263.013071895425,1086.19607843137,1727.54248366013,534.705882352941,113.535947712418,1069.35294117647,685.686274509804,576.516339869281,289.601307189542,1511.7908496732,991.091503267974,286.928104575163,227.718954248366,1008.05882352941,910.339869281046,225.045751633987,130.254901960784,589.993464052288,1530.2091503268,544.013071895425,227.901960784314,1018.33333333333,128.901960784314,153,17.3242119222431,11.35211180501,0.755390970814642,0.962264150943396,0.75,0.169481819420994,52256.2810457516,32739.5751633987,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_805536,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
807688,2506.5223880597,898.194029850746,102.865671641791,659.865671641791,1723.85074626866,1587.86567164179,542.462686567164,247.238805970149,1115.73134328358,3397.76119402985,1306.49253731343,136.462686567164,1082.49253731343,998.611940298507,644.761194029851,347.164179104478,1823.59701492537,1498.29850746269,354.835820895522,235.850746268657,1018.64179104478,1480.05970149254,254.805970149254,1400.28358208955,1962.29850746269,975.746268656716,462.298507462687,274.55223880597,1055.40298507463,130.10447761194,67,11.0341800171759,7.850380297407,0.702726358824338,0.917808219178082,0.761363636363636,1.48043478978887,53032.8656716418,33829.4029850746,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_807688,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
807699,1829.62471395881,255.794050343249,101.556064073227,627.340961098398,1619.11212814645,437.759725400458,784.75057208238,247.922196796339,1089.72311212815,2084.7299771167,504.240274599542,114.572082379863,1071.04118993135,2424.38901601831,646.643020594966,772.141876430206,1764.96338672769,3524.85354691076,372.929061784897,1675.39359267735,1015.94965675057,2440.70480549199,285.787185354691,723.933638443936,597.688787185355,678.089244851259,410.446224256293,230.263157894737,997.203661327231,128.745995423341,437,24.5651461347701,22.8060788247387,0.37160297693162,0.971111111111111,0.791666666666667,0.12220060462784,53156.5629290618,33536.7505720824,FAAGSCC_12,AG,1,neutrophils,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,neutrophils,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_807699,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
808765,700.307692307692,200.316239316239,74.7948717948718,623.598290598291,727.65811965812,601.931623931624,341.769230769231,274.324786324786,1101.70085470085,1551.81196581197,931.358974358974,116.57264957265,1061.23076923077,1198.24786324786,716.42735042735,278.880341880342,1840.23076923077,1451.05982905983,326.393162393162,237.128205128205,1029.28205128205,1115.24786324786,209.581196581197,394.521367521367,1625.45299145299,1000.5641025641,462.555555555556,309.717948717949,1032.94871794872,128.08547008547,117,13.3700401969987,11.1483075026379,0.552025055176779,0.966942148760331,0.818181818181818,0.255668757826185,53089.7435897436,32035.9487179487,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,1,FAAGSCC_12_808765,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
809097,994.804020100502,71.6180904522613,58.608040201005,621.582914572864,737.844221105528,560.065326633166,387.286432160804,276.758793969849,1137.24120603015,1772.43216080402,1647.92462311558,223.542713567839,1073.6432160804,1047.21105527638,597.507537688442,275.643216080402,1718.65829145729,1462.78894472362,307.321608040201,354.010050251256,1062.66834170854,1144.82914572864,224.467336683417,272.86432160804,678.115577889447,849.211055276382,430.748743718593,210.015075376884,1040.00502512563,130.748743718593,199,21.5284357467172,11.8044213300838,0.836270143556405,0.952153110047847,0.650326797385621,-0.811297258711727,53050.7889447236,32071.7386934673,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,1,FAAGSCC_12_809097,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
809277,1150.32105263158,377.794736842105,85.0052631578947,611.710526315789,774.894736842105,1438.02631578947,1343.3,258.510526315789,1096.96315789474,2688.26842105263,784.947368421053,117.252631578947,1065.44736842105,796.7,530.4,307.589473684211,1452.62105263158,1676.47894736842,295.236842105263,226.926315789474,978.078947368421,3309.26842105263,271.178947368421,164.742105263158,602.078947368421,1279.41578947368,475.021052631579,261.5,1029.87894736842,130.742105263158,190,21.1170457465451,11.564091761721,0.836727926755092,0.95959595959596,0.714285714285714,0.497013441522924,54056.7578947368,32604.9526315789,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_809277,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
810541,2469.94690265487,1066.53097345133,1072.21238938053,633.327433628319,935.132743362832,810.185840707965,632.345132743363,248.858407079646,1089.04424778761,4818.67256637168,601.566371681416,136.088495575221,1066.74336283186,2961.8407079646,767.58407079646,787.495575221239,1754.58407079646,3066.17699115044,368.194690265487,243.115044247788,1027.0796460177,2944.6814159292,262.389380530973,790.734513274336,700.469026548673,1478.82300884956,520.690265486726,430.41592920354,1051.72566371681,130.646017699115,113,15.101908475355,9.61084889462437,0.771359525093374,0.933884297520661,0.70625,1.55354395588416,53368.1504424779,33895.3805309735,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_810541,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
810737,2940.14563106796,239.932038834951,98.2135922330097,634.728155339806,1635.1359223301,1035.25242718447,281.834951456311,249.757281553398,1123.27184466019,5802.21359223301,670.95145631068,116.281553398058,1080.87378640777,807.941747572816,464.611650485437,268.980582524272,1678.55339805825,1624.19417475728,310.553398058252,229.04854368932,988.446601941748,1833.83495145631,228.805825242718,146.067961165049,593.611650485437,2286.08737864078,532.932038834951,302.378640776699,1046.96116504854,131.504854368932,103,16.5445738207784,8.33320551478753,0.863889085787829,0.872881355932203,0.64375,-1.24693134538815,53556.9708737864,33148.0873786408,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_810737,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
810826,1552.5175879397,246.361809045226,202.48743718593,708.060301507538,4811.28140703518,655.969849246231,409.417085427136,274.628140703518,1135.37688442211,2548.56783919598,757.331658291457,127.306532663317,1066.14070351759,858.170854271357,477.628140703518,275.1608040201,1534.79396984925,1420.80904522613,270.412060301508,222.21608040201,1027.9648241206,1125.43216080402,194.974874371859,150.733668341709,4963.05025125628,857.663316582915,439.502512562814,232.804020100503,1034.71859296482,129.894472361809,199,29.8779819765362,8.63931276443887,0.957282848871094,0.938679245283019,0.491358024691358,-1.10905602910158,53976.5376884422,32629.4874371859,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_810826,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
811925,704.5,172.5,76.9769230769231,614.761538461538,823.615384615385,414.984615384615,293.515384615385,260.907692307692,1094.75384615385,948.753846153846,550.853846153846,109.469230769231,1067.05384615385,703.8,445.323076923077,269.046153846154,1426.12307692308,1043.53076923077,257.046153846154,217.123076923077,979.038461538462,946.353846153846,184.376923076923,118.515384615385,591.523076923077,728.738461538462,412.015384615385,210.369230769231,1002.2,129.807692307692,130,15.4215090496258,10.7464161932793,0.717220827722156,0.948905109489051,0.787878787878788,1.5295714687059,53328.2538461538,32251.6384615385,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,14,FAAGSCC_12_811925,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
812023,1015.40298507463,472.029850746269,146.34328358209,646.888059701493,1689.97014925373,329.865671641791,296.111940298507,256.186567164179,1069.83582089552,2390.20895522388,719.522388059701,124.15671641791,1067.67164179104,631.238805970149,464.402985074627,269.037313432836,1432.35820895522,921.365671641791,229.05223880597,213.179104477612,986.55223880597,808.358208955224,165.791044776119,229.850746268657,618.253731343284,1005.39552238806,446.350746268657,231.380597014925,1034.57462686567,130.477611940299,134,14.6274308556308,11.7436585941669,0.596178708813948,0.964028776978417,0.744444444444444,-0.408493421645548,53921.0597014925,32543.5223880597,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_812023,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
813488,2062.95192307692,583.6875,142.004807692308,619.682692307692,597.259615384615,578.927884615385,357.072115384615,257.0,1097.46634615385,3047.1875,790.870192307692,117.5625,1058.61057692308,835.3125,562.399038461538,306.956730769231,1479.08173076923,1147.64903846154,287.956730769231,225.408653846154,1008.70673076923,1012.62019230769,221.086538461538,148.581730769231,866.538461538462,925.326923076923,454.764423076923,256.177884615385,1044.09615384615,129.605769230769,208,25.9556937434887,10.6519455754685,0.911910310328888,0.88135593220339,0.571428571428571,0.356269044076202,53893.6201923077,33394.7932692308,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_813488,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
813952,1499.10377358491,420.891509433962,238.650943396226,684.117924528302,6107.21226415094,754.872641509434,404.86320754717,277.528301886792,1149.48113207547,2681.28773584906,1109.46226415094,139.75,1067.41981132075,3205.10377358491,605.839622641509,317.702830188679,1887.87735849057,2108.77358490566,357.212264150943,228.301886792453,1055.42452830189,1292.08018867925,216.292452830189,207.231132075472,693.231132075472,1012.68396226415,470.212264150943,244.221698113208,1092.36320754717,132.547169811321,212,20.9534227212638,14.5553534016553,0.719345196275703,0.828125,0.566844919786096,-1.09929124032914,53213.2971698113,32704.9386792453,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_813952,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
814317,3890.05263157895,465.947368421053,180.929824561404,688.780701754386,4875.55263157895,653.342105263158,1390.94736842105,245.763157894737,1088.52631578947,6558.35964912281,2879.47368421053,135.026315789474,1075.97368421053,2083.71052631579,1332.0350877193,1651.88596491228,2054.27192982456,2464.35087719298,315.412280701754,225.956140350877,1045.61403508772,1887.16666666667,228.40350877193,645.087719298246,792.771929824561,1875.4298245614,524.201754385965,572.429824561404,1049.14912280702,132.078947368421,114,23.2787628408833,8.01653229333212,0.938833622804769,0.682634730538922,0.4,-0.705864268198921,53509.0964912281,33084.0087719298,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_814317,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
815119,1046.83333333333,70.0925925925926,51.5925925925926,601.361111111111,224.083333333333,2512.58333333333,1944.44444444444,260.555555555556,1112.19444444444,2194.47222222222,428.046296296296,120.240740740741,1064.40740740741,2145.10185185185,743.314814814815,546.305555555556,5895.30555555556,2299.89814814815,315.824074074074,231.481481481481,1018.77777777778,2942.63888888889,239.305555555556,195.777777777778,643.87962962963,1595.06481481481,483.796296296296,245.314814814815,1015.80555555556,128.62962962963,108,13.1582836192086,10.534718102653,0.599179238753638,0.939130434782609,0.755244755244755,1.21523851907162,53110.962962963,33863.9814814815,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_815119,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
815566,782.915993537964,1203.91437802908,309.163166397415,639.21647819063,59.6494345718901,753.441033925687,484.844911147011,299.702746365105,1148.79967689822,1971.23424878837,3288.6268174475,156.880452342488,1072.79483037157,1134.22132471729,652.495961227787,301.678513731826,1677.70436187399,1289.52019386107,287.504038772213,334.798061389338,1129.97415185784,978.924071082391,189.479806138934,167.654281098546,1184.91276252019,553.050080775444,328.576736672052,192.670436187399,983.095315024233,127.746365105008,619,37.2188826843689,21.7135542045054,0.812183858655294,0.946483180428134,0.707428571428571,-0.358376828673654,52874.7819063005,32064.6009693053,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_815566,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
815891,2758.62048192771,218.475903614458,86.078313253012,635.963855421687,1320.48192771084,2917.93975903615,398.602409638554,272.879518072289,1106.33734939759,4788.31927710843,830.993975903614,133.885542168675,1067.92771084337,2027.24698795181,907.313253012048,559.228915662651,1762.50602409639,1670.15060240964,325.66265060241,227.885542168675,999.379518072289,1234.11445783133,218.536144578313,184.048192771084,601.987951807229,1360.92168674699,535.632530120482,230.198795180723,1025.86144578313,127.192771084337,166,26.2134694340402,8.32099644054235,0.948281006337364,0.878306878306878,0.58041958041958,-1.3071499251371,53231.6024096386,32942.3493975904,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_815891,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
816632,1365.81696428571,257.455357142857,89.5491071428571,669.28125,3447.03125,2235.95089285714,919.4375,254.705357142857,1118.38392857143,2174.5625,534.928571428571,126.053571428571,1082.25,1489.55803571429,916.566964285714,605.973214285714,1957.85267857143,2029.16517857143,313.745535714286,225.294642857143,1048.29464285714,1252.69196428571,201.5,302.035714285714,609.955357142857,963.049107142857,473.803571428571,248.928571428571,1035.26339285714,130.241071428571,224,23.3079431640653,12.6155244195027,0.840858956479378,0.937238493723849,0.622222222222222,-0.885427329758944,53631.6116071429,33754.2053571429,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_816632,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
816784,1672.40201005025,304.768844221106,124.748743718593,645.824120603015,2509.57286432161,344.155778894472,291.688442211055,247.050251256281,1077.43718592965,3610.53266331658,2211.73366834171,118.879396984925,1068.56281407035,663.909547738694,501.768844221106,273.984924623116,1414.94472361809,1031.89949748744,306.386934673367,226.884422110553,980.939698492462,936.402010050251,212.854271356784,135.306532663317,584.708542713568,1792.97487437186,494.326633165829,450.824120603015,1058.37185929648,129.110552763819,199,21.4278766877457,12.7606596335261,0.803342885812372,0.865217391304348,0.646103896103896,0.0336997525149104,53082.2512562814,33050.5778894472,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_816784,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
816976,1152.9156626506,387.385542168675,100.542168674699,611.963855421687,531.975903614458,304.698795180723,315.843373493976,257.469879518072,1093.43373493976,2966.01204819277,680.843373493976,109.542168674699,1071.89156626506,693.192771084337,465.746987951807,278.168674698795,1370.20481927711,1104.98795180723,298.638554216867,223.542168674699,984.879518072289,1141.44578313253,230.373493975904,120.518072289157,591.939759036145,1682.96385542169,486.722891566265,248.843373493976,1012.79518072289,131.722891566265,83,11.23992976713,9.41332595290763,0.546453036678413,0.922222222222222,0.754545454545455,-0.434757749257583,53351.5662650602,32936.2289156627,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_816976,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
816981,1981.17857142857,734.75,294.904761904762,731.333333333333,7570.66666666667,1816.03571428571,1377.4880952381,250.011904761905,1078.46428571429,4677.44047619048,5481.89285714286,130.797619047619,1068.67857142857,1238.47619047619,788.166666666667,1012.40476190476,1669.64285714286,1705.08333333333,310.880952380952,231.02380952381,1077.63095238095,1977.25,215.166666666667,173.702380952381,1017.86904761905,2117.17857142857,524.178571428571,1142.70238095238,1071.14285714286,132.309523809524,84,13.8746635359848,7.92992650905109,0.820574140668931,0.91304347826087,0.666666666666667,-1.39379528972117,53280.869047619,33163.0952380952,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_816981,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
817916,1617.12,232.864,62.728,615.28,632.056,2564.408,1269.992,254.928,1138.888,3243.072,476.32,123.984,1063.968,4310.2,803.648,978.096,2276.464,4254.2,414.816,240.2,1084.984,2950.984,253.608,415.136,650.688,1675.416,501.76,245.208,1038.96,131.312,125,16.715975961842,9.87080157044608,0.807036860921375,0.954198473282443,0.735294117647059,-1.56860192707402,53190.992,33904.88,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_817916,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
819152,1402.20289855072,624.36231884058,353.95652173913,780.086956521739,9735.21739130435,669.31884057971,2052.21739130435,431.985507246377,1109.73913043478,2639.3768115942,564.014492753623,144.086956521739,1076.73913043478,6211.5652173913,1600.69565217391,408.68115942029,1590.79710144928,1793.07246376812,292.31884057971,229.608695652174,1014.07246376812,1252.39130434783,211.913043478261,179.391304347826,767.594202898551,996.63768115942,438.95652173913,650.942028985507,1072.08695652174,132.884057971014,69,11.8941518022162,7.44551443131793,0.779838214707016,0.907894736842105,0.696969696969697,-1.15154150508481,52734.3043478261,32770.8550724638,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3+,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_819152,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
819333,3107.13402061856,832.40206185567,100.134020618557,674.113402061856,2527.23711340206,3530.16494845361,472.051546391753,264.618556701031,1154.44329896907,4331.15463917526,3763.77319587629,131.237113402062,1096.0,3711.68041237113,720.690721649485,468.412371134021,3470.09278350515,2115.73195876289,313.927835051546,239.123711340206,1030.21649484536,1520.84536082474,211.948453608247,229.845360824742,696.494845360825,1296.55670103093,484.690721649484,604.030927835052,1245.60824742268,133.123711340206,97,12.6659118757938,10.8595323595147,0.514679599560613,0.822033898305085,0.532967032967033,-0.0652101094600986,52824.5463917526,33680.2783505155,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_819333,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
819374,3282.9068627451,433.063725490196,85.9166666666667,634.720588235294,1214.32352941176,2436.97058823529,813.598039215686,253.259803921569,1164.3137254902,5201.33333333333,786.029411764706,133.941176470588,1076.9362745098,2456.70098039216,1039.20588235294,963.725490196078,3670.16666666667,2088.78921568627,356.166666666667,233.622549019608,1381.95588235294,1485.61274509804,218.789215686275,232.21568627451,694.279411764706,1320.0931372549,495.622549019608,268.343137254902,1072.22549019608,131.28431372549,204,20.9758546886418,12.8826687777357,0.789176419642629,0.898678414096916,0.728571428571429,-1.30466959129784,53237.2696078431,33738.6274509804,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_819374,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
819578,453.823056300268,1023.23592493298,229.908847184987,610.865951742627,255.764075067024,628.721179624665,403.911528150134,266.495978552279,1130.28686327078,1074.60053619303,1299.43163538874,107.14745308311,1070.8418230563,908.772117962466,483.73726541555,278.790884718499,1542.87131367292,1457.33243967828,253.702412868633,249.12600536193,1070.55495978552,1335.72386058981,189.471849865952,153.87399463807,3585.5764075067,608.525469168901,379.833780160858,209.833780160858,989.849865951743,128.761394101877,373,26.7282718004297,17.8718974280516,0.743575989248431,0.953964194373402,0.727095516569201,-0.212582042507342,53307.1367292225,33057.2761394102,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_819578,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
820074,982.855769230769,285.211538461538,112.086538461538,634.817307692308,1375.95192307692,676.692307692308,406.509615384615,264.115384615385,1096.78846153846,1439.84615384615,977.384615384615,118.211538461538,1072.66346153846,730.596153846154,469.173076923077,269.615384615385,1506.07692307692,1075.04807692308,266.778846153846,224.269230769231,1053.11538461538,916.471153846154,192.740384615385,205.788461538462,838.759615384615,880.403846153846,461.471153846154,238.057692307692,1049.5,130.134615384615,104,14.0786302121757,9.413221520614,0.743606317344508,0.962962962962963,0.8,1.23241405267974,52738.0384615385,32257.2307692308,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_820074,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
820092,619.243070362473,1073.67164179104,266.02132196162,615.835820895522,95.3518123667378,824.422174840085,953.950959488273,264.73987206823,1117.53091684435,1477.99786780384,667.475479744136,120.213219616205,1060.8592750533,2207.95735607676,1004.59701492537,325.025586353945,1647.22601279318,2421.31769722814,347.622601279318,233.944562899787,998.782515991471,1577.64818763326,342.710021321962,145.579957356077,598.034115138593,566.761194029851,360.498933901919,204.106609808102,979.765458422175,127.923240938166,469,30.1647945924028,19.9228593414611,0.750854841973099,0.957142857142857,0.735109717868339,0.348335076386979,53643.618336887,32648.4157782516,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_820092,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
821654,831.0,287.132653061225,63.734693877551,609.30612244898,666.295918367347,437.69387755102,766.071428571429,266.632653061225,1101.13265306122,1671.41836734694,669.959183673469,106.755102040816,1060.31632653061,838.295918367347,769.642857142857,299.387755102041,1551.09183673469,1247.87755102041,297.540816326531,226.255102040816,1020.07142857143,1149.84693877551,218.84693877551,1084.55102040816,2601.79591836735,757.704081632653,391.938775510204,226.479591836735,1021.28571428571,130.683673469388,98,13.0969774298166,9.57502883572461,0.682284340665432,0.933333333333333,0.753846153846154,-1.42171559464933,52738.0408163265,32395.4591836735,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_821654,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
822973,3219.86486486487,331.63963963964,90.027027027027,635.657657657658,1576.13513513514,635.306306306306,680.81981981982,241.486486486486,1106.36036036036,5567.01801801802,1089.72972972973,121.855855855856,1074.74774774775,734.054054054054,538.162162162162,287.396396396396,1467.43243243243,1164.17117117117,269.837837837838,233.855855855856,1009.85585585586,1127.63063063063,208.306306306306,168.036036036036,611.810810810811,1349.91891891892,482.531531531532,342.954954954955,1048.17117117117,132.054054054054,111,13.652222661701,11.0782124566666,0.584410012817036,0.880952380952381,0.569230769230769,-0.450324776234729,53085.1621621622,33536.5585585586,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_822973,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
823320,649.363636363636,155.534090909091,78.2727272727273,617.090909090909,602.329545454545,272.227272727273,283.238636363636,247.386363636364,1068.98863636364,1778.625,532.670454545455,111.397727272727,1085.14772727273,779.590909090909,522.329545454545,577.011363636364,1528.81818181818,1754.54545454545,266.886363636364,224.965909090909,1005.61363636364,2061.81818181818,211.875,812.522727272727,691.522727272727,1497.60227272727,478.056818181818,222.465909090909,1043.32954545455,129.238636363636,88,12.9464763255452,8.72148901202127,0.739043819133263,0.936170212765958,0.752136752136752,-0.062498020816652,52623.7045454545,33081.7159090909,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_823320,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
824497,1179.08866995074,133.487684729064,61.7487684729064,616.541871921182,650.960591133005,1955.38916256158,2411.73891625616,265.256157635468,1096.90640394089,2896.06403940887,840.650246305419,121.931034482759,1070.92610837438,3813.11822660099,2003.97536945813,1601.58620689655,1812.89162561576,1904.17733990148,326.586206896552,231.07881773399,1002.34975369458,1242.15270935961,209.679802955665,299.857142857143,690.931034482759,845.852216748768,410.428571428571,220.300492610837,1033.09359605911,130.177339901478,203,25.4460420296694,10.4729492993509,0.911375990271922,0.926940639269406,0.588405797101449,1.10098433029106,52936.236453202,32754.802955665,FAAGSCC_12,AG,1,M2 macrophages,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_824497,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
824745,645.760869565217,515.184782608696,605.45652173913,874.152173913043,17046.8586956522,517.684782608696,354.565217391304,262.826086956522,1114.19565217391,1599.40217391304,924.684782608696,157.25,1075.40217391304,1283.09782608696,898.652173913043,311.304347826087,1998.77173913043,1320.84782608696,329.695652173913,234.967391304348,1025.66304347826,1042.64130434783,226.326086956522,436.184782608696,939.391304347826,977.010869565217,462.728260869565,220.75,1031.86956521739,130.076086956522,92,13.9063759193484,8.42627573595984,0.79551876757863,0.938775510204082,0.696969696969697,0.744947362100327,52442.8804347826,32868.3369565217,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_824745,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
824968,662.008547008547,184.094017094017,93.8376068376068,612.897435897436,1494.48717948718,641.880341880342,372.888888888889,269.444444444444,1130.02564102564,1868.63247863248,568.863247863248,120.153846153846,1067.53846153846,919.717948717949,529.606837606838,263.418803418803,1703.80341880342,1502.49572649573,317.547008547009,227.410256410256,1051.60683760684,1294.7264957265,220.760683760684,261.222222222222,2153.60683760684,1051.92307692308,482.51282051282,225.478632478632,1024.11965811966,129.495726495727,117,12.8410740232329,11.6071058169286,0.427734126266308,0.959016393442623,0.8125,0.850555105437936,53187.7521367521,32720.5299145299,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_824968,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
825268,1571.30158730159,192.238095238095,101.444444444444,642.190476190476,3107.12698412698,3634.0,406.47619047619,265.031746031746,1147.90476190476,2842.84126984127,622.365079365079,132.269841269841,1067.92063492063,1678.42857142857,1037.42857142857,353.603174603175,2525.14285714286,4098.92063492064,408.380952380952,249.428571428571,1035.39682539683,4670.46031746032,267.936507936508,308.904761904762,721.015873015873,1740.52380952381,499.015873015873,313.396825396825,1058.03174603175,129.619047619048,63,11.426593761935,7.07508231180254,0.785251571526787,0.954545454545455,0.715909090909091,1.17923022715364,52804.746031746,33762.3015873016,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_825268,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
825276,2917.33830845771,351.328358208955,95.7064676616916,637.955223880597,1984.57213930348,1368.46766169154,606.363184079602,247.646766169154,1084.1144278607,4487.3631840796,527.915422885572,111.925373134328,1086.8855721393,6355.37313432836,736.179104477612,335.860696517413,5766.30845771144,4815.55721393035,357.681592039801,245.278606965174,1024.51243781095,2650.29850746269,232.661691542289,193.049751243781,615.004975124378,1281.92537313433,491.950248756219,239.835820895522,1050.80099502488,129.199004975124,201,24.5611366348397,11.3864149722644,0.886047329995184,0.83402489626556,0.485507246376812,0.851613089899281,53762.328358209,33539.0796019901,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_825276,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
825699,567.541176470588,1116.21764705882,271.988235294118,661.435294117647,2198.03529411765,718.052941176471,485.0,286.794117647059,1138.44705882353,1316.02352941176,858.635294117647,133.570588235294,1063.28823529412,1238.97058823529,840.011764705882,337.9,2035.44705882353,1229.0,312.0,234.782352941176,1045.06470588235,1069.62352941176,232.847058823529,245.770588235294,1009.64117647059,1097.54117647059,485.617647058824,229.017647058824,1090.42352941176,130.911764705882,170,16.1945160478368,13.4027137730218,0.561306261076788,0.949720670391062,0.755555555555556,0.878822053354304,52436.3588235294,32840.8470588235,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_825699,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
826171,776.253846153846,420.515384615385,80.4384615384615,628.361538461538,939.661538461538,504.853846153846,288.369230769231,246.084615384615,1075.41538461538,1800.76153846154,681.453846153846,107.584615384615,1065.74615384615,637.484615384615,412.684615384615,273.446153846154,1400.40769230769,905.738461538462,216.638461538462,210.576923076923,987.592307692308,836.923076923077,180.430769230769,139.984615384615,618.138461538462,1388.57692307692,582.776923076923,285.784615384615,1019.06153846154,130.738461538462,130,13.9908596099815,11.917278541981,0.523882887919875,0.955882352941176,0.773809523809524,1.42548570033463,54125.8846153846,33305.7692307692,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_826171,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
826581,694.059701492537,253.835820895522,159.10447761194,673.567164179104,4059.85074626866,985.119402985075,442.149253731343,252.65671641791,1080.85074626866,1511.37313432836,1352.46268656716,126.582089552239,1069.86567164179,3088.16417910448,649.910447761194,276.671641791045,1516.07462686567,1606.64179104478,281.358208955224,225.626865671642,994.179104477612,1281.49253731343,237.761194029851,128.776119402985,589.671641791045,1069.0447761194,528.164179104478,404.89552238806,1027.62686567164,131.537313432836,67,10.2151600393609,8.35936983685292,0.574748940024848,0.943661971830986,0.744444444444444,0.606109645397585,53510.0895522388,33306.4029850746,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_826581,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
826605,1146.11363636364,63.1931818181818,52.2386363636364,636.477272727273,990.329545454546,4128.5,450.068181818182,261.329545454545,1136.81818181818,3106.26136363636,559.511363636364,122.647727272727,1078.07954545455,2734.78409090909,932.977272727273,1102.68181818182,2269.84090909091,4004.97727272727,332.125,231.352272727273,1020.29545454545,3756.46590909091,344.284090909091,1900.92045454545,632.272727272727,1415.0,487.602272727273,279.136363636364,1028.88636363636,128.375,88,12.2753711699766,9.19616196414092,0.662394157600384,0.926315789473684,0.733333333333333,-0.353136958749016,52936.625,33488.0909090909,FAAGSCC_12,AG,1,other APCs,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,other APCs,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,9,FAAGSCC_12_826605,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
827016,437.50390625,653.03515625,149.4765625,620.97265625,101.7734375,653.68359375,295.69140625,253.81640625,1085.6484375,1298.1328125,705.0,116.38671875,1067.76171875,1369.57421875,576.1875,273.86328125,1515.6875,1900.15234375,329.24609375,225.83984375,993.9296875,1886.15625,218.62109375,144.48828125,594.40625,570.484375,359.43359375,206.91015625,986.84765625,127.98046875,256,21.1232439702319,15.6725205411114,0.670448422828739,0.927536231884058,0.711111111111111,-0.542627068266147,53661.84375,32651.3984375,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_827016,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
827045,1169.0,70.7954545454545,55.9848484848485,636.227272727273,815.681818181818,329.712121212121,322.863636363636,255.712121212121,1074.25,2296.87121212121,394.916666666667,106.075757575758,1070.2196969697,599.340909090909,404.909090909091,264.128787878788,1360.5,924.371212121212,248.204545454545,215.151515151515,979.227272727273,845.340909090909,192.598484848485,118.583333333333,581.757575757576,1016.97727272727,420.530303030303,219.560606060606,1008.88636363636,128.643939393939,132,15.6021094864358,11.1777228911567,0.697665327330156,0.897959183673469,0.733333333333333,0.109848934856712,54204.4393939394,32896.4393939394,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_827045,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
828497,2925.47826086957,231.876811594203,107.159420289855,649.311594202899,2769.76811594203,609.782608695652,375.311594202899,269.405797101449,1099.48550724638,4629.96376811594,871.13768115942,126.021739130435,1072.25362318841,905.688405797102,573.855072463768,304.086956521739,1443.80434782609,1091.76086956522,312.54347826087,228.971014492754,990.036231884058,985.420289855072,212.123188405797,141.695652173913,795.405797101449,889.326086956522,426.782608695652,221.050724637681,1016.5652173913,131.673913043478,138,18.8513940404712,11.0319022628284,0.810886448978355,0.775280898876405,0.58974358974359,1.47941310298725,53558.3260869565,32717.4855072464,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_828497,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
828681,1659.39153439153,294.333333333333,113.037037037037,653.888888888889,2568.97354497354,308.121693121693,1157.3544973545,246.544973544974,1077.89947089947,2520.81481481481,3131.46031746032,126.656084656085,1071.04232804233,1126.74074074074,1011.89417989418,2491.69841269841,2315.39153439153,3288.17989417989,371.619047619048,236.243386243386,1062.15343915344,2496.98412698413,267.386243386243,593.433862433862,907.058201058201,981.746031746032,455.137566137566,317.349206349206,1038.06349206349,131.534391534392,189,17.131972153964,14.2859326176404,0.551952511879659,0.935643564356436,0.741176470588235,-1.27835802790751,52410.8253968254,32593.2857142857,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_828681,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
828835,1632.22480620155,183.248062015504,139.503875968992,671.093023255814,2339.06976744186,1531.47286821705,497.953488372093,267.0,1306.87596899225,2825.3023255814,1596.7519379845,124.06976744186,1082.10852713178,3249.68217054264,1012.44186046512,345.782945736434,2361.16279069767,2380.06976744186,343.976744186047,241.821705426357,1029.09302325581,1739.89147286822,231.22480620155,302.193798449612,595.286821705426,931.806201550388,454.961240310078,312.62015503876,1039.94573643411,129.976744186047,129,16.7651705016397,9.81730368569216,0.810616553699908,0.969924812030075,0.80625,0.313168769880368,52713.6201550388,33575.2945736434,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1+,PD-1+,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_828835,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
828984,405.944668008048,219.550301810865,105.555331991952,630.70523138833,1662.476861167,899.28370221328,1279.40643863179,268.251509054326,1088.07947686117,743.154929577465,751.178068410463,118.124748490946,1067.69517102616,849.58953722334,652.997987927565,280.664989939638,1417.23038229376,1167.73641851107,338.223340040241,234.114688128773,980.016096579477,1009.27565392354,229.151911468813,116.777665995976,583.900402414487,591.931589537223,364.894366197183,205.907444668008,990.660965794769,128.557344064386,994,40.0109012096474,31.7642789575436,0.608060598814877,0.974509803921569,0.746246246246246,-0.693245441377042,53477.0794768612,32467.323943662,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_828984,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
829018,2724.63063063063,399.477477477478,119.441441441441,619.459459459459,581.756756756757,636.630630630631,397.792792792793,274.495495495496,1120.47747747748,4996.9009009009,994.342342342342,117.207207207207,1075.31531531532,2265.18918918919,564.720720720721,297.900900900901,1838.08108108108,1866.0,276.756756756757,219.135135135135,1006.13513513514,1417.83783783784,191.873873873874,269.486486486487,687.513513513514,765.009009009009,407.810810810811,218.18018018018,1024.44144144144,130.621621621622,111,19.4813579405813,7.90047114755329,0.914077270490557,0.834586466165414,0.544117647058823,0.407761936948972,53805.1351351351,32687.3423423423,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_829018,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
829233,755.855421686747,150.578313253012,87.9277108433735,639.168674698795,1970.10843373494,276.578313253012,295.66265060241,248.843373493976,1074.06024096386,1685.6265060241,692.180722891566,124.325301204819,1061.81927710843,1177.69879518072,686.096385542169,300.373493975904,2113.9156626506,1482.90361445783,232.963855421687,213.349397590361,1027.22891566265,1179.18072289157,182.21686746988,173.614457831325,641.698795180723,948.120481927711,411.759036144578,214.277108433735,1038.02409638554,129.626506024096,83,11.5100980904585,9.20974632675064,0.599806746610861,0.943181818181818,0.768518518518518,0.104651586091284,53275.9397590361,32223.3373493976,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_829233,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
829268,1179.93181818182,277.943181818182,120.545454545455,643.818181818182,1831.30681818182,288.056818181818,287.488636363636,252.045454545455,1073.15909090909,1906.01136363636,601.454545454545,115.579545454545,1072.21590909091,631.704545454545,399.840909090909,265.931818181818,1358.11363636364,1035.30681818182,257.431818181818,217.909090909091,986.727272727273,1009.57954545455,205.670454545455,131.488636363636,587.420454545455,956.988636363636,532.693181818182,353.420454545455,1033.88636363636,130.159090909091,88,13.4978577871026,8.4396242005647,0.780419263852701,0.956521739130435,0.752136752136752,1.56021963851166,54059.7613636364,33142.5454545455,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_829268,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
829713,446.953781512605,810.147058823529,208.285714285714,623.621848739496,1798.53361344538,2337.63025210084,321.096638655462,265.529411764706,1093.71848739496,1046.12605042017,836.03781512605,121.344537815126,1069.89075630252,745.676470588235,539.100840336134,385.071428571429,1462.07983193277,1151.90336134454,294.264705882353,220.802521008403,992.668067226891,1038.23109243697,215.747899159664,862.605042016807,653.966386554622,656.928571428571,367.31512605042,209.886554621849,1018.60924369748,128.823529411765,238,20.2481222164668,15.052767940689,0.668829867373295,0.948207171314741,0.74375,-0.279681269565818,53763.6470588235,32108.037815126,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,18,FAAGSCC_12_829713,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
830741,1011.7625,663.7,76.625,620.4375,372.8375,282.1375,275.4,248.675,1073.125,2360.8625,568.6875,116.05,1078.475,663.6375,413.7125,273.725,1385.4375,962.525,281.9875,221.975,977.9875,930.2,220.5625,133.65,580.3875,1694.9625,567.3,233.7875,1029.0125,130.5875,80,10.7205945459803,9.5203126304075,0.459766947446144,0.919540229885058,0.727272727272727,1.24146155253408,53135.525,33305.6625,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_830741,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
830939,5297.27586206897,1577.48275862069,1320.36781609195,657.275862068965,2118.4367816092,2672.37931034483,1144.14942528736,254.379310344828,1090.71264367816,7882.66666666667,674.333333333333,146.229885057471,1097.41379310345,1243.37931034483,522.64367816092,310.563218390805,1604.24137931034,1430.09195402299,311.195402298851,234.51724137931,991.080459770115,1579.08045977011,242.0,192.19540229885,606.67816091954,2023.19540229885,589.48275862069,376.183908045977,1069.06896551724,129.505747126437,87,14.0625264116744,9.61367011471066,0.729821756532856,0.805555555555556,0.564935064935065,-1.20756015418661,53363.0114942529,33903.2183908046,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_830939,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
831021,1903.47474747475,858.262626262626,353.010101010101,692.484848484848,3738.09090909091,1430.18181818182,924.515151515152,246.191919191919,1079.34343434343,3868.21212121212,592.232323232323,137.727272727273,1081.49494949495,1299.76767676768,637.10101010101,338.080808080808,2186.28282828283,1430.62626262626,267.232323232323,229.040404040404,1014.9595959596,2388.51515151515,221.949494949495,200.818181818182,607.969696969697,2055.69696969697,504.030303030303,264.343434343434,1095.62626262626,132.828282828283,99,12.4785316916813,10.123417092222,0.584676285573452,0.98019801980198,0.825,0.100219469901547,52709.1616161616,33730.5757575758,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_831021,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
831786,2073.04761904762,444.136054421769,125.027210884354,624.761904761905,1138.8843537415,2135.31972789116,443.795918367347,254.21768707483,1097.16326530612,4145.37414965986,518.687074829932,118.0,1087.07482993197,2559.80952380952,544.775510204082,309.571428571429,1553.08163265306,1556.12244897959,266.319727891156,216.040816326531,987.122448979592,1426.4693877551,189.251700680272,141.952380952381,606.374149659864,1395.10884353741,506.163265306122,230.265306122449,1023.31972789116,131.428571428571,147,19.3795481698981,10.4805873205345,0.841146975563206,0.896341463414634,0.6125,-0.727454894667758,53531.8503401361,33048.6598639456,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_831786,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
832332,490.381546134663,1104.97755610973,269.226932668329,626.309226932668,318.428927680798,569.997506234414,423.094763092269,270.765586034913,1133.48877805486,1229.16209476309,1471.33416458853,119.209476309227,1064.22693266833,935.304239401496,562.049875311721,295.852867830424,1608.49875311721,1082.06483790524,232.356608478803,217.775561097257,1145.54862842893,968.997506234414,179.955112219451,170.047381546135,3356.97755610973,684.620947630923,376.02493765586,215.790523690773,1028.61845386534,130.26433915212,401,31.7183168245019,16.3824731753591,0.856287901432564,0.954761904761905,0.760910815939279,-1.47587988607864,52465.4812967581,32857.8304239401,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_832332,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
832338,644.082474226804,386.164948453608,378.340206185567,601.20618556701,523.752577319588,2429.1030927835,879.618556701031,269.443298969072,1126.84536082474,980.762886597938,449.298969072165,107.422680412371,1056.57731958763,4608.27835051546,1037.10309278351,1214.09278350515,1734.48453608247,1385.87628865979,287.587628865979,220.154639175258,1007.44329896907,1088.07216494845,192.474226804124,188.164948453608,669.865979381443,803.40206185567,461.40206185567,222.938144329897,1007.29896907216,129.340206185567,97,11.7378903486983,10.5118153205913,0.444969875827007,0.950980392156863,0.801652892561983,-0.524286483061317,53399.0824742268,32854.9587628866,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_832338,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
833208,2578.60869565217,917.521739130435,99.0,612.608695652174,833.104347826087,303.591304347826,282.417391304348,245.869565217391,1075.9652173913,5710.46086956522,597.44347826087,121.391304347826,1112.75652173913,1381.39130434783,467.834782608696,283.521739130435,1544.41739130435,1146.44347826087,261.139130434783,219.895652173913,987.4,963.286956521739,207.608695652174,124.313043478261,582.173913043478,1668.73913043478,530.530434782609,230.278260869565,1032.34782608696,130.260869565217,115,13.3531991252108,11.0819244063385,0.557900534625499,0.92,0.746753246753247,-0.0351474128885137,54187.8434782609,33104.7217391304,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_833208,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
833272,1392.69696969697,624.954545454545,284.984848484848,633.030303030303,1519.60606060606,543.757575757576,305.621212121212,250.575757575758,1086.09090909091,2123.43939393939,1036.57575757576,119.575757575758,1060.12121212121,7209.51515151515,700.681818181818,320.439393939394,1729.84848484848,8005.84848484848,476.015151515152,254.121212121212,989.424242424242,3527.40909090909,331.469696969697,229.363636363636,594.621212121212,1063.90909090909,468.015151515152,279.530303030303,1032.74242424242,128.060606060606,66,10.4066168943117,8.08334862533352,0.629807987440182,0.956521739130435,0.825,0.108063874779813,54051.7727272727,32584.6666666667,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_833272,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
834306,1005.0,298.6484375,616.2578125,987.84375,24114.109375,634.390625,450.3359375,278.703125,1128.1796875,2565.8203125,810.9140625,159.421875,1075.0625,923.2734375,522.7890625,297.3515625,1514.28125,942.21875,200.0859375,207.8046875,1195.2578125,645.1171875,149.65625,120.984375,591.296875,885.1015625,435.328125,215.671875,1052.0078125,130.7734375,128,22.6803139180556,7.4467406639384,0.944561344619506,0.870748299319728,0.677248677248677,1.40195676889272,52529.5625,32928.7890625,FAAGSCC_12,AG,1,Unknown,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,Other,Other,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_834306,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
834540,2164.94444444444,238.355555555556,474.588888888889,898.233333333333,14392.4,737.622222222222,331.455555555556,248.977777777778,1105.27777777778,4673.83333333333,671.077777777778,138.622222222222,2462.5,815.155555555556,456.622222222222,267.555555555556,1615.23333333333,1167.8,228.4,216.966666666667,1009.97777777778,1013.51111111111,185.577777777778,202.266666666667,1955.27777777778,1951.11111111111,497.244444444444,255.455555555556,1082.78888888889,129.755555555556,90,14.611102684809,8.08700370664269,0.832860166300044,0.891089108910891,0.6,0.100886072833882,53962.4555555556,33438.8666666667,FAAGSCC_12,AG,1,endothelial cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX+,endothelial cells,Endothelial,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_834540,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
834631,1349.70535714286,320.401785714286,172.133928571429,674.732142857143,4075.86607142857,3645.17857142857,620.464285714286,271.625,1160.50892857143,2724.04464285714,518.214285714286,116.339285714286,1080.55357142857,1137.08035714286,623.401785714286,482.5,2306.08928571429,2446.10714285714,287.035714285714,218.821428571429,1027.33035714286,2545.01785714286,199.714285714286,249.267857142857,609.919642857143,1291.69642857143,498.794642857143,248.428571428571,1026.48214285714,131.598214285714,112,15.7971212895662,9.3852190445272,0.804384212394756,0.888888888888889,0.678787878787879,-1.39911989461759,54002.5357142857,32775.4375,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_834631,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
835015,657.425925925926,1610.25925925926,339.469135802469,614.617283950617,140.814814814815,563.049382716049,265.0,252.006172839506,1089.16666666667,1390.74691358025,921.493827160494,118.524691358025,1069.52469135802,657.530864197531,447.820987654321,256.740740740741,1468.38271604938,869.771604938272,244.240740740741,215.740740740741,991.864197530864,814.679012345679,176.246913580247,109.277777777778,592.20987654321,624.697530864198,369.820987654321,208.586419753086,994.981481481482,129.493827160494,162,15.8582925227105,13.0350027451563,0.569534243190542,0.947368421052632,0.723214285714286,0.404030502869857,53738.7777777778,32617.6543209877,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_835015,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
835177,3123.82653061224,364.357142857143,101.387755102041,616.530612244898,968.836734693878,439.908163265306,786.010204081633,237.469387755102,1073.54081632653,4756.18367346939,506.316326530612,117.295918367347,1086.94897959184,1130.10204081633,1752.23469387755,512.540816326531,4867.05102040816,1938.01020408163,328.69387755102,234.714285714286,1034.27551020408,1278.80612244898,209.928571428571,510.357142857143,748.479591836735,1605.71428571429,516.551020408163,233.632653061224,1017.79591836735,127.224489795918,98,15.2667186608223,11.4625669764448,0.660506181385871,0.690140845070423,0.4375,0.0416638188015435,53876.5816326531,33021.5102040816,FAAGSCC_12,AG,1,effector CD8+ T cells,,TIM3+,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,effector CD8+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_835177,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
836200,1331.46511627907,130.798449612403,64.7906976744186,635.434108527132,1774.68992248062,506.108527131783,1298.1007751938,243.77519379845,1075.72093023256,2406.19379844961,1094.76744186047,124.674418604651,1093.46511627907,1637.14728682171,783.682170542636,371.596899224806,2428.5503875969,2297.7984496124,366.496124031008,247.806201550388,1047.6976744186,2326.99224806202,257.031007751938,1918.70542635659,1055.45736434109,893.596899224806,421.093023255814,250.046511627907,1044.20930232558,129.209302325581,129,15.4256100842248,11.0022785313618,0.700912219005008,0.902097902097902,0.661538461538462,0.63458916383532,53038.5891472868,33822.6976744186,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6+,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_836200,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
836454,503.388489208633,978.129496402878,225.388489208633,613.086330935252,97.273381294964,261.165467625899,279.73381294964,250.071942446043,1080.46762589928,1421.70503597122,788.94964028777,116.107913669065,1067.35971223022,833.992805755396,438.985611510791,269.532374100719,1397.3381294964,2183.48920863309,281.05035971223,224.791366906475,974.36690647482,2138.90647482014,201.517985611511,128.467625899281,586.395683453237,566.920863309353,365.482014388489,205.064748201439,980.122302158273,126.94964028777,139,17.4331967729142,10.7010905136442,0.789435055825231,0.858024691358025,0.609649122807018,-1.21849632576673,53760.2014388489,32636.4964028777,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_836454,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
837412,654.480769230769,1133.80769230769,280.528846153846,617.721153846154,357.139423076923,517.538461538462,469.533653846154,257.245192307692,1096.17788461538,1259.66346153846,906.8125,115.682692307692,1058.54326923077,700.918269230769,465.524038461538,269.153846153846,1391.22596153846,1060.16826923077,315.572115384615,227.870192307692,982.230769230769,992.826923076923,222.471153846154,118.418269230769,586.870192307692,602.6875,368.985576923077,207.918269230769,983.793269230769,129.076923076923,208,16.6547831329559,15.9682053910135,0.284163144323943,0.962962962962963,0.8125,1.11288154803088,53643.0673076923,32621.5384615385,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_837412,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
837547,804.578571428571,1485.29285714286,352.214285714286,620.385714285714,751.728571428571,231.0,240.014285714286,246.835714285714,1082.35714285714,1633.32857142857,1087.63571428571,115.371428571429,1066.32857142857,630.335714285714,472.264285714286,262.085714285714,1381.41428571429,987.842857142857,280.635714285714,220.878571428571,975.378571428571,891.2,205.842857142857,114.707142857143,587.55,682.171428571429,384.092857142857,220.15,1022.05,129.55,140,16.1039648511727,11.1610597546875,0.720877165534414,0.939597315436242,0.729166666666667,-1.2453435452663,53852.55,32597.6785714286,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_837547,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
837601,588.867403314917,1112.35359116022,249.685082872928,619.099447513812,665.232044198895,654.237569060773,377.154696132597,268.182320441989,1131.53591160221,1299.04419889503,979.828729281768,115.187845303867,1074.20994475138,823.32044198895,568.237569060773,273.165745856354,1768.26519337017,1044.75690607735,234.580110497238,217.563535911602,998.574585635359,870.348066298343,163.303867403315,147.900552486188,1931.13259668508,790.270718232044,417.386740331492,224.580110497238,1020.80110497238,130.165745856354,181,17.2732479951594,13.3754579271469,0.632763303956232,0.957671957671958,0.760504201680672,1.22077961423513,53647.1767955801,32705.5524861878,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_837601,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
838305,1007.32738095238,127.10119047619,117.52380952381,636.857142857143,2160.77976190476,2006.77976190476,2826.90476190476,250.779761904762,1089.77976190476,2020.52976190476,642.791666666667,120.619047619048,1072.84523809524,2247.47023809524,819.904761904762,1093.05952380952,1877.625,1835.04761904762,351.440476190476,237.922619047619,1020.35119047619,1632.24404761905,264.803571428571,412.071428571429,674.238095238095,1308.73214285714,497.345238095238,320.208333333333,1009.0,128.630952380952,168,19.6041083919962,11.0588930531387,0.825698969058707,0.949152542372881,0.803827751196172,-1.50511088538987,53700.6964285714,33756.1726190476,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_838305,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
839120,495.286871961102,774.149108589951,200.286871961102,627.821717990275,849.81847649919,546.244732576985,394.012965964344,264.7471636953,1130.91410048622,1044.2755267423,1482.02755267423,111.361426256078,1064.90437601297,925.416531604538,538.291734197731,286.001620745543,1594.39059967585,1185.45380875203,226.90113452188,216.700162074554,1219.43111831442,909.62074554295,167.789303079417,135.183144246353,1459.65478119935,768.226904376013,402.706645056726,219.672609400324,1045.91896272285,131.826580226904,617,34.8273425164999,22.73762971352,0.757472385381298,0.967084639498433,0.686318131256952,0.827772275654177,52481.4311183144,32894.1296596434,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_839120,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
839143,1996.95535714286,485.455357142857,252.3125,644.866071428571,2604.02678571429,312.196428571429,295.910714285714,254.008928571429,1079.95535714286,4020.46428571429,520.928571428571,116.589285714286,1066.97321428571,1079.40178571429,543.6875,277.401785714286,1567.02678571429,2170.52678571429,323.642857142857,221.607142857143,1050.91964285714,1746.22321428571,209.553571428571,718.508928571429,648.741071428571,1694.29464285714,490.616071428571,226.955357142857,1032.70535714286,129.607142857143,112,19.1236504928273,8.38298945701042,0.898800859353606,0.794326241134752,0.622222222222222,-0.0561221937393806,54200.8214285714,33020.2589285714,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_839143,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
839205,496.55023923445,1045.62200956938,226.655502392344,625.784688995215,141.598086124402,420.334928229665,313.674641148325,254.765550239234,1119.98086124402,908.727272727273,637.468899521531,107.507177033493,1061.42583732057,588.578947368421,353.717703349282,259.894736842105,1403.54066985646,766.626794258373,167.622009569378,202.086124401914,998.856459330144,601.215311004785,133.244019138756,97.2966507177033,579.894736842105,644.684210526316,365.444976076555,204.215311004785,990.267942583732,130.234449760766,209,16.9676811794803,15.768813364734,0.369214919301695,0.954337899543379,0.768382352941177,-0.80373239646738,53925.1578947368,32255.004784689,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_839205,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
839258,1608.26153846154,1425.09230769231,196.261538461538,640.615384615385,1214.29230769231,774.446153846154,560.4,240.169230769231,1078.0,3640.24615384615,562.369230769231,112.169230769231,1071.03076923077,754.584615384615,457.353846153846,316.6,1584.16923076923,1037.66153846154,288.876923076923,222.969230769231,986.553846153846,995.138461538462,224.369230769231,169.6,579.215384615385,1063.53846153846,444.923076923077,494.953846153846,1032.30769230769,130.830769230769,65,11.4891822724518,7.54527899345534,0.754126675308246,0.866666666666667,0.738636363636364,-0.090129790989622,53398.1384615385,33631.8153846154,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_839258,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
839681,476.859237536657,758.087976539589,190.24926686217,608.076246334311,102.41348973607,572.046920821114,389.422287390029,270.428152492669,1134.88856304985,1259.46041055718,1276.84457478006,119.290322580645,1062.53958944282,817.674486803519,470.821114369502,278.706744868035,1559.36363636364,1006.41055718475,211.856304985337,213.838709677419,1324.70967741935,725.744868035191,154.856304985337,135.33137829912,584.134897360704,556.741935483871,345.733137829912,200.601173020528,987.715542521994,129.642228739003,341,23.906083060543,18.2190826681384,0.647446691962468,0.957865168539326,0.738095238095238,-0.878636310959987,52562.7214076246,32870.7829912023,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_839681,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
839756,1889.16111111111,532.538888888889,131.7,622.477777777778,591.616666666667,2252.23888888889,441.683333333333,281.288888888889,1137.75,3903.58888888889,952.227777777778,123.277777777778,1071.52222222222,1728.43333333333,1197.61666666667,368.088888888889,1542.25,4181.42222222222,315.377777777778,223.294444444444,995.033333333333,2558.76111111111,208.294444444444,198.305555555556,611.533333333333,775.288888888889,405.872222222222,222.283333333333,1026.82222222222,131.938888888889,180,20.8073789258948,12.0573380970808,0.814990623351342,0.853080568720379,0.631578947368421,-0.299641065498507,53852.7944444445,32667.6111111111,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_839756,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
840933,877.0,435.253333333333,94.1866666666667,618.093333333333,620.24,2382.62666666667,557.84,265.266666666667,1088.78666666667,2058.74666666667,710.106666666667,116.813333333333,1058.2,1339.81333333333,1178.14666666667,1716.45333333333,2095.28,3661.30666666667,357.8,250.586666666667,1018.68,6645.92,272.986666666667,558.053333333333,711.4,1411.24,605.266666666667,376.186666666667,1041.96,128.466666666667,75,11.462977184699,8.37736491696277,0.682570990077217,0.949367088607595,0.75,-0.716414327073123,53570.52,33402.7466666667,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_840933,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
841305,740.3,316.9375,62.30625,616.925,1259.71875,590.725,369.5875,265.25625,1121.31875,1763.83125,1163.475,110.70625,1060.0125,828.7375,435.11875,275.09375,1464.9875,886.88125,188.1125,205.23125,1131.78125,628.38125,135.84375,106.45,579.80625,932.26875,432.85,316.2,1030.2875,130.50625,160,17.9895488080935,11.3797191828807,0.774500001037852,0.96969696969697,0.855614973262032,1.45753843477032,53695.66875,32744.0375,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_841305,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
841455,2797.14074074074,394.6,130.437037037037,667.414814814815,2295.53333333333,295.666666666667,309.466666666667,252.318518518518,1082.99259259259,5219.12592592593,1141.9037037037,120.466666666667,1077.12592592593,694.585185185185,458.2,270.42962962963,1363.04444444444,982.674074074074,259.466666666667,220.874074074074,972.474074074074,920.466666666667,199.266666666667,122.607407407407,587.77037037037,1663.83703703704,524.437037037037,1152.34814814815,1064.48148148148,131.948148148148,135,17.1446756335888,11.0056458274927,0.766764994041155,0.808383233532934,0.529411764705882,-1.10476310980188,54066.5185185185,33168.7333333333,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_841455,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
841677,572.771863117871,569.908745247148,127.212927756654,612.380228136882,93.4714828897338,285.076045627376,276.897338403042,254.079847908745,1078.11787072243,1330.01520912548,1039.84790874525,117.228136882129,1068.44866920152,571.798479087453,409.901140684411,264.296577946768,1370.89733840304,850.882129277566,230.570342205323,214.855513307985,973.897338403042,764.171102661597,169.984790874525,112.148288973384,583.859315589354,571.0,358.007604562738,206.190114068441,986.281368821293,130.159695817491,263,21.1723170188067,15.8430161687011,0.663372650055463,0.963369963369963,0.769005847953216,0.700068253096229,53921.2243346008,32587.2927756654,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_841677,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
842574,581.400673400673,1315.30976430976,297.104377104377,621.636363636364,97.2457912457912,296.720538720539,370.0,253.501683501683,1076.9595959596,1496.9595959596,937.30303030303,121.989898989899,1060.22558922559,660.538720538721,442.521885521886,263.703703703704,1438.98653198653,1403.3771043771,296.939393939394,226.804713804714,991.619528619529,1804.38383838384,208.239057239057,167.47138047138,586.178451178451,567.989898989899,360.464646464646,205.191919191919,986.464646464646,126.451178451178,297,22.2252545521881,17.3637689809237,0.624201994142058,0.94888178913738,0.717391304347826,-0.109723333931103,53716.5521885522,32639.7003367003,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_842574,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
842629,631.080152671756,732.87786259542,173.931297709924,615.748091603053,72.6946564885496,660.217557251908,421.114503816794,282.774809160305,1144.79007633588,1517.54580152672,1634.96564885496,133.75572519084,1069.71374045802,925.339694656488,527.18320610687,280.248091603053,1560.76335877863,971.374045801527,206.969465648855,210.358778625954,1094.50763358779,607.248091603053,134.492366412214,97.3740458015267,594.904580152672,552.423664122137,332.351145038168,195.992366412214,983.213740458015,128.511450381679,262,19.2894968223299,17.4280788786574,0.428586067187513,0.956204379562044,0.808641975308642,0.801320388356052,53044.5954198473,32246.5877862595,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_842629,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
843035,737.945454545455,565.372727272727,200.118181818182,659.6,3349.18181818182,582.745454545455,398.190909090909,274.245454545454,1128.42727272727,1563.42727272727,1158.11818181818,150.8,1074.34545454545,944.472727272727,510.727272727273,282.654545454545,1581.15454545455,980.2,216.545454545455,219.018181818182,1209.72727272727,674.145454545455,146.590909090909,114.1,994.627272727273,942.909090909091,444.272727272727,222.336363636364,1058.03636363636,127.709090909091,110,13.9827511814074,10.0463730543719,0.695544221318426,0.973451327433628,0.763888888888889,0.870100696502306,52465.2363636364,32503.3272727273,FAAGSCC_12,AG,1,CD4+ T cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,CD4+ T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,6,FAAGSCC_12_843035,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
843452,2538.44,331.613333333333,106.213333333333,649.253333333333,2096.42666666667,323.44,415.48,239.613333333333,1073.90666666667,4177.96,873.853333333333,120.813333333333,1078.89333333333,797.413333333333,939.133333333333,292.893333333333,1734.96,1226.34666666667,292.573333333333,226.613333333333,997.2,1031.73333333333,205.946666666667,236.186666666667,820.933333333333,1115.54666666667,468.2,339.106666666667,1046.48,133.84,75,11.851601735298,8.2211855509675,0.72028604311589,0.949367088607595,0.681818181818182,0.841528525081781,53087.1733333333,33555.56,FAAGSCC_12,AG,1,stromal cells,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,stromal cells,Stromal,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_843452,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
843735,772.483050847458,152.016949152542,92.0847457627119,651.0,2845.30508474576,616.957627118644,382.177966101695,251.966101694915,1189.20338983051,1887.33898305085,1291.21186440678,114.813559322034,1053.86440677966,718.864406779661,440.06779661017,274.008474576271,1434.99152542373,1150.71186440678,267.813559322034,224.737288135593,991.084745762712,1052.72881355932,208.110169491525,141.067796610169,578.338983050847,1210.71186440678,472.254237288136,307.78813559322,1036.18644067797,131.550847457627,118,13.2351346218055,11.3479537793595,0.51463179930525,0.951612903225806,0.756410256410256,-1.39748159593054,53064.0508474576,33355.186440678,FAAGSCC_12,AG,1,M2 macrophages,,TIM3-,PD-L1-,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,M2 macrophages,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_843735,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
844236,1751.29285714286,439.907142857143,1482.62857142857,668.264285714286,3199.58571428571,662.792857142857,818.207142857143,234.135714285714,1065.24285714286,2870.5,622.635714285714,119.185714285714,1081.97142857143,2345.03571428571,659.028571428571,1099.98571428571,1721.63571428571,3065.42142857143,279.942857142857,228.2,1045.58571428571,3063.94285714286,221.314285714286,313.007142857143,673.692857142857,1104.97142857143,506.657142857143,429.128571428571,1055.65714285714,131.442857142857,140,15.5640163647955,11.8601616942057,0.647548199457726,0.915032679738562,0.673076923076923,0.436116126981505,53022.3,33539.9928571429,FAAGSCC_12,AG,1,regulatory T cells,,TIM3-,PD-L1+,PD-1-,p-S6-,Ki67-,FAAGSCC_12,gH2AX-,regulatory T cells,Immune,FA,Human 2024,Anogenital,No,2011,Vulva,Stage 0,24.0,FANCG,very seldom,female,No,HPV positive,na,10,FAAGSCC_12_844236,,,stroma_ad_carcinoma_in_situ_FAAGSCC_12_10,
